Citrus Sinensis ID: 005825
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 675 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S972 | 847 | Receptor-like serine/thre | yes | no | 0.942 | 0.750 | 0.431 | 1e-143 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.949 | 0.769 | 0.414 | 1e-142 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.952 | 0.756 | 0.420 | 1e-142 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.903 | 0.779 | 0.419 | 1e-141 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.96 | 0.763 | 0.413 | 1e-138 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.952 | 0.762 | 0.418 | 1e-137 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.945 | 0.755 | 0.419 | 1e-136 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.970 | 0.764 | 0.406 | 1e-132 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.974 | 0.781 | 0.401 | 1e-130 | |
| Q9SXB5 | 820 | G-type lectin S-receptor- | no | no | 0.946 | 0.779 | 0.395 | 1e-129 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 509 bits (1312), Expect = e-143, Method: Compositional matrix adjust.
Identities = 289/670 (43%), Positives = 405/670 (60%), Gaps = 34/670 (5%)
Query: 28 TVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVP-DTVVWVANRDRPISD 86
+ T + I + ++S SQ FELGFF+P S YLGIW++ +P T VWVANRD P+S
Sbjct: 31 SATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90
Query: 87 HNAVLTISNNGKLVLLNQTNGTIWSTNASS-EAKNPVA-QLRDDGNLVIRDNSSVNTTEN 144
N L IS+N LV+ +Q++ +WSTN + + ++PVA +L D GN V+RD S N
Sbjct: 91 SNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD-SKNNKPSG 148
Query: 145 YLWQSFDYPTDTLLQDMKMGWDLKNRR-ERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCT 203
+LWQSFD+PTDTLL DMKMGWD K+ R L SW++ DDPS G F+ +L P+
Sbjct: 149 FLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYI 208
Query: 204 FNGSVKYTCTGEWTGDGF--VSALSNTNFLYKQFLVENQDEISYWYEPYNRPSIMT-LKL 260
+N +G W G+ F V + +++ F EN ++ Y Y N+ +I + L L
Sbjct: 209 YNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSF-TENNQQVVYSYR-VNKTNIYSILSL 266
Query: 261 SPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPMCQCLEGFRLKSQ 320
S +G + R W E + W +L+ P D C Y CG C + P+C C++GF ++
Sbjct: 267 SSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMNE 326
Query: 321 FN--QTGPIKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLKNCTC 378
+ + C R C D F++L ++ PD E S+++ + L++C CLK C C
Sbjct: 327 QAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNC 386
Query: 379 KAYANSNVTEG-SGCLMWFGELLDASRPIRNFT--GQSVYLRQPASGPGNKKLLWIIVI- 434
A+AN+++ G SGC++W G L D IRN+ GQ +Y+R A +K++ +I
Sbjct: 387 TAFANTDIRNGGSGCVIWSGGLFD----IRNYAKGGQDLYVRVAAGDLEDKRIKSKKIIG 442
Query: 435 --VVPPMVLLPSVYIFCRQRRKCKEKENMET-------SQDLLAFDITTRPNEFSEANGD 485
+ ++LL S IF +RK K ++T SQD L ++ ++
Sbjct: 443 SSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTS---- 498
Query: 486 RRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSG 545
+ +K+ LPL ++A AT NFS + KLG+GGFG VYKG LL+G+E+AVKRLS S
Sbjct: 499 KENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSS 558
Query: 546 QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLG 605
QG +EF NE+ LIAKLQH NLVR+LGCC+++GEK+LI EY+ N SLD LFD T+ L
Sbjct: 559 QGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLN 618
Query: 606 WQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665
WQ R II GIA+GLLYLH SR RIIHRDLKASNVLLD++M PKISDFG+AR+FG +E
Sbjct: 619 WQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREET 678
Query: 666 QGNTKRIVGT 675
+ NT+R+VGT
Sbjct: 679 EANTRRVVGT 688
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 507 bits (1306), Expect = e-142, Method: Compositional matrix adjust.
Identities = 280/675 (41%), Positives = 401/675 (59%), Gaps = 34/675 (5%)
Query: 24 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPD-TVVWVANRDR 82
++ DT+ +RDGE ++S+ +RF GFFS G S+ RY+GIW+ ++ T+VWVANRD
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 83 PISDHNAVLTISNNGKLVLLNQTNGT--IWSTNASSEAKNP--VAQLRDDGNLVIRDNSS 138
PI+D + ++ SN G L + N T IWSTN S P VA L D GNLV+ D
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDP-- 134
Query: 139 VNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHVL 198
T W+SFD+PTDT L M++G+ K+ +R L+SW+S DP G R++
Sbjct: 135 --VTGRSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192
Query: 199 PKMCTFNGSVKYTCTGEWTGDGFVSALSN-TNFLYKQFLVENQDEISYWYEPYNRPSIMT 257
P++ + G + G WTG + +++ V N+DE+S+ Y + I
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252
Query: 258 LKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTIC-GPDQKPM-CQCLEGF 315
++ +G + R W W++ +S+P + C Y +CG N C P K C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312
Query: 316 RLK---SQFNQTGPIKC-ERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAE 371
K F + C ++ +S C + D F+KL +K PD + S++ ++ L++C
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQR 372
Query: 372 CLKNCTCKAYANS--NVTEGS-GCLMWFGELLDASRPIRNFTGQSVYLRQPA-------- 420
CLKNC+C AYA++ G+ GCL W G +LDA + +GQ Y+R
Sbjct: 373 CLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLN--SGQDFYIRVDKEELARWNR 430
Query: 421 SGPGNKKLLWIIVIVVPPMVLLPSVYIFCRQRRKCKEKENMETSQDLLAFDITTRPNEFS 480
+G K+ + +I+I + V+L +V +FC R + K + +S + P +F
Sbjct: 431 NGLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPV-----PFDFD 485
Query: 481 EANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRL 540
E+ +DK+++ LPLF L ++ AAT NFS + KLG GGFGPVYKG L N E+AVKRL
Sbjct: 486 ESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRL 545
Query: 541 SSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTK 600
S SGQG+EEFKNE+ LI+KLQHRNLVRILGCC+E EK+L+ EY+PNKSLD F+F +
Sbjct: 546 SRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQ 605
Query: 601 KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
+ L W R+ I+ GIA+G+LYLH SR RIIHRDLKASN+LLD +M PKISDFG+AR+F
Sbjct: 606 RAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIF 665
Query: 661 GGDELQGNTKRIVGT 675
GG++++G T R+VGT
Sbjct: 666 GGNQMEGCTSRVVGT 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 506 bits (1304), Expect = e-142, Method: Compositional matrix adjust.
Identities = 284/676 (42%), Positives = 406/676 (60%), Gaps = 33/676 (4%)
Query: 23 SLAADTVTPAS--FIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPD-TVVWVAN 79
S++A+T++ + I +VS FELGFF PG YLGIW++ + T VWVAN
Sbjct: 26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85
Query: 80 RDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASS-EAKNP-VAQLRDDGNLVIRDNS 137
RD P+S L IS++ LV+L+Q++ +WSTN + + ++P VA+L D+GN V+RD S
Sbjct: 86 RDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-S 143
Query: 138 SVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHV 197
+ + LWQSFD+PTDTLL +MK+GWD K R++ SW+S DDPS G F+ +L+
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203
Query: 198 LPKMCTFNGSVKYTCTGEWTGDGFVSALSNTNFLYKQF-LVENQDEISYWYEPYNRPSIM 256
P++ +N + +G W G F F Y F +++E++Y +
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYS 263
Query: 257 TLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPMCQCLEGFR 316
L +S SG + R W E + W++ + P D C +Y CG C + P+C C++GF+
Sbjct: 264 RLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFK 323
Query: 317 LKSQFN---QTGPIKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECL 373
++ + G C R C GD F++L +K PD S+++ + +++C +CL
Sbjct: 324 PRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCL 383
Query: 374 KNCTCKAYANSNVT-EGSGCLMWFGELLDASRPIRNFT--GQSVYLRQPASGPGNKKLLW 430
++C C A+AN+++ GSGC+ W GEL D IRN+ GQ +Y+R A+ +K+
Sbjct: 384 RDCNCTAFANTDIRGSGSGCVTWTGELFD----IRNYAKGGQDLYVRLAATDLEDKRNRS 439
Query: 431 IIVI---VVPPMVLLPSVYIFCRQRRKCKEKENMET--------SQDLLAFDITTRPNEF 479
+I + ++LL S IF +RK K +ET S+DLL ++
Sbjct: 440 AKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVIS---- 495
Query: 480 SEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKR 539
S + R + + D LPL VA AT NFS KLG+GGFG VYKG+LL+G+E+AVKR
Sbjct: 496 SRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKR 555
Query: 540 LSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPT 599
LS S QG +EFKNE+ LIA+LQH NLVR+L CC++ GEK+LI EY+ N SLD LFD +
Sbjct: 556 LSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKS 615
Query: 600 KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659
+ L WQ R II GIA+GLLYLH SRFRIIHRDLKASN+LLD+ M PKISDFG+AR+
Sbjct: 616 RNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARI 675
Query: 660 FGGDELQGNTKRIVGT 675
FG DE + NT+++VGT
Sbjct: 676 FGRDETEANTRKVVGT 691
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 504 bits (1297), Expect = e-141, Method: Compositional matrix adjust.
Identities = 285/679 (41%), Positives = 398/679 (58%), Gaps = 69/679 (10%)
Query: 10 HLLSLIFFLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRK 69
HLL + F ++ ++ A D + ++DG+ +VS FE+GFFSPG S++RYLGIW++K
Sbjct: 8 HLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKK 67
Query: 70 VP-DTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNA-----SSEAKNPVA 123
+ TVVWVANRD P+ D + L +S NG L L N N IWS+++ + +NP+
Sbjct: 68 ISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIV 127
Query: 124 QLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDD 183
Q+ D GNLV+R++ ++Y+WQS DYP D L MK G + R+L+SWR+ DD
Sbjct: 128 QILDTGNLVVRNSGD---DQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDD 184
Query: 184 PSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGEWTGDGFVSALS-NTNFLYKQFLVENQDE 242
PS G +TN++D + +P+ SV TG W G F + N +Y+ V ++E
Sbjct: 185 PSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEE 244
Query: 243 ISYWYEPYNRPSIMT-LKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTIC 301
+ Y Y+ N PS++T ++L+P+G + R W ++ W+ S D C +Y CG+ C
Sbjct: 245 VYYTYKLEN-PSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSC 303
Query: 302 GPDQKPMCQCLEGFRLKS-QFNQTGPIK--CERSHSSECIKG-DQFIKLDNIKAPDFIEV 357
++ P C+CL+GF K+ Q G C R +C KG D F+K+ +K PD
Sbjct: 304 NINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTS 363
Query: 358 SLNQSMNLQQCAAECLKNCTCKAYANSNVTEGS-GCLMWFGELLDASRPIRNFTGQSVYL 416
+++M+L +C CL+NCTC AY+ ++ +G GC++WFG+L+D N GQ +Y+
Sbjct: 364 WYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE--YNENGQDLYV 421
Query: 417 RQPASGPGNKKLLWIIVIVVPPMVLLPSVYIFCRQRRKCKEKENMETSQDLLAFDITTRP 476
R +S +I T
Sbjct: 422 RLASS-------------------------------------------------EIETLQ 432
Query: 477 NEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVA 536
E S + R+ + +D LP L +V+ AT FS KLG+GGFGPVYKG L G+EVA
Sbjct: 433 RESSRVSS-RKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVA 491
Query: 537 VKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLF 596
VKRLS S QG+EEFKNE+ LIAKLQHRNLV+ILG C+++ E++LI EY PNKSLD F+F
Sbjct: 492 VKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIF 551
Query: 597 DPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656
D ++R L W R+ II+GIA+G+LYLH SR RIIHRDLKASNVLLD DMN KISDFGL
Sbjct: 552 DKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGL 611
Query: 657 ARMFGGDELQGNTKRIVGT 675
AR GGDE + NT R+VGT
Sbjct: 612 ARTLGGDETEANTTRVVGT 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 493 bits (1268), Expect = e-138, Method: Compositional matrix adjust.
Identities = 291/703 (41%), Positives = 414/703 (58%), Gaps = 55/703 (7%)
Query: 10 HLLSLIFFLSMKVSLAADTVTPASFIRDG---EKLVSSSQRFELGFFSPGKSKSRYLGIW 66
+L ++F + S+AA+T+ +RDG + LVS + FELGFFSPG S R+LGIW
Sbjct: 10 YLSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIW 69
Query: 67 FRKVPD-TVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEA---KNPV 122
+ + D VVWVANR PISD + VL ISN+G LVLL+ N T+WS+N S N V
Sbjct: 70 YGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRV 129
Query: 123 AQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDD 182
+ D GN V+ + T+ +W+SF++PTDT L M++ + + SWRS+
Sbjct: 130 VSIHDTGNFVLSETD----TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSET 185
Query: 183 DPSPGKFTNRLDIHVLPKMCTFNGS-VKYTCTGEWTGDGFVSALSN----TNFLYKQFLV 237
DPSPG ++ +D P++ + G+ + +G+W F + + N TN+LY L
Sbjct: 186 DPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIF-TGIPNMSLLTNYLYGFKLS 244
Query: 238 ENQDE---ISYWYEPYNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGY 294
DE + + Y P + ++ K+ +G WNE +W + S PD C +Y
Sbjct: 245 SPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNR 304
Query: 295 CGANTICG-PDQKPMCQCLEGFRLKSQFN------QTGPIKCERSHSSECIKGDQFIKLD 347
CG IC +C C+ G+ S N + P+KCER+ S + D+F+ L
Sbjct: 305 CGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNIS---VGEDEFLTLK 361
Query: 348 NIKAPDFIEVSLNQSMNLQQCAAECLKNCTCKAYANSNVTEGSGCLMWFGELLDASRPIR 407
++K PDF E+ + ++ + C CL+NC+C AY+ + G GC++W +L+D ++
Sbjct: 362 SVKLPDF-EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVD----LQ 413
Query: 408 NFT--GQSVYLRQPASGPG-NKKLLWIIVIVVPPMVLLPSVYIFCRQRRKCKEK------ 458
F G S+++R S G N+K +++ V V+L ++ R K K+
Sbjct: 414 QFEAGGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYC 473
Query: 459 -ENMETSQDLLAFDITTRPNEFSEANGD-----RRDKSKDSWLPLFSLASVAAATENFSM 512
+N +TS ++ D+T S +G S LP+FSL ++A AT +F
Sbjct: 474 GKNTDTS--VVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCK 531
Query: 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGC 572
E +LG GGFGPVYKG L +G E+AVKRLS +SGQG++EFKNE++LIAKLQHRNLVR+LGC
Sbjct: 532 ENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGC 591
Query: 573 CIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRII 632
C E EK+L+ EYMPNKSLD FLFD TK+ L+ W+ R IIEGIA+GLLYLH SR RII
Sbjct: 592 CFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRII 651
Query: 633 HRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
HRDLK SNVLLD +MNPKISDFG+AR+FGG++ + NT R+VGT
Sbjct: 652 HRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGT 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 489 bits (1259), Expect = e-137, Method: Compositional matrix adjust.
Identities = 283/677 (41%), Positives = 402/677 (59%), Gaps = 34/677 (5%)
Query: 19 SMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVP-DTVVWV 77
+ VS + T + I + ++S SQ FELGFF+P S YLGIW++ +P T VWV
Sbjct: 22 AFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWV 81
Query: 78 ANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASS-EAKNPVA-QLRDDGNLVIRD 135
ANRD P+S N L IS N LV+ +Q++ +WSTN + + ++PVA +L D+GN ++RD
Sbjct: 82 ANRDNPLSSSNGTLKISGNN-LVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD 140
Query: 136 NSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDI 195
+++ LWQSFD+PTDTLL +MK+GWD K R L SW++ DDPS G+F+ +L+
Sbjct: 141 SNN-----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLET 195
Query: 196 HVLPKMCTFNGSVKYTCTGEWTGDGFVSALSNTNFLYKQF-LVENQDEISYWYEPYNRPS 254
P+ + +G W G F S Y + +++E++Y Y
Sbjct: 196 SEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNL 255
Query: 255 IMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPMCQCLEG 314
L L+ +G + R W E + W +L+ P D C Y CG C + P C C++G
Sbjct: 256 YSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKG 315
Query: 315 FRLKSQFN---QTGPIKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAE 371
F+ ++ + G C R C D F +L +K PD +++ + L+ C
Sbjct: 316 FKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKER 375
Query: 372 CLKNCTCKAYANSNVTEG-SGCLMWFGELLDASRPIRNFT--GQSVYLRQPASGPGNKKL 428
CL++C C A+AN+++ G SGC++W E+LD +RN+ GQ +Y+R A+ +K++
Sbjct: 376 CLEDCNCTAFANADIRNGGSGCVIWTREILD----MRNYAKGGQDLYVRLAAAELEDKRI 431
Query: 429 LWIIVI---VVPPMVLLPSVYIFCRQRRKCKEKENMET-------SQDLLAFDITTRPNE 478
+I + ++LL S IF +RK K ++T SQD L D+
Sbjct: 432 KNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRG 491
Query: 479 FSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVK 538
++ + KS+ LPL L ++A AT NFS + KLG+GGFG VYKGRLL+G+E+AVK
Sbjct: 492 YTS----KEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVK 547
Query: 539 RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDP 598
RLS S QG +EF NE+ LIAKLQH NLVR+LGCC+++GEK+LI EY+ N SLD LFD
Sbjct: 548 RLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQ 607
Query: 599 TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
T+ L WQ R II GIA+GLLYLH SR RIIHRDLKASNVLLD++M PKISDFG+AR
Sbjct: 608 TRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMAR 667
Query: 659 MFGGDELQGNTKRIVGT 675
+FG +E + NT+R+VGT
Sbjct: 668 IFGREETEANTRRVVGT 684
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 485 bits (1249), Expect = e-136, Method: Compositional matrix adjust.
Identities = 284/677 (41%), Positives = 401/677 (59%), Gaps = 39/677 (5%)
Query: 27 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPD-TVVWVANRDRPIS 85
+T+ + ++DG+ + S +RF GFFS G SK RY+GIW+ +V + T+VWVANRD PI+
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 86 DHNAVLTISNNGKLVLLNQTNGT--IWSTNASSEAKNP--VAQLRDDGNLVIRDNSSVNT 141
D + ++ S G L + NGT IWST+ + P VA+L D GNLV+ D
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDP----V 138
Query: 142 TENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKM 201
T W+SF++PT+TLL MK G+ ++ +R ++SWRS DP G T R++ P+M
Sbjct: 139 TGKSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQM 198
Query: 202 CTFNGSVKYTCTGEWTGDGFVSALSNTN-FLYKQFLVENQDEISYWYEPYNRPSIMTLKL 260
+ G + TG WTG + TN F++ V N DE+S Y + + L
Sbjct: 199 MMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVL 258
Query: 261 SPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPD--QKPMCQCLEGFRLK 318
+ +G + R WN +W +S P+D C Y +CG N C +K C CL G+ K
Sbjct: 259 NETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPK 318
Query: 319 SQ---FNQTGPIKCERSHSSECIKGDQ-FIKLDNIKAPDFIEVSLNQSMNLQQCAAECLK 374
+ F + C R + G + F KL +K P+ V+++ ++ L++C CLK
Sbjct: 319 TPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLK 378
Query: 375 NCTCKAYANS---NVTEGSGCLMWFGELLDASRPIRNFTGQSVYLRQPAS---------G 422
NC+C AYA++ + GCL W G +LD + +GQ YLR S
Sbjct: 379 NCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLS--SGQDFYLRVDKSELARWNGNGA 436
Query: 423 PGNKKLLWIIV-IVVPPMVLLPSVYIFCRQRRKCKEKENMETSQDLLA---FDITTRPNE 478
G K+L+ I++ ++ M+LL S + + R+RR+ + + + A FD+ E
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDL-----E 491
Query: 479 FSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVK 538
S + DKS+ LPLF L+++A AT NF+ + KLG GGFGPVYKG L NG E+AVK
Sbjct: 492 DSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVK 551
Query: 539 RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDP 598
RLS SGQG+EEFKNE+ LI+KLQHRNLVRILGCC+E EK+L+ EY+PNKSLD F+F
Sbjct: 552 RLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHE 611
Query: 599 TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
++ L W R+GII GI +G+LYLH SR RIIHRDLKASNVLLD +M PKI+DFGLAR
Sbjct: 612 EQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLAR 671
Query: 659 MFGGDELQGNTKRIVGT 675
+FGG++++G+T R+VGT
Sbjct: 672 IFGGNQIEGSTNRVVGT 688
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 472 bits (1214), Expect = e-132, Method: Compositional matrix adjust.
Identities = 283/696 (40%), Positives = 409/696 (58%), Gaps = 41/696 (5%)
Query: 5 SSMLQHLLSLIFFLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSR-YL 63
S +L ++ ++ ++ + + + T + I + LVS FE+GFF ++ SR YL
Sbjct: 14 SFLLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF---RTNSRWYL 70
Query: 64 GIWFRKVPD-TVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNAS--SEAKN 120
G+W++KV D T VWVANRD P+S+ L IS N LVLL+ +N +W TN + +E
Sbjct: 71 GMWYKKVSDRTYVWVANRDNPLSNAIGTLKISGNN-LVLLDHSNKPVWWTNLTRGNERSP 129
Query: 121 PVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRS 180
VA+L +GN V+RD+S+ + +E YLWQSFDYPTDTLL +MK+G++LK R+L+SWRS
Sbjct: 130 VVAELLANGNFVMRDSSNNDASE-YLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRS 188
Query: 181 DDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGEWTGDGFVSALSNTNFLYKQF-LVEN 239
DDPS G F+ +L+ LP+ + +G W G F + Y + +EN
Sbjct: 189 SDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIEN 248
Query: 240 QDEISYWYEPYNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIP-DDYCGKYGYCGAN 298
+E++Y + N L L G+ R W W+ +S P D C Y CG
Sbjct: 249 NEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPY 308
Query: 299 TICGPDQKPMCQCLEGF--RLKSQFNQ-TGPIKCERSHSSECIKGDQFIKLDNIKAPDFI 355
C + P+C C++GF R Q++Q C R C GD F ++ +K P+
Sbjct: 309 AYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSC-SGDGFTRMKKMKLPETT 367
Query: 356 EVSLNQSMNLQQCAAECLKNCTCKAYANSNVTEG-SGCLMWFGELLDASRPIRNFT---- 410
++++S+ +++C C+ +C C A+AN+++ G SGC++W L D IRN+
Sbjct: 368 MATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLED----IRNYATDAI 423
Query: 411 -GQSVYLRQPASGPGNKKLLW--IIVIVVPPMVLLPSVYIFCRQRRKCKEKE-------N 460
GQ +Y+R A+ K+ II + V VLL + +FC +RK K + N
Sbjct: 424 DGQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLI-MFCLWKRKQKRAKASAISIAN 482
Query: 461 METSQDLLAFD-ITTRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEG 519
+ +Q+L + + + EFS G+ + + + LPL + +V ATENFS KLG+G
Sbjct: 483 TQRNQNLPMNEMVLSSKREFS---GEYKFEELE--LPLIEMETVVKATENFSSCNKLGQG 537
Query: 520 GFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579
GFG VYKGRLL+G+E+AVKRLS S QG +EF NE+ LIA+LQH NLV++LGCCIE EK
Sbjct: 538 GFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEK 597
Query: 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKAS 639
+LI EY+ N SLD +LF T++ L W R I G+A+GLLYLH SRFRIIHRDLK S
Sbjct: 598 MLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVS 657
Query: 640 NVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
N+LLD++M PKISDFG+AR+F DE + NT ++VGT
Sbjct: 658 NILLDKNMIPKISDFGMARIFERDETEANTMKVVGT 693
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 465 bits (1196), Expect = e-130, Method: Compositional matrix adjust.
Identities = 284/707 (40%), Positives = 402/707 (56%), Gaps = 49/707 (6%)
Query: 1 MNGYSSMLQHLLSLIFF--LSMKVSLA-ADTVTPASFIRDGEKLVSSSQRFELGFFSPGK 57
M G++ L + +L+ F L VS + +++ T IR+G+ L+S + FELGFF+P
Sbjct: 1 MAGFNRNLTLVTTLLIFHQLCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKN 60
Query: 58 SKSRYLGIWFRKV-PDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASS 116
S RY+GIW++ + P TVVWVANR++P+ DH L I+++G LV++N N TIWSTN
Sbjct: 61 STLRYVGIWYKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEP 120
Query: 117 EAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLS 176
E+ N VA L G+LV+ +S + W+SF+ PTDT L M++ + R
Sbjct: 121 ESNNTVAVLFKTGDLVLCSDSD---RRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFI 177
Query: 177 SWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGEWTG---DGFVSALSNTNFLYK 233
W+S+ DPSPGK++ +D ++ + G + +G W G L TN++Y
Sbjct: 178 PWKSESDPSPGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYG 237
Query: 234 QFLVENQDE---ISYWYEPYNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCG 290
L D + + Y + + + P G + WN+D W+ L P C
Sbjct: 238 FKLSSPPDRDGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECE 297
Query: 291 KYGYCGANTICGPDQK---PMCQCLEGFR--LKSQFNQTG---------PIKCERSHSSE 336
KY CG ++C ++ C C++GF + Q+N P+ C +S +
Sbjct: 298 KYNRCGNYSVCDDSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAG 357
Query: 337 CIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLKNCTCKAYANSNVTEGSGCLMWF 396
+ D F L IK PDF V L+ N + C C ++C+CKAYA + G GC++W
Sbjct: 358 --QEDGFTVLKGIKVPDFGSVVLHN--NSETCKDVCARDCSCKAYA---LVVGIGCMIWT 410
Query: 397 GELLDASRPIRNFTGQSVYLRQPASGPGNKK---LLWIIVI-VVPPMVLLPSVYIFCRQR 452
+L+D R G S+ +R S G K LWIIV V+ +L ++I + +
Sbjct: 411 RDLIDMEHFERG--GNSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFK 468
Query: 453 RKCK----EKENMETSQDLLAFDITTRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATE 508
+ K +K+++ S + D ++ P GD+ D LP+FS SVA+AT
Sbjct: 469 KSLKAFLWKKKDITVSDIIENRDYSSSP--IKVLVGDQVDTPD---LPIFSFDSVASATG 523
Query: 509 NFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVR 568
+F+ E KLG+GGFG VYKG G E+AVKRLS +S QGLEEFKNE+LLIAKLQHRNLVR
Sbjct: 524 DFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVR 583
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSR 628
+LGCCIE EK+L+ EYMPNKSLD FLFD +K+ L W+ R +I GIA+GLLYLH SR
Sbjct: 584 LLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSR 643
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+IIHRDLKASN+LLD +MNPKISDFG+AR+F + NT R+VGT
Sbjct: 644 LKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGT 690
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 463 bits (1192), Expect = e-129, Method: Compositional matrix adjust.
Identities = 276/698 (39%), Positives = 399/698 (57%), Gaps = 59/698 (8%)
Query: 6 SMLQHLLSL-IFFLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLG 64
S + H+LSL FFLS VSLA + + + D E +VSS + F GFFSP S +RY G
Sbjct: 8 SPIVHVLSLSCFFLS--VSLAHERALFSGTLNDSETIVSSFRTFRFGFFSPVNSTNRYAG 65
Query: 65 IWFRKVP-DTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAK--NP 121
IW+ +P TV+WVAN+D PI+D + V++IS +G LV+ + +WSTN S+ A +
Sbjct: 66 IWYNSIPVQTVIWVANKDTPINDSSGVISISEDGNLVVTDGQRRVLWSTNVSTRASANST 125
Query: 122 VAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERY-LSSWRS 180
VA+L + GNLV++D + T+ YLW+SF YPTD+ L +M +G + + ++SW +
Sbjct: 126 VAELLESGNLVLKDAN----TDAYLWESFKYPTDSWLPNMLVGTNARTGGGNITITSWTN 181
Query: 181 DDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTC---TGEWTGDGF--VSALSNTNFLYKQF 235
DPSPG +T L + P++ FN + +G W G F + + FLY+ F
Sbjct: 182 PSDPSPGSYTAALVLAPYPELFIFNNNDNNATVWRSGPWNGLMFNGLPDVYPGLFLYR-F 240
Query: 236 LVENQDEISYWYEPYNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYC 295
V + S N ++ L L GF R+ W+E W +P C Y C
Sbjct: 241 KVNDDTNGSATMSYANDSTLRHLYLDYRGFAIRRDWSEARRNWTLGSQVPATECDIYSRC 300
Query: 296 GANTICGPDQKPMCQCLEGFRLKSQF-----NQTG------PIKCERSHSSECIKGDQFI 344
G T C P + P C C++GFR ++ N +G P++CER ++ D+F+
Sbjct: 301 GQYTTCNPRKNPHCSCIKGFRPRNLIEWNNGNWSGGCIRKLPLQCERQNNKG--SADRFL 358
Query: 345 KLDNIKAPDFIEVSLNQSMNLQQCAAECLKNCTCKAYANSNVTEGSGCLMWFGELLDASR 404
KL +K PDF S + +C CL++C+C A+A+ G GC++W L+D+
Sbjct: 359 KLQRMKMPDFARRS---EASEPECFMTCLQSCSCIAFAHG---LGYGCMIWNRSLVDSQV 412
Query: 405 PIRNFTGQSVYLRQPASGPGNKKLLWI-------IVIVVPPMVLLPSVYIFCRQRRKCKE 457
+ S+ L +++ + I I +V ++L + + R ++K +
Sbjct: 413 LSASGMDLSIRLAHSEFKTQDRRPILIGTSLAGGIFVVATCVLLARRIVMKKRAKKKGTD 472
Query: 458 KENMETSQDLLAFDITTRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLG 517
E + + LA G R+K K+ LPLF +A AT+NFS+ KLG
Sbjct: 473 AEQIFKRVEALA--------------GGSREKLKE--LPLFEFQVLATATDNFSLSNKLG 516
Query: 518 EGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG 577
+GGFGPVYKG LL G+E+AVKRLS SGQGLEE E+++I+KLQHRNLV++ GCCI
Sbjct: 517 QGGFGPVYKGMLLEGQEIAVKRLSQASGQGLEELVTEVVVISKLQHRNLVKLFGCCIAGE 576
Query: 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLK 637
E++L+ E+MP KSLD ++FDP + +LL W R II GI +GLLYLH SR RIIHRDLK
Sbjct: 577 ERMLVYEFMPKKSLDFYIFDPREAKLLDWNTRFEIINGICRGLLYLHRDSRLRIIHRDLK 636
Query: 638 ASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
ASN+LLD ++ PKISDFGLAR+F G+E + NT+R+VGT
Sbjct: 637 ASNILLDENLIPKISDFGLARIFPGNEDEANTRRVVGT 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 675 | ||||||
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.930 | 0.783 | 0.483 | 1e-173 | |
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.921 | 0.575 | 0.481 | 1e-166 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.964 | 0.783 | 0.466 | 1e-165 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.946 | 0.764 | 0.470 | 1e-163 | |
| 359493723 | 867 | PREDICTED: G-type lectin S-receptor-like | 0.952 | 0.741 | 0.467 | 1e-162 | |
| 147816068 | 819 | hypothetical protein VITISV_030742 [Viti | 0.952 | 0.785 | 0.467 | 1e-162 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.927 | 0.763 | 0.475 | 1e-161 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.934 | 0.777 | 0.451 | 1e-160 | |
| 224115136 | 843 | predicted protein [Populus trichocarpa] | 0.96 | 0.768 | 0.463 | 1e-159 | |
| 224076591 | 834 | predicted protein [Populus trichocarpa] | 0.952 | 0.770 | 0.457 | 1e-159 |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1582), Expect = e-173, Method: Compositional matrix adjust.
Identities = 328/679 (48%), Positives = 430/679 (63%), Gaps = 51/679 (7%)
Query: 11 LLSLIFFLSMK-VSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRK 69
S +F S+ +S +AD +TP ++DG+ L+S SQ FELGFFSPG SK RY+GIW++K
Sbjct: 9 FFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKYRYVGIWYKK 68
Query: 70 VPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDG 129
P+TVVWVANR+ P++DH VLTI N G LVLL+Q IWS+N+SS PVAQL D G
Sbjct: 69 SPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAGPVAQLLDSG 128
Query: 130 NLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKF 189
NLV+RDN S TE+Y WQSFD P+DTLL MK+GW+LK +ERYL +WRS DPSPG F
Sbjct: 129 NLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRSISDPSPGDF 188
Query: 190 TNRLDIHVLPKMCTFNGSVKYTCTGEWTGDGFVSALSNTNFLYKQFLVENQDEISYWYEP 249
T RLDIH LP++ GSVK +G W G F N +++ LV N+DEI Y Y
Sbjct: 189 TYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNEDEIYYTYRL 248
Query: 250 YNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPMC 309
N L L+ SG V R + ++ W ++S+P D C YG CGAN IC P+C
Sbjct: 249 LNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGICRTRTSPIC 308
Query: 310 QCLEGFR------LKSQFNQTGPIKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSM 363
+CL+GF+ L Q N G KCE + +C G+ F+KL +K PD +E LN+SM
Sbjct: 309 ECLKGFKSIPEEELDIQ-NFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDLLEFRLNESM 367
Query: 364 NLQQCAAECLKNCTCKAYANSNVT---EGSGCLMWFGELLDASRPIRNFTGQSVYLRQPA 420
NL++C AEC KNC+C A+A +N++ +GSGCLMWFG L+D + GQ +++R PA
Sbjct: 368 NLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIGQDIHIRVPA 427
Query: 421 S----GPGNKKLLWIIVIVVPPMVLLPSVYIFCRQRRKCKEKENMETSQDLLAFDITTRP 476
S +K+ + +V M L +++ RR KE ME
Sbjct: 428 SELEMARSSKRKKMLKTALVASMSALLGIFVSGMDRR----KEGMEA------------- 470
Query: 477 NEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVA 536
PLF L ++A AT NF+ + +G GGFG VYKG+LL G+E+A
Sbjct: 471 -------------------PLFDLDTIATATNNFAPDSIIGAGGFGSVYKGKLLTGQEIA 511
Query: 537 VKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLF 596
VK+LS SGQG+EEF+NE++LIAKLQHRNLV +LG CI + E++LI EYMPNKSLD F+F
Sbjct: 512 VKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLIYEYMPNKSLDYFIF 571
Query: 597 DPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656
D + LLGW+ R II GIA+GLLYLH S+ +I+HRDLK SNVLLD ++ PKISDFGL
Sbjct: 572 DHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVLLDSNLIPKISDFGL 631
Query: 657 ARMFGGDELQGNTKRIVGT 675
AR+ G D + T+R++GT
Sbjct: 632 ARISGDDGKETKTRRVIGT 650
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1526), Expect = e-166, Method: Compositional matrix adjust.
Identities = 318/661 (48%), Positives = 409/661 (61%), Gaps = 39/661 (5%)
Query: 26 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPIS 85
AD++ I D E LVSS Q FELGFFSPG SK+RYLGIW++ P T VWVANR+ PI+
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 86 DHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENY 145
D VLTI NNG LVLLNQ+ IWS N S +NPVAQL + GNLV+RD S+ T+++Y
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDGSN-ETSKSY 414
Query: 146 LWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFN 205
+WQSFD P+DT+L MK+GW+LK +R L+SW+S DDPS G F+ DI+VLP +
Sbjct: 415 IWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLGV 474
Query: 206 GSVKYTCTGEWTGDGFVSALSNTNFLYKQFLVENQDEISYWYEPYNRPSIMTLKLSPSGF 265
GS K +G W G F N +YK V N DE+ YE N I L L+ SGF
Sbjct: 475 GSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSGF 534
Query: 266 VTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPMCQCLEGFRLKSQ----- 320
+ R L + S+ WDEL+SIP + C YG+CGAN IC + +C+CL GF KSQ
Sbjct: 535 LQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWDM 594
Query: 321 FNQTGPIKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLKNCTCKA 380
FN + C R +C + F+K+ +K PD I+ + ++L++C CL NC+C A
Sbjct: 595 FNTSS--GCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTA 652
Query: 381 YANSNVTEGSGCLMWFGELLDASRPIRNFTGQSVYLRQPASGPG------NKKLLWIIVI 434
YA +N GCLMW G+L+D + +Y+R S G KKL+ I+VI
Sbjct: 653 YAYTNPNGSGGCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVI 712
Query: 435 VVPPMVLLPSVYIFCRQRRKCKEKENMETSQDLLAFDITTRPNEFSEANGDRRDKSKDSW 494
+L + + R + K M T D+ K ++
Sbjct: 713 STFSGILTLGLSFWFRFWK----KRTMGT---------------------DQESKKENLE 747
Query: 495 LPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNE 554
LPLF L ++A AT NFS K+G GGFG VYKG L G VAVKRLS S QG++EFKNE
Sbjct: 748 LPLFDLPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSAQGVQEFKNE 807
Query: 555 MLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIE 614
+LIAKLQH+NLVR+LGCCI+ E+IL+ EYMPNKSLD F+FD ++ LL W R I+
Sbjct: 808 AVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLAWDKRCEIVM 867
Query: 615 GIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVG 674
GIA+GLLYLH SRF+IIHRDLK SN+LLD ++NPKISDFGLAR+FG +E++ TKRIVG
Sbjct: 868 GIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEMETRTKRIVG 927
Query: 675 T 675
T
Sbjct: 928 T 928
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1515), Expect = e-165, Method: Compositional matrix adjust.
Identities = 316/678 (46%), Positives = 426/678 (62%), Gaps = 27/678 (3%)
Query: 11 LLSLIFFLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKV 70
LLS++FFLS+ S A +++ + DG+ LVSS FELGFFSPG S++RY+GIW++K+
Sbjct: 16 LLSIVFFLSIP-STAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKI 74
Query: 71 PD-TVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDG 129
TVVWVANR+ P++D + +L ++G L +N TNGTIWS+N S A NPVAQL D G
Sbjct: 75 SSFTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTG 134
Query: 130 NLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKF 189
NLV+R + N EN+LWQSFDYP D+ L MK G RYL+SW+S DPS GK+
Sbjct: 135 NLVVRAEND-NDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKY 193
Query: 190 TNRLDIHVLPKMCTFNGSVKYTCTGEWTGDGFVSALS-NTNFLYKQFLVENQDEISYWYE 248
TN+LD + LP+ GSV +G W G F ++ N +Y V NQ+EI Y Y+
Sbjct: 194 TNKLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVFNQEEIYYKYQ 253
Query: 249 PYNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPM 308
N + + LSP G + R W + + +W + D C ++ CGA+ +C + P
Sbjct: 254 IANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNSPA 313
Query: 309 CQCLEGFRLKSQFNQTGP---IKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNL 365
C CL+ F KS T C R +C G+ FIK IK PD + N+++NL
Sbjct: 314 CDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTINL 373
Query: 366 QQCAAECLKNCTCKAYANSNVTEG-SGCLMWFGELLDASRPIRNFTGQSVYLR------- 417
++C CLKNC+C AYAN +V +G SGC++WFG+L+D + N GQ +Y+R
Sbjct: 374 EECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQ--YNENGQDIYIRIAASVID 431
Query: 418 QPASGPGNKKLLWIIVIVVPPMVLLPSVYIFCRQRRKCKEKENMETSQDLLAFDITTRPN 477
+P G K++ I++ V L ++ +F R RK K+++ ++ T P
Sbjct: 432 KPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREG------NVVTNP- 484
Query: 478 EFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAV 537
E + + +++D LPLF LA++ AT FS+ KLG+GGFGPVYKG L +G+E+AV
Sbjct: 485 ---EQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGILQDGQEIAV 541
Query: 538 KRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD 597
KRLS +S QG+ EF+NE++ IAKLQHRNLV++LGCCIE E++LI EYMPNKSLD F+FD
Sbjct: 542 KRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKSLDSFIFD 601
Query: 598 PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
+ LL W R II GIA+GLLYLH SR RIIHRDLKASN+LLD +MNPKISDFG+A
Sbjct: 602 KRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPKISDFGMA 661
Query: 658 RMFGGDELQGNTKRIVGT 675
R FGGDE NT RIVGT
Sbjct: 662 RSFGGDETSANTSRIVGT 679
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 581 bits (1497), Expect = e-163, Method: Compositional matrix adjust.
Identities = 319/678 (47%), Positives = 431/678 (63%), Gaps = 39/678 (5%)
Query: 25 AADTVTPASFIRDG--EKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVP-DTVVWVANRD 81
A+T+T + IRDG LVS FELGFFSPG S++RY+GIW++ +P TVVWVANR+
Sbjct: 18 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 77
Query: 82 RPISDHNAVLTISNNGKLVLLNQTNGTI-WSTNASSEAKNPVAQLRDDGNLVIRDNSSVN 140
PI+D + L + N G LVL++ N T+ WS+N+ A++ + +L D GNLV+RD VN
Sbjct: 78 NPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMGELLDSGNLVLRDEKDVN 137
Query: 141 TTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPK 200
+ +YLWQSFDYP+DT+L MK+GWDL+ +R LS+W+S DDPS G FT + P+
Sbjct: 138 SG-SYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 196
Query: 201 MCTFNGSVKYTCTGEWTGDGFV--SALSNTNFLYKQFLVENQDEISYWYEPYNRPSIMTL 258
+ + GS KY +G W G GF +AL Y F V+N +E+ Y Y N+ I L
Sbjct: 197 LVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDF-VDNGEEVYYTYNLKNKSLITRL 255
Query: 259 KLS-PSGFV-TRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPMCQCLEGFR 316
++ +GF+ R WNE S W+ +P DYC Y CGA C Q P+C+CLE F
Sbjct: 256 VMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCIISQSPVCECLEKFT 315
Query: 317 LKS--QFNQTGPIK-CERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECL 373
KS +N + C R+ +C KGD F+K +K PD +N++MNL++C ++CL
Sbjct: 316 PKSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCL 375
Query: 374 KNCTCKAYANSNVTEGSGCLMWFGELLDASRPIRNFT--GQSVYLRQPASGPG------N 425
+NC+C AY +++ E SGC +WFG+L+D IR F GQ +Y+R AS
Sbjct: 376 QNCSCMAYTATDIKERSGCAIWFGDLID----IRQFPDGGQEIYIRMNASESSECLSLIK 431
Query: 426 KKLLWIIVIVVPPMVLLPSVYIFCRQRRKCKEKENMETSQDLLAFDITTRPNEFSEANGD 485
++ + I V +LL + YIF ++ K K + LL + + + SE G
Sbjct: 432 MEMGIALSIFVACGMLLVAYYIF-KRTEKLKAHYSF-----LLVYHVCDSHSLLSEKTGG 485
Query: 486 RRDKS--------KDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAV 537
R+++ +D LPLF ++A AT FS+ K+GEGGFGPVYKG L +G+E+AV
Sbjct: 486 NREENDQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLEDGQEIAV 545
Query: 538 KRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD 597
K LS SGQGL EFKNE++LI KLQHRNLV++LGCCI+ EKIL+ EYMPN+SLD F+FD
Sbjct: 546 KTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRSLDSFIFD 605
Query: 598 PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
T+ +LL W R II GIA+GLLYLH SR RI+HRDLKASNVLLD+DMNPKISDFGLA
Sbjct: 606 QTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLA 665
Query: 658 RMFGGDELQGNTKRIVGT 675
RM GGD+ +GNT R++GT
Sbjct: 666 RMVGGDQTEGNTTRVIGT 683
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493723|ref|XP_002280706.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 579 bits (1492), Expect = e-162, Method: Compositional matrix adjust.
Identities = 321/687 (46%), Positives = 425/687 (61%), Gaps = 44/687 (6%)
Query: 11 LLSLIFFLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRK- 69
+ + +F L +++S+ DT+T I D E + S+ FELGFFSP SK RYLGI ++K
Sbjct: 10 IFTYVFSL-LRISIGVDTITVNQLITDAETITSAGGSFELGFFSPANSKHRYLGIRYKKE 68
Query: 70 VPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDG 129
+ VVWVANR+ P++D + VL +++ G LV+L+ N T+WS+ +S A+NP AQL D G
Sbjct: 69 LNRAVVWVANRENPLNDSSGVLKVTSQGILVVLDGANKTLWSSTSSRPAQNPNAQLLDSG 128
Query: 130 NLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKF 189
NLV+++ + N EN+LWQSFDYP +TLL MK+GW+ +RYLSSW+S DDPS G F
Sbjct: 129 NLVMKNGNDGNP-ENFLWQSFDYPCNTLLPGMKLGWNRVTGLDRYLSSWKSADDPSIGTF 187
Query: 190 TNRLDIHVLPKMCTFNGSVKYTCTGEWTGDGFVSALSNT-NFLYKQFLVENQDEISYWYE 248
T +D P++ N SV +G W G F T N +Y V N+ EI + Y
Sbjct: 188 TYGIDPSGSPQIFVRNVSVVTFRSGPWNGIRFSGYPHFTPNPVYTYDFVLNEKEIYFIYY 247
Query: 249 PYNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPM 308
N + L L+P G+ R W ++ +W + S+ +D C Y CGAN IC DQ P
Sbjct: 248 LVNSSLLTRLVLTPDGYAQRFTWIDEKGQWVKYSSVQNDDCDNYALCGANGICKIDQSPK 307
Query: 309 CQCLEGFRLKSQFN---QTGPIKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNL 365
C+C++GFR + Q N C RS +C KGD+F+K +K PD N+SMNL
Sbjct: 308 CECMKGFRPRFQSNWDMADWSDGCVRSTPLDCQKGDRFVKFSGVKLPDTRTSWFNESMNL 367
Query: 366 QQCAAECLKNCTCKAYANSNVT-EGSGCLMWFGELLDASRPIRNFT--GQSVYLRQPAS- 421
++CA+ CL+NC+C AY NSN++ EGSGCL+WFG L D IR F GQ Y+R AS
Sbjct: 368 KECASLCLRNCSCTAYVNSNISGEGSGCLLWFGNLTD----IREFAENGQEFYVRMSASE 423
Query: 422 ----------GPGNKKLLWIIVIVVPPMVLLPSV---YIFCRQRRKCKEKENMETSQDLL 468
+K + +I I + +VLL V Y+ + +++ K K ME + D
Sbjct: 424 SDAFSSTNISSKKKQKQVIVISISITGIVLLILVLTWYMLKKMKQQLKRKGYMEHNSD-- 481
Query: 469 AFDITTRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGR 528
G+ + + LPLF LA++ AT NFS + KLGEGGFGPVYKG
Sbjct: 482 --------------GGETSEGQEHLELPLFELATLLNATNNFSSDNKLGEGGFGPVYKGI 527
Query: 529 LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588
L +GEE+AVKRLS S QGL+EFKNE+ IAKLQHRNLV++LGCCI EK+LI EY+PN
Sbjct: 528 LEDGEEIAVKRLSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCICGREKMLIYEYLPN 587
Query: 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN 648
KSLD+F+FD + +L W R II GIA+GLLYLH SR RIIHRDLKA NVLLD DMN
Sbjct: 588 KSLDLFIFDQMRGIVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAENVLLDNDMN 647
Query: 649 PKISDFGLARMFGGDELQGNTKRIVGT 675
PKISDFG+AR FGG+EL +T R+ GT
Sbjct: 648 PKISDFGIARSFGGNELGASTTRVAGT 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147816068|emb|CAN61538.1| hypothetical protein VITISV_030742 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1491), Expect = e-162, Method: Compositional matrix adjust.
Identities = 321/687 (46%), Positives = 425/687 (61%), Gaps = 44/687 (6%)
Query: 11 LLSLIFFLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRK- 69
+ + +F L +++S+ DT+T I D E + S+ FELGFFSP SK RYLGI ++K
Sbjct: 10 IFTYVFSL-LRISIGVDTITVNQLITDAETITSAGGSFELGFFSPANSKHRYLGIRYKKE 68
Query: 70 VPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDG 129
+ VVWVANR+ P++D + VL +++ G LV+L+ N T+WS+ +S A+NP AQL D G
Sbjct: 69 LNRAVVWVANRENPLNDSSGVLKVTSQGILVVLDGANKTLWSSTSSRPAQNPNAQLLDSG 128
Query: 130 NLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKF 189
NLV+++ + N EN+LWQSFDYP +TLL MK+GW+ +RYLSSW+S DDPS G F
Sbjct: 129 NLVMKNGNDGNP-ENFLWQSFDYPCNTLLPGMKLGWNRVTGLDRYLSSWKSADDPSIGTF 187
Query: 190 TNRLDIHVLPKMCTFNGSVKYTCTGEWTGDGFVSALSNT-NFLYKQFLVENQDEISYWYE 248
T +D P++ N SV +G W G F T N +Y V N+ EI + Y
Sbjct: 188 TYGIDPSGSPQIFVRNVSVVTFRSGPWNGIRFSGYPHFTPNPVYTYDFVLNEKEIYFIYY 247
Query: 249 PYNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPM 308
N + L L+P G+ R W ++ +W + S+ +D C Y CGAN IC DQ P
Sbjct: 248 LVNSSLLTRLVLTPDGYAQRFTWIDEKGQWVKYSSVQNDDCDNYALCGANGICKIDQSPK 307
Query: 309 CQCLEGFRLKSQFN---QTGPIKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNL 365
C+C++GFR + Q N C RS +C KGD+F+K +K PD N+SMNL
Sbjct: 308 CECMKGFRPRFQSNWDMADWSDGCVRSTPLDCQKGDRFVKFSGVKLPDTRTSWFNESMNL 367
Query: 366 QQCAAECLKNCTCKAYANSNVT-EGSGCLMWFGELLDASRPIRNFT--GQSVYLRQPAS- 421
++CA+ CL+NC+C AY NSN++ EGSGCL+WFG L D IR F GQ Y+R AS
Sbjct: 368 KECASLCLRNCSCTAYVNSNISGEGSGCLLWFGNLTD----IREFAENGQEFYVRMSASE 423
Query: 422 ----------GPGNKKLLWIIVIVVPPMVLLPSV---YIFCRQRRKCKEKENMETSQDLL 468
+K + +I I + +VLL V Y+ + +++ K K ME + D
Sbjct: 424 SDAFSSTNISSKKKQKQVIVISISITGIVLLILVLTWYMLKKMKQQLKRKGYMEHNSD-- 481
Query: 469 AFDITTRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGR 528
G+ + + LPLF LA++ AT NFS + KLGEGGFGPVYKG
Sbjct: 482 --------------GGETSEGQEHLELPLFELATLLNATNNFSSDNKLGEGGFGPVYKGI 527
Query: 529 LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588
L +GEE+AVKRLS S QGL+EFKNE+ IAKLQHRNLV++LGCCI EK+LI EY+PN
Sbjct: 528 LEDGEEIAVKRLSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCICGREKMLIYEYLPN 587
Query: 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN 648
KSLD+F+FD + +L W R II GIA+GLLYLH SR RIIHRDLKA NVLLD DMN
Sbjct: 588 KSLDLFIFDQMRGIVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAENVLLDNDMN 647
Query: 649 PKISDFGLARMFGGDELQGNTKRIVGT 675
PKISDFG+AR FGG+EL +T R+ GT
Sbjct: 648 PKISDFGIARSFGGNELXASTTRVAGT 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1486), Expect = e-161, Method: Compositional matrix adjust.
Identities = 318/669 (47%), Positives = 418/669 (62%), Gaps = 43/669 (6%)
Query: 25 AADTVTPASFIRDG--EKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVP-DTVVWVANRD 81
A+T+T + IRDG LVS FELGFFSPG S++RY+GIW++ +P TVVWVANR+
Sbjct: 24 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 83
Query: 82 RPISDHNAVLTISNNGKLVLLNQTNGTI-WSTNASSEAKNPVAQLRDDGNLVIRDNSSVN 140
PI+D + L + N G VL++ N T+ WS+N+ A++ + +L+D GNLV+RD N
Sbjct: 84 NPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSNSKKAAQSAMGELQDSGNLVLRDEKDDN 143
Query: 141 TTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPK 200
+ YLWQSFDYP+DTLL MK+GWDL+ +R LS+W+S DDPS G FT + P+
Sbjct: 144 SGI-YLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 202
Query: 201 MCTFNGSVKYTCTGEWTGDGFVSALS-NTNFLYKQFLVENQDEISYWYEPYNRPSIMTLK 259
+ + GS KY +G W G GF L+ N ++ V++ +E+ Y Y N+ I +
Sbjct: 203 LVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEEVYYTYNLKNKSLITRIV 262
Query: 260 LSPSG-FVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPMCQCLEGFRLK 318
++ + F R WNE + W ++P DYC Y CGA C Q P+CQCLE F +
Sbjct: 263 MNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIMSQSPVCQCLEKFTPR 322
Query: 319 S--QFNQTGPIK-CERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLKN 375
S +N K C R+ +C KGD F+K +K PD +N++MNL++C ++CL+N
Sbjct: 323 SPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCLQN 382
Query: 376 CTCKAYANSNVTEGSGCLMWFGELLDASRPIRNFT--GQSVYLRQPASGPGNKKLLWI-- 431
C+C AY +N+ E SGC +WFG+L+D IR F+ GQ +Y+R AS K I
Sbjct: 383 CSCMAYTATNIKERSGCAVWFGDLID----IRQFSAAGQEIYIRLNASESRAKAASKIKM 438
Query: 432 -----IVIVVPPMVLLPSVYIFCRQRRKCKEKENMETSQDLLAFDITTRPNEFSEANGDR 486
+ I V +LL + YIF +RK K D I + P E
Sbjct: 439 TVGSALSIFVACGILLVAYYIF---KRKAKHIGGNREEND----QIDSGPKE-------- 483
Query: 487 RDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQ 546
D LPLF ++A AT FS KLGEGGFGPVYKG L +G+E+A K LS SGQ
Sbjct: 484 -----DLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTLSRSSGQ 538
Query: 547 GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW 606
GL EFKNE++LI KLQHRNLV++LGCCI+ EKIL+ EYMPNKSLD F+FD T+ +LL W
Sbjct: 539 GLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRGKLLDW 598
Query: 607 QARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQ 666
R II GIA+GLLYLH SR RI+HRDLKASNVLLD+DMNPKISDFGLARMFGGD+ +
Sbjct: 599 SKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFGGDQTE 658
Query: 667 GNTKRIVGT 675
GNT R+VGT
Sbjct: 659 GNTTRVVGT 667
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1475), Expect = e-160, Method: Compositional matrix adjust.
Identities = 306/678 (45%), Positives = 412/678 (60%), Gaps = 47/678 (6%)
Query: 15 IFFLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTV 74
+FF +K+S A D + +RDGE LVS+ FELGFF+P S SRYLG+W++K P TV
Sbjct: 12 LFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWYKKSPQTV 71
Query: 75 VWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIR 134
VWVANR PIS+ L +++ G LVLLN TN +WS+N S+ +NPVAQL D GNLV+R
Sbjct: 72 VWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNPVAQLLDSGNLVVR 131
Query: 135 DNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLD 194
D + N +N+LWQSFDYP DTLL MK+G +L +LSSW+ ++P+PG+FT +D
Sbjct: 132 DGND-NKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPAPGQFTLGID 190
Query: 195 IHVLPKMCTFNGSVKYTCTGEWTGDGFVSALS-NTNFLYKQFLVENQDEISYWYEPYNRP 253
+ P++ + G W G F + +Y V N++E+ + +E N
Sbjct: 191 VQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFNRNEVYFKFELQNSS 250
Query: 254 SIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPMCQCLE 313
L ++PSG V W+ +N+W + D C Y CGAN C + P+C CL+
Sbjct: 251 VFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGANARCDSNSSPVCDCLD 310
Query: 314 GFRLKSQF-----NQTGPIKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQC 368
GF KS N TG C R +C D F +K PD + S +L +C
Sbjct: 311 GFIHKSPTEWNSQNWTG--GCIRRTPLDCTDKDGFQSYTGVKLPDTSSSWYDDSFSLVEC 368
Query: 369 AAECLKNCTCKAYANSNVT-EGSGCLMWFGELLDASRPIRNFTGQSVYLRQPASGPG--- 424
C++NC+C AYAN + GSGCL WFG+L+D R GQ +Y+R AS G
Sbjct: 369 EGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEG--GQDIYIRLAASQSGVTG 426
Query: 425 ----NKKLLWIIV---IVVPPMVLLPSVYIFCRQRRKCKEKENMETSQDLLAFDITTRPN 477
KK ++ +++ +L+ + +FC +RRK ++ N E
Sbjct: 427 EKKRKKKTHAGVIGGAVILGSSILILGI-VFCIRRRKHRKNGNFE--------------- 470
Query: 478 EFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAV 537
DR+++ + LP+ L ++ AT+NFS KLGEGGFG VYKG L+ G+E+AV
Sbjct: 471 -------DRKEEEME--LPMLDLTTIEHATDNFSSSKKLGEGGFGAVYKGELIEGQEIAV 521
Query: 538 KRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD 597
KRLS SGQGL EFKNE+LLIAKLQHRNLV++LGCCI + EK+LI EYMPN+SLD F+FD
Sbjct: 522 KRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDEKMLIYEYMPNRSLDSFIFD 581
Query: 598 PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
PT+++ L W R II+GIA+GLLYLH SR RIIHRD+KASN+LLD ++NPKISDFGLA
Sbjct: 582 PTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKASNILLDNELNPKISDFGLA 641
Query: 658 RMFGGDELQGNTKRIVGT 675
RMFGGD+ + NTKR+VGT
Sbjct: 642 RMFGGDQTEANTKRVVGT 659
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115136|ref|XP_002316951.1| predicted protein [Populus trichocarpa] gi|222860016|gb|EEE97563.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1468), Expect = e-159, Method: Compositional matrix adjust.
Identities = 314/677 (46%), Positives = 426/677 (62%), Gaps = 29/677 (4%)
Query: 11 LLSLIFFLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKV 70
+ L+ FL K S A D+++P+ F+ DG+ LVS FELGFFSPG SK YLGIW++ +
Sbjct: 9 ITKLLLFL-FKFSTALDSISPSEFMIDGKTLVSEKGTFELGFFSPGISKKSYLGIWYKNI 67
Query: 71 P-DTVVWVANRDRPISDHNAVLTISNNGKLVLL-NQTNGTIWSTNASSEAKNPVAQLRDD 128
P T+VWVANR PI+D + +L + N +VLL N TN +WS+N++ +A +P+ QL D
Sbjct: 68 PVRTIVWVANRRNPINDSSGLLKVDNCSDIVLLSNNTNTVVWSSNSTKKASSPILQLLDS 127
Query: 129 GNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGK 188
GNLV+RD + + LWQSFDYP DT+L MK+GWDL+ + LSSW+S DDPSPG
Sbjct: 128 GNLVLRDKN--DGRSGLLWQSFDYPCDTMLPGMKIGWDLRAGFDWRLSSWKSSDDPSPGD 185
Query: 189 FTNRLDIHVLPKMCTFNGSVKYTCTGEWTGDGFVSALS-NTNFLYKQFLVENQDEISYWY 247
FT ++ P++ + GS K+ +G W G GF + N ++ V N E+ Y +
Sbjct: 186 FTMGIERESNPEVVAWKGSKKHYRSGPWNGVGFSGSTEVKPNPVFYFTFVSNNIEVYYIF 245
Query: 248 EPYNRPSIMTLKLSPSGFVTRQ--LWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQ 305
+ +++T + RQ WNE++ W S+P D+C YG CGAN C +
Sbjct: 246 NLKSESTVITRLVLNHTTSDRQCYTWNEETQTWVLQVSVPRDHCDNYGLCGANANCIFNA 305
Query: 306 KPMCQCLEGFRLKS--QFNQTGPIK-CERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQS 362
P+CQCLE F+ KS ++N+ + C R+ +C KGD FIK D +K PD +N+
Sbjct: 306 IPVCQCLEKFKPKSPEEWNKMDWSQGCVRNKELDCQKGDGFIKFDGLKLPDATHSWVNKD 365
Query: 363 MNLQQCAAECLKNCTCKAYANSNVTEG-SGCLMWFGELLDASRPIRNFTGQSVYLRQPAS 421
MNL++C A+CL NC+C AY+N ++ G SGC WFG+L+D + GQ +Y+R AS
Sbjct: 366 MNLKECKAKCLGNCSCMAYSNLDIRGGGSGCANWFGDLMDIR--LVPGGGQELYIRMHAS 423
Query: 422 GPGNKKL-----LWIIVIVVPPMVLLPSVYIFCRQRRKCKEKENMETSQDLLAFDITTRP 476
G+++ + I V ++L + + K K EN TS + D
Sbjct: 424 EIGDREAKANMKIAAIATAVVGLILGTLTISYHVSKEKAKSAEN--TSSERTENDWKNDT 481
Query: 477 NEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVA 536
N NG +++ D LPLF+ +++A AT NFS+ KLGEGGFGPVY+G+L +G E+A
Sbjct: 482 N-----NGGQKE---DMELPLFAFSAIADATNNFSVNNKLGEGGFGPVYRGKLEDGLEIA 533
Query: 537 VKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLF 596
VKRLS SGQG EFKNE++LI KLQHRNLV++LGCC ++ EK+LI EYMPN+SLD F+F
Sbjct: 534 VKRLSRCSGQGFSEFKNEVILINKLQHRNLVKLLGCCSQREEKMLIYEYMPNRSLDFFIF 593
Query: 597 DPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656
D TK RLL W R II GIA+GLLYLH SR RIIHRDLKASNVLLD MNPKISDFGL
Sbjct: 594 DETKGRLLDWSRRFNIISGIARGLLYLHQDSRLRIIHRDLKASNVLLDDHMNPKISDFGL 653
Query: 657 ARMFGGDELQGNTKRIV 673
ARMF D+ +G+T R+
Sbjct: 654 ARMFVADQTEGDTSRVT 670
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076591|ref|XP_002304966.1| predicted protein [Populus trichocarpa] gi|222847930|gb|EEE85477.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 569 bits (1467), Expect = e-159, Method: Compositional matrix adjust.
Identities = 310/678 (45%), Positives = 429/678 (63%), Gaps = 35/678 (5%)
Query: 17 FLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVW 76
S K + + DT+T + +G+ L+S+SQ FELGFF+PG S++ Y+GIW++ +P T VW
Sbjct: 19 LFSSKFASSLDTLTATQSLINGQTLISTSQGFELGFFTPGNSRNWYVGIWYKNIPRTYVW 78
Query: 77 VANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDN 136
VANRD+P+S+ + I N + L + +WS+N ++ A+NPV QL D GNLV+++
Sbjct: 79 VANRDKPLSNSSGTFKIFNQ-SIALFDLAGKVVWSSNQTN-ARNPVMQLLDSGNLVLKEQ 136
Query: 137 SSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIH 196
V+ + +LWQSFDYPTDTLL DMK+GWDL +RYLSSW+S +DP G F+ +L+ H
Sbjct: 137 --VSESGQFLWQSFDYPTDTLLPDMKLGWDLNTGLDRYLSSWKSSEDPGTGDFSFKLEYH 194
Query: 197 VLPKMCTFNGSVKYTCTGEWTGDGF--VSALSNTNFLYKQFLVENQDEISYWYEPYNRPS 254
P++ + + +G W G F V + ++L F+ E QDE+ Y + +
Sbjct: 195 GFPEVFLWKDNEIEYRSGPWNGQRFSGVPEMKPVDYLSFNFITE-QDEVYYSFHIATKNL 253
Query: 255 IMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPMCQCLEG 314
L ++ SG + R W ++ +W++ + P D C Y CGA IC + P+C+CL+G
Sbjct: 254 YSRLTVTSSGLLQRFAWIPETQQWNKFWYAPKDQCDNYKECGAYGICDSNASPVCKCLKG 313
Query: 315 FRLKSQFN---QTGPIKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAE 371
F+ K+ + G C R + EC+K D+F+ + N+K P +++SM+L+ C
Sbjct: 314 FQPKNHQAWDLRDGSGGCVRKTNLECLK-DKFLHMKNMKLPQSTTSFVDRSMSLKNCELL 372
Query: 372 CLKNCTCKAYANSNVTEG-SGCLMWFGELLDASRPIRNFT--GQSVYLRQPAS--GPGNK 426
C +NC+C AYANSN++ G SGC++W GEL D +R + GQ +Y+R AS G G
Sbjct: 373 CSRNCSCTAYANSNISNGGSGCVIWTGELFD----LRQYPEGGQDLYVRLAASDIGDGGS 428
Query: 427 KLLWIIVIVVPPMVLLPSVYIFCRQRRK--------CKEKENMETSQDLLAFDITTRPNE 478
II I V +L+ S+ F +RK ++K E SQDLL ++ +
Sbjct: 429 ADTIIICIAVGIGILILSLTGFSIWKRKRLLSVCNGTQQKGPQERSQDLLLNEVVINKKD 488
Query: 479 FSEANGDRRDKSKDSW-LPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAV 537
+S +KS D LPLF +++AAAT NF E KLGEGGFG V+KGRL+ G+EVAV
Sbjct: 489 YSG------EKSTDELELPLFDFSTIAAATGNFCDENKLGEGGFGCVHKGRLVEGQEVAV 542
Query: 538 KRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD 597
KRLS +SGQG EEFKNE+ LIA+LQHRNLVR+LGCCIE EKILI E+M N+SLD LF+
Sbjct: 543 KRLSKKSGQGTEEFKNEVRLIARLQHRNLVRLLGCCIEMDEKILIYEFMENRSLDSVLFN 602
Query: 598 PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
K LL WQ R II G A+GLLYLH SRFRIIHRDLKASN+LLD + PKISDFG+A
Sbjct: 603 KAKSSLLNWQRRFNIICGTARGLLYLHQDSRFRIIHRDLKASNILLDGEWTPKISDFGMA 662
Query: 658 RMFGGDELQGNTKRIVGT 675
R+FGGD+ Q NT+RIVGT
Sbjct: 663 RIFGGDQTQANTRRIVGT 680
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 675 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.601 | 0.518 | 0.374 | 2.1e-141 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.971 | 0.774 | 0.429 | 8.3e-138 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.958 | 0.767 | 0.422 | 5.4e-134 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.985 | 0.782 | 0.407 | 5.4e-134 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.945 | 0.782 | 0.413 | 9.6e-128 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.92 | 0.731 | 0.422 | 1.3e-125 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.268 | 0.225 | 0.662 | 1.7e-124 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.977 | 0.783 | 0.4 | 5.8e-121 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.281 | 0.236 | 0.623 | 6.7e-119 | |
| TAIR|locus:2197704 | 831 | AT1G61390 [Arabidopsis thalian | 0.934 | 0.759 | 0.408 | 1.3e-116 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 766 (274.7 bits), Expect = 2.1e-141, Sum P(2) = 2.1e-141
Identities = 159/425 (37%), Positives = 246/425 (57%)
Query: 10 HLLSLIFFLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRK 69
HLL + F ++ ++ A D + ++DG+ +VS FE+GFFSPG S++RYLGIW++K
Sbjct: 8 HLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKK 67
Query: 70 VP-DTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEA-----KNPVA 123
+ TVVWVANRD P+ D + L +S NG L L N N IWS+++S + +NP+
Sbjct: 68 ISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIV 127
Query: 124 QLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDD 183
Q+ D GNLV+R++ ++Y+WQS DYP D L MK G + R+L+SWR+ DD
Sbjct: 128 QILDTGNLVVRNSGD---DQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDD 184
Query: 184 PSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGEWTGDGFVSALS-NTNFLYKQFLVENQDE 242
PS G +TN++D + +P+ SV TG W G F + N +Y+ V ++E
Sbjct: 185 PSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEE 244
Query: 243 ISYWYEPYNRPSIMT-LKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTIC 301
+ Y Y+ N PS++T ++L+P+G + R W ++ W+ S D C +Y CG+ C
Sbjct: 245 VYYTYKLEN-PSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSC 303
Query: 302 GPDQKPMCQCLEGFRLKS-QFNQTGPIK--CERSHSSECIKG-DQFIKLDNIKAPDFIEV 357
++ P C+CL+GF K+ Q G C R +C KG D F+K+ +K PD
Sbjct: 304 NINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTS 363
Query: 358 SLNQSMNLQQCAAECLKNCTCKAYANSNVTEGS-GCLMWFGELLDASRPIRNFTGQSVYL 416
+++M+L +C CL+NCTC AY+ ++ +G GC++WFG+L+D N GQ +Y+
Sbjct: 364 WYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE--YNENGQDLYV 421
Query: 417 RQPAS 421
R +S
Sbjct: 422 RLASS 426
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1349 (479.9 bits), Expect = 8.3e-138, P = 8.3e-138
Identities = 294/684 (42%), Positives = 408/684 (59%)
Query: 11 LLSLIFFLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKV 70
L +I FL+ V + + T + I + ++S SQ FELGFF+P S YLGIW++ +
Sbjct: 14 LFIIILFLAFSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKII 73
Query: 71 P-DTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASS-EAKNPVA-QLRD 127
P T VWVANRD P+S N L IS+N LV+ +Q++ +WSTN + + ++PVA +L D
Sbjct: 74 PIRTYVWVANRDNPLSSSNGTLKISDNN-LVIFDQSDRPVWSTNITGGDVRSPVAAELLD 132
Query: 128 DGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRR-ERYLSSWRSDDDPSP 186
GN V+RD+ + N +LWQSFD+PTDTLL DMKMGWD K+ R L SW++ DDPS
Sbjct: 133 YGNFVLRDSKN-NKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSS 191
Query: 187 GKFTNRLDIHVLPKMCTFNG-SVKYTCTGEWTGDGF--VSALSNTNFLYKQFLVENQDEI 243
G F+ +L P+ +N S+ Y +G W G+ F V + +++ F EN ++
Sbjct: 192 GDFSTKLRTSGFPEFYIYNKESITYR-SGPWLGNRFSSVPGMKPVDYIDNSF-TENNQQV 249
Query: 244 SYWYEPYNRPSIMT-LKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICG 302
Y Y N+ +I + L LS +G + R W E + W +L+ P D C Y CG C
Sbjct: 250 VYSYR-VNKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCD 308
Query: 303 PDQKPMCQCLEGFR-LKSQFN-QTGPIKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLN 360
+ P+C C++GF + Q + + C R C D F++L ++ PD E S++
Sbjct: 309 ANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVD 368
Query: 361 QSMNLQQCAAECLKNCTCKAYANSNVTEG-SGCLMWFGELLDASRPIRNFT--GQSVYLR 417
+ + L++C CLK C C A+AN+++ G SGC++W G L D IRN+ GQ +Y+R
Sbjct: 369 KGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFD----IRNYAKGGQDLYVR 424
Query: 418 QPASGPGNKKXXXXXXXXXXXXXXXX---SVYIFCRQRRKCKEKENMETSQDLLAFDITT 474
A +K+ S IF +RK K ++T L +
Sbjct: 425 VAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDS 484
Query: 475 RPNEFSEANGDRRDK-SKDSWL--PLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLN 531
NE +A+ K +K +L PL ++A AT NFS + KLG+GGFG VYKG LL+
Sbjct: 485 LMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLD 544
Query: 532 GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSL 591
G+E+AVKRLS S QG +EF NE+ LIAKLQH NLVR+LGCC+++GEK+LI EY+ N SL
Sbjct: 545 GKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSL 604
Query: 592 DVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI 651
D LFD T+ L WQ R II GIA+GLLYLH SR RIIHRDLKASNVLLD++M PKI
Sbjct: 605 DSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKI 664
Query: 652 SDFGLARMFGGDELQGNTKRIVGT 675
SDFG+AR+FG +E + NT+R+VGT
Sbjct: 665 SDFGMARIFGREETEANTRRVVGT 688
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 5.4e-134, P = 5.4e-134
Identities = 290/687 (42%), Positives = 409/687 (59%)
Query: 12 LSLIFFLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVP 71
L LI FL+ VS + T + I + ++S SQ FELGFF+P S YLGIW++ +P
Sbjct: 15 LILILFLAFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIP 74
Query: 72 -DTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASS-EAKNPVA-QLRDD 128
T VWVANRD P+S N L IS N LV+ +Q++ +WSTN + + ++PVA +L D+
Sbjct: 75 IRTYVWVANRDNPLSSSNGTLKISGNN-LVIFDQSDRPVWSTNITGGDVRSPVAAELLDN 133
Query: 129 GNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGK 188
GN ++RD+++ LWQSFD+PTDTLL +MK+GWD K R L SW++ DDPS G+
Sbjct: 134 GNFLLRDSNN-----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGE 188
Query: 189 FTNRLDIHVLPK--MCTFNGSVKYTCTGEWTGDGFVSALSNTNFLYKQF-LVENQDEISY 245
F+ +L+ P+ +C+ S+ Y +G W G F S Y + +++E++Y
Sbjct: 189 FSTKLETSEFPEFYICS-KESILYR-SGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTY 246
Query: 246 WYEPYNRPSIMT-LKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPD 304
Y N+ ++ + L L+ +G + R W E + W +L+ P D C Y CG C +
Sbjct: 247 SYR-INKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSN 305
Query: 305 QKPMCQCLEGFR-LKSQF--NQTGPIKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQ 361
P C C++GF+ + Q + G C R C D F +L +K PD +++
Sbjct: 306 SLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDR 365
Query: 362 SMNLQQCAAECLKNCTCKAYANSNVTEG-SGCLMWFGELLDASRPIRNFT--GQSVYLRQ 418
+ L+ C CL++C C A+AN+++ G SGC++W E+LD +RN+ GQ +Y+R
Sbjct: 366 EIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILD----MRNYAKGGQDLYVRL 421
Query: 419 PASGPGNKKXXXXXXXXXXXXXXXX---SVYIFCRQRRKCKEKENMET-------SQDLL 468
A+ +K+ S IF +RK K ++T SQD L
Sbjct: 422 AAAELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSL 481
Query: 469 AFDITTRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGR 528
D+ ++ + KS+ LPL L ++A AT NFS + KLG+GGFG VYKGR
Sbjct: 482 INDVVVSRRGYTS----KEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGR 537
Query: 529 LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588
LL+G+E+AVKRLS S QG +EF NE+ LIAKLQH NLVR+LGCC+++GEK+LI EY+ N
Sbjct: 538 LLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLEN 597
Query: 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN 648
SLD LFD T+ L WQ R II GIA+GLLYLH SR RIIHRDLKASNVLLD++M
Sbjct: 598 LSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMT 657
Query: 649 PKISDFGLARMFGGDELQGNTKRIVGT 675
PKISDFG+AR+FG +E + NT+R+VGT
Sbjct: 658 PKISDFGMARIFGREETEANTRRVVGT 684
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 5.4e-134, P = 5.4e-134
Identities = 286/701 (40%), Positives = 407/701 (58%)
Query: 1 MNGYSSMLQHLLSLIFFLSM---KVSLAADTVTPASF--IRDGEKLVSSSQRFELGFFSP 55
M G + FFL + S++A+T++ + I +VS FELGFF P
Sbjct: 1 MRGLPNFYHSYTFFFFFLLILFPAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKP 60
Query: 56 GKSKSRYLGIWFRKVPD-TVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNA 114
G YLGIW++ + T VWVANRD P+S L IS++ LV+L+Q++ +WSTN
Sbjct: 61 GLDSRWYLGIWYKAISKRTYVWVANRDTPLSSSIGTLKISDSN-LVVLDQSDTPVWSTNL 119
Query: 115 SS-EAKNP-VAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRE 172
+ + ++P VA+L D+GN V+RD+ + + + LWQSFD+PTDTLL +MK+GWD K
Sbjct: 120 TGGDVRSPLVAELLDNGNFVLRDSKN-SAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFN 178
Query: 173 RYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGEWTGDGFVSALSNTNFLY 232
R++ SW+S DDPS G F+ +L+ P++ +N + +G W G F F Y
Sbjct: 179 RFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEY 238
Query: 233 KQF-LVENQDEISYWYEPYNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGK 291
F +++E++Y + L +S SG + R W E + W++ + P D C +
Sbjct: 239 MVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDE 298
Query: 292 YGYCGANTICGPDQKPMCQCLEGFRLKS-QF--NQTGPIKCERSHSSECIKGDQFIKLDN 348
Y CG C + P+C C++GF+ ++ Q + G C R C GD F++L
Sbjct: 299 YKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKK 358
Query: 349 IKAPDFIEVSLNQSMNLQQCAAECLKNCTCKAYANSNVT-EGSGCLMWFGELLDASRPIR 407
+K PD S+++ + +++C +CL++C C A+AN+++ GSGC+ W GEL D IR
Sbjct: 359 MKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFD----IR 414
Query: 408 NFT--GQSVYLRQPASG---PGNKKXXXXXXXXXXXXXXXXSVYIFCRQRRKCKEKENME 462
N+ GQ +Y+R A+ N+ S IF +RK K +E
Sbjct: 415 NYAKGGQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIE 474
Query: 463 T--------SQDLLAFDITTRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMEC 514
T S+DLL ++ S + R + + D LPL VA AT NFS
Sbjct: 475 TPIVDHQLRSRDLLMNEVVIS----SRRHISRENNTDDLELPLMEFEEVAMATNNFSNAN 530
Query: 515 KLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCI 574
KLG+GGFG VYKG+LL+G+E+AVKRLS S QG +EFKNE+ LIA+LQH NLVR+L CC+
Sbjct: 531 KLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCV 590
Query: 575 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHR 634
+ GEK+LI EY+ N SLD LFD ++ L WQ R II GIA+GLLYLH SRFRIIHR
Sbjct: 591 DAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHR 650
Query: 635 DLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
DLKASN+LLD+ M PKISDFG+AR+FG DE + NT+++VGT
Sbjct: 651 DLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGT 691
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1254 (446.5 bits), Expect = 9.6e-128, P = 9.6e-128
Identities = 286/692 (41%), Positives = 399/692 (57%)
Query: 8 LQHLLSL-IFFLSMKVSLAAD--TVTPASFIRDGEKLVSSSQRFELGFFSPGKSKS---R 61
+ L SL +F +S +S+A D +TP F++DG+ L S Q F+LGFFS + + R
Sbjct: 4 IHSLFSLSLFLISSSLSVALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHR 63
Query: 62 YLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWS-----TNASS 116
+LG+W+ + P VVWVANR+ P+ + L +S+ G L L + + +WS T AS
Sbjct: 64 FLGLWYME-PFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASK 122
Query: 117 EAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLS 176
A NP+ ++ GNL+ D E LWQSFDYP +T+L MK+G + K + E LS
Sbjct: 123 TANNPLLKISCSGNLISSDGE-----EAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLS 177
Query: 177 SWRSDDDPSPGKFTNRLDIHVLPKMCTF-NGSVKYTCT-GEWTGDGFVSA--LSNTNFLY 232
SW++ DPSPG FT LD LP++ NG Y+ G W G F A + N L+
Sbjct: 178 SWKTLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLF 237
Query: 233 KQFLVENQDEISYWYEPYNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKY 292
+ E++Y + P +R + L L+ +G + R + ++ N+W + P+D C Y
Sbjct: 238 DYKFTSSAQEVNYSWTPRHR-IVSRLVLNNTGKLHRFIQSKQ-NQWILANTAPEDECDYY 295
Query: 293 GYCGANTICGPDQK--PMCQCLEGFRLKS--QFN-QTGPIKCERSHSSECIKGDQFIKLD 347
CGA +CG + K P C CL+GF+ KS ++N G C + C K D F+K
Sbjct: 296 SICGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFP 355
Query: 348 NIKAPD--FIEVSLNQSMNLQQCAAECLKNCTCKAYANSNVTEGS-GCLMWFGELLDASR 404
+K PD + M L+ C +C NC+C AYAN+++ EG GCL+WFG+L+D R
Sbjct: 356 GLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDM-R 414
Query: 405 PIRNFTGQSVYLRQPASGPGNK-KXXXXXXXXXXXXXXXXSVYIFCRQRRKCKEKENMET 463
+F GQ VY+R + K + V +F R+K ++ E
Sbjct: 415 EYSSF-GQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGE- 472
Query: 464 SQDLLAFDITTRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGP 523
N + + +D LP+F +++ AT++FS LG GGFGP
Sbjct: 473 -------------------NFRKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGP 513
Query: 524 VYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583
VYKG+L +G+E+AVKRLS+ SGQG+EEFKNE+ LIAKLQHRNLVR+LGCCI+ E +LI
Sbjct: 514 VYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIY 573
Query: 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL 643
EYMPNKSLD F+FD + L W+ R+ II G+A+G+LYLH SR RIIHRDLKA NVLL
Sbjct: 574 EYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLL 633
Query: 644 DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
D DMNPKISDFGLA+ FGGD+ + +T R+VGT
Sbjct: 634 DNDMNPKISDFGLAKSFGGDQSESSTNRVVGT 665
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1234 (439.4 bits), Expect = 1.3e-125, P = 1.3e-125
Identities = 281/665 (42%), Positives = 388/665 (58%)
Query: 41 LVSSSQRFELGFFSPGKSKSRYLGIWFRKVPD-TVVWVANRDRPISDHNAVLTISNNGKL 99
LVS + FELGFFSPG S R+LGIW+ + D VVWVANR PISD + VL ISN+G L
Sbjct: 44 LVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNL 103
Query: 100 VLLNQTNGTIWSTNASSEA---KNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDT 156
VLL+ N T+WS+N S N V + D GN V+ + T+ +W+SF++PTDT
Sbjct: 104 VLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSETD----TDRPIWESFNHPTDT 159
Query: 157 LLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGS-VKYTCTGE 215
L M++ + + SWRS+ DPSPG ++ +D P++ + G+ + +G+
Sbjct: 160 FLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQ 219
Query: 216 WTGDGFVSALSN----TNFLYKQFLVENQDEISYWYEPY--NRPSIMT-LKLSPSGFVTR 268
W F + + N TN+LY L DE Y Y + PS++ K+ +G
Sbjct: 220 WNSAIF-TGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEE 278
Query: 269 QLWNEDSNEWDELFSIPDDYCGKYGYCGANTICG-PDQKPMCQCLEGFRLKSQFNQT-G- 325
WNE +W + S PD C +Y CG IC +C C+ G+ S N + G
Sbjct: 279 LRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGC 338
Query: 326 ----PIKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLKNCTCKAY 381
P+KCER+ S + D+F+ L ++K PDF E+ + ++ + C CL+NC+C AY
Sbjct: 339 RRRTPLKCERNIS---VGEDEFLTLKSVKLPDF-EIPEHNLVDPEDCRERCLRNCSCNAY 394
Query: 382 ANSNVTEGSGCLMWFGELLDASRPIRNFTGQSVYLRQPASGPG-NKKXXXXXXXXXXXXX 440
+ + G GC++W +L+D + G S+++R S G N+K
Sbjct: 395 S---LVGGIGCMIWNQDLVDLQQ--FEAGGSSLHIRLADSEVGENRKTKIAVIVAVLVGV 449
Query: 441 XXXSVYIFCRQRRKCKEKEN-----METSQDLLAFDITTRPNEFSEANG--DRRDKSK-- 491
++ R K K+ + T ++ D+T S +G D + K
Sbjct: 450 ILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAV 509
Query: 492 -DSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEE 550
S LP+FSL ++A AT +F E +LG GGFGPVYKG L +G E+AVKRLS +SGQG++E
Sbjct: 510 NTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDE 569
Query: 551 FKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARI 610
FKNE++LIAKLQHRNLVR+LGCC E EK+L+ EYMPNKSLD FLFD TK+ L+ W+ R
Sbjct: 570 FKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRF 629
Query: 611 GIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTK 670
IIEGIA+GLLYLH SR RIIHRDLK SNVLLD +MNPKISDFG+AR+FGG++ + NT
Sbjct: 630 SIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTV 689
Query: 671 RIVGT 675
R+VGT
Sbjct: 690 RVVGT 694
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 634 (228.2 bits), Expect = 1.7e-124, Sum P(2) = 1.7e-124
Identities = 120/181 (66%), Positives = 145/181 (80%)
Query: 495 LPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNE 554
L F + ++ AT NFS+ KLG+GGFG VYKG+L +G+E+AVKRLSS SGQG EEF NE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 555 MLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIE 614
++LI+KLQHRNLVR+LGCCIE+ EK+LI E+M NKSLD FLFD K+ + W R II+
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595
Query: 615 GIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVG 674
GIA+GLLYLHH SR R+IHRDLK SN+LLD MNPKISDFGLARM+ G E Q NT+R+VG
Sbjct: 596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655
Query: 675 T 675
T
Sbjct: 656 T 656
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1190 (424.0 bits), Expect = 5.8e-121, P = 5.8e-121
Identities = 282/705 (40%), Positives = 393/705 (55%)
Query: 1 MNGYSSMLQHLLSLIFF--LSMKVSLA-ADTVTPASFIRDGEKLVSSSQRFELGFFSPGK 57
M G++ L + +L+ F L VS + +++ T IR+G+ L+S + FELGFF+P
Sbjct: 1 MAGFNRNLTLVTTLLIFHQLCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKN 60
Query: 58 SKSRYLGIWFRKV-PDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASS 116
S RY+GIW++ + P TVVWVANR++P+ DH L I+++G LV++N N TIWSTN
Sbjct: 61 STLRYVGIWYKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEP 120
Query: 117 EAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLS 176
E+ N VA L G+LV+ +S + W+SF+ PTDT L M++ + R
Sbjct: 121 ESNNTVAVLFKTGDLVLCSDSD---RRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFI 177
Query: 177 SWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGEWTG---DGFVSALSNTNFLYK 233
W+S+ DPSPGK++ +D ++ + G + +G W G L TN++Y
Sbjct: 178 PWKSESDPSPGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYG 237
Query: 234 QFLVENQDE---ISYWYEPYNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCG 290
L D + + Y + + + P G + WN+D W+ L P C
Sbjct: 238 FKLSSPPDRDGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECE 297
Query: 291 KYGYCGANTICGPDQKPM----CQCLEGFRL--KSQFNQTG-PIKCERSHSSEC----IK 339
KY CG ++C D K C C++GF + Q+N C+R C +
Sbjct: 298 KYNRCGNYSVCD-DSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVA 356
Query: 340 G--DQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLKNCTCKAYANSNVTEGSGCLMWFG 397
G D F L IK PDF V L+ N + C C ++C+CKAYA + G GC++W
Sbjct: 357 GQEDGFTVLKGIKVPDFGSVVLHN--NSETCKDVCARDCSCKAYA---LVVGIGCMIWTR 411
Query: 398 ELLDASRPIRNFTGQSVYLRQPAS--GPGNKKXXXXXXXXXXXXXXXXSVYIFCRQRRKC 455
+L+D R G S+ +R S G G + + I+ + K
Sbjct: 412 DLIDMEHFERG--GNSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKK 469
Query: 456 KEKENMETSQDLLAFDITTRPNEFSEAN-----GDRRDKSKDSWLPLFSLASVAAATENF 510
K + +D+ DI ++S + GD+ D + D LP+FS SVA+AT +F
Sbjct: 470 SLKAFLWKKKDITVSDIIEN-RDYSSSPIKVLVGDQVD-TPD--LPIFSFDSVASATGDF 525
Query: 511 SMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
+ E KLG+GGFG VYKG G E+AVKRLS +S QGLEEFKNE+LLIAKLQHRNLVR+L
Sbjct: 526 AEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLL 585
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
GCCIE EK+L+ EYMPNKSLD FLFD +K+ L W+ R +I GIA+GLLYLH SR +
Sbjct: 586 GCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLK 645
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
IIHRDLKASN+LLD +MNPKISDFG+AR+F + NT R+VGT
Sbjct: 646 IIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGT 690
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 612 (220.5 bits), Expect = 6.7e-119, Sum P(2) = 6.7e-119
Identities = 121/194 (62%), Positives = 150/194 (77%)
Query: 483 NG-DRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLS 541
NG +R+D S ++ F + ++ AT NFS KLG+GGFGPVYKG+L++G+E+ VKRL+
Sbjct: 463 NGFERQDVSGVNF---FEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLA 519
Query: 542 SQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKK 601
S SGQG EEF NE+ LI+KLQHRNLVR+LG CI+ EK+LI E+M NKSLD+F+FDP K
Sbjct: 520 SSSGQGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLK 579
Query: 602 RLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
L W R II+GIA+GLLYLH SR R+IHRDLK SN+LLD MNPKISDFGLARMF
Sbjct: 580 FELDWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQ 639
Query: 662 GDELQGNTKRIVGT 675
G + Q NT+R+VGT
Sbjct: 640 GTQYQDNTRRVVGT 653
|
|
| TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1149 (409.5 bits), Expect = 1.3e-116, P = 1.3e-116
Identities = 282/690 (40%), Positives = 381/690 (55%)
Query: 11 LLSLIFFLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKV 70
LL LI F + + +T +P S G+ L S +ELGFFSP S+ +Y+GIWF+ +
Sbjct: 30 LLLLIIFPTFGYA-DINTSSPLSI---GQTLSSPDGVYELGFFSPNNSRKQYVGIWFKNI 85
Query: 71 -PDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDG 129
P VVWVANRD+P++ A LTIS+NG L+LL+ T IWST + + A+L D G
Sbjct: 86 APQVVVWVANRDKPVTKTAANLTISSNGSLILLDGTQDVIWSTGEAFTSNKCHAELLDTG 145
Query: 130 NLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKF 189
NLV+ D+ S T LW+SF+ +T+L + +D+ + R L+SWRS+ DPSPG+F
Sbjct: 146 NLVVIDDVSGKT----LWKSFENLGNTMLPQSSVMYDIPRGKNRVLTSWRSNSDPSPGEF 201
Query: 190 TNRLDIHVLPKMCTFNGSVKYTCTGEWTGDGFVSALSNTNFLYKQFLVENQD----EISY 245
T V P+ GS Y +G W F S + + Y QD S+
Sbjct: 202 TLEFTPQVPPQGLIRRGSSPYWRSGPWAKTRF-SGIPGIDASYVSPFTVLQDVAKGTASF 260
Query: 246 WYEPYNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQ 305
Y + + L+ G + + LWN D W F P C Y CG +C +
Sbjct: 261 SYSMLRNYKLSYVTLTSEGKM-KILWN-DGKSWKLHFEAPTSSCDLYRACGPFGLCVRSR 318
Query: 306 KPMCQCLEGFRLKS-----QFNQTG------PIKCERSHSSECIKG---DQFIKLDNIKA 351
P C CL+GF KS + N T + C ++SS +G D F + +K
Sbjct: 319 NPKCICLKGFVPKSDDEWKKGNWTSGCVRRTQLSCH-TNSSTKTQGKETDSFYHMTRVKT 377
Query: 352 PDFIEVSLNQSMNLQQCAAECLKNCTCKAYANSNVTEGSGCLMWFGELLDASRPIRNFTG 411
PD +++ +N +QC +CL NC+C A+A G GCL+W EL+D + + + G
Sbjct: 378 PDLYQLA--GFLNAEQCYQDCLGNCSCTAFA---YISGIGCLVWNRELVDTVQFLSD--G 430
Query: 412 QSVYLRQPAS---GPGNKKXXXXXXXXXXXXXXXX-SVYIFCRQRRKCKEKENM--ETSQ 465
+S+ LR +S G K + Y R R K E M +SQ
Sbjct: 431 ESLSLRLASSELAGSNRTKIILGTTVSLSIFVILVFAAYKSWRYRTKQNEPNPMFIHSSQ 490
Query: 466 DLLAFDITTRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVY 525
D A D+ P + S N LF + ++ AT NFS KLG+GGFGPVY
Sbjct: 491 DAWAKDM--EPQDVSGVN-------------LFDMHTIRTATNNFSSSNKLGQGGFGPVY 535
Query: 526 KGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585
KG+L++G+E+AVKRLSS SGQG +EF NE+ LI+KLQH+NLVR+LGCCI+ EK+LI EY
Sbjct: 536 KGKLVDGKEIAVKRLSSSSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEY 595
Query: 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR 645
+ NKSLDVFLFD T K + WQ R II+G+A+GLLYLH SR R+IHRDLK SN+LLD
Sbjct: 596 LVNKSLDVFLFDSTLKFEIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDE 655
Query: 646 DMNPKISDFGLARMFGGDELQGNTKRIVGT 675
M PKISDFGLARM G + Q NT+R+VGT
Sbjct: 656 KMIPKISDFGLARMSQGTQYQDNTRRVVGT 685
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 675 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-41 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 4e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-38 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 1e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-36 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 1e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-25 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 1e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-17 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 3e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-17 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 7e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.002 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.002 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 0.002 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.003 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.003 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.004 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.004 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 62/154 (40%), Positives = 86/154 (55%), Gaps = 10/154 (6%)
Query: 511 SMECKLGEGGFGPVYKGRLLNG-----EEVAVKRL-SSQSGQGLEEFKNEMLLIAKLQHR 564
++ KLGEG FG VYKG L EVAVK L S Q +EEF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
N+V++LG C E+ ++++EYMP L +L + + L + IA+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
S+ IHRDL A N L+ ++ KISDFGL+R
Sbjct: 121 --SK-NFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-41
Identities = 62/154 (40%), Positives = 84/154 (54%), Gaps = 11/154 (7%)
Query: 511 SMECKLGEGGFGPVYKGRLL-----NGEEVAVKRL-SSQSGQGLEEFKNEMLLIAKLQHR 564
++ KLGEG FG VYKG+L EVAVK L S Q +EEF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
N+V++LG C E+ +++EYM L +L K L + IA+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE 119
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
S+ IHRDL A N L+ ++ KISDFGL+R
Sbjct: 120 --SK-NFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 4e-41
Identities = 53/115 (46%), Positives = 71/115 (61%), Gaps = 6/115 (5%)
Query: 71 PDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGN 130
TVVWVANR P++D + L + ++G LVL + +WS+N S + VA L+DDGN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 131 LVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPS 185
LV+ DNS LWQSFD+PTDTLL K G ++ R L+SW+S+ DPS
Sbjct: 61 LVLYDNSG-----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 60/161 (37%), Positives = 83/161 (51%), Gaps = 11/161 (6%)
Query: 510 FSMECKLGEGGFGPVYKGRLL-----NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQH 563
+ KLGEG FG VYKG L +VAVK L + + EEF E ++ KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
N+VR+LG C + ++ EYMP L FL L + + + IA+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
S+ +HRDL A N L+ ++ KISDFGL+R D+
Sbjct: 119 E--SK-NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD 156
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 63/155 (40%), Positives = 86/155 (55%), Gaps = 14/155 (9%)
Query: 515 KLGEGGFGPVYKGRLLNGE----EVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRI 569
KLGEG FG VYKG+L + EVAVK L S + ++F E ++ KL H N+VR+
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARIGIIEGIAQGLLYL 623
LG C E+ L+LEYM L +L F +K L + + IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
S+ + +HRDL A N L+ D+ KISDFGL+R
Sbjct: 122 A--SK-KFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 51/119 (42%), Positives = 68/119 (57%), Gaps = 6/119 (5%)
Query: 35 IRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTIS 94
+ G+ LVSS FELGFF Y I ++ TVVWVANRD P S + LT+
Sbjct: 4 LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQ 62
Query: 95 NNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYP 153
++G LV+ + + +WS+N + N V L DDGNLV+ D+ N+LWQSFDYP
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 8e-38
Identities = 62/163 (38%), Positives = 88/163 (53%), Gaps = 10/163 (6%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC 573
LGEGGFG VY R G++VA+K + S LEE E+ ++ KL H N+V++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 574 IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIH 633
++ L++EY SL L + K L + I+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 634 RDLKASNVLLD-RDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
RDLK N+LLD + K++DFGL+++ D+ T IVGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 56/164 (34%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 515 KLGEGGFGPVYKGRLLN-GEEVAVKRL--SSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
KLG G FG VYK + G+ VAVK L S+ + + + E+ ++ +L H N+VR++
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 572 CCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRI 631
++ L++EY L +L ++ L I I +GL YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 632 IHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
IHRDLK N+LLD + KI+DFGLA+ + VGT
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGT 161
|
Length = 260 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 52/120 (43%), Positives = 70/120 (58%), Gaps = 7/120 (5%)
Query: 33 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLT 92
+ + G+ LVS + FELGFF+ Y I ++ TVVWVANRD P+SD + LT
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSSSRTVVWVANRDNPVSD-SCTLT 59
Query: 93 ISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDY 152
+ ++G LVL + +WS+N + N V L DDGNLVI D+ N+LWQSFDY
Sbjct: 60 LQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 56/173 (32%), Positives = 80/173 (46%), Gaps = 21/173 (12%)
Query: 510 FSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRNLV 567
+ + KLGEG FG VY R G+ VA+K + + + E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARIGIIEGIAQGLLY 622
R+ ++ + L++EY L L + R Q I L Y
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ--------ILSALEY 112
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
LH I+HRDLK N+LLD D + K++DFGLAR E VGT
Sbjct: 113 LH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 59/177 (33%), Positives = 83/177 (46%), Gaps = 21/177 (11%)
Query: 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRN 565
++ LG G FG VY GE +AVK LS S + LE + E+ +++ LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 566 LVRILGCCIEQGEKIL--ILEYMPNKSLDVFL-----FDPTKKRLLGWQARIGIIEGIAQ 618
+VR G ++ + L LEY+ SL L R Q I +
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--------ILE 112
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
GL YLH I+HRD+K +N+L+D D K++DFG A+ G E T + GT
Sbjct: 113 GLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 57/152 (37%), Positives = 82/152 (53%), Gaps = 13/152 (8%)
Query: 515 KLGEGGFGPVYKGRLLN-----GEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRNLVR 568
+LGEG FG V R GE+VAVK L+ S Q +F+ E+ ++ L H N+V+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 569 ILGCCIEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
G C + G + LI+EY+P+ SL +L + L I +G+ YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKGMDYLG-- 126
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
S+ R IHRDL A N+L++ + KISDFGLA+
Sbjct: 127 SQ-RYIHRDLAARNILVESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 56/172 (32%), Positives = 88/172 (51%), Gaps = 15/172 (8%)
Query: 509 NFSMECKLGEGGFGPVYKG-RLLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRN 565
N+ + +G G FG VYKG L G+ VA+K++S + + L+ E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARIGIIEGIAQGLLYL 623
+V+ +G +ILEY N SL + F P + L+ + + QGL YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-----AVYVYQVLQGLAYL 115
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
H +IHRD+KA+N+L +D K++DFG+A + +VGT
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 56/163 (34%), Positives = 91/163 (55%), Gaps = 11/163 (6%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC 573
K+G+GGFG VYK R G+EVA+K + +S + E+ NE+ ++ K +H N+V+ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 574 IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIG-IIEGIAQGLLYLHHYSRFRII 632
+++ E +++E+ SL L T + L +++I + + + +GL YLH II
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLT--ESQIAYVCKELLKGLEYLHSN---GII 120
Query: 633 HRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
HRD+KA+N+LL D K+ DFGL+ +VGT
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 59/158 (37%), Positives = 82/158 (51%), Gaps = 7/158 (4%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E+ +E KLG G FG V+ G +VAVK L + E F E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLV 64
Query: 568 RILGCCIEQGEKILIL-EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
++ C + E I I+ EYM SL FL K+L + + IA+G+ YL
Sbjct: 65 QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE-- 120
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
IHRDL A N+L+ ++ KI+DFGLAR+ DE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 53/152 (34%), Positives = 84/152 (55%), Gaps = 4/152 (2%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E F++E KLG G FG V++G N VA+K L S ++F+ E+ + +L+H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
+ C +I E M SL FL P + ++L + I + +A+G+ YL
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ- 123
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659
IHRDL A N+L+ D+ K++DFGLAR+
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-25
Identities = 30/65 (46%), Positives = 45/65 (69%)
Query: 337 CIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLKNCTCKAYANSNVTEGSGCLMWF 396
C GD F++L N+K PD +++S+ L++C CL NC+C AYA +++ GSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWT 60
Query: 397 GELLD 401
GEL+D
Sbjct: 61 GELVD 65
|
Length = 66 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 55/167 (32%), Positives = 88/167 (52%), Gaps = 15/167 (8%)
Query: 514 CKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEF----KNEMLLIAKLQHRNLVR 568
++GEG +G VYK R GE VA+K++ ++ + E F E+ L+ KL+H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62
Query: 569 ILGCCIE--QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
+ +G ++ EYM + L L P K Q + ++ + +GL YLH
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTES-QIK-CYMKQLLEGLQYLHSN 119
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIV 673
I+HRD+K SN+L++ D K++DFGLAR + T R++
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 54/156 (34%), Positives = 85/156 (54%), Gaps = 14/156 (8%)
Query: 516 LGEGGFGPVYKGRLL-NGE----EVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRI 569
LG G FG VYKG + GE VA+K L ++ + +E +E ++A + H ++VR+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 570 LGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSR 628
LG C+ ++ LI + MP L ++ + +G Q + IA+G+ YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYL---EE 127
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
R++HRDL A NVL+ + KI+DFGLA++ DE
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 67/153 (43%), Positives = 82/153 (53%), Gaps = 19/153 (12%)
Query: 516 LGEGGFGPV--YKGRLLN---GEEVAVKRLSSQSGQGLEE-FKNEMLLIAKLQHRNLVRI 569
LGEG FG V Y N GE VAVK L + GQ +K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 570 LGCCIEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH--H 625
GCC EQG K LI+EY+P SL +L K L + + I +G+ YLH H
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
Y IHRDL A NVLLD D KI DFGLA+
Sbjct: 128 Y-----IHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 54/166 (32%), Positives = 86/166 (51%), Gaps = 17/166 (10%)
Query: 515 KLGEGGFGPVYKG-RLLNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
K+GEG G VYK G+EVA+K RL Q+ + + NE+L++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYYD 82
Query: 572 CCIEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARIG-IIEGIAQGLLYLHHYSRF 629
+ E +++EYM SL D+ R+ + +I + + QGL YLH
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDII--TQNFVRMN--EPQIAYVCREVLQGLEYLH---SQ 135
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+IHRD+K+ N+LL +D + K++DFG A + + +VGT
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 57/159 (35%), Positives = 83/159 (52%), Gaps = 27/159 (16%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFK----NEMLLIAKLQHRNLVRI 569
KLGEG +G VYK R GE VA+K++ + E E+ L+ +L+H N+V+
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVK- 62
Query: 570 LGCCIEQGEKI-LILEYMPNKSLDVFL------FDPTKKRLLGWQARIGIIEGIAQGLLY 622
L I K+ L+ EY + L +L P + + +Q + +GL Y
Sbjct: 63 LLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQ--------LLRGLAY 113
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
H S RI+HRDLK N+L++RD K++DFGLAR FG
Sbjct: 114 CH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 60/165 (36%), Positives = 82/165 (49%), Gaps = 27/165 (16%)
Query: 516 LGEGGFGPVYKGRL--LNGEE----VAVKRL-SSQSGQGLEEFKNEMLLIAKLQHRNLVR 568
LGEG FG VYKG L N VA+K L + + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLLGWQARIGIIEG 615
+LG C ++ ++ EY+ + L FL D T K L + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 616 IAQGLLYL--HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
IA G+ YL HH+ +HRDL A N L+ + KISDFGL+R
Sbjct: 133 IAAGMEYLSSHHF-----VHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 58/165 (35%), Positives = 90/165 (54%), Gaps = 10/165 (6%)
Query: 511 SMECKLGEGGFGPVYKGRL-LNGEE---VAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRN 565
++E +G G FG V +GRL L G++ VA+K L + S + +F E ++ + H N
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
++R+ G + ++I EYM N SLD FL + K +G++ GIA G+ YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL-- 122
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTK 670
S +HRDL A N+L++ ++ K+SDFGL+R E TK
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRL-SSQSGQGLEEFKNEMLLIAKLQHRN 565
+ LG+G G VYK R G+ A+K++ + ++ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARI--GIIEGIAQGLLYL 623
+V+ G ++GE ++LEYM SL L K++ + I I +GL YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
H IIHRD+K SN+L++ KI+DFG+++
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISK 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 53/161 (32%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 516 LGEGGFGPVYKGRLLNGEE------VAVKRLSSQSGQGLEE-FKNEMLLIAKLQHRNLVR 568
LGEG FG V+ G + E VAVK L + + F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARIG---------IIEGIA 617
G C E I++ EYM + L+ FL P L + +G I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
G++YL + +HRDL N L+ D+ KI DFG++R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 49/144 (34%), Positives = 78/144 (54%), Gaps = 8/144 (5%)
Query: 516 LGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE 575
+G+G FG V G G++VAVK L S + F E ++ L+H NLV++LG ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 576 QGEKILILEYMPNKSLDVFLFDPTKKR-LLGWQARIGIIEGIAQGLLYLHHYSRFRIIHR 634
++ EYM SL +L ++ R ++ ++G + +G+ YL +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 635 DLKASNVLLDRDMNPKISDFGLAR 658
DL A NVL+ D+ K+SDFGLA+
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 14/171 (8%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
E F + KLGEG +G VYK G+ VA+K + + L+E E+ ++ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60
Query: 567 VRILGCCIEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARIGII-EGIAQGLLYLH 624
V+ G + + +++EY S D + T K L + I I +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLT--EEEIAAILYQTLKGLEYLH 116
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ IHRD+KA N+LL+ + K++DFG++ + NT ++GT
Sbjct: 117 ---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 8e-21
Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 23/172 (13%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKR--LSSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
++G+G FG VY R +G+ +K LS+ S + E+ NE+ ++ KL H N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 572 CCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEG--------IAQGLLYL 623
E+G+ +++EY L + KK+ + E + L YL
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKI----KKQK---KEGKPFPEEQILDWFVQLCLALKYL 119
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
H SR +I+HRD+K N+ L + K+ DFG++++ T +VGT
Sbjct: 120 H--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 6/155 (3%)
Query: 515 KLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCI 574
++G G FG V+ G L +VA+K + + E+F E ++ KL H LV++ G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 575 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHR 634
E+ L+ E+M + L +L ++ + +G+ + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 635 DLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT 669
DL A N L+ + K+SDFG+ R D+ +T
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 93.3 bits (230), Expect = 2e-20
Identities = 58/176 (32%), Positives = 89/176 (50%), Gaps = 14/176 (7%)
Query: 509 NFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQH-R 564
++ + KLGEG FG VY R + + VA+K L+ + + +E F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
N+V++ ++G L++EY+ SL+ L +K L + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 625 HYSRFRIIHRDLKASNVLLDRDMN-PKISDFGLARMFGGD----ELQGNTKRIVGT 675
IIHRD+K N+LLDRD K+ DFGLA++ + VGT
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
|
Length = 384 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 59/157 (37%), Positives = 81/157 (51%), Gaps = 6/157 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E + KLG G FG V+ G +VA+K L S E F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
R L + Q +I EYM N SL FL P +L I + IA+G+ ++
Sbjct: 65 R-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIE--- 119
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
R IHRDL+A+N+L+ + KI+DFGLAR+ +E
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 9e-20
Identities = 54/153 (35%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 515 KLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCI 574
KLG G FG V++G N VAVK L + ++F E ++ KL+H L+++ C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 575 EQGEKILIL-EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL--HHYSRFRI 631
E I I+ E M SL +L R L I + +A G+ YL +Y
Sbjct: 72 -LEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQNY----- 124
Query: 632 IHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
IHRDL A NVL+ + K++DFGLAR+ D
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDI 157
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 9e-20
Identities = 56/158 (35%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 516 LGEGGFGPVYKG--RLLNGEE--VAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
LG G FG V KG + +G+E VAVK L G +EF E ++A+L H +VR++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 571 GCCIEQGEK-ILILEYMPNKSLDVFLFDP---TKKRLLGWQARIGIIEGIAQGLLYLHHY 626
G C +GE +L++E P L +L L ++ A G+ YL
Sbjct: 63 GVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES- 113
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
F +HRDL A NVLL KISDFG++R G
Sbjct: 114 KHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 19/182 (10%)
Query: 506 ATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL---SSQSGQGLEEFKNEMLLIAKL 561
++ + KLGEG FG VYK R + G VA+K++ + + G + + E+ ++ KL
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64
Query: 562 QHRNLVRILGCCIEQGEKI--------LILEYMPNKSLDVFLFDPTKKRLLGWQARIGII 613
+H N+V ++ +E+ +K ++ YM + L L +P +L Q + +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENP-SVKLTESQIK-CYM 121
Query: 614 EGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIV 673
+ +G+ YLH I+HRD+KA+N+L+D KI+DFGLAR + G
Sbjct: 122 LQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 674 GT 675
GT
Sbjct: 179 GT 180
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 2e-19
Identities = 61/159 (38%), Positives = 92/159 (57%), Gaps = 12/159 (7%)
Query: 516 LGEGGFGPVYKGRLL-NGEEV----AVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRI 569
LG G FG VYKG + GE V A+K L+ +G + EF +E L++A + H +LVR+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
LG C+ + L+ + MP+ L ++ + K +G Q + IA+G++YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGN 668
R++HRDL A NVL+ + KI+DFGLAR+ GDE + N
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 19/164 (11%)
Query: 516 LGEGGFGPVYKGRLLNGE----EVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
LGEG FG V +G+L + +VAVK +L + +EEF +E + H N++++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 570 LGCCIEQGEK------ILILEYMPNKSLDVFLFDP---TKKRLLGWQARIGIIEGIAQGL 620
+G C E ++IL +M + L FL L Q + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR-MFGGD 663
YL S IHRDL A N +L DM ++DFGL++ ++ GD
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 52/173 (30%), Positives = 77/173 (44%), Gaps = 40/173 (23%)
Query: 509 NFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN-----------EML 556
+ KLGEG + VYK R G VA+K++ L E K E+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIK 54
Query: 557 LIAKLQHRNLVRILGCCIEQGEKILILEYMP--------NKSLDVFLFDPTKKRLLGWQA 608
L+ +L+H N++ +L + L+ E+M +KS+ L K +
Sbjct: 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI--VLTPADIKSYM-LM- 110
Query: 609 RIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
+GL YLH I+HRDLK +N+L+ D K++DFGLAR FG
Sbjct: 111 -------TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 54/173 (31%), Positives = 87/173 (50%), Gaps = 15/173 (8%)
Query: 509 NFSMECKLGEGGFGPVYKG-RLLNGEEVAVKR--LSSQSGQGLEEFKNEMLLIAKLQHRN 565
+F + K+G+G FG V+K R + A+K+ LS + + EE +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRL---LGWQARIGIIEGIAQGLLY 622
++R +++G+ +++EY N L L + L W+ I Q LL
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-------QILLG 113
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
L H +I+HRD+K+ N+ LD N KI D G+A++ + NT IVGT
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN--EMLLIAKLQHRNLVRILG 571
K+GEG +G VYK R L GE VA+K++ + E+ L+ +L H N++++L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 572 CCIEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+G+ L+ E+M + L + + + +Q + QGL + H
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQ--------LLQGLAFCH- 115
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663
I+HRDLK N+L++ + K++DFGLAR FG
Sbjct: 116 --SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 54/180 (30%), Positives = 85/180 (47%), Gaps = 30/180 (16%)
Query: 516 LGEGGFGPVYKGR---LLNGEE---VAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVR 568
+G+G FG V++ R LL E VAVK L + S +F+ E L+A+ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRL-------------------LGWQAR 609
+LG C L+ EYM L+ FL + + L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 610 IGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR-MFGGDELQGN 668
+ I + +A G+ YL S + +HRDL N L+ +M KI+DFGL+R ++ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 50/149 (33%), Positives = 76/149 (51%), Gaps = 6/149 (4%)
Query: 516 LGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE 575
LG G FG V+ G+ +VA+K + + ++F E ++ KL H NLV++ G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 576 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRD 635
Q ++ EYM N L +L +K LG + + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 636 LKASNVLLDRDMNPKISDFGLARMFGGDE 664
L A N L+ D K+SDFGLAR D+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQ 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 49/154 (31%), Positives = 82/154 (53%), Gaps = 6/154 (3%)
Query: 511 SMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
+M+ KLG G +G VY+G VAVK L + +EEF E ++ +++H NLV++
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
LG C + +I E+M +L +L + ++ + + + I+ + YL +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLE---KK 123
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663
IHRDL A N L+ + K++DFGL+R+ GD
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 57/154 (37%), Positives = 85/154 (55%), Gaps = 16/154 (10%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFK-NEMLLIAKLQHRNLVRIL 570
K+GEG +G VYK R L GE VA+K RL ++ +G+ E+ L+ +L H N+VR+L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLL 64
Query: 571 GCCIEQGEKILILEYMPNKSLDVFL---FDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
+ + L+ E+ LD+ L D + L + + QG+ Y H S
Sbjct: 65 DVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--S 117
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
R++HRDLK N+L+DR+ K++DFGLAR FG
Sbjct: 118 H-RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 54/162 (33%), Positives = 80/162 (49%), Gaps = 24/162 (14%)
Query: 516 LGEGGFGPVYKGRL-----LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
LG+G FG V R GE VAVK+L + + L +F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 571 GCCIEQGEK--ILILEYMPNKSLDVFL------FDPTKKRLLGWQARIGIIEGIAQGLLY 622
G C G + L++EY+P SL +L D K L Q I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
L R +HRDL N+L++ + KI DFGL ++ D+
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 55/157 (35%), Positives = 80/157 (50%), Gaps = 17/157 (10%)
Query: 516 LGEGGFGPVYKG--RLLNGE----EVAVKRL-SSQSGQGLEEFKNEMLLIAKLQHRNLVR 568
LG G FG VY+G R +G+ +VAVK L S S Q +F E L+++K H+N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARIGIIEGIAQGLLYLH 624
++G E+ + ++LE M L FL + P + L + + +A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 625 HYSRFRIIHRDLKASNVLLDR---DMNPKISDFGLAR 658
IHRD+ A N LL KI+DFG+AR
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 57/160 (35%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 516 LGEGGFGPVYKGRLLN----GEE---VAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLV 567
LG G FG VY+G + G VAVK L + Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKR----LLGWQARIGIIEGIAQGLLYL 623
++LG C+ + +I+E M L +L D +R LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 624 HHYSRFRIIHRDLKASNVLL-----DRDMNPKISDFGLAR 658
+ IHRDL A N L+ D D KI DFGLAR
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 54/149 (36%), Positives = 79/149 (53%), Gaps = 14/149 (9%)
Query: 515 KLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGL-EEFKNEMLLIAKLQHRNLVRILGCC 573
K+G+G FG VYKG L EVAVK S L +F E ++ + H N+V+++G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 574 IEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
+++ +++E +P SL FL T K+LL + A G+ YL S+
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQ------MSLDAAAGMEYLE--SK- 112
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLAR 658
IHRDL A N L+ + KISDFG++R
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 57/157 (36%), Positives = 81/157 (51%), Gaps = 5/157 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E+ + KLG G FG V+ G N +VAVK L + ++ F E L+ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
R+ ++ +I EYM SL FL ++L I IA+G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE--- 120
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
R IHRDL+A+NVL+ + KI+DFGLAR+ +E
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 54/151 (35%), Positives = 85/151 (56%), Gaps = 16/151 (10%)
Query: 516 LGEGGFGPVYKG-RLLNGEEVAVKRLS----SQSGQG-LEEFKNEMLLIAKLQHRNLVRI 569
LG G FG VY+G L +G+ AVK +S Q+GQ +++ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
LG E+ + LE +P SL L + + ++ R I GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH--D 120
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
R +HRD+K +N+L+D + K++DFG+A+
Sbjct: 121 R-NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 56/158 (35%), Positives = 82/158 (51%), Gaps = 26/158 (16%)
Query: 516 LGEGGFGPVYKG-RLLNGEEVAVKR--LSSQSGQG-------LEEFKNEMLLIAKLQHRN 565
+G G FG VY G +GE +AVK+ L S S L+ E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARIGIIEGIAQGL 620
+V+ LG ++ + LEY+P S+ L F+ T R + I +GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
YLH +R IIHRD+K +N+L+D KISDFG+++
Sbjct: 120 NYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 47/168 (27%), Positives = 87/168 (51%), Gaps = 21/168 (12%)
Query: 515 KLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQG--LEEFKNEMLLIAKLQHRNLVRILG 571
++GEG G V+K + GE VA+K+++ + +G + E+ + QH +V++L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 572 CCIEQGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+L++EYMP+ + + L + K + +++G+A Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYM-----RMLLKGVA----YMH- 116
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIV 673
I+HRDLK +N+L+ D KI+DFGLAR+F +E + + ++
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 54/177 (30%), Positives = 93/177 (52%), Gaps = 30/177 (16%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLS------SQSGQGLEEFKNEMLLIAKLQHRNLVR 568
LG G F Y+ R + G +AVK+++ S+ + +E + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
+LG E L +E+M S+ L + K+ ++ I E + +GL YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122
Query: 627 SRFRIIHRDLKASNVLLD---RDMNPKISDFGLA-----RMFGGDELQGNTKRIVGT 675
+IIHRD+K +N+L+D + + +I+DFG A + G E QG +++GT
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG---QLLGT 171
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 55/157 (35%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
K+GEG +G VYKGR G+ VA+K RL S+ E+ L+ +LQH N+V +
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 572 CCIEQGEKILILEYMP---NKSLDVF----LFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
+++ LI E++ K LD D + +Q I QG+L+ H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ--------ILQGILFCH 118
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
R++HRDLK N+L+D K++DFGLAR FG
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 54/153 (35%), Positives = 71/153 (46%), Gaps = 18/153 (11%)
Query: 515 KLGEGGFGPVYKGRLLN--GE--EVAVKRLSSQSGQG-LEEFKNEMLLIAKLQHRNLVRI 569
KLG+G FG V +G G+ VAVK L S +++F E ++ L H NL+R+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGII----EGIAQGLLYLHH 625
G + ++ E P SL L L I + IA G+ YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFL-----ISTLCDYAVQIANGMRYLE- 114
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
S+ R IHRDL A N+LL D KI DFGL R
Sbjct: 115 -SK-RFIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 51/153 (33%), Positives = 87/153 (56%), Gaps = 10/153 (6%)
Query: 516 LGEGGFGPVYKGRL-LNGEE---VAVKRLSS-QSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
+G G FG V++G L + G + VA+K L + + ++F +E ++ + H N++R+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
G + ++I EYM N +LD +L D +Q +G++ GIA G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQL-VGMLRGIAAGMKYL---SDMN 127
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663
+HRDL A N+L++ ++ K+SDFGL+R+ D
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-17
Identities = 34/110 (30%), Positives = 49/110 (44%), Gaps = 5/110 (4%)
Query: 213 TGEWTGDGFVSAL---SNTNFLYKQFLVENQDEISYWYEPYNRPSIMTLKLSPSGFVTRQ 269
+G W G F + ++Y EN +E+ Y Y N L LS G + R
Sbjct: 3 SGPWNGIRFSGIPEMQKLSYYVYN--FTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60
Query: 270 LWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPMCQCLEGFRLKS 319
W +S +W+ +S P D C YG CG C + P C C++GF K+
Sbjct: 61 TWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 52/159 (32%), Positives = 75/159 (47%), Gaps = 22/159 (13%)
Query: 510 FSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN--EMLLIAKLQ-HRN 565
+ + +LG+G FG VY R GE VA+K++ + EE N E+ + KL H N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 566 LVRILGCCIEQGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARIGIIEGIAQG 619
+V++ E E + EYM K F + R + +Q I QG
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQ--------ILQG 111
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
L ++H + F HRDLK N+L+ KI+DFGLAR
Sbjct: 112 LAHIHKHGFF---HRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 51/154 (33%), Positives = 83/154 (53%), Gaps = 22/154 (14%)
Query: 516 LGEGGFGPVYKGRL-LNGEE---VAVKRLSS-QSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
+G G FG V +GRL L G+ VA+K L S + + +F +E ++ + H N++ +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 571 GCCIEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
G + ++I E+M N +LD FL F + +G++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--------LVGMLRGIAAGMKYL- 122
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
S +HRDL A N+L++ ++ K+SDFGL+R
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 55/157 (35%), Positives = 85/157 (54%), Gaps = 21/157 (13%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLS-SQSGQGLEEFK-NEMLLIAKLQHRNLVRILG 571
K+GEG +G VYK R + E +A+K++ Q +G+ E+ L+ ++QH N+VR+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 572 CCIEQGEKILILEYMP---NKSLDV---FLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+ L+ EY+ K +D F +P + +Q I+ GIA Y H
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----YCHS 120
Query: 626 YSRFRIIHRDLKASNVLLDRDMNP-KISDFGLARMFG 661
+ R++HRDLK N+L+DR N K++DFGLAR FG
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154
|
Length = 294 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 51/152 (33%), Positives = 78/152 (51%), Gaps = 11/152 (7%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCI 574
LG+G +G VY R L +A+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 575 EQGEKILILEYMPNKSLDVFL---FDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRI 631
E G + +E +P SL L + P K Q I + I +GL YLH +I
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIIFYTKQILEGLKYLHDN---QI 129
Query: 632 IHRDLKASNVLLDRDMNP-KISDFGLARMFGG 662
+HRD+K NVL++ KISDFG ++ G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 12/150 (8%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---EMLLIAKLQHRNLVRIL 570
++G G FG VY R + E VA+K++S Q E++++ E+ + +L+H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIG-IIEGIAQGLLYLHHYSRF 629
GC + + L++EY + D+ + KK L + I I G QGL YLH + R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDIL--EVHKKPL--QEVEIAAICHGALQGLAYLHSHER- 136
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLARM 659
IHRD+KA N+LL K++DFG A +
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 65/183 (35%), Positives = 94/183 (51%), Gaps = 31/183 (16%)
Query: 512 MECKLGEGGFGPVYKGRLLN---GEE---VAVKRLSSQSGQGL-EEFKNEMLLIAKLQHR 564
ME +LGE FG VYKG L GE+ VA+K L ++ L EEFK+E ++ ++LQH
Sbjct: 10 ME-ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP 68
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLLGWQARIG 611
N+V +LG ++ +I Y + L FL D T K L +
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 612 IIEGIAQGLLYL--HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR-MFGGD--ELQ 666
I+ IA G+ +L HH ++H+DL NVL+ +N KISD GL R ++ D +L
Sbjct: 129 IVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 667 GNT 669
GN+
Sbjct: 184 GNS 186
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 16/156 (10%)
Query: 516 LGEGGFGPVYKGRLLNGEE------VAVKRLSSQSGQGLE-EFKNEMLLIAKLQHRNLVR 568
LG G FG V+ + EE V VK L + L+ EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARIGIIEGIAQGLLY 622
+LG C E +ILEY L FL + K L + ++ + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
L S R +HRDL A N L+ K+S L++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-17
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 11/92 (11%)
Query: 326 PIKCERSHSSECIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLKNCTCKAYANSN 385
P+ C S+ D F+KL ++K PD +++L++C CL NC+C AYA +N
Sbjct: 2 PLNCGGDGST-----DGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN 54
Query: 386 VTEGSGCLMWFGELLDASRPIRNFTGQSVYLR 417
GCL+W G L + + G ++YLR
Sbjct: 55 G--SGGCLLWNGLLNNLRSL--SSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 52/156 (33%), Positives = 86/156 (55%), Gaps = 8/156 (5%)
Query: 509 NFSMECKLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRN 565
NF K+GEG +G VYK R L GE VA+K RL +++ E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+V++L + + L+ E++ ++ L F+ D + + + + QGL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
+ R++HRDLK N+L++ + K++DFGLAR FG
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 54/165 (32%), Positives = 82/165 (49%), Gaps = 14/165 (8%)
Query: 516 LGEGGFGPVYKGRLLNGEEV-AVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILG 571
LG+G FG V R + ++ A+K L + + +E E +++++ H +V+ L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LH 59
Query: 572 CCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
+ EK+ L+LEY P L L + R +AR E I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAE-IVLALEYLH---SLG 113
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
II+RDLK N+LLD D + K++DFGLA+ + + NT GT
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 54/184 (29%), Positives = 81/184 (44%), Gaps = 32/184 (17%)
Query: 515 KLGEGGFGPVY------------KGRLLNGEE-----VAVKRL-SSQSGQGLEEFKNEML 556
KLGEG FG V+ K N VAVK L S E+F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 557 LIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL--------FDPTKKRLLGWQA 608
++++L N+ R+LG C +I+EYM N L+ FL + L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 609 RIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR-MFGGD--EL 665
+ + IA G+ YL +HRDL N L+ ++ KI+DFG++R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 666 QGNT 669
QG
Sbjct: 189 QGRA 192
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 53/161 (32%), Positives = 79/161 (49%), Gaps = 31/161 (19%)
Query: 516 LGEGGFGPVYKG-RLLNGEEVAVK----------RLSSQSGQGLEEFKNEMLLIAKLQHR 564
+G+G +G VY + GE +AVK R S+ ++ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 565 NLVRILGCCIEQGEKIL--ILEYMPNKSLDVFL-----FDPTKKRLLGWQARIGIIEGIA 617
N+V+ LG E E+ L LEY+P S+ L F+ R Q +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VL 118
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+GL YLH I+HRDLKA N+L+D D KISDFG+++
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 43/152 (28%), Positives = 83/152 (54%), Gaps = 6/152 (3%)
Query: 507 TENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565
+ + + +LG+G FG VYK + G A K + +S + LE+F E+ ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+V + + + +++E+ +LD + ++ L Q R + + + L +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH- 120
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
++IHRDLKA N+LL D + K++DFG++
Sbjct: 121 --SHKVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 54/163 (33%), Positives = 84/163 (51%), Gaps = 22/163 (13%)
Query: 509 NFSMECKLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRN 565
NF KLGEG + VYKGR GE VA+K L ++ G + E+ L+ +L+H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59
Query: 566 LVRILGCCIEQGEKILILEYMPN---KSLDVF----LFDPTKKRLLGWQARIGIIEGIAQ 618
+VR+ + + +L+ EYM K +D DP + +Q + +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LLK 111
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
G+ + H R++HRDLK N+L+++ K++DFGLAR FG
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 51/157 (32%), Positives = 87/157 (55%), Gaps = 16/157 (10%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLS-SQSGQGLEEFK-NEMLLIAKLQ---HRNLVRI 569
+GEG +G VYK R L G VA+K++ S +G+ E+ L+ +L+ H N+VR+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 570 LGCC-IEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
L C + ++ L+ E++ ++ L +L K L + ++ + +G+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
+ RI+HRDLK N+L+ D KI+DFGLAR++
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 58/157 (36%), Positives = 85/157 (54%), Gaps = 13/157 (8%)
Query: 516 LGEGGFGPV----YKGRLLN-GEEVAVKRLSSQSGQG-LEEFKNEMLLIAKLQHRNLVRI 569
LGEG FG V Y N GE+VAVK L +SG + + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 570 LGCCIEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
G C E G LI+E++P+ SL +L P K + + ++ I +G+ YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLG--S 127
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
R + +HRDL A NVL++ + KI DFGL + D+
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 56/171 (32%), Positives = 89/171 (52%), Gaps = 16/171 (9%)
Query: 509 NFSMECKLGEGGFGPVYKGRL-LNGEE---VAVKRLSS-QSGQGLEEFKNEMLLIAKLQH 563
+E +G G FG V GRL L G+ VA+K L + + + +F +E ++ + H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARI---GIIEGIAQGL 620
N++ + G + +++ EYM N SLD FL ++ G I G++ GIA G+
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL-----RKHDGQFTVIQLVGMLRGIASGM 119
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKR 671
YL S +HRDL A N+L++ ++ K+SDFGL+R+ D T R
Sbjct: 120 KYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 54/162 (33%), Positives = 80/162 (49%), Gaps = 21/162 (12%)
Query: 515 KLGEGGFGPVYKGR---LLNGEE---VAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVR 568
+LGEG FG V+ LL ++ VAVK L S ++F+ E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFL--FDPTKKRL----------LGWQARIGIIEGI 616
G C E +++ EYM + L+ FL P K L L + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 617 AQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
A G++YL + +HRDL N L+ + + KI DFG++R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 53/145 (36%), Positives = 79/145 (54%), Gaps = 10/145 (6%)
Query: 515 KLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCI 574
+GEG FG V +G G++VAVK + + F E ++ KL H+NLVR+LG +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 575 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARI-GIIEGIAQGLLYLHHYSRFRIIH 633
G I ++E M +L FL T+ R L ++ +A+G+ YL +++H
Sbjct: 70 HNGLYI-VMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 634 RDLKASNVLLDRDMNPKISDFGLAR 658
RDL A N+L+ D K+SDFGLAR
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 45/147 (30%), Positives = 80/147 (54%), Gaps = 12/147 (8%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC 573
++G G +G VYK R + GE VA+K + + G E + E+ ++ + +H N+V G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 574 IEQGEKILILEYMPNKSL-DVF--LFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
+ + + +++EY SL D++ P + + + R E + +GL YLH
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR----ETL-KGLAYLHE---TG 121
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLA 657
IHRD+K +N+LL D + K++DFG++
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 16/151 (10%)
Query: 515 KLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKN---EMLLIAKLQHRNLVRIL 570
+LG G G V K G+ +AVK + + K E+ ++ K +V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 571 GCCIEQGEKILILEYMPNKSLDVFL---FDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
G G+ + +EYM SLD L +R+LG I + +GL YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE-- 118
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ +IIHRD+K SN+L++ K+ DFG++
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 7/172 (4%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRN 565
+++ + +G G VY L N E+VA+KR+ + ++E + E+ +++ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+V+ + E L++ Y+ SL + + L +++ + +GL YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF--GGDELQGNTKRIVGT 675
+ IHRD+KA N+LL D + KI+DFG++ GGD + K VGT
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 16/151 (10%)
Query: 516 LGEGGFGPVY------KGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
LG+G FG VY GR L ++V S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
GC + + +EYMP S+ L + + + R I +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH--- 121
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
I+HRD+K +N+L D N K+ DFG ++
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 54/166 (32%), Positives = 90/166 (54%), Gaps = 24/166 (14%)
Query: 516 LGEGGFGPVYKGRLLNGE---EVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
LGEG FG V +G+L + +VAVK +++ + +E+F +E + + + H N++R++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 571 GCCIEQGEK------ILILEYMPNKSLDVFLFDPTKKRL------LGWQARIGIIEGIAQ 618
G C++ E ++IL +M + L FL RL L Q + + IA
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL---YSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA-RMFGGD 663
G+ YL S IHRDL A N +L+ +MN ++DFGL+ +++ GD
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 54/157 (34%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E+ +E KLG+G FG V+ G VA+K L + E F E ++ KL+H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
++ E+ I + EYM SL FL K L Q + + IA G+ Y+
Sbjct: 65 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 119
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
R +HRDL+A+N+L+ ++ K++DFGLAR+ +E
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 50/153 (32%), Positives = 85/153 (55%), Gaps = 19/153 (12%)
Query: 516 LGEGGFGPVYKGRLLNGE----EVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRIL 570
+G+G FG VY G L++ + AVK L+ + + +E+F E +++ H N++ +L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 571 GCCI-EQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARIGIIEGIAQGLLYLHH 625
G C+ +G +++L YM + L F+ PT K L+G+ ++ A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYL-- 114
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ + +HRDL A N +LD K++DFGLAR
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 40/180 (22%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRL-SSQSGQGLEEFKNEMLLIAK 560
+ ++ LGEG FG V K + VAVK L + + L + +EM ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 561 L-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD--------------PTKKRL-- 603
+ +H+N++ +LG C ++G +++EY + +L FL P ++ L
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 604 -----LGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+Q +A+G+ +L S+ + IHRDL A NVL+ D KI+DFGLAR
Sbjct: 132 KDLVSFAYQ--------VARGMEFLA--SK-KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 54/171 (31%), Positives = 82/171 (47%), Gaps = 29/171 (16%)
Query: 509 NFSMECKLGEGGFGPVYKGRLLN--GEE----VAVKRLSSQSGQGLEEFKNEMLLIAKLQ 562
N ++ +LGEG FG V+ N E+ VAVK L S ++F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLLGWQAR 609
H ++V+ G C+E I++ EYM + L+ FL P + L
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE---LTQSQM 122
Query: 610 IGIIEGIAQGLLYL--HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ I + IA G++YL H+ +HRDL N L+ ++ KI DFG++R
Sbjct: 123 LHIAQQIAAGMVYLASQHF-----VHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 50/158 (31%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLE-EFKNEMLLIAKLQHRN 565
E +LGEG G V K RL N + A+K +++ L+ + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 566 LVRILGCCIE--QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIG------IIEGIA 617
+V+ G ++ + +EY SLD K++ RIG I E +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY-----KKVKKRGGRIGEKVLGKIAESVL 115
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655
+GL YLH SR +IIHRD+K SN+LL R K+ DFG
Sbjct: 116 KGLSYLH--SR-KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 54/159 (33%), Positives = 81/159 (50%), Gaps = 6/159 (3%)
Query: 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565
E+ + KLG G FG V+ G +VAVK L + E F E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
LV++ E+ I + EYM SL FL D + R L + + +A G+ Y+
Sbjct: 63 LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
R IHRDL+++N+L+ + KI+DFGLAR+ +E
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 34/173 (19%)
Query: 510 FSMECKLGEGGFGPVYKGRLLN---GEEVAVKRL--SSQSGQGLEEFK-NEMLLIAKLQH 563
+ +E +G G +G VYK + N G+E A+K+ + G+ + E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 564 RNLVRILGCCIEQGEKI--LILEYMPNKSLDVFLF----------DPTKKRLLGWQARIG 611
N+V ++ +E +K L+ +Y + + F K LL WQ
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-WQ---- 116
Query: 612 IIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP----KISDFGLARMF 660
I G+ YLH S + ++HRDLK +N+L+ + KI D GLAR+F
Sbjct: 117 ----ILNGVHYLH--SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 56/164 (34%), Positives = 86/164 (52%), Gaps = 26/164 (15%)
Query: 516 LGEGGFGPVYKGRLL-NGEE----VAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRI 569
LG G FG V+KG + G+ VA+K + +SG Q +E + ML + L H +VR+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 570 LGCCIEQGEKI-LILEYMPNKSLDVFL------FDPTKKRLLGWQARIGIIEGIAQGLLY 622
LG C G + L+ + P SL + DP +RLL W +I A+G+ Y
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQI------AKGMYY 124
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQ 666
L + R++HR+L A N+LL D +I+DFG+A + D+ +
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 48/144 (33%), Positives = 83/144 (57%), Gaps = 6/144 (4%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC 573
+LG+G FG VYK + G A K + ++S + LE++ E+ ++A H +V++LG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 574 IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIH 633
G+ +++E+ P ++D + + + L Q ++ I + + L YLH +IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLH---SMKIIH 133
Query: 634 RDLKASNVLLDRDMNPKISDFGLA 657
RDLKA NVLL D + K++DFG++
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 52/150 (34%), Positives = 77/150 (51%), Gaps = 6/150 (4%)
Query: 515 KLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCI 574
+LG G FG V G+ +VA+K + S +EF E ++ KL H LV++ G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 575 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHR 634
+Q ++ EYM N L +L + KR Q + + + + +G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLRE-HGKRFQPSQL-LEMCKDVCEGMAYLESK---QFIHR 124
Query: 635 DLKASNVLLDRDMNPKISDFGLARMFGGDE 664
DL A N L+D K+SDFGL+R DE
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 31/172 (18%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLS--SQSGQGLEEFKNEMLLIA 559
E ++ +LG+G FG VY+G VA+K ++ + + +E F NE ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMK 64
Query: 560 KLQHRNLVRILGCCIEQGEKILILEYM-------------PNKSLDVFLFDPTKKRLLGW 606
+ ++VR+LG ++++E M P + L PT ++ +
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 607 QARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
A I A G+ YL + +HRDL A N ++ D+ KI DFG+ R
Sbjct: 125 AAEI------ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 49/149 (32%), Positives = 78/149 (52%), Gaps = 10/149 (6%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLS---SQSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
++G G FG VY R + N E VA+K++S QS + ++ E+ + KL+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
GC + + L++EY + D+ K+ L + G QGL YLH ++
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLARM 659
+IHRD+KA N+LL K+ DFG A +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 45/161 (27%), Positives = 70/161 (43%), Gaps = 23/161 (14%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKN----EMLLIAKLQ 562
+ + +GEG +G V K R GE VA+K+ E+ K E+ ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLR 58
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARIGIIEGIA 617
H N+V + +G L+ EY+ L++ P R WQ +
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LL 110
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
Q + Y H IIHRD+K N+L+ K+ DFG AR
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 16/169 (9%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNG-----EEVAVKRLSSQSGQ-GLEEFKNEMLLIAKL 561
+ ++ L EG FG ++ G L++ EEV VK + + + + E L+ L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKS-LDVFLFDP-----TKKRLLGWQARIGIIEG 615
H+N++ IL CIE GE +L N L +FL + L Q + +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR-MFGGD 663
IA G+ YLH + +IH+D+ A N ++D ++ KI+D L+R +F D
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 6/150 (4%)
Query: 515 KLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCI 574
+LG G FG V+ G+ +VA+K ++ + E+F E ++ KL H LV++ G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 575 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHR 634
+Q ++ E+M N L +L ++ L + + + + +G+ YL R IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHR 124
Query: 635 DLKASNVLLDRDMNPKISDFGLARMFGGDE 664
DL A N L+ K+SDFG+ R DE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 55/155 (35%), Positives = 86/155 (55%), Gaps = 12/155 (7%)
Query: 516 LGEGGFGPVYKGRLL-NGEE----VAVKRL-SSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
LG G FG VYKG + GE+ VA+K L + S + +E +E ++A + + ++ R+
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
LG C+ + LI + MP L ++ + K +G Q + IA+G+ YL
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEER--- 128
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
R++HRDL A NVL+ + KI+DFGLA++ G DE
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 58/174 (33%), Positives = 88/174 (50%), Gaps = 26/174 (14%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE--------VAVKRLSSQ-SGQGLEEFKNEMLLI 558
+ + LGEG FG V + ++ VAVK L + + L + +EM L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 559 AKL-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLL 604
+ +H+N++ +LG C ++G +I+EY +L FL FD TK + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 605 GWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
++ + +A+G+ YL SR R IHRDL A NVL+ D KI+DFGLAR
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 49/149 (32%), Positives = 80/149 (53%), Gaps = 10/149 (6%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---EMLLIAKLQHRNLVRIL 570
++G G FG VY R + E VA+K++S Q E++++ E+ + +++H N +
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
GC + + L++EY + D L + KK L + I G QGL YLH ++
Sbjct: 92 GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAITHGALQGLAYLHSHN--- 145
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLARM 659
+IHRD+KA N+LL K++DFG A +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 46/156 (29%), Positives = 81/156 (51%), Gaps = 21/156 (13%)
Query: 515 KLGEGGFGPVYKGRLLN-GEEVAVKRLSSQS-GQGLEEFK-NEMLLIAKLQHRNLVRILG 571
K+GEG +G V+K + E VA+KR+ +G+ E+ L+ +L+H+N+VR+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 572 CCIEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+ L+ EY ++ L + DP + +Q + +GL + H
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQ--------LLKGLAFCHS 117
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
+ ++HRDLK N+L++++ K++DFGLAR FG
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 10/174 (5%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS---SQSGQGLEEFKNEMLLIAKLQ 562
NF +E K+G+G F VYK LL+G VA+K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTK-KRLLGWQARIGIIEGIAQGLL 621
H N+++ L IE E ++LE L + K KRL+ + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
++H S+ RI+HRD+K +NV + K+ D GL R F ++ VGT
Sbjct: 121 HMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 27/175 (15%)
Query: 516 LGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCC 573
+GEG +G VYK R G+ VA+K + EE K E ++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 574 IEQGEKI------LILEYMPNKSL-DVFLFDPTKKRLLGWQARIG------IIEGIAQGL 620
I++ L++E S+ D+ K L R+ I+ +GL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
YLH ++IHRD+K N+LL ++ K+ DFG++ + NT +GT
Sbjct: 127 AYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIGT 176
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E+ ++ KLG+G FG V+ G +VA+K L + E F E ++ KL+H LV
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLV 64
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
+ E+ I + E+M SL FL + K L Q + + IA G+ Y+
Sbjct: 65 PLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE--- 119
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
R IHRDL+A+N+L+ ++ KI+DFGLAR+ +E
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 21/161 (13%)
Query: 516 LGEGGFGPVYKGRLLNG---EEVAVKRLSSQSGQG-LEEFKNEMLLIAKL-QHRNLVRIL 570
+GEG FG V K R+ + A+KR+ + + +F E+ ++ KL H N++ +L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 571 GCCIEQGEKILILEYMPNKSLDVFL-------FDP------TKKRLLGWQARIGIIEGIA 617
G C +G L +EY P+ +L FL DP + L Q + +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+G+ YL S+ + IHRDL A N+L+ + KI+DFGL+R
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 9/150 (6%)
Query: 510 FSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRNLV 567
F++ +G+G FG VYK + VA+K + ++ +E+ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
+ G ++ + +I+EY S D K L I+ + GL YLH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLH--- 115
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
IHRD+KA+N+LL + + K++DFG++
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 25/175 (14%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFK-----NEMLLIAKL 561
++F +GEG F V + +E A+K L + Q ++E K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 562 -QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARIGIIEG 615
H ++++ ++ +LEY PN L ++ D R
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--------YAAE 110
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTK 670
I L YLH S+ IIHRDLK N+LLD+DM+ KI+DFG A++ + + K
Sbjct: 111 ILLALEYLH--SK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 25/161 (15%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKR-LSSQSGQG-----LEEFKNEMLLIAKLQHRNLV 567
K+G+G FG V+K R + VA+K+ L +G L E K ++ L+H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 74
Query: 568 RILGCCIEQGEK--------ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG 619
++ C + L+ E+ + L L + K L ++ ++ + G
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV--MKMLLNG 131
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
L Y+H R +I+HRD+KA+N+L+ +D K++DFGLAR F
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 29/158 (18%)
Query: 515 KLGEGGFGPVYKG-RLLNGEEVAVKRLSSQSGQG--LEEFKNEMLLIAKLQHRNLVRILG 571
K+G G FG VY L GE +AVK + Q ++E +EM ++ L+H NLV+ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 572 CCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEG----------IAQGLL 621
+ + + + +EY +L+ L G I + +GL
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELL-------------EHGRILDEHVIRVYTLQLLEGLA 113
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659
YLH + I+HRD+K +N+ LD + K+ DFG A
Sbjct: 114 YLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 52/165 (31%), Positives = 77/165 (46%), Gaps = 26/165 (15%)
Query: 515 KLGEGGFGPVYKGRLLNGEE------VAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVR 568
+LGEG FG V+ N VAVK L + ++F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFL--FDPTKKRL-----------LGWQARIGIIEG 615
G C + I++ EYM + L+ FL P L LG + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 616 IAQGLLYL--HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
IA G++YL H+ +HRDL N L+ ++ KI DFG++R
Sbjct: 132 IASGMVYLASQHF-----VHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 48/144 (33%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 516 LGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLE-EFKNEMLLIAKLQHRNLVRILGCCI 574
LG+G FG V+KG L + VAVK Q L+ +F +E ++ + H N+V+++G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 575 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHR 634
++ +++E +P D F KK L + + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 635 DLKASNVLLDRDMNPKISDFGLAR 658
DL A N L+ + KISDFG++R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 57/164 (34%), Positives = 81/164 (49%), Gaps = 23/164 (14%)
Query: 515 KLGEGGFGPVYKGRL-LNGEE----VAVKRLSS-QSGQGLEEFKNEMLLIAKLQHRNLVR 568
+LGE FG +YKG L L G + VA+K L + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFLF--------------DPTKKRLLGWQARIGIIE 614
+LG ++ ++ EY+ L FL D T K L + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 615 GIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
IA G+ YL S F +H+DL A N+L+ ++ KISD GL+R
Sbjct: 132 QIAAGMEYLS--SHF-FVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 47/151 (31%), Positives = 82/151 (54%), Gaps = 16/151 (10%)
Query: 516 LGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGL------EEFKNEMLLIAKLQHRNLVRI 569
LG+G +G VY G G+ +AVK++ + L E+ + E+ L+ L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
LG C++ + +E++P S+ L F P + + + I++G+A YLH+
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHNNC 122
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
++HRD+K +NV+L + K+ DFG AR
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 54/190 (28%), Positives = 91/190 (47%), Gaps = 40/190 (21%)
Query: 515 KLGEGGFGPVYKGRLLNGEE-----------------VAVKRLSSQSGQGLE-EFKNEML 556
KLGEG FG V+ ++N ++ VAVK L + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 557 LIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL--------------FDPTKKR 602
++++L+ N++R+LG C+++ +I EYM N L+ FL P
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 603 LL--GWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR-M 659
L + + + + IA G+ YL S +HRDL N L+ ++ KI+DFG++R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 660 FGGD--ELQG 667
+ GD +QG
Sbjct: 189 YAGDYYRIQG 198
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 31/178 (17%)
Query: 509 NFSMECKLGEGGFGPVYKGRL--LNG----EEVAVKRLSSQSGQG-LEEFKNEMLLIAKL 561
N + LGEG FG V K L G VAVK L + L + +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTK--------------------- 600
H +++++ G C + G +LI+EY SL FL + K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 601 KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+R L I I++G+ YL + +++HRDL A NVL+ KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 52/162 (32%), Positives = 82/162 (50%), Gaps = 16/162 (9%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E+ +E KLG G FG V+ +VAVK + S +E F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKR-----LLGWQARIGIIEGIAQGLLY 622
+ L + + +I E+M SL FL + L+ + A+I A+G+ +
Sbjct: 65 K-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAF 117
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ + IHRDL+A+N+L+ + KI+DFGLAR+ +E
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 43/153 (28%), Positives = 85/153 (55%), Gaps = 11/153 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
E+F + ++G G +G VYK R +N GE A+K + + G+ + E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 567 VRILGCCIEQGEKILILEYMPNKSL-DVF-LFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
V G + + + + +E+ SL D++ + P + + + +R + QGL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
+ +HRD+K +N+LL + + K++DFG++
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 53/154 (34%), Positives = 84/154 (54%), Gaps = 15/154 (9%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRL---SSQSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
++GEG +G VY+ R +GE VA+K++ + + G + + E+ L+ L+H N+V +
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72
Query: 571 GCCI-EQGEKI-LILEYMPNKSLDVF-LFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
+ + + I L++EY D+ L D Q + ++ + +GL YLH
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ---DLASLLDNMPTPFSESQVK-CLMLQLLRGLQYLHE-- 126
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
F IIHRDLK SN+LL KI+DFGLAR +G
Sbjct: 127 NF-IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 52/181 (28%), Positives = 81/181 (44%), Gaps = 31/181 (17%)
Query: 515 KLGEGGFGPVYKGRLLNGEE---------------VAVKRLSSQ-SGQGLEEFKNEMLLI 558
KLGEG FG V+ E VAVK L + + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 559 AKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIE---- 614
++L++ N++R+LG C+ +I EYM N L+ FL + I +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 615 -----GIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR-MFGGD--ELQ 666
IA G+ YL + +HRDL N L+ KI+DFG++R ++ GD +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 667 G 667
G
Sbjct: 189 G 189
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 24/156 (15%)
Query: 516 LGEGGFGPVY------KGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
LG+G FG VY GR L ++V S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 570 LGCCIEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARIGII-----EGIAQGLLY 622
GC ++ EK L +EYMP S+ K +L + A + I +G+ Y
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSV--------KDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
LH I+HRD+K +N+L D N K+ DFG ++
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 32/182 (17%)
Query: 515 KLGEGGFGPVYKGRLLNGEE-----------------VAVKRLSSQSGQGLE-EFKNEML 556
KLGEG FG V+ E+ VAVK L + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 557 LIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL--------FDPTKKRLLGWQA 608
++++L+ N++R+L CI +I EYM N L+ FL + + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 609 RIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR-MFGGD--EL 665
I + IA G+ YL S +HRDL N L+ ++ KI+DFG++R ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 666 QG 667
QG
Sbjct: 189 QG 190
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 504 AAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQH 563
A + + +G+G FG V G G +VAVK + + + + F E ++ +L+H
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 58
Query: 564 RNLVRILGCCIEQ-GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
NLV++LG +E+ G ++ EYM SL +L + +LG + + + + Y
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
L + +HRDL A NVL+ D K+SDFGL +
Sbjct: 118 LEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 48/147 (32%), Positives = 76/147 (51%), Gaps = 10/147 (6%)
Query: 515 KLGEGGFGPVY-KGRLLNGEEVAVKRLSSQSGQGLEEFKN---EMLLIAKLQHRNLVRIL 570
++G G FG VY E VAVK++S Q E++++ E+ + +L+H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
GC +++ L++EY + D+ K+ L I G QGL YLH ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLA 657
+IHRD+KA N+LL K++DFG A
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA 168
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 25/173 (14%)
Query: 510 FSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQH 563
F++ LG+G FG V + +L + ++VAVK L + S +EEF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 564 RNLVRILGCCIEQGEK------ILILEYMPNKSLDVFLFDPTKKRL------LGWQARIG 611
N+++++G + K ++IL +M + L FL R+ L Q +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL---MSRIGEEPFTLPLQTLVR 117
Query: 612 IIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR-MFGGD 663
+ IA G+ YL S IHRDL A N +L+ +M ++DFGL++ ++ GD
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 45/168 (26%), Positives = 85/168 (50%), Gaps = 20/168 (11%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQG-LEEFKNEMLLIAKLQH---RNLVRIL 570
+G G +G VY+G+ + G VA+K ++ + + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 571 GCCIEQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
G ++ +I+EY S+ + P ++ + II + L Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALKYIHKVG-- 121
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRI--VGT 675
+IHRD+KA+N+L+ N K+ DFG+A + Q ++KR VGT
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 59/174 (33%), Positives = 88/174 (50%), Gaps = 39/174 (22%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL---SSQSG---QGLEEFKNEMLLIAK 560
+ + ++ EG +G VY+ R GE VA+K+L + G L E +LL K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI--NILL--K 60
Query: 561 LQHRNLVRI----LGCCIEQGEKI-LILEYMPN--KSL-----DVFLFDPTKKRLLGWQA 608
LQH N+V + +G ++ KI +++EY+ + KSL FL K +L Q
Sbjct: 61 LQHPNIVTVKEVVVGSNLD---KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML--Q- 114
Query: 609 RIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662
++ G+A +LH I+HRDLK SN+LL+ KI DFGLAR +G
Sbjct: 115 ---LLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 51/164 (31%), Positives = 89/164 (54%), Gaps = 13/164 (7%)
Query: 515 KLGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQG-LEEFKNEMLLIAKLQHRNLVRILGC 572
++G+G FG VYKG +EV A+K + + + +E+ + E+ ++++ + R G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 573 CIEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRI 631
++ + +I+EY+ S LD+ P ++ + I+ I +GL YLH R
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE---RK 122
Query: 632 IHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
IHRD+KA+NVLL + K++DFG+A +++ NT VGT
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 54/157 (34%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 516 LGEGGFGPVYKGRLL-NGEE----VAVKRL-SSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
LG G FG VYKG + +GE VA+K L + S + +E +E ++A + + R+
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
LG C+ + L+ + MP L ++ + K +G Q + IA+G+ YL
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEE---V 128
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQ 666
R++HRDL A NVL+ + KI+DFGLAR+ DE +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 8/150 (5%)
Query: 516 LGEGGFGPVYKGRLLNGE-EVAVKRLSSQSGQGLEEF--KNEMLLIAKLQHRNLVRILGC 572
+G G FG V+ R + V +K++ + E +NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 573 CIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRII 632
+E ++++EY P +L ++ +KR I+ Q LL LHH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYI----QKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 633 HRDLKASNVLLDR-DMNPKISDFGLARMFG 661
HRDLK N+LLD+ M KI DFG++++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILS 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 32/180 (17%)
Query: 515 KLGEGGFGPVYK-GRLLNGEEVAVKRLSSQSGQGLEEFKNEML-----LIAKLQHRNLV- 567
+G+G FG V K R +G+ + K + + + E + + L ++ +L+H N+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 568 ---RILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIG---IIEGIAQGL 620
RI+ + + +++EY L + K+R I I + Q L
Sbjct: 64 YYDRII---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERK-----YIEEEFIWRILTQLL 115
Query: 621 LYLHH-----YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
L L+ ++HRDLK +N+ LD + N K+ DFGLA++ G D K VGT
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 45/146 (30%), Positives = 82/146 (56%), Gaps = 10/146 (6%)
Query: 515 KLGEGGFGPVYKGRLLNGEE---VAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
+LG+G FG VYK + N E A K + ++S + LE++ E+ ++A H N+V++L
Sbjct: 12 ELGDGAFGKVYKAQ--NKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 572 CCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRI 631
+ +++E+ ++D + + ++ L Q R+ + + + L YLH +I
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN---KI 124
Query: 632 IHRDLKASNVLLDRDMNPKISDFGLA 657
IHRDLKA N+L D + K++DFG++
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 50/162 (30%), Positives = 84/162 (51%), Gaps = 21/162 (12%)
Query: 509 NFSMECKLGEGGFGPVYK-GRLLNGEEVAVKR--LSSQSGQGLEEFKNEMLLIAKLQHRN 565
+F + KLG+G +G VYK RL + + A+K L S S + E+ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 566 LVR-----ILGC--CIEQGEKILILEYMPNKSLDVFLFDPTK-KRLLGWQARIGIIEGIA 617
++ + G CI ++EY P L + K ++L+ Q I +
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659
+GL LH +I+HRDLK++N+LL + KI D G++++
Sbjct: 114 RGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV 152
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 25/171 (14%)
Query: 508 ENFSMECKLGEGGFGPVYK------GRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL 561
E+ E +GEG FG V + G +N +K +S++ +F E+ ++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH--RDFAGELEVLCKL 59
Query: 562 -QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-------FDPTKKR------LLGWQ 607
H N++ +LG C +G + +EY P +L FL DP + L Q
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 608 ARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ +A G+ YL S + IHRDL A NVL+ ++ KI+DFGL+R
Sbjct: 120 QLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 54/176 (30%), Positives = 86/176 (48%), Gaps = 20/176 (11%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL-----SSQSGQGLEEFKNEMLLIAKL 561
+ + KLG+G +G V+K E VA+K++ ++ Q F+ M L
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTFREIMFLQELG 64
Query: 562 QHRNLVRILGCCIEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG 619
H N+V++L + +K L+ EYM + L + +L + I+ + +
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
L Y+H S +IHRDLK SN+LL+ D K++DFGLAR EL+ N + V T
Sbjct: 120 LKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLT 170
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 52/166 (31%), Positives = 86/166 (51%), Gaps = 26/166 (15%)
Query: 516 LGEGGFGPVYKGRLLNGEE--------VAVKRLSSQSGQ-GLEEFKNEMLLIAKL-QHRN 565
LGEG FG V + ++ VAVK L S + + L + +EM ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARIGI 612
++ +LG C + G +I+EY +L +L ++PT+ + L ++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 613 IEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+A+G+ YL + + IHRDL A NVL+ D KI+DFGLAR
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 44/153 (28%), Positives = 81/153 (52%), Gaps = 11/153 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
++ + ++G G +G VYK R L GE AVK + + G + E+ ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 567 VRILGCCIEQGEKILILEYMPNKSL-DVF-LFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
V G + + + + +EY SL D++ + P + + + R + QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
+ +HRD+K +N+LL + + K++DFG+A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 57/164 (34%), Positives = 86/164 (52%), Gaps = 25/164 (15%)
Query: 505 AATENFSMECKLGEGGFGPVYKG-RLLNGEEVAVKRLSSQSGQGLEEFK--NEMLLIAKL 561
AAT ++E KLGEG + VYKG +NG+ VA+K +S ++ +G+ F E L+ L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60
Query: 562 QHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFL------FDPTKKRLLGWQARIGIIE 614
+H N+V +L I E + + EYM + L ++ P RL +Q
Sbjct: 61 KHANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ------- 111
Query: 615 GIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ +GL Y+H I+HRDLK N+L+ K++DFGLAR
Sbjct: 112 -LLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 40/180 (22%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQG------------------LEEFKNEML 556
LGEG +G V K L G+ VA+K++ L E K
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK---- 72
Query: 557 LIAKLQHRNLVRILGCCIEQGEKILILEYMPN---KSLD--VFLFDPTKKRLLGWQARIG 611
++ +++H N++ ++ +E L+++ M + K +D + L + K +L Q
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-LQ---- 127
Query: 612 IIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKR 671
I GL LH + +HRDL +N+ ++ KI+DFGLAR +G +
Sbjct: 128 ----ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
|
Length = 335 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 49/179 (27%), Positives = 89/179 (49%), Gaps = 23/179 (12%)
Query: 510 FSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFK----NEMLLIAKLQHR 564
F + ++GEG +G VYK R GE VA+K++ + + E F E+ ++ +L HR
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHR 66
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW----------QARIGIIE 614
N+V + + K L++ +K +F+ L+G ++
Sbjct: 67 NIVNLKEIVTD---KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 615 GIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIV 673
+ +GL Y H + +HRD+K SN+LL+ K++DFGLAR++ +E + T +++
Sbjct: 124 QLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 52/155 (33%), Positives = 76/155 (49%), Gaps = 24/155 (15%)
Query: 514 CKLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
KLGEG + VYKGR L G+ VA+K RL + G + E L+ L+H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TL 68
Query: 571 GCCIEQGEKI-LILEYMPNKSLDVFL------FDPTKKRLLGWQARIGIIEGIAQGLLYL 623
I + + L+ EY+ + L ++ RL +Q + +GL Y
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ--------LLRGLAYC 119
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
H R++HRDLK N+L+ K++DFGLAR
Sbjct: 120 HQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 16/157 (10%)
Query: 515 KLGEGGFGPVYKG--RLLNGEE-VAVKRLSSQSGQGLEEFKNEMLLIAK----LQHRNLV 567
+LG G FG V KG ++ E+ VAVK L + + K+E+L A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
R++G C E +L++E L+ FL K + + + ++ ++ G+ YL +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+HRDL A NVLL KISDFGL++ G DE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 24/162 (14%)
Query: 509 NFSMECKLGEGGFGPVY--KGRLLNGEEVAVKR--LSSQSGQGLEEFKNEMLLIAKLQHR 564
+ + K+GEG FG +Y K + + E +K L+ + E K E++L+AK++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDS-EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSL-------DVFLFDPTKKRLLGWQARIGIIEGIA 617
N+V E G +++EY L LF ++ ++L W +I +
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQISL----- 112
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRD-MNPKISDFGLAR 658
GL ++H +I+HRD+K+ N+ L ++ M K+ DFG+AR
Sbjct: 113 -GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 516 LGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCI 574
+G G +G VYKGR + ++A ++ +G EE K E+ ++ K HRN+ G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 575 EQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSR 628
++ + L++E+ S+ L TK L + I I +GL +LH +
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
++IHRD+K NVLL + K+ DFG++ D G +GT
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 174
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 10/154 (6%)
Query: 515 KLGEGGFGPVYKG--RLLNGE-EVAVKRLSSQSGQGL-EEFKNEMLLIAKLQHRNLVRIL 570
+LG G FG V KG ++ + +VA+K L +++ + + +E E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
G C E +L++E L+ FL KK + + ++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+HRDL A NVLL KISDFGL++ G D+
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 49/155 (31%), Positives = 70/155 (45%), Gaps = 21/155 (13%)
Query: 515 KLGEGGFGPVYKG---RLLNGEEVAVKRL-SSQSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
++G G FG V G R ++ V VK L +S + F E+ +L H N+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 571 GCCIEQGEKILILEYMPNKSLDVFL--------FDPTKKRLLGWQARIGIIEGIAQGLLY 622
G CIE +L+LE+ P L +L K L + A GLL+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV------ASGLLW 115
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
LH + IH DL N L D++ KI D+GLA
Sbjct: 116 LH---QADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 25/182 (13%)
Query: 508 ENFSMECKLGEGGFGPVY------KGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL 561
N+ + LG G FG VY GR L ++V S ++ + + + E+ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 562 QHRNLVRILGCCIEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARIGII-----E 614
+H +V+ GC + EK L +EYMP S+ K +L + A +
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI--------KDQLKAYGALTENVTRRYTR 113
Query: 615 GIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGN-TKRIV 673
I QG+ YLH I+HRD+K +N+L D N K+ DFG ++ + G K +
Sbjct: 114 QILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 674 GT 675
GT
Sbjct: 171 GT 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 51/149 (34%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 515 KLGEGGFGPVYKGRL---LNGEEVAVKRL-SSQSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
++G G FG V G + +V VK L S S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARI--GIIEGIAQGLLYLHHYSR 628
G C E +L++E+ P L +L K L+ + IA GLL+LH +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---K 118
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLA 657
IH DL N LL D+ KI D+GL+
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 50/180 (27%), Positives = 91/180 (50%), Gaps = 10/180 (5%)
Query: 497 LFSLASVAAATENFSMECKLGEGGFGPVYKG-RLLNGEEVAVKRLSSQSGQGLEEFKNEM 555
L ++ SV + ++ K+G+G G VY + G+EVA+K+++ Q E NE+
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 556 LLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEG 615
L++ + +H N+V L + E +++EY+ SL D + + +
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
Q L +LH ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 515 KLGEGGFGPVYKG--RLLNGEE--VAVKRLSSQSGQGL-EEFKNEMLLIAKLQHRNLVRI 569
+GEG FG VY+G E+ VAVK + + + E+F E ++ + H ++V++
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
+G E I ++E P L +L K L + I ++ L YL S+
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLE--SK- 126
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLAR 658
R +HRD+ A NVL+ K+ DFGL+R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 49/176 (27%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 509 NFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS---SQSGQGLEEFKNEMLLIAKLQHR 564
NF +E K+G G F VY+ LL+ + VA+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLD-VFLFDPTKKRLLG----WQARIGIIEGIAQG 619
N+++ L IE E ++LE L + + +KRL+ W+ + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
H +SR R++HRD+K +NV + K+ D GL R F ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 49/180 (27%), Positives = 92/180 (51%), Gaps = 10/180 (5%)
Query: 497 LFSLASVAAATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEM 555
L ++ S+ + ++ K+G+G G V+ + G+EVA+K+++ Q E NE+
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 556 LLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEG 615
L++ +L++ N+V L + E +++EY+ SL D + + +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
Q L +LH ++IHRD+K+ NVLL D + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 50/180 (27%), Positives = 91/180 (50%), Gaps = 10/180 (5%)
Query: 497 LFSLASVAAATENFSMECKLGEGGFGPVYKG-RLLNGEEVAVKRLSSQSGQGLEEFKNEM 555
L S+ SV + ++ K+G+G G VY + G+EVA+K+++ Q E NE+
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 556 LLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEG 615
L++ + ++ N+V L + E +++EY+ SL D + + +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
Q L +LH ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 42/166 (25%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 516 LGEGGFGP--VYK----GRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
LG+G FG +Y+ L+ +EV + RLS + + NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
++ ++ +EY +L + K +L + + + I + Y+H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
I+HRD+K N+ L + K+ DFG++++ G + T +VGT
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 516 LGEGGFGPVY--------KGRLLNGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKL-QHRN 565
LGEG FG V K + VAVK L + + L + +EM ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARIGI 612
++ +LG C + G +++EY +L +L FD K + L ++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 613 IEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+A+G+ YL + + IHRDL A NVL+ D KI+DFGLAR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 25/163 (15%)
Query: 516 LGEGGFGPVYK------GRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVR 568
+GEG FG V K G ++ +K +S+ +F E+ ++ KL H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 60
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFL-------FDPTKKRLLGWQARIG------IIEG 615
+LG C +G L +EY P+ +L FL DP + +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+A+G+ YL S+ + IHRDL A N+L+ + KI+DFGL+R
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 25/174 (14%)
Query: 516 LGEGGFGPVYKGRLLN-GEEVAVKRL-----SSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
LG+G FG VY + G E+AVK++ S ++ + + + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 570 LGCCIEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARIGII-----EGIAQGLLY 622
GC + E+ L +E+MP S+ K +L + A + I +G+ Y
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSI--------KDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGN-TKRIVGT 675
LH I+HRD+K +N+L D N K+ DFG ++ L G K + GT
Sbjct: 122 LHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 45/158 (28%), Positives = 84/158 (53%), Gaps = 17/158 (10%)
Query: 515 KLGEGGFGPVYKGRLLN--GEEVAVKRL---SSQSGQGLEEFKNEMLL--IAKLQHRNLV 567
++GEG +G V+K R L G VA+KR+ + + G L + +L + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 568 RILGCCI-----EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
R+ C + + L+ E++ ++ L +L D + + + ++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
LH + R++HRDLK N+L+ K++DFGLAR++
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 510 FSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFK---NEMLLIAKLQHRN 565
F + ++G+GG+G V+ + + GE VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
LV++L + L +EY+P L L AR + E + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALH- 118
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
IHRDLK N L+D + K++DFGL+
Sbjct: 119 --ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 47/146 (32%), Positives = 73/146 (50%), Gaps = 7/146 (4%)
Query: 515 KLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLE-EFKNEMLLIAKLQHRNLVRILGC 572
++G G FG V+ GRL + VAVK L+ +F E ++ + H N+VR++G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 573 CIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRII 632
C ++ +++E + FL T+ L + I ++E A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 633 HRDLKASNVLLDRDMNPKISDFGLAR 658
HRDL A N L+ KISDFG++R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 5e-11
Identities = 49/180 (27%), Positives = 88/180 (48%), Gaps = 10/180 (5%)
Query: 497 LFSLASVAAATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEM 555
L S+ SV + ++ K+G+G G VY + G+EVA+++++ Q E NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 556 LLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEG 615
L++ + ++ N+V L + E +++EY+ SL D + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
Q L +LH ++IHRD+K+ N+LL D + K++DFG + Q +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC 573
K+GEG G V R +G +VAVK + + Q E NE++++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 574 IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIH 633
+ E +++E++ +L D + L + + E + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 634 RDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
RD+K+ ++LL D K+SDFG D + K +VGT
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGT 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 7e-11
Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 45/172 (26%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---------EMLLIAKLQHRN 565
+G G +G V G +VA+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLD----VF-LFDPTKKRLLGWQARIGIIEGIAQ-- 618
++ +L IL + + V L + +++ ++ + + Q
Sbjct: 61 IIGLL----------DILRPPSPEDFNDVYIVTELMETDLHKVI--KSPQPLTDDHIQYF 108
Query: 619 ------GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
GL YLH +IHRDLK SN+L++ + + KI DFGLAR DE
Sbjct: 109 LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 7e-11
Identities = 53/167 (31%), Positives = 76/167 (45%), Gaps = 21/167 (12%)
Query: 516 LGEGGFGPVYKGRLLNGEEV-AVKRLSSQ----SGQGLEEFKNEMLLIAKLQHRNLVRIL 570
LG G FG V R + A+K LS Q +E NE ++ ++H LV +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKK--RLLGWQARIGIIEGIAQGLLYLHHYSR 628
G + L++EY+P L F +K R AR + + L YLH
Sbjct: 68 GSFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARFYAAQ-VVLALEYLHSLD- 121
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
I++RDLK N+LLD D KI+DFG A+ ++G T + GT
Sbjct: 122 --IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 42/143 (29%), Positives = 73/143 (51%), Gaps = 10/143 (6%)
Query: 515 KLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC 573
K+GEG G V + G +VAVK++ + Q E NE++++ QH N+V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 574 IEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRII 632
+ E +++E++ +L D+ T R+ Q + + + L +LH +I
Sbjct: 86 LVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAT-VCLAVLKALSFLHAQ---GVI 137
Query: 633 HRDLKASNVLLDRDMNPKISDFG 655
HRD+K+ ++LL D K+SDFG
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 48/161 (29%), Positives = 70/161 (43%), Gaps = 33/161 (20%)
Query: 516 LGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKN---EMLLIAKLQHRNLVRILG 571
+G G +G V G +VA+K+LS + Q K E+ L+ + H N++ +L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 572 CCIEQGEKILILEYMPNKSL----DVFLFDP---------TKKRLLGWQARIGIIEGIAQ 618
+ P SL DV+L K + L ++ I +
Sbjct: 82 V------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659
GL Y+H IIHRDLK SN+ ++ D KI DFGLAR
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 516 LGEGGFGPVYKGRLLNGEE--------VAVKRLSSQSGQ-GLEEFKNEMLLIAKL-QHRN 565
LGEG FG V L ++ VAVK L + + L + +EM ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARIGI 612
++ +LG C + G +I+EY +L +L +D + + ++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 613 IEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+A+G+ YL + + IHRDL A NVL+ + KI+DFGLAR
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 49/147 (33%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 515 KLGEGGFGPVYKGRL-LNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
KLGEG + VYKGR L VA+K RL + G + E+ L+ L+H N+V +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 572 CCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRI 631
+ L+ EY+ +K L +L D + ++ + + + +GL Y H R ++
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQ-LLRGLNYCH---RRKV 125
Query: 632 IHRDLKASNVLLDRDMNPKISDFGLAR 658
+HRDLK N+L++ K++DFGLAR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 13/151 (8%)
Query: 514 CKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEEFKNEMLLIAKLQHR-----NLV 567
+LG G +G V K R + + AVKR+ + +E K +L+ + R V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQK-RLLMDLDISMRSVDCPYTV 63
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIE-GIAQGLLYLHHY 626
G +G+ + +E M + SLD F K L + +G I I + L YLH
Sbjct: 64 TFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH-- 120
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
S+ +IHRD+K SNVL++R+ K+ DFG++
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 24/170 (14%)
Query: 500 LASVAAATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN----- 553
+V T + +G G FG V R L G+ VA+K++ ++ F
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54
Query: 554 ----EMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 609
E+ L+ L+H N++ + I E I + + L L R L Q
Sbjct: 55 RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFI 110
Query: 610 IGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659
+ I +GL Y+H ++HRDLK SN+L++ + + KI DFGLAR+
Sbjct: 111 QYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 510 FSMECKLGEGGFGPVY---KGRLLNGEEVAV-KRLSSQSGQGLEEFKN--EMLLIAKLQH 563
+ ++ +LG+G FG VY + + E + V K + E + E L++KL H
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARIGIIEGIAQGLL 621
+V+ +E+ +I EY + LD L T K L Q + E Q LL
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ----VCEWFIQLLL 117
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662
+H+ + RI+HRDLKA N+ L ++ KI DFG++R+ G
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 515 KLGEGGFGPVYKG---RLLNGE---EVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRNLV 567
+LG+G FG VY+G ++ GE VAVK ++ S S + EF NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLF-------DPTKKRLLGWQARIGIIEGIAQGL 620
R+LG + ++++E M + L +L + + Q I + IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
YL+ + +HRDL A N ++ D KI DFG+ R
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 18/153 (11%)
Query: 514 CKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN--EMLLIAKLQ-HRNLVRI 569
K+GEG F V K + G+ A+K + + + LE+ N E+ + +L H N++R+
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 570 LGCCIEQ--GEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARIGIIEGIAQGLLYLHH 625
+ ++ G L+ E M D+ L++ K KR L + R+ + Q L L H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP-EKRVKSY--MYQLLKSLDH 115
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
R I HRD+K N+L+ D K++DFG R
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 12/159 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRL--LNGEE----VAVKRLSSQSGQGLEE-FKNEMLLIAK 560
N S LG G FG V + L+ + VAVK L + E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 561 L-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG 619
L H N+V +LG C G ++I EY L FL ++ L + + +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ +L + IHRDL A NVLL KI DFGLAR
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 52/174 (29%), Positives = 80/174 (45%), Gaps = 30/174 (17%)
Query: 519 GGFGPVYKGR-LLNGEEVAVKRLSSQSGQG---LEEFKNEMLLIAKLQHRNLVRILGCCI 574
G +G V+ + G+ A+K + +++ E ++++ Q +V++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 575 EQGEKILIL--EYMPNKSLDVFL-----FDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
QG+K L L EY+P L L D ARI I E I L YLH
Sbjct: 63 -QGKKNLYLVMEYLPGGDLASLLENVGSLDED-------VARIYIAE-IVLALEYLH--- 110
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLA------RMFGGDELQGNTKRIVGT 675
IIHRDLK N+L+D + + K++DFGL+ R ++ + KRIVGT
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 49/147 (33%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 515 KLGEGGFGPVYKGRL-LNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
KLGEG + V+KGR L VA+K RL + G + E+ L+ L+H N+V +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 572 CCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRI 631
L+ EY+ +K L ++ D + +I + + I +GL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYM-DDCGNIMSMHNVKIFLYQ-ILRGLAYCH---RRKV 125
Query: 632 IHRDLKASNVLLDRDMNPKISDFGLAR 658
+HRDLK N+L++ K++DFGLAR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 18/176 (10%)
Query: 509 NFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSS---QSGQGLEEFKNEMLLIAKLQHR 564
NF +E K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLL-----GWQARIGIIEGIAQG 619
N+++ IE E ++LE L + K++ L W+ + + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
H +SR R++HRD+K +NV + K+ D GL R F ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 48/147 (32%), Positives = 76/147 (51%), Gaps = 10/147 (6%)
Query: 515 KLGEGGFGPVYKGRL-LNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
KLGEG + V+KGR L VA+K RL + G + E+ L+ L+H N+V +
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 572 CCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRI 631
+ L+ EY+ + L +L D + +I + + + +GL Y H +I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCHKR---KI 124
Query: 632 IHRDLKASNVLLDRDMNPKISDFGLAR 658
+HRDLK N+L++ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 21/160 (13%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKR-LSSQSGQGLEEFK-NEMLLIAKLQHR 564
E + +GEG +G V K + G+ VA+K+ L S+ + +++ E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDP------TKKRLLGWQARIGIIEGIAQ 618
NLV ++ + L+ E++ + LD P ++ L +Q I+ GI
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-FQ----ILRGIE- 114
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ H ++ IIHRD+K N+L+ + K+ DFG AR
Sbjct: 115 ---FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 48/150 (32%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 511 SMECKLGEGGFGPVYKGRL-LNGEE---VAVKRL-SSQSGQGLEEFKNEMLLIAKLQHRN 565
+E LG G FG + +G L L + VA+ L + S + F E L + + H N
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+VR+ G +++ EYM N +LD FL + +L+ Q +G++ G+A G+ YL
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQL-MGMLPGLASGMKYL-- 123
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFG 655
S +H+ L A VL++ D+ KIS F
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 48/171 (28%), Positives = 92/171 (53%), Gaps = 13/171 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQG-LEEFKNEMLLIAKLQHRN 565
E F+ ++G+G FG V+KG ++V A+K + + + +E+ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 566 LVRILGCCIEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
+ + G ++ + +I+EY+ S LD+ P + + +++ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLH 118
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ IHRD+KA+NVLL + K++DFG+A +++ NT VGT
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 13/167 (7%)
Query: 516 LGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCI 574
+G G +G VYKGR + ++A ++ + EE K E+ ++ K HRN+ G I
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 575 EQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSR 628
++ + L++E+ S+ L TK L I I +GL +LH +
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYICREILRGLAHLHAH-- 140
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
++IHRD+K NVLL + K+ DFG++ D G +GT
Sbjct: 141 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 49/171 (28%), Positives = 89/171 (52%), Gaps = 13/171 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQG-LEEFKNEMLLIAKLQHRN 565
E F+ K+G+G FG V+KG ++V A+K + + + +E+ + E+ ++++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 566 LVRILGCCIEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
+ + G ++ + +I+EY+ S LD+ P + + I+ I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLH 118
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ IHRD+KA+NVLL K++DFG+A +++ N VGT
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 15/172 (8%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE-VAVKRLSSQ---SGQGLEEFKNEMLLIAKLQH 563
++ +G G FG V+ R E A+K ++ + + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
++R+ +Q +++EY+P L F + R E I L YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALEYL 117
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
H I++RDLK N+LLD++ + K++DFG A+ +L+ T + GT
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 29/173 (16%)
Query: 506 ATENFSMECKLGEGGFGPVY----KGRLLNGEE--VAVKRLS-SQSGQGLEEFKNEMLLI 558
A E +M +LG+G FG VY KG + + E VA+K ++ + S + EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 559 AKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD-------------PTKKRLLG 605
+ ++VR+LG + ++I+E M L +L P+ K++
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM-- 121
Query: 606 WQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
I + IA G+ YL+ + +HRDL A N ++ D KI DFG+ R
Sbjct: 122 ----IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 53/154 (34%), Positives = 81/154 (52%), Gaps = 24/154 (15%)
Query: 515 KLGEGGFGPVYKGRL-LNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
KLGEG + VYKG+ +NG+ VA+K RL + G + E L+ L+H N+V +L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIV-LLH 69
Query: 572 CCIEQGEKI-LILEYMPNKSLDVFL------FDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
I E + L+ EY+ + L ++ P +L +Q + +GL Y+H
Sbjct: 70 DIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQ--------LLRGLSYIH 120
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
R+ I+HRDLK N+L+ K++DFGLAR
Sbjct: 121 Q--RY-ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 48/157 (30%), Positives = 84/157 (53%), Gaps = 16/157 (10%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQ-GLE-EFKNEMLLIAKLQ---HRNLVR 568
++G G +G VYK R +G VA+K + Q+ + GL E+ L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 569 ILGCC----IEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
++ C ++ K+ L+ E++ ++ L +L D L + ++ +GL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
H I+HRDLK N+L+ K++DFGLAR++
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 13/165 (7%)
Query: 516 LGEGGFGPVYKGRLLN-GEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILG 571
LG+GGFG V ++ G+ A K+L + +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS-LA 59
Query: 572 CCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
E + + L++ M L +++ + +A + I GL +LH + R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLH---QRR 115
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
I++RDLK NVLLD N +ISD GLA G K GT
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 26/154 (16%)
Query: 515 KLGEGGFGPVYKGRLL-NGEEVAVKRL-SSQSGQGLEEFKNEMLLIAKLQHRNLVRILGC 572
++G G G VYK G A+K + + + E+ ++ + H N+V+
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 573 CIEQGEKILILEYMPNKSLD-------VFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
GE ++LE+M SL+ FL D ++ I+ GIA YLH
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------ILSGIA----YLH- 185
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659
R I+HRD+K SN+L++ N KI+DFG++R+
Sbjct: 186 --RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217
|
Length = 353 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 55/174 (31%), Positives = 82/174 (47%), Gaps = 28/174 (16%)
Query: 516 LGEGGFGPVY------KGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
LG+GGFG V G+L +++ KRL + +G E E ++AK+ R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVS- 57
Query: 570 LGCCIE-QGEKILILEYMPNKSLDVFLFDPTKK-------RLLGWQARIGIIEGIAQGLL 621
L + + + L++ M L +++ ++ R + A+I GL
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQI------ISGLE 111
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+LH RII+RDLK NVLLD D N +ISD GLA + Q TK GT
Sbjct: 112 HLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGT 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 42/152 (27%), Positives = 81/152 (53%), Gaps = 13/152 (8%)
Query: 515 KLGEGGFGPVYKGRLL----NGEEVAVKRL--SSQSGQGLEEFKNEMLLIAKLQHRNLVR 568
K+GEG FG K L+ +G++ +K + S S + EE + E+ +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSR 628
E G ++++Y D++ ++ +L + +I ++ Q L L H
Sbjct: 64 YQESFEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQI--LDWFVQICLALKHVHD 119
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
+I+HRD+K+ N+ L +D K+ DFG+AR+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 45/165 (27%), Positives = 73/165 (44%), Gaps = 15/165 (9%)
Query: 516 LGEGGFGPVYKGRLLNGEEV-AVKRLSSQS--GQGLEE-FKNEMLLIAKLQHRNLVRILG 571
LG GGFG V ++ + A+K + + G +E +E ++ + H +V+ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVK-LY 59
Query: 572 CCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
+ + I +++EY L L D + + AR I + YLH+
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLHNRG--- 113
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
II+RDLK N+LLD + K+ DFG A+ + T GT
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGT 155
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 23/162 (14%)
Query: 508 ENFSMECKLGEGGFGPVYKG-RLLNGEEVAVKRLSSQSGQ-----GLEEFKNEMLLIAKL 561
+ +GEG +G V G +VA+K++S Q L E K ++ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 562 QHRNLVRILGC----CIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGI 616
+H N++ IL E + ++ E M L+ K + L + I
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQI 115
Query: 617 AQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR
Sbjct: 116 LRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 20/153 (13%)
Query: 516 LGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN---LVRILG 571
+G G FG V K G +AVKR+ S E+ + M L ++ + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 572 CCIEQGEKILILEYMPNKSLDVF---LFDPTKKRL----LGWQARIGIIEGIAQGLLYLH 624
+G+ + +E M + SLD F +++ K + LG I + L YL
Sbjct: 71 ALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNYLK 124
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
+IIHRD+K SN+LLDR+ N K+ DFG++
Sbjct: 125 --EELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 43/152 (28%), Positives = 78/152 (51%), Gaps = 9/152 (5%)
Query: 514 CKLGEGGFGPVYKGR-LLNGEEVAVKR-LSSQSGQGLEEFK-NEMLLIAKLQHRNLVRIL 570
K+GEG +G V+K R G+ VA+K+ + S+ +++ E+ ++ +L+H NLV ++
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
+ + L+ EY + L+ +P R + II Q + + H ++
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN--- 120
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662
IHRD+K N+L+ + K+ DFG AR+ G
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 517 GEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEEFKN---EMLLIAKLQHRNLVRILGC 572
G+G FG V + + +++ A+K ++ Q +N E ++ +L H LV L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN-LWY 67
Query: 573 CIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRI 631
+ E + L+++ + L L K + Q + I E I L YLH I
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYLHSK---GI 121
Query: 632 IHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665
IHRD+K N+LLD + I+DF +A D L
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 508 ENFSMECKLGEGGFGPVYKG-RLLNGEEVAVKRLSS--QSGQGLEEFKNEMLLIAKLQHR 564
E ++ ++G G +G V GE+VA+K+LS QS + E+ L+ +QH
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 565 NLVRILGCCIEQG------EKILILEYMPNKSLDV--FLFDPTKKRLLGWQARIGIIEGI 616
N++ +L + L++ YM + K + L +Q +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ--------M 126
Query: 617 AQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
GL Y+H IIHRDLK N+ ++ D KI DFGLAR
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 19/174 (10%)
Query: 516 LGEGGFGPVYK-------GRLLNGEEVAVKRLS-----SQSGQGLEEFKNEMLLIAK-LQ 562
LG G FG VYK LL +E+ V + + + + + +E+ +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
H N+VR +E ++++ + L + F KK+ + I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
YLH R I+HRDL +N++L D I+DFGLA+ + +VGT
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGT 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-08
Identities = 26/80 (32%), Positives = 45/80 (56%), Gaps = 7/80 (8%)
Query: 340 GDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLK-NCTCKAYANSNVTEGSGCLMW-FG 397
D F++L N K P F + ++ +L++CA++CL NC+C+++ +N T GCL+W
Sbjct: 3 DDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNNGT--KGCLLWSES 59
Query: 398 ELLDASRPIRNFTGQSVYLR 417
L DA + G +Y +
Sbjct: 60 SLGDA--RLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 59/189 (31%), Positives = 88/189 (46%), Gaps = 18/189 (9%)
Query: 497 LFSLASVAAATENFSMECKLGEGGFGPVYK-GRLLNGEEVAVKRLSSQSGQGLEEFKNEM 555
+ L S+ T+ + + +G+G +G VYK +G AVK L S EE + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 556 LLIAKL-QHRNLVRILGCCIEQ-----GEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 609
++ L H N+V+ G + G+ L+LE S+ + K LL R
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124
Query: 610 I--GIIEGIAQG-LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQ 666
+ +I I G LL L H RIIHRD+K +N+LL + K+ DFG++ L+
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 667 GNTKRIVGT 675
NT VGT
Sbjct: 185 RNTS--VGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 43/171 (25%), Positives = 73/171 (42%), Gaps = 11/171 (6%)
Query: 488 DKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQG 547
D D +P A A+ +++ L G G V+ G+ V Q G
Sbjct: 46 DDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPDPVVLKIGQKGTT 104
Query: 548 LEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQ 607
L E +L+ + H +++R+ + ++L P+ S D++ + + R L
Sbjct: 105 LIE----AMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPID 157
Query: 608 ARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ I + I +GL YLH RIIHRD+K N+ ++ I D G A+
Sbjct: 158 QALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 46/163 (28%), Positives = 75/163 (46%), Gaps = 26/163 (15%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKR-LSSQSGQGLEEFK-NEMLLIAKLQHRN-LVRIL 570
K+GEG +G VYK R G+ VA+K+ +G+ E+ L+ L +VR+L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 571 GCCIEQGEK-------ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY- 622
+E E+ L+ EY+ + L F+ D + R + + +Y
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRG----PGR-PLPAKTIKSFMYQ 118
Query: 623 ----LHHYSRFRIIHRDLKASNVLLDRDMNP-KISDFGLARMF 660
+ H + ++HRDLK N+L+D+ KI+D GL R F
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 21/158 (13%)
Query: 516 LGEGGFGPVYKG--------RLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
LG+G F ++KG L+ EV +K L E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
G C+ E I++ EY+ SLD +L + W+ +E Q LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK-----LEVAKQLAWALHFLE 117
Query: 628 RFRIIHRDLKASNVLLDRDM-----NP---KISDFGLA 657
+ H ++ A NVLL R+ NP K+SD G++
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 45/149 (30%), Positives = 67/149 (44%), Gaps = 35/149 (23%)
Query: 532 GEEVAVKRLSSQSGQGLEEFKN---------EMLLIAKLQHRNLVRILGCCIEQ------ 576
G+ VA+K+LS F+N E++L+ + H+N++ +L Q
Sbjct: 41 GQNVAIKKLS-------RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93
Query: 577 GEKILILEYMPNKSLDVFLFDPTKKRL--LGWQARIGIIEGIAQGLLYLHHYSRFRIIHR 634
+ L++E M V D +R+ L +Q GI +LH IIHR
Sbjct: 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGI--------KHLHSAG---IIHR 142
Query: 635 DLKASNVLLDRDMNPKISDFGLARMFGGD 663
DLK SN+++ D KI DFGLAR G
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARIGIIEGIAQGLLYL 623
+V G + + + +E+M SLD P +LG I + +GL YL
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL 119
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
Y+ RI+HRD+K SN+L++ K+ DFG++
Sbjct: 120 --YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 38/147 (25%), Positives = 73/147 (49%), Gaps = 6/147 (4%)
Query: 516 LGEGGFG-PVYKGRLLNGEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC 573
+GEG FG + + + ++ A+K + +S +E+ + E +L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 574 IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIH 633
G +++EY L + + +L I++ Q L + H R++H
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDT---ILQWFVQMCLGVQHIHEKRVLH 123
Query: 634 RDLKASNVLLDRDMNPKISDFGLARMF 660
RD+K+ N+ L ++ K+ DFG AR+
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLL 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 8/143 (5%)
Query: 515 KLGEGGFGPV-YKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC 573
K+GEG G V G++VAVK++ + Q E NE++++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 574 IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIH 633
+ E +++E++ +L D + + + + + L YLH+ +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 634 RDLKASNVLLDRDMNPKISDFGL 656
RD+K+ ++LL D K+SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 23/160 (14%)
Query: 516 LGEGGFGPVYKGRLLN---------GEEVAVKR-LSSQSGQGLEEFKNEMLLIAKLQHRN 565
LG+G F +YKG L G+EV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
LV++ G C+ E I++ EY+ LDVFL L W ++ + + +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 626 YSRFRIIHRDLKASNVLLDRDMNP-------KISDFGLAR 658
+++H ++ N+L+ R K+SD G+
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 27/62 (43%), Positives = 37/62 (59%), Gaps = 9/62 (14%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR--MFGGDELQGNTKRIV 673
IA GL +LH II+RDLK NV+LD + + KI+DFG+ + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 674 GT 675
GT
Sbjct: 163 GT 164
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 29/146 (19%)
Query: 532 GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI--------------LGCCIEQG 577
+ VAVK++ Q ++ E+ +I +L H N+V++ +G E
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 578 EKILILEYMPNKSLDVFLFDPTKK---RLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHR 634
++ EYM +V P + RL +Q + +GL Y+H + ++HR
Sbjct: 90 SVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ--------LLRGLKYIHSAN---VLHR 138
Query: 635 DLKASNVLLD-RDMNPKISDFGLARM 659
DLK +NV ++ D+ KI DFGLAR+
Sbjct: 139 DLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 8/143 (5%)
Query: 515 KLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC 573
K+GEG G V + +G+ VAVK++ + Q E NE++++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 574 IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIH 633
+ E +++E++ +L D + + + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 634 RDLKASNVLLDRDMNPKISDFGL 656
RD+K+ ++LL D K+SDFG
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 11/137 (8%)
Query: 516 LGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCI 574
+ G G YKG+ + NG + VK ++ + E + + KLQH N+V+++G C
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCR 753
Query: 575 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHR 634
+ LI EY+ K+L L R L W+ R I GIA+ L +LH ++
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 635 DLKASNVLLDRDMNPKI 651
+L +++D P +
Sbjct: 808 NLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 31/146 (21%), Positives = 54/146 (36%), Gaps = 13/146 (8%)
Query: 515 KLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV-RILGCC 573
L G VY E+ +K S+ E + +L + + V ++L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62
Query: 574 IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIH 633
G L++E++ ++LD + + I E +A+ L LH + H
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKED----------IAEQLAELLAKLHQLPLLVLCH 112
Query: 634 RDLKASNVLLDRDMNPKISDFGLARM 659
DL N+L+D I D+ A
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFK-NEMLLIAKLQHRNLVRILGC 572
CK+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ +
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 573 CIEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY-----LHH 625
+ ++ L+ +Y + + F K + + + G+ + LLY +H+
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 626 YSRFRIIHRDLKASNVLL----DRDMNPKISDFGLARMF 660
++HRDLK +N+L+ KI+D G AR+F
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 45/167 (26%), Positives = 80/167 (47%), Gaps = 15/167 (8%)
Query: 509 NFSMECKLGEGGFGPVYKGRLLNGEEV----AVKRLSS----QSGQGLEEFKNEMLLIAK 560
NF + LG G +G V+ R ++G + A+K L Q + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 561 LQHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG 619
++ + L + K+ LIL+Y+ L F +R + + I G +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSG--EI 114
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQ 666
+L L H + II+RD+K N+LLD + + ++DFGL++ F DE++
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 21/137 (15%)
Query: 532 GEEVAVKRLSS--QSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG------EKILIL 583
G VAVK+LS Q+ + E++L+ + H+N++ +L Q + L++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 584 EYMPNKSLDVFLFDPTKKRL--LGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNV 641
E M V + +R+ L +Q GI H IIHRDLK SN+
Sbjct: 106 ELMDANLCQVIHMELDHERMSYLLYQMLCGI-----------KHLHSAGIIHRDLKPSNI 154
Query: 642 LLDRDMNPKISDFGLAR 658
++ D KI DFGLAR
Sbjct: 155 VVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 52/162 (32%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 516 LGEGGFGPV---YKGRLLNGEEVAVKRLSS--QSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
+G G +G V Y RL ++VAVK+LS QS E+ L+ ++H N++ +L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 571 -----GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
IE ++ Y+ + L + K + L + +I + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEV----YLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQG 667
IIHRDLK SNV ++ D +I DFGLAR DE+ G
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG 174
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 40/171 (23%)
Query: 508 ENFSMECKLGEGGFGPVYKG-RLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
+ +G G +G V +G++VA+K++ ++ +AK R L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVPTLAKRTLREL 55
Query: 567 VRILGCCIEQGEKILILE-YMPNKSL--DVFL-FDPTKKRLLGWQARIGIIEG------- 615
+IL + I I + P + DV++ D + L II
Sbjct: 56 -KILRH-FKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHH------IIHSDQPLTEE 107
Query: 616 --------IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ +GL Y+H + +IHRDLK SN+L++ D +I DFG+AR
Sbjct: 108 HIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 516 LGEGGFGPVY-KGRLLNGEEVAVKRLSSQSGQGLEEFKNEM----LLIAKLQHRNLVRIL 570
+G+G FG V R +G AVK L ++ +E + M +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG-L 61
Query: 571 GCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
+ EK+ +L+Y+ L F ++ L +AR E +A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLH---SL 115
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
II+RDLK N+LLD + ++DFGL + G E + T GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 50/166 (30%), Positives = 72/166 (43%), Gaps = 34/166 (20%)
Query: 516 LGEGGFGPV----YKGRLLNGEEVAVKRLSSQSGQGLEEFKNEM------LLIAKLQHRN 565
LG G FG V YK GE A+K L +E ++ M +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 566 LVRILGCCIEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARIGIIEGIAQG 619
LV + C + ++EY L DVF ++ R + + A + + G
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF----SEPRAVFYAACVVL------G 113
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR--MFGGD 663
L YLH +I++RDLK N+LLD + KI+DFGL + M GD
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 15/167 (8%)
Query: 509 NFSMECKLGEGGFGPVYKGRLLNGEE----VAVKRLSS----QSGQGLEEFKNEMLLIAK 560
NF + LG G +G V+ R + G + A+K L Q + E + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 561 LQHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG 619
++ + L + K+ LIL+Y+ L L+ ++ + R+ I E +
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY--QREHFTESEVRVYIAEIV--- 115
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQ 666
L L H + II+RD+K N+LLD + + ++DFGL++ F +E +
Sbjct: 116 -LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 32/133 (24%), Positives = 53/133 (39%), Gaps = 20/133 (15%)
Query: 531 NGEEVAVKR--LSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588
VAVK+ L S S + L+ + E++ +LQH N++ + I E ++ M
Sbjct: 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83
Query: 589 KSLDVFL-------FDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNV 641
S + L I++ + L Y+H IHR +KAS++
Sbjct: 84 GSCEDLLKTHFPEGLPELAIAF--------ILKDVLNALDYIHSKG---FIHRSVKASHI 132
Query: 642 LLDRDMNPKISDF 654
LL D +S
Sbjct: 133 LLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 25/83 (30%), Positives = 38/83 (45%), Gaps = 18/83 (21%)
Query: 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEG------IAQGLLYLHHYSRFRIIHR 634
L++EYMP L + R + IA+ +L L + IHR
Sbjct: 78 LVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHR 125
Query: 635 DLKASNVLLDRDMNPKISDFGLA 657
D+K N+L+D D + K++DFGL
Sbjct: 126 DIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 15/159 (9%)
Query: 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFK-NEMLLIAKLQHRNLVRILGC 572
CK+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ +
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 573 CIEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY-----LHH 625
+ ++ L+ +Y + + F K + + + + + LLY +H+
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 626 YSRFRIIHRDLKASNVLL----DRDMNPKISDFGLARMF 660
++HRDLK +N+L+ KI+D G AR+F
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEM----LLIAKLQHRNLVRIL 570
+G+G FG V + +G+ AVK L ++ +E K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG-L 61
Query: 571 GCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
+ +K+ +L+Y+ L F ++ +AR E IA L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLH---SL 115
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
II+RDLK N+LLD + ++DFGL + G E T GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 11/157 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGE--EVAVKRLSSQS---GQGLEEFKNEMLLIAKLQ 562
E+F+ LG G FG V N + VA+KR + ++ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
H V + G ++ L+LE++ FL +R + +G AQ +L
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-----RRNKRFPNDVGCFYA-AQIVLI 143
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659
+ I++RDLK N+LLD+D K++DFG A++
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 25/58 (43%), Positives = 36/58 (62%), Gaps = 3/58 (5%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIV 673
I +GL YLH I+HRD+K N+L++ + KI DFGLAR+ DE + T+ +V
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 53/168 (31%), Positives = 76/168 (45%), Gaps = 32/168 (19%)
Query: 516 LGEGGFGPVYKG-RLLNGEEVAVKRLSS--QSGQGLEEFKNEMLLIAKLQHRNLVRILGC 572
+G G +G V G VAVK+LS QS + E+ L+ ++H N++ +L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 573 CIEQGEKILILEYMPNKSL----DVFLF---------DPTKKRLLGWQARIGIIEGIAQG 619
+ P +SL DV+L + K + L +I I +G
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQG 667
L Y+H IIHRDLK SN+ ++ D KI DFGLAR DE+ G
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 176
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 516 LGEGGFGPV------YKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
LG+GGFG V G++ +++ KRL +SG+ + + E+L K+ +V +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
+ L++ M L +++ +R L + I I G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLH---SM 114
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLA 657
I++RD+K NVLLD N ++SD GLA
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 46/172 (26%)
Query: 516 LGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAK-LQHRNLVRILGC- 572
+G G FG VY+ ++ E+VA+K++ ++KN LLI K L H N++ +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128
Query: 573 ---CIEQGEKIL----ILEYMP-------------NKSLDVFLFDPTKKRLLGWQARIGI 612
C ++ EK + ++E++P N +L +FL +L +Q
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-----KLYSYQ----- 178
Query: 613 IEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD-RDMNPKISDFGLAR-MFGG 662
+ + L Y+H S+F I HRDLK N+L+D K+ DFG A+ + G
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224
|
Length = 440 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 42/149 (28%), Positives = 76/149 (51%), Gaps = 12/149 (8%)
Query: 516 LGEGGFGPVYKGRLLNGEEV----AVKRLSSQSGQGLEEF--KNEMLLIAKLQHRNLVRI 569
LG+G FG V+ R + G + A+K L + + + K E ++A++ H +V++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
+G+ LIL+++ L F K ++ + + +A+ L L H
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LAELALALDHLHSL 117
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLAR 658
II+RDLK N+LLD + + K++DFGL++
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 28/158 (17%)
Query: 516 LGEGGFGPVYKGRLLNGEE----VAVKRLSS----QSGQGLEEFKNEMLLIAKLQHRNLV 567
LG+GG+G V++ R + G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 568 RILGCCIEQGEKILILEYMPNKSL-------DVFLFDPTKKRLLGWQARIGIIEGIAQGL 620
++ G+ LILEY+ L +F+ D L ++
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL-------------SEIS 110
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
L L H + II+RDLK N+LLD + K++DFGL +
Sbjct: 111 LALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 21/43 (48%), Positives = 31/43 (72%), Gaps = 3/43 (6%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ +GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 12/148 (8%)
Query: 516 LGEGGFGPV------YKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
+ L+L M L ++ + +A E I GL LH +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLH---QE 121
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLA 657
RI++RDLK N+LLD + +ISD GLA
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 27/172 (15%)
Query: 516 LGEGGFGPV------YKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
LG+GGFG V G++ + + KR+ + G+ + NE ++ K+ + +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDP-----TKKRLLGWQARIGIIEGIAQGLLYLH 624
+ L+L M L +++ ++R L + A I L L
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEI---------LCGLE 116
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA-RMFGGDELQGNTKRIVGT 675
R ++RDLK N+LLD + +ISD GLA ++ G+ ++G VGT
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGT 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 39/142 (27%), Positives = 64/142 (45%), Gaps = 21/142 (14%)
Query: 532 GEEVAVKRLSSQSGQGLEE---FKNEMLLIAKLQHRNLVRIL--GCCIEQGEKILILEYM 586
G EVA+K L + + + + F+ E L A+L H N+V +L G G + EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEG---IAQGLLYLHHYSRFRIIHRDLKASNVLL 643
P ++L + +L + E + Q L L I+HRDLK N+++
Sbjct: 62 PGRTL---------REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112
Query: 644 D-RDMNP--KISDFGLARMFGG 662
+ P K+ DFG+ + G
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPG 134
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 12/145 (8%)
Query: 516 LGEGGFGPVYKG-RLLNGEEVAVKRLSSQSGQGLE-EFKNEMLLIAKLQHRNLVRILGCC 573
LG G G VYK LL +AVK + L+ + +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 574 IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIH 633
+ + E+M SLDV+ P + +LG RI + + +GL YL +I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIP--EHVLG---RIAV--AVVKGLTYLW---SLKILH 118
Query: 634 RDLKASNVLLDRDMNPKISDFGLAR 658
RD+K SN+L++ K+ DFG++
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 48/159 (30%), Positives = 72/159 (45%), Gaps = 31/159 (19%)
Query: 516 LGEGGFGPV-YKGRLLNGEEVAVKRLSS--QSGQGLEEFKNEMLLIAKLQHRNLVRILGC 572
+G G +G V G +VA+K+L QS + E+ L+ ++H N++ +L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 573 CIEQGEKILILEYMPNKSLDVF----LFDPTKKRLLG--------WQARIG-IIEGIAQG 619
+ P+ SLD F L P LG + RI ++ + +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
L Y+H IIHRDLK N+ ++ D KI DFGLAR
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 44/150 (29%), Positives = 68/150 (45%), Gaps = 14/150 (9%)
Query: 515 KLGEGGFGPVYKGRLLNGEEVA---VKRL-SSQSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
++G G FG V + VA VK L ++ S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKR----LLGWQARIGIIEGIAQGLLYLHHY 626
G C+E +L+ EY L +L R LL Q R+ IA G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-RMAC--EIAAGVTHMH-- 116
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGL 656
+ +H DL N L D+ K+ D+G+
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 21/137 (15%)
Query: 535 VAVKRLSS--QSGQGLEEFKNEMLLIAKLQHRNLVRILGC-----CIEQGEKI-LILEYM 586
VA+K+LS Q+ + E++L+ + H+N++ +L +E+ + + L++E M
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104
Query: 587 PNKSLDVFLFDPTKKRL--LGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD 644
V + +R+ L +Q GI H IIHRDLK SN+++
Sbjct: 105 DANLCQVIQMELDHERMSYLLYQMLCGI-----------KHLHSAGIIHRDLKPSNIVVK 153
Query: 645 RDMNPKISDFGLARMFG 661
D KI DFGLAR G
Sbjct: 154 SDCTLKILDFGLARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 26/62 (41%), Positives = 34/62 (54%), Gaps = 9/62 (14%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR--MFGGDELQGNTKRIV 673
I GL +LH II+RDLK NVLLD + + KI+DFG+ + + GG T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 674 GT 675
GT
Sbjct: 158 GT 159
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 18/158 (11%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEM--LLIAKLQHR 564
+ ++G G G VYK R G +AVK++ + EE K + L + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHD 72
Query: 565 --NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW--QARIG-IIEGIAQG 619
+V+ G I + + +E M D KR+ G + +G + I +
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELMST------CLDKLLKRIQGPIPEDILGKMTVAIVKA 126
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
L YL + +IHRD+K SN+LLD N K+ DFG++
Sbjct: 127 LHYLK--EKHGVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 516 LGEGGFGPVYKGRLLNGEE-VAVKRLSSQSGQGLEEFKN----EMLLIAKLQHRNLVRIL 570
+GEG +G V K R +E VA+K+ EE K E+ ++ L+ N+V +
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
+G+ L+ EY+ L++ P + + R I + I +H +
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKA----IHWCHKND 120
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLAR 658
I+HRD+K N+L+ + K+ DFG AR
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 22/153 (14%)
Query: 516 LGEGGFGPV------YKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDP-----TKKRLLGWQARIGIIEGIAQGLLYLH 624
+ L+L M L +++ ++R + + A I GL LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC------GLEDLH 119
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
R RI++RDLK N+LLD + +ISD GLA
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 41/140 (29%), Positives = 66/140 (47%), Gaps = 27/140 (19%)
Query: 535 VAVKRLSS--QSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLD 592
VA+K+LS Q+ + E++L+ + H+N++ +L + P KSL+
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99
Query: 593 VF--------LFDPTKKRLLGWQ---ARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNV 641
F L D +++ + R+ + + Q L + H IIHRDLK SN+
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYL--LYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 642 LLDRDMNPKISDFGLARMFG 661
++ D KI DFGLAR G
Sbjct: 158 VVKSDCTLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 32/159 (20%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFK-NEMLLIAKLQHR----NL 566
+LG+G +G VYK G +A+K RL L+E K N++++ + H+ +
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSPYI 61
Query: 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEG--------IAQ 618
V G +G + +EYM SLD K G A GI E + +
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLD--------KLYAGGVATEGIPEDVLRRITYAVVK 113
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
GL +L IIHRD+K +NVL++ + K+ DFG++
Sbjct: 114 GLKFLK--EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 15/165 (9%)
Query: 509 NFSMECKLGEGGFGPVYKGRLLNGEEV----AVKRLSS----QSGQGLEEFKNEMLLIAK 560
NF + LG G +G V+ R + G + A+K L Q + +E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 561 LQHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG 619
++ + L + K+ LIL+Y+ + L+ +R + + G +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSG--EI 114
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+L L H + I++RD+K N+LLD + + ++DFGL++ F +E
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 516 LGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEEFKNEM----LLIAKLQHRNLVRIL 570
LG+G FG V RL + AVK L ++ + M +L H L + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ-L 61
Query: 571 GCCIEQGEKIL-ILEYMPNKSLDVFLFDPTK-KRLLGWQARIGIIEGIAQGLLYLHHYSR 628
CC + +++ ++E++ L +F K +R +AR E I L++LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAE-ITSALMFLHDKG- 116
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
II+RDLK NVLLD + + K++DFG+ +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 12/167 (7%)
Query: 516 LGEGGFGPVYK-GRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCC 573
+G+G +G V+K NG + AVK L EE + E ++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 574 ----IEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSR 628
++ G+++ L+LE S+ + K+ + I I + + L+ L H
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI--LHEALMGLQHLHV 142
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ IHRD+K +N+LL + K+ DFG++ L+ NT VGT
Sbjct: 143 NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 19/174 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHR--- 564
++F +LG G G V K + + ++L + +N+++ ++ H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 565 -NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARIGIIEGIAQGLL 621
+V G GE + +E+M SLD L + + + +LG + I ++ G+A
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-KVSIAVLRGLA---- 117
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
YL + +I+HRD+K SN+L++ K+ DFG++ G + VGT
Sbjct: 118 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 165
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 24/154 (15%)
Query: 516 LGEGGFGPV------YKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVS- 64
Query: 570 LGCCIEQGEKI-LILEYMPNKSLDVFLFDP-----TKKRLLGWQARIGIIEGIAQGLLYL 623
L E + + L+L M L +++ ++R + + A + GL L
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAEL------CCGLEDL 118
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
R RI++RDLK N+LLD + +ISD GLA
Sbjct: 119 Q---RERIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 3/45 (6%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
I GL Y+H + ++HRDLK N+L++ D KI DFGLAR F
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 43/174 (24%), Positives = 69/174 (39%), Gaps = 41/174 (23%)
Query: 519 GGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG 577
G FG VY + G+ A+K L + N K + + + QG
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-----VKAERAIM-------MIQG 54
Query: 578 EK----------------ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
E L++EY+ + + LG + IA+ +L
Sbjct: 55 ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAKQYIAEVVL 108
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ + IIHRD+K N+L+D+ + K++DFGL+R G E K+ VGT
Sbjct: 109 GVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGT 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 16/157 (10%)
Query: 509 NFSMECKLGEGGFGPV----YKGRLLNGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKL 561
+F M LG G FG V +KG GE A+K L + + ++ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
H +V ++ ++ +LE++ L F R A+ E +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAE-LVLAFE 132
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
YLH II+RDLK N+LLD + K++DFG A+
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
I GL +LH II+RDLK NVLLD+D + KI+DFG+ +
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 516 LGEGGFGPVYKGRLLNGEEV-AVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILG 571
LG+G FG V L +EV A+K L ++ E ++A + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 572 CCIEQGEKIL-ILEYMPNKSLDVFLFDPTKKRLLGW-QARIGIIEGIAQGLLYLHHYSRF 629
CC + +++ ++EY+ L +F + R ++R E + L++LH R
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAE-VTLALMFLH---RH 115
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+I+RDLK N+LLD + + K++DFG+ +
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 51/193 (26%), Positives = 86/193 (44%), Gaps = 44/193 (22%)
Query: 486 RRDKSKDSWLPLF-----SLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKR 539
R++K+ D++L + + + E+F + +G G FG V R + ++V A+K
Sbjct: 16 RKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL 75
Query: 540 LSSQSGQGLEEFKNEML-------------LIAKLQHRNLVRILGCCIEQGEKIL--ILE 584
LS K EM+ ++A +V++ Q +K L ++E
Sbjct: 76 LS----------KFEMIKRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVME 123
Query: 585 YMPNKSLDVFL--FDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVL 642
YMP L + +D +K W AR E + L +H IHRD+K N+L
Sbjct: 124 YMPGGDLVNLMSNYDIPEK----W-ARFYTAE-VVLALDAIHSMG---FIHRDVKPDNML 174
Query: 643 LDRDMNPKISDFG 655
LD+ + K++DFG
Sbjct: 175 LDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
I L YLH +++RDLK N++LD+D + KI+DFGL +
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 48/148 (32%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 516 LGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILG 571
LG+G FG V L GE AVK L +E E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 572 CCIEQGEKIL-ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
C + E + ++E++ L + D K R ++A E I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAE-IVCGLQFLHSKG--- 116
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLAR 658
II+RDLK NV+LDRD + KI+DFG+ +
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 18/43 (41%), Positives = 29/43 (67%)
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
Q LL +HH +IHRD+K++N+LL + K+ DFG ++M+
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY 193
|
Length = 496 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 37/121 (30%), Positives = 60/121 (49%), Gaps = 22/121 (18%)
Query: 550 EFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE---YMPNKSLDV----FLFDPT--- 599
+ +NE+L + +L H N+++I E+IL E YM + D F++D
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260
Query: 600 KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659
K R L Q R I++ + + Y+H ++IHRD+K N+ L+ D + DFG A
Sbjct: 261 KDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 660 F 660
F
Sbjct: 317 F 317
|
Length = 501 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 17/87 (19%)
Query: 577 GEKILILEYMPNKSLDVFLFDPTKK------RLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
GE + +E+M SLD L KK +LG +I I + +GL YL + +
Sbjct: 72 GEISICMEHMDGGSLDQVL----KKAGRIPENILG---KISI--AVLRGLTYLR--EKHK 120
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLA 657
I+HRD+K SN+L++ K+ DFG++
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 516 LGEGGFGPVYKGRLLN-GEEVAVK-----RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
+G GGFG VY R + G+ A+K R+ + G+ L + ML + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 570 LGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSR 628
+ +K+ IL+ M L L ++ + I GL ++H +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILGLEHMH--NR 116
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLA 657
F +++RDLK +N+LLD + +ISD GLA
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 516 LGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEEFKNEM----LLIAKLQHRNLVRIL 570
+G+G FG V R E+ AVK L ++ +E K+ M +L+ ++H LV +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
+ +L+Y+ L F ++ L +AR E IA L YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLH---SLN 116
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
I++RDLK N+LLD + ++DFGL + E G T GT
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 18/45 (40%), Positives = 29/45 (64%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
+A+ +L + + IHRD+K N+L+DR + K+SDFGL+ F
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 48/150 (32%), Positives = 75/150 (50%), Gaps = 15/150 (10%)
Query: 516 LGEGGFGPVY-KGRLLNGEEVAVKRLSSQSGQGLEEFKNEM----LLIAKLQHRNLVRIL 570
+G+G FG V R L+G+ AVK L + +E K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG-L 61
Query: 571 GCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGW-QARIGIIEGIAQGLLYLHHYSR 628
+ EK+ +L+++ L F ++R +AR E IA L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAE-IASALGYLH---S 114
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
I++RDLK N+LLD + ++DFGL +
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 47/159 (29%), Positives = 67/159 (42%), Gaps = 38/159 (23%)
Query: 516 LGEGGFGPVYKGRL----LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQH----RNL- 566
+G G FG V RL G A+K+L K+EML ++ H R++
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLR----------KSEMLEKEQVAHVRAERDIL 55
Query: 567 -------VRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGW-QARIGIIEGIA 617
V L + + LI+EY+P + L KK + R I E I
Sbjct: 56 AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETI- 111
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656
L + + IHRD+K N+LLD + K+SDFGL
Sbjct: 112 ---LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 8/149 (5%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEE--FKNEMLLIAKLQHRNLVRILGC 572
+G+G +G V R +G++ +K+L+ ++ E + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 573 CI-EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRI 631
E G +++ + L L + K L Q ++ IA L YLH I
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ-IAMALQYLHEK---HI 123
Query: 632 IHRDLKASNVLLDRDMNPKISDFGLARMF 660
+HRDLK NV L R K+ D G+AR+
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 20/54 (37%), Positives = 32/54 (59%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT 669
A+ L L + +F +I+RDLK N+LLD + + DFGL ++ D+ + NT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 23/154 (14%)
Query: 516 LGEGGFGPVY------KGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
+G GGFG VY G++ + + KR+ + G+ L + ML + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 570 LGCCIEQGEKI-LILEYMPNKSLDVFL-----FDPTKKRLLGWQARIGIIEGIAQGLLYL 623
+ +K+ IL+ M L L F + R + II G+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATE----IILGLE------ 111
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
H ++RF +++RDLK +N+LLD + +ISD GLA
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 20/41 (48%), Positives = 25/41 (60%), Gaps = 3/41 (7%)
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ L Y+H + F HRDLK N+L + D KI DFGLAR
Sbjct: 114 RALKYIHTANVF---HRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
I+ GL +LH R II+RDLK NV+LD + + KI+DFG+ +
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 24/89 (26%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 557 LIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGI 616
L++++ H +L + G C+ E I++ E++ + LDV L + + W +I + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 617 AQGLLYLHHYSRFRIIHRDLKASNVLLDR 645
A L YL + ++H ++ A N+LL R
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLAR 152
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 18/43 (41%), Positives = 29/43 (67%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
IA+ +L L H ++ I++RDLK N+LLD + + DFGL++
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK 144
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 20/47 (42%), Positives = 31/47 (65%), Gaps = 3/47 (6%)
Query: 613 IEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659
I +A L YLH + IIHRDLK N+L+ + + K++DFGL+++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 36/120 (30%), Positives = 59/120 (49%), Gaps = 17/120 (14%)
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARIGIIEGIAQGLLYL 623
+V G GE + +E+M SLD L + +++LG + I +I +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVI----KGLTYL 119
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFG--------LARMFGGDELQGNTKRIVGT 675
+ +I+HRD+K SN+L++ K+ DFG +A F G + +R+ GT
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
IA GL +LH II+RDLK NV+LD + + KI+DFG+ +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
I L YLH S +++RDLK N++LD+D + KI+DFGL +
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 22/155 (14%)
Query: 516 LGEGGFGPVYKGRLLN-GEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILG 571
LG G FG V R ++ A+K L + + K E ++A+ + +VR+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 572 CCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEG------IAQGLLYLHH 625
++ +++Y+P + L R+GI IA+ +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI------------RMGIFPEDLARFYIAELTCAVES 116
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
+ IHRD+K N+L+DRD + K++DFGL F
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 59/210 (28%), Positives = 82/210 (39%), Gaps = 70/210 (33%)
Query: 516 LGEGGFGPVYK------GRLLNGEEVAVKRLSSQSGQGLEEFKNEM----LLIAKLQHRN 565
LG G FG V + + + VAVK L + G E+K M +LI H N
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKML--KEGATASEYKALMTELKILIHIGHHLN 72
Query: 566 LVRILGCCIEQGEKIL-ILEYMPNKSLDVFL------FDPT----------------KKR 602
+V +LG C + G ++ I+EY +L +L F P K+R
Sbjct: 73 VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132
Query: 603 LL-----------GWQA--RIGIIEGIAQG---------LLYLHHYSRFRI--------- 631
L G+ + +E +G L L YS F++
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYS-FQVARGMEFLAS 191
Query: 632 ---IHRDLKASNVLLDRDMNPKISDFGLAR 658
IHRDL A N+LL + KI DFGLAR
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 21/43 (48%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+AQG+ +L + IHRD+ A NVLL KI DFGLAR
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 18/45 (40%), Positives = 27/45 (60%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
IA+ + + IHRD+K N+L+DRD + K++DFGL F
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 516 LGEGGFGPVYKGRLLNGEEV----AVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
+G G + V RL +++ VK+ + ++ + E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 572 CCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQ-ARIGIIEGIAQGLLYLHHYSRF 629
C + ++ L++EY+ L +F ++R L + AR E I L +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLHERG-- 116
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLAR 658
II+RDLK NVLLD D + K++D+G+ +
Sbjct: 117 -IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 18/40 (45%), Positives = 28/40 (70%), Gaps = 3/40 (7%)
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659
L YLH+Y I+HRDLK N+L+ + K++DFGL+++
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
I L YLH SR +++RD+K N++LD+D + KI+DFGL +
Sbjct: 104 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 20/152 (13%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---EMLLIAKLQHRNLVRILG 571
LG+G FG V R +G+ A+K L + +E + E ++ +H L +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 572 CCIEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
+ ++EY+ L L F + R G + I L YLH
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE--------IVSALDYLH-- 112
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+I++RDLK N++LD+D + KI+DFGL +
Sbjct: 113 -SGKIVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
I GL +LH I++RDLK N+LLD D + KI+DFG+ +
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.003
Identities = 46/171 (26%), Positives = 69/171 (40%), Gaps = 33/171 (19%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQ-SGQGL--EEFKNEMLLIAKLQHRNLVRIL 570
+G+GG G VY + VA+K++ S L + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLG--WQ---------------ARIGII 613
C G+ + MP ++ T K LL WQ A + I
Sbjct: 69 SIC-SDGD--PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 614 EGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
I + Y+H S+ ++HRDLK N+LL I D+G A +E
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEE 167
|
Length = 932 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 29/104 (27%), Positives = 47/104 (45%), Gaps = 7/104 (6%)
Query: 554 EMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGII 613
E+ ++ + HR ++ ++ K + MP D+F + + L + I I
Sbjct: 136 EIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQ 191
Query: 614 EGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
+ + L YLH IIHRD+K N+ LD N + DFG A
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+A+G+ +L SR + IHRDL A N+LL + KI DFGLAR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQ-ARIGIIEGIAQGLL 621
H LV + C + ++EY+ L +F ++R L + AR E I+ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 110
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
YLH II+RDLK NVLLD + + K++D+G+ +
Sbjct: 111 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 6/58 (10%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE---LQGNTK 670
+A+G+ +L + IHRDL A N+LL KI DFGLAR D ++GN +
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 675 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.96 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.95 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.95 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.95 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.94 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.94 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.94 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.94 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.94 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.93 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.93 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.93 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.93 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.93 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.93 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.93 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.93 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.92 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.92 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.92 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.92 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.92 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.92 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.91 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.91 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.91 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.91 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.91 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.91 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.91 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.91 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.91 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.91 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.91 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.91 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.91 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.91 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.91 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.9 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.9 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.9 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.9 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.9 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.9 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.9 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.9 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.9 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.9 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.9 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.9 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.9 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.9 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.9 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.9 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.9 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.9 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.9 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.9 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.9 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.9 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.9 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.89 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.89 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.89 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.89 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.89 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.89 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.89 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.89 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.89 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.89 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.89 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.89 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.89 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.89 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.89 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.89 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.89 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.89 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.89 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.89 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.89 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.89 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.88 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.88 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.88 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.88 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.88 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.88 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.88 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.88 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.88 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.88 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.88 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.88 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.88 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.88 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.88 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.88 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.88 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.88 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.88 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.88 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.88 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.88 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.88 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.88 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.88 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.88 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.87 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.87 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.87 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.87 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.87 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.87 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.87 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.87 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.87 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.87 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.87 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.87 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.87 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.87 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.87 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.87 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.87 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.87 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.87 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.87 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.87 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.87 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.87 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.87 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.87 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.87 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.86 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.86 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.86 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.86 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.86 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.86 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.86 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.86 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.86 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.86 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.86 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.86 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.86 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.86 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.86 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.86 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.86 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.86 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.86 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.86 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.86 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.86 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.86 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.86 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.86 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.86 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.86 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.85 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.85 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.85 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.85 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.85 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.85 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.85 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.85 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.85 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.85 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.85 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.85 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.85 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.85 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.85 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.85 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.85 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.85 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.85 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.85 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.85 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.85 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.85 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.85 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.84 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.84 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.84 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.84 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.84 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.84 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.84 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.84 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.84 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.84 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.84 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.84 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.84 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.84 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.84 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.84 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.84 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.84 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.84 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.83 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.83 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.83 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.83 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.83 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.83 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.83 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.83 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.83 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.83 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.82 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.82 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.82 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.82 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.82 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.82 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.82 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.82 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.82 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.81 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.81 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.81 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.81 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.81 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.81 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.81 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.81 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.81 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.81 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.81 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.81 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.8 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.8 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.8 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.8 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.79 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.79 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.78 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.78 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.78 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.78 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.78 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.77 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.77 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.77 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.77 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.76 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.73 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.72 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.72 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.64 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.63 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.62 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.61 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.6 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.31 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.22 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.18 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.07 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.65 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.62 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.54 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.52 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.3 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.28 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.25 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.23 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.19 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.19 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.13 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.04 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.03 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.01 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.01 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.01 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.77 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.76 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.76 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.75 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.7 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.67 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.56 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.54 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.35 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.2 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.19 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.11 | |
| PLN02236 | 344 | choline kinase | 96.97 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.93 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.71 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.61 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.6 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.59 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.3 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.17 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.08 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.99 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.71 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.66 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.65 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.46 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.34 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.23 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.16 Aligned_cols=168 Identities=51% Similarity=0.811 Sum_probs=154.2
Q ss_pred CCCcccHHHHHHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEE
Q 005825 494 WLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC 573 (675)
Q Consensus 494 ~~~~~~~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~ 573 (675)
....|++.++..+|++|...+.||+|+||.||+|.+.+++.||||++.....+..++|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999998865433156799999999999999999999999
Q ss_pred EeCC-eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 005825 574 IEQG-EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKIS 652 (675)
Q Consensus 574 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 652 (675)
.+.+ +++||||||++|+|+++|+..... .++|..|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875444 78999999999999999999999998899999999999999999999999
Q ss_pred eeccceecCC
Q 005825 653 DFGLARMFGG 662 (675)
Q Consensus 653 DFGla~~~~~ 662 (675)
|||||+....
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999976654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=273.11 Aligned_cols=152 Identities=32% Similarity=0.554 Sum_probs=136.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
..+|.+.++||+|+|++||+|++. ++.+||||.+.+. .....+....|+++|+.++|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888889999999999999874 5899999999765 4455677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC------CCeEEeeeccc
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD------MNPKISDFGLA 657 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~------~~~kl~DFGla 657 (675)
||++||+|..|++ +.+.+++.+...+..|+|.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999994 4457899999999999999999999998 9999999999999764 46899999999
Q ss_pred eecCCCc
Q 005825 658 RMFGGDE 664 (675)
Q Consensus 658 ~~~~~~~ 664 (675)
|.+....
T Consensus 163 R~L~~~~ 169 (429)
T KOG0595|consen 163 RFLQPGS 169 (429)
T ss_pred hhCCchh
Confidence 9997554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=264.21 Aligned_cols=161 Identities=30% Similarity=0.450 Sum_probs=138.4
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCc-------cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSG-------QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG 577 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~-------~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~ 577 (675)
..+.|.+.+.||+|+||.|-+|.. .+|+.||||+++++.. ......++|+++|++|+|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346778889999999999999964 5799999999986421 12334679999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC---CCeEEeee
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD---MNPKISDF 654 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DF 654 (675)
..|||||||+||+|.+++. ..+.+.+..-..++.|++.|+.|||+++ |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999984 3456777777889999999999999998 9999999999999765 78999999
Q ss_pred ccceecCCCcccCCCCceecC
Q 005825 655 GLARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 655 Gla~~~~~~~~~~~~~~~~GT 675 (675)
|||+..+... .+++.+||
T Consensus 324 GlAK~~g~~s---fm~TlCGT 341 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGT 341 (475)
T ss_pred chhhccccce---ehhhhcCC
Confidence 9999987443 46678887
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=257.15 Aligned_cols=162 Identities=28% Similarity=0.406 Sum_probs=142.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
..++|++.++||+|+||+||.++.. +++.+|+|.+++.. ....+..+.|..||.+++||+||+++-.|++.+++||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999999765 58999999998752 3356788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|+||+.||.|..+| ++++.+++....-++..|+.||.|||+++ ||||||||+|||||++|+++|+|||||+.--
T Consensus 103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999999 45567888776677778999999999998 9999999999999999999999999999765
Q ss_pred CCcccCCCCceecC
Q 005825 662 GDELQGNTKRIVGT 675 (675)
Q Consensus 662 ~~~~~~~~~~~~GT 675 (675)
.++. .|.+++||
T Consensus 177 ~~~~--~t~tfcGT 188 (357)
T KOG0598|consen 177 KDGD--ATRTFCGT 188 (357)
T ss_pred cCCC--ccccccCC
Confidence 4443 35557888
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=264.55 Aligned_cols=151 Identities=40% Similarity=0.625 Sum_probs=133.4
Q ss_pred cceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCc--cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-eEEEEEEec
Q 005825 510 FSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG-EKILILEYM 586 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~ 586 (675)
+.+.+.||+|+||+||+|.+.....||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. ...+|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344466999999999999997666699999986432 22569999999999999999999999999888 799999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC-CeEEeeeccceecCCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-NPKISDFGLARMFGGD 663 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 663 (675)
++|+|..+++.. ....+++..++.++.+||+||.|||++.+ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999764 46689999999999999999999999864 99999999999999997 9999999999987543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=265.28 Aligned_cols=160 Identities=34% Similarity=0.481 Sum_probs=145.7
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
..|...+.||+|||+.||+++. ..|+.||+|++.+. .....+.+.+||+|.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5789999999999999999997 77999999999763 3345677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|++++++|..++. +.+.+++.++..+..||+.||.|||+++ |||||||..|++|++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999994 5678999999999999999999999987 999999999999999999999999999999877
Q ss_pred cccCCCCceecC
Q 005825 664 ELQGNTKRIVGT 675 (675)
Q Consensus 664 ~~~~~~~~~~GT 675 (675)
+.+..| ++||
T Consensus 172 ~Erk~T--lCGT 181 (592)
T KOG0575|consen 172 GERKKT--LCGT 181 (592)
T ss_pred ccccce--ecCC
Confidence 655444 8888
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=228.39 Aligned_cols=109 Identities=47% Similarity=0.803 Sum_probs=82.2
Q ss_pred CcEEEEecCCCCCCCC--cceEEEeeCCeEEEEeCCCCeEEEe-ccCCCC-CCceEEEccCCCEEEEeCCCCCCCcceee
Q 005825 72 DTVVWVANRDRPISDH--NAVLTISNNGKLVLLNQTNGTIWST-NASSEA-KNPVAQLRDDGNLVIRDNSSVNTTENYLW 147 (675)
Q Consensus 72 ~tvVW~Anr~~pv~~~--~~~l~l~~~G~Lvl~~~~g~~vWss-~~~~~~-~~~~a~L~d~GNlVl~~~~~~~~~~~~lW 147 (675)
+||||+|||+.|+... .++|.|+.||+|+|++..++.+|++ ++.+.. .+.+|+|+|+|||||+|. .+.+||
T Consensus 2 ~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-----~~~~lW 76 (114)
T PF01453_consen 2 RTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-----SGNVLW 76 (114)
T ss_dssp --------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-----TSEEEE
T ss_pred cccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-----cceEEE
Confidence 6899999999999543 4899999999999999999999999 555433 578999999999999995 678999
Q ss_pred eeccCCchhhhccccccccccCCCceeEEEecCCCCCC
Q 005825 148 QSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPS 185 (675)
Q Consensus 148 qSFd~PtDTlLpg~~l~~~~~tg~~~~l~S~~s~~dps 185 (675)
|||||||||+||+|+|+.+..++.+..++||++.+|||
T Consensus 77 ~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 77 QSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp ESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred eecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999999988887777899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=250.16 Aligned_cols=158 Identities=30% Similarity=0.396 Sum_probs=136.1
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-eEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG-EKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~-~~~lV~Ey 585 (675)
+.+..+.||+|..|+|||++++ +++.+|+|.+... .+...+++.+|++++++.+||+||+++|.|.... ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4556689999999999999874 6889999999643 3445678999999999999999999999999999 59999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCcc
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (675)
|++|||+.++.. .+.+++...-.|+.+|++||.|||+.. +||||||||+|||++..|+|||+|||.++.+...
T Consensus 160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999943 356889999999999999999999732 4999999999999999999999999999988544
Q ss_pred cCCCCceecC
Q 005825 666 QGNTKRIVGT 675 (675)
Q Consensus 666 ~~~~~~~~GT 675 (675)
.-.+.+||
T Consensus 233 --~a~tfvGT 240 (364)
T KOG0581|consen 233 --IANTFVGT 240 (364)
T ss_pred --hccccccc
Confidence 22335665
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=256.77 Aligned_cols=162 Identities=30% Similarity=0.457 Sum_probs=140.2
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEKI 580 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~~ 580 (675)
..+.|+.+++||+|.||.||+|+. .+|+.||+|++.-.. .....-..+||.||++|.||||++|.+...+. ...|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 456788889999999999999975 679999999997543 44456677899999999999999999999877 6899
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||+|||+. +|.-++.. ....++..++..++.|++.||+|+|.++ |+|||||.+|||||.+|.+||+|||||+++
T Consensus 195 lVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999975 66666632 3446889999999999999999999998 999999999999999999999999999999
Q ss_pred CCCcccCCCCcee
Q 005825 661 GGDELQGNTKRIV 673 (675)
Q Consensus 661 ~~~~~~~~~~~~~ 673 (675)
..++....|.++|
T Consensus 269 ~~~~~~~~T~rVv 281 (560)
T KOG0600|consen 269 TPSGSAPYTSRVV 281 (560)
T ss_pred cCCCCcccccceE
Confidence 8887766777765
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=259.22 Aligned_cols=153 Identities=39% Similarity=0.633 Sum_probs=137.9
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
+.+.+.+.||+|-||+|+.|++.....||+|.++.. ....+.|.+|+.+|++|+|+|||+|+|+|..++.++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 344566899999999999999988889999999864 4455789999999999999999999999999889999999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCcc
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (675)
.|+|.+||.. .....+...+.+.++.|||+||+||+++. +|||||.++||||+++..+||+||||||.+..++.
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999975 23556888999999999999999999997 99999999999999999999999999997766654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=253.94 Aligned_cols=153 Identities=30% Similarity=0.438 Sum_probs=137.4
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~ 580 (675)
..++|.+.+.||+|+|++|++|+. ..++++|||++.+. .....+-+..|-.+|.+| .||.|++|+..|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 457899999999999999999975 45899999999764 234455677889999999 8999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+|+||.++|+|.++|. +.+.+++.....++.+|+.||+|||.++ ||||||||+|||||++|++||+|||-|+.+
T Consensus 151 FvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999994 4577899889999999999999999998 999999999999999999999999999999
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
.+.+
T Consensus 225 ~~~~ 228 (604)
T KOG0592|consen 225 SPSQ 228 (604)
T ss_pred Chhh
Confidence 7644
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=234.90 Aligned_cols=157 Identities=32% Similarity=0.447 Sum_probs=140.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.+|+..+.||.|+||+|.+++.+ +|..+|+|++++... ...+...+|..+|+.+.||++++|.+.+.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57888899999999999999865 488999999987532 34567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||++||.|..+|+ +.+.+++....-+|.+|+.||+|||+.+ |++|||||+|||||++|.+||+|||+|+.+.+.
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999994 4567888888999999999999999998 999999999999999999999999999988543
Q ss_pred cccCCCCceecC
Q 005825 664 ELQGNTKRIVGT 675 (675)
Q Consensus 664 ~~~~~~~~~~GT 675 (675)
|-+++||
T Consensus 198 -----T~TlCGT 204 (355)
T KOG0616|consen 198 -----TWTLCGT 204 (355)
T ss_pred -----EEEecCC
Confidence 4457776
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=237.55 Aligned_cols=149 Identities=25% Similarity=0.380 Sum_probs=130.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
+.|+.+.++|+|+||.||+++.++ |+.||||++.... +...+-.++|+++|++++|+|+|.|+.+|..+...+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457777899999999999999765 9999999987532 3334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|++..-|+++-. ....++.....+++.|+++|+.|+|++. +|||||||+||||+..+.+||+|||+||.+.+
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 999888877652 2334777888899999999999999997 99999999999999999999999999999974
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=247.34 Aligned_cols=150 Identities=27% Similarity=0.391 Sum_probs=135.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
..++|+++..||+|+||.||+++.+ +|..+|+|+|++. ....++.++.|-++|...++|+||+|+..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4579999999999999999999765 5999999999874 34556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+|||++..+| .+...|++.....++.+++.|++-||+.+ +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999 45667888877777788999999999998 9999999999999999999999999997653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-29 Score=240.99 Aligned_cols=166 Identities=27% Similarity=0.452 Sum_probs=140.3
Q ss_pred CCcceeeeeCCcCceeEEEEE-EcCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEE-EEEeCCe-EEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILG-CCIEQGE-KILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g-~~~~~~~-~~lV 582 (675)
.+|+++++||+|+||+||++. +.+|..+|.|.++-. ..+..+....|+.+|++|+|||||++++ -+.+..+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468888999999999999996 578999999998732 3445667889999999999999999998 4555555 8899
Q ss_pred EEecCCCCHHHHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCC-CceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 583 LEYMPNKSLDVFLFDPT-KKRLLGWQARIGIIEGIAQGLLYLHHYSR-FRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|||+..|+|...+...+ ..+.+++++.++++.|+++||..+|.+-+ .-|+||||||.||+|+.+|.+||+||||+|++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999986532 35678999999999999999999998321 13999999999999999999999999999999
Q ss_pred CCCcccCCCCceecC
Q 005825 661 GGDELQGNTKRIVGT 675 (675)
Q Consensus 661 ~~~~~~~~~~~~~GT 675 (675)
....+. ....|||
T Consensus 179 ~s~~tf--A~S~VGT 191 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGT 191 (375)
T ss_pred cchhHH--HHhhcCC
Confidence 776653 3346777
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=208.61 Aligned_cols=109 Identities=36% Similarity=0.792 Sum_probs=103.2
Q ss_pred eeeCccCCCceeee-eecCceeeEEEEeeecCeeEEEEeecCCCceEEEEECcCccEEEEEecCCCCceEEeeeccCCCC
Q 005825 211 TCTGEWTGDGFVSA-LSNTNFLYKQFLVENQDEISYWYEPYNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYC 289 (675)
Q Consensus 211 ~~~g~w~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~~~~~~~~W~~~~~~p~~~C 289 (675)
||+|+|+|..|+++ ++....++.+.|+.++++.+++|...+.+.++|++||++|++++|.|++++++|.++|++|.|+|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 89999999999998 77667778899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCccCCCCcccCCCCCCCCCccCCCccCC
Q 005825 290 GKYGYCGANTICGPDQKPMCQCLEGFRLKS 319 (675)
Q Consensus 290 ~~~~~CG~~g~C~~~~~~~C~C~~Gf~~~~ 319 (675)
|+|+.||+||+|+.+..|.|+|||||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999988889999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=206.51 Aligned_cols=115 Identities=43% Similarity=0.742 Sum_probs=101.7
Q ss_pred CcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCCCCeEEEe
Q 005825 33 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWST 112 (675)
Q Consensus 33 ~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~g~~vWss 112 (675)
+.|.+|++|+|+++.|++|||.+......+.+|||+..+.++||.||++.|. +..++|.|+.||+|+|+|.+|.++|++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 5688899999999999999999876544899999987767899999999984 456899999999999999999999999
Q ss_pred ccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCC
Q 005825 113 NASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYP 153 (675)
Q Consensus 113 ~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~P 153 (675)
++.+.....+|+|+|+|||||++. .+.+||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~-----~~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDS-----DGNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECC-----CCCEEEcCCCCC
Confidence 987534567899999999999986 568999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=225.99 Aligned_cols=151 Identities=34% Similarity=0.566 Sum_probs=132.6
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC-ccC-HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS-GQG-LEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~-~~~-~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.+|...++||+|.||.||+|+. .+|+.||||+++... ..+ .....+|++.|+.++|+||+.|+++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4577778999999999999985 569999999998542 222 3457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
||+ .+|+..+++ +...+...+...++.++++||+|||.+. |+||||||.|+|++++|.+||+||||||.++...
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 589888865 3456888999999999999999999998 9999999999999999999999999999997543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=240.12 Aligned_cols=151 Identities=26% Similarity=0.509 Sum_probs=137.5
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
-+|++.+.||+|.||+|-+++. ..|++||||.+++. +.++.-.+++|++||..|+||||+.++.+|..++...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4678889999999999999975 67999999999864 4455667899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||..+|.|.+|+ ...+.+++.+...+++||..|+.|+|.+. ++|||||.+|||||+++++||+||||+.++..+
T Consensus 133 EYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999 44567999999999999999999999987 999999999999999999999999999988654
Q ss_pred c
Q 005825 664 E 664 (675)
Q Consensus 664 ~ 664 (675)
.
T Consensus 207 k 207 (668)
T KOG0611|consen 207 K 207 (668)
T ss_pred c
Confidence 4
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=259.39 Aligned_cols=152 Identities=35% Similarity=0.566 Sum_probs=135.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcCcc-CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSGQ-GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE 578 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~ 578 (675)
.+.+.+..++||+|+||+||+|+.. +...||||.|+..... ..++|++|+++++.++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 4456677789999999999999753 3567999999976554 77899999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCC-------C----cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC
Q 005825 579 KILILEYMPNKSLDVFLFDPT-------K----KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM 647 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 647 (675)
.++|+|||..|+|.+||.... . ...++..+.+.||.|||.||+||-+++ ++||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 999999999999999996311 1 334888999999999999999999987 99999999999999999
Q ss_pred CeEEeeeccceec
Q 005825 648 NPKISDFGLARMF 660 (675)
Q Consensus 648 ~~kl~DFGla~~~ 660 (675)
.|||+||||+|..
T Consensus 641 ~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 641 VVKISDFGLSRDI 653 (774)
T ss_pred EEEecccccchhh
Confidence 9999999999865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=244.94 Aligned_cols=151 Identities=30% Similarity=0.428 Sum_probs=133.2
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCH-HHHHHHHHHHHhcC-CCceeeEEEEEEeCC-eEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGL-EEFKNEMLLIAKLQ-HRNLVRILGCCIEQG-EKIL 581 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~-~~f~~E~~il~~l~-H~nIv~l~g~~~~~~-~~~l 581 (675)
..++|.+.++||.|+||.||+|+- ..++.||||+++++-.... -.=.+|++.|++|. |||||+|.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 457899999999999999999974 5689999999987533322 22457999999998 999999999999988 8999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||| ..+|.+++++. .+.+++..+..|+.||++||+|+|++| +.|||+||||||+.....+||+||||||-+.
T Consensus 88 VfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 99999 56899988754 678999999999999999999999998 9999999999999999999999999999875
Q ss_pred C
Q 005825 662 G 662 (675)
Q Consensus 662 ~ 662 (675)
.
T Consensus 162 S 162 (538)
T KOG0661|consen 162 S 162 (538)
T ss_pred c
Confidence 4
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=235.91 Aligned_cols=148 Identities=30% Similarity=0.492 Sum_probs=128.3
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC--------------ccCHHHHHHHHHHHHhcCCCceeeEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS--------------GQGLEEFKNEMLLIAKLQHRNLVRIL 570 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--------------~~~~~~f~~E~~il~~l~H~nIv~l~ 570 (675)
..++|++.+.||+|.||.|-+|+. .+++.||||++.+.. ....+..++|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 458899999999999999999986 468999999996531 11245789999999999999999999
Q ss_pred EEEEeC--CeEEEEEEecCCCCHHHHhcCCCCccc-CCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC
Q 005825 571 GCCIEQ--GEKILILEYMPNKSLDVFLFDPTKKRL-LGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM 647 (675)
Q Consensus 571 g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 647 (675)
.+.-+. +..|||+||+..|.+... ....+ +...++.++++++..||+|||.++ ||||||||+|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 998655 478999999999987432 22333 889999999999999999999998 99999999999999999
Q ss_pred CeEEeeeccceec
Q 005825 648 NPKISDFGLARMF 660 (675)
Q Consensus 648 ~~kl~DFGla~~~ 660 (675)
++||+|||.+-.+
T Consensus 248 ~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 248 TVKISDFGVSNEF 260 (576)
T ss_pred cEEeeccceeeec
Confidence 9999999999877
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=239.11 Aligned_cols=161 Identities=29% Similarity=0.474 Sum_probs=138.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc----Cc-cCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ----SG-QGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGE 578 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~----~~-~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~ 578 (675)
..+.|.+.+.||+|+||+|+.|+. .+++.||||.+.+. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 457899999999999999999975 46899999977653 12 23456778999999999 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC-CCeEEeeeccc
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD-MNPKISDFGLA 657 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla 657 (675)
.++||||+.+|+|.+++.. .+.+.+.+...++.|++.|++|||.++ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999943 556888999999999999999999998 9999999999999999 99999999999
Q ss_pred eecC-CCcccCCCCceecC
Q 005825 658 RMFG-GDELQGNTKRIVGT 675 (675)
Q Consensus 658 ~~~~-~~~~~~~~~~~~GT 675 (675)
+... .++ ...+.+||
T Consensus 169 ~~~~~~~~---~l~t~cGs 184 (370)
T KOG0583|consen 169 AISPGEDG---LLKTFCGS 184 (370)
T ss_pred cccCCCCC---cccCCCCC
Confidence 9984 322 23345665
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=244.58 Aligned_cols=148 Identities=36% Similarity=0.541 Sum_probs=130.4
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC--C---cEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN--G---EEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~--g---~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
++..+.++||+|+||.||+|++.. + ..||||..+.. ......+|.+|+++|++++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344555899999999999998643 2 23899998852 355678999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++|||+++||+|+++|.... ..++..+++.++.+.|+||+|||++. +|||||.++|+|++.++.+||+||||++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999995432 25899999999999999999999998 99999999999999999999999999885
Q ss_pred c
Q 005825 660 F 660 (675)
Q Consensus 660 ~ 660 (675)
-
T Consensus 312 ~ 312 (474)
T KOG0194|consen 312 G 312 (474)
T ss_pred C
Confidence 4
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=249.57 Aligned_cols=154 Identities=33% Similarity=0.561 Sum_probs=137.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC----CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
......+.++||.|.||+|++|+++- ...||||.|+... ....++|+.|+.||.+++||||++|.|+....+..+
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 34566778999999999999998742 3579999999753 445678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||.|||+||+|+.||+.. .+.+.+.+...++++||.||+||-+.+ .+||||.++|||++.+..+||+||||+|.+
T Consensus 707 IiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999643 456899999999999999999999987 999999999999999999999999999988
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
.++.
T Consensus 782 edd~ 785 (996)
T KOG0196|consen 782 EDDP 785 (996)
T ss_pred ccCC
Confidence 6655
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=241.91 Aligned_cols=159 Identities=31% Similarity=0.481 Sum_probs=140.1
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++|.+.+.||+|+||.||||+- .+.+.||+|.+.+. .....+.+++|++|+++++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5788889999999999999975 45889999999764 34456779999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|+.| +|..+|. ..+.+++.....|+.++..||.|||+.. |+|||+||+||||+..+++|++|||+||-+..+.
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 9999994 4567899999999999999999999987 9999999999999999999999999999886544
Q ss_pred ccCCCCceecC
Q 005825 665 LQGNTKRIVGT 675 (675)
Q Consensus 665 ~~~~~~~~~GT 675 (675)
. ..++|.||
T Consensus 155 ~--vltsikGt 163 (808)
T KOG0597|consen 155 S--VLTSIKGT 163 (808)
T ss_pred e--eeeeccCc
Confidence 2 34456665
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=239.25 Aligned_cols=160 Identities=34% Similarity=0.510 Sum_probs=136.5
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHh--cCCCceeeEEEEEEeCC----eEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAK--LQHRNLVRILGCCIEQG----EKIL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~--l~H~nIv~l~g~~~~~~----~~~l 581 (675)
...++.++||+|.||.||||.+. ++.||||++.. +..+.|++|-+|.+. ++|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34456678999999999999984 58999999964 455778888887765 58999999999987666 8999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc------CCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY------SRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
|+||.++|+|.+||. ...++|....+|+..+++||+|||+. ++++|+|||||.+||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999994 45789999999999999999999964 45689999999999999999999999999
Q ss_pred cceecCCCcccCCCCceecC
Q 005825 656 LARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 656 la~~~~~~~~~~~~~~~~GT 675 (675)
||.++......+.+-.-|||
T Consensus 362 LAl~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred eeEEecCCCCCcchhhhhhh
Confidence 99999776655555445665
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=240.69 Aligned_cols=160 Identities=33% Similarity=0.491 Sum_probs=142.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
...|...++||+|+-|.||.++. .+++.||||++........+-+.+|+.+|+..+|+|||+++..+..++++|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 35667778999999999999964 56889999999876555667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCcc
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (675)
|++|+|.+.+. ...+++.++..|++++++||+|||.++ |||||||.+||||+.++.+||+|||++..+..++.
T Consensus 352 m~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999883 345899999999999999999999998 99999999999999999999999999999987776
Q ss_pred cCCCCceecC
Q 005825 666 QGNTKRIVGT 675 (675)
Q Consensus 666 ~~~~~~~~GT 675 (675)
+.. ++|||
T Consensus 425 KR~--TmVGT 432 (550)
T KOG0578|consen 425 KRS--TMVGT 432 (550)
T ss_pred ccc--cccCC
Confidence 443 37887
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=228.94 Aligned_cols=150 Identities=32% Similarity=0.488 Sum_probs=131.4
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC--eEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG--EKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~--~~~lV~E 584 (675)
.++...+.||+|+||.||++...+ |+..|||.+........+.+.+|+.+|.+++|||||+.+|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456777899999999999998754 8999999987653333677899999999999999999999855444 6889999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-CCCeEEeeeccceecCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-DMNPKISDFGLARMFGG 662 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~ 662 (675)
|+++|+|.+++..... .+++.....+..||++||+|||+++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999954322 6899999999999999999999988 999999999999999 79999999999998864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=222.78 Aligned_cols=152 Identities=30% Similarity=0.450 Sum_probs=128.1
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCc-cC-HHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSG-QG-LEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEKI 580 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~-~~-~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~~ 580 (675)
..+.|+.++.|++|+||.||+|+. ++++.||+|+++.... .+ --.-.+||.+|.+++|||||.+-.+.+.. +..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 346788889999999999999986 4689999999985321 11 12457899999999999999998887644 4799
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||||||+. +|..++..- ...+...+...+..|+++||+|||.+. |+||||||+|+|+++.|.+||+||||||.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99999965 777777432 246778888899999999999999998 999999999999999999999999999999
Q ss_pred CCC
Q 005825 661 GGD 663 (675)
Q Consensus 661 ~~~ 663 (675)
+..
T Consensus 228 gsp 230 (419)
T KOG0663|consen 228 GSP 230 (419)
T ss_pred cCC
Confidence 765
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-26 Score=231.35 Aligned_cols=174 Identities=29% Similarity=0.425 Sum_probs=141.0
Q ss_pred CCCCCCcccHHHHHHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHH--hcCCCceee
Q 005825 491 KDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIA--KLQHRNLVR 568 (675)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~--~l~H~nIv~ 568 (675)
..+.+|.+-. .....+..+.+.||+|.||+||+|++ .|+.||||++... +.+.+.+|.+|.. .|+|+||..
T Consensus 197 SGSGlplLVQ---RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 197 SGSGLPLLVQ---RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred CCCCchhHhH---HhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhh
Confidence 3455555433 34557889999999999999999999 5789999999753 3355666776665 469999999
Q ss_pred EEEEEEeCC----eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-----cCCCceEecCCCCC
Q 005825 569 ILGCCIEQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH-----YSRFRIIHRDLKAS 639 (675)
Q Consensus 569 l~g~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~iiHrDlkp~ 639 (675)
+++.-..+. .+|||.+|.+.|||.+||.+ ..++-...++++..+|.||++||- ++++.|.|||||+.
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 999865543 68999999999999999943 568889999999999999999994 67889999999999
Q ss_pred CEEEcCCCCeEEeeeccceecCCC--cccCCCCceecC
Q 005825 640 NVLLDRDMNPKISDFGLARMFGGD--ELQGNTKRIVGT 675 (675)
Q Consensus 640 NILl~~~~~~kl~DFGla~~~~~~--~~~~~~~~~~GT 675 (675)
|||+.+++.+.|+|+|||.....+ +.....+..|||
T Consensus 346 NILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGT 383 (513)
T KOG2052|consen 346 NILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGT 383 (513)
T ss_pred cEEEccCCcEEEeeceeeEEecccCCcccCCCCCccce
Confidence 999999999999999999888654 333344445776
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=195.76 Aligned_cols=113 Identities=46% Similarity=0.790 Sum_probs=99.8
Q ss_pred CcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCCCCeEEEe
Q 005825 33 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWST 112 (675)
Q Consensus 33 ~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~g~~vWss 112 (675)
+.|..++.|+|+++.|++|||.+... ..+.+|||+..++++||+|||+.|+.+ .+.|.|+.||+|+|++.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 46788999999999999999998654 688999998766789999999999865 3889999999999999999999999
Q ss_pred ccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccC
Q 005825 113 NASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDY 152 (675)
Q Consensus 113 ~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~ 152 (675)
++.......+|+|+|+|||||++. .+.+|||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~-----~~~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDS-----DGNFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECC-----CCCEEeCCCCC
Confidence 987435567899999999999986 56799999997
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-26 Score=237.56 Aligned_cols=151 Identities=32% Similarity=0.549 Sum_probs=133.9
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccC-HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQG-LEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~-~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
+.....+.++||+|-||+|.+++...+..||||+++...... ..+|..|+++|.+++|||||+|+|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 345566779999999999999999888999999999865544 4799999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||++|+|.+|+...... .+.-...+.|+.|||.||+||.+.. ++||||.++|+|++.++++||+|||++|-+
T Consensus 616 YmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence 99999999999654322 2445566789999999999999876 999999999999999999999999999955
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=237.50 Aligned_cols=162 Identities=28% Similarity=0.406 Sum_probs=139.5
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeE
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEK 579 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~ 579 (675)
...++|.++.+||+|+||+|+++++. +++.+|||.+++.. ...++..+.|..|+.... ||.|++|+.+++.++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34579999999999999999999875 48899999999863 345677888998888775 99999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+.||++..+. ....+++..+.-++..|+.||.|||+++ |||||||.+|||||.+|++||+||||+|.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999943333 3456888888889999999999999998 99999999999999999999999999996
Q ss_pred cCCCcccCCCCceecC
Q 005825 660 FGGDELQGNTKRIVGT 675 (675)
Q Consensus 660 ~~~~~~~~~~~~~~GT 675 (675)
-...+. .|.+++||
T Consensus 518 ~m~~g~--~TsTfCGT 531 (694)
T KOG0694|consen 518 GMGQGD--RTSTFCGT 531 (694)
T ss_pred cCCCCC--ccccccCC
Confidence 543332 46678998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=224.01 Aligned_cols=151 Identities=25% Similarity=0.398 Sum_probs=136.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
..++|++.++||.|.-++||+|+. +.++.||||++..+. ....++++.|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 457899999999999999999974 668999999997543 334689999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
.||.+||+.++++..-.. -+++..+..|.+++++||.|||.++ .||||||+.||||+.+|.|||+|||.+.-+
T Consensus 104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeee
Confidence 999999999999754333 3888999999999999999999998 999999999999999999999999977655
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=228.27 Aligned_cols=152 Identities=31% Similarity=0.543 Sum_probs=131.1
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC-----------------CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN-----------------GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRI 569 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~-----------------g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l 569 (675)
++|++.++||+|+||.||++.+.+ +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578888999999999999997532 3479999987642 2345679999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHhcCCC----------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 005825 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPT----------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIH 633 (675)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 633 (675)
++++.+.+..++||||+++++|.+++.... ....+++...+.++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885321 1134678889999999999999999987 999
Q ss_pred cCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 634 RDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 634 rDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||||+|||+++++.+||+|||+++.+..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~ 190 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYA 190 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceeccc
Confidence 99999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-25 Score=233.55 Aligned_cols=154 Identities=30% Similarity=0.446 Sum_probs=130.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE------cCCcEEEEEEecCcCc-cCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL------LNGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQG 577 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~ 577 (675)
..++|++.++||+|+||.||+|+. .+++.||||+++.... ...+.+..|+.++.++ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346889999999999999999974 2356899999975332 3346789999999999 8999999999987654
Q ss_pred -eEEEEEEecCCCCHHHHhcCCCC--------------------------------------------------------
Q 005825 578 -EKILILEYMPNKSLDVFLFDPTK-------------------------------------------------------- 600 (675)
Q Consensus 578 -~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 600 (675)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999853211
Q ss_pred ---cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 601 ---KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 601 ---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
...+.+.+...++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 134778888999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-26 Score=215.47 Aligned_cols=152 Identities=32% Similarity=0.433 Sum_probs=134.6
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
..++|++.+.||+|-||.||.|+.+ ++-.||+|++.+. ..+..+++.+|++|-+.|+||||.++++++.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3468899999999999999999864 5778999999764 23445679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++||.++|+|...|.+. +...+++.....++.|+|.||.|+|... ||||||||+|+|++..+.+||+|||-+..-.
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999642 3456788888899999999999999887 9999999999999999999999999998654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=221.21 Aligned_cols=151 Identities=31% Similarity=0.490 Sum_probs=127.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCc-c-CHHHHHHHHHHHHhcCCCc-eeeEEEEEEeCC-----
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSG-Q-GLEEFKNEMLLIAKLQHRN-LVRILGCCIEQG----- 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~-~-~~~~f~~E~~il~~l~H~n-Iv~l~g~~~~~~----- 577 (675)
...|...++||+|+||+||+|+. .+|+.||+|++..... + .-....+|+.++++++|+| ||+|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566678899999999999975 5689999999975433 2 2234678999999999999 999999998877
Q ss_pred -eEEEEEEecCCCCHHHHhcCCCCc-ccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 578 -EKILILEYMPNKSLDVFLFDPTKK-RLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 578 -~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
..++|+||+ .-+|..++...... ..++......+..||++||+|||+++ |+||||||+||||++.|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 788999999 56888888543321 34666788899999999999999998 9999999999999999999999999
Q ss_pred cceecC
Q 005825 656 LARMFG 661 (675)
Q Consensus 656 la~~~~ 661 (675)
+||.+.
T Consensus 166 lAra~~ 171 (323)
T KOG0594|consen 166 LARAFS 171 (323)
T ss_pred hHHHhc
Confidence 999775
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=233.28 Aligned_cols=148 Identities=25% Similarity=0.358 Sum_probs=132.5
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||+||+++.. +++.||||++++.. ......++.|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999764 58899999997532 233457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||+++|+|.+++.. ...+++.....++.|++.||+|||+++ |+||||||+|||+++++++||+|||+|+.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999843 456889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=234.80 Aligned_cols=151 Identities=36% Similarity=0.606 Sum_probs=133.3
Q ss_pred HHHHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 502 SVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 502 ~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
+-.+..+.+.+.+.||+|.||+||+|++-+ .||||.++-. ..+..++|++|+..+++.+|.||+-+.|+|..+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 334455677788999999999999999843 5999999854 34567899999999999999999999999998877
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
.||+.+++|-+|..+|+.. +..++..+.+.||.|||+||.|||.+. |||||||..||+|.+++.|||+|||||..
T Consensus 463 AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 9999999999999999754 355888899999999999999999998 99999999999999999999999999864
Q ss_pred c
Q 005825 660 F 660 (675)
Q Consensus 660 ~ 660 (675)
-
T Consensus 538 k 538 (678)
T KOG0193|consen 538 K 538 (678)
T ss_pred e
Confidence 3
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=229.04 Aligned_cols=149 Identities=26% Similarity=0.398 Sum_probs=133.2
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 48899999997532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+++++|.+++. ....+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999994 3346788899999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=232.28 Aligned_cols=152 Identities=23% Similarity=0.281 Sum_probs=134.0
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
....++|++.++||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334578999999999999999999875 5889999998642 223345688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++|+|.+++.. ..+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999843 24788888999999999999999987 99999999999999999999999999998
Q ss_pred cCC
Q 005825 660 FGG 662 (675)
Q Consensus 660 ~~~ 662 (675)
+..
T Consensus 192 ~~~ 194 (370)
T cd05621 192 MDE 194 (370)
T ss_pred ccc
Confidence 753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=233.10 Aligned_cols=147 Identities=27% Similarity=0.357 Sum_probs=131.1
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||.||+++. .+++.||||++.+. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4788999999999999999976 46899999998643 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999843 346788888899999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=232.71 Aligned_cols=146 Identities=23% Similarity=0.343 Sum_probs=130.6
Q ss_pred CcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.|+..++||+|+||+||+|+. .+++.||||++.... ....+.+..|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999976 458899999997532 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999999843 345788888889999999999999987 999999999999999999999999998755
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=232.33 Aligned_cols=148 Identities=25% Similarity=0.367 Sum_probs=132.9
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||+||+++.. +++.||||+++... ......+..|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999874 58999999997531 234466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||+++|+|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999853 346889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=227.51 Aligned_cols=149 Identities=26% Similarity=0.376 Sum_probs=133.5
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.+.||+|+||.||+|+.. +++.||||.++.. .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 67899999999999999999875 5889999998753 2234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+++++|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999843 345788888899999999999999987 99999999999999999999999999998754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=228.18 Aligned_cols=150 Identities=27% Similarity=0.376 Sum_probs=132.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC--CcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN--GEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~--g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|++.+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999997643 368999998643 22345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999843 346888999999999999999999987 9999999999999999999999999998774
Q ss_pred C
Q 005825 662 G 662 (675)
Q Consensus 662 ~ 662 (675)
.
T Consensus 183 ~ 183 (340)
T PTZ00426 183 T 183 (340)
T ss_pred C
Confidence 3
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-24 Score=219.64 Aligned_cols=150 Identities=28% Similarity=0.350 Sum_probs=131.4
Q ss_pred CcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.|+..+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999986 468999999987432 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999998887532 2335889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=230.53 Aligned_cols=147 Identities=24% Similarity=0.370 Sum_probs=130.8
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||.||+++.. +++.||||.+.+.. ....+.+.+|++++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999864 58899999987532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||+++|+|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|..+
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999843 346788888889999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=232.26 Aligned_cols=151 Identities=28% Similarity=0.448 Sum_probs=136.1
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
+-|++.+.||+|+-|.|..|+. .+|+.+|||++.+. .......+.+|+.+|+.+.|||+++|++++.++.++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5678889999999999999975 57999999999764 2233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++|.|.+++ .+.+.+.+++..+++.||..|+.|+|+.+ |+||||||+|+|||..+++||+|||||.+-.++
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999999 45677899999999999999999999987 999999999999999999999999999986554
Q ss_pred c
Q 005825 664 E 664 (675)
Q Consensus 664 ~ 664 (675)
.
T Consensus 166 k 166 (786)
T KOG0588|consen 166 K 166 (786)
T ss_pred c
Confidence 4
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=231.83 Aligned_cols=146 Identities=25% Similarity=0.393 Sum_probs=130.1
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.|+..++||+|+||.||+|+.. +++.||||.+.+.. ....+.+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 58899999997532 2335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|+++|+|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999999843 345788888889999999999999987 999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=225.51 Aligned_cols=141 Identities=27% Similarity=0.330 Sum_probs=125.9
Q ss_pred eeeCCcCceeEEEEEE-cCCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 005825 514 CKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNK 589 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 589 (675)
+.||+|+||.||+++. .+++.||||+++... ......+..|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 468999999997532 233457888999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 590 SLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 590 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+|..++. ....+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 9999884 3456889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=224.38 Aligned_cols=149 Identities=25% Similarity=0.354 Sum_probs=132.5
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999875 58999999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+++++|.+++.. ...+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999843 346888899999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=247.68 Aligned_cols=151 Identities=38% Similarity=0.648 Sum_probs=134.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC--Cc----EEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN--GE----EVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~--g~----~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
..+..+.+.||+|.||.||+|.+.+ +. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3455677899999999999998754 33 4999999865 456678999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 580 ILILEYMPNKSLDVFLFDPT----KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
+|++|||++|+|..||.+.+ ....+.-.+.+.++.+||+|+.||++++ +|||||.++|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997542 1456888999999999999999999998 9999999999999999999999999
Q ss_pred cceec
Q 005825 656 LARMF 660 (675)
Q Consensus 656 la~~~ 660 (675)
|||.+
T Consensus 848 lArDi 852 (1025)
T KOG1095|consen 848 LARDI 852 (1025)
T ss_pred hhHhh
Confidence 99944
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=235.59 Aligned_cols=152 Identities=18% Similarity=0.220 Sum_probs=133.2
Q ss_pred CcceeeeeCCcCceeEEEEEEc-C-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-N-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.|.+.+.||+|+||.||++... + ++.||+|.+..........++.|+.++++++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999753 3 6788999876544445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 587 PNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 587 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
++|+|.+++... .....+++.+...++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999988542 23446888899999999999999999987 999999999999999999999999999987543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=224.61 Aligned_cols=141 Identities=28% Similarity=0.328 Sum_probs=126.2
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNK 589 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 589 (675)
+.||+|+||.||+++.. +++.||||.+++. .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 5899999999753 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 590 SLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 590 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+|..++.. ...+++.+...++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 99988843 346889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=234.05 Aligned_cols=160 Identities=32% Similarity=0.489 Sum_probs=137.5
Q ss_pred cceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------eEEE
Q 005825 510 FSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG------EKIL 581 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~------~~~l 581 (675)
+...+.||+|+||.||+|+. ..|+.||||..+... ....+....|+++|++++|+|||++++.-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44557899999999999985 569999999998643 345677889999999999999999999865443 5789
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc--CCC--CeEEeeeccc
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD--RDM--NPKISDFGLA 657 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~--~~kl~DFGla 657 (675)
||||+++|||...|.+++....|++.+.+.+..+++.||.|||+++ |+||||||.||++- ++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998888888999999999999999999999987 99999999999983 333 4699999999
Q ss_pred eecCCCcccCCCCceecC
Q 005825 658 RMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 658 ~~~~~~~~~~~~~~~~GT 675 (675)
|-+..++ ..+.++||
T Consensus 172 rel~d~s---~~~S~vGT 186 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGT 186 (732)
T ss_pred ccCCCCC---eeeeecCc
Confidence 9997766 35568887
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-24 Score=222.55 Aligned_cols=140 Identities=23% Similarity=0.285 Sum_probs=125.3
Q ss_pred eCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCH
Q 005825 516 LGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSL 591 (675)
Q Consensus 516 IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (675)
||+|+||.||+++.. +++.||+|.++.. .......+..|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 4889999998753 233456788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 592 DVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 592 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 999843 345889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-24 Score=224.32 Aligned_cols=141 Identities=26% Similarity=0.321 Sum_probs=125.7
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNK 589 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 589 (675)
+.||+|+||.||+++.. +++.||+|.++.. .......+..|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999864 5899999999753 2234556788999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 590 SLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 590 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+|..++.. ...+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99988843 346889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.8e-24 Score=224.34 Aligned_cols=151 Identities=22% Similarity=0.330 Sum_probs=134.1
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||.||+++.. +++.||||+++... ....+.+..|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47889999999999999999864 58899999997532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++++|.+++... ...+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998542 246889999999999999999999987 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=222.99 Aligned_cols=151 Identities=21% Similarity=0.276 Sum_probs=132.9
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||.||+++.. +++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 5788999998752 2223456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++|+|.+++... ...+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999542 345788888999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=227.48 Aligned_cols=154 Identities=23% Similarity=0.277 Sum_probs=134.6
Q ss_pred HHHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005825 503 VAAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE 578 (675)
Q Consensus 503 ~~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~ 578 (675)
+....++|++.+.||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++.+.+++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3445689999999999999999999875 5889999998642 22334568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.++||||+++|+|.+++.. ..++...+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999999843 24678888889999999999999987 9999999999999999999999999999
Q ss_pred ecCCC
Q 005825 659 MFGGD 663 (675)
Q Consensus 659 ~~~~~ 663 (675)
.+...
T Consensus 191 ~~~~~ 195 (371)
T cd05622 191 KMNKE 195 (371)
T ss_pred EcCcC
Confidence 87543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=228.48 Aligned_cols=151 Identities=24% Similarity=0.294 Sum_probs=132.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
..++|++.++||+|+||.||+++.. +++.||+|.+++. .....+.+..|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999864 5889999999642 22334567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++|+|.+++.. ..++......++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 24677888889999999999999987 9999999999999999999999999998775
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 194 ~~ 195 (370)
T cd05596 194 AN 195 (370)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=222.74 Aligned_cols=150 Identities=21% Similarity=0.302 Sum_probs=132.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.+.||+|+||.||+++.. +++.||||.+.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999864 5889999998742 2234466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999843 2345788889999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=228.79 Aligned_cols=153 Identities=32% Similarity=0.446 Sum_probs=131.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEE------cCCcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL------LNGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~ 578 (675)
.++|++.++||+|+||.||+|+. .++..||||+++... ....+.+.+|+.++..+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999963 235689999997532 23456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCC-----------------------------------------------------------
Q 005825 579 KILILEYMPNKSLDVFLFDPT----------------------------------------------------------- 599 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 599 (675)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999885321
Q ss_pred -------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 600 -------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 600 -------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
....+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 0124788899999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=218.35 Aligned_cols=149 Identities=33% Similarity=0.466 Sum_probs=120.1
Q ss_pred CcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-----EEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE-----KILI 582 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~-----~~lV 582 (675)
.|...+++|.|+||.||+|.+.+ ++.||||+.-.+.. .-..|+.+|++++|||||+|+-+|....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667899999999999998754 78999999865432 22368999999999999999999875432 3589
Q ss_pred EEecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC-CCeEEeeeccceec
Q 005825 583 LEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD-MNPKISDFGLARMF 660 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~~ 660 (675)
|||||. +|..++++. .....++.....-+..||.+||+|||+.+ |+||||||+|+|+|.+ |.+||+|||-|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999975 677777532 12344566666678999999999999977 9999999999999976 89999999999999
Q ss_pred CCCcc
Q 005825 661 GGDEL 665 (675)
Q Consensus 661 ~~~~~ 665 (675)
..++.
T Consensus 177 ~~~ep 181 (364)
T KOG0658|consen 177 VKGEP 181 (364)
T ss_pred ccCCC
Confidence 76653
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=226.25 Aligned_cols=150 Identities=26% Similarity=0.415 Sum_probs=134.6
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+..|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999875 58999999997532 244567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++++|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999854 256888999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=221.10 Aligned_cols=142 Identities=26% Similarity=0.310 Sum_probs=125.3
Q ss_pred eeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 005825 514 CKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNK 589 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 589 (675)
+.||+|+||.||+++. .+++.||+|.++.. ......++..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 46899999999753 2234567788999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 590 SLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH-YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 590 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+|..++. ....+++.....++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 9998884 33468899999999999999999997 55 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=222.27 Aligned_cols=148 Identities=26% Similarity=0.361 Sum_probs=129.8
Q ss_pred CcceeeeeCCcCceeEEEEEE----cCCcEEEEEEecCc----CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeE
Q 005825 509 NFSMECKLGEGGFGPVYKGRL----LNGEEVAVKRLSSQ----SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~----~~g~~vAvK~l~~~----~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~ 579 (675)
+|++.++||+|+||.||+++. .+++.||+|++.+. .....+.+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999975 35789999998642 122345688899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++|+|.+++.. ...+++.+...++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999843 345888999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 005825 660 FGG 662 (675)
Q Consensus 660 ~~~ 662 (675)
+..
T Consensus 155 ~~~ 157 (332)
T cd05614 155 FLS 157 (332)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=224.93 Aligned_cols=148 Identities=25% Similarity=0.371 Sum_probs=132.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|+..+.||+|+||.||+++.. +++.||||.++.. .....+.+..|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 5889999999743 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999843 346888899999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.3e-24 Score=219.51 Aligned_cols=154 Identities=31% Similarity=0.486 Sum_probs=131.7
Q ss_pred eeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCC
Q 005825 514 CKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKS 590 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (675)
+.||.|-||+||-|+. ++|+.||||.+.+. .......+++|+.||.+++||.||.|...|+..+..++|||-+.|--
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 7899999999999976 46999999999764 34556789999999999999999999999999999999999997666
Q ss_pred HHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---CCCeEEeeeccceecCCCcccC
Q 005825 591 LDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDFGLARMFGGDELQG 667 (675)
Q Consensus 591 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~~~~~ 667 (675)
|+-+|.. ..+.++++....++.||+.||.|||.++ |+|+||||+||||.. --++||+|||+||++++...+
T Consensus 650 LEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR- 723 (888)
T KOG4236|consen 650 LEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR- 723 (888)
T ss_pred HHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh-
Confidence 6655543 3456888888888999999999999998 999999999999954 347999999999999877654
Q ss_pred CCCceecC
Q 005825 668 NTKRIVGT 675 (675)
Q Consensus 668 ~~~~~~GT 675 (675)
+.+|||
T Consensus 724 --rsVVGT 729 (888)
T KOG4236|consen 724 --RSVVGT 729 (888)
T ss_pred --hhhcCC
Confidence 346777
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=216.24 Aligned_cols=148 Identities=30% Similarity=0.438 Sum_probs=129.8
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57899999999999999999864 58899999987532 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++ +|.+++... ...+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 985 898887432 335788899999999999999999987 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-24 Score=235.66 Aligned_cols=150 Identities=32% Similarity=0.474 Sum_probs=132.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCC-cEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEE-Ee------CC
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNG-EEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCC-IE------QG 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g-~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~-~~------~~ 577 (675)
.-+.++.+.|.+|||+.||++....+ ..+|+|++-.......+..++||++|++|+ |+|||.+++.. .. .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 45677889999999999999998765 999999998777888899999999999998 99999999943 21 13
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
+.+|.||||++|+|-+++...... .|.+.+.++|+.++++|+++||.. +++|||||||.|||||+.+++.||||||-|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 678999999999999999654333 399999999999999999999987 578999999999999999999999999987
Q ss_pred e
Q 005825 658 R 658 (675)
Q Consensus 658 ~ 658 (675)
.
T Consensus 194 t 194 (738)
T KOG1989|consen 194 T 194 (738)
T ss_pred c
Confidence 4
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=219.99 Aligned_cols=150 Identities=25% Similarity=0.327 Sum_probs=133.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.++||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999875 58899999987542 2335679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|+++++|.+++.. ...+++.....++.|++.||+|||+.+ .|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 9999999999843 345788999999999999999999864 49999999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=220.90 Aligned_cols=150 Identities=20% Similarity=0.277 Sum_probs=131.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||.||+++... ++.+|+|.+.+. .....+.+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478899999999999999998754 788999998642 1223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+++|+|.+++... ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999532 345788888999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=220.66 Aligned_cols=141 Identities=30% Similarity=0.414 Sum_probs=124.5
Q ss_pred eeeCCcCceeEEEEEE----cCCcEEEEEEecCc----CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 514 CKLGEGGFGPVYKGRL----LNGEEVAVKRLSSQ----SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~----~~g~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++||+|+||.||+++. ..++.||||.++.. .......+..|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 35789999998753 123345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+++++|.+++. ....+.+.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 99999999984 3445778888889999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=222.10 Aligned_cols=161 Identities=30% Similarity=0.478 Sum_probs=140.2
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCcc---CHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeE
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQ---GLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEK 579 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~ 579 (675)
.....|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+......
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345788999999999999999998765 999999999865432 3468999999999998 99999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC----CCeEEeeec
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD----MNPKISDFG 655 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~DFG 655 (675)
++|||++.||.|.+.+... .+++.+...++.||+.|++|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999998543 2899999999999999999999987 9999999999999543 479999999
Q ss_pred cceecCCCcccCCCCceecC
Q 005825 656 LARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 656 la~~~~~~~~~~~~~~~~GT 675 (675)
+|+.....+ ....++||
T Consensus 185 la~~~~~~~---~~~~~~Gt 201 (382)
T KOG0032|consen 185 LAKFIKPGE---RLHTIVGT 201 (382)
T ss_pred CceEccCCc---eEeeecCC
Confidence 999997632 34456776
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=225.87 Aligned_cols=154 Identities=31% Similarity=0.440 Sum_probs=131.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC------CcEEEEEEecCcCc-cCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCC
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQG 577 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~ 577 (675)
..++|++.++||+|+||.||+|+... +..||||+++.... ...+.|.+|+.+++++. ||||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35688899999999999999997521 34799999975432 33467999999999996 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCC----------------------------------------------------------
Q 005825 578 EKILILEYMPNKSLDVFLFDPT---------------------------------------------------------- 599 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 599 (675)
..+|||||+++|+|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999998875321
Q ss_pred -----------------------------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc
Q 005825 600 -----------------------------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD 644 (675)
Q Consensus 600 -----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 644 (675)
....+++.++..++.||++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0124778888999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccceecCC
Q 005825 645 RDMNPKISDFGLARMFGG 662 (675)
Q Consensus 645 ~~~~~kl~DFGla~~~~~ 662 (675)
+++.+||+|||+++.+..
T Consensus 272 ~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 272 QGKIVKICDFGLARDIMH 289 (400)
T ss_pred CCCEEEEEeCCcceeccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=225.43 Aligned_cols=163 Identities=26% Similarity=0.440 Sum_probs=141.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-EEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE-KILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~-~~lV 582 (675)
.++|...+++|+|+||.++..+. .+++.+++|.+... .....+..++|+.++++++|||||.+.+.+++++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 35788889999999999999965 45789999998743 23334567899999999999999999999999998 9999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||++||+|.+.+...+ ...++++....++.|++.|+.|||++. |+|||||+.||+++++..|||.|||+||.++.
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999996543 567888999999999999999999877 99999999999999999999999999999987
Q ss_pred CcccCCCCceecC
Q 005825 663 DELQGNTKRIVGT 675 (675)
Q Consensus 663 ~~~~~~~~~~~GT 675 (675)
+... ..+++||
T Consensus 159 ~~~~--a~tvvGT 169 (426)
T KOG0589|consen 159 EDSL--ASTVVGT 169 (426)
T ss_pred chhh--hheecCC
Confidence 7632 3447777
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=219.23 Aligned_cols=146 Identities=27% Similarity=0.361 Sum_probs=127.8
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCC-CceeeEEEEEEeCCeEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQH-RNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H-~nIv~l~g~~~~~~~~~lV~ 583 (675)
+|++.+.||+|+||.||+|+.. +++.||||++++. .....+.+..|+.++..+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788999999999999999875 4789999999753 23345678889999999976 46888999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 99999999998843 345788999999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=226.34 Aligned_cols=153 Identities=34% Similarity=0.497 Sum_probs=130.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~ 578 (675)
.++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.+++++ +|+||++++++|.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457889999999999999998742 24579999997543 23345788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCC-----------------------------------------------------------
Q 005825 579 KILILEYMPNKSLDVFLFDPT----------------------------------------------------------- 599 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 599 (675)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred --------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 600 --------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 600 --------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
....+++.+.+.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 1124778889999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-23 Score=218.30 Aligned_cols=147 Identities=27% Similarity=0.346 Sum_probs=127.9
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
+|++.+.||+|+||.||+|+.. +++.||||.+++.. ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999875 47899999987532 22345577788888777 5899999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999988843 345888999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=214.87 Aligned_cols=149 Identities=25% Similarity=0.398 Sum_probs=131.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999875 58899999987532 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|++++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999988776542 2345888899999999999999999987 99999999999999999999999999988743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=213.31 Aligned_cols=149 Identities=30% Similarity=0.475 Sum_probs=131.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc----CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457889999999999999999753 36689999998643 2334679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||||+++|+|++++... ...+++.+++.++.|++.||+|||+++ ++||||||+|||++.++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998542 346889999999999999999999987 999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=219.06 Aligned_cols=144 Identities=28% Similarity=0.345 Sum_probs=126.7
Q ss_pred eeeCCcCceeEEEEEE----cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 514 CKLGEGGFGPVYKGRL----LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
+.||+|+||.||+++. .+++.||+|+++... ......+..|+.++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999975 357899999997532 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 9999999843 346889999999999999999999987 999999999999999999999999999876433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=213.93 Aligned_cols=149 Identities=26% Similarity=0.329 Sum_probs=133.5
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++++.||+|.-|+||++++.+ +..+|+|++.+.. .....+.+.|-+||+.++||.++.|++.++..+..++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 567788999999999999999866 5899999998653 345567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||++||+|..+++. +..+.+++..+.-++..|+.||+|||-.| ||.|||||+||||.++|++-|+||-|+...
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999998865 34567888888888889999999999998 999999999999999999999999998765
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-23 Score=215.15 Aligned_cols=149 Identities=30% Similarity=0.412 Sum_probs=129.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.++||+|+||.||+|+.. +++.||||.++.... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 688999999875432 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 577777643 2345788889999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=223.45 Aligned_cols=142 Identities=23% Similarity=0.315 Sum_probs=126.4
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
..++|++.++||+|+||.||+++.. +++.||+|.... ..+.+|+.++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3468999999999999999999864 588999997542 456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++. ++|..++.. ...+++.+.+.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 164 ~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 164 RYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred cCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 985 688888743 345789999999999999999999987 999999999999999999999999999764
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=218.96 Aligned_cols=141 Identities=26% Similarity=0.364 Sum_probs=124.4
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
+.||+|+||.||+++.. +++.||+|.+++. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 5789999999753 223445678899888877 799999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++|..++.. ...+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 999988843 346889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=218.75 Aligned_cols=144 Identities=28% Similarity=0.424 Sum_probs=125.4
Q ss_pred cceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHH---HhcCCCceeeEEEEEEeCCeEEEE
Q 005825 510 FSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLI---AKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il---~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
|++.+.||+|+||.||+++.. +++.||||.+++.. ....+.+..|+.++ ++++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999864 58999999997532 23345677776655 567899999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|||+++++|..++.. ..+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999988742 35899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=223.67 Aligned_cols=145 Identities=28% Similarity=0.427 Sum_probs=126.6
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|+..++||+|+||.||+++.. +++.||||.+..... ...+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999864 589999999975432 3356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.... ...+.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999986432 3456777889999999999999987 99999999999999999999999999987743
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=212.37 Aligned_cols=150 Identities=29% Similarity=0.462 Sum_probs=130.1
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecC--cCccCHHHHHHHHHHHHhcCCCceeeEEEEEEe-----CCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSS--QSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE-----QGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~-----~~~ 578 (675)
...|...+.||+|+||.|..+.. .+|+.||||++.. ......++..+|+++|+.++|+||+.+.+.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 45566678999999999999976 4689999999973 345567788999999999999999999999865 347
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.|+|+|+| ..+|...++ .+..++......+..|+++||+|+|+.+ |+||||||.|+|++.+..+||+||||||
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 778888884 3444888888899999999999999987 9999999999999999999999999999
Q ss_pred ecCCC
Q 005825 659 MFGGD 663 (675)
Q Consensus 659 ~~~~~ 663 (675)
.+...
T Consensus 174 ~~~~~ 178 (359)
T KOG0660|consen 174 YLDKF 178 (359)
T ss_pred ecccc
Confidence 99643
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=218.31 Aligned_cols=141 Identities=26% Similarity=0.368 Sum_probs=124.2
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
++||+|+||.||+|+.. +++.||||.++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 47899999987532 23455678899998876 799999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence 999988843 346888899999999999999999987 999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-23 Score=212.73 Aligned_cols=151 Identities=34% Similarity=0.514 Sum_probs=131.5
Q ss_pred CCcceeeeeCCcCceeEEEEEE-----cCCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-----LNGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.+|++.++||+|+||.||+|.. .+++.||+|.++... .+...+|.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 246789999997533 3344679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC--------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC
Q 005825 582 ILEYMPNKSLDVFLFDPT--------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM 647 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 647 (675)
||||+++++|.+++.... ....+++.+.+.++.+++.||+|||+++ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 1235788899999999999999999987 99999999999999999
Q ss_pred CeEEeeeccceecC
Q 005825 648 NPKISDFGLARMFG 661 (675)
Q Consensus 648 ~~kl~DFGla~~~~ 661 (675)
.+||+|||+++.+.
T Consensus 162 ~~kl~dfg~~~~~~ 175 (283)
T cd05090 162 HVKISDLGLSREIY 175 (283)
T ss_pred cEEecccccccccc
Confidence 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=219.01 Aligned_cols=141 Identities=23% Similarity=0.349 Sum_probs=125.2
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
+.||+|+||.||+++.. +++.||||.+++. .....+.++.|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999864 5889999999753 223456688999999998 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|+|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 99998884 3356899999999999999999999987 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=217.43 Aligned_cols=142 Identities=29% Similarity=0.357 Sum_probs=122.3
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHh-cCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAK-LQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
++||+|+||.||+|+.. +++.||||.++... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 47899999997532 2334556667777765 4899999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999988843 345888889999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=217.77 Aligned_cols=150 Identities=35% Similarity=0.585 Sum_probs=129.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCc----EEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGE----EVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.+|++.+.||+|+||.||+|++. +++ .||||.++... ....+++..|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57899999999999999999863 333 48999987543 34457899999999999999999999999764 5779
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|+||+++|+|.+++... ...+++...+.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998543 335788899999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 161 ~~ 162 (316)
T cd05108 161 AD 162 (316)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=210.04 Aligned_cols=151 Identities=36% Similarity=0.517 Sum_probs=135.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.++|++.++||+|+||.||+|...++..||+|.++.. ....+.+..|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3678999999999999999999888889999998753 334678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++++|.+++... ....+++..++.++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999998643 2345788899999999999999999987 99999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=218.60 Aligned_cols=150 Identities=25% Similarity=0.332 Sum_probs=132.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.++||+|+||.||+++.. +++.+|+|.++... ....+.+.+|++++++++||||+++++++.+.++.++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999875 58889999887542 2334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|+++++|.+++.. ...+++.....++.+++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999843 345788888999999999999999753 39999999999999999999999999998663
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-23 Score=209.08 Aligned_cols=148 Identities=30% Similarity=0.487 Sum_probs=132.9
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
++|++.+.||+|+||.||+++..++..+|+|.++.. ....+.|..|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468888999999999999999888889999998743 3345789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+|+|.+++... ...+++..+..++.+++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 99999998542 235889999999999999999999987 9999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-24 Score=225.41 Aligned_cols=155 Identities=32% Similarity=0.513 Sum_probs=139.1
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
...+..+.++||-|-||.||.|.++. .-.||||.|+. ....+++|+.|..+|+.++|||+|+|+|+|......|||+|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 34566778999999999999998865 56799999986 56678999999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
||..|+|.+||.+..+. .++....+.++.||+.||+||..++ +|||||.++|+|+.++..+||+||||+|++.++.
T Consensus 344 fM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred cccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 99999999999765443 4566778899999999999999987 9999999999999999999999999999998775
Q ss_pred c
Q 005825 665 L 665 (675)
Q Consensus 665 ~ 665 (675)
.
T Consensus 420 Y 420 (1157)
T KOG4278|consen 420 Y 420 (1157)
T ss_pred e
Confidence 3
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=208.02 Aligned_cols=151 Identities=32% Similarity=0.482 Sum_probs=135.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.++|++.+.||+|++|.||+|...+++.||+|.++.. ....+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 4678899999999999999999877889999998753 334678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++++|.+++.... ...+++.....++.+++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999985432 346889999999999999999999987 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=211.96 Aligned_cols=149 Identities=28% Similarity=0.356 Sum_probs=131.2
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
+|++.++||+|+||+||++... +++.||||.+.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999864 68899999997532 2233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|+++++|..++... ....+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999888542 2345889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=217.27 Aligned_cols=147 Identities=27% Similarity=0.360 Sum_probs=127.9
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~ 583 (675)
+|+..+.||+|+||.||+++.. +++.||||.+++.. ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999864 58899999987532 234466888999998885 577888999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||+++|+|..++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999999884 3346889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-23 Score=217.36 Aligned_cols=146 Identities=26% Similarity=0.410 Sum_probs=126.2
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----eEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG-----EKI 580 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~-----~~~ 580 (675)
+|++.++||+|+||.||+|+.. +++.||||+++.. ......++.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788999999999999999864 5899999998743 2234457889999999999999999999986432 479
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||++ ++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68988884 3345889999999999999999999987 999999999999999999999999999865
Q ss_pred C
Q 005825 661 G 661 (675)
Q Consensus 661 ~ 661 (675)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=211.35 Aligned_cols=145 Identities=31% Similarity=0.404 Sum_probs=126.6
Q ss_pred eCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCH
Q 005825 516 LGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSL 591 (675)
Q Consensus 516 IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (675)
||+|+||+||++... +++.||||.+.... ....+.+..|+.++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 68899999987532 22345678899999999999999999999999999999999999999
Q ss_pred HHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 592 DVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 592 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
..++... .....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 9887542 23456899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=211.32 Aligned_cols=151 Identities=32% Similarity=0.551 Sum_probs=132.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-----CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-----NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~ 579 (675)
..+|++.+.||+|+||.||++... +++.||+|+++.......+.|.+|+.++++++||||+++++++... ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 357888999999999999999742 4789999999865555667899999999999999999999987543 468
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 8999999999999998532 345889999999999999999999987 99999999999999999999999999997
Q ss_pred cCC
Q 005825 660 FGG 662 (675)
Q Consensus 660 ~~~ 662 (675)
+..
T Consensus 158 ~~~ 160 (284)
T cd05081 158 LPQ 160 (284)
T ss_pred ccC
Confidence 743
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=216.77 Aligned_cols=141 Identities=28% Similarity=0.404 Sum_probs=124.4
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
+.||+|+||.||+++.. +++.||||.+++. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 5889999998753 233456778888888876 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|+|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 999988843 346888999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=219.76 Aligned_cols=154 Identities=29% Similarity=0.455 Sum_probs=136.0
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.....|.+...||+|.|++|.+++. ..+..||||.+.+.. ....+.+.+|+++|..+.|||||+|+.+...+..+++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3457899999999999999999976 458999999998753 2334568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||..+|.+.+++. +.+.+.+.+...++.|+..|++|||.+. |+|||||++||||+.++++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 999999999999994 3444556778889999999999999998 9999999999999999999999999999886
Q ss_pred CCc
Q 005825 662 GDE 664 (675)
Q Consensus 662 ~~~ 664 (675)
...
T Consensus 207 ~~~ 209 (596)
T KOG0586|consen 207 YGL 209 (596)
T ss_pred ccc
Confidence 443
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-23 Score=216.67 Aligned_cols=141 Identities=28% Similarity=0.358 Sum_probs=121.7
Q ss_pred eeeCCcCceeEEEEEE-cCCcEEEEEEecCcC---ccCHHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS---GQGLEEFKNEML-LIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~-il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
+.||+|+||+||+++. .+++.+|||++.+.. .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999986 468999999987532 223345566655 56779999999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++|..++. ....+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 99998884 3456889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=207.35 Aligned_cols=149 Identities=31% Similarity=0.499 Sum_probs=133.4
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
++|.+.+.||+|+||.||+++..++..+|||.++.. ....++|.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 467888999999999999998877778999998753 3345789999999999999999999999999889999999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 99999998542 235889999999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=228.63 Aligned_cols=156 Identities=21% Similarity=0.292 Sum_probs=133.2
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC----
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG---- 577 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~---- 577 (675)
...++|.+.++||+|+||+||+++. .+++.||||.+... .......+.+|+.++..++|+||+++...+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457999999999999999999975 46899999998653 2334567889999999999999999988775433
Q ss_pred ----eEEEEEEecCCCCHHHHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 005825 578 ----EKILILEYMPNKSLDVFLFDPT-KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKIS 652 (675)
Q Consensus 578 ----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 652 (675)
..++||||+++|+|.+++.... ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 3679999999999999986432 2456889999999999999999999987 9999999999999999999999
Q ss_pred eeccceecCCC
Q 005825 653 DFGLARMFGGD 663 (675)
Q Consensus 653 DFGla~~~~~~ 663 (675)
|||+++.+...
T Consensus 186 DFGls~~~~~~ 196 (496)
T PTZ00283 186 DFGFSKMYAAT 196 (496)
T ss_pred ecccCeecccc
Confidence 99999987543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=223.46 Aligned_cols=146 Identities=26% Similarity=0.357 Sum_probs=128.1
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
....|.+.+.||+|+||.||+++... ++.||||... ...+.+|++++++++|+|||++++++..++..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34689999999999999999998754 7889999643 2346789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
++. ++|..++.. ....+++.+++.|+.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 241 ~~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 995 688888743 2346899999999999999999999987 999999999999999999999999999987543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=216.09 Aligned_cols=141 Identities=26% Similarity=0.363 Sum_probs=124.9
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
++||+|+||+||+++.. +++.||+|++++.. ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 37999999999999874 57899999998532 23445688999999888 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 99998884 3346899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=232.69 Aligned_cols=150 Identities=24% Similarity=0.347 Sum_probs=131.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||.||+|+.. +++.||||++..... ...++|.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999875 589999999975322 23467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCC--------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 584 EYMPNKSLDVFLFDP--------TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
||+++++|.+++... .....+++...+.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988531 11234567788899999999999999987 9999999999999999999999999
Q ss_pred cceec
Q 005825 656 LARMF 660 (675)
Q Consensus 656 la~~~ 660 (675)
+|+..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99977
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.7e-23 Score=215.87 Aligned_cols=141 Identities=28% Similarity=0.343 Sum_probs=120.6
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEML-LIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~-il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
++||+|+||.||+++.. +++.||+|.+.+.. .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 58899999987532 222344555554 67889999999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++|...+.. ...+.+.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 999888843 345778888889999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=215.37 Aligned_cols=141 Identities=28% Similarity=0.353 Sum_probs=121.4
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEML-LIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~-il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
+.||+|+||+||+|+.. +++.||||++.... ....+++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999874 68999999987532 222344555554 56789999999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++|..++.. ...+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999998843 446888889999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=210.80 Aligned_cols=143 Identities=22% Similarity=0.373 Sum_probs=125.3
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCccC---HHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeEEEEEEec
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQG---LEEFKNEMLLIAKLQHRNLVRILGCCIE----QGEKILILEYM 586 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~---~~~f~~E~~il~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~ 586 (675)
..|++|++|.||+|.+ +|+.||||+++...... .+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 78899999997643333 4678899999999999999999999977 34688999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++|+|.+++.. ...+++.....++.+++.||.|||+.. .++||||||+|||+++++.+||+|||+++.+..
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999953 346889999999999999999999852 288999999999999999999999999987643
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=209.79 Aligned_cols=153 Identities=30% Similarity=0.486 Sum_probs=131.4
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE 578 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~ 578 (675)
..++|++.++||+|+||.||+|... .+..||||+++... .....+|.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 25679999986432 2334578999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEE
Q 005825 579 KILILEYMPNKSLDVFLFDPTK-------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI 651 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 651 (675)
.++||||+++++|.+++..... ...+.+..+..++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854211 234678889999999999999999987 999999999999999999999
Q ss_pred eeeccceecC
Q 005825 652 SDFGLARMFG 661 (675)
Q Consensus 652 ~DFGla~~~~ 661 (675)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05062 161 GDFGMTRDIY 170 (277)
T ss_pred CCCCCccccC
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=206.95 Aligned_cols=148 Identities=28% Similarity=0.468 Sum_probs=133.6
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
++|++.++||+|+||.||+|+. .+++.||+|+++.......+.+.+|+.++.+++||||+++++.+..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5788899999999999999986 468899999997654455667889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999998843 346788999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=208.83 Aligned_cols=143 Identities=31% Similarity=0.459 Sum_probs=122.6
Q ss_pred eeCCcCceeEEEEEEcC---CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCC
Q 005825 515 KLGEGGFGPVYKGRLLN---GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKS 590 (675)
Q Consensus 515 ~IG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (675)
+||+|+||.||+|+..+ ...+|+|.+.... ......|.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 69999999999997543 3568888876432 2334678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 591 LDVFLFDPTK--KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 591 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|.+++..... ....++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 9999865322 233567788899999999999999987 999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-23 Score=210.04 Aligned_cols=153 Identities=35% Similarity=0.564 Sum_probs=138.4
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
...+|++.++||+|+||.||+|...+++.+|+|.++........++..|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34578888999999999999999888999999999876555677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.+++... ....+++..+..++.+++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999653 2346789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=213.95 Aligned_cols=141 Identities=26% Similarity=0.369 Sum_probs=123.1
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHh-cCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAK-LQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
+.||+|+||+||+|+.. +++.||||.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 47899999997532 2334566778888876 4899999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|+|..++.. ...+++.+...++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999999843 345788899999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=207.31 Aligned_cols=150 Identities=34% Similarity=0.581 Sum_probs=132.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC----CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|++.+.||+|+||.||+|+... ...||||.++... .....+|..|+.++++++||||+++++.+.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578899999999999999998742 4579999987543 2345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998542 236889999999999999999999987 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=203.39 Aligned_cols=161 Identities=30% Similarity=0.430 Sum_probs=136.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc----Ccc----CHHHHHHHHHHHHhcC-CCceeeEEEEEEe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ----SGQ----GLEEFKNEMLLIAKLQ-HRNLVRILGCCIE 575 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~----~~~----~~~~f~~E~~il~~l~-H~nIv~l~g~~~~ 575 (675)
.-++|...+.||+|..+.|.++.. .++++.|+|++... ... ..++-..|+.||+++. ||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 445677778999999999988854 56899999998632 111 2345678999999985 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
+...++|+|.|+.|.|.++| .....++++...+|+.|+..|++|||.+. |+||||||+|||+|++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 99999999999999999999 45667999999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCcccCCCCceecC
Q 005825 656 LARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 656 la~~~~~~~~~~~~~~~~GT 675 (675)
+|..+.+.+. .+.++||
T Consensus 169 Fa~~l~~Gek---LrelCGT 185 (411)
T KOG0599|consen 169 FACQLEPGEK---LRELCGT 185 (411)
T ss_pred eeeccCCchh---HHHhcCC
Confidence 9999976653 2334555
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=220.65 Aligned_cols=152 Identities=32% Similarity=0.482 Sum_probs=130.1
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~ 578 (675)
.++|.+.++||+|+||.||+|++. .++.||||+++.... ...+.+..|+.++.++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346778899999999999999853 246899999985432 23457889999999997 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCC-----------------------------------------------------------
Q 005825 579 KILILEYMPNKSLDVFLFDPT----------------------------------------------------------- 599 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 599 (675)
.++||||+++|+|.++++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999986421
Q ss_pred ------------------------------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE
Q 005825 600 ------------------------------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL 643 (675)
Q Consensus 600 ------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 643 (675)
....+++...+.|+.|++.||+|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 1124677788899999999999999887 9999999999999
Q ss_pred cCCCCeEEeeeccceecC
Q 005825 644 DRDMNPKISDFGLARMFG 661 (675)
Q Consensus 644 ~~~~~~kl~DFGla~~~~ 661 (675)
++++.+||+|||+++.+.
T Consensus 273 ~~~~~~kL~DfGla~~~~ 290 (401)
T cd05107 273 CEGKLVKICDFGLARDIM 290 (401)
T ss_pred eCCCEEEEEecCcceecc
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=232.74 Aligned_cols=151 Identities=26% Similarity=0.380 Sum_probs=133.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|.+.++||+|+||.||+|+.. +++.||||+++... ....+.+..|+.+++.++||||+++++++......+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999875 58899999997532 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++.. ...+++...+.|+.||+.||+|||.++ |+||||||+||||+.++.+||+|||+++....
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 999999999999843 345788889999999999999999987 99999999999999999999999999997654
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
.
T Consensus 157 ~ 157 (669)
T cd05610 157 R 157 (669)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=214.08 Aligned_cols=141 Identities=30% Similarity=0.393 Sum_probs=123.0
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
++||+|+||.||+++.. +++.||+|.++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 58899999997532 23445677788888754 899999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++|..++.. ...+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999988843 345788899999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=207.39 Aligned_cols=147 Identities=42% Similarity=0.665 Sum_probs=127.1
Q ss_pred ceeeeeCCcCceeEEEEEEc-----CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 511 SMECKLGEGGFGPVYKGRLL-----NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~~-----~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.+.+.||+|+||.||+|++. .+..|+||.++... ....+.|.+|++.+++++||||++++|++.+.+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35689999999999999876 25789999997532 3346889999999999999999999999998888999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|+++|+|.++|... ....+++..+..|+.||++||+|||+++ ++|++|+|+|||+++++.+||+|||+++...
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 99999999999653 2346899999999999999999999987 9999999999999999999999999999873
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=206.52 Aligned_cols=149 Identities=33% Similarity=0.511 Sum_probs=132.6
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
.+|++.+.||+|+||.||+++..++..+|+|.+... .....+|.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 357788999999999999998877788999998643 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++|.+++... ...+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 99999998542 236889999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=209.69 Aligned_cols=152 Identities=33% Similarity=0.559 Sum_probs=133.4
Q ss_pred CCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888899999999999999742 345699999876555556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC----------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEE
Q 005825 582 ILEYMPNKSLDVFLFDPT----------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI 651 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 651 (675)
||||+++++|.+++.... +...+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999985321 2235899999999999999999999987 999999999999999999999
Q ss_pred eeeccceecCC
Q 005825 652 SDFGLARMFGG 662 (675)
Q Consensus 652 ~DFGla~~~~~ 662 (675)
+|||+++.+..
T Consensus 162 ~dfg~~~~~~~ 172 (288)
T cd05093 162 GDFGMSRDVYS 172 (288)
T ss_pred ccCCccccccC
Confidence 99999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=214.08 Aligned_cols=141 Identities=28% Similarity=0.330 Sum_probs=119.7
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEML-LIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~-il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
+.||+|+||.||+++.. +++.||+|.+.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 57889999987532 222334444544 56789999999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++|..++.. ...+.+.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 999999843 345677788889999999999999987 999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=209.64 Aligned_cols=153 Identities=29% Similarity=0.475 Sum_probs=130.6
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE 578 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~ 578 (675)
..++|++.++||+|+||.||+|... .+..||+|.++... .....++.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999653 24589999987432 2234568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCC-------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEE
Q 005825 579 KILILEYMPNKSLDVFLFDPT-------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI 651 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 651 (675)
.++||||+++|+|.+++.... ....+.+.....++.|++.||.|||+++ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999995321 1234567788899999999999999987 999999999999999999999
Q ss_pred eeeccceecC
Q 005825 652 SDFGLARMFG 661 (675)
Q Consensus 652 ~DFGla~~~~ 661 (675)
+|||+++.+.
T Consensus 161 ~Dfg~~~~~~ 170 (288)
T cd05061 161 GDFGMTRDIY 170 (288)
T ss_pred CcCCcccccc
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=189.68 Aligned_cols=148 Identities=30% Similarity=0.471 Sum_probs=126.5
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|...++||+|.||+||+|+.. .++.||+|+++... ...-....+|+-+++.++|.|||++++.....+.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556689999999999999865 48899999987532 22335678899999999999999999999888899999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+. .+|.++... -.+.++......++.|+++||.|+|+++ +.||||||+|.|+..+|+.|++|||+||.++-
T Consensus 83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 94 567777632 3456788888899999999999999988 99999999999999999999999999998753
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-22 Score=210.67 Aligned_cols=148 Identities=29% Similarity=0.448 Sum_probs=129.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|.+.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999865 57889999987543 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++ +|.+++... ...+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 985 788777432 345788888999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=211.12 Aligned_cols=151 Identities=30% Similarity=0.499 Sum_probs=129.9
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC---------------CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN---------------GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILG 571 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~---------------g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g 571 (675)
++|++.++||+|+||.||+++..+ ...||+|.++... ....+.|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987532 2358999987542 233457999999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHhcCCC---------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEE
Q 005825 572 CCIEQGEKILILEYMPNKSLDVFLFDPT---------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVL 642 (675)
Q Consensus 572 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 642 (675)
++...+..++||||+++++|.+++.... ....+++..++.++.+++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999985321 1124688899999999999999999987 999999999999
Q ss_pred EcCCCCeEEeeeccceecC
Q 005825 643 LDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 643 l~~~~~~kl~DFGla~~~~ 661 (675)
+++++.+||+|||+++.+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EcCCCcEEecccccccccc
Confidence 9999999999999998663
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=207.28 Aligned_cols=151 Identities=28% Similarity=0.487 Sum_probs=124.4
Q ss_pred CCcceeeeeCCcCceeEEEEEEc--CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhc---CCCceeeEEEEEEe-----
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL--NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKL---QHRNLVRILGCCIE----- 575 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~--~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l---~H~nIv~l~g~~~~----- 575 (675)
.+|++.++||+|+||.||+|+.. +++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46889999987532 22234566777777665 69999999999863
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
....++||||++ ++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999996 6898888542 2335789999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCC
Q 005825 656 LARMFGGD 663 (675)
Q Consensus 656 la~~~~~~ 663 (675)
+|+.+...
T Consensus 156 ~~~~~~~~ 163 (290)
T cd07862 156 LARIYSFQ 163 (290)
T ss_pred ceEeccCC
Confidence 99877543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=206.65 Aligned_cols=145 Identities=32% Similarity=0.423 Sum_probs=124.3
Q ss_pred eeeCCcCceeEEEEEEcC---CcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 005825 514 CKLGEGGFGPVYKGRLLN---GEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNK 589 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 589 (675)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999997643 46799999875432 33457889999999999999999999999999999999999999
Q ss_pred CHHHHhcCCC--CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 590 SLDVFLFDPT--KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 590 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+|.+++.... .....++.....++.|++.||+|||+.+ ++||||||+||++++++++||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999986432 1234567778889999999999999987 9999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=209.06 Aligned_cols=152 Identities=32% Similarity=0.543 Sum_probs=133.2
Q ss_pred CCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.+|.+.+.||+|+||.||+++.. ++..+++|.++.......+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999742 356799999876555556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC
Q 005825 582 ILEYMPNKSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN 648 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 648 (675)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985421 1235889999999999999999999987 999999999999999999
Q ss_pred eEEeeeccceecCC
Q 005825 649 PKISDFGLARMFGG 662 (675)
Q Consensus 649 ~kl~DFGla~~~~~ 662 (675)
+||+|||+++....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-24 Score=232.46 Aligned_cols=150 Identities=37% Similarity=0.562 Sum_probs=131.8
Q ss_pred ceeeeeCCcCceeEEEEEE-cCCc----EEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 511 SMECKLGEGGFGPVYKGRL-LNGE----EVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~-~~g~----~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
+..++||+|+||+||+|.+ ++|+ +||||++... ..+...++..|+.+|++++||||+||+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 4457899999999999965 4443 7899998754 4456789999999999999999999999998765 889999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
||+.|.|.+|++.. +..+..+..+.+..|||+||.|||++. ++||||.++|+||.+-.++||+|||+|+++..++
T Consensus 778 ~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999653 445788999999999999999999886 9999999999999999999999999999998776
Q ss_pred cc
Q 005825 665 LQ 666 (675)
Q Consensus 665 ~~ 666 (675)
.+
T Consensus 853 ~e 854 (1177)
T KOG1025|consen 853 KE 854 (1177)
T ss_pred cc
Confidence 54
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=207.97 Aligned_cols=151 Identities=34% Similarity=0.572 Sum_probs=132.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC------CcEEEEEEecCcCcc-CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLSSQSGQ-GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~-~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
++|.+.+.||+|+||.||+|+..+ ++.||||.++..... ..+.|.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 467888999999999999997633 478999999865443 4578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCC-----------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCe
Q 005825 581 LILEYMPNKSLDVFLFDPT-----------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP 649 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 649 (675)
+||||+++++|.+++.... ....+++.+...++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999985421 2345788899999999999999999987 9999999999999999999
Q ss_pred EEeeeccceecC
Q 005825 650 KISDFGLARMFG 661 (675)
Q Consensus 650 kl~DFGla~~~~ 661 (675)
||+|||+++.+.
T Consensus 162 kl~d~g~~~~~~ 173 (280)
T cd05049 162 KIGDFGMSRDVY 173 (280)
T ss_pred EECCcccceecc
Confidence 999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=217.28 Aligned_cols=147 Identities=27% Similarity=0.397 Sum_probs=128.1
Q ss_pred CcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----eEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG-----EKI 580 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~-----~~~ 580 (675)
+|++.++||+|+||.||+++. .+++.||||++... .....+++.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 46899999998753 2234567889999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||+. ++|.+++. ....+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 57877773 3346889999999999999999999987 999999999999999999999999999876
Q ss_pred CC
Q 005825 661 GG 662 (675)
Q Consensus 661 ~~ 662 (675)
..
T Consensus 154 ~~ 155 (372)
T cd07853 154 EP 155 (372)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=207.52 Aligned_cols=151 Identities=36% Similarity=0.586 Sum_probs=131.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC------CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
++|++.+.||+|+||.||+|.... ...||+|.++... ....++|.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999997643 2579999987543 233567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC
Q 005825 581 LILEYMPNKSLDVFLFDPTK-------------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM 647 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 647 (675)
++|||+++++|.+++..... ...+++...+.++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999854211 145788999999999999999999987 99999999999999999
Q ss_pred CeEEeeeccceecC
Q 005825 648 NPKISDFGLARMFG 661 (675)
Q Consensus 648 ~~kl~DFGla~~~~ 661 (675)
.+||+|||+++...
T Consensus 162 ~~~L~dfg~~~~~~ 175 (283)
T cd05048 162 TVKISDFGLSRDIY 175 (283)
T ss_pred cEEECCCcceeecc
Confidence 99999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=208.60 Aligned_cols=151 Identities=31% Similarity=0.516 Sum_probs=130.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-----------------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-----------------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRI 569 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-----------------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l 569 (675)
++|++.++||+|+||.||+++.. ++..+|+|.++... ......|..|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999998532 23468999997543 3345689999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHhcCCC--------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCE
Q 005825 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPT--------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNV 641 (675)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NI 641 (675)
++++...+..++||||+++++|.+++.... ....+++.+...++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999986421 1234778889999999999999999987 99999999999
Q ss_pred EEcCCCCeEEeeeccceecC
Q 005825 642 LLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 642 Ll~~~~~~kl~DFGla~~~~ 661 (675)
|+++++.+||+|||+++.+.
T Consensus 162 li~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred EEcCCCCEEeccCccccccc
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-24 Score=208.50 Aligned_cols=160 Identities=29% Similarity=0.514 Sum_probs=140.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.+-|.++++||+|+||.||++..+ .|+.+|||.+.- ...++++..|+.||.+.+.|++|+++|.+.....+|+||||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 345778899999999999999654 599999999873 45778999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCcc
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (675)
+..|++.++++. +++++.+.++..|+...++||+|||... -||||||+.||||.-+|++||+|||.|..+...-.
T Consensus 110 CGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 110 CGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred cCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 999999999853 4667999999999999999999999875 89999999999999999999999999988754433
Q ss_pred cCCCCceecC
Q 005825 666 QGNTKRIVGT 675 (675)
Q Consensus 666 ~~~~~~~~GT 675 (675)
+.+| ++||
T Consensus 185 KRNT--VIGT 192 (502)
T KOG0574|consen 185 KRNT--VIGT 192 (502)
T ss_pred hhCc--cccC
Confidence 3333 6776
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=204.35 Aligned_cols=151 Identities=32% Similarity=0.539 Sum_probs=131.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.++|++.++||+|+||.||+|+..+...||+|+++.. ....++|..|+.++++++||||+++++.+. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 3578999999999999999998877778999999753 334567999999999999999999999874 45689999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
++++|.+++... ....+++..+..++.+++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999542 2345789999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-22 Score=215.98 Aligned_cols=146 Identities=22% Similarity=0.359 Sum_probs=128.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc---CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL---NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
...+|.+.++||+|+||.||++... .++.||+|.+... +.+.+|+.++++++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3468999999999999999999753 3578999988642 3456899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||++. ++|.+++ .....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99986 6788887 23456899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
.
T Consensus 238 ~ 238 (392)
T PHA03207 238 H 238 (392)
T ss_pred c
Confidence 3
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=205.64 Aligned_cols=150 Identities=32% Similarity=0.564 Sum_probs=131.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc----CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.+|++.+.||+|+||.||+|+.. .+..+|+|.++... ....+.|..|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888899999999999999763 23479999987532 23356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++... ...+++.+.+.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999542 245789999999999999999999987 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=215.48 Aligned_cols=152 Identities=30% Similarity=0.475 Sum_probs=128.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEE------cCCcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeC-C
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL------LNGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQ-G 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~-~ 577 (675)
.++|++.++||+|+||.||+|.. .+++.||||+++... ....+.+..|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35789999999999999999963 347889999997543 23346788999999999 689999999988654 4
Q ss_pred eEEEEEEecCCCCHHHHhcCCCC---------------------------------------------------------
Q 005825 578 EKILILEYMPNKSLDVFLFDPTK--------------------------------------------------------- 600 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 600 (675)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999853210
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 601 -------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 601 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
...+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 124678888999999999999999987 9999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=204.46 Aligned_cols=150 Identities=32% Similarity=0.531 Sum_probs=133.6
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.+|++.++||+|+||.||+|... .++.||+|.++.. ....+++.+|++++++++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 46788899999999999999865 4889999998753 344678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++++|.+++... ....+++..++.++.|+++||+|||+++ ++||||||+||++++++.+||+|||+++.+..
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999998542 2345789999999999999999999987 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=211.54 Aligned_cols=141 Identities=30% Similarity=0.385 Sum_probs=124.5
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
+.||+|+||+||+++.. +++.||||.+++. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 4789999999753 233456678899999888 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++|..++.. ...+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 999988843 346899999999999999999999987 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=208.73 Aligned_cols=153 Identities=31% Similarity=0.519 Sum_probs=132.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC-----------------CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceee
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN-----------------GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVR 568 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~-----------------g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~ 568 (675)
..+|++.++||+|+||.||+++..+ +..||+|.+.... ....+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678889999999999999987542 2468999987543 234568999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCCHHHHhcCCC--------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCC
Q 005825 569 ILGCCIEQGEKILILEYMPNKSLDVFLFDPT--------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASN 640 (675)
Q Consensus 569 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N 640 (675)
+++++...+..++||||+++++|.+++.... ....+++...+.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985432 1226889999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeeeccceecCC
Q 005825 641 VLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 641 ILl~~~~~~kl~DFGla~~~~~ 662 (675)
|++++++.+||+|||+++.+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred eeecCCCceEEccccceeeccc
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=205.57 Aligned_cols=149 Identities=33% Similarity=0.593 Sum_probs=125.2
Q ss_pred ceeeeeCCcCceeEEEEEEcC-Cc--EEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC------CeE
Q 005825 511 SMECKLGEGGFGPVYKGRLLN-GE--EVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ------GEK 579 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~~~-g~--~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~------~~~ 579 (675)
.+.++||+|+||.||+|+..+ +. .+|+|.++.. .....+.+..|+.++++++||||+++++++.+. ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456899999999999998754 32 6899988753 233456789999999999999999999988542 246
Q ss_pred EEEEEecCCCCHHHHhcCC---CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecc
Q 005825 580 ILILEYMPNKSLDVFLFDP---TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 656 (675)
++||||+++|+|..++... .....+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887422 12345889999999999999999999987 99999999999999999999999999
Q ss_pred ceecCC
Q 005825 657 ARMFGG 662 (675)
Q Consensus 657 a~~~~~ 662 (675)
++.+..
T Consensus 159 ~~~~~~ 164 (272)
T cd05075 159 SKKIYN 164 (272)
T ss_pred ccccCc
Confidence 987643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=206.68 Aligned_cols=150 Identities=33% Similarity=0.510 Sum_probs=126.8
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCc----EEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGE----EVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
++|++.+.||+|+||.||+|.+. +++ .+++|.+..... ....++..|+.+++++.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46788899999999999999863 344 478888764322 33467888888999999999999999875 456788
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++||+++|+|.+++... ...+++.....++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999542 346889999999999999999999987 9999999999999999999999999998774
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 161 ~~ 162 (279)
T cd05111 161 PD 162 (279)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=208.47 Aligned_cols=149 Identities=26% Similarity=0.305 Sum_probs=131.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.++||+|+||.||+++.. ++..+|+|.++... ....+++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999864 57889999887542 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++++|.+++.. ...+++.....++.|+++||.|||+.. +++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 999999999843 355788999999999999999999742 39999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-23 Score=221.53 Aligned_cols=153 Identities=33% Similarity=0.485 Sum_probs=131.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
...|+.++.||.|+||.||.++. .+.+.||||++.-. +......+..|+..|.++.|||+|.+-|+|......|||
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 34677778999999999999986 45788999998743 333456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||| -||..+++- ...+++.+.++..|+.+.++||+|||++. .||||||+.||||++.|.|||+|||-|.+..+
T Consensus 105 MEYC-lGSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 105 MEYC-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHH-hccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 9999 456666662 23457888999999999999999999987 99999999999999999999999999998866
Q ss_pred Ccc
Q 005825 663 DEL 665 (675)
Q Consensus 663 ~~~ 665 (675)
..+
T Consensus 179 Ans 181 (948)
T KOG0577|consen 179 ANS 181 (948)
T ss_pred hhc
Confidence 543
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=208.33 Aligned_cols=154 Identities=32% Similarity=0.541 Sum_probs=133.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC------CcEEEEEEecCc-CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQG 577 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~------g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~ 577 (675)
..++|++.+.||+|+||.||++...+ ...+|+|.+... ......++.+|+.++.++ +|+||+++++++.+.+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 44678899999999999999997632 368999998753 223446788999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCC-------------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc
Q 005825 578 EKILILEYMPNKSLDVFLFDP-------------TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD 644 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 644 (675)
..++||||+++++|..++... .....+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998532 22346889999999999999999999887 99999999999999
Q ss_pred CCCCeEEeeeccceecCC
Q 005825 645 RDMNPKISDFGLARMFGG 662 (675)
Q Consensus 645 ~~~~~kl~DFGla~~~~~ 662 (675)
+++.+||+|||+++.+..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 167 EDHVMKIADFGLARDIHH 184 (293)
T ss_pred CCCeEEeCcccccccccc
Confidence 999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=213.16 Aligned_cols=145 Identities=23% Similarity=0.332 Sum_probs=126.4
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.....+|++.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++.+.+..++|
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 344568999999999999999999875 4678999975432 235689999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|||+. ++|.+++.. ....+++..+..|+.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 136 ~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 136 LPHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 99995 688887743 3346899999999999999999999987 999999999999999999999999999854
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=207.68 Aligned_cols=141 Identities=28% Similarity=0.390 Sum_probs=121.0
Q ss_pred eeCCcCceeEEEEEEcC-------------------------CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeE
Q 005825 515 KLGEGGFGPVYKGRLLN-------------------------GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569 (675)
Q Consensus 515 ~IG~G~fG~Vy~~~~~~-------------------------g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l 569 (675)
+||+|+||.||+|.... ...||+|.+........++|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876544445678999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC--
Q 005825 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-- 647 (675)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-- 647 (675)
++++.+....++||||+++++|+.++... ...+++..++.++.||++||+|||+++ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999998532 345788999999999999999999887 99999999999997654
Q ss_pred -----CeEEeeeccceec
Q 005825 648 -----NPKISDFGLARMF 660 (675)
Q Consensus 648 -----~~kl~DFGla~~~ 660 (675)
.+||+|||+++..
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 3899999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=212.41 Aligned_cols=139 Identities=27% Similarity=0.344 Sum_probs=119.8
Q ss_pred eCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhc---CCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 516 LGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKL---QHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 516 IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
||+|+||+||+|+.. +++.||||++.+.. ......+..|..++.+. +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 58999999986432 12234455677777665 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|+|..++. ....+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 99998884 3456888999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=204.20 Aligned_cols=150 Identities=33% Similarity=0.547 Sum_probs=128.1
Q ss_pred cceeeeeCCcCceeEEEEEEcC----CcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-----
Q 005825 510 FSMECKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE----- 578 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~----- 578 (675)
|.+.+.||+|+||.||+|.... +..||||+++... ....+.+..|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4677899999999999998642 3679999987532 2345679999999999999999999999876554
Q ss_pred -EEEEEEecCCCCHHHHhcCCC---CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeee
Q 005825 579 -KILILEYMPNKSLDVFLFDPT---KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDF 654 (675)
Q Consensus 579 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 654 (675)
.++||||+++++|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999985431 2346889999999999999999999987 999999999999999999999999
Q ss_pred ccceecCC
Q 005825 655 GLARMFGG 662 (675)
Q Consensus 655 Gla~~~~~ 662 (675)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05035 158 GLSKKIYS 165 (273)
T ss_pred cceeeccc
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=204.45 Aligned_cols=150 Identities=33% Similarity=0.572 Sum_probs=131.8
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC-C---cEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN-G---EEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~-g---~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
..|++.+.||+|+||.||+|+... + ..||||.++.. .....++|..|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457888999999999999998643 3 36999998754 233456899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|++++... ...+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998542 345889999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=205.29 Aligned_cols=153 Identities=29% Similarity=0.458 Sum_probs=132.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC------CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
.++|++.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678899999999999999997642 4689999987543 23345788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC-------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 005825 580 ILILEYMPNKSLDVFLFDPT-------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKIS 652 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 652 (675)
++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999986432 1234788899999999999999999887 9999999999999999999999
Q ss_pred eeccceecCC
Q 005825 653 DFGLARMFGG 662 (675)
Q Consensus 653 DFGla~~~~~ 662 (675)
|||+++.+..
T Consensus 162 dfg~~~~~~~ 171 (277)
T cd05032 162 DFGMTRDIYE 171 (277)
T ss_pred Ccccchhhcc
Confidence 9999986643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-22 Score=206.85 Aligned_cols=150 Identities=35% Similarity=0.554 Sum_probs=129.3
Q ss_pred CcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
+|++.+.||+|+||.||+|+.. ....+|+|.+..... ...+.+.+|+.++++++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4678899999999999999753 235789998875432 335679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC---------------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCC
Q 005825 582 ILEYMPNKSLDVFLFDPT---------------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASN 640 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N 640 (675)
||||+++++|.+++.... ....+++.+.+.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999975321 1235788999999999999999999887 9999999999
Q ss_pred EEEcCCCCeEEeeeccceecC
Q 005825 641 VLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 641 ILl~~~~~~kl~DFGla~~~~ 661 (675)
||+++++.+||+|||+++.+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-22 Score=201.72 Aligned_cols=152 Identities=36% Similarity=0.558 Sum_probs=136.3
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
..++|.+.++||+|+||.||++...+++.||||.++.. ....+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 34688999999999999999999888889999998753 34567899999999999999999999999988899999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.+++... ....+++.++..++.+++.||.|||+++ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999643 2345889999999999999999999987 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=206.32 Aligned_cols=154 Identities=30% Similarity=0.466 Sum_probs=133.6
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC-----CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEe-CCe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN-----GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIE-QGE 578 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~-~~~ 578 (675)
..++|++.+.||+|+||.||+|...+ +..|++|+++... ....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45788999999999999999998755 6889999987542 2345678899999999999999999999876 467
Q ss_pred EEEEEEecCCCCHHHHhcCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEee
Q 005825 579 KILILEYMPNKSLDVFLFDPTKK-----RLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISD 653 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 653 (675)
.++++||+++++|..++...... ..+++.++..++.+++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998543222 46889999999999999999999987 99999999999999999999999
Q ss_pred eccceecCC
Q 005825 654 FGLARMFGG 662 (675)
Q Consensus 654 FGla~~~~~ 662 (675)
||+++.+..
T Consensus 161 ~g~~~~~~~ 169 (280)
T cd05043 161 NALSRDLFP 169 (280)
T ss_pred CCCcccccC
Confidence 999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-23 Score=214.93 Aligned_cols=160 Identities=28% Similarity=0.418 Sum_probs=140.4
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
..|+..++||+|+||.||+|.. ..++.||+|++... .....+.+++|+.+++.++|+||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4566668999999999999986 45899999999854 344568899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCcc
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (675)
+.+|++.+.| .....+.+....-|..++..||.|||.+. .||||||+.||||..+|.+||+|||.|..+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999998 33445577777888999999999999987 99999999999999999999999999999877666
Q ss_pred cCCCCceecC
Q 005825 666 QGNTKRIVGT 675 (675)
Q Consensus 666 ~~~~~~~~GT 675 (675)
+. .+++||
T Consensus 167 rr--~tfvGT 174 (467)
T KOG0201|consen 167 RR--KTFVGT 174 (467)
T ss_pred cc--cccccc
Confidence 54 447887
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=204.82 Aligned_cols=148 Identities=27% Similarity=0.493 Sum_probs=133.2
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
++|++.++||+|+||.||+|+.. +++.||+|.++.........+++|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57788899999999999999864 58899999987655455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++++|.+++.. ...+++.+...++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+.
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 99999999843 346889999999999999999999987 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=202.96 Aligned_cols=143 Identities=31% Similarity=0.501 Sum_probs=126.8
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCH
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSL 591 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (675)
++||+|+||.||+|+.. +++.+|+|.+.... ......|.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999874 68999999886532 33456799999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 592 DVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 592 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
.+++.. ....+++.+...++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 999853 2345789999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=203.24 Aligned_cols=145 Identities=35% Similarity=0.567 Sum_probs=129.3
Q ss_pred cceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCH--HHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 510 FSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGL--EEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~--~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
|++.+.||+|+||+||+++... ++.+|+|.+........ .....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999998765 67899999986543322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++++|.+++. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||.+..+
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999995 4556899999999999999999999987 999999999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=208.54 Aligned_cols=153 Identities=31% Similarity=0.541 Sum_probs=132.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc--------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL--------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQ 576 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~ 576 (675)
..+|.+.+.||+|+||.||+++.. ++..||+|.++... ....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467888899999999999999742 24579999987532 34457799999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE
Q 005825 577 GEKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL 643 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 643 (675)
...++||||+++++|.+++.... ....+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 99999999999999999986421 1235788899999999999999999987 9999999999999
Q ss_pred cCCCCeEEeeeccceecCC
Q 005825 644 DRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 644 ~~~~~~kl~DFGla~~~~~ 662 (675)
++++.+||+|||+|+.+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 171 TENNVMKIADFGLARDVNN 189 (304)
T ss_pred cCCCcEEECCCccceeccc
Confidence 9999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-22 Score=204.89 Aligned_cols=149 Identities=28% Similarity=0.341 Sum_probs=130.4
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.|+..++||+|+||+||++... +++.+|+|.+.... ....+.+.+|+.++++++|+||+++.+.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677789999999999999864 58899999987532 2233457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|+++++|..++... ....+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999999888542 2345899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-22 Score=202.16 Aligned_cols=150 Identities=37% Similarity=0.540 Sum_probs=133.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.+.|++.++||+|+||.||+|...+++.||+|.+... ....+.|.+|+.++++++|+||+++++++ ..+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 4678899999999999999999888999999998753 33457899999999999999999999986 456789999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++++|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999998543 2346889999999999999999999887 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-22 Score=205.68 Aligned_cols=150 Identities=31% Similarity=0.431 Sum_probs=133.5
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.+.||+|+||.||+++.. +++.+|+|.++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47889999999999999999875 58999999987532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+|||+++++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999843 356889999999999999999999987 999999999999999999999999999877443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=205.89 Aligned_cols=150 Identities=35% Similarity=0.561 Sum_probs=130.6
Q ss_pred CCcceeeeeCCcCceeEEEEEE-----cCCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-----LNGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEK 579 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~ 579 (675)
..|++.++||+|+||.||+++. .+++.||+|.++... ....+.+.+|+.++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4568889999999999999974 347889999987543 33456799999999999999999999999875 568
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++++|.+++... ...+++.++..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999998432 235799999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 005825 660 FGG 662 (675)
Q Consensus 660 ~~~ 662 (675)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=203.39 Aligned_cols=145 Identities=26% Similarity=0.383 Sum_probs=128.1
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.++||+|+||.||+|+. .+++.||+|.+... .....+++.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999986 46889999998654 233456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|..+. .+++.....++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999997653 3577888899999999999999987 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=202.04 Aligned_cols=149 Identities=32% Similarity=0.573 Sum_probs=133.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.++|++.+.||+|+||.||++... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888899999999999999874 78899999986433 5678999999999999999999999999989999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++++|.+++.... ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999985432 236899999999999999999999987 9999999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=213.68 Aligned_cols=152 Identities=31% Similarity=0.489 Sum_probs=128.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcCc-cCHHHHHHHHHHHHhc-CCCceeeEEEEEEeC-Ce
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQ-GE 578 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~-~~ 578 (675)
++|++.+.||+|+||.||+|+.. .++.||+|+++.... ...+.+..|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 57889999999999999999642 257899999875322 2345678899999999 899999999998754 46
Q ss_pred EEEEEEecCCCCHHHHhcCCCC----------------------------------------------------------
Q 005825 579 KILILEYMPNKSLDVFLFDPTK---------------------------------------------------------- 600 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 600 (675)
.+++|||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999998853211
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 601 KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 601 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 126789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=207.37 Aligned_cols=151 Identities=35% Similarity=0.519 Sum_probs=129.9
Q ss_pred CcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcCcc-CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSGQ-GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
+|++.++||+|+||.||+|+.. +++.||||+++..... ..+.|..|+.++.+++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4677789999999999999763 2578999999854332 34678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCC-------------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC
Q 005825 582 ILEYMPNKSLDVFLFDP-------------TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN 648 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 648 (675)
++||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998421 11235788889999999999999999987 999999999999999999
Q ss_pred eEEeeeccceecCC
Q 005825 649 PKISDFGLARMFGG 662 (675)
Q Consensus 649 ~kl~DFGla~~~~~ 662 (675)
+||+|||+++.+..
T Consensus 163 ~kl~Dfg~~~~~~~ 176 (283)
T cd05091 163 VKISDLGLFREVYA 176 (283)
T ss_pred eEeccccccccccc
Confidence 99999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=205.78 Aligned_cols=151 Identities=32% Similarity=0.548 Sum_probs=132.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.+|+..++||+|+||.||+++.. ++..+|+|.++.......+.|.+|+.++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999642 356899999886555566789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCC------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCe
Q 005825 582 ILEYMPNKSLDVFLFDPTK------------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP 649 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 649 (675)
||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864221 135789999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceecC
Q 005825 650 KISDFGLARMFG 661 (675)
Q Consensus 650 kl~DFGla~~~~ 661 (675)
||+|||+++.+.
T Consensus 162 kL~dfg~~~~~~ 173 (280)
T cd05092 162 KIGDFGMSRDIY 173 (280)
T ss_pred EECCCCceeEcC
Confidence 999999998663
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=204.34 Aligned_cols=149 Identities=28% Similarity=0.344 Sum_probs=129.9
Q ss_pred cceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 510 FSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
|+..+.||+|+||.||++... +++.||||.+..... ...+.+..|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999864 588999999875322 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.+++... ....+++.++..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 9999999988542 2235888999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=203.00 Aligned_cols=143 Identities=29% Similarity=0.398 Sum_probs=124.1
Q ss_pred eCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCH
Q 005825 516 LGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSL 591 (675)
Q Consensus 516 IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (675)
||+|+||.||+++.. +++.+|+|.+.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 58999999986422 12234566799999999999999999999999999999999999999
Q ss_pred HHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 592 DVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 592 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
..++... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 9888542 2334788999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=202.99 Aligned_cols=149 Identities=34% Similarity=0.538 Sum_probs=131.1
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|++.+.||+|++|.||+|+.. +++.||||+++... ....+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999874 58999999987432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++ ++|.+++........+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.++
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 688888754444456899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=205.21 Aligned_cols=150 Identities=27% Similarity=0.430 Sum_probs=134.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
...+|++.+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.+.||||+++++.+..+.+.++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 346889999999999999999986 4588999999986555556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|+++++|.+++.. ..+++.+...++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999842 34788899999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-22 Score=204.44 Aligned_cols=148 Identities=29% Similarity=0.476 Sum_probs=132.1
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
.|++.++||+|+||.||+++.. ++..+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3577789999999999999875 478899999876555566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++|..++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999988753 2346899999999999999999999987 9999999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-22 Score=204.07 Aligned_cols=150 Identities=33% Similarity=0.525 Sum_probs=129.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCc----EEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGE----EVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~----~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
.++|++.++||+|+||.||+|+. .+++ .||+|.++... ....+++.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35788889999999999999975 3444 48999987542 3345678899999999999999999999975 4577
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++|||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998542 345889999999999999999999987 999999999999999999999999999987
Q ss_pred CC
Q 005825 661 GG 662 (675)
Q Consensus 661 ~~ 662 (675)
..
T Consensus 160 ~~ 161 (279)
T cd05109 160 DI 161 (279)
T ss_pred cc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-22 Score=201.72 Aligned_cols=150 Identities=33% Similarity=0.546 Sum_probs=132.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
++|++.++||+|+||.||++...++..+|+|.++... ...+.|.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4688889999999999999998888899999997633 24567999999999999999999999875 456899999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++|.+++... ....+++.++..++.+++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999998642 2345789999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-22 Score=205.89 Aligned_cols=151 Identities=27% Similarity=0.430 Sum_probs=135.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
...+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 347899999999999999999986 4689999999976555556778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|+++++|.+++.. ..+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....+
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999999842 34788899999999999999999987 999999999999999999999999999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=203.00 Aligned_cols=150 Identities=28% Similarity=0.421 Sum_probs=132.4
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999875 58999999986432 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|++++.|..++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999999887732 345899999999999999999999987 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.7e-22 Score=202.32 Aligned_cols=154 Identities=31% Similarity=0.438 Sum_probs=132.0
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34556666679999999999999864 57889999988665556678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-CCCeEEeeeccceecC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-DMNPKISDFGLARMFG 661 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 661 (675)
||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999864322212277888889999999999999987 999999999999976 6799999999998764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.8e-22 Score=207.52 Aligned_cols=152 Identities=33% Similarity=0.544 Sum_probs=131.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc--------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL--------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQ 576 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~ 576 (675)
.++|.+.+.||+|+||.||+++.. +...+|+|.++... .....++..|+.++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357899999999999999999752 23579999997542 33456788999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE
Q 005825 577 GEKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL 643 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 643 (675)
+..++||||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999996432 1235889999999999999999999887 9999999999999
Q ss_pred cCCCCeEEeeeccceecC
Q 005825 644 DRDMNPKISDFGLARMFG 661 (675)
Q Consensus 644 ~~~~~~kl~DFGla~~~~ 661 (675)
++++.+||+|||+|+.+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 174 TEDNVMKIADFGLARDIH 191 (307)
T ss_pred cCCCcEEECCCccccccc
Confidence 999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-23 Score=204.41 Aligned_cols=162 Identities=29% Similarity=0.337 Sum_probs=137.2
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCcc---CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQ---GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
..++|..+++||+|.||+|.+++- ..++.+|+|++++.... ....-..|-++|...+||.+..|--.++..+++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 347888899999999999999974 56999999999976433 34556778999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||..||.|.-+| .+.+.+++....-+-..|..||.|||++. ||.||||.+|.|||++|++||+||||++.--
T Consensus 246 VMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999998777 34556777666667888999999999987 9999999999999999999999999998532
Q ss_pred CCcccCCCCceecC
Q 005825 662 GDELQGNTKRIVGT 675 (675)
Q Consensus 662 ~~~~~~~~~~~~GT 675 (675)
.. ...+++.+||
T Consensus 320 ~~--g~t~kTFCGT 331 (516)
T KOG0690|consen 320 KY--GDTTKTFCGT 331 (516)
T ss_pred cc--cceeccccCC
Confidence 22 2346667887
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=200.10 Aligned_cols=149 Identities=32% Similarity=0.531 Sum_probs=130.4
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
++|.+.++||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 468888999999999999999877778999998753 234567899999999999999999999875 456889999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++|.+++... ....+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 99999999643 2345789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-22 Score=204.17 Aligned_cols=142 Identities=27% Similarity=0.422 Sum_probs=120.7
Q ss_pred eeCCcCceeEEEEEEcCC---cEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCC
Q 005825 515 KLGEGGFGPVYKGRLLNG---EEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKS 590 (675)
Q Consensus 515 ~IG~G~fG~Vy~~~~~~g---~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (675)
+||+|+||.||+++..++ ..+++|.++... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975443 346677766433 2345789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 591 LDVFLFDPTK-KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 591 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
|.+++..... ....++.....++.||++||+|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 9999864322 234566777889999999999999987 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-22 Score=202.44 Aligned_cols=142 Identities=29% Similarity=0.474 Sum_probs=123.1
Q ss_pred eeeCCcCceeEEEEEEcCCc-----------EEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 514 CKLGEGGFGPVYKGRLLNGE-----------EVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~-----------~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
++||+|+||.||+|...+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999875432 5788887654333 6789999999999999999999999988 788999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC-------CeEEeeec
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-------NPKISDFG 655 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-------~~kl~DFG 655 (675)
|||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999995432 26889999999999999999999887 99999999999999888 79999999
Q ss_pred cceecCC
Q 005825 656 LARMFGG 662 (675)
Q Consensus 656 la~~~~~ 662 (675)
+++.+..
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9987643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=203.57 Aligned_cols=151 Identities=31% Similarity=0.504 Sum_probs=131.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeC------C
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQ------G 577 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~------~ 577 (675)
+++.|++.+.||+|+||.||+|+.. +++.||+|.+... .....++..|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5677888899999999999999864 5889999998753 34556788999999998 699999999998753 4
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 688999999999999998542 2346889999999999999999999987 999999999999999999999999999
Q ss_pred eecC
Q 005825 658 RMFG 661 (675)
Q Consensus 658 ~~~~ 661 (675)
+.+.
T Consensus 159 ~~~~ 162 (272)
T cd06637 159 AQLD 162 (272)
T ss_pred eecc
Confidence 8764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-22 Score=205.50 Aligned_cols=150 Identities=28% Similarity=0.454 Sum_probs=134.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.++|++.++||+|+||.||+++.. +++.+|+|.++.......+.|..|+.++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457888899999999999999874 5889999999765555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++++|..++... ...+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999998432 345889999999999999999999987 9999999999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=200.89 Aligned_cols=149 Identities=31% Similarity=0.487 Sum_probs=131.6
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-----ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-----GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
++|.+.+.||+|++|.||++... ++++||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999864 58999999886432 1234578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++++|.+++.. ...+++.....++.+++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 345788888999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 005825 662 G 662 (675)
Q Consensus 662 ~ 662 (675)
.
T Consensus 156 ~ 156 (263)
T cd06625 156 T 156 (263)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.4e-22 Score=207.36 Aligned_cols=151 Identities=34% Similarity=0.579 Sum_probs=129.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCc--EEEEEEecCc-CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGE--EVAVKRLSSQ-SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~--~vAvK~l~~~-~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|++.+.||+|+||.||+|+.. ++. .+|+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888999999999999999864 343 4688877643 233456789999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC
Q 005825 582 ILEYMPNKSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN 648 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 648 (675)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999986421 1235789999999999999999999987 999999999999999999
Q ss_pred eEEeeeccceec
Q 005825 649 PKISDFGLARMF 660 (675)
Q Consensus 649 ~kl~DFGla~~~ 660 (675)
+||+|||+++..
T Consensus 163 ~kl~dfg~~~~~ 174 (303)
T cd05088 163 AKIADFGLSRGQ 174 (303)
T ss_pred EEeCccccCccc
Confidence 999999999743
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.8e-22 Score=207.14 Aligned_cols=152 Identities=34% Similarity=0.491 Sum_probs=132.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~ 578 (675)
.++|.+.++||+|+||.||++... .+..||||.++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357889999999999999999641 35579999987542 23346789999999999 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.++||||+++++|.+++... ....+++.+...++.+++.||+|||+++ |+|+||||+|||+++++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999998542 2234899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCC
Q 005825 659 MFGG 662 (675)
Q Consensus 659 ~~~~ 662 (675)
.+..
T Consensus 190 ~~~~ 193 (302)
T cd05055 190 DIMN 193 (302)
T ss_pred cccC
Confidence 7643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=200.39 Aligned_cols=143 Identities=33% Similarity=0.545 Sum_probs=123.6
Q ss_pred eeCCcCceeEEEEEEc---CCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCC
Q 005825 515 KLGEGGFGPVYKGRLL---NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKS 590 (675)
Q Consensus 515 ~IG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (675)
.||+|+||.||+|.+. ++..||+|.+..... ...++|.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999763 355799999876432 33567999999999999999999999885 457899999999999
Q ss_pred HHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 591 LDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 591 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9999853 2346889999999999999999999987 999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=200.68 Aligned_cols=148 Identities=30% Similarity=0.465 Sum_probs=128.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-----ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-----GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEK 579 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~ 579 (675)
++|++.++||+|+||.||+++.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999864 58999999885321 12345788999999999999999999998764 457
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999999843 345788888999999999999999987 99999999999999999999999999986
Q ss_pred cC
Q 005825 660 FG 661 (675)
Q Consensus 660 ~~ 661 (675)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-22 Score=205.88 Aligned_cols=152 Identities=25% Similarity=0.389 Sum_probs=132.8
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.+.||+|+||.||+++.. .++.||+|.++.. .....+.+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999875 6899999998753 223356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++++|..++........+++.....++.+++.||.|||+.. +|+||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999999854333346899999999999999999999742 39999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-22 Score=201.93 Aligned_cols=143 Identities=24% Similarity=0.392 Sum_probs=123.4
Q ss_pred eeeCCcCceeEEEEEEcC-------------CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 514 CKLGEGGFGPVYKGRLLN-------------GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~-------------g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
+.||+|+||.||+|+... ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2358999887654455568899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC-------eEEee
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN-------PKISD 653 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~kl~D 653 (675)
+||||+++++|+.++.. ....+++..++.++.||++||+|||+++ |+||||||+|||+++++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999998853 2345889999999999999999999987 999999999999987664 89999
Q ss_pred eccceecC
Q 005825 654 FGLARMFG 661 (675)
Q Consensus 654 FGla~~~~ 661 (675)
||++..+.
T Consensus 156 ~g~~~~~~ 163 (262)
T cd05077 156 PGIPITVL 163 (262)
T ss_pred CCCCcccc
Confidence 99997664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-22 Score=217.14 Aligned_cols=149 Identities=23% Similarity=0.413 Sum_probs=122.4
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--------
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ-------- 576 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~-------- 576 (675)
...+|++.++||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999874 58899999886422 2345799999999999999999887432
Q ss_pred CeEEEEEEecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC-CeEEeee
Q 005825 577 GEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-NPKISDF 654 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DF 654 (675)
...++||||+++ +|.+++... .....+++.....++.||+.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 136789999985 666665321 23456889999999999999999999987 99999999999998664 7999999
Q ss_pred ccceecCC
Q 005825 655 GLARMFGG 662 (675)
Q Consensus 655 Gla~~~~~ 662 (675)
|+|+.+..
T Consensus 216 Gla~~~~~ 223 (440)
T PTZ00036 216 GSAKNLLA 223 (440)
T ss_pred ccchhccC
Confidence 99987743
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=202.94 Aligned_cols=145 Identities=41% Similarity=0.559 Sum_probs=126.6
Q ss_pred ceeeeeCCcCceeEEEEEE-----cCCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeEEEE
Q 005825 511 SMECKLGEGGFGPVYKGRL-----LNGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEKILI 582 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~~lV 582 (675)
+..+.||+|+||+||++.. .+++.||+|.++... ....+.|.+|+.++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988653 357889999997543 23456789999999999999999999998764 357899
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++.. ..+++..+..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999843 24899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=202.52 Aligned_cols=150 Identities=31% Similarity=0.463 Sum_probs=131.6
Q ss_pred CCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcCcc-CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSGQ-GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
++|+..+.||+|+||.||+|+.. +.+.|++|.+...... ..+++..|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999853 2467999988754333 4578999999999999999999999999989999
Q ss_pred EEEEecCCCCHHHHhcCCCCc------ccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeee
Q 005825 581 LILEYMPNKSLDVFLFDPTKK------RLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDF 654 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 654 (675)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998643311 25899999999999999999999987 999999999999999999999999
Q ss_pred ccceec
Q 005825 655 GLARMF 660 (675)
Q Consensus 655 Gla~~~ 660 (675)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=200.46 Aligned_cols=152 Identities=27% Similarity=0.453 Sum_probs=132.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||.||+|+.. +++.||||.++.. .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999864 6899999987642 2233457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPT-KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+++++|.+++.... ....+++.....++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885322 2345788889999999999999999987 99999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=198.51 Aligned_cols=143 Identities=31% Similarity=0.488 Sum_probs=127.5
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCHH
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLD 592 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (675)
++||+|+||.||+|...+++.+|+|.++.... .....|.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999876433 23457889999999999999999999999999999999999999999
Q ss_pred HHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 593 VFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 593 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++... ...+++..++.++.+++.||.|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 988532 345789999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=198.72 Aligned_cols=151 Identities=29% Similarity=0.437 Sum_probs=133.8
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|++.+.||+|++|.||+++.. +++.|++|.+... .....+++..|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999874 5889999998643 234567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++++|.+++... ....+++.....++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999998643 2346889999999999999999999987 999999999999999999999999999977543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-22 Score=205.86 Aligned_cols=150 Identities=34% Similarity=0.565 Sum_probs=129.1
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC-C--cEEEEEEecCc-CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN-G--EEVAVKRLSSQ-SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~-g--~~vAvK~l~~~-~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV 582 (675)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.|..|+.++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998743 3 34788888743 233456789999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCe
Q 005825 583 LEYMPNKSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP 649 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 649 (675)
|||+++++|.+++.... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985421 1235888999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceec
Q 005825 650 KISDFGLARMF 660 (675)
Q Consensus 650 kl~DFGla~~~ 660 (675)
||+|||+++..
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998743
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=198.98 Aligned_cols=152 Identities=30% Similarity=0.469 Sum_probs=134.5
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999876 7899999988642 2233568999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+++++|..++... .....+++.++..++.+++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988542 22456889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=201.13 Aligned_cols=151 Identities=32% Similarity=0.594 Sum_probs=132.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC-C---cEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN-G---EEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~-g---~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|+..+.||+|+||.||+|+... + ..+|+|.++... ....+.+..|+.++++++||||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3578888999999999999998743 3 379999987542 3345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++++|.+++.. ....+++.++..++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999853 2346889999999999999999999987 9999999999999999999999999998774
Q ss_pred C
Q 005825 662 G 662 (675)
Q Consensus 662 ~ 662 (675)
.
T Consensus 159 ~ 159 (268)
T cd05063 159 D 159 (268)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=206.27 Aligned_cols=152 Identities=34% Similarity=0.549 Sum_probs=131.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc--------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL--------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQ 576 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~ 576 (675)
.++|.+.++||+|+||.||+++.. ....+|+|.++... .....++..|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888999999999999999742 24579999987532 23456788999999999 699999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE
Q 005825 577 GEKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL 643 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 643 (675)
+..++||||+++|+|.+++.... ....+++.+...++.|++.||.|||+++ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999985421 1245889999999999999999999987 9999999999999
Q ss_pred cCCCCeEEeeeccceecC
Q 005825 644 DRDMNPKISDFGLARMFG 661 (675)
Q Consensus 644 ~~~~~~kl~DFGla~~~~ 661 (675)
++++.+||+|||+++.+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 168 TEDNVMKIADFGLARGVH 185 (314)
T ss_pred cCCCcEEEcccccccccc
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=203.79 Aligned_cols=148 Identities=33% Similarity=0.538 Sum_probs=133.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
+.|++.++||+|+||.||+|+.. +++.+++|.+........+.+..|+.++++++||||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 67888899999999999999875 48899999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++++|..++... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 999999887432 345889999999999999999999887 999999999999999999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=204.46 Aligned_cols=152 Identities=32% Similarity=0.534 Sum_probs=132.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
.++|++.+.||+|+||.||+++.. ++..||+|.++... ....++|.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999863 46789999987542 23456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC-------------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCC
Q 005825 580 ILILEYMPNKSLDVFLFDPT-------------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASN 640 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N 640 (675)
++||||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1234788889999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeeeccceecC
Q 005825 641 VLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 641 ILl~~~~~~kl~DFGla~~~~ 661 (675)
|++++++.+||+|||+++.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred eEecCCCceEECccccceecc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=197.35 Aligned_cols=151 Identities=23% Similarity=0.377 Sum_probs=133.5
Q ss_pred CcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|+..+.||+|+||.||.++. .+++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999975 45889999987643 234456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999985432 346789999999999999999999887 999999999999999999999999999877443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=203.33 Aligned_cols=159 Identities=26% Similarity=0.357 Sum_probs=134.3
Q ss_pred HHHHHHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEE---
Q 005825 500 LASVAAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCI--- 574 (675)
Q Consensus 500 ~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~--- 574 (675)
+..+....++|++.+.||+|+||.||+++.. +++.+|+|.++.. .....++..|+.++.++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445567789999999999999999999864 5789999988652 22346788999999999 6999999999984
Q ss_pred --eCCeEEEEEEecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEE
Q 005825 575 --EQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI 651 (675)
Q Consensus 575 --~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 651 (675)
.++..++||||+++++|.+++... .....+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345689999999999999887532 22346788889999999999999999987 999999999999999999999
Q ss_pred eeeccceecCC
Q 005825 652 SDFGLARMFGG 662 (675)
Q Consensus 652 ~DFGla~~~~~ 662 (675)
+|||+++.+..
T Consensus 166 ~dfg~~~~~~~ 176 (286)
T cd06638 166 VDFGVSAQLTS 176 (286)
T ss_pred ccCCceeeccc
Confidence 99999987643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=199.21 Aligned_cols=150 Identities=32% Similarity=0.486 Sum_probs=132.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.++|++.++||+|+||.||++...++..+|+|.++.. ....+.|.+|+.++++++|+||+++.+.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4688999999999999999999877888999998753 3345678999999999999999999999887 7789999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++++|.+++... ....+++..++.++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999998543 2345788899999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=210.34 Aligned_cols=147 Identities=29% Similarity=0.386 Sum_probs=125.2
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG----- 577 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~----- 577 (675)
..++|++.+.||+|+||.||+++.. +++.||||+++.. ......++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999864 5899999999753 2234567889999999999999999999986543
Q ss_pred -eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecc
Q 005825 578 -EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656 (675)
Q Consensus 578 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 656 (675)
..++||||+++ +|...+. ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 57999999976 4555552 23678888899999999999999987 99999999999999999999999999
Q ss_pred ceecC
Q 005825 657 ARMFG 661 (675)
Q Consensus 657 a~~~~ 661 (675)
|+...
T Consensus 170 a~~~~ 174 (359)
T cd07876 170 ARTAC 174 (359)
T ss_pred ccccc
Confidence 98653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=198.39 Aligned_cols=147 Identities=41% Similarity=0.627 Sum_probs=130.9
Q ss_pred eeeCCcCceeEEEEEEcC----CcEEEEEEecCcCcc-CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQSGQ-GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~-~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
++||+|+||.||+++... +..||+|.++..... ..+.+..|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998754 788999999864333 367899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCC------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 589 KSLDVFLFDPTK------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 589 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++|.+++..... ...+++..+..++.|+++||+|||+++ ++||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999965321 367899999999999999999999987 99999999999999999999999999998865
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=198.97 Aligned_cols=148 Identities=33% Similarity=0.498 Sum_probs=131.1
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-----ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-----GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999875 68999999886432 22456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 345788999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=207.83 Aligned_cols=152 Identities=32% Similarity=0.534 Sum_probs=130.9
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC--------CcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN--------GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQG 577 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~ 577 (675)
.+|.+.+.||+|+||.||+++... ...||+|.++... ....+++..|+.++.++ +||||+++++++.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468888999999999999997421 2368999887532 23456899999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc
Q 005825 578 EKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD 644 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 644 (675)
..++||||+++|+|.+++.... ....+.+.+++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986421 2345788999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccceecCC
Q 005825 645 RDMNPKISDFGLARMFGG 662 (675)
Q Consensus 645 ~~~~~kl~DFGla~~~~~ 662 (675)
+++.+||+|||+++.+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 169 EDNVMKIADFGLARDVHN 186 (334)
T ss_pred CCCcEEECCcccceeccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=204.74 Aligned_cols=146 Identities=23% Similarity=0.375 Sum_probs=130.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.+.||+|+||.||+++.. .++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+.++++.++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999864 47899999987542 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
||+++++|.+++.. ...+++.....++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999943 346888999999999999999999987 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=201.55 Aligned_cols=152 Identities=33% Similarity=0.520 Sum_probs=131.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC------CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......|..|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678999999999999999998743 5679999886433 23345799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC---CeEEe
Q 005825 580 ILILEYMPNKSLDVFLFDPT----KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM---NPKIS 652 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~ 652 (675)
++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 99999999999999985432 1235889999999999999999999987 99999999999998754 69999
Q ss_pred eeccceecC
Q 005825 653 DFGLARMFG 661 (675)
Q Consensus 653 DFGla~~~~ 661 (675)
|||+++.+.
T Consensus 162 dfg~~~~~~ 170 (277)
T cd05036 162 DFGMARDIY 170 (277)
T ss_pred cCccccccC
Confidence 999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=207.25 Aligned_cols=142 Identities=23% Similarity=0.279 Sum_probs=115.3
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEc--CCcEEEEEEecCcC-----ccCHHHHHHHHHHHHhcCCCceee-EEEEEEeC
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLL--NGEEVAVKRLSSQS-----GQGLEEFKNEMLLIAKLQHRNLVR-ILGCCIEQ 576 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~--~g~~vAvK~l~~~~-----~~~~~~f~~E~~il~~l~H~nIv~-l~g~~~~~ 576 (675)
...++|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.|.+|+++|++++|+|++. ++. .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence 34578999999999999999999764 57788999876331 123456999999999999999985 443 2
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCC-CCCCEEEcCCCCeEEeeec
Q 005825 577 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDL-KASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DFG 655 (675)
++.++||||+++++|.... ... ...++.++++||.|||+++ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 5689999999999996321 111 1357889999999999987 999999 9999999999999999999
Q ss_pred cceecCCC
Q 005825 656 LARMFGGD 663 (675)
Q Consensus 656 la~~~~~~ 663 (675)
+|+.+...
T Consensus 158 lA~~~~~~ 165 (365)
T PRK09188 158 LASVFRRR 165 (365)
T ss_pred cceecccC
Confidence 99987543
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=199.19 Aligned_cols=148 Identities=34% Similarity=0.556 Sum_probs=129.9
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCcc---------CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQ---------GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE 578 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~---------~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~ 578 (675)
+|.+.+.||+|+||.||+|... +++.+|+|.+...... ..+.+..|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3567789999999999999864 5889999988653222 23568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.++||||+++++|..++.. ...+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999943 356788889999999999999999987 9999999999999999999999999998
Q ss_pred ecCC
Q 005825 659 MFGG 662 (675)
Q Consensus 659 ~~~~ 662 (675)
.+..
T Consensus 155 ~~~~ 158 (267)
T cd06628 155 KLEA 158 (267)
T ss_pred cccc
Confidence 7753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-22 Score=212.15 Aligned_cols=148 Identities=24% Similarity=0.383 Sum_probs=129.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
..-|..++.||-|+||+|.+++.. +...+|+|.|++.+ ......++.|-+||+..+.+-||+|+-.|++++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 356777889999999999999754 46789999998653 34566788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|||++||++-.+| .+.+.+++..+..++..++.|+++.|..+ +|||||||+|||||.+|++||+||||+.-+
T Consensus 708 MdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999998 34566777776666777999999999998 999999999999999999999999998644
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=197.70 Aligned_cols=150 Identities=29% Similarity=0.510 Sum_probs=135.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.++|++.+.||+|+||.||++... +++.+|+|.+........+.+..|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999864 5788999999865555678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++++|.+++... ...+++.+...++.|++.||+|||+++ |+|+||||+||++++++.+||+|||++..+.
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence 9999999988432 246889999999999999999999987 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-22 Score=212.37 Aligned_cols=147 Identities=30% Similarity=0.406 Sum_probs=128.3
Q ss_pred CcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-C-----CceeeEEEEEEeCCeEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-H-----RNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H-----~nIv~l~g~~~~~~~~~l 581 (675)
+|.+.+.||+|+||.|.+|.. .+++.||||+++.+ ....++-..|+.+|..|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 889999999999999999976 45999999999863 445566788999999997 4 489999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC--CCeEEeeecccee
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD--MNPKISDFGLARM 659 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DFGla~~ 659 (675)
|+|.+ .-+|.++++.. +...++......|+.||+.||.+||+.+ |||+|||||||||-+. ..+||+|||.|..
T Consensus 266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99988 67899999764 3445888999999999999999999887 9999999999999653 3799999999987
Q ss_pred cC
Q 005825 660 FG 661 (675)
Q Consensus 660 ~~ 661 (675)
..
T Consensus 341 ~~ 342 (586)
T KOG0667|consen 341 ES 342 (586)
T ss_pred cC
Confidence 54
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=203.48 Aligned_cols=148 Identities=30% Similarity=0.443 Sum_probs=129.8
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999865 58899999987432 33345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++ ++|..++... ...+++.....++.||++||+|||+.+ |+|+||||+||++++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 5888888542 335788899999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=206.20 Aligned_cols=157 Identities=27% Similarity=0.336 Sum_probs=138.4
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
...+.|+..++||+|+||.||-++.+ +|+.+|.|++.++ ..++....++|-.+|.+++.+.||.|--.+..++.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34577888899999999999999764 5999999988653 2345566788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||+..|+||+|.-+|.... ...+++...+-++.+|+.||++||.+. |+.|||||+|||||+.|+++|+|+|||..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 9999999999998886543 356888888999999999999999887 999999999999999999999999999998
Q ss_pred CCCcc
Q 005825 661 GGDEL 665 (675)
Q Consensus 661 ~~~~~ 665 (675)
.+.+.
T Consensus 338 ~~g~~ 342 (591)
T KOG0986|consen 338 PEGKP 342 (591)
T ss_pred CCCCc
Confidence 76654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-23 Score=230.63 Aligned_cols=169 Identities=25% Similarity=0.280 Sum_probs=143.2
Q ss_pred HHHHHHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEe
Q 005825 500 LASVAAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE 575 (675)
Q Consensus 500 ~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~ 575 (675)
..++....++|.+.++||+|+||.|..++.. .++.+|+|++.+- ......-|+.|-++|.--..+-|+.|+-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3445566789999999999999999999875 5889999999862 33455679999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
..++|+|||||+||+|-.++... ..+++.-+..++..|.-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 99999999999999999999433 35777766667777999999999988 9999999999999999999999999
Q ss_pred cceecCCCcccCCCCceecC
Q 005825 656 LARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 656 la~~~~~~~~~~~~~~~~GT 675 (675)
-+-.+..+..-. ....|||
T Consensus 221 sClkm~~dG~V~-s~~aVGT 239 (1317)
T KOG0612|consen 221 SCLKMDADGTVR-SSVAVGT 239 (1317)
T ss_pred hHHhcCCCCcEE-eccccCC
Confidence 998887666422 2235777
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=201.38 Aligned_cols=149 Identities=35% Similarity=0.568 Sum_probs=130.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC-Cc----EEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN-GE----EVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~-g~----~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.+|++.+.||+|+||.||+|...+ ++ .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 577888999999999999998643 33 689998875432 345678999999999999999999999987 78999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++|+|.+++... ...+++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998542 334889999999999999999999987 9999999999999999999999999998775
Q ss_pred C
Q 005825 662 G 662 (675)
Q Consensus 662 ~ 662 (675)
.
T Consensus 161 ~ 161 (279)
T cd05057 161 V 161 (279)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=199.83 Aligned_cols=147 Identities=32% Similarity=0.457 Sum_probs=128.6
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc----------cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG----------QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG 577 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~----------~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~ 577 (675)
+|...+.||+|+||.||+|... +++.||+|.++.... ...+.+..|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999764 588999998763211 11346888999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999853 356888999999999999999999987 999999999999999999999999999
Q ss_pred eecC
Q 005825 658 RMFG 661 (675)
Q Consensus 658 ~~~~ 661 (675)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-21 Score=195.30 Aligned_cols=150 Identities=23% Similarity=0.416 Sum_probs=132.2
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
+|++.++||+|+||.||++... +++.+|+|.++.. .....+.+..|+.++++++|+||+++++.+.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999864 5889999998643 2344577889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++++|.+++... ....+++.....++.|++.||.|||+++ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999999988532 3345788889999999999999999987 99999999999999999999999999987744
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=203.00 Aligned_cols=148 Identities=32% Similarity=0.467 Sum_probs=130.8
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCcc-----CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQ-----GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
+|++.+.||+|+||.||+|... +++.||||.++..... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999864 5899999999754322 234677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999985422 36899999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=199.25 Aligned_cols=142 Identities=32% Similarity=0.525 Sum_probs=123.7
Q ss_pred eeCCcCceeEEEEEE---cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 005825 515 KLGEGGFGPVYKGRL---LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNK 589 (675)
Q Consensus 515 ~IG~G~fG~Vy~~~~---~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 589 (675)
+||+|+||.||+|.+ .+++.+|+|+++... ....+++..|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999965 357889999987543 234567999999999999999999999875 45678999999999
Q ss_pred CHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 590 SLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 590 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+|.+++.. ...+++.....++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 99999843 346889999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=199.61 Aligned_cols=146 Identities=30% Similarity=0.520 Sum_probs=129.8
Q ss_pred CcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCc------cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSG------QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~------~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
+|...+.||+|+||+||+|...+++.+|||.++.... ...+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999888899999999874321 1235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|||+++++|.+++.+ ...+++.....++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999843 345788888999999999999999987 999999999999999999999999999865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-22 Score=215.83 Aligned_cols=156 Identities=32% Similarity=0.470 Sum_probs=131.0
Q ss_pred eeeeeCCcCceeEEEEEEc-CCcEEEEEEecC----cCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe--EEEEEE
Q 005825 512 MECKLGEGGFGPVYKGRLL-NGEEVAVKRLSS----QSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE--KILILE 584 (675)
Q Consensus 512 ~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~----~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~--~~lV~E 584 (675)
..++||+|+|-+||+|.+. +|.+||--.++. +.+...++|..|+.+|+.|+|||||+++..+.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3468999999999999764 477887443331 245566899999999999999999999999987665 789999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-CCCeEEeeeccceecCCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-DMNPKISDFGLARMFGGD 663 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~ 663 (675)
+|..|+|..|+. +.+....+....+++||++||.|||.+. +||||||||.+||+|+. .|.|||+|+|||.++...
T Consensus 124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999994 4556788899999999999999999985 68999999999999974 689999999999998654
Q ss_pred cccCCCCceecC
Q 005825 664 ELQGNTKRIVGT 675 (675)
Q Consensus 664 ~~~~~~~~~~GT 675 (675)
.. +.++||
T Consensus 200 ~a----ksvIGT 207 (632)
T KOG0584|consen 200 HA----KSVIGT 207 (632)
T ss_pred cc----ceeccC
Confidence 42 346777
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-21 Score=196.40 Aligned_cols=149 Identities=30% Similarity=0.552 Sum_probs=132.9
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
.+|++.+.||+|+||.||++...+++.+|+|.++.. .....+|..|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 478888999999999999998877889999998753 3345679999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++|.+++... ...+++.....++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 99999998532 235788999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=202.10 Aligned_cols=150 Identities=28% Similarity=0.457 Sum_probs=135.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
..+|++.++||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35799999999999999999975 56899999999765555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++++|..++.. ..+++.++..++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+...
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999998842 35789999999999999999999987 999999999999999999999999999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=200.65 Aligned_cols=149 Identities=34% Similarity=0.542 Sum_probs=131.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-----CCcEEEEEEecCcCcc-CHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-----NGEEVAVKRLSSQSGQ-GLEEFKNEMLLIAKLQHRNLVRILGCCIE--QGEK 579 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-----~g~~vAvK~l~~~~~~-~~~~f~~E~~il~~l~H~nIv~l~g~~~~--~~~~ 579 (675)
+.|++.+.||+|+||.||+++.. .++.+|||.++..... ..+.|..|+.++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777799999999999999853 3689999999864332 46789999999999999999999999887 5578
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999542 235899999999999999999999987 99999999999999999999999999998
Q ss_pred cC
Q 005825 660 FG 661 (675)
Q Consensus 660 ~~ 661 (675)
+.
T Consensus 159 ~~ 160 (284)
T cd05038 159 LP 160 (284)
T ss_pred cc
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=209.24 Aligned_cols=148 Identities=28% Similarity=0.378 Sum_probs=125.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC------
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ------ 576 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~------ 576 (675)
..++|++.+.||+|+||.||+++.. .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999764 58899999997532 23346788899999999999999999998643
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecc
Q 005825 577 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 656 (675)
...++||||+++ +|...+. ..+++..+..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999975 5666552 24778888899999999999999987 99999999999999999999999999
Q ss_pred ceecCC
Q 005825 657 ARMFGG 662 (675)
Q Consensus 657 a~~~~~ 662 (675)
|+....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=200.85 Aligned_cols=149 Identities=31% Similarity=0.392 Sum_probs=128.6
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++++++|+||+++.+++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 588999999875432 23346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||++ ++|..++... ...+.+.....++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 9996 6776666432 234678888889999999999999987 999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=196.28 Aligned_cols=148 Identities=32% Similarity=0.539 Sum_probs=129.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEe-CCeEEEEEEec
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE-QGEKILILEYM 586 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~ 586 (675)
.+|++.+.||+|+||.||++... +..||+|.++.. ...+.|.+|+.++++++|+|++++++++.+ .+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 47888899999999999999764 778999998743 335679999999999999999999998654 45789999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++++|.+++... ....+++...+.++.+++.||+|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999998542 2335789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=203.84 Aligned_cols=143 Identities=27% Similarity=0.458 Sum_probs=118.6
Q ss_pred eeeCCcCceeEEEEEEc---CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL---NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE--QGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~ 588 (675)
++||+|+||.||+|+.. +++.||+|.++.. .....+.+|+.++++++||||+++++++.. ....++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 68999999999999864 4678999998753 223567889999999999999999999864 3468899999864
Q ss_pred CCHHHHhcCC------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE----cCCCCeEEeeeccce
Q 005825 589 KSLDVFLFDP------TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL----DRDMNPKISDFGLAR 658 (675)
Q Consensus 589 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~ 658 (675)
+|..++... .....+++.....++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 777776421 12235788889999999999999999987 9999999999999 456789999999999
Q ss_pred ecCC
Q 005825 659 MFGG 662 (675)
Q Consensus 659 ~~~~ 662 (675)
.+..
T Consensus 161 ~~~~ 164 (317)
T cd07868 161 LFNS 164 (317)
T ss_pred ccCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-23 Score=198.09 Aligned_cols=152 Identities=28% Similarity=0.416 Sum_probs=129.9
Q ss_pred hcCCcceeeeeCCcCceeEEEEE-EcCCcEEEEEEecC--cCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSS--QSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~-~~~g~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++.|++-+.||+|.|+.||++. .++|+.+|+|.+.. -+....+++.+|+.|-+.|+|||||+|.....+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 34678888999999999999995 46799999998753 2344778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---CCCeEEeeecccee
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDFGLARM 659 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~ 659 (675)
+|+|.|++|..-+- .+..+++...-..++||+.||.|+|.++ |||||+||+|+||.. ..-+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999965552 2345677778889999999999999998 999999999999943 45689999999999
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
+++.
T Consensus 163 l~~g 166 (355)
T KOG0033|consen 163 VNDG 166 (355)
T ss_pred eCCc
Confidence 9843
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=195.64 Aligned_cols=143 Identities=35% Similarity=0.527 Sum_probs=128.1
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCcc-CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCHH
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQ-GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLD 592 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (675)
++||+|+||.||++...+++.||+|.++..... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998764333 4568999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 593 VFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 593 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++... ...+++...+.++.+++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 998542 235788899999999999999999987 9999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=200.52 Aligned_cols=147 Identities=31% Similarity=0.447 Sum_probs=129.2
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.++||+|++|.||+|+.. +++.||||.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999875 588999999875332 2335577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+++ +|.+++... ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 985 898888542 235788899999999999999999987 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=198.03 Aligned_cols=144 Identities=35% Similarity=0.469 Sum_probs=127.5
Q ss_pred eeeCCcCceeEEEEEEcC--C--cEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLLN--G--EEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~--g--~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
++||+|++|.||+|.+.+ + ..||||.++.... ...+.+..|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999987554 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++|.+++..... ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999865332 46899999999999999999999987 99999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=200.60 Aligned_cols=152 Identities=28% Similarity=0.460 Sum_probs=133.1
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.+.||+|+||.||+++. .+++.+|||.+.... .....++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999985 578999999886432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+++++|.+++... .....+++.....++.+|+.||+|||+++ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988532 22456889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=202.27 Aligned_cols=149 Identities=26% Similarity=0.388 Sum_probs=131.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++|++.++||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999875 489999999865322 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|+++++|..+... ...+++.++..++.||++||+|||+.+ |+|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999887632 334889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=207.88 Aligned_cols=148 Identities=28% Similarity=0.380 Sum_probs=126.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC------
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ------ 576 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~------ 576 (675)
..++|++.+.||+|+||.||+++.. .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999864 5889999999753 223456788999999999999999999987543
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecc
Q 005825 577 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 656 (675)
...++||||+++ +|...+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 6666662 23778888999999999999999987 99999999999999999999999999
Q ss_pred ceecCC
Q 005825 657 ARMFGG 662 (675)
Q Consensus 657 a~~~~~ 662 (675)
|+....
T Consensus 173 a~~~~~ 178 (364)
T cd07875 173 ARTAGT 178 (364)
T ss_pred ccccCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=199.55 Aligned_cols=159 Identities=29% Similarity=0.396 Sum_probs=135.2
Q ss_pred HHHHHHhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005825 500 LASVAAATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQG 577 (675)
Q Consensus 500 ~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~ 577 (675)
..++..+.++|++.+.||+|+||.||++.. .+++.+|+|.+... .....++..|+.++.++ +||||+++++++...+
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 344555678999999999999999999987 45889999998753 22346788899999999 7999999999987543
Q ss_pred -----eEEEEEEecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEE
Q 005825 578 -----EKILILEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI 651 (675)
Q Consensus 578 -----~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 651 (675)
..++||||+++++|.+++... .....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 589999999999999988532 22346889999999999999999999887 999999999999999999999
Q ss_pred eeeccceecCC
Q 005825 652 SDFGLARMFGG 662 (675)
Q Consensus 652 ~DFGla~~~~~ 662 (675)
+|||+++.+..
T Consensus 170 ~dfg~~~~~~~ 180 (291)
T cd06639 170 VDFGVSAQLTS 180 (291)
T ss_pred eecccchhccc
Confidence 99999987643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=207.74 Aligned_cols=149 Identities=30% Similarity=0.395 Sum_probs=127.8
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC------
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ------ 576 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~------ 576 (675)
..++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999999986 468899999987532 22345678899999999999999999987543
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecc
Q 005825 577 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 656 (675)
...++++|++ +++|..++. ...+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999987 789988773 235889999999999999999999987 99999999999999999999999999
Q ss_pred ceecCC
Q 005825 657 ARMFGG 662 (675)
Q Consensus 657 a~~~~~ 662 (675)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07878 165 ARQADD 170 (343)
T ss_pred ceecCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=198.51 Aligned_cols=150 Identities=29% Similarity=0.461 Sum_probs=129.5
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC----CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
++|.+.++||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 567888999999999999998643 3468999887544 3455689999999999999999999999875 567899
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999532 335899999999999999999999987 99999999999999999999999999987644
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
.
T Consensus 160 ~ 160 (270)
T cd05056 160 E 160 (270)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=196.57 Aligned_cols=148 Identities=32% Similarity=0.513 Sum_probs=132.9
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|++.+.||+|+||.||+|... +++.||+|.++.... ...+.+..|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 688999999876543 2567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.+++.. ...+++..+..++.++++||+|||+.+ |+|+||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 999999999843 345788889999999999999999987 99999999999999999999999999987743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-22 Score=208.92 Aligned_cols=139 Identities=34% Similarity=0.499 Sum_probs=123.5
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCHH
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLD 592 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (675)
++-||.|+-|.||+|++ .++.||||+++.. =..+|+-|++|+||||+.+.|+|....-++|||||++.|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 46799999999999998 5688999998632 135788999999999999999999999999999999999999
Q ss_pred HHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCcc
Q 005825 593 VFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665 (675)
Q Consensus 593 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (675)
..|+ ....+.......+..+||.||.|||.+. |||||||.-||||+.+..|||+|||-++.+....+
T Consensus 201 ~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST 267 (904)
T KOG4721|consen 201 EVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST 267 (904)
T ss_pred HHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhh
Confidence 9994 3456777788889999999999999886 99999999999999999999999999998865543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=200.20 Aligned_cols=148 Identities=28% Similarity=0.356 Sum_probs=129.8
Q ss_pred CcceeeeeCCcCceeEEEEEE----cCCcEEEEEEecCcC----ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeE
Q 005825 509 NFSMECKLGEGGFGPVYKGRL----LNGEEVAVKRLSSQS----GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~ 579 (675)
+|++.+.||+|+||.||+++. .+|+.||+|+++... ....+++..|+.++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999976 368899999987532 22346788999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999843 345788888889999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 005825 660 FGG 662 (675)
Q Consensus 660 ~~~ 662 (675)
+..
T Consensus 155 ~~~ 157 (290)
T cd05613 155 FHE 157 (290)
T ss_pred ccc
Confidence 744
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-21 Score=198.07 Aligned_cols=149 Identities=32% Similarity=0.530 Sum_probs=131.3
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
+|+..++||+|++|.||+|+.. +++.||||.++.... ...+.+..|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999875 588999999875432 33567788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++ +|.+++........+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 88888754443456899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=201.15 Aligned_cols=148 Identities=24% Similarity=0.372 Sum_probs=131.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.++||+|+||+||+++.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56788899999999999999864 58899999886543 34457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+++++|..++.. .+.+++.....++.+++.||.|||+.+ +++||||||+||++++++.++|+|||+++.+
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 999999998843 346889999999999999999999743 3999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=9e-21 Score=194.43 Aligned_cols=152 Identities=28% Similarity=0.455 Sum_probs=134.8
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.+.||+|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999864 57899999987532 33567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.+++........+++.....++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999999864333356889999999999999999999987 99999999999999999999999999987644
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-21 Score=198.43 Aligned_cols=149 Identities=30% Similarity=0.487 Sum_probs=123.4
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--cCHHHHHHHHHHHHhc---CCCceeeEEEEEEeC-----C
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKL---QHRNLVRILGCCIEQ-----G 577 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l---~H~nIv~l~g~~~~~-----~ 577 (675)
+|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+..|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999875 588999999875322 2234566777777665 699999999998642 3
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
..++||||+++ +|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 888887542 2335889999999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 005825 658 RMFGG 662 (675)
Q Consensus 658 ~~~~~ 662 (675)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.5e-21 Score=196.55 Aligned_cols=148 Identities=30% Similarity=0.488 Sum_probs=128.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-----ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-----GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEK 579 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~ 579 (675)
.+|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888899999999999999864 58899999886432 12345688999999999999999999998753 567
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
+++|||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999843 335788889999999999999999887 99999999999999999999999999986
Q ss_pred cC
Q 005825 660 FG 661 (675)
Q Consensus 660 ~~ 661 (675)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 63
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=223.62 Aligned_cols=158 Identities=23% Similarity=0.374 Sum_probs=131.1
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeE
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEK 579 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~ 579 (675)
...++|.+.++||+|+||+||+++.. .++.+|+|.+... .......|..|+.++.+++|||||++++++.+. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999864 4778999988743 223456789999999999999999999998654 468
Q ss_pred EEEEEecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCC----CceEecCCCCCCEEEcCC--------
Q 005825 580 ILILEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSR----FRIIHRDLKASNVLLDRD-------- 646 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiHrDlkp~NILl~~~-------- 646 (675)
+|||||+++++|..+|... .....+++...+.|+.||+.||+|||..+. .+||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999998542 123468999999999999999999998542 349999999999999642
Q ss_pred ---------CCeEEeeeccceecCC
Q 005825 647 ---------MNPKISDFGLARMFGG 662 (675)
Q Consensus 647 ---------~~~kl~DFGla~~~~~ 662 (675)
..+||+|||+++.+..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred ccccccCCCCceEEccCCccccccc
Confidence 3589999999987743
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.2e-21 Score=200.48 Aligned_cols=150 Identities=26% Similarity=0.331 Sum_probs=133.2
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCcc---CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQ---GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.+.||+|+||.||++...+ ++.+|+|.+...... ..+.+..|+.++++++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468889999999999999998754 899999999754322 4567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||+++++|.+++... ....+++.....++.|+++||+|||..+ ++|+||||+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999998532 2346889999999999999999999987 9999999999999999999999999998663
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.9e-21 Score=200.54 Aligned_cols=143 Identities=28% Similarity=0.465 Sum_probs=118.6
Q ss_pred eeeCCcCceeEEEEEEc---CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL---NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE--QGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~ 588 (675)
.+||+|+||.||+|+.. ++..||+|.++... ....+.+|+.++++++||||+++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 58999999999999864 35789999987532 33567889999999999999999999854 4578999999875
Q ss_pred CCHHHHhcCC------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE----cCCCCeEEeeeccce
Q 005825 589 KSLDVFLFDP------TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL----DRDMNPKISDFGLAR 658 (675)
Q Consensus 589 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~ 658 (675)
+|.+++... .....+++.....++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666665321 12335788899999999999999999987 9999999999999 567799999999999
Q ss_pred ecCC
Q 005825 659 MFGG 662 (675)
Q Consensus 659 ~~~~ 662 (675)
.+..
T Consensus 161 ~~~~ 164 (317)
T cd07867 161 LFNS 164 (317)
T ss_pred ccCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=198.39 Aligned_cols=151 Identities=28% Similarity=0.418 Sum_probs=126.4
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHH-HHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLL-IAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~i-l~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++|++.+.||+|+||.||+++.. +++.||+|+++... .....++..|+.+ ++.++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999875 58999999987542 2233455566665 566789999999999999999999999
Q ss_pred ecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|++ ++|.+++... .....+++.....++.||+.||+|||++. +++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 6888777432 23356899999999999999999999862 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=204.03 Aligned_cols=154 Identities=27% Similarity=0.370 Sum_probs=134.1
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
+.+-|.+.+.||+|-|..|-+++. -.|+.||||++.+.. ......+.+|++.|+.++|||||+|+.+...+..+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 345677788999999999999974 579999999998643 33456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE-cCCCCeEEeeeccceecC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL-DRDMNPKISDFGLARMFG 661 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl-~~~~~~kl~DFGla~~~~ 661 (675)
+|+=.+|+|.+|+.... ..+.+....+++.||+.|+.|+|+.+ ++||||||+|+++ .+-|.+||+|||++..+.
T Consensus 96 LELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999996543 34788888999999999999999988 9999999999887 557899999999998886
Q ss_pred CCc
Q 005825 662 GDE 664 (675)
Q Consensus 662 ~~~ 664 (675)
+.+
T Consensus 171 PG~ 173 (864)
T KOG4717|consen 171 PGK 173 (864)
T ss_pred Ccc
Confidence 654
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=202.26 Aligned_cols=151 Identities=38% Similarity=0.656 Sum_probs=127.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCc----EEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGE----EVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
.++|+..+.||+|+||.||+|... +++ .||+|.+..... ....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999763 343 578998875432 2345788999999999999999999998754 567
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 899999999999998532 335788899999999999999999987 999999999999999999999999999977
Q ss_pred CCC
Q 005825 661 GGD 663 (675)
Q Consensus 661 ~~~ 663 (675)
...
T Consensus 160 ~~~ 162 (303)
T cd05110 160 EGD 162 (303)
T ss_pred cCc
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.8e-21 Score=200.73 Aligned_cols=150 Identities=28% Similarity=0.457 Sum_probs=127.7
Q ss_pred CcceeeeeCCcCceeEEEEEEc---CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL---NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEKI 580 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~~ 580 (675)
.|++.++||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999864 47899999998632 33456788899999999999999999999988 7899
Q ss_pred EEEEecCCCCHHHHhcCCC--CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC----CCCeEEeee
Q 005825 581 LILEYMPNKSLDVFLFDPT--KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR----DMNPKISDF 654 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kl~DF 654 (675)
+||||+++ +|.+++.... ....++......++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5666553221 2236788899999999999999999987 999999999999999 999999999
Q ss_pred ccceecCC
Q 005825 655 GLARMFGG 662 (675)
Q Consensus 655 Gla~~~~~ 662 (675)
|+++.+..
T Consensus 157 g~~~~~~~ 164 (316)
T cd07842 157 GLARLFNA 164 (316)
T ss_pred ccccccCC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=196.99 Aligned_cols=143 Identities=35% Similarity=0.602 Sum_probs=123.2
Q ss_pred eeeCCcCceeEEEEEEcC-Cc--EEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLLN-GE--EVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~-g~--~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
+.||+|+||.||+|+..+ +. .+|+|.++... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 43 57888887532 34456789999999999 799999999999999999999999999
Q ss_pred CCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 589 KSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 589 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
++|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985421 1235789999999999999999999987 9999999999999999999999999
Q ss_pred ccee
Q 005825 656 LARM 659 (675)
Q Consensus 656 la~~ 659 (675)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=198.17 Aligned_cols=148 Identities=31% Similarity=0.508 Sum_probs=129.9
Q ss_pred CcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCc------cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSG------QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
+|+..+.||+|+||.||+++. .+++.||+|.++.... ...+.+..|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999975 5689999999874321 134678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC-CeEEeeeccceec
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-NPKISDFGLARMF 660 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~ 660 (675)
||||+++++|.+++.. ...+++.....++.|++.||+|||+++ ++|+||||+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 346788999999999999999999987 99999999999998776 5999999999877
Q ss_pred CC
Q 005825 661 GG 662 (675)
Q Consensus 661 ~~ 662 (675)
..
T Consensus 155 ~~ 156 (268)
T cd06630 155 AA 156 (268)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-21 Score=197.50 Aligned_cols=149 Identities=32% Similarity=0.506 Sum_probs=132.8
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999864 68999999987543 23356799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+ +++|.+++... ...+++.++..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999998543 256899999999999999999999987 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-21 Score=194.68 Aligned_cols=150 Identities=39% Similarity=0.634 Sum_probs=131.3
Q ss_pred cceeeeeCCcCceeEEEEEEcC-----CcEEEEEEecCcCcc-CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 510 FSMECKLGEGGFGPVYKGRLLN-----GEEVAVKRLSSQSGQ-GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~~~-~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
|++.+.||+|+||.||+++..+ +..||+|.++..... ..+.+..|+.++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566899999999999998754 488999999764333 5678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854221 12899999999999999999999987 999999999999999999999999999877543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=202.84 Aligned_cols=145 Identities=26% Similarity=0.418 Sum_probs=128.7
Q ss_pred ceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 005825 511 SMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNK 589 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 589 (675)
.....||+|+||.||++... ++..||||.+........+.+.+|+.++++++||||+++++.+..++..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 33467999999999999864 58899999987655555677899999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 590 SLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 590 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+|.+++.. ..+++.+...++.||+.||+|||+++ |+||||||+||++++++.+||+|||+++.+..
T Consensus 105 ~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 105 ALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred cHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 99998732 34788999999999999999999987 99999999999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-21 Score=195.11 Aligned_cols=146 Identities=34% Similarity=0.573 Sum_probs=127.9
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
++|++.+.||+|+||.||++.. .++.||+|.++.. ...+.+.+|+.++++++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688889999999999999975 6788999998643 2346789999999999999999999998754 5799999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 999999986432 335788999999999999999999987 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-22 Score=196.33 Aligned_cols=153 Identities=28% Similarity=0.454 Sum_probs=125.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc---C--CcEEEEEEecCcCcc-C-HHHHHHHHHHHHhcCCCceeeEEEEEEe-CCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL---N--GEEVAVKRLSSQSGQ-G-LEEFKNEMLLIAKLQHRNLVRILGCCIE-QGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~---~--g~~vAvK~l~~~~~~-~-~~~f~~E~~il~~l~H~nIv~l~g~~~~-~~~ 578 (675)
...|+...+||+|.||.||+|.-. + .+++|+|+++..... + .....+|+.+++.++||||+.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 356788889999999999999532 2 347999999864221 1 2345689999999999999999999877 678
Q ss_pred EEEEEEecCCCCHHHHhc--CCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC----CCeEEe
Q 005825 579 KILILEYMPNKSLDVFLF--DPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD----MNPKIS 652 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~ 652 (675)
.+|++||.+. +|..+++ +..+.+.++......|+.||+.|+.|||++- |+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999976 5555553 2234467888889999999999999999997 9999999999999877 899999
Q ss_pred eeccceecCCC
Q 005825 653 DFGLARMFGGD 663 (675)
Q Consensus 653 DFGla~~~~~~ 663 (675)
|||+||++...
T Consensus 179 DlGlaR~~~~p 189 (438)
T KOG0666|consen 179 DLGLARLFNNP 189 (438)
T ss_pred cccHHHHhhcc
Confidence 99999998543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=194.35 Aligned_cols=149 Identities=29% Similarity=0.482 Sum_probs=134.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.++|+..++||+|+||.||+++..+ ++.+++|.++.... .+++.+|++++++++||||+++++.+.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678888999999999999998765 78999999875432 67899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.+++.. ....+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999999843 2356899999999999999999999987 99999999999999999999999999987744
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-21 Score=195.75 Aligned_cols=150 Identities=31% Similarity=0.539 Sum_probs=125.9
Q ss_pred cceeeeeCCcCceeEEEEEEc----CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 005825 510 FSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG------ 577 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~----~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~------ 577 (675)
|.+.+.||+|+||.||+|.+. .++.||||.++.. .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999753 3688999998754 2334567899999999999999999999986543
Q ss_pred eEEEEEEecCCCCHHHHhcCC---CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeee
Q 005825 578 EKILILEYMPNKSLDVFLFDP---TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDF 654 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 654 (675)
..++++||+++|+|..++... .....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 247889999999999887432 12235788899999999999999999987 999999999999999999999999
Q ss_pred ccceecCC
Q 005825 655 GLARMFGG 662 (675)
Q Consensus 655 Gla~~~~~ 662 (675)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05074 158 GLSKKIYS 165 (273)
T ss_pred cccccccC
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-21 Score=197.27 Aligned_cols=149 Identities=27% Similarity=0.354 Sum_probs=133.2
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
+|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++.+.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999875 58999999997532 2346789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|+++++|..++.. ...+++.+...++.++++||.|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999843 246888999999999999999999987 999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-21 Score=202.82 Aligned_cols=145 Identities=22% Similarity=0.311 Sum_probs=125.3
Q ss_pred eeeeeCCc--CceeEEEEEE-cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 512 MECKLGEG--GFGPVYKGRL-LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 512 ~~~~IG~G--~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
+.++||+| +|++||+++. .+++.||||+++... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999976 468999999997542 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++++|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++||+.+..+
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 9999999985322 234789999999999999999999987 999999999999999999999999865443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-22 Score=189.18 Aligned_cols=155 Identities=28% Similarity=0.347 Sum_probs=137.1
Q ss_pred HhcCCcceeeeeCCcCceeEEEEE-EcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----e
Q 005825 505 AATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG-----E 578 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~-----~ 578 (675)
...++|++.++||+|||.-||.++ ..+++.+|+|++.-...++.+..++|++.-++++||||++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 456799999999999999999997 5678999999998777778889999999999999999999998875433 5
Q ss_pred EEEEEEecCCCCHHHHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 579 KILILEYMPNKSLDVFLFDPT-KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
.||+++|...|+|.+.+.... +...+++.+.+.|+.+|++||++||+.. ++.+||||||.|||+.+++.++|.|||-+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999886543 3447899999999999999999999985 47999999999999999999999999987
Q ss_pred eec
Q 005825 658 RMF 660 (675)
Q Consensus 658 ~~~ 660 (675)
...
T Consensus 177 ~~a 179 (302)
T KOG2345|consen 177 TQA 179 (302)
T ss_pred ccc
Confidence 654
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.5e-21 Score=194.05 Aligned_cols=142 Identities=37% Similarity=0.573 Sum_probs=123.7
Q ss_pred eeeCCcCceeEEEEEEcC----CcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
++||+|+||.||+|+... +..+|+|.++.... ...+++..|+.+++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999886433 24567999999999999999999999875 5578999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++|.+++.. ...+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 999999953 236889999999999999999999987 99999999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=207.36 Aligned_cols=152 Identities=30% Similarity=0.520 Sum_probs=131.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC---C--cEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN---G--EEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~---g--~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
.+...+.++||+|-||.||+|.+.+ | -.||||..+.+ .....+.|+.|..+|++++|||||+|+|+|.+ ...|
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 3445566789999999999997532 3 35899998874 45667889999999999999999999999976 4689
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||||+.+-|.|..||... ...++......++.||..||+|||+.. .+||||.++|||+...-.+||+||||+|-+
T Consensus 467 ivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999999543 445888888999999999999999986 999999999999999999999999999988
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
..+.
T Consensus 542 ed~~ 545 (974)
T KOG4257|consen 542 EDDA 545 (974)
T ss_pred cccc
Confidence 6543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.9e-21 Score=195.70 Aligned_cols=148 Identities=26% Similarity=0.478 Sum_probs=131.6
Q ss_pred CcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc-CccCHHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQ---HRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~---H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.|+..++||+|+||.||+|.. .+++.||+|.++.. .....+++.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999986 46899999998754 3345667899999999997 999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++++|.+++.. ..+++.....++.+++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998843 26889999999999999999999987 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=193.86 Aligned_cols=148 Identities=31% Similarity=0.494 Sum_probs=128.6
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc-----CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ-----SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEK 579 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~ 579 (675)
.+|++.+.||+|+||.||+++.. +++.||+|.+... ..+..+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57899999999999999999864 5899999987532 123446788999999999999999999998764 457
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999843 335788889999999999999999987 99999999999999999999999999987
Q ss_pred cC
Q 005825 660 FG 661 (675)
Q Consensus 660 ~~ 661 (675)
+.
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 63
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-21 Score=200.96 Aligned_cols=145 Identities=30% Similarity=0.438 Sum_probs=128.7
Q ss_pred ceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 005825 511 SMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNK 589 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 589 (675)
....+||+|+||.||+++.. +++.||+|.+........+.+.+|+.++..++||||+++++.+..++..++||||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33457999999999999864 68999999987654555677889999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 590 SLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 590 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+|..++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 104 ~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 104 ALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 99988732 35789999999999999999999987 99999999999999999999999999976643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=193.40 Aligned_cols=150 Identities=29% Similarity=0.426 Sum_probs=135.2
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.+.||+|++|.||+++... ++.|+||++..... ...+.+..|+..+.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468888999999999999998764 89999999876543 4467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH-YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++++|.+++.. ...+++..+..++.|+++||+|||+ .+ ++|+||+|+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999943 2568899999999999999999998 77 999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.6e-21 Score=197.92 Aligned_cols=149 Identities=28% Similarity=0.442 Sum_probs=133.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.++|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36888999999999999999975 46789999998754445567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.+++.. ..+++.++..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+..
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999999842 34788899999999999999999987 99999999999999999999999999886644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=191.19 Aligned_cols=150 Identities=27% Similarity=0.414 Sum_probs=130.0
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC-CeEEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ-GEKILILE 584 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~-~~~~lV~E 584 (675)
+|++.+.||+|++|.||++... +++.||+|++.... ....+.+.+|+.++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999864 47899999987532 23456788999999999999999999987644 46789999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|+++++|.+++... ....+++.++..++.+++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999998642 2345899999999999999999999987 99999999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=195.07 Aligned_cols=143 Identities=33% Similarity=0.571 Sum_probs=121.4
Q ss_pred eeeCCcCceeEEEEEEcC----CcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEe-CCeEEEEEEecC
Q 005825 514 CKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE-QGEKILILEYMP 587 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~ 587 (675)
+.||+|+||.||+|...+ ...||+|++... .....+.+..|+.+++.++||||+++++++.. .+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998632 457999998643 23345788899999999999999999998764 456889999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++|.+++... ...+.+...+.++.+++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999998542 234677888899999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=199.35 Aligned_cols=148 Identities=31% Similarity=0.455 Sum_probs=130.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+.|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+.++++++||||+++++.+...+..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34666788999999999999764 57899999987432 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.+++. ...+++.....++.++++||.|||+++ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 99999999883 245788999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-22 Score=223.38 Aligned_cols=151 Identities=33% Similarity=0.481 Sum_probs=125.2
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEe------
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE------ 575 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~------ 575 (675)
.+..++|+..+.||+||||.||+++. -||+.+|||+|... +......+.+|+.++++|+|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 45567899999999999999999985 48999999999754 33445678899999999999999998876643
Q ss_pred --------------------------------------------------------------------------------
Q 005825 576 -------------------------------------------------------------------------------- 575 (675)
Q Consensus 576 -------------------------------------------------------------------------------- 575 (675)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHH
Q 005825 576 -------------------------Q--------GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622 (675)
Q Consensus 576 -------------------------~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y 622 (675)
. ..+||=||||+...+.+++.+..... .-...++++++|+.||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 0 12467799999888888885432211 345667899999999999
Q ss_pred HHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 623 LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
+|+++ ||||||||.||+||++..|||+|||+|..
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 99998 99999999999999999999999999987
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.8e-21 Score=197.04 Aligned_cols=150 Identities=28% Similarity=0.419 Sum_probs=131.9
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++|++.++||+|+||.||+|... +++.||||+++.. .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46889999999999999999875 5889999998753 23345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|++++.+..+.. +...+++.+...++.+|+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999988776663 2344789999999999999999999987 999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=194.77 Aligned_cols=148 Identities=30% Similarity=0.446 Sum_probs=130.7
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+-|+..++||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3467778999999999999976 468899999886432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.+++.. ..+++.....++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 999999998832 35789999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-21 Score=198.77 Aligned_cols=144 Identities=29% Similarity=0.431 Sum_probs=124.0
Q ss_pred eeeCCcCceeEEEEEEcC--------CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 514 CKLGEGGFGPVYKGRLLN--------GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+.||+|+||.||+|.... ..+||+|.+........+++.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997532 335888888765445567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC--------eEEeeeccc
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN--------PKISDFGLA 657 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~kl~DFGla 657 (675)
+++|+|..++... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999543 235789999999999999999999987 999999999999987765 699999998
Q ss_pred eecCC
Q 005825 658 RMFGG 662 (675)
Q Consensus 658 ~~~~~ 662 (675)
.....
T Consensus 156 ~~~~~ 160 (258)
T cd05078 156 ITVLP 160 (258)
T ss_pred cccCC
Confidence 76543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=191.64 Aligned_cols=150 Identities=25% Similarity=0.425 Sum_probs=131.9
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|++.++||+|+||.||+++.. +++.||+|++... .....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999764 5889999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.+++... ....+++.+.+.++.|++.||+|||+++ ++|+||+|+||+++.++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999988532 2235788999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.6e-22 Score=195.05 Aligned_cols=141 Identities=28% Similarity=0.398 Sum_probs=127.3
Q ss_pred eeeCCcCceeEEEEE-EcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEEEecCCCCH
Q 005825 514 CKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILILEYMPNKSL 591 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (675)
+.||+|+++.|--+. +.++.++|||++.+.......++.+|++++...+ |+||+.|+.+|++....|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999885 5689999999999876667788999999999996 99999999999999999999999999999
Q ss_pred HHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC---eEEeeeccceec
Q 005825 592 DVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN---PKISDFGLARMF 660 (675)
Q Consensus 592 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla~~~ 660 (675)
..++. ++..+.+.++..+..+|+.||.|||.++ |.||||||+|||..+... +||+||.|+.-+
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence 99984 4566889999999999999999999998 999999999999976544 799999998654
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=196.57 Aligned_cols=150 Identities=29% Similarity=0.419 Sum_probs=127.8
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCe-----
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGE----- 578 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~----- 578 (675)
++|++.+.||+|+||.||+|+.. +++.||||.++... ......+.+|+.+++++. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999875 58999999886532 223467888999999995 6999999999987665
Q ss_pred EEEEEEecCCCCHHHHhcCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-CCCeEEeeec
Q 005825 579 KILILEYMPNKSLDVFLFDPTK--KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-DMNPKISDFG 655 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFG 655 (675)
.++||||+++ +|.+++..... ...+++.....++.||++||.|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78888754322 346899999999999999999999987 999999999999998 8899999999
Q ss_pred cceecC
Q 005825 656 LARMFG 661 (675)
Q Consensus 656 la~~~~ 661 (675)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=187.56 Aligned_cols=142 Identities=19% Similarity=0.185 Sum_probs=109.3
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCcCcc--C-------HHHH-----------------HHHHHHHHhcCCCce
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQ--G-------LEEF-----------------KNEMLLIAKLQHRNL 566 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~--~-------~~~f-----------------~~E~~il~~l~H~nI 566 (675)
...||+|+||.||+|...+|+.||||+++..... . ...| ..|+.++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999888999999999753211 1 1122 349999999987776
Q ss_pred eeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHH-HhcCCCceEecCCCCCCEEEcC
Q 005825 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL-HHYSRFRIIHRDLKASNVLLDR 645 (675)
Q Consensus 567 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrDlkp~NILl~~ 645 (675)
.....+.. ...+|||||++++++..... ....++..+...++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44332222 23489999999987765432 234578888999999999999999 5666 99999999999998
Q ss_pred CCCeEEeeeccceecCCC
Q 005825 646 DMNPKISDFGLARMFGGD 663 (675)
Q Consensus 646 ~~~~kl~DFGla~~~~~~ 663 (675)
++.++|+|||+|...+.+
T Consensus 153 ~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 153 DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred CCcEEEEEccccccCCCc
Confidence 478999999999876443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=195.10 Aligned_cols=148 Identities=28% Similarity=0.434 Sum_probs=131.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
..|+..++||+|+||.||+|... +++.||+|.++... ......+.+|+.+++++.||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45677789999999999999864 58899999987532 34456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.+++.. ..+++.+...++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++.+..
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 999999998842 35788888999999999999999887 99999999999999999999999999987754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-21 Score=207.09 Aligned_cols=154 Identities=33% Similarity=0.512 Sum_probs=132.4
Q ss_pred eeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCHHH
Q 005825 515 KLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDV 593 (675)
Q Consensus 515 ~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 593 (675)
+||+|.||+||-|++.+ ...+|||.+..+.....+-+++|+.+-++++|.|||+++|.+.+++..-|.||-+|||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999755 66899999988777778889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCcccC--CHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc-CCCCeEEeeeccceecCCCcccCCCC
Q 005825 594 FLFDPTKKRLL--GWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD-RDMNPKISDFGLARMFGGDELQGNTK 670 (675)
Q Consensus 594 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (675)
+|.. +-+++ .+.+.-.+..||++||.|||++. |+|||||-+|+|++ -.|.+||+|||-++.+.+-. ..|.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--cccc
Confidence 9953 34455 66777788999999999999998 99999999999995 57899999999999885432 2344
Q ss_pred ceecC
Q 005825 671 RIVGT 675 (675)
Q Consensus 671 ~~~GT 675 (675)
++-||
T Consensus 735 TFTGT 739 (1226)
T KOG4279|consen 735 TFTGT 739 (1226)
T ss_pred ccccc
Confidence 44454
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=194.60 Aligned_cols=149 Identities=27% Similarity=0.419 Sum_probs=133.2
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788889999999999999865 58899999987543 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999843 26889999999999999999999987 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=196.33 Aligned_cols=148 Identities=32% Similarity=0.512 Sum_probs=129.8
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|+..+.||+|++|.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999874 58899999987532 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++ ++|..++... ....+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 6888888543 2346889999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.6e-22 Score=210.82 Aligned_cols=153 Identities=35% Similarity=0.493 Sum_probs=133.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc--CCc--EEEEEEecCcCcc-CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL--NGE--EVAVKRLSSQSGQ-GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~--~g~--~vAvK~l~~~~~~-~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
++..+.++||+|+||.|++|.+. .|+ .||||.++..... ....|++|+.+|.+|+|||+++|+|+..+ ...+||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 34456689999999999999874 344 6899999875443 67899999999999999999999999887 678899
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+|+.+.|||.+.|++ .....+-......++.|||.||.||..++ +|||||.++|+||.....|||+||||.|-++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999976 34455667778889999999999999987 99999999999999999999999999999977
Q ss_pred Ccc
Q 005825 663 DEL 665 (675)
Q Consensus 663 ~~~ 665 (675)
++.
T Consensus 265 ned 267 (1039)
T KOG0199|consen 265 NED 267 (1039)
T ss_pred CCc
Confidence 664
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-20 Score=189.59 Aligned_cols=149 Identities=34% Similarity=0.509 Sum_probs=133.5
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|++.+.||+|++|.||+++.. +++.||+|.+..... ...+.+.+|++++++++|||++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 578999999986543 3557899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999999843 356899999999999999999999987 999999999999999999999999999987543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-22 Score=213.24 Aligned_cols=151 Identities=26% Similarity=0.444 Sum_probs=134.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.+.+.++..||.|+||+||++..++ +...|.|.|...+...++.|+.|++||+..+||+||+|++.|...+.+++..||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3456677889999999999998655 455678888877888889999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|.||-.+.++.. -.+.|.+.++..++.+++.||.|||++. |||||||+.|||++-+|.++|+|||.+.....
T Consensus 111 C~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred cCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh
Confidence 999999998854 3456889999999999999999999987 99999999999999999999999998876543
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=197.72 Aligned_cols=147 Identities=29% Similarity=0.484 Sum_probs=128.3
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|++.++||+|+||.||+|+.. +|+.+|+|+++... ......+..|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999874 58999999987532 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++ ++|.+++... ...+++.....++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 97 4777776432 345899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.6e-21 Score=212.33 Aligned_cols=154 Identities=23% Similarity=0.373 Sum_probs=119.8
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC--CcEEEEEEe--------------cC---cCccCHHHHHHHHHHHHhcCCCce
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN--GEEVAVKRL--------------SS---QSGQGLEEFKNEMLLIAKLQHRNL 566 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~--g~~vAvK~l--------------~~---~~~~~~~~f~~E~~il~~l~H~nI 566 (675)
..++|++.++||+|+||+||++.... +...++|.+ .+ ........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999986532 222222211 10 112234568899999999999999
Q ss_pred eeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc
Q 005825 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD 644 (675)
Q Consensus 567 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 644 (675)
+++++++...+..++|+|++. ++|..++..... ...........|+.||+.||+|||+++ ||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999985 566666643211 112234566789999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccceecCCC
Q 005825 645 RDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 645 ~~~~~kl~DFGla~~~~~~ 663 (675)
.++.+||+|||+|+.+...
T Consensus 302 ~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCEEEEeCCCceecCcc
Confidence 9999999999999987543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=196.27 Aligned_cols=150 Identities=30% Similarity=0.441 Sum_probs=129.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~~lV 582 (675)
++|+..+.||+|+||.||+|... +++.+|+|.++... ......+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888899999999999999875 58899999997432 22234577899999999999999999999877 889999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++ +|.+++... ...+++.....++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 898887532 235899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=208.50 Aligned_cols=150 Identities=23% Similarity=0.304 Sum_probs=121.9
Q ss_pred HHHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCC------CceeeEEEEEEe
Q 005825 503 VAAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQH------RNLVRILGCCIE 575 (675)
Q Consensus 503 ~~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H------~nIv~l~g~~~~ 575 (675)
+....++|++.++||+|+||+||+|+.. .++.||||+++.. ....+++..|+.++.+++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445789999999999999999999864 5788999999743 2234556778887777755 458899998876
Q ss_pred C-CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc-CCCceEecCCCCCCEEEcCCC------
Q 005825 576 Q-GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY-SRFRIIHRDLKASNVLLDRDM------ 647 (675)
Q Consensus 576 ~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~------ 647 (675)
. .+.++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 5 4788999987 7788888743 34688999999999999999999974 5 99999999999998765
Q ss_pred ----------CeEEeeeccceec
Q 005825 648 ----------NPKISDFGLARMF 660 (675)
Q Consensus 648 ----------~~kl~DFGla~~~ 660 (675)
.+||+|||++...
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred cccccCCCCceEEECCCCccccC
Confidence 4999999988653
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-20 Score=186.86 Aligned_cols=150 Identities=35% Similarity=0.560 Sum_probs=135.1
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+||+++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999875 688999999986554566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++|.+++... ...+++..+..++.+++.||+|||..+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999998542 246899999999999999999999977 999999999999999999999999999887554
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=208.28 Aligned_cols=153 Identities=25% Similarity=0.394 Sum_probs=121.1
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-----------------cCCcEEEEEEecCcCccCHHH--------------HHHH
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-----------------LNGEEVAVKRLSSQSGQGLEE--------------FKNE 554 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-----------------~~g~~vAvK~l~~~~~~~~~~--------------f~~E 554 (675)
..++|++.++||+|+||.||+|.. ..++.||||+++.......++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 235689999987543222223 3457
Q ss_pred HHHHHhcCCCce-----eeEEEEEEe--------CCeEEEEEEecCCCCHHHHhcCCC---------------------C
Q 005825 555 MLLIAKLQHRNL-----VRILGCCIE--------QGEKILILEYMPNKSLDVFLFDPT---------------------K 600 (675)
Q Consensus 555 ~~il~~l~H~nI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~ 600 (675)
+.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788877655 677888753 356899999999999999986321 1
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 601 KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 601 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 123467788899999999999999987 9999999999999999999999999997653
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=194.07 Aligned_cols=156 Identities=29% Similarity=0.456 Sum_probs=132.2
Q ss_pred HHHHHhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEe---
Q 005825 501 ASVAAATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIE--- 575 (675)
Q Consensus 501 ~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~--- 575 (675)
.++..+.+.|++.+.||+|+||.||+|+. .+++.+|+|.+... .....++..|+.++.++ +||||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 34445668899999999999999999987 45889999998653 23446788999999998 69999999999863
Q ss_pred ---CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 005825 576 ---QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKIS 652 (675)
Q Consensus 576 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 652 (675)
....+++|||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 45789999999999999988542 2345778888899999999999999987 9999999999999999999999
Q ss_pred eeccceecC
Q 005825 653 DFGLARMFG 661 (675)
Q Consensus 653 DFGla~~~~ 661 (675)
|||+++.+.
T Consensus 164 dfg~~~~~~ 172 (282)
T cd06636 164 DFGVSAQLD 172 (282)
T ss_pred eCcchhhhh
Confidence 999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-20 Score=188.30 Aligned_cols=150 Identities=34% Similarity=0.499 Sum_probs=134.2
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--cCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEKILIL 583 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~~lV~ 583 (675)
+|+..+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|+.++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999876 689999999875432 4567899999999999999999999999988 8899999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++++|.+++.. ...+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999853 237899999999999999999999987 999999999999999999999999999887554
Q ss_pred c
Q 005825 664 E 664 (675)
Q Consensus 664 ~ 664 (675)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=193.10 Aligned_cols=153 Identities=30% Similarity=0.467 Sum_probs=132.8
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC-----
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQG----- 577 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~----- 577 (675)
..+++|++.+.||+|+||.||+|+.. +++.+++|.+.... ...+.+..|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999875 57899999987533 3456799999999999 6999999999997654
Q ss_pred -eEEEEEEecCCCCHHHHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 578 -EKILILEYMPNKSLDVFLFDPT-KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 578 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999885422 2356889999999999999999999987 9999999999999999999999999
Q ss_pred cceecC
Q 005825 656 LARMFG 661 (675)
Q Consensus 656 la~~~~ 661 (675)
++....
T Consensus 159 ~~~~~~ 164 (275)
T cd06608 159 VSAQLD 164 (275)
T ss_pred cceecc
Confidence 997653
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=182.23 Aligned_cols=143 Identities=20% Similarity=0.235 Sum_probs=112.7
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCcCcc--C------------------------HHHHHHHHHHHHhcCCCce
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQ--G------------------------LEEFKNEMLLIAKLQHRNL 566 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~--~------------------------~~~f~~E~~il~~l~H~nI 566 (675)
...||+|+||.||+|+..+|+.||||+++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754211 0 1124578999999999987
Q ss_pred eeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCEEEcC
Q 005825 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH-YSRFRIIHRDLKASNVLLDR 645 (675)
Q Consensus 567 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~ 645 (675)
.....+... ..+|||||++++++..... ....++..+...++.+++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 3489999999986544321 12346778888999999999999999 77 99999999999999
Q ss_pred CCCeEEeeeccceecCCCc
Q 005825 646 DMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 646 ~~~~kl~DFGla~~~~~~~ 664 (675)
++.++|+|||+|+.+.++.
T Consensus 153 ~~~~~liDFG~a~~~~~~~ 171 (190)
T cd05145 153 DGKPYIIDVSQAVELDHPN 171 (190)
T ss_pred CCCEEEEEcccceecCCCC
Confidence 8899999999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=193.46 Aligned_cols=151 Identities=29% Similarity=0.413 Sum_probs=130.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~~lV~ 583 (675)
++|+..++||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999874 58899999987532 23456799999999999999999999998654 3689999
Q ss_pred EecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 584 EYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||+++++|.+++... .....+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999887432 23445788899999999999999999987 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=193.04 Aligned_cols=141 Identities=29% Similarity=0.355 Sum_probs=118.3
Q ss_pred eeCCcCceeEEEEEEc-CCcEEEEEEecCcCc---cCHHHHHHHHHHHH---hcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 515 KLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG---QGLEEFKNEMLLIA---KLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 515 ~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~il~---~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
.||+|+||.||+++.. +++.+|+|.+.+... .....+.+|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 588999998865321 12233445544333 3479999999999999999999999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 9999998843 346899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=189.22 Aligned_cols=151 Identities=26% Similarity=0.425 Sum_probs=131.1
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|+..+.||+|+||.||++... +++.+|||.+... .....+.+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999764 5889999998653 233456899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC-CCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD-MNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~ 663 (675)
+++++|.+++... ....+++..+..++.++++||+|||+++ ++|+||||+||+++++ ..+||+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999542 2345789999999999999999999987 9999999999999865 46899999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=194.15 Aligned_cols=145 Identities=37% Similarity=0.557 Sum_probs=124.9
Q ss_pred eeeCCcCceeEEEEEEcC-------CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 514 CKLGEGGFGPVYKGRLLN-------GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~-------g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+.||+|+||.||+|+..+ ++.+|||.+.... .....++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997642 3579999886533 23466899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC-----CeEEeeecc
Q 005825 586 MPNKSLDVFLFDPT----KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-----NPKISDFGL 656 (675)
Q Consensus 586 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~kl~DFGl 656 (675)
+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986421 2235788999999999999999999887 99999999999999877 899999999
Q ss_pred ceecC
Q 005825 657 ARMFG 661 (675)
Q Consensus 657 a~~~~ 661 (675)
++.+.
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 98653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=192.14 Aligned_cols=153 Identities=28% Similarity=0.465 Sum_probs=128.3
Q ss_pred CcceeeeeCCcCceeEEEEEEcC--CcEEEEEEecCc----------CccCHHHHHHHHHHHHh-cCCCceeeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLLN--GEEVAVKRLSSQ----------SGQGLEEFKNEMLLIAK-LQHRNLVRILGCCIE 575 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~~--g~~vAvK~l~~~----------~~~~~~~f~~E~~il~~-l~H~nIv~l~g~~~~ 575 (675)
+|++.+.||+|+||.||++.... ++.+|+|.+... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999998754 688999987532 12234567788888865 799999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeee
Q 005825 576 QGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDF 654 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 654 (675)
.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.. +++|+||||+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887432 22346888999999999999999999632 3999999999999999999999999
Q ss_pred ccceecCCC
Q 005825 655 GLARMFGGD 663 (675)
Q Consensus 655 Gla~~~~~~ 663 (675)
|++......
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999876544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=195.12 Aligned_cols=149 Identities=32% Similarity=0.492 Sum_probs=128.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
...|+..++||+|+||.||+|+.. +++.||+|.+..... ...+++.+|+.++++++||||+++.+++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999864 589999999864322 2345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|||++ |++.+++.. ....+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++...
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 566666532 2345899999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=193.34 Aligned_cols=142 Identities=30% Similarity=0.397 Sum_probs=124.7
Q ss_pred eCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCH
Q 005825 516 LGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSL 591 (675)
Q Consensus 516 IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (675)
||+|+||+||++... +++.+|+|.+.... ....+.+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999764 58899999986432 23345678899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 592 DVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 592 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
.+++.... ...+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 99985432 235889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-21 Score=198.15 Aligned_cols=154 Identities=29% Similarity=0.420 Sum_probs=129.7
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc-------CccCHHHHHHHHHHHHhcCCCceeeEEEEEE-eCCe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ-------SGQGLEEFKNEMLLIAKLQHRNLVRILGCCI-EQGE 578 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~-------~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~-~~~~ 578 (675)
++|-++++||+|+|+.||++.+ ...+.||||+-... .....+...+|.+|-+.|+||-||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 5677788999999999999964 45788999975421 1122345667899999999999999999996 4556
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---CCCeEEeeec
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDFG 655 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFG 655 (675)
.+-|+||++|.+|+-|| ...+.++++++..|+.||+.||.||.+. .+||||-||||.||||-. -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 78999999999999999 4466789999999999999999999998 578999999999999954 5789999999
Q ss_pred cceecCCCcc
Q 005825 656 LARMFGGDEL 665 (675)
Q Consensus 656 la~~~~~~~~ 665 (675)
|++++.++..
T Consensus 619 LSKIMdddSy 628 (775)
T KOG1151|consen 619 LSKIMDDDSY 628 (775)
T ss_pred hhhhccCCcc
Confidence 9999976643
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=193.19 Aligned_cols=140 Identities=26% Similarity=0.418 Sum_probs=125.8
Q ss_pred eCCcCceeEEEEEEcC-CcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCH
Q 005825 516 LGEGGFGPVYKGRLLN-GEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSL 591 (675)
Q Consensus 516 IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (675)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|+.++.+++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998864 89999999875432 3456789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 592 DVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 592 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence 999853 236899999999999999999999987 9999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=229.35 Aligned_cols=143 Identities=28% Similarity=0.485 Sum_probs=123.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
...|...+.||+|+||.||+|+. .+++.||||+++..... ...|++++++++|||||+++++|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577778999999999999986 57899999998753221 23468899999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+++|+|.++++ .++|.++..|+.|||+||+|||+.+..+|+||||||+||+++.++.+++. ||++...
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 99999999993 27899999999999999999997766679999999999999999988876 7766543
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=189.98 Aligned_cols=141 Identities=27% Similarity=0.368 Sum_probs=125.9
Q ss_pred eCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCH
Q 005825 516 LGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSL 591 (675)
Q Consensus 516 IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (675)
||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999875 48899999987532 23446799999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 592 DVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 592 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 999943 345788999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-20 Score=191.35 Aligned_cols=148 Identities=33% Similarity=0.526 Sum_probs=129.9
Q ss_pred cceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeEEEEEE
Q 005825 510 FSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEKILILE 584 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~~lV~E 584 (675)
|++.++||+|+||.||+|+.. +++.+|+|++.... ....+.+..|+.++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999875 48899999998642 33456788999999999999999999999988 78999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|+++ +|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 888887432 246889999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.2e-20 Score=191.64 Aligned_cols=149 Identities=30% Similarity=0.477 Sum_probs=126.5
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++|++.+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999875 68899999986532 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-CCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-DMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 661 (675)
|++ ++|.+++... ....+++.....++.||+.||+|||+++ ++||||||+||++++ ++.+||+|||+++.+.
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 5777776432 2223577788889999999999999987 999999999999985 5679999999998654
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=194.71 Aligned_cols=152 Identities=30% Similarity=0.481 Sum_probs=129.9
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC----
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG---- 577 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~---- 577 (675)
...++|++.++||+|+||.||+|... +++.||||+++... ......+..|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35578999999999999999999875 58899999997532 233456788999999999999999999987655
Q ss_pred ------eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEE
Q 005825 578 ------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI 651 (675)
Q Consensus 578 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 651 (675)
..++|+||+++ ++..++.. ....+++.....++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 66666633 2346889999999999999999999987 999999999999999999999
Q ss_pred eeeccceecCC
Q 005825 652 SDFGLARMFGG 662 (675)
Q Consensus 652 ~DFGla~~~~~ 662 (675)
+|||+++.+..
T Consensus 158 ~dfg~~~~~~~ 168 (302)
T cd07864 158 ADFGLARLYNS 168 (302)
T ss_pred CcccccccccC
Confidence 99999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-20 Score=204.36 Aligned_cols=170 Identities=28% Similarity=0.462 Sum_probs=143.8
Q ss_pred cHHHHHHhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEe-
Q 005825 499 SLASVAAATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIE- 575 (675)
Q Consensus 499 ~~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~- 575 (675)
.+..+...++.|++.+.||+|.+|.||+++. .+++.+|||++... ....+++..|..+++.. +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3445566778899999999999999999975 56888999998763 34457788889999887 69999999999964
Q ss_pred ----CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEE
Q 005825 576 ----QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI 651 (675)
Q Consensus 576 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 651 (675)
++.+|||||||.+||..++++... ...+.|..+..|+..+++||.+||... +||||||-.||||++++.|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 458999999999999999997654 667899999999999999999999887 999999999999999999999
Q ss_pred eeeccceecCCCcccCCCCceecC
Q 005825 652 SDFGLARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 652 ~DFGla~~~~~~~~~~~~~~~~GT 675 (675)
.|||++..+...- +...+.+||
T Consensus 165 vDFGvSaQldsT~--grRnT~iGt 186 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV--GRRNTFIGT 186 (953)
T ss_pred eeeeeeeeeeccc--ccccCcCCC
Confidence 9999999885443 333345676
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-20 Score=191.19 Aligned_cols=146 Identities=26% Similarity=0.411 Sum_probs=129.6
Q ss_pred cceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 510 FSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
|...++||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999986 46889999998755445566788999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 999999843 35788999999999999999999987 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=194.72 Aligned_cols=150 Identities=30% Similarity=0.468 Sum_probs=133.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV 582 (675)
++|.+.+.||+|+||.||+++.. +++.||+|.+... .....+.+..|+.++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999875 6899999998753 2233467889999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999843 346899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
.
T Consensus 155 ~ 155 (280)
T cd05581 155 N 155 (280)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-20 Score=191.75 Aligned_cols=151 Identities=31% Similarity=0.468 Sum_probs=135.0
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
..++.|+..+.||+|++|.||++... +++.+++|.++.... ..+.+..|++++++++|+||+++++.+...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35567888899999999999999876 588999999976433 5678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||+++++|.+++.... ..+++..+..++.+++.||+|||..+ |+|+||||+||+++.++.+||+|||++..+.
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 9999999999995422 36899999999999999999999987 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=198.74 Aligned_cols=149 Identities=30% Similarity=0.500 Sum_probs=127.8
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeC--CeE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQ--GEK 579 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~--~~~ 579 (675)
..++|++.+.||+|+||.||+|... +++.+|||++... .......+..|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888899999999999999875 5889999998642 223445677899999999 999999999998654 368
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 589888743 26788999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 005825 660 FGG 662 (675)
Q Consensus 660 ~~~ 662 (675)
+..
T Consensus 157 ~~~ 159 (337)
T cd07852 157 LSE 159 (337)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=192.15 Aligned_cols=149 Identities=28% Similarity=0.375 Sum_probs=131.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|+..+.||+|+||.||++... +++.+|+|.+.... ....+++.+|+.++++++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777789999999999999875 58899999987643 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH-YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++++|.+++.... ..++......++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||++..+.
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999985422 568888899999999999999998 66 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-20 Score=197.65 Aligned_cols=150 Identities=26% Similarity=0.399 Sum_probs=129.1
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC----
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG---- 577 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~---- 577 (675)
...++|++.+.||+|+||.||++.. .+++.||||+++... ....+.+..|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999975 468999999986432 223456889999999999999999999987553
Q ss_pred --eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 578 --EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 578 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
..++||||+ +++|..++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999998 7799888732 35889999999999999999999987 9999999999999999999999999
Q ss_pred cceecCC
Q 005825 656 LARMFGG 662 (675)
Q Consensus 656 la~~~~~ 662 (675)
+++....
T Consensus 164 ~~~~~~~ 170 (343)
T cd07880 164 LARQTDS 170 (343)
T ss_pred ccccccc
Confidence 9987644
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-20 Score=189.32 Aligned_cols=156 Identities=26% Similarity=0.450 Sum_probs=130.7
Q ss_pred CcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE--QGEKILIL 583 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~--~~~~~lV~ 583 (675)
+|++.+.||.|+||.||++.. .+++.+|+|.+... .....+++..|+.++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999976 45789999998743 23345678899999999999999999998764 34678999
Q ss_pred EecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcC--CCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYS--RFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||+++++|.+++... .....+++...+.++.+++.||+|||..+ ..+++|+||||+||++++++.+||+|||+++.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998542 22456899999999999999999999332 334999999999999999999999999999987
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
....
T Consensus 161 ~~~~ 164 (265)
T cd08217 161 GHDS 164 (265)
T ss_pred cCCc
Confidence 5443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=193.06 Aligned_cols=148 Identities=28% Similarity=0.368 Sum_probs=128.9
Q ss_pred CcceeeeeCCcCceeEEEEEE----cCCcEEEEEEecCcC----ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeE
Q 005825 509 NFSMECKLGEGGFGPVYKGRL----LNGEEVAVKRLSSQS----GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~ 579 (675)
+|++.+.||+|++|.||+++. .+++.||||.+++.. ....+.+..|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999974 357889999987432 22345788999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999999843 345788899999999999999999887 99999999999999999999999999987
Q ss_pred cCC
Q 005825 660 FGG 662 (675)
Q Consensus 660 ~~~ 662 (675)
+..
T Consensus 155 ~~~ 157 (288)
T cd05583 155 FLA 157 (288)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=193.78 Aligned_cols=150 Identities=33% Similarity=0.478 Sum_probs=128.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--cCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~~l 581 (675)
.++|++.++||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999874 589999999874322 2234567899999999999999999998765 46899
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++ +|.+++... ...+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 788877432 356899999999999999999999988 9999999999999999999999999998875
Q ss_pred C
Q 005825 662 G 662 (675)
Q Consensus 662 ~ 662 (675)
.
T Consensus 160 ~ 160 (309)
T cd07845 160 L 160 (309)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=197.25 Aligned_cols=148 Identities=28% Similarity=0.431 Sum_probs=127.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----eE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG-----EK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~-----~~ 579 (675)
.++|++.++||+|+||.||+|+. .+++.||||.++... ......+..|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 47899999999999999999976 468999999987432 334567889999999999999999999876543 57
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++|+||+++ +|..++. ...+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 7777763 235888999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 005825 660 FGG 662 (675)
Q Consensus 660 ~~~ 662 (675)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=193.30 Aligned_cols=151 Identities=28% Similarity=0.482 Sum_probs=127.2
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG----- 577 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~----- 577 (675)
..++|++.++||+|+||.||+++.. +++.||||.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467999999999999999999864 58999999986432 222345678999999999999999999987654
Q ss_pred ---eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeee
Q 005825 578 ---EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDF 654 (675)
Q Consensus 578 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 654 (675)
..++||||+++ +|..++.. ....+++.+...++.||+.||+|||+++ ++|+||||+||++++++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 35999999975 78777743 2335889999999999999999999987 999999999999999999999999
Q ss_pred ccceecCC
Q 005825 655 GLARMFGG 662 (675)
Q Consensus 655 Gla~~~~~ 662 (675)
|+++.+..
T Consensus 164 g~~~~~~~ 171 (310)
T cd07865 164 GLARAFSL 171 (310)
T ss_pred CCcccccC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=190.26 Aligned_cols=141 Identities=30% Similarity=0.352 Sum_probs=118.5
Q ss_pred eeCCcCceeEEEEEEc-CCcEEEEEEecCcCc---cCHHHHHHHHH---HHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 515 KLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG---QGLEEFKNEML---LIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 515 ~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~---il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
.||+|+||.||+++.. +++.||+|.+..... .....+..|.. +++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999999875321 12223444443 3444579999999999999999999999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999999884 3456899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=193.17 Aligned_cols=142 Identities=27% Similarity=0.426 Sum_probs=127.3
Q ss_pred eeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCHH
Q 005825 514 CKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLD 592 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (675)
.+||+|+||.||++.. .+++.||||++..........+.+|+.++++++|+||+++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999987 468999999987544455667999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 593 VFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 593 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++.. ..+++.....++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+..
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 98732 34788999999999999999999987 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-20 Score=188.50 Aligned_cols=150 Identities=27% Similarity=0.495 Sum_probs=130.9
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999875 4889999998653 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC-CeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-NPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 662 (675)
+++++|.+++... ....+++..+..++.++++||.|||+.+ ++|+||||+||++++++ .+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999998543 2335789999999999999999999987 99999999999998875 569999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.4e-20 Score=196.52 Aligned_cols=149 Identities=29% Similarity=0.399 Sum_probs=127.1
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC------
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ------ 576 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~------ 576 (675)
..++|+..+.||+|+||.||+++.. +++.||||.+... ......++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999864 6899999998643 223345678899999999999999999998643
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecc
Q 005825 577 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 656 (675)
...++||||++ ++|.+.+.. .++......++.|++.||+|||..+ |+||||||+||++++++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999996 478777732 2788888999999999999999987 99999999999999999999999999
Q ss_pred ceecCCC
Q 005825 657 ARMFGGD 663 (675)
Q Consensus 657 a~~~~~~ 663 (675)
++.....
T Consensus 165 ~~~~~~~ 171 (353)
T cd07850 165 ARTAGTS 171 (353)
T ss_pred ceeCCCC
Confidence 9977543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.1e-20 Score=190.43 Aligned_cols=147 Identities=33% Similarity=0.520 Sum_probs=128.4
Q ss_pred cceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 510 FSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
|++.++||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999864 68999999987532 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+ ++|.+++.... ...+++..+..++.|+++||+|||+++ ++||||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 68998885322 236899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=192.05 Aligned_cols=149 Identities=32% Similarity=0.501 Sum_probs=128.2
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
+.|...+.||+|+||.||+++.. +++.||+|.+..... .....+..|+.++++++|||++++++++.+.+..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34777889999999999999864 588999999874322 23457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+++ +|.+++.. ....+++.++..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++....
T Consensus 105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99975 77776643 2345889999999999999999999987 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=197.28 Aligned_cols=149 Identities=23% Similarity=0.399 Sum_probs=128.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIE----QGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~----~~~~ 579 (675)
..+|++.+.||+|+||.||++... +++.||+|++.... ....+.+..|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999864 58999999987532 2345678889999999999999999988753 3468
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+. ++|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 689888843 345899999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 005825 660 FGG 662 (675)
Q Consensus 660 ~~~ 662 (675)
+..
T Consensus 157 ~~~ 159 (334)
T cd07855 157 LSS 159 (334)
T ss_pred ecc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.9e-20 Score=195.95 Aligned_cols=149 Identities=26% Similarity=0.418 Sum_probs=128.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----Ce
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ-----GE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~-----~~ 578 (675)
.++|.+.+.||+|+||.||+++. .+++.||||.++.. ......++..|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999986 45899999998753 233455678899999999999999999988654 35
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.++||||+. ++|.+++. ....+++.....++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 68888874 3346889999999999999999999987 9999999999999999999999999998
Q ss_pred ecCC
Q 005825 659 MFGG 662 (675)
Q Consensus 659 ~~~~ 662 (675)
....
T Consensus 157 ~~~~ 160 (337)
T cd07858 157 TTSE 160 (337)
T ss_pred ccCC
Confidence 7744
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-19 Score=184.11 Aligned_cols=152 Identities=24% Similarity=0.436 Sum_probs=134.7
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|++.+.||+|+||.||++... +++.+++|++..... ...+++..|++++++++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999875 588999999975432 4566789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPT-KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++++|.+++.... ....+++.....++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999985432 1356899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=194.35 Aligned_cols=154 Identities=29% Similarity=0.380 Sum_probs=130.6
Q ss_pred HHHHHHhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC
Q 005825 500 LASVAAATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ 576 (675)
Q Consensus 500 ~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~ 576 (675)
..++...+++|.+.+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345566789999999999999999999975 468999999997532 22346788899999999999999999988643
Q ss_pred ------CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeE
Q 005825 577 ------GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPK 650 (675)
Q Consensus 577 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 650 (675)
...++++|++ +++|..++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888876 7899887732 35889999999999999999999987 99999999999999999999
Q ss_pred EeeeccceecC
Q 005825 651 ISDFGLARMFG 661 (675)
Q Consensus 651 l~DFGla~~~~ 661 (675)
|+|||+++...
T Consensus 161 l~dfg~~~~~~ 171 (345)
T cd07877 161 ILDFGLARHTD 171 (345)
T ss_pred Eeccccccccc
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=188.31 Aligned_cols=146 Identities=25% Similarity=0.370 Sum_probs=123.8
Q ss_pred cceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeC--CeEEEEEE
Q 005825 510 FSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQ--GEKILILE 584 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~--~~~~lV~E 584 (675)
|++.++||+|+||.||+|+.. +++.||+|+++... .........|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999864 58899999987532 222334557888899885 99999999999987 88999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|++ ++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++ +.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 5777777432 346899999999999999999999987 999999999999999 9999999999987643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=186.02 Aligned_cols=142 Identities=24% Similarity=0.329 Sum_probs=120.0
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc---cCHHHHHHHHHHH-HhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG---QGLEEFKNEMLLI-AKLQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~il-~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
+.||+|+||.||+|... +++.||||.++.... .....+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 588999999875321 2223445555444 455899999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999843 345788899999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=192.11 Aligned_cols=146 Identities=30% Similarity=0.415 Sum_probs=123.6
Q ss_pred CcceeeeeCCcCceeEEEEEEc-C--CcEEEEEEecCcC--ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeC----Ce
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-N--GEEVAVKRLSSQS--GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQ----GE 578 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~--g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~----~~ 578 (675)
+|++.+.||+|+||.||+++.. . +..||||++.... ....+.+..|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999864 3 7789999987532 22356788899999999 599999999976543 35
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.++++||++ ++|.+++. ....+++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+|+
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788899886 68988884 3456889999999999999999999987 9999999999999999999999999998
Q ss_pred ecC
Q 005825 659 MFG 661 (675)
Q Consensus 659 ~~~ 661 (675)
.+.
T Consensus 154 ~~~ 156 (332)
T cd07857 154 GFS 156 (332)
T ss_pred ecc
Confidence 764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.6e-20 Score=194.07 Aligned_cols=147 Identities=28% Similarity=0.415 Sum_probs=126.3
Q ss_pred CCcc-eeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccC--------------HHHHHHHHHHHHhcCCCceeeEEE
Q 005825 508 ENFS-MECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQG--------------LEEFKNEMLLIAKLQHRNLVRILG 571 (675)
Q Consensus 508 ~~f~-~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~--------------~~~f~~E~~il~~l~H~nIv~l~g 571 (675)
++|. +.+.||+|+||.||+|+.. +++.||||.++...... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3467999999999999864 58999999986532211 125778999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEE
Q 005825 572 CCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI 651 (675)
Q Consensus 572 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 651 (675)
++...+..++||||++ ++|.+++. ....+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 68988884 3345888999999999999999999987 999999999999999999999
Q ss_pred eeeccceecC
Q 005825 652 SDFGLARMFG 661 (675)
Q Consensus 652 ~DFGla~~~~ 661 (675)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998775
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=192.32 Aligned_cols=150 Identities=29% Similarity=0.439 Sum_probs=128.8
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEe-CCeE
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE-QGEK 579 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~-~~~~ 579 (675)
...+++|++.+.||+|+||.||+++.. +++.||||++... .....+.+..|+.++.+++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999764 6899999988642 22345678899999999999999999999876 4578
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+ +++|..++.. ..+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 5689888732 34678888889999999999999987 99999999999999999999999999986
Q ss_pred cC
Q 005825 660 FG 661 (675)
Q Consensus 660 ~~ 661 (675)
..
T Consensus 158 ~~ 159 (328)
T cd07856 158 QD 159 (328)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-19 Score=184.12 Aligned_cols=149 Identities=23% Similarity=0.326 Sum_probs=122.3
Q ss_pred HHhcCCcceeeee--CCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeE
Q 005825 504 AAATENFSMECKL--GEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 504 ~~~~~~f~~~~~I--G~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~ 579 (675)
....++|.+.+.+ |+|+||.||+++. .+++.+|+|.+........ |+.....+ +||||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3445677776766 9999999999986 4588899999875322111 22222222 799999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC-CeEEeeeccce
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-NPKISDFGLAR 658 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~ 658 (675)
++||||+++++|.+++.. ...+++.+...++.|+++||.|||+.+ ++||||||+||+++.++ .+||+|||+++
T Consensus 85 ~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 999999999999999843 237899999999999999999999987 99999999999999988 99999999998
Q ss_pred ecCCC
Q 005825 659 MFGGD 663 (675)
Q Consensus 659 ~~~~~ 663 (675)
.+...
T Consensus 159 ~~~~~ 163 (267)
T PHA03390 159 IIGTP 163 (267)
T ss_pred ecCCC
Confidence 76543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.5e-21 Score=193.41 Aligned_cols=162 Identities=28% Similarity=0.341 Sum_probs=134.1
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCc---cCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSG---QGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~ 580 (675)
...+|..+.+||+|+||+|.+++-+. .+.+|||+|++... ...+--+.|-++|+.. +-|.+++|..+++.-+++|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34678889999999999999997654 67899999997632 2344566788888776 4689999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||+.||+|-.++. .-+.+.+..+.-+|..||-||-+||+++ ||.||||.+||+||.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999988873 3445667778889999999999999998 999999999999999999999999999853
Q ss_pred CCCcccCCCCceecC
Q 005825 661 GGDELQGNTKRIVGT 675 (675)
Q Consensus 661 ~~~~~~~~~~~~~GT 675 (675)
--+ ...|++.+||
T Consensus 501 i~~--~~TTkTFCGT 513 (683)
T KOG0696|consen 501 IFD--GVTTKTFCGT 513 (683)
T ss_pred ccC--CcceeeecCC
Confidence 222 2346677887
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.82 E-value=8e-20 Score=186.17 Aligned_cols=152 Identities=29% Similarity=0.471 Sum_probs=132.7
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|++.++||+|+||.||+++.. +++.+|+|.+.... .....++..|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999754 68899999987532 23356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPT-KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++++|.+++.+.. ....+++.....++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999985421 2356888999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.3e-20 Score=195.66 Aligned_cols=153 Identities=25% Similarity=0.333 Sum_probs=130.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--------cCHHHHHHHHHHHHhcC---CCceeeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--------QGLEEFKNEMLLIAKLQ---HRNLVRILGCCI 574 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~f~~E~~il~~l~---H~nIv~l~g~~~ 574 (675)
..+|..++.+|+|+||.|..|.++ +..+|+||.+.+... ...-.+-.|+.||+.++ |+||++++.+|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 356888999999999999999764 467899999876421 11223557999999997 999999999999
Q ss_pred eCCeEEEEEEec-CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEee
Q 005825 575 EQGEKILILEYM-PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISD 653 (675)
Q Consensus 575 ~~~~~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 653 (675)
+++..||+||-. ++.+|.+++ ..+..+.+.+...|+.||+.|+++||.++ |||||||-+|+.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 999999999977 466777777 45567899999999999999999999998 99999999999999999999999
Q ss_pred eccceecCCCcc
Q 005825 654 FGLARMFGGDEL 665 (675)
Q Consensus 654 FGla~~~~~~~~ 665 (675)
||-|...+....
T Consensus 714 fgsaa~~ksgpf 725 (772)
T KOG1152|consen 714 FGSAAYTKSGPF 725 (772)
T ss_pred ccchhhhcCCCc
Confidence 999988765543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.1e-20 Score=193.71 Aligned_cols=148 Identities=29% Similarity=0.436 Sum_probs=130.1
Q ss_pred CcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----eEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG-----EKI 580 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~-----~~~ 580 (675)
+|++.+.||+|+||.||+|+... ++.||||++.... ....+.+..|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47888999999999999998754 8999999987643 344568999999999999999999999998775 789
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||++ ++|.+++.. ...+++..+..++.+++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 488888843 337899999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 005825 661 GGD 663 (675)
Q Consensus 661 ~~~ 663 (675)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.2e-21 Score=217.47 Aligned_cols=152 Identities=31% Similarity=0.427 Sum_probs=130.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.+-+++...+||.|.||.||-|.. .+|+..|||-++.. .........+|+.++..+.|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 344566668999999999999975 56899999988754 334556788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++|+|.+.+. ..+..++....-+..|++.|++|||+++ |+||||||+||+|+.+|.+|++|||-|+.+..
T Consensus 1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999983 3334555555667889999999999998 99999999999999999999999999998855
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
.
T Consensus 1387 ~ 1387 (1509)
T KOG4645|consen 1387 N 1387 (1509)
T ss_pred c
Confidence 4
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=188.22 Aligned_cols=150 Identities=26% Similarity=0.385 Sum_probs=126.1
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.++|++.+.||+|+||.||+|+..+ ++.||||.++... .....++..|+.++.+.. ||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3678888999999999999998865 8999999997532 233456777887777775 999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||+++ +|..++... ...+++..+..++.++++||+|||+.. +|+||||+|+||++++++.+||+|||+++.+.
T Consensus 94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99854 677666332 236889999999999999999999742 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-20 Score=174.16 Aligned_cols=153 Identities=27% Similarity=0.397 Sum_probs=127.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc-CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV 582 (675)
..+.....+.||+|++|.|-+-++ .+|+..|+|++... ..+..++..+|+++..+. ..|.+|+++|........++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 344555567899999999988875 46999999999864 345567788899877654 799999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 583 LEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||.| ..||+.+-.+- .+...+++.-.-+|+..|.+||.|||++- .+||||+||+|||++.+|++||+|||++-.+.
T Consensus 124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9999 56888775321 34566788888899999999999999975 69999999999999999999999999998764
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=190.55 Aligned_cols=144 Identities=23% Similarity=0.223 Sum_probs=122.4
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCC
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKS 590 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (675)
.+.+|.|+++.|++++. +++.||||++... .....+.+..|+.++++++||||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556666666554 6899999998754 34456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 591 LDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 591 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|.+++.... ...+++.....++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+..+.
T Consensus 86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 999986432 235788888999999999999999987 9999999999999999999999999987653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.6e-19 Score=183.91 Aligned_cols=149 Identities=33% Similarity=0.520 Sum_probs=125.3
Q ss_pred cceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCc--cCHHHHHHHHHHHHhc---CCCceeeEEEEEEeCCe-----
Q 005825 510 FSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSG--QGLEEFKNEMLLIAKL---QHRNLVRILGCCIEQGE----- 578 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l---~H~nIv~l~g~~~~~~~----- 578 (675)
|++.+.||+|+||.||+|+... ++.+|+|+++.... .....+..|+.++.++ .||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678999999999999999764 89999999974322 2234566788777666 59999999999988776
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.+++|||+++ +|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||+++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7888875422 235899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCC
Q 005825 659 MFGGD 663 (675)
Q Consensus 659 ~~~~~ 663 (675)
.+...
T Consensus 156 ~~~~~ 160 (287)
T cd07838 156 IYSFE 160 (287)
T ss_pred eccCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=187.52 Aligned_cols=148 Identities=32% Similarity=0.433 Sum_probs=127.8
Q ss_pred cceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEEEec
Q 005825 510 FSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
|++.+.||+|+||.||+|+.. +++.||||++..... .......+|+..+++++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999875 478999999875422 22334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 889988885432 246899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.7e-19 Score=186.98 Aligned_cols=145 Identities=33% Similarity=0.490 Sum_probs=125.2
Q ss_pred cceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 510 FSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
|...++||+|+||.||+|+.. +++.|++|++..... ...+.+..|+.++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666688999999999999864 588999999874322 2335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+. ++|.+++.. ....+++.++..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 96 567666632 2345889999999999999999999987 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=191.55 Aligned_cols=143 Identities=24% Similarity=0.304 Sum_probs=123.1
Q ss_pred eeeCCc--CceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEG--GFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G--~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
+.||+| +||+||+++.. +++.||||.+.... ....+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 99999999864 68999999987532 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
++|.+++.... ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+...
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 99999885432 234788888999999999999999987 999999999999999999999999865433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=190.91 Aligned_cols=146 Identities=30% Similarity=0.447 Sum_probs=124.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG------ 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~------ 577 (675)
.++|...+.||+|+||.||+|+.. +++.||||+++... ......+..|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999864 68999999987532 223456889999999999999999999987543
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
+.++|+||+.. +|..++ ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 776655 234788899999999999999999987 999999999999999999999999999
Q ss_pred eecC
Q 005825 658 RMFG 661 (675)
Q Consensus 658 ~~~~ 661 (675)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=187.88 Aligned_cols=150 Identities=29% Similarity=0.396 Sum_probs=124.0
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+|...++||+|+||.||+++.. +++.+|+|.+.... ......+..|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 5566678999999999999864 58999999987532 234567889999999996 99999999999999999999999
Q ss_pred cCCCCHHHHhcC--CCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 586 MPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 586 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++. ++..+... ......+++.....++.+++.||+|||+.. +|+||||||+||++++++.+||+|||+++.+.
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 864 55443211 112356889999999999999999999752 39999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=188.85 Aligned_cols=150 Identities=33% Similarity=0.513 Sum_probs=126.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG------ 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~------ 577 (675)
.++|++.++||+|+||.||+|+.. +++.+|||++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999864 588999999864322 22346788999999999999999999875443
Q ss_pred --eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 578 --EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 578 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
..++||||+++ +|...+.. ....+++..+..++.|+++||+|||+++ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 66666643 2346899999999999999999999987 9999999999999999999999999
Q ss_pred cceecCC
Q 005825 656 LARMFGG 662 (675)
Q Consensus 656 la~~~~~ 662 (675)
+++....
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=185.72 Aligned_cols=148 Identities=33% Similarity=0.519 Sum_probs=129.3
Q ss_pred cceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 510 FSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
|+..+.||+|++|.||+++.. +++.+++|.++.... .....+..|+.++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456789999999999999874 688999999875432 24567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
++ +|.+++... ...+++..+..++.+++.||.|||+.+ |+|+||||+||++++++.+||+|||.+..+...
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 75 888877432 246889999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.8e-19 Score=184.60 Aligned_cols=148 Identities=20% Similarity=0.312 Sum_probs=110.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC----CcEEEEEEecCcCccCH-----------HHHHHHHHHHHhcCCCceeeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQSGQGL-----------EEFKNEMLLIAKLQHRNLVRILG 571 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~-----------~~f~~E~~il~~l~H~nIv~l~g 571 (675)
.+.|++.++||+|+||.||+|+..+ +..+|+|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998654 34566665432221111 11223334556678999999999
Q ss_pred EEEeCC----eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC
Q 005825 572 CCIEQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM 647 (675)
Q Consensus 572 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 647 (675)
++.... ..++++|++. .++.+.+.. ....++.....|+.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876544 3467788764 355555522 223567788899999999999999987 99999999999999999
Q ss_pred CeEEeeeccceecC
Q 005825 648 NPKISDFGLARMFG 661 (675)
Q Consensus 648 ~~kl~DFGla~~~~ 661 (675)
.+||+|||+|+.+.
T Consensus 164 ~~~l~DFGla~~~~ 177 (294)
T PHA02882 164 RGYIIDYGIASHFI 177 (294)
T ss_pred cEEEEEcCCceeec
Confidence 99999999998774
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=191.42 Aligned_cols=147 Identities=29% Similarity=0.418 Sum_probs=126.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC---------
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--------- 576 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--------- 576 (675)
..+|.+.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999864 5889999998765556667899999999999999999999776543
Q ss_pred -----CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-CCCeE
Q 005825 577 -----GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-DMNPK 650 (675)
Q Consensus 577 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~k 650 (675)
...++||||++ ++|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 588887732 35788999999999999999999987 999999999999974 56789
Q ss_pred EeeeccceecC
Q 005825 651 ISDFGLARMFG 661 (675)
Q Consensus 651 l~DFGla~~~~ 661 (675)
|+|||+++.+.
T Consensus 156 l~dfg~~~~~~ 166 (342)
T cd07854 156 IGDFGLARIVD 166 (342)
T ss_pred ECCcccceecC
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-21 Score=184.95 Aligned_cols=150 Identities=30% Similarity=0.404 Sum_probs=123.6
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCc-cCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++.+.+..||.|+||+|+|-.. +.|+.+|||+++.... ...++++.|.+...+- +.||||+++|.+..++.-|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3455567899999999999865 5699999999986533 5567889999866555 68999999999999999999999
Q ss_pred ecCCCCHHHHhcC--CCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 585 YMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 585 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+| ..||+.+-.. ......+++.-.-.|...+..||.||.+.. .|||||+||+||||+..|.+||+|||++-.+
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 99 5677766421 123445777777788888999999999865 6999999999999999999999999998765
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=185.43 Aligned_cols=147 Identities=35% Similarity=0.515 Sum_probs=129.5
Q ss_pred cceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 510 FSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+..|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999875 48999999998643 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+ ++|.+++.... ..+++..+..++.+++.||+|||+++ |+||||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 8 58999985421 46889999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-19 Score=186.77 Aligned_cols=149 Identities=34% Similarity=0.514 Sum_probs=127.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+.++++++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666789999999999999864 5789999998642 2223457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+. +++.+++... ...+++.++..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+..
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9997 5777766432 345788999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=180.43 Aligned_cols=141 Identities=31% Similarity=0.417 Sum_probs=126.0
Q ss_pred eCCcCceeEEEEEEc-CCcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCH
Q 005825 516 LGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSL 591 (675)
Q Consensus 516 IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (675)
||+|+||.||++... +++.+|+|.+..... ...+.+..|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 488999999875432 2456899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 592 DVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 592 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
.+++.. ...+++.....++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 999843 335889999999999999999999987 99999999999999999999999999987744
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-19 Score=182.87 Aligned_cols=150 Identities=29% Similarity=0.438 Sum_probs=124.9
Q ss_pred CcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCc-----CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQ-----SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998643 445666655431 222344677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 583 LEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|||+++++|..++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++ +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888532 23456899999999999999999999987 999999999999975 569999999998774
Q ss_pred C
Q 005825 662 G 662 (675)
Q Consensus 662 ~ 662 (675)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-19 Score=179.08 Aligned_cols=161 Identities=24% Similarity=0.367 Sum_probs=136.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|.++++||+|+|.+|..+++. +.+.+|+|++++. ..+...-.+.|-.++... +||.+|-|..+++....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999874 5788999999864 344566788888888776 69999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|.||++||+|--++ ++++.+++..+..+...|.-||.|||+++ ||.||||.+|+|||.+|++||+|+|+++.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999996555 45567888887778888999999999998 9999999999999999999999999998643
Q ss_pred CCcccCCCCceecC
Q 005825 662 GDELQGNTKRIVGT 675 (675)
Q Consensus 662 ~~~~~~~~~~~~GT 675 (675)
++. ..|.+.+||
T Consensus 403 ~~g--d~tstfcgt 414 (593)
T KOG0695|consen 403 GPG--DTTSTFCGT 414 (593)
T ss_pred CCC--cccccccCC
Confidence 222 235567776
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-19 Score=189.71 Aligned_cols=149 Identities=29% Similarity=0.424 Sum_probs=128.6
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe----
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE---- 578 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~---- 578 (675)
..++|++.+.||+|++|.||+|+.. +++.||||++... .....+.+..|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999875 5789999998753 22334567889999999999999999988766554
Q ss_pred --EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecc
Q 005825 579 --KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656 (675)
Q Consensus 579 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 656 (675)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6799888843 35899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCC
Q 005825 657 ARMFGG 662 (675)
Q Consensus 657 a~~~~~ 662 (675)
++.+..
T Consensus 165 ~~~~~~ 170 (343)
T cd07851 165 ARHTDD 170 (343)
T ss_pred cccccc
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=170.05 Aligned_cols=137 Identities=20% Similarity=0.280 Sum_probs=105.6
Q ss_pred eeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-----CCCceeeEEEEEEeCC---eEE-EE
Q 005825 512 MECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-----QHRNLVRILGCCIEQG---EKI-LI 582 (675)
Q Consensus 512 ~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-----~H~nIv~l~g~~~~~~---~~~-lV 582 (675)
..+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+ .||||++++|++.++. ..+ +|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 346899999999996 2223444 79988765445567899999999999 5799999999998864 333 78
Q ss_pred EEe--cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHH-HHHHhcCCCceEecCCCCCCEEEcC----CCCeEEeeec
Q 005825 583 LEY--MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGL-LYLHHYSRFRIIHRDLKASNVLLDR----DMNPKISDFG 655 (675)
Q Consensus 583 ~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kl~DFG 655 (675)
+|| +++++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5689999999431 24444 34567777777 9999998 999999999999974 3479999954
Q ss_pred ccee
Q 005825 656 LARM 659 (675)
Q Consensus 656 la~~ 659 (675)
.++.
T Consensus 155 G~~~ 158 (210)
T PRK10345 155 GEST 158 (210)
T ss_pred CCcc
Confidence 4443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.3e-19 Score=200.54 Aligned_cols=155 Identities=34% Similarity=0.516 Sum_probs=132.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc----C----CcEEEEEEecCcCc-cCHHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL----N----GEEVAVKRLSSQSG-QGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQ 576 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~----~----g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~ 576 (675)
.++..+.+.||+|.||.|++|... . ...||||.++.... ...+.+..|+++|..+ +|+||+.++|+|.+.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344456679999999999999742 1 45799999986433 4567899999999998 699999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCC-----------Cc--ccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE
Q 005825 577 GEKILILEYMPNKSLDVFLFDPT-----------KK--RLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL 643 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 643 (675)
+..++|+||++.|+|.++|+... .. ..+...+.+.++.|||.||+||++.. +|||||.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999996543 00 23888999999999999999999887 9999999999999
Q ss_pred cCCCCeEEeeeccceecCCCc
Q 005825 644 DRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 644 ~~~~~~kl~DFGla~~~~~~~ 664 (675)
.++..+||+||||||.....+
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~ 472 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKD 472 (609)
T ss_pred cCCCEEEEccccceeccCCCC
Confidence 999999999999999765443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-19 Score=175.40 Aligned_cols=150 Identities=25% Similarity=0.374 Sum_probs=124.6
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc-CccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++.+.+..||.|+-|.|++++.+ .|..+|||.+.+. ..+..++++..++++.+-+ .|.||+.+|+|......++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 44555678999999999999875 4899999999864 3445677888888877765 8999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
.|.- -+++++.+ -.+++++.-.-++...+..||.||.+++ .|||||+||+|||+|+.|++|++|||++-.+-.
T Consensus 172 lMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 172 LMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 9843 45566543 2345778777789999999999999987 699999999999999999999999999976643
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=176.72 Aligned_cols=133 Identities=20% Similarity=0.150 Sum_probs=115.0
Q ss_pred cCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCHHHHhcC
Q 005825 519 GGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD 597 (675)
Q Consensus 519 G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 597 (675)
|.+|.||+++.. +++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999864 58899999997532 234455555666799999999999999999999999999999998843
Q ss_pred CCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 598 PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 598 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
...+++.....++.|++.||+|||+.+ |+||||||+||++++++.+|++|||+++.+..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~ 137 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED 137 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence 335889999999999999999999987 99999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-19 Score=176.79 Aligned_cols=149 Identities=26% Similarity=0.337 Sum_probs=122.4
Q ss_pred HhcCCccee-eeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEe----CC
Q 005825 505 AATENFSME-CKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIE----QG 577 (675)
Q Consensus 505 ~~~~~f~~~-~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~----~~ 577 (675)
..+++|++. ++||-|-.|+|..+.. .+++.+|+|+|... ...++|+++--+. .|||||.+++++.. ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 456777765 5799999999999965 56899999998642 3345677765444 59999999999864 34
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---CCCeEEeee
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDF 654 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DF 654 (675)
.+++|||.|+||.|...+.+ .....+.+++...|..||+.|+.|||... |.||||||+|+|... +..+||+||
T Consensus 133 cLLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 57899999999999998854 34456899999999999999999999987 999999999999964 557999999
Q ss_pred ccceecCC
Q 005825 655 GLARMFGG 662 (675)
Q Consensus 655 Gla~~~~~ 662 (675)
|+|+.-.+
T Consensus 209 GFAK~t~~ 216 (400)
T KOG0604|consen 209 GFAKETQE 216 (400)
T ss_pred ccccccCC
Confidence 99997654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-19 Score=171.70 Aligned_cols=145 Identities=25% Similarity=0.457 Sum_probs=125.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEE-EcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCC--eEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQG--EKIL 581 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~--~~~l 581 (675)
..++|++.+++|+|.+++||.|. ..+.+.++||.+++ ...+.+.+|++||..+. ||||++|++...++. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45789999999999999999997 45688999999985 34467889999999998 999999999987654 5689
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC-CCeEEeeeccceec
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD-MNPKISDFGLARMF 660 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~~ 660 (675)
|+||+++.+...+. ..+...+...++.+++.||.|+|+.| |+|||+||.|+++|.. ..++|+|+|||..+
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999999887665 34677788889999999999999998 9999999999999865 56999999999987
Q ss_pred CC
Q 005825 661 GG 662 (675)
Q Consensus 661 ~~ 662 (675)
-+
T Consensus 184 Hp 185 (338)
T KOG0668|consen 184 HP 185 (338)
T ss_pred CC
Confidence 43
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.5e-18 Score=169.30 Aligned_cols=149 Identities=38% Similarity=0.543 Sum_probs=132.5
Q ss_pred cceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCcc-CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 510 FSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQ-GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+..|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999998865 889999999865444 57789999999999999999999999999899999999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++|.+++..... .+++.....++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999999853221 1788999999999999999999986 999999999999999999999999999988544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-20 Score=179.77 Aligned_cols=149 Identities=30% Similarity=0.548 Sum_probs=120.4
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecC--cCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--------
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSS--QSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ-------- 576 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~-------- 576 (675)
+.|.-..+||+|.||+||+|+.. +++.||+|++-- +....-..-.+|+++|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45555679999999999999864 478899887542 1222234457899999999999999999988543
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecc
Q 005825 577 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 656 (675)
...++|+.+++. +|.-+|.. ....++..++.++..++..||.|+|... |+|||+||+|+|++.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 247999999964 66666633 3345788889999999999999999876 99999999999999999999999999
Q ss_pred ceecCC
Q 005825 657 ARMFGG 662 (675)
Q Consensus 657 a~~~~~ 662 (675)
||.+.-
T Consensus 171 ar~fs~ 176 (376)
T KOG0669|consen 171 ARAFST 176 (376)
T ss_pred ccceec
Confidence 988743
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=195.61 Aligned_cols=149 Identities=24% Similarity=0.315 Sum_probs=106.1
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-C----CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEE------EE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-N----GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGC------CI 574 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~----g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~------~~ 574 (675)
..++|++.++||+|+||.||+|++. + +..||||++..... .+.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999874 4 68999999864221 1212221 1122222222222211 24
Q ss_pred eCCeEEEEEEecCCCCHHHHhcCCCCc-----------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCC
Q 005825 575 EQGEKILILEYMPNKSLDVFLFDPTKK-----------------RLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLK 637 (675)
Q Consensus 575 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 637 (675)
+..+.++||||+++++|.+++...... ..........|+.||+.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566899999999999999988542110 01112335578999999999999987 9999999
Q ss_pred CCCEEEcC-CCCeEEeeeccceecC
Q 005825 638 ASNVLLDR-DMNPKISDFGLARMFG 661 (675)
Q Consensus 638 p~NILl~~-~~~~kl~DFGla~~~~ 661 (675)
|+|||+++ ++.+||+|||+|+.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~ 307 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLR 307 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccc
Confidence 99999986 5799999999998663
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=183.42 Aligned_cols=163 Identities=23% Similarity=0.347 Sum_probs=135.2
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecC--cCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSS--QSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV 582 (675)
....|+++++||+||-++||++...+.+.+|+|++.. .+.+....|.+|+.+|.+|+ |.+||+|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3467888899999999999999998888999998763 35667889999999999996 99999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||= ..+|.++|.... .....| .+..+..|+++|+.++|+++ |||.||||.|+|+-+ |.+||+|||+|.-+..
T Consensus 439 mE~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9974 678999995432 223334 56678999999999999998 999999999999965 5899999999999877
Q ss_pred CcccCCCCceecC
Q 005825 663 DELQGNTKRIVGT 675 (675)
Q Consensus 663 ~~~~~~~~~~~GT 675 (675)
+.+...-..-+||
T Consensus 512 DTTsI~kdsQvGT 524 (677)
T KOG0596|consen 512 DTTSIVKDSQVGT 524 (677)
T ss_pred cccceeeccccCc
Confidence 7654333334555
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=163.70 Aligned_cols=151 Identities=25% Similarity=0.380 Sum_probs=126.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEE-EcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCC-CceeeEEEEEEeCCeEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQH-RNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-~nIv~l~g~~~~~~~~~lV~ 583 (675)
..+.|.+.++||.|+||.+|.|. ..+|++||||.-+... ....+.-|.++...++| ..|.++..+..++..-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 45789999999999999999996 4679999999876533 23456778888888875 67888888888999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---CCCeEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~ 660 (675)
|++ |.||++++.- ..+.++-++.+.++.|++.-++|+|.++ .|||||||+|+|..- -..+.++|||||+.+
T Consensus 91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 988 8999998742 3445788899999999999999999998 999999999999854 346899999999988
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
-...
T Consensus 165 ~d~~ 168 (341)
T KOG1163|consen 165 RDIR 168 (341)
T ss_pred cccc
Confidence 5443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-20 Score=179.77 Aligned_cols=151 Identities=26% Similarity=0.418 Sum_probs=123.7
Q ss_pred eeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----eEEEEEE
Q 005825 513 ECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG-----EKILILE 584 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~-----~~~lV~E 584 (675)
.+.||-|+||.||...+ ++|+.||.|++..- .-...+++.+|+++|.-++|.|+...++..+-.. +.|+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 36799999999999987 46999999998642 2223567889999999999999999988876543 5678888
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
+| ..+|.+++- ....++.....-+..||++||+|||+.+ |.||||||.|.|++.+..+||+||||||.-+.++
T Consensus 138 Lm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 88 457777773 3345666677778999999999999987 9999999999999999999999999999877666
Q ss_pred ccCCCC
Q 005825 665 LQGNTK 670 (675)
Q Consensus 665 ~~~~~~ 670 (675)
...+|.
T Consensus 211 ~~hMTq 216 (449)
T KOG0664|consen 211 RLNMTH 216 (449)
T ss_pred hhhhHH
Confidence 554443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.4e-20 Score=190.76 Aligned_cols=159 Identities=25% Similarity=0.303 Sum_probs=136.1
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCc-EEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGE-EVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~-~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.+++....||-|+||.|=+++..... .+|+|.+++. .....+.+..|-.||...+.|.||+|+-.|.+.+..|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45556678999999999998875433 3888988764 3345567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|-+-||.|-..|. .++.++..+..-++..+.+|++|||.++ ||.|||||+|.+||.+|-+||.|||+|+.++..
T Consensus 500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999994 3456777777788889999999999998 999999999999999999999999999999766
Q ss_pred cccCCCCceecC
Q 005825 664 ELQGNTKRIVGT 675 (675)
Q Consensus 664 ~~~~~~~~~~GT 675 (675)
+. |-+.+||
T Consensus 574 ~K---TwTFcGT 582 (732)
T KOG0614|consen 574 RK---TWTFCGT 582 (732)
T ss_pred Cc---eeeecCC
Confidence 53 5567887
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=165.11 Aligned_cols=143 Identities=12% Similarity=0.117 Sum_probs=117.1
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHH---H------HHHHHHHHHhcCCCceeeEEEEEEe
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLE---E------FKNEMLLIAKLQHRNLVRILGCCIE 575 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~---~------f~~E~~il~~l~H~nIv~l~g~~~~ 575 (675)
...++|+..+.||.|+||.||+... ++..+|||.+.+......+ . +.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3568999999999999999999766 5778999999764333222 2 6899999999999999999888664
Q ss_pred C--------CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC
Q 005825 576 Q--------GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM 647 (675)
Q Consensus 576 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 647 (675)
. ...+|||||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999987641 222 24558999999999988 99999999999999988
Q ss_pred CeEEeeeccceecCCC
Q 005825 648 NPKISDFGLARMFGGD 663 (675)
Q Consensus 648 ~~kl~DFGla~~~~~~ 663 (675)
++|+|||..+....+
T Consensus 173 -i~liDfg~~~~~~e~ 187 (232)
T PRK10359 173 -LRIIDLSGKRCTAQR 187 (232)
T ss_pred -EEEEECCCcccccch
Confidence 999999999877433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-17 Score=159.80 Aligned_cols=143 Identities=38% Similarity=0.632 Sum_probs=126.9
Q ss_pred eCCcCceeEEEEEEcC-CcEEEEEEecCcCcc-CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCHHH
Q 005825 516 LGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQ-GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDV 593 (675)
Q Consensus 516 IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 593 (675)
||+|++|.||+++..+ ++++++|++...... ..+.+.+|+..+++++|++|+++++++......+++||++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998864 899999999864332 35789999999999999999999999999999999999999999999
Q ss_pred HhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-CCCeEEeeeccceecCCC
Q 005825 594 FLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-DMNPKISDFGLARMFGGD 663 (675)
Q Consensus 594 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~ 663 (675)
++.... ..+++..+..++.+++++|.|||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 984321 35788999999999999999999987 999999999999999 899999999999877543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.3e-18 Score=169.02 Aligned_cols=149 Identities=16% Similarity=0.139 Sum_probs=115.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEE--EcCCcEEEEEEecCcCcc------------------------CHHHHHHHHHHHH
Q 005825 506 ATENFSMECKLGEGGFGPVYKGR--LLNGEEVAVKRLSSQSGQ------------------------GLEEFKNEMLLIA 559 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~--~~~g~~vAvK~l~~~~~~------------------------~~~~f~~E~~il~ 559 (675)
....|++.+.||+|+||.||+|. ..+|+.||||.++..... ....+..|+.++.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 33468888999999999999998 567999999998743210 0123568999999
Q ss_pred hcCCC--ceeeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCC
Q 005825 560 KLQHR--NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLK 637 (675)
Q Consensus 560 ~l~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 637 (675)
++.|. .+.++++. ...++||||+++.+|..... ....+...+...++.||+.+|.+||+++ +|+|||||
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dik 176 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLS 176 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCC
Confidence 99753 34455543 23589999999988876542 1223455566789999999999999876 49999999
Q ss_pred CCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 638 ASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 638 p~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|+||+++ ++.++|+|||+|+..+...
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccCCcc
Confidence 9999999 8899999999999776544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=164.80 Aligned_cols=136 Identities=21% Similarity=0.300 Sum_probs=114.7
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCcc--------CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQ--------GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~--------~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
+.||+|++|.||+|+. .+..++||+....... ....+..|+.++..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999986543211 124578899999999999988877777778888999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++|++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999988421 12 77889999999999999987 99999999999999 7899999999998643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-17 Score=158.68 Aligned_cols=133 Identities=21% Similarity=0.219 Sum_probs=106.6
Q ss_pred eeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCcc----CHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEEEec
Q 005825 512 MECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQ----GLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 512 ~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~----~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
....|++|+||+||.+.- .+.+++.+.++....- ....|.+|+++|++++ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997765 6778888887753221 1125889999999995 5889999886 4579999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCC-CCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDL-KASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+|.+|...+. . ....++.+++++|.++|.++ |+|||| ||+|||+++++.++|+|||+|....+
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999865431 0 11346788999999999998 999999 79999999999999999999996643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.5e-19 Score=190.14 Aligned_cols=150 Identities=27% Similarity=0.461 Sum_probs=136.4
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
..++|.+...+|.|++|.|||++. ..++..|||.++........-.+.|+-+++..+|||||.++|.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 346888889999999999999986 4589999999998777778888999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|+.+|+|.+.-+ ..+.+++.++..+++...+||+|||..+ -+|||||-.|||+++.+.+|++|||.+..++
T Consensus 93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh
Confidence 999999988763 3467888899999999999999999998 8999999999999999999999999987664
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=162.41 Aligned_cols=146 Identities=18% Similarity=0.175 Sum_probs=113.7
Q ss_pred HHHHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCcc----------------------CHHHHHHHHHHHH
Q 005825 502 SVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQ----------------------GLEEFKNEMLLIA 559 (675)
Q Consensus 502 ~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~----------------------~~~~f~~E~~il~ 559 (675)
++......|.+.+.||+|+||.||++...+|+.||||++...... ....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444457888999999999999999888999999987642210 0123667889999
Q ss_pred hcCCC--ceeeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCC
Q 005825 560 KLQHR--NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLK 637 (675)
Q Consensus 560 ~l~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 637 (675)
++.|+ .+.+.++. ...++||||+++++|...... .....++.+++.++.++|+.+ |+|||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 99887 45555442 456899999999998765410 234568889999999999987 9999999
Q ss_pred CCCEEEcCCCCeEEeeeccceecCCC
Q 005825 638 ASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 638 p~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|+||++++++.+||+|||+|..+..+
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCCc
Confidence 99999999999999999999877554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.8e-18 Score=186.91 Aligned_cols=148 Identities=33% Similarity=0.480 Sum_probs=117.4
Q ss_pred cceeeeeCCcCcee-EEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 510 FSMECKLGEGGFGP-VYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 510 f~~~~~IG~G~fG~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
|...+.+|.|+-|+ ||+|.+ ++++||||++-. ....-.++|+..|..- +||||||+++.-.+...+||..|.+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 34446789998765 699988 678999999864 2334567899999887 5999999999988999999999998
Q ss_pred CCCHHHHhcCCCCc-ccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---C--CCeEEeeeccceecC
Q 005825 588 NKSLDVFLFDPTKK-RLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---D--MNPKISDFGLARMFG 661 (675)
Q Consensus 588 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~--~~~kl~DFGla~~~~ 661 (675)
..+|++++...... ....-...+.+..|++.||++||+.+ ||||||||+||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 67999999542111 11111345678899999999999976 999999999999976 2 579999999999997
Q ss_pred CCcc
Q 005825 662 GDEL 665 (675)
Q Consensus 662 ~~~~ 665 (675)
.+..
T Consensus 663 ~~~s 666 (903)
T KOG1027|consen 663 GGKS 666 (903)
T ss_pred CCcc
Confidence 7654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=163.75 Aligned_cols=138 Identities=34% Similarity=0.470 Sum_probs=123.7
Q ss_pred CceeEEEEEEcC-CcEEEEEEecCcCccC-HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCHHHHhcC
Q 005825 520 GFGPVYKGRLLN-GEEVAVKRLSSQSGQG-LEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD 597 (675)
Q Consensus 520 ~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~-~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 597 (675)
+||.||+|+..+ ++.+|+|++....... .+.+..|++.+++++|+||+++++.+......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998764 8999999998654444 68999999999999999999999999999999999999999999999853
Q ss_pred CCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 598 PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 598 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
. ..+++..+..++.+++++|.|||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 2 22788999999999999999999987 999999999999999999999999999987553
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=185.78 Aligned_cols=141 Identities=22% Similarity=0.315 Sum_probs=114.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCc-------cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSG-------QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~-------~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
...|...++||+|+||.||+|.+.+...++.+++.+... ...+++.+|++++.+++|++++....++......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 344466789999999999999875544333322322111 1235688999999999999999988888887888
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+|+.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998873 35678999999999999987 9999999999999 678999999999987
Q ss_pred cCC
Q 005825 660 FGG 662 (675)
Q Consensus 660 ~~~ 662 (675)
...
T Consensus 477 ~~~ 479 (535)
T PRK09605 477 SDL 479 (535)
T ss_pred CCc
Confidence 643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.5e-17 Score=160.11 Aligned_cols=133 Identities=22% Similarity=0.337 Sum_probs=108.4
Q ss_pred eeCCcCceeEEEEEEcCCcEEEEEEecCcCc--c------CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 515 KLGEGGFGPVYKGRLLNGEEVAVKRLSSQSG--Q------GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 515 ~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~--~------~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.||+|+||.||+|.. ++..+++|....... . ..+++..|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 568899998654221 1 1356778999999999887665555666677789999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+|++|.+++... .. .++.+++++|.+||+.+ ++|+|++|+||+++ ++.++++|||+++....
T Consensus 80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~ 141 (199)
T TIGR03724 80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE 141 (199)
T ss_pred CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence 999999887321 10 78899999999999987 99999999999999 88999999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.5e-18 Score=163.75 Aligned_cols=147 Identities=21% Similarity=0.382 Sum_probs=121.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEE-EEeCCeEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGC-CIEQGEKILIL 583 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~-~~~~~~~~lV~ 583 (675)
.+.|.+.+.||+|.||.+-+++.+. ...+++|.+.+ .....++|.+|...--.| .|.||+.-++. |+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3578888999999999999998754 77899999875 234568899998765555 58999876654 56777888999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc--CCCCeEEeeeccceecC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD--RDMNPKISDFGLARMFG 661 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGla~~~~ 661 (675)
||+|.|+|.+-+- ...+.+.....++.|++.||.|+|++. ++|||||.+|||+- +...+||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999988772 234667778889999999999999987 99999999999993 34589999999998754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=162.80 Aligned_cols=151 Identities=25% Similarity=0.378 Sum_probs=126.5
Q ss_pred cCCcceeeeeCCcCceeEEEEE-EcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.-+|++.++||+|+||+++.|+ +-++++||||.-..++ ..-+++.|....+.|. .+.|..++-+..++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4589999999999999999996 5689999999765432 2345666777776664 6899999999899999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC-----CCeEEeeecccee
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD-----MNPKISDFGLARM 659 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~kl~DFGla~~ 659 (675)
++ |.||++++- -..+.++.++...||.|+..-++|+|++. +|.|||||+|+||... ..+.|+|||||+.
T Consensus 105 LL-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 88 899999873 34567899999999999999999999998 9999999999999653 4589999999998
Q ss_pred cCCCcc
Q 005825 660 FGGDEL 665 (675)
Q Consensus 660 ~~~~~~ 665 (675)
+-..++
T Consensus 179 YrDp~T 184 (449)
T KOG1165|consen 179 YRDPKT 184 (449)
T ss_pred hcCccc
Confidence 865544
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-17 Score=168.54 Aligned_cols=162 Identities=25% Similarity=0.401 Sum_probs=138.0
Q ss_pred cHHHHHHhcCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEE
Q 005825 499 SLASVAAATENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILG 571 (675)
Q Consensus 499 ~~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g 571 (675)
...++.....+++...++.+|.||.||+|.++ +.+.|-||.++.. ++.....+..|.-++..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34456666778888899999999999999553 3567889988865 3445678999999999999999999999
Q ss_pred EEEeC-CeEEEEEEecCCCCHHHHhc-----CCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC
Q 005825 572 CCIEQ-GEKILILEYMPNKSLDVFLF-----DPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR 645 (675)
Q Consensus 572 ~~~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 645 (675)
++.+. ...+++|.++.-|+|..||. +....+.+.-.+...++.|++.|++|||.++ |||.||.++|+++|+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 99765 46789999999999999997 4445566777888999999999999999988 999999999999999
Q ss_pred CCCeEEeeeccceecCCC
Q 005825 646 DMNPKISDFGLARMFGGD 663 (675)
Q Consensus 646 ~~~~kl~DFGla~~~~~~ 663 (675)
..++||+|=.|+|.+-+.
T Consensus 432 ~LqVkltDsaLSRDLFP~ 449 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPG 449 (563)
T ss_pred heeEEeccchhccccCcc
Confidence 999999999999977443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-17 Score=177.29 Aligned_cols=147 Identities=24% Similarity=0.338 Sum_probs=123.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.+..|.+...+|+|+|+.|-.+.. .+++..+||++.+.. ..-.+|+.++.+. +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 467888888999999999999875 568899999998642 2334567665555 6999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE-cCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL-DRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl-~~~~~~kl~DFGla~~~~~ 662 (675)
|++.++-+...+.. .+... .++..|+.+|+.|+.|||+++ |+||||||+|||+ ++.++++|+|||.++.+.+
T Consensus 396 e~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999988777632 22222 677789999999999999988 9999999999999 5999999999999998865
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
+
T Consensus 469 ~ 469 (612)
T KOG0603|consen 469 S 469 (612)
T ss_pred h
Confidence 5
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=166.14 Aligned_cols=145 Identities=25% Similarity=0.354 Sum_probs=122.0
Q ss_pred CcceeeeeCCcCceeEEEEEEcCC--cEEEEEEecCcCccCHHHHHHHHHHHHhcCC----CceeeEEEEE-EeCCeEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLLNG--EEVAVKRLSSQSGQGLEEFKNEMLLIAKLQH----RNLVRILGCC-IEQGEKIL 581 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~~g--~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H----~nIv~l~g~~-~~~~~~~l 581 (675)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999987553 5788888765433333378889999998873 5888898888 47778899
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC-----CCeEEeeecc
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD-----MNPKISDFGL 656 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~kl~DFGl 656 (675)
||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|++||+.+ ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99976 999999774433 567899999999999999999999998 9999999999999764 4699999999
Q ss_pred ce
Q 005825 657 AR 658 (675)
Q Consensus 657 a~ 658 (675)
|+
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.3e-16 Score=164.08 Aligned_cols=149 Identities=25% Similarity=0.456 Sum_probs=129.4
Q ss_pred HHHHhcCCcceeeeeCCcCceeEEEEEEc----CCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeC
Q 005825 502 SVAAATENFSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQ 576 (675)
Q Consensus 502 ~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~ 576 (675)
.+....+.|...++||+|.|++||++.+. ..+.||+|.+... +...++.+|+++|..+. |.||+++.+++...
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34566788999999999999999999753 3678999999753 34467899999999995 89999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-CCCeEEeeec
Q 005825 577 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-DMNPKISDFG 655 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFG 655 (675)
+...+|+||++.....++... ++..+...++..+..||+++|+++ ||||||||.|+|.+. .+.-.|.|||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred CeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 999999999999999998843 567788889999999999999998 999999999999975 5678999999
Q ss_pred cceecC
Q 005825 656 LARMFG 661 (675)
Q Consensus 656 la~~~~ 661 (675)
||....
T Consensus 179 LA~~~d 184 (418)
T KOG1167|consen 179 LAQRYD 184 (418)
T ss_pred hHHHHH
Confidence 998543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=141.71 Aligned_cols=137 Identities=22% Similarity=0.228 Sum_probs=116.2
Q ss_pred eeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCC--CceeeEEEEEEeCCeEEEEEEecCCC
Q 005825 512 MECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQH--RNLVRILGCCIEQGEKILILEYMPNK 589 (675)
Q Consensus 512 ~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~g 589 (675)
+.+.||+|.++.||+++..+ ..+++|....... ...+..|+.++..++| +++++++++...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 34789999999999999854 7899999875433 5678999999999976 58999999988888899999999988
Q ss_pred CHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 590 SLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 590 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||+++...
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 76533 456667789999999999998755569999999999999999999999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.1e-16 Score=149.17 Aligned_cols=140 Identities=19% Similarity=0.232 Sum_probs=100.5
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCcCcc--CHHHH----------------------HHHHHHHHhcCCC--ce
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQ--GLEEF----------------------KNEMLLIAKLQHR--NL 566 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~--~~~~f----------------------~~E~~il~~l~H~--nI 566 (675)
.+.||+|+||.||+|...++++||||+++..... ....+ ..|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3679999999999999888999999988753211 11111 3566666666543 34
Q ss_pred eeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCEEEcC
Q 005825 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH-YSRFRIIHRDLKASNVLLDR 645 (675)
Q Consensus 567 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~ 645 (675)
.+.+++ ...++||||++++.+........ ... .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 455443 24689999999955432111100 011 4567889999999999998 66 99999999999999
Q ss_pred CCCeEEeeeccceecCCCc
Q 005825 646 DMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 646 ~~~~kl~DFGla~~~~~~~ 664 (675)
++.++|+|||.|+.+..++
T Consensus 150 ~~~~~liDfg~a~~~~~~~ 168 (187)
T cd05119 150 DGKVYIIDVPQAVEIDHPN 168 (187)
T ss_pred CCcEEEEECcccccccCcc
Confidence 8999999999998775543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=5e-16 Score=157.75 Aligned_cols=154 Identities=23% Similarity=0.252 Sum_probs=127.1
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcC-C-Cc----eeeEEEEEEeCC
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-H-RN----LVRILGCCIEQG 577 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H-~n----Iv~l~g~~~~~~ 577 (675)
..+++|.+..++|+|.||.|.++.... +..||||+++. .....++-+.|+++|.++. + |+ +|.+.+++.-.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 347899999999999999999997643 78999999985 3344566778999999994 2 32 788888898899
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC------------
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR------------ 645 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~------------ 645 (675)
+.++|+|.| |.|+.++|... ...+++-.....|+.|++++++|||+.. ++|-||||+|||+-+
T Consensus 165 hiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred ceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 999999988 67999999653 4456888999999999999999999987 999999999999832
Q ss_pred --------CCCeEEeeeccceecCCCc
Q 005825 646 --------DMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 646 --------~~~~kl~DFGla~~~~~~~ 664 (675)
+..+||+|||-|..-.+..
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h 266 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH 266 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc
Confidence 2358999999999765444
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-16 Score=156.55 Aligned_cols=147 Identities=30% Similarity=0.398 Sum_probs=118.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG------ 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~------ 577 (675)
..+|..+..+|.|.- .|..+.+ ..+++||+|++... .....++..+|..++..+.|+||++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456666777888877 5555543 35889999988643 2334567788999999999999999999996443
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
+.++||||| ..+|...+. ..++-.+...|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 579999999 457777764 23666778899999999999999988 999999999999999999999999999
Q ss_pred eecCCC
Q 005825 658 RMFGGD 663 (675)
Q Consensus 658 ~~~~~~ 663 (675)
+.-+.+
T Consensus 166 r~e~~~ 171 (369)
T KOG0665|consen 166 RTEDTD 171 (369)
T ss_pred cccCcc
Confidence 976444
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.62 E-value=5e-16 Score=123.04 Aligned_cols=66 Identities=48% Similarity=1.098 Sum_probs=57.9
Q ss_pred CCCCCceEEeeccCCCCccceeccccCCHHHHHHHHhccCceeeeecccccCCceeEEeccccccc
Q 005825 337 CIKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLKNCTCKAYANSNVTEGSGCLMWFGELLDA 402 (675)
Q Consensus 337 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~~~~~~~~C~~w~~~l~~~ 402 (675)
|+.+|+|+++++|++|++....++.+.++++|++.||+||||+||+|.+..++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 545799999999999999877666678999999999999999999998655578899999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.5e-16 Score=160.36 Aligned_cols=155 Identities=21% Similarity=0.296 Sum_probs=131.8
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcC------CCceeeEEEEEEeCCe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ------HRNLVRILGCCIEQGE 578 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~------H~nIv~l~g~~~~~~~ 578 (675)
-...|.+....|+|-|+.|.+|.... |+.||||+|..+. ...+.=+.|++||++|. .-+.++|+..|.+.++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 45789998999999999999998643 7899999998643 33344567999999995 3489999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC-CeEEeeeccc
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-NPKISDFGLA 657 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla 657 (675)
++||+|-+ ..+|.+.|........|.......++.|+.-||..|...+ |+|.||||.|||+.+.. .+||||||-|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999977 5689999976666666788888899999999999999887 99999999999998764 5799999999
Q ss_pred eecCCCcc
Q 005825 658 RMFGGDEL 665 (675)
Q Consensus 658 ~~~~~~~~ 665 (675)
...+.++.
T Consensus 585 ~~~~enei 592 (752)
T KOG0670|consen 585 SFASENEI 592 (752)
T ss_pred cccccccc
Confidence 98877764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4e-15 Score=155.08 Aligned_cols=135 Identities=27% Similarity=0.326 Sum_probs=112.1
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-----C---CceeeEEEEEEeC-
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-----H---RNLVRILGCCIEQ- 576 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-----H---~nIv~l~g~~~~~- 576 (675)
.++|.+.++||=|-|++||++.+ ...+.||+|+.+. .....+.-+.||++|++++ | ..||+|++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 37899999999999999999976 4578899999985 3344566788999999984 3 3699999999754
Q ss_pred ---CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC
Q 005825 577 ---GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD 646 (675)
Q Consensus 577 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~ 646 (675)
.+.+||+|++ |-+|..++.... .+-++.....+|++||+.||.|||.++ +|||-||||+||||-..
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 4899999998 777777775433 345788889999999999999999988 69999999999999543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.4e-14 Score=149.38 Aligned_cols=150 Identities=37% Similarity=0.557 Sum_probs=128.5
Q ss_pred cceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCcc---CHHHHHHHHHHHHhcCCC-ceeeEEEEEEeCCeEEEEEEe
Q 005825 510 FSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQ---GLEEFKNEMLLIAKLQHR-NLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~H~-nIv~l~g~~~~~~~~~lV~Ey 585 (675)
|.+.+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++...+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999876 78999999864332 367899999999999988 799999999777778999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC-CeEEeeeccceecCCCc
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-NPKISDFGLARMFGGDE 664 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 664 (675)
+.++++.+++........+.......+..+++.++.|+|..+ ++|||+||+||+++... .+|++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977643211126788889999999999999999998 99999999999999988 79999999999775543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.6e-14 Score=145.86 Aligned_cols=136 Identities=21% Similarity=0.258 Sum_probs=105.5
Q ss_pred eeeC-CcCceeEEEEEEcCCcEEEEEEecCcC-------------ccCHHHHHHHHHHHHhcCCCce--eeEEEEEEeCC
Q 005825 514 CKLG-EGGFGPVYKGRLLNGEEVAVKRLSSQS-------------GQGLEEFKNEMLLIAKLQHRNL--VRILGCCIEQG 577 (675)
Q Consensus 514 ~~IG-~G~fG~Vy~~~~~~g~~vAvK~l~~~~-------------~~~~~~f~~E~~il~~l~H~nI--v~l~g~~~~~~ 577 (675)
..|| .|+.|+||.++.. +..++||+..... ......+.+|+.++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 7889999998874 6788998875311 1223567889999999998775 67777754432
Q ss_pred ----eEEEEEEecCC-CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 005825 578 ----EKILILEYMPN-KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKIS 652 (675)
Q Consensus 578 ----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 652 (675)
..++|||++++ .+|.+++.. ..++.. .+.+|+++|.+||+.+ |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 699888743 223433 3568999999999998 9999999999999999999999
Q ss_pred eeccceecC
Q 005825 653 DFGLARMFG 661 (675)
Q Consensus 653 DFGla~~~~ 661 (675)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.1e-13 Score=151.59 Aligned_cols=142 Identities=22% Similarity=0.286 Sum_probs=100.2
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCH----------------------------------------HHHHH
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGL----------------------------------------EEFKN 553 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~----------------------------------------~~f~~ 553 (675)
+.||.|++|+||+|++.+|+.||||+.++...... -.|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999875321100 02444
Q ss_pred HHHHHHhc----CCCceeeEEEEEE-eCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHH-HHHHHHhcC
Q 005825 554 EMLLIAKL----QHRNLVRILGCCI-EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQ-GLLYLHHYS 627 (675)
Q Consensus 554 E~~il~~l----~H~nIv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~~ 627 (675)
|...+.++ +|.+-+.+-..+. .....+|||||++|++|.++...... .. .+..++..+++ .+..+|+.+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 55555444 2333333322332 23457999999999999887632111 11 23456666666 467888877
Q ss_pred CCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 628 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
++|+|+||.||++++++.++|+|||+++.+.++
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 999999999999999999999999999988643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-13 Score=158.85 Aligned_cols=148 Identities=25% Similarity=0.350 Sum_probs=114.7
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeEE
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ---HRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~---H~nIv~l~g~~~~~~~~~ 580 (675)
......|.+.+.||+|+||+||+|...+|+.||+|.-+....- +|.-=.+++.+|+ -+-|.++..+..-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3445788899999999999999999888999999998764332 1111122333333 233444444445566778
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-------CCCeEEee
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-------DMNPKISD 653 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------~~~~kl~D 653 (675)
||+||.+.|+|.+++. ..+.++|...+.++.|+++-++.||..+ |||+||||+|+||.. ...++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999994 5667899999999999999999999998 999999999999943 34689999
Q ss_pred eccceec
Q 005825 654 FGLARMF 660 (675)
Q Consensus 654 FGla~~~ 660 (675)
||-+-.+
T Consensus 845 fG~siDm 851 (974)
T KOG1166|consen 845 FGRSIDM 851 (974)
T ss_pred cccceee
Confidence 9998654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.8e-12 Score=121.42 Aligned_cols=131 Identities=21% Similarity=0.139 Sum_probs=98.3
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCcee-eEEEEEEeCCeEEEEEEecCCCCHH
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV-RILGCCIEQGEKILILEYMPNKSLD 592 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (675)
+.|+.|.++.||+++.. ++.+++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 67899999999999874 77899998765322 234567899999988765544 455443 33458999999998875
Q ss_pred HHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcC--CCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 593 VFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS--RFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 593 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
... .....++.+++++|+.||... +..++|+|++|.||+++ ++.++++|||.|..-
T Consensus 80 ~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 80 TED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 320 011235678999999999876 33469999999999999 668999999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.7e-12 Score=105.01 Aligned_cols=71 Identities=17% Similarity=0.272 Sum_probs=59.7
Q ss_pred CCCCceEEeeccCCCCccceeccccCCHHHHHHHHhc---cCceeeeecccccCCceeEEecccc-cccCCcccCCCCce
Q 005825 338 IKGDQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLK---NCTCKAYANSNVTEGSGCLMWFGEL-LDASRPIRNFTGQS 413 (675)
Q Consensus 338 ~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~A~~~~~~~~~~~C~~w~~~l-~~~~~~~~~~~~~~ 413 (675)
.....|+++.++++|+... .++++|+++|++ ||||+||+|.+. +++|.+|.++| .+.++... .+.+
T Consensus 6 ~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~--~~gC~~W~~~l~~d~~~~~~--~g~~ 75 (80)
T cd00129 6 KSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA--RKQCLWFPFNSMSGVRKEFS--HGFD 75 (80)
T ss_pred ecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC--CCCeEEecCcchhhHHhccC--CCce
Confidence 3457899999999998765 579999999999 999999999753 46899999999 99877654 5788
Q ss_pred eeecc
Q 005825 414 VYLRQ 418 (675)
Q Consensus 414 lylrv 418 (675)
+|+|.
T Consensus 76 Ly~r~ 80 (80)
T cd00129 76 LYENK 80 (80)
T ss_pred eEeEC
Confidence 99973
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.6e-12 Score=106.72 Aligned_cols=80 Identities=36% Similarity=0.749 Sum_probs=63.7
Q ss_pred CCCCCCC---CceEEeeccCCCCccceeccccCCHHHHHHHHhccCceeeeecccccCCceeEEecccccccCCcccCCC
Q 005825 334 SSECIKG---DQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLKNCTCKAYANSNVTEGSGCLMWFGELLDASRPIRNFT 410 (675)
Q Consensus 334 ~~~C~~~---~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~~~~~~~~C~~w~~~l~~~~~~~~~~~ 410 (675)
+++|..+ +.|.++.++++|++.... ...++++|++.||+||+|+||+|.+. +++|++|...+.+.+.... .
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~~--~~~C~~~~~~~~~~~~~~~--~ 75 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNNG--SGGCLLWNGLLNNLRSLSS--G 75 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecCC--CCeEEEEeceecceEeecC--C
Confidence 3466543 689999999999886543 66799999999999999999999752 5679999999988765433 4
Q ss_pred CceeeeccC
Q 005825 411 GQSVYLRQP 419 (675)
Q Consensus 411 ~~~lylrv~ 419 (675)
+..+|||++
T Consensus 76 ~~~~yiKv~ 84 (84)
T cd01098 76 GGTLYLRLA 84 (84)
T ss_pred CcEEEEEeC
Confidence 578999975
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.1e-11 Score=137.55 Aligned_cols=147 Identities=16% Similarity=0.200 Sum_probs=94.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCcc------------------------------C----HH---
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQ------------------------------G----LE--- 549 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~------------------------------~----~~--- 549 (675)
..|+. +.||.|++|+||+|++.+ |+.||||++++.... . .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 689999999999999987 999999999753110 0 01
Q ss_pred ---HHHHHHHHHHhc----CCCceeeEEEEEEe-CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHH-H
Q 005825 550 ---EFKNEMLLIAKL----QHRNLVRILGCCIE-QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG-L 620 (675)
Q Consensus 550 ---~f~~E~~il~~l----~H~nIv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-L 620 (675)
.|..|+..+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++..... . ..+. ..++...++. +
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~-g~d~---~~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-A-GTDM---KLLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-c-CCCH---HHHHHHHHHHHH
Confidence 133444444444 24444444344333 346789999999999977531111 1 1111 1122222221 2
Q ss_pred HHHHhcCCCceEecCCCCCCEEEcCCC----CeEEeeeccceecCCC
Q 005825 621 LYLHHYSRFRIIHRDLKASNVLLDRDM----NPKISDFGLARMFGGD 663 (675)
Q Consensus 621 ~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGla~~~~~~ 663 (675)
.-++..+ ++|+|+||.||+++.++ .+++.|||++..+.++
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 2334455 99999999999999988 9999999999988654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.3e-12 Score=142.85 Aligned_cols=142 Identities=25% Similarity=0.348 Sum_probs=110.0
Q ss_pred eeeeeCCcCceeEEEEEEc-CCcEEEEEEec----C-cCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 512 MECKLGEGGFGPVYKGRLL-NGEEVAVKRLS----S-QSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 512 ~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~----~-~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
..+.+|.|++|.|+..... ..+..+.|... . ... .....+..|+.+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3468999999988777542 33333433322 1 111 111226678888888999999888777777777666799
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|+++ +|..++.+ ...+...++-.++.|+..|+.|||..+ |.||||||+|++++..+.+||+|||.+..+
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceee
Confidence 9999 99998843 345777888899999999999999998 999999999999999999999999999876
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=9.7e-12 Score=147.60 Aligned_cols=90 Identities=17% Similarity=0.222 Sum_probs=69.0
Q ss_pred hcCC-CceeeEEEEE-------EeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 005825 560 KLQH-RNLVRILGCC-------IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRI 631 (675)
Q Consensus 560 ~l~H-~nIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 631 (675)
.++| +||.+++++| .+.+..++++||+ +++|.++|... ...+++.+++.|+.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 5788888877 2334567788987 66999999532 345899999999999999999999987 9
Q ss_pred EecCCCCCCEEEcCCCCeEEeeec
Q 005825 632 IHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 632 iHrDlkp~NILl~~~~~~kl~DFG 655 (675)
+||||||+||||+..+.+|++|||
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~ 125 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESA 125 (793)
T ss_pred eeccCCchhEEEcccCcEEEeecc
Confidence 999999999999654444333333
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.3e-10 Score=113.99 Aligned_cols=143 Identities=19% Similarity=0.251 Sum_probs=111.4
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCC--CceeeEEEEEEeCC---eEEEEEEecC
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQH--RNLVRILGCCIEQG---EKILILEYMP 587 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H--~nIv~l~g~~~~~~---~~~lV~Ey~~ 587 (675)
+.|+.|..+.||+++..+|+.+++|....... .....+..|++++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887778999999765322 245678999999999975 45677888776543 5689999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS---------------------------------------- 627 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------- 627 (675)
|.++...+.. ..++..++..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988665421 24666777788888888888888421
Q ss_pred -------------CCceEecCCCCCCEEEcC--CCCeEEeeeccceec
Q 005825 628 -------------RFRIIHRDLKASNVLLDR--DMNPKISDFGLARMF 660 (675)
Q Consensus 628 -------------~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~ 660 (675)
+..++|+|++|.||+++. ++.+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 667899999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.4e-12 Score=137.35 Aligned_cols=144 Identities=27% Similarity=0.312 Sum_probs=117.5
Q ss_pred eeCCcCceeEEEEEE----cCCcEEEEEEecCcCcc--CHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEEEecC
Q 005825 515 KLGEGGFGPVYKGRL----LNGEEVAVKRLSSQSGQ--GLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 515 ~IG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~~~--~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
.+|+|+||.|++++. ..+..+|+|.+++.... .......|..++..++ ||.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998753 34778999988764221 1225667888999997 9999999999999999999999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
+|.|...+. ....+.......+...++-|++++|+.+ |+|||+|++||+++.+|++|+.|||+.+..-..+
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 999987773 3344555555556667899999999988 9999999999999999999999999999875444
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.5e-10 Score=108.79 Aligned_cols=139 Identities=14% Similarity=0.110 Sum_probs=99.3
Q ss_pred eeeCCcCceeEEEEEEcC-------CcEEEEEEecCc-------------C---------ccCHHHHH----HHHHHHHh
Q 005825 514 CKLGEGGFGPVYKGRLLN-------GEEVAVKRLSSQ-------------S---------GQGLEEFK----NEMLLIAK 560 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~-------g~~vAvK~l~~~-------------~---------~~~~~~f~----~E~~il~~ 560 (675)
..||.|--+.||.|...+ +..+|||..+.. . ....+.+. .|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 478999965421 0 00122333 79999998
Q ss_pred cCC--CceeeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHH-HhcCCCceEecCCC
Q 005825 561 LQH--RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL-HHYSRFRIIHRDLK 637 (675)
Q Consensus 561 l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrDlk 637 (675)
+.. -++.+++++ ...+|||||+.+..+..... +...++..+...+..+++.+|..| |..+ |+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 853 566677764 46789999998754422111 112244455567788999999999 6666 9999999
Q ss_pred CCCEEEcCCCCeEEeeeccceecCCC
Q 005825 638 ASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 638 p~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+.|||++ ++.+.|+|||.|.....+
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCCCC
Confidence 9999997 468999999999877544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.3e-10 Score=106.02 Aligned_cols=136 Identities=21% Similarity=0.295 Sum_probs=104.0
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEE-ecCc--Cc-----cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKR-LSSQ--SG-----QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~-l~~~--~~-----~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
..+.+|+-..+|.+.+.+ .++.+|. +++. .+ ...++-.+|+.+|++++--.|..-.-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 367899999999997744 3455553 3332 11 1134577899999999766665555566788888999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
++|..|.+.+... +..++..|-.-+.-||..+ |+|+||.++||++..+. +.++||||+..-...+
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~E 145 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEVE 145 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccHH
Confidence 9999999888332 3567788888999999998 99999999999998775 9999999999765444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.07 E-value=1e-09 Score=112.07 Aligned_cols=149 Identities=26% Similarity=0.378 Sum_probs=99.6
Q ss_pred CcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCc---CccCHHHHHHHHHHHHhcCC-----------CceeeEEEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQH-----------RNLVRILGCC 573 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H-----------~nIv~l~g~~ 573 (675)
.+...+.||.|+++.||.+++.+ ++++|||..... .....+++++|.-.+..+.+ .-++.+ +..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEE
Confidence 44566889999999999999865 899999986532 23456778877766655433 222221 111
Q ss_pred E---------eC---C-----eEEEEEEecCCCCHHHHhc---C-CCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceE
Q 005825 574 I---------EQ---G-----EKILILEYMPNKSLDVFLF---D-PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRII 632 (675)
Q Consensus 574 ~---------~~---~-----~~~lV~Ey~~~gsL~~~l~---~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 632 (675)
. .. . +.+++|+-+ .++|.+++. . ......+....++.+..|+.+.+++||+++ ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 1 11 1 236677766 678877753 1 111234556677888899999999999998 99
Q ss_pred ecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 633 HRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 633 HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|+||||+|++++++|.++|+||+.....+.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~ 197 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGT 197 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCc
Confidence 999999999999999999999998887654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.1e-11 Score=116.06 Aligned_cols=138 Identities=25% Similarity=0.464 Sum_probs=114.2
Q ss_pred ceeeeeCCcCceeEEEEEEcCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 511 SMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
.+..+|.+...|+.|+|++.. ..+++|++.-. .....+.|.+|.-.|+-+.||||..++|.|..+.++.+|..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 445688899999999999954 45666776532 233457899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEe-cCCCCCCEEEcCCCCeEEe
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIH-RDLKASNVLLDRDMNPKIS 652 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH-rDlkp~NILl~~~~~~kl~ 652 (675)
|+|...|++. .....+..+..+++.+||+|++|||+.. ++|- --|....+++|++.+++|+
T Consensus 272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee
Confidence 9999999764 3445677889999999999999999976 3444 4688999999999998875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.7e-09 Score=99.46 Aligned_cols=150 Identities=23% Similarity=0.272 Sum_probs=107.6
Q ss_pred eeeeeCCcCceeEEEEEEcCCcEEEEEE-ecCc-------CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 512 MECKLGEGGFGPVYKGRLLNGEEVAVKR-LSSQ-------SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 512 ~~~~IG~G~fG~Vy~~~~~~g~~vAvK~-l~~~-------~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
....|-||+-+.|+++.+ .|+...||. ..+. .....++..+|++++.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999988 456666663 3221 1123457888999999987555554444566677778999
Q ss_pred EecCC-CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC---CeEEeeecccee
Q 005825 584 EYMPN-KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM---NPKISDFGLARM 659 (675)
Q Consensus 584 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla~~ 659 (675)
||+++ .++.+++........ .......++..|-+.+.-||..+ |||+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 577777754322222 22233678889999999999988 99999999999996654 358999999976
Q ss_pred cCCCccc
Q 005825 660 FGGDELQ 666 (675)
Q Consensus 660 ~~~~~~~ 666 (675)
-..+|.+
T Consensus 166 s~~~EDK 172 (229)
T KOG3087|consen 166 SRLPEDK 172 (229)
T ss_pred ccCcccc
Confidence 6444433
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=6.5e-08 Score=98.98 Aligned_cols=135 Identities=17% Similarity=0.118 Sum_probs=97.7
Q ss_pred CceeEEEEEEcCCcEEEEEEecCcCc-----------cCHHHHHHHHHHHHhcCC--CceeeEEEEEEe-----CCeEEE
Q 005825 520 GFGPVYKGRLLNGEEVAVKRLSSQSG-----------QGLEEFKNEMLLIAKLQH--RNLVRILGCCIE-----QGEKIL 581 (675)
Q Consensus 520 ~fG~Vy~~~~~~g~~vAvK~l~~~~~-----------~~~~~f~~E~~il~~l~H--~nIv~l~g~~~~-----~~~~~l 581 (675)
....|++.++ +|+.+.||+...... .....+.+|...+.++.. -....++++... ...-+|
T Consensus 34 ~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 34 EGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 3344666665 677899997643221 111247889999988853 344455666543 235789
Q ss_pred EEEecCCC-CHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-------CCCeEEee
Q 005825 582 ILEYMPNK-SLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-------DMNPKISD 653 (675)
Q Consensus 582 V~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------~~~~kl~D 653 (675)
|+|++++. +|.+++.+.. ....+...+..++.+++..+.-||..+ |+|+|+++.|||++. +..+.|+|
T Consensus 113 Vte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred EEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 99999986 8998874211 223455667789999999999999998 999999999999975 46899999
Q ss_pred ecccee
Q 005825 654 FGLARM 659 (675)
Q Consensus 654 FGla~~ 659 (675)
|+.++.
T Consensus 189 l~r~~~ 194 (268)
T PRK15123 189 LHRAQI 194 (268)
T ss_pred CCcccc
Confidence 999865
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.9e-09 Score=107.59 Aligned_cols=89 Identities=29% Similarity=0.500 Sum_probs=68.6
Q ss_pred CCCceeeEEEEEEe---------------------------CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHH
Q 005825 562 QHRNLVRILGCCIE---------------------------QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIE 614 (675)
Q Consensus 562 ~H~nIv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 614 (675)
+|||||++.++|.+ +..+|+||.-. ..+|.+++-. ...+...+.-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc----CCCchHHHHHHHH
Confidence 59999998888753 23568888755 4578888732 2345566677888
Q ss_pred HHHHHHHHHHhcCCCceEecCCCCCCEEE--cCCC--CeEEeeeccce
Q 005825 615 GIAQGLLYLHHYSRFRIIHRDLKASNVLL--DRDM--NPKISDFGLAR 658 (675)
Q Consensus 615 ~ia~~L~yLH~~~~~~iiHrDlkp~NILl--~~~~--~~kl~DFGla~ 658 (675)
|+++|+.|||.++ |.|||+|.+|||| |+|+ ...|+|||.+-
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence 9999999999998 9999999999998 4554 46889999664
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.9e-10 Score=127.00 Aligned_cols=142 Identities=20% Similarity=0.225 Sum_probs=113.1
Q ss_pred CcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcC-ccCHHHHHHHHHH--HHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 509 NFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQS-GQGLEEFKNEMLL--IAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~f~~E~~i--l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++...+.||.+.|=+|.+|+.++|. |+||+.-+.. ....+.|.++++- +..++|||.+.+.-+-...+..|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6677789999999999999998887 8899876543 4455666655443 4556899999887776666667788777
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
+. -+|.+.| ..+..+...+..-|+.|++.||.-+|..+ |.|+|||.+||||+.-.=+.|+||.--|
T Consensus 103 vk-hnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 VK-HNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred Hh-hhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 74 3565555 34556777888889999999999999988 9999999999999999999999998555
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.8e-08 Score=94.31 Aligned_cols=128 Identities=25% Similarity=0.287 Sum_probs=83.5
Q ss_pred eEEEEEEcCCcEEEEEEecCcC--------------c-------c-----CHHHHHHHHHHHHhcCCC--ceeeEEEEEE
Q 005825 523 PVYKGRLLNGEEVAVKRLSSQS--------------G-------Q-----GLEEFKNEMLLIAKLQHR--NLVRILGCCI 574 (675)
Q Consensus 523 ~Vy~~~~~~g~~vAvK~l~~~~--------------~-------~-----~~~~f~~E~~il~~l~H~--nIv~l~g~~~ 574 (675)
.||.|...++..+|||.-+... . . .....+.|.+.|.++... ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999999999999754210 0 0 023466799999999765 566776552
Q ss_pred eCCeEEEEEEecC--CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHH-HhcCCCceEecCCCCCCEEEcCCCCeEE
Q 005825 575 EQGEKILILEYMP--NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL-HHYSRFRIIHRDLKASNVLLDRDMNPKI 651 (675)
Q Consensus 575 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrDlkp~NILl~~~~~~kl 651 (675)
...|||||++ |..+..+.... +.......++.+++..+..+ |..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 3479999999 65554433111 11233455777788866664 5665 9999999999999988 9999
Q ss_pred eeeccceecCCC
Q 005825 652 SDFGLARMFGGD 663 (675)
Q Consensus 652 ~DFGla~~~~~~ 663 (675)
+|||.|.....+
T Consensus 148 IDf~qav~~~~p 159 (188)
T PF01163_consen 148 IDFGQAVDSSHP 159 (188)
T ss_dssp --GTTEEETTST
T ss_pred EecCcceecCCc
Confidence 999999877543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.7e-08 Score=108.18 Aligned_cols=100 Identities=33% Similarity=0.505 Sum_probs=90.0
Q ss_pred HHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCC
Q 005825 558 IAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLK 637 (675)
Q Consensus 558 l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 637 (675)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ....++|.-...+..+|+.||+|||.-. -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568899999999999999999999999999999999964 3456889999999999999999999753 23999999
Q ss_pred CCCEEEcCCCCeEEeeeccceecC
Q 005825 638 ASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 638 p~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+.|+++|....+||+|||+..+..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999998874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3e-09 Score=120.61 Aligned_cols=151 Identities=26% Similarity=0.356 Sum_probs=117.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC--CcEEEEEEecCcC--ccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN--GEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~--g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV 582 (675)
..|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456667789999999998886533 4456777665432 223344555777777776 99999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHH-hcCCCceEecCCCCCCEEEcCCC-CeEEeeeccceec
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH-HYSRFRIIHRDLKASNVLLDRDM-NPKISDFGLARMF 660 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~ 660 (675)
+||..++++...+..... ...+....-.++.|+..++.|+| +.+ +.||||||+|.+++..+ ..|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999877731111 12334455568889999999999 777 99999999999999999 9999999999887
Q ss_pred CC
Q 005825 661 GG 662 (675)
Q Consensus 661 ~~ 662 (675)
..
T Consensus 176 ~~ 177 (601)
T KOG0590|consen 176 RN 177 (601)
T ss_pred cc
Confidence 55
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.5e-07 Score=83.62 Aligned_cols=88 Identities=19% Similarity=0.255 Sum_probs=63.2
Q ss_pred eEEEeeCCeEEEEeCC-CCeEEEeccCCCC-CCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhccccccccc
Q 005825 90 VLTISNNGKLVLLNQT-NGTIWSTNASSEA-KNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDL 167 (675)
Q Consensus 90 ~l~l~~~G~Lvl~~~~-g~~vWss~~~~~~-~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~ 167 (675)
++.++.||+||+++.. +.++|++++.... ....+.|+++|||||++. .+.++|+| ++
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-----~g~~vW~S--~t-------------- 81 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG-----DGRVVWSS--NT-------------- 81 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC-----CCCEEEEe--cc--------------
Confidence 3556689999999875 5899999986432 236789999999999985 46789987 11
Q ss_pred cCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeC
Q 005825 168 KNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTG 214 (675)
Q Consensus 168 ~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g 214 (675)
....|.|.+.|+++|+.+++-. ...+.|.+.
T Consensus 82 ---------------~~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf 112 (114)
T smart00108 82 ---------------TGANGNYVLVLLDDGNLVIYDS-DGNFLWQSF 112 (114)
T ss_pred ---------------cCCCCceEEEEeCCCCEEEECC-CCCEEeCCC
Confidence 0134568899999999766532 234677653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.4e-07 Score=91.06 Aligned_cols=140 Identities=20% Similarity=0.200 Sum_probs=98.4
Q ss_pred CcceeeeeCCcCceeEEEEEEcCCcEEEEEEecC----------c----------Ccc--CHHHHHHHHHHHHhcCCC--
Q 005825 509 NFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSS----------Q----------SGQ--GLEEFKNEMLLIAKLQHR-- 564 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~----------~----------~~~--~~~~f~~E~~il~~l~H~-- 564 (675)
-..+.++||.|--+.||.|..+.|.++|||.=+. . +.. .....++|.++|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3456689999999999999999999999994211 0 000 123456788999998754
Q ss_pred ceeeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc
Q 005825 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD 644 (675)
Q Consensus 565 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 644 (675)
.+.+.+++ +...+||||++|-.|...- +.-...-.|+..|++-+.-+-+.| |||+|+.+-||+++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 66666554 4568999999997664321 112223334455555544444555 99999999999999
Q ss_pred CCCCeEEeeeccceecCCC
Q 005825 645 RDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 645 ~~~~~kl~DFGla~~~~~~ 663 (675)
++|.+.++||--+.....+
T Consensus 237 ~dg~~~vIDwPQ~v~~~hp 255 (304)
T COG0478 237 EDGDIVVIDWPQAVPISHP 255 (304)
T ss_pred cCCCEEEEeCcccccCCCC
Confidence 9999999999877665443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=7.9e-07 Score=87.80 Aligned_cols=108 Identities=23% Similarity=0.217 Sum_probs=85.7
Q ss_pred HHHHHHHHHHHHhcC--CCceeeEEEEEEeCC----eEEEEEEecCCC-CHHHHhcCCCCcccCCHHHHHHHHHHHHHHH
Q 005825 548 LEEFKNEMLLIAKLQ--HRNLVRILGCCIEQG----EKILILEYMPNK-SLDVFLFDPTKKRLLGWQARIGIIEGIAQGL 620 (675)
Q Consensus 548 ~~~f~~E~~il~~l~--H~nIv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L 620 (675)
.....+|...+.++. .-...+.+++..... .-+||+|++++. +|.+++.... ..+...+..++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 456788888888875 344566777766533 458999999984 8999884321 245566788999999999
Q ss_pred HHHHhcCCCceEecCCCCCCEEEcCCC---CeEEeeeccceecC
Q 005825 621 LYLHHYSRFRIIHRDLKASNVLLDRDM---NPKISDFGLARMFG 661 (675)
Q Consensus 621 ~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla~~~~ 661 (675)
+-||+.+ |+|+|++|.|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999998 99999999999999887 89999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.7e-07 Score=82.16 Aligned_cols=88 Identities=19% Similarity=0.258 Sum_probs=63.6
Q ss_pred EEEee-CCeEEEEeCC-CCeEEEeccCCC-CCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhccccccccc
Q 005825 91 LTISN-NGKLVLLNQT-NGTIWSTNASSE-AKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDL 167 (675)
Q Consensus 91 l~l~~-~G~Lvl~~~~-g~~vWss~~~~~-~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~ 167 (675)
+.++. ||+||+++.. +.++|++|+... .....+.|.++|||||++. .+.++|+|=-
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-----~g~~vW~S~~---------------- 82 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG-----SGTVVWSSNT---------------- 82 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC-----CCcEEEEecc----------------
Confidence 44555 8999999865 589999998653 3456789999999999986 4578998610
Q ss_pred cCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCc
Q 005825 168 KNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGE 215 (675)
Q Consensus 168 ~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~ 215 (675)
....+.+.+.|+++|+..++-.+ ..+.|.+..
T Consensus 83 ---------------~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 83 ---------------TRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred ---------------cCCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 01246688999999996665333 356787653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.1e-07 Score=100.19 Aligned_cols=123 Identities=21% Similarity=0.272 Sum_probs=99.8
Q ss_pred EEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHH
Q 005825 528 RLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQ 607 (675)
Q Consensus 528 ~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 607 (675)
+..++.+|.|...+.......+...+-++-|+.++||||++++......+..|||+|-+ --|..++.. +...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHH
Confidence 34568889999888655534455777889999999999999999999999999999977 345555532 2234
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 608 ARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 608 ~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
.....+.||+.||.|||+.+ .++|++|.-.-|++++.|+.||++|.++...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 44556789999999999877 5999999999999999999999999988654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.3e-06 Score=93.32 Aligned_cols=140 Identities=19% Similarity=0.282 Sum_probs=111.5
Q ss_pred eeEEEEE-EcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeEEEEEEecCC-CCHHHHh
Q 005825 522 GPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE----QGEKILILEYMPN-KSLDVFL 595 (675)
Q Consensus 522 G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~l 595 (675)
.+.|++. ..||..+++|+++....+....-..-++.++++.|+|||++..++.. ...++|||+|.|+ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 5678885 46899999999965443333333456788999999999999998863 3468899999985 6776665
Q ss_pred cCC------------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 596 FDP------------TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 596 ~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+.. ......++...+.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+--|+...+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 432 22345678889999999999999999998 888999999999999999999999988888666
Q ss_pred c
Q 005825 664 E 664 (675)
Q Consensus 664 ~ 664 (675)
.
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 5
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.3e-07 Score=108.33 Aligned_cols=112 Identities=27% Similarity=0.370 Sum_probs=78.8
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
...+|..++.|..|++|.||..+.+. .+++|+|+-+. .- ..+ + ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~l-ilR---n---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL-ILR---N---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccccc-ch-hhh---c---cccccCCccee-----------------
Confidence 45788999999999999999998754 67788843332 11 001 1 33333444444
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|+-...+. ..+.++- +++.+++|||+.+ |+|||+||+|.||+.-|++|++|||+.++-
T Consensus 136 ----gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ----GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ----chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 44444442 2222322 2378999999998 999999999999999999999999999853
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.2e-06 Score=80.86 Aligned_cols=139 Identities=15% Similarity=0.145 Sum_probs=103.3
Q ss_pred eCCcCceeEEEEEEcCCcEEEEEEecCc------CccCHHHHHHHHHHHHhcCC--CceeeEEEEEEeCC----eEEEEE
Q 005825 516 LGEGGFGPVYKGRLLNGEEVAVKRLSSQ------SGQGLEEFKNEMLLIAKLQH--RNLVRILGCCIEQG----EKILIL 583 (675)
Q Consensus 516 IG~G~fG~Vy~~~~~~g~~vAvK~l~~~------~~~~~~~f~~E~~il~~l~H--~nIv~l~g~~~~~~----~~~lV~ 583 (675)
-|+||-+.|++-.+. |+.+-+|+-... -+.....|.+|+..|.++.. -.+.+.+....... .-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 466888889987764 447888876521 14567889999999999853 33555552222221 368999
Q ss_pred EecCC-CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC--eEEeeecccee
Q 005825 584 EYMPN-KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN--PKISDFGLARM 659 (675)
Q Consensus 584 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFGla~~ 659 (675)
|-+++ -+|.+++.+. .....+...+..++.+|++.++-||..+ +.|+|+-+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97754 6888887432 1224567778899999999999999998 999999999999986666 99999987764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.1e-06 Score=97.45 Aligned_cols=142 Identities=18% Similarity=0.236 Sum_probs=93.2
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCccC------------------------------HHH----------HHH
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQG------------------------------LEE----------FKN 553 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~------------------------------~~~----------f~~ 553 (675)
+.|+.++-|+||+|++.+|+.||||+.++.-... .++ +..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5789999999999999999999999876531100 011 222
Q ss_pred HHHHHHhc----CCCceeeEEEEEE-eCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHH-HHHHHhcC
Q 005825 554 EMLLIAKL----QHRNLVRILGCCI-EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG-LLYLHHYS 627 (675)
Q Consensus 554 E~~il~~l----~H~nIv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-L~yLH~~~ 627 (675)
|..-+.++ ++..-+++=.++. -.....|+|||++|-.+.+...... ...+ +..|+..++++ +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHHHHHHHHHHhcC
Confidence 33333333 2222233333332 2457899999999999988753221 2233 23344444443 22333344
Q ss_pred CCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 628 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
++|.|..|.||+++.++++-+.|||+...+++.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999999887654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.5e-07 Score=102.47 Aligned_cols=148 Identities=23% Similarity=0.275 Sum_probs=116.9
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE--cCCcEEEEEEecCcCccCHHH--HHHHHHHHHhc-CCCceeeEEEEEEeCCeEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL--LNGEEVAVKRLSSQSGQGLEE--FKNEMLLIAKL-QHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~--~~g~~vAvK~l~~~~~~~~~~--f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~ 580 (675)
...+|.++..||.|.|+.|++... .++..+++|.+.+.......+ -..|+.+...+ .|.++++....+..-...+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 456888899999999999999864 457789999887643322222 23455555555 5888888877777777888
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC-CCeEEeeecccee
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD-MNPKISDFGLARM 659 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~ 659 (675)
+=-||++++++...+ .-...++...++.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999987766 23345677788889999999999999887 9999999999999886 7889999999863
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=6.2e-06 Score=82.57 Aligned_cols=139 Identities=17% Similarity=0.158 Sum_probs=86.3
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCc--eeeEEEEEEeCCeEEEEEEecCCCC-
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN--LVRILGCCIEQGEKILILEYMPNKS- 590 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gs- 590 (675)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 68999999999984 24567778776422 3456788999999886433 4677888777778889999999973
Q ss_pred HHHHh---------------------cCCCCcccCCHHHHH-HHHH----------HHHH-HHHHHHh-cCCCceEecCC
Q 005825 591 LDVFL---------------------FDPTKKRLLGWQARI-GIIE----------GIAQ-GLLYLHH-YSRFRIIHRDL 636 (675)
Q Consensus 591 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------~ia~-~L~yLH~-~~~~~iiHrDl 636 (675)
+...+ +.... .......+. .+.. .+.. ...+|.. ..+..++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 22111 11000 000100000 0000 0111 1222221 12335789999
Q ss_pred CCCCEEEcCCCCeEEeeecccee
Q 005825 637 KASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 637 kp~NILl~~~~~~kl~DFGla~~ 659 (675)
.|.||++++++ +.|+||+.|..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999988 99999998874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.30 E-value=5e-07 Score=98.51 Aligned_cols=152 Identities=24% Similarity=0.319 Sum_probs=118.3
Q ss_pred CCcceeeeeCC--cCceeEEEEEE---cCCcEEEEEEecC--cCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeE
Q 005825 508 ENFSMECKLGE--GGFGPVYKGRL---LNGEEVAVKRLSS--QSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEK 579 (675)
Q Consensus 508 ~~f~~~~~IG~--G~fG~Vy~~~~---~~g~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~ 579 (675)
..|...+.+|. |.+|.||.++. .++..+|+|+-+. ..+.....=.+|+...++++ |+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566678999 99999999976 3578899998442 22233333445666667774 99999988888889999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHH----HHHHHHhcCCCceEecCCCCCCEEEcCC-CCeEEeee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQ----GLLYLHHYSRFRIIHRDLKASNVLLDRD-MNPKISDF 654 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DF 654 (675)
++-+|++ +.+|.++.+. ....++......+..+..+ ||.++|... |+|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~-~~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeeccc-cchhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 9988887 4778777643 2334566667777777777 999999987 9999999999999998 89999999
Q ss_pred ccceecCCCcc
Q 005825 655 GLARMFGGDEL 665 (675)
Q Consensus 655 Gla~~~~~~~~ 665 (675)
|+...++....
T Consensus 268 ~~v~~i~~~~~ 278 (524)
T KOG0601|consen 268 GLVSKISDGNF 278 (524)
T ss_pred ceeEEccCCcc
Confidence 99999876653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.4e-05 Score=78.17 Aligned_cols=140 Identities=16% Similarity=0.170 Sum_probs=93.7
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHH---------HHHHHHHhcCC---CceeeEEEE
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFK---------NEMLLIAKLQH---RNLVRILGC 572 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~---------~E~~il~~l~H---~nIv~l~g~ 572 (675)
...++|...+.+-......|.+-.. +++.+.+|..+.......+.|. +++..+.+++. ...+.++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4567888888887777777777766 5688899987654333333322 33333444432 223333333
Q ss_pred EEe-----CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC
Q 005825 573 CIE-----QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM 647 (675)
Q Consensus 573 ~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 647 (675)
... ....+|+|||++|..|.++.. ++. .++..+++++.-||+.| +.|+|..|.|+++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 222 234568999999988865531 221 25566888899999998 99999999999999655
Q ss_pred CeEEeeeccceec
Q 005825 648 NPKISDFGLARMF 660 (675)
Q Consensus 648 ~~kl~DFGla~~~ 660 (675)
+++.||+..+..
T Consensus 173 -i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 -IRIIDTQGKRMS 184 (229)
T ss_pred -EEEEECcccccc
Confidence 999999988754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.9e-06 Score=69.40 Aligned_cols=60 Identities=38% Similarity=0.878 Sum_probs=47.6
Q ss_pred CceEEeeccCCCCccceeccccCCHHHHHHHHhc-cCceeeeecccccCCceeEEec-ccccccC
Q 005825 341 DQFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLK-NCTCKAYANSNVTEGSGCLMWF-GELLDAS 403 (675)
Q Consensus 341 ~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~A~~~~~~~~~~~C~~w~-~~l~~~~ 403 (675)
..|..++++.+++..... ....++++|++.|+. +|+|.||.|.. .+.+|.+|. +.+.+..
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~--~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWSESSLGDAR 65 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC--CCCEEEEeeCCccccce
Confidence 568999999998665432 345789999999999 99999999975 356799999 6666654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.3e-06 Score=81.90 Aligned_cols=62 Identities=24% Similarity=0.144 Sum_probs=53.9
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|+|.+++.. ....+++.++..|+.||+.||.|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 688888853 2346899999999999999999999875 999999999999999 9999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.9e-05 Score=80.17 Aligned_cols=141 Identities=14% Similarity=0.137 Sum_probs=87.9
Q ss_pred eeCCcCc-eeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEEEecCCCCHH
Q 005825 515 KLGEGGF-GPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILILEYMPNKSLD 592 (675)
Q Consensus 515 ~IG~G~f-G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (675)
.|-.|.. ..||+.... +..+.||+..... ...+..|++++..+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 788999764 4678888876432 345678898888874 445667888877767789999999998886
Q ss_pred HHh-------------------cCCCC-cccCC-H-HHHHHHHH--------------------HHHHHHHHHHh----c
Q 005825 593 VFL-------------------FDPTK-KRLLG-W-QARIGIIE--------------------GIAQGLLYLHH----Y 626 (675)
Q Consensus 593 ~~l-------------------~~~~~-~~~l~-~-~~~~~i~~--------------------~ia~~L~yLH~----~ 626 (675)
... +.... ..... + ..++.-.. .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11000 00111 0 01110000 01111222211 1
Q ss_pred CCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 627 ~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
..+.++|+|+.|.|||++++..+.|+||+.|..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999988889999998874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.6e-05 Score=77.94 Aligned_cols=145 Identities=23% Similarity=0.222 Sum_probs=87.7
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCC--ceeeEEEEEEe---CCeEEEEEEecC
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHR--NLVRILGCCIE---QGEKILILEYMP 587 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~--nIv~l~g~~~~---~~~~~lV~Ey~~ 587 (675)
.+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++..... ....+++||+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999999877 68999997653 4456788899888888533 35677765533 235789999999
Q ss_pred CCCHHH----------------Hh---cCC-CCcccCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005825 588 NKSLDV----------------FL---FDP-TKKRLLGWQA---------RIGI------------IEGIAQ-GLLYLHH 625 (675)
Q Consensus 588 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~ 625 (675)
+..+.. .+ +.. .......+.. .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 998877 11 111 0111111110 0000 111222 3334432
Q ss_pred ----cCCCceEecCCCCCCEEEc-CCCCeEEeeeccceec
Q 005825 626 ----YSRFRIIHRDLKASNVLLD-RDMNPKISDFGLARMF 660 (675)
Q Consensus 626 ----~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~ 660 (675)
..+..++|+|+.|.|||++ +++.+.|.||+.+..-
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2345699999999999999 6666789999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.19 E-value=6.1e-06 Score=79.97 Aligned_cols=106 Identities=23% Similarity=0.214 Sum_probs=83.7
Q ss_pred HHHHHHHHhcCC-CceeeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 005825 552 KNEMLLIAKLQH-RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630 (675)
Q Consensus 552 ~~E~~il~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 630 (675)
..|.-++..+++ +++.+++|+|- .++|.||.+.+++...-..-..-...+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888986 69999999993 4778999998765421000011124689999999999999999999865556
Q ss_pred eEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 631 IIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 631 iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
+.-.|++|+|+-+++++++|++|...+-...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999999876553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.9e-07 Score=96.91 Aligned_cols=81 Identities=28% Similarity=0.394 Sum_probs=71.9
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
.+++.|+++...+|.++|.+.......++.....++.|++.|++| ++ .+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999766556667888899999999999999 55 999999999999999999999999999
Q ss_pred eecCCCc
Q 005825 658 RMFGGDE 664 (675)
Q Consensus 658 ~~~~~~~ 664 (675)
-.+...+
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 8776555
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.04 E-value=6.9e-05 Score=89.36 Aligned_cols=79 Identities=18% Similarity=0.399 Sum_probs=58.6
Q ss_pred eeeeCCcCceeEEEEEEcCC---cEEEEEEecCcC-ccCHHHHHHHHHHHHhcC-CCce--eeEEEEEEeC---CeEEEE
Q 005825 513 ECKLGEGGFGPVYKGRLLNG---EEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQ-HRNL--VRILGCCIEQ---GEKILI 582 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g---~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~-H~nI--v~l~g~~~~~---~~~~lV 582 (675)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |+++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47889999999999877554 367777764322 223457889999999995 6654 7888888764 467899
Q ss_pred EEecCCCCH
Q 005825 583 LEYMPNKSL 591 (675)
Q Consensus 583 ~Ey~~~gsL 591 (675)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.9e-06 Score=85.73 Aligned_cols=97 Identities=29% Similarity=0.346 Sum_probs=80.2
Q ss_pred HHHHHhcCCCceeeEEEEEEeC-----CeEEEEEEecCCCCHHHHhcCCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005825 555 MLLIAKLQHRNLVRILGCCIEQ-----GEKILILEYMPNKSLDVFLFDPTK-KRLLGWQARIGIIEGIAQGLLYLHHYSR 628 (675)
Q Consensus 555 ~~il~~l~H~nIv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 628 (675)
.+-|-.+.|.|||+++.|+.+. .+..++.|||+.|+|..+|++..+ ...+....-.+++.||..||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 3445566799999999988644 357899999999999999975432 34566677778999999999999996 5
Q ss_pred CceEecCCCCCCEEEcCCCCeEEe
Q 005825 629 FRIIHRDLKASNVLLDRDMNPKIS 652 (675)
Q Consensus 629 ~~iiHrDlkp~NILl~~~~~~kl~ 652 (675)
++|+|+++..+-|++..++-+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred CccccCCcchhheeecCCceEEec
Confidence 789999999999999999999985
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.1e-05 Score=86.98 Aligned_cols=139 Identities=19% Similarity=0.274 Sum_probs=88.4
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCccC---------------------------HH----------HHHHHHH
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQG---------------------------LE----------EFKNEML 556 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~---------------------------~~----------~f~~E~~ 556 (675)
+.|+.-+.|.|++|++++|+.||||+-++.-... .+ .|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999866431110 00 1333443
Q ss_pred HHH----hcCCCc------eeeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHH-HHh
Q 005825 557 LIA----KLQHRN------LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY-LHH 625 (675)
Q Consensus 557 il~----~l~H~n------Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~ 625 (675)
-.. .+.|-+ |.+++-.+ ...+.|+||||+|..+.+.-.-. ...++.. .|+..+.++... +-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~---~i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAID--KRGISPH---DILNKLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHH--HcCCCHH---HHHHHHHHHHHHHHHh
Confidence 222 234555 22332222 34689999999999887664321 1223333 334434443221 122
Q ss_pred cCCCceEecCCCCCCEEEcC----CCCeEEeeeccceecCC
Q 005825 626 YSRFRIIHRDLKASNVLLDR----DMNPKISDFGLARMFGG 662 (675)
Q Consensus 626 ~~~~~iiHrDlkp~NILl~~----~~~~kl~DFGla~~~~~ 662 (675)
. +++|+|-.|-||++.. ++.+.+-|||+.+.+..
T Consensus 320 ~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 T---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred c---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3 3999999999999984 67899999999887643
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.01 E-value=6.9e-05 Score=66.32 Aligned_cols=100 Identities=24% Similarity=0.440 Sum_probs=66.5
Q ss_pred CEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEe-cCCCCCCCCcceEEEeeCCeEEEEeCCCCeEEEeccCCC
Q 005825 39 EKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVA-NRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSE 117 (675)
Q Consensus 39 ~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~A-nr~~pv~~~~~~l~l~~~G~Lvl~~~~g~~vWss~~~~~ 117 (675)
+.+.+.+|.+.|-|-..|+ |-|. .. ..++||.. +...+.. ..+.+.|..||||||+|..+.++|++...
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~-~~-~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~-- 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLY-DS-NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY-- 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEE-ET-TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS--
T ss_pred cccccccccccceECCCCe-----EEEE-cC-CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC--
Confidence 4565655888888887765 3333 22 25679999 4333332 45889999999999999999999999433
Q ss_pred CCCceEEEcc--CCCEEEEeCCCCCCCcceeeeeccCCc
Q 005825 118 AKNPVAQLRD--DGNLVIRDNSSVNTTENYLWQSFDYPT 154 (675)
Q Consensus 118 ~~~~~a~L~d--~GNlVl~~~~~~~~~~~~lWqSFd~Pt 154 (675)
.....+..++ .||++ +.. ...+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~-----~~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKN-----DSLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EES-----TSSEEEESS----
T ss_pred CccEEEeccCcccCCCc-ccc-----ceEEeECCCCCCC
Confidence 3566777777 89998 653 3568898866663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.01 E-value=7.4e-05 Score=73.95 Aligned_cols=155 Identities=19% Similarity=0.231 Sum_probs=99.0
Q ss_pred cHHHHHHhcCCcceeee---eCCcCceeEEEEEEcCCcEEEEEEecCcCcc---------CHHH---------------H
Q 005825 499 SLASVAAATENFSMECK---LGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQ---------GLEE---------------F 551 (675)
Q Consensus 499 ~~~~~~~~~~~f~~~~~---IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~---------~~~~---------------f 551 (675)
+...+....+...+.+. |..|--..||+|...++..+|||+.+..... +..+ .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 44445555555555444 5567778899998888999999987642111 1111 2
Q ss_pred HHHHHHHHhcC--CCceeeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 005825 552 KNEMLLIAKLQ--HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629 (675)
Q Consensus 552 ~~E~~il~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 629 (675)
..|+.-|.++. +-.+.+-+++. +-.|||||+.......-. .+...+...+...+..++++.+.-|-...
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 24566666653 33444444442 457999999755211111 11112223356667778888888887633
Q ss_pred ceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 630 RIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 630 ~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++|+||..-|||+. ++.+.|+|||-|.....+
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 499999999999999 889999999998876544
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00044 Score=72.32 Aligned_cols=78 Identities=15% Similarity=0.126 Sum_probs=58.0
Q ss_pred ceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCC---CceeeEEEEEEeC---CeEEEEEE
Q 005825 511 SMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQH---RNLVRILGCCIEQ---GEKILILE 584 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H---~nIv~l~g~~~~~---~~~~lV~E 584 (675)
.-.+.||+|..+.||+....++ .+.+|..+. ......|..|...|+.+.. ..+.+++++|... +..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3346799999999999987666 466666432 1133588999999998853 4678889888543 56899999
Q ss_pred ecCCCCH
Q 005825 585 YMPNKSL 591 (675)
Q Consensus 585 y~~~gsL 591 (675)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00015 Score=73.08 Aligned_cols=140 Identities=16% Similarity=0.177 Sum_probs=77.3
Q ss_pred eeeCCcCce-eEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCC---ceeeEEEEEEeC---CeEEEEEEec
Q 005825 514 CKLGEGGFG-PVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHR---NLVRILGCCIEQ---GEKILILEYM 586 (675)
Q Consensus 514 ~~IG~G~fG-~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~---nIv~l~g~~~~~---~~~~lV~Ey~ 586 (675)
+.|+.|+.. .||+. +..+.+|..+. ......+..|.+++..+... .+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457766665 58875 23466776443 22345788999999887532 344455544332 2358899999
Q ss_pred CCCCHHHH------------------hcCCCCcc-c------------C-CHHHHH--HHH-------HHHHHH-HHH-H
Q 005825 587 PNKSLDVF------------------LFDPTKKR-L------------L-GWQARI--GII-------EGIAQG-LLY-L 623 (675)
Q Consensus 587 ~~gsL~~~------------------l~~~~~~~-~------------l-~~~~~~--~i~-------~~ia~~-L~y-L 623 (675)
+|.++... |+.-.... . + .|.... .+. .+.... ++. +
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 99776322 11100000 0 0 111110 000 011111 111 1
Q ss_pred Hh--cCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 624 HH--YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 624 H~--~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
+. ..+..++|+|+.|.|||++++....|.||+.|..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1234489999999999999876678999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00032 Score=70.58 Aligned_cols=142 Identities=16% Similarity=0.205 Sum_probs=83.0
Q ss_pred eeeCCcCceeEEEEEEcC--CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCc-eeeEEEEEEeCCeEEEEEEecCCCC
Q 005825 514 CKLGEGGFGPVYKGRLLN--GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN-LVRILGCCIEQGEKILILEYMPNKS 590 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~--g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey~~~gs 590 (675)
+.|..|-...+|+....+ ++.+.+|....... .......|+.++..+.... ..++++... ..+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567778888999998764 67888887654322 2223357888888885333 444544432 247999999977
Q ss_pred HHHH-----------------hcCCCCc--------ccC-CHHHHHHHHH----------------------HHHHHHHH
Q 005825 591 LDVF-----------------LFDPTKK--------RLL-GWQARIGIIE----------------------GIAQGLLY 622 (675)
Q Consensus 591 L~~~-----------------l~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~~L~y 622 (675)
+... ++..... ... .+.....+.. .+...+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 1111110 011 1211111111 11111122
Q ss_pred H----Hhc-CCCceEecCCCCCCEEEcC-CCCeEEeeeccceec
Q 005825 623 L----HHY-SRFRIIHRDLKASNVLLDR-DMNPKISDFGLARMF 660 (675)
Q Consensus 623 L----H~~-~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~ 660 (675)
| ... .+..++|+|+.+.|||+++ +..+.|+||..|..-
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 2 111 2345999999999999998 578999999988753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00044 Score=66.98 Aligned_cols=125 Identities=24% Similarity=0.377 Sum_probs=90.0
Q ss_pred CCcceeeeeCCcCc-eeEEEEEEcCCcEEEEEEecC---cCc------------------cCHHHHHHHHHHHHhcC---
Q 005825 508 ENFSMECKLGEGGF-GPVYKGRLLNGEEVAVKRLSS---QSG------------------QGLEEFKNEMLLIAKLQ--- 562 (675)
Q Consensus 508 ~~f~~~~~IG~G~f-G~Vy~~~~~~g~~vAvK~l~~---~~~------------------~~~~~f~~E~~il~~l~--- 562 (675)
.+++.++.||+|.- |.||+++. +|+.+|+|..+. ... ....-|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 99999998 667999998321 000 11235888999888885
Q ss_pred CCce--eeEEEEEEeC------------------CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHH
Q 005825 563 HRNL--VRILGCCIEQ------------------GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622 (675)
Q Consensus 563 H~nI--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y 622 (675)
+.++ |+.+||..-. ...-||.||++... .+. ..-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 3456 8999997322 12357788775543 111 2234567778888
Q ss_pred HHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 623 LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
+|..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999986 4589999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00087 Score=65.39 Aligned_cols=128 Identities=17% Similarity=0.250 Sum_probs=88.3
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCcC----------------ccCHHHHHHHHHHHHhcC------CCceeeEE
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQS----------------GQGLEEFKNEMLLIAKLQ------HRNLVRIL 570 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~----------------~~~~~~f~~E~~il~~l~------H~nIv~l~ 570 (675)
...||+|+.=.||.- ++.....||++.... ....+++.+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 357999999888854 445567888877544 123466777776655555 88999999
Q ss_pred EEEEeCCeEEEEEEecCC------CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc
Q 005825 571 GCCIEQGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD 644 (675)
Q Consensus 571 g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 644 (675)
|+..+....-+|+|.+.+ .+|.+++.+ ..++. . +...+-+-..||-+.+ |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999998888999998753 356777732 23443 2 3333444456666666 99999999999995
Q ss_pred CC--C--CeEEee
Q 005825 645 RD--M--NPKISD 653 (675)
Q Consensus 645 ~~--~--~~kl~D 653 (675)
.. + .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 42 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00078 Score=72.75 Aligned_cols=75 Identities=15% Similarity=0.224 Sum_probs=55.6
Q ss_pred eeeCCcCceeEEEEEEcCC-cEEEEEEecCc------C-ccCHHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeEEEE
Q 005825 514 CKLGEGGFGPVYKGRLLNG-EEVAVKRLSSQ------S-GQGLEEFKNEMLLIAKLQ---HRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g-~~vAvK~l~~~------~-~~~~~~f~~E~~il~~l~---H~nIv~l~g~~~~~~~~~lV 582 (675)
+.||.|.+..||++...+| +.|.||.-.+. . +...+++..|.+.|..+. -..+.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6799999999999998777 58999985421 1 234567788888887763 3457777777 44567899
Q ss_pred EEecCCCC
Q 005825 583 LEYMPNKS 590 (675)
Q Consensus 583 ~Ey~~~gs 590 (675)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998744
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00038 Score=71.16 Aligned_cols=139 Identities=15% Similarity=0.091 Sum_probs=79.7
Q ss_pred eeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeEEEEEEecCCCCHHH
Q 005825 515 KLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL-VRILGCCIEQGEKILILEYMPNKSLDV 593 (675)
Q Consensus 515 ~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~ 593 (675)
.+..|-...+|+... +++.+++|...............|..+++.+....+ .+++.... .++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 355677788998874 566788887654322211235788888888864333 34444432 368999999877642
Q ss_pred H-----------------hcCCC-CcccCCHHHHH-HHHHH---------HHHHHHHHHhc-----CCCceEecCCCCCC
Q 005825 594 F-----------------LFDPT-KKRLLGWQARI-GIIEG---------IAQGLLYLHHY-----SRFRIIHRDLKASN 640 (675)
Q Consensus 594 ~-----------------l~~~~-~~~~l~~~~~~-~i~~~---------ia~~L~yLH~~-----~~~~iiHrDlkp~N 640 (675)
. ++... ....++...++ ....+ +.+.+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 11112221111 11111 11112222111 12358999999999
Q ss_pred EEEcCCCCeEEeeecccee
Q 005825 641 VLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 641 ILl~~~~~~kl~DFGla~~ 659 (675)
|++++++ ++|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00058 Score=64.11 Aligned_cols=130 Identities=21% Similarity=0.265 Sum_probs=89.1
Q ss_pred ceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCcee-eEEEEEEeCCeEEEEEEecCCC
Q 005825 511 SMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV-RILGCCIEQGEKILILEYMPNK 589 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~g 589 (675)
+..+.|++|.+|.||+|.+. |.++|+|.-+.+ .....+..|+++|..+.-.++. +++.+. +.++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 34468999999999999985 458888886643 3457789999999999866654 344443 345669999999
Q ss_pred CHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCC-CCCEEEcCCCCeEEeeeccceec
Q 005825 590 SLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLK-ASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 590 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk-p~NILl~~~~~~kl~DFGla~~~ 660 (675)
.|.+.-... +.++... ++.+---|-..+ |-|..|. |..++|-.+..+.|+||.-|.+-
T Consensus 98 ~L~~~~~~~------~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIGG------DRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhcc------cHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 987765211 2233333 333322233333 8888886 66666666669999999999844
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0025 Score=66.59 Aligned_cols=143 Identities=20% Similarity=0.161 Sum_probs=87.5
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCC--ceeeEEEE------EEeCCeEEEEEE
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHR--NLVRILGC------CIEQGEKILILE 584 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~--nIv~l~g~------~~~~~~~~lV~E 584 (675)
.+.|..|....+|+....+ ..+++|+... ....+...|+.++..+++. .+.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778778999987644 4688888764 2345566788888777533 34454442 123446789999
Q ss_pred ecCCCCHHH----H----------hcC----CC----CcccCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 005825 585 YMPNKSLDV----F----------LFD----PT----KKRLLGWQARI----------GIIEGIAQGLLYLHH----YSR 628 (675)
Q Consensus 585 y~~~gsL~~----~----------l~~----~~----~~~~l~~~~~~----------~i~~~ia~~L~yLH~----~~~ 628 (675)
+++|..+.. . ++. .. ......|.... .....+..++.++.+ ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999977532 1 010 00 01112332211 011223344555553 223
Q ss_pred CceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 629 FRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 629 ~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
..++|+|+.|.|||++++..+.|.||+.|..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999987789999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0022 Score=67.19 Aligned_cols=142 Identities=25% Similarity=0.313 Sum_probs=84.9
Q ss_pred eeeCCcCceeEEEEEEcC-------CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeEEEEEEe
Q 005825 514 CKLGEGGFGPVYKGRLLN-------GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL-VRILGCCIEQGEKILILEY 585 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~-------g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nI-v~l~g~~~~~~~~~lV~Ey 585 (675)
+.|..|--..+|+....+ ++.+++|+..... ........|.+++..+....+ .++++.+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667677899887654 4788888865432 233456778888888753333 355555532 358999
Q ss_pred cCCCCHHHH-----------------hcCCCCc--c----cC--CHHHHHH--------------------------HHH
Q 005825 586 MPNKSLDVF-----------------LFDPTKK--R----LL--GWQARIG--------------------------IIE 614 (675)
Q Consensus 586 ~~~gsL~~~-----------------l~~~~~~--~----~l--~~~~~~~--------------------------i~~ 614 (675)
++|..+... +|..... . .. -|..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998876431 1111100 0 01 0111100 111
Q ss_pred HHHHHHHHHHh------cCCCceEecCCCCCCEEEcCC----CCeEEeeeccceec
Q 005825 615 GIAQGLLYLHH------YSRFRIIHRDLKASNVLLDRD----MNPKISDFGLARMF 660 (675)
Q Consensus 615 ~ia~~L~yLH~------~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~~ 660 (675)
.+...+.+|.. ..+..++|+|+.|.|||++++ +.++|+||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22233344432 245568999999999999985 88999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0074 Score=63.76 Aligned_cols=141 Identities=19% Similarity=0.171 Sum_probs=77.2
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCC--CceeeEEEE------EEeCCeEEEEEEe
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQH--RNLVRILGC------CIEQGEKILILEY 585 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H--~nIv~l~g~------~~~~~~~~lV~Ey 585 (675)
+.|..|....+|+....+| .+++|+.... ..+....|+.++..|.. -.+.+.+.. ....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777788999887655 6888887521 22333445555555532 123333321 1234567899999
Q ss_pred cCCCCHHH-----H---------hcCCC--------CcccCCH-HHHHHH------------H-HHHHHHHHHHHhc---
Q 005825 586 MPNKSLDV-----F---------LFDPT--------KKRLLGW-QARIGI------------I-EGIAQGLLYLHHY--- 626 (675)
Q Consensus 586 ~~~gsL~~-----~---------l~~~~--------~~~~l~~-~~~~~i------------~-~~ia~~L~yLH~~--- 626 (675)
++|..+.. . ++... ....+.| .....- . ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99975421 1 11100 0011112 211111 1 1111122333211
Q ss_pred -CCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 627 -SRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 627 -~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
-+..++|+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 24469999999999999977666899999885
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0092 Score=62.72 Aligned_cols=143 Identities=21% Similarity=0.216 Sum_probs=83.4
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCC--ceeeEEEEE------EeCCeEEEEEE
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHR--NLVRILGCC------IEQGEKILILE 584 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~--nIv~l~g~~------~~~~~~~lV~E 584 (675)
.+.++.|--..+|+....++ .+.+|+..... ..++...|+.++..|... .+.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34567777788999876555 57778765421 234555677777776422 244444421 12356789999
Q ss_pred ecCCCCHHH----H----------hcCC------CC---cccCCHHHHH------------HHHHHHHHHHHHHHh----
Q 005825 585 YMPNKSLDV----F----------LFDP------TK---KRLLGWQARI------------GIIEGIAQGLLYLHH---- 625 (675)
Q Consensus 585 y~~~gsL~~----~----------l~~~------~~---~~~l~~~~~~------------~i~~~ia~~L~yLH~---- 625 (675)
|++|..+.. . ++.. .. .....|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865421 0 1110 00 0011222111 011223345555543
Q ss_pred cCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 626 ~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
..+..++|+|+.+.||++++++.+.|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234569999999999999998877999999884
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0072 Score=64.61 Aligned_cols=142 Identities=16% Similarity=0.227 Sum_probs=83.7
Q ss_pred eeeCCcCceeEEEEEEcC-----CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCcee-eEEEEEEeCCeEEEEEEecC
Q 005825 514 CKLGEGGFGPVYKGRLLN-----GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV-RILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~ 587 (675)
+.|-.|-.-.+|+....+ ++.|.+|........... -.+|..++..+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456557778899987543 367888877654333333 36788888888654444 556665332 5899998
Q ss_pred CCCHHHH-----------------hcCCC-C--cccCCHHHHHHHHH-----------------HHHHHHHHHH----h-
Q 005825 588 NKSLDVF-----------------LFDPT-K--KRLLGWQARIGIIE-----------------GIAQGLLYLH----H- 625 (675)
Q Consensus 588 ~gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~-----------------~ia~~L~yLH----~- 625 (675)
+.+|... +|... . .....|.+...+.. .+...+..|. .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 11111 0 10111222222221 1112222222 1
Q ss_pred cCCCceEecCCCCCCEEEcC-CCCeEEeeeccceec
Q 005825 626 YSRFRIIHRDLKASNVLLDR-DMNPKISDFGLARMF 660 (675)
Q Consensus 626 ~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~ 660 (675)
..+..++|+|+++.|||+++ ++.++|+||..|..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 23446899999999999986 478999999998754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.005 Score=63.65 Aligned_cols=32 Identities=25% Similarity=0.450 Sum_probs=26.6
Q ss_pred CceEecCCCCCCEEEcCCCC-eEEeeeccceec
Q 005825 629 FRIIHRDLKASNVLLDRDMN-PKISDFGLARMF 660 (675)
Q Consensus 629 ~~iiHrDlkp~NILl~~~~~-~kl~DFGla~~~ 660 (675)
..++|+|++|.|||+++++. .-|.||+.|..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 35899999999999997555 579999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0017 Score=52.42 Aligned_cols=49 Identities=18% Similarity=0.323 Sum_probs=34.8
Q ss_pred eccCCCCccceeccccCCHHHHHHHHhccCceeeeecccccCCceeEEeccc
Q 005825 347 DNIKAPDFIEVSLNQSMNLQQCAAECLKNCTCKAYANSNVTEGSGCLMWFGE 398 (675)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~~~~~~~~C~~w~~~ 398 (675)
+++.++.++.... ...+.++|++.|+.+|+|.||.|... ...|+++...
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~~--~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNTK--SKKCFLKSSE 58 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEECC--CCeEEcccCC
Confidence 4555555443322 24589999999999999999999742 3569987664
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.019 Score=59.49 Aligned_cols=76 Identities=17% Similarity=0.234 Sum_probs=49.0
Q ss_pred cceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeEEEEEEec
Q 005825 510 FSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ---HRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.+..+.++.|....+|+.. .+++.+.||.-.. .....|..|..-|+.|. --.+.+++++....+..+|||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445678989999999987 5678899998762 33467888888777773 455778999888777789999999
Q ss_pred CCC
Q 005825 587 PNK 589 (675)
Q Consensus 587 ~~g 589 (675)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.00025 Score=82.11 Aligned_cols=149 Identities=18% Similarity=0.193 Sum_probs=102.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
..+.|.+.+-+..|+++.++.++-.. +...++|..... .....+....+-.++-..+||-+++..--+.......|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45677777888899999999875432 333333333211 12223333444444444566777766655566778899
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+++|..+++|...|+... ..+.......+..+.++++|||... +.|||++|.|+|...+++.+++|||+....
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999998885422 2333333344555889999999875 899999999999999999999999965543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0022 Score=65.81 Aligned_cols=135 Identities=15% Similarity=0.159 Sum_probs=91.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEec----------Cc----------CccCH--HHHHHHHHHHHhcC-CC
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLS----------SQ----------SGQGL--EEFKNEMLLIAKLQ-HR 564 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~----------~~----------~~~~~--~~f~~E~~il~~l~-H~ 564 (675)
.-+++.+.||-|--+.||.+-..+|++.++|.=. .+ +...+ -....|+..|+.+. |.
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3567889999999999999999889999988311 00 01111 12446888888885 32
Q ss_pred -ceeeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE
Q 005825 565 -NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL 643 (675)
Q Consensus 565 -nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 643 (675)
.+.+.+++ +..++|||++.+-.|...-+ ..+.. .+...+..-+--|..++ +||+|..--||++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~---~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPP---TLYDDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeee------cCChH---HHHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence 34445444 45689999999887754331 11222 23333334444555666 9999999999999
Q ss_pred cCCCCeEEeeeccce
Q 005825 644 DRDMNPKISDFGLAR 658 (675)
Q Consensus 644 ~~~~~~kl~DFGla~ 658 (675)
+++..++++||--..
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999997443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.026 Score=59.02 Aligned_cols=144 Identities=16% Similarity=0.234 Sum_probs=82.4
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecC--cCccCHHHHHHHHHHHHhcCC--CceeeEEEEEEeCC--eEEEEEEecC
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSS--QSGQGLEEFKNEMLLIAKLQH--RNLVRILGCCIEQG--EKILILEYMP 587 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~H--~nIv~l~g~~~~~~--~~~lV~Ey~~ 587 (675)
+.+..|---.+|..... ++++.++ ... ..........+|..+|+.+.- .-+.+.++.|.++. ..+.||||++
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 44433332333333332 6777777 331 122344566778888888753 44556778887766 6799999999
Q ss_pred CCCHHHHhcCC-----------------------------------CCcccCCHHHHHHHHH--------HHHHHHHHHH
Q 005825 588 NKSLDVFLFDP-----------------------------------TKKRLLGWQARIGIIE--------GIAQGLLYLH 624 (675)
Q Consensus 588 ~gsL~~~l~~~-----------------------------------~~~~~l~~~~~~~i~~--------~ia~~L~yLH 624 (675)
|..+...+... ...+.-.|......+. ....-..+|+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 84332111000 0000111211111000 1222344554
Q ss_pred hc-----CCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 625 HY-----SRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 625 ~~-----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++ ++..++|+|+.+.||+++.+..+-|.||+++..
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 32 335699999999999999998899999999875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.04 Score=58.46 Aligned_cols=73 Identities=15% Similarity=0.203 Sum_probs=49.0
Q ss_pred eeCCcCceeEEEEEEcCC-cEEEEEEecC-------cCccCHHHHHHHHHHHHhcC--CC-ceeeEEEEEEeCCeEEEEE
Q 005825 515 KLGEGGFGPVYKGRLLNG-EEVAVKRLSS-------QSGQGLEEFKNEMLLIAKLQ--HR-NLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 515 ~IG~G~fG~Vy~~~~~~g-~~vAvK~l~~-------~~~~~~~~f~~E~~il~~l~--H~-nIv~l~g~~~~~~~~~lV~ 583 (675)
.||.|....||++..+++ +.|+||.-.+ .-+...++-.-|...|.... -| .+.+++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998654 6899996432 11334556667777776653 23 35555544 455667999
Q ss_pred EecCCC
Q 005825 584 EYMPNK 589 (675)
Q Consensus 584 Ey~~~g 589 (675)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.00071 Score=74.72 Aligned_cols=142 Identities=17% Similarity=0.090 Sum_probs=96.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCc-eeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN-LVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey 585 (675)
+..+...+.++++++++++|.+-.-.+....+.+... .....++++|.+++||| .++.++-+..++..++++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3444445678899999999987533334445555432 45567899999999999 77777777777788999999
Q ss_pred cCCC-CHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNK-SLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
...+ +-.... ......+..-+...+.+.-+++|+|||+.. -+|+| ||+..+ +..|..||+.+..+.+.
T Consensus 316 ~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 316 CSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 9887 211111 011112333334455666678899999754 58998 787766 68999999998877544
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.051 Score=57.36 Aligned_cols=136 Identities=24% Similarity=0.303 Sum_probs=79.9
Q ss_pred CceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCc------eeeEEEE----EEeCCeEEEEEEecCCC
Q 005825 520 GFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN------LVRILGC----CIEQGEKILILEYMPNK 589 (675)
Q Consensus 520 ~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~n------Iv~l~g~----~~~~~~~~lV~Ey~~~g 589 (675)
.-..+|+....+|+. ++|..+.. ....+...|+..|..+.-.. |.++-|- ...+...+-++||++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 456788888877776 77777654 44556666777776663211 2222222 12223678899999998
Q ss_pred CHHH-H--------------hc----C-----CCCcccCCHHH-------------HHHHHHHHHHHHHHHHhc----CC
Q 005825 590 SLDV-F--------------LF----D-----PTKKRLLGWQA-------------RIGIIEGIAQGLLYLHHY----SR 628 (675)
Q Consensus 590 sL~~-~--------------l~----~-----~~~~~~l~~~~-------------~~~i~~~ia~~L~yLH~~----~~ 628 (675)
.+.. . |+ + ........|.. ......++...++.+.+. -+
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8872 1 01 0 11111233430 001222344444444431 12
Q ss_pred C---ceEecCCCCCCEEEcCCCC-eEEeeeccce
Q 005825 629 F---RIIHRDLKASNVLLDRDMN-PKISDFGLAR 658 (675)
Q Consensus 629 ~---~iiHrDlkp~NILl~~~~~-~kl~DFGla~ 658 (675)
. .+||+|+.|.||+++.+.. +.+.||+-|.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2 2999999999999999885 8999999876
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.13 Score=55.73 Aligned_cols=73 Identities=11% Similarity=0.060 Sum_probs=49.8
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCc----C---ccCHHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeEEEE
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ----S---GQGLEEFKNEMLLIAKLQ---HRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~----~---~~~~~~f~~E~~il~~l~---H~nIv~l~g~~~~~~~~~lV 582 (675)
.+.||.|....||+.... +..+.||+-... . +....+-..|...|..+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 468999999999998864 456889975421 1 113344444566665543 357888888876 456888
Q ss_pred EEecCC
Q 005825 583 LEYMPN 588 (675)
Q Consensus 583 ~Ey~~~ 588 (675)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.18 Score=52.89 Aligned_cols=29 Identities=24% Similarity=0.328 Sum_probs=25.5
Q ss_pred CceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 629 FRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 629 ~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46899999999999988 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.087 Score=56.00 Aligned_cols=142 Identities=17% Similarity=0.241 Sum_probs=80.3
Q ss_pred eeeCCcCceeEEEEEEcC----CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCcee-eEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV-RILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
+.|..|=-..+|+....+ +..|.+|........ .-.-.+|..+++.+...++. ++++++. .+ +|.||+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 445556667788886543 237888877653332 22346788888888655553 5566653 22 48999988
Q ss_pred CCHHHH-----------------hcCCC-C--cccCCHHHHHHHHHH----------------------HHHHHHHHHh-
Q 005825 589 KSLDVF-----------------LFDPT-K--KRLLGWQARIGIIEG----------------------IAQGLLYLHH- 625 (675)
Q Consensus 589 gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~----------------------ia~~L~yLH~- 625 (675)
..|..- +|... . ....-|.....+..+ +.+-+..+.+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 766321 11111 0 111122222222111 1112222221
Q ss_pred ----cCCCceEecCCCCCCEEEcC-CCCeEEeeeccceec
Q 005825 626 ----YSRFRIIHRDLKASNVLLDR-DMNPKISDFGLARMF 660 (675)
Q Consensus 626 ----~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~ 660 (675)
..+.-+.|+|+.+.|||+++ ++.++++||..|..-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 12234799999999999975 578999999988753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.064 Score=56.30 Aligned_cols=143 Identities=17% Similarity=0.183 Sum_probs=92.5
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCc-------Cc--cCHHH-----------------HHHHHHHHHhcCCCce
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ-------SG--QGLEE-----------------FKNEMLLIAKLQHRNL 566 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~-------~~--~~~~~-----------------f~~E~~il~~l~H~nI 566 (675)
...|..|--.-||.+.-.+|..+|||+.+.. .. .+.-+ ...|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3567888889999999889999999976521 00 00011 2246666666654433
Q ss_pred eeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC
Q 005825 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD 646 (675)
Q Consensus 567 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~ 646 (675)
.----... ....|||+|+....-..- ..+...+....+..+..++++-|.-|.+.+ +++|.||.--|+|+. +
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aP---kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAP---KLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCc---ccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 21111100 234789999964322111 122334555667778888888888888877 599999999999985 4
Q ss_pred CCeEEeeeccceecCCC
Q 005825 647 MNPKISDFGLARMFGGD 663 (675)
Q Consensus 647 ~~~kl~DFGla~~~~~~ 663 (675)
|.+.|+|.+-+.-...+
T Consensus 301 G~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHDHP 317 (520)
T ss_pred CEEEEEEccccccCCCh
Confidence 58999998877655433
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.028 Score=55.55 Aligned_cols=30 Identities=33% Similarity=0.552 Sum_probs=21.8
Q ss_pred ceEecCCCCCCEEE-cCCCCeEEeeecccee
Q 005825 630 RIIHRDLKASNVLL-DRDMNPKISDFGLARM 659 (675)
Q Consensus 630 ~iiHrDlkp~NILl-~~~~~~kl~DFGla~~ 659 (675)
-+.|+|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8899999999998874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.19 Score=61.38 Aligned_cols=142 Identities=20% Similarity=0.264 Sum_probs=77.9
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC--CCc--eeeEEE--------EEEe-CC--e
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ--HRN--LVRILG--------CCIE-QG--E 578 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~--H~n--Iv~l~g--------~~~~-~~--~ 578 (675)
+.|+ |..-.+|+.+..+++.+++|+..... .......|..+|..|. ++. +.+++- .... .+ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4454 45678899888788899999987542 2234444555554442 122 222221 1111 22 4
Q ss_pred EEEEEEecCCCCHHHH-------h----------c----C---CCCcccCCHHH-----------------HHHHHHHHH
Q 005825 579 KILILEYMPNKSLDVF-------L----------F----D---PTKKRLLGWQA-----------------RIGIIEGIA 617 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~-------l----------~----~---~~~~~~l~~~~-----------------~~~i~~~ia 617 (675)
.+-+++|++|..+.+. + + + ....+.+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999999877551 0 0 0 01112223321 112222222
Q ss_pred HHHH----HHHhcCCCceEecCCCCCCEEEcCCC--CeE-Eeeeccce
Q 005825 618 QGLL----YLHHYSRFRIIHRDLKASNVLLDRDM--NPK-ISDFGLAR 658 (675)
Q Consensus 618 ~~L~----yLH~~~~~~iiHrDlkp~NILl~~~~--~~k-l~DFGla~ 658 (675)
.... .....-+..+||+|+.+.|||++.+. ++. |+|||.+.
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 2221 11122345699999999999999875 554 99999875
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.1 Score=56.17 Aligned_cols=74 Identities=11% Similarity=0.106 Sum_probs=50.9
Q ss_pred eeeeCCcCceeEEEEEEcC-CcEEEEEEecC------cCccCHHHHHHHHHHHHhcC--CC-ceeeEEEEEEeCCeEEEE
Q 005825 513 ECKLGEGGFGPVYKGRLLN-GEEVAVKRLSS------QSGQGLEEFKNEMLLIAKLQ--HR-NLVRILGCCIEQGEKILI 582 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~------~~~~~~~~f~~E~~il~~l~--H~-nIv~l~g~~~~~~~~~lV 582 (675)
.+.||-|.-.-||++...+ ++.|+||.-.+ .-+...++-.-|...|+... -| .+.+++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3689999999999999753 56799996432 11345667777777777653 23 45556554 45566789
Q ss_pred EEecCC
Q 005825 583 LEYMPN 588 (675)
Q Consensus 583 ~Ey~~~ 588 (675)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999965
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 675 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-31 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-31 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 675 | |||
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-88 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 9e-85 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-76 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-61 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-53 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-46 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-44 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 8e-43 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-42 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-42 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-42 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-42 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-40 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-39 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-38 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-38 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-38 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 7e-37 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-36 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-36 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-36 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-36 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-36 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 9e-36 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-35 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-35 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-35 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-35 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-34 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-34 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-34 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 5e-34 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-34 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 7e-34 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 7e-34 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 7e-34 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-33 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-33 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-33 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-33 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-33 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-33 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-33 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-33 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 4e-33 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-33 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-33 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 7e-33 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 8e-33 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-32 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-32 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-32 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-32 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-32 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-32 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-32 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 9e-32 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-31 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-31 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-31 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-31 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-31 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-31 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 3e-31 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-31 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 8e-31 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-30 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-30 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-30 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-30 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 7e-30 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 7e-30 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 8e-30 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-29 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-29 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-29 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-29 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-29 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 4e-29 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-29 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 5e-29 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 6e-29 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-28 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-28 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-28 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-28 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 6e-28 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 8e-28 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-27 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-27 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-27 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 7e-27 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-26 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-26 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-26 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-26 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-26 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 6e-26 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 6e-26 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 6e-26 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-26 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 9e-26 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-25 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-25 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 5e-25 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 6e-25 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 6e-25 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 6e-25 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 9e-25 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-24 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-24 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-24 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-24 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 5e-24 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 6e-24 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 7e-24 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 8e-24 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-23 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-23 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-23 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-23 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-23 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-23 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-23 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-23 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 6e-23 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 7e-23 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 7e-23 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 7e-23 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 7e-23 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-22 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-22 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-22 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 4e-22 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-22 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-22 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-21 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-21 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-21 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-21 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-21 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-21 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-21 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-21 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-21 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-21 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-21 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 7e-21 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-20 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-20 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-20 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-20 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-20 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-20 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-20 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-20 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-20 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-20 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-20 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 9e-20 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 9e-20 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-19 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-19 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-19 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-19 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-19 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-19 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-19 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 4e-19 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-19 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-19 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 9e-19 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-18 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-18 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 8e-18 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-17 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-17 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-17 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 5e-17 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-16 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-16 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-16 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-15 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-15 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 7e-15 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 9e-15 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 9e-15 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 9e-15 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-14 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-14 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 9e-14 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-13 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-13 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-13 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 5e-13 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 6e-13 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-12 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-12 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-12 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-12 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-12 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-08 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-12 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-12 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-12 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-12 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-12 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-12 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 7e-12 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 7e-12 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 1e-11 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-11 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-11 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-11 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 2e-11 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 3e-05 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 3e-11 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-11 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 6e-11 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-11 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 2e-10 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-10 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 4e-10 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 5e-08 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 5e-10 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 7e-10 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 7e-10 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-09 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 3e-09 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 6e-09 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 2e-06 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 7e-09 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 8e-09 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 9e-09 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-08 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-08 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-08 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-08 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 2e-08 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-08 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-08 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 3e-07 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 6e-05 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-07 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 9e-07 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 6e-06 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 1e-05 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 7e-06 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 7e-05 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 7e-06 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 8e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 9e-06 |
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 4e-88
Identities = 75/201 (37%), Positives = 103/201 (51%), Gaps = 14/201 (6%)
Query: 485 DRRDKSKDSWLPLFSLASVAAATENFSMEC------KLGEGGFGPVYKGRLLNGEEVAVK 538
++ + D+ FS + T NF K+GEGGFG VYKG + N VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 539 RLSS----QSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVF 594
+L++ + + ++F E+ ++AK QH NLV +LG + + L+ YMPN SL
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 595 LFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDF 654
L L W R I +G A G+ +LH IHRD+K++N+LLD KISDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 655 GLARMFGGDELQGNTKRIVGT 675
GLAR T RIVGT
Sbjct: 178 GLARASEKFAQTVMTSRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 9e-85
Identities = 77/184 (41%), Positives = 110/184 (59%), Gaps = 3/184 (1%)
Query: 494 WLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLE-EFK 552
L FSL + A++NFS + LG GGFG VYKGRL +G VAVKRL + QG E +F+
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 553 NEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRL-LGWQARIG 611
E+ +I+ HRNL+R+ G C+ E++L+ YM N S+ L + + + L W R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 612 IIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKR 671
I G A+GL YLH + +IIHRD+KA+N+LLD + + DFGLA++ + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-A 194
Query: 672 IVGT 675
+ GT
Sbjct: 195 VRGT 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 2e-76
Identities = 69/179 (38%), Positives = 107/179 (59%), Gaps = 4/179 (2%)
Query: 498 FSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLL 557
L + AT NF + +G G FG VYKG L +G +VA+KR + +S QG+EEF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 558 IAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRL-LGWQARIGIIEGI 616
++ +H +LV ++G C E+ E ILI +YM N +L L+ + + W+ R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 617 AQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
A+GL YLH + IIHRD+K+ N+LLD + PKI+DFG+++ + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-61
Identities = 54/189 (28%), Positives = 84/189 (44%), Gaps = 17/189 (8%)
Query: 498 FSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLL 557
++ + + G FG V+K +L E VAVK Q Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 558 IAKLQHRNLVRILGCCIE----QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGII 613
+ ++H N+++ +G + LI + SL FL K ++ W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 614 EGIAQGLLYLHH-------YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQ 666
E +A+GL YLH + I HRD+K+ NVLL ++ I+DFGLA F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 667 GNTKRIVGT 675
G+T VGT
Sbjct: 188 GDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 4e-53
Identities = 56/197 (28%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 498 FSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNE--M 555
+ + + +N + +G G +G VYKG L + VAVK S + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 556 LLIAKLQHRNLVRILGCCIE-----QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARI 610
+ ++H N+ R + + E +L++EY PN SL +L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114
Query: 611 GIIEGIAQGLLYLH------HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG-- 662
+ + +GL YLH + + I HRDL + NVL+ D ISDFGL+ G
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 663 ----DELQGNTKRIVGT 675
E VGT
Sbjct: 175 LVRPGEEDNAAISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 51/170 (30%), Positives = 91/170 (53%), Gaps = 6/170 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRN 565
+ +++ K+G G FG V++ +G +VAVK L Q + + EF E+ ++ +L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+V +G + ++ EY+ SL L + L + R+ + +A+G+ YLH+
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
I+HR+LK+ N+L+D+ K+ DFGL+R+ L +K GT
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGT 202
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 11/169 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
+ +E +G G FG V K + ++VA+K++ S+S + F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
++ G C+ L++EY SL L + +QG+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 628 RFRIIHRDLKASNVLLDRDMN-PKISDFGLARMFGGDELQGNTKRIVGT 675
+IHRDLK N+LL KI DFG A ++Q + G+
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGS 166
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-43
Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 23/181 (12%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQG-------LEEFKNEMLLIA 559
E ++G+GGFG V+KGRL+ + VA+K L +G +EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 560 KLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG 619
L H N+V++ G +++E++P L L D K + W ++ ++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLD-----RDMNPKISDFGLARMFGGDELQGNTKRIVG 674
+ Y+ + I+HRDL++ N+ L + K++DFGL++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 675 T 675
Sbjct: 189 N 189
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 6/165 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
+ LG+G FG K GE + +K L + F E+ ++ L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
++ +G + I EY+ +L + + W R+ + IA G+ YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH-- 125
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKR 671
IIHRDL + N L+ + N ++DFGLAR+ ++ Q R
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 7/157 (4%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRN 565
+ + KL E G ++KGR G ++ VK L + S + +F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 566 LVRILGCCIEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
++ +LG C I +MP SL L + T + + +A+G+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
H I L + +V++D DM +IS + F
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRL----SSQSGQGLEEFKNEMLLIAKLQH 563
++E +G GGFG VY+ G+EVAVK Q +E + E L A L+H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
N++ + G C+++ L++E+ L+ L + + + IA+G+ YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYL 121
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNP--------KISDFGLARMFGGDELQGNT 669
H + IIHRDLK+SN+L+ + + KI+DFGLAR +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 10/170 (5%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRN 565
++ ++G G FG VYKG+ +G+ VAVK L+ + Q L+ FKNE+ ++ K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
++ +G I + ++ SL L K + I I A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLH- 137
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
IIHRDLK++N+ L D KI DFGLA +++ G+
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNE--MLLIAKLQHR 564
+ ++ +G+G +G V++G GE VAVK SS+ + + E + L+H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 565 NLVRILGCCIEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGL 620
N++ + + LI Y SL +L + L + + I+ IA GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118
Query: 621 LYLH-----HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF--GGDELQGNTKRIV 673
+LH + I HRDLK+ N+L+ ++ I+D GLA M ++L V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 674 GT 675
GT
Sbjct: 179 GT 180
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNE--MLLIAKLQHRN 565
+ M ++G+G +G V+ G+ GE+VAVK + + E + ++H N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 566 LVRILGCCIEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
++ + I+ LI +Y N SL +L K L ++ + + GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 622 YLH-----HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF--GGDELQGNTKRIVG 674
+LH + I HRDLK+ N+L+ ++ I+D GLA F +E+ VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 675 T 675
T
Sbjct: 209 T 209
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRN 565
E + +G+G FG VY GR +GE VA++ + + + L+ FK E++ + +H N
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+V +G C+ +I ++L + D K +L I + I +G+ YLH
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH- 147
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKR 671
++ I+H+DLK+ NV D + I+DFGL + G + +
Sbjct: 148 -AK-GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 56/165 (33%), Positives = 80/165 (48%), Gaps = 15/165 (9%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLN-----GEEVAVKRLSSQSG-QGLEEFKNEMLLIAKL 561
LGEG FG V GE VAVK L + +G Q +K E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 562 QHRNLVRILGCCIEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG 619
H ++++ GCC + G L++EY+P SL +L + +G + + I +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ YLH ++ IHRDL A NVLLD D KI DFGLA+
Sbjct: 147 MAYLH--AQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 12/164 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-----NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ 562
+ +LG+G FG V R GE VAVK+L + + L +F+ E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 563 HRNLVRILGCCIEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGL 620
H N+V+ G C G + LI+EY+P SL +L K + + I +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
YL ++ R IHRDL N+L++ + KI DFGL ++ D+
Sbjct: 128 EYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 12/164 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-----NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ 562
+ +LG+G FG V R GE VAVK+L + + L +F+ E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 563 HRNLVRILGCCIEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGL 620
H N+V+ G C G + LI+EY+P SL +L K + + I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
YL ++ R IHRDL N+L++ + KI DFGL ++ D+
Sbjct: 159 EYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 57/165 (34%), Positives = 84/165 (50%), Gaps = 13/165 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-----NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKL 561
LGEG FG V R GE+VAVK L +SG + + K E+ ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 562 QHRNLVRILGCCIEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG 619
H N+V+ G C E G LI+E++P+ SL +L P K + + ++ I +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ YL SR + +HRDL A NVL++ + KI DFGL + D+
Sbjct: 139 MDYLG--SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-----NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ 562
+ +LG+G FG V R G VAVK+L +F+ E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 563 HRNLVRILGCCIEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGL 620
+V+ G G + L++EY+P+ L FL + L + I +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
YL SR R +HRDL A N+L++ + + KI+DFGLA++ D+
Sbjct: 141 EYLG--SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 24/204 (11%)
Query: 485 DRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQS 544
D S LPL ++A ++ +G+G FG V++G+ GEEVAVK SS+
Sbjct: 22 DMTTSGSGSGLPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE 77
Query: 545 GQGLEEFKNE--MLLIAKLQHRNLVRILGCCIEQGEKI----LILEYMPNKSLDVFLFDP 598
+ E + L+H N++ + + L+ +Y + SL +L
Sbjct: 78 ---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--- 131
Query: 599 TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR-----IIHRDLKASNVLLDRDMNPKISD 653
+ + + I + A GL +LH I HRDLK+ N+L+ ++ I+D
Sbjct: 132 -NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190
Query: 654 FGLARMF--GGDELQGNTKRIVGT 675
GLA D + VGT
Sbjct: 191 LGLAVRHDSATDTIDIAPNHRVGT 214
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 12/163 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE-----VAVKRL-SSQSGQGLEEFKNEMLLIAKL 561
F LG G FG VYKG + E VA+K L + S + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
+ ++ R+LG C+ ++ I + MP L ++ + K +G Q + IA+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
YL R++HRDL A NVL+ + KI+DFGLA++ G +E
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
+ ++G G FG V+ G LN ++VA+K + + E+F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 66
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
++ G C+EQ L+ E+M + L +L T++ L + +G+ + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+IHRDL A N L+ + K+SDFG+ R D+
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-35
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 7/159 (4%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGE-EVAVKRL-SSQSGQGLEEFKNEMLLIAKLQHRN 565
E+ + ++G G FG V+ GRL VAVK + +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+VR++G C ++ +++E + FL T+ L + + ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLE- 230
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
IHRDL A N L+ KISDFG++R
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 568 RILGCCIEQGEKILI-LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
++LG +E+ + I EYM SL +L + +LG + + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+HRDL A NVL+ D K+SDFGL +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 12/163 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE-----VAVKRLSSQSG-QGLEEFKNEMLLIAKL 561
LG G FG V+KG + E V +K + +SG Q + + ML I L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
H ++VR+LG C ++ + +Y+P SL + + LG Q + IA+G+
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMY 129
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
YL ++HR+L A NVLL +++DFG+A + D+
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 568 RILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
++LG +E+ + ++ EYM SL +L + +LG + + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+HRDL A NVL+ D K+SDFGL +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE------VAVKRLSSQSGQGLEEFKNEMLLIAKL 561
+ ++ +LGEG FG V+ N VAVK L S ++F+ E L+ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL------------FDPTKKRLLGWQAR 609
QH+++VR G C E +++ EYM + L+ FL + LG
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 610 IGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ + +A G++YL + +HRDL N L+ + + KI DFG++R
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 49/158 (31%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGE-EVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
+ +M+ KLG G +G VY+G VAVK L + + +EEF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
V++LG C + +I E+M +L +L + ++ + + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ IHRDL A N L+ + K++DFGL+R+ GD
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 22/170 (12%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE------VAVKRLSSQSGQGLEEFKNEMLLIAKL 561
+ ++ +LGEG FG V+ N VAVK L + ++F+ E L+ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLLGWQA 608
QH ++V+ G C + I++ EYM + L+ FL K LG
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 609 RIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ I IA G++YL + +HRDL N L+ ++ KI DFG++R
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-34
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E ++ +LG G FG V G+ +VAVK + S +EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
+ G C ++ ++ EY+ N L +L + + L + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ IHRDL A N L+DRD+ K+SDFG+ R D+
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 12/163 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE-----VAVKRL-SSQSGQGLEEFKNEMLLIAKL 561
F LG G FG VYKG + E VA+K L + S + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
+ ++ R+LG C+ ++ I + MP L ++ + K +G Q + IA+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
YL R++HRDL A NVL+ + KI+DFGLA++ G +E
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 6/157 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
++ + +LG G FG V G+ +VA+K + S +EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 82
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
++ G C +Q +I EYM N L +L + Q + + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ +HRDL A N L++ K+SDFGL+R DE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE---VAVKRL-SSQSGQGLEEFKNEMLLIAKL-Q 562
+ + +GEG FG V K R+ A+KR+ S +F E+ ++ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLLGWQAR 609
H N++ +LG C +G L +EY P+ +L FL + L Q
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 610 IGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ +A+G+ YL S+ + IHRDL A N+L+ + KI+DFGL+R
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE----VAVKRL--SSQSGQGLEEFKNEMLLIAKL 561
+ LGEG FG V +G L + VAVK + + S + +EEF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 562 QHRNLVRILGCCIEQG-----EKILILEYMPNKSLDVFL---FDPTKKRLLGWQARIGII 613
H N++R+LG CIE + ++IL +M L +L T + + Q + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 614 EGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
IA G+ YL S +HRDL A N +L DM ++DFGL++
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 57/171 (33%), Positives = 77/171 (45%), Gaps = 23/171 (13%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE------VAVKRL-SSQSGQGLEEFKNEMLLIAK 560
+LGE FG VYKG L VA+K L G EEF++E +L A+
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLLGWQ 607
LQH N+V +LG + +I Y + L FL D T K L
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 608 ARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ ++ IA G+ YL S ++H+DL NVL+ +N KISD GL R
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 55/157 (35%), Positives = 81/157 (51%), Gaps = 6/157 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E + +LG G FG V+ G +VAVK L S + F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
R+ ++ I I EYM N SL FL P L + + IA+G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
IHRDL+A+N+L+ ++ KI+DFGLAR+ +E
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 512 MECKLGEGGFGPVYKGRLLNGE---EVAVKRL--SSQSGQGLEEFKNEMLLIAKLQHRNL 566
+ +LG G FG V KG + VAVK L + +E E ++ +L + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 567 VRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
VR++G C + E L++E L+ +L + R + + I ++ ++ G+ YL
Sbjct: 81 VRMIGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-- 133
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+HRDL A NVLL KISDFGL++ DE
Sbjct: 134 -EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 49/164 (29%), Positives = 72/164 (43%), Gaps = 13/164 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGE----EVAVKRL---SSQSGQGLEEFKNEMLLIAK 560
++ + KLG+G FG V +G VAVK L + +++F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGL 620
L HRNL+R+ G + K+ + E P SL L + +A+G+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGM 134
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
YL R IHRDL A N+LL KI DFGL R ++
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 512 MECKLGEGGFGPVYKGRLLNGEE---VAVKRL-SSQSGQGLEEFKNEMLLIAKLQHRNLV 567
+ +LG G FG V +G ++ VA+K L EE E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 568 RILGCCIEQGEKILI-LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
R++G C Q E +++ +E L FL K+ + ++ ++ G+ YL
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL--- 126
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+HRDL A NVLL KISDFGL++ G D+
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 51/157 (32%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E+ +E KLG G FG V+ +VAVK + S +E F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 246
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
++ ++ I I E+M SL FL + I IA+G+ ++
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ IHRDL+A+N+L+ + KI+DFGLAR+ +E
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 49/166 (29%), Positives = 76/166 (45%), Gaps = 18/166 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE----VAVKRL--SSQSGQGLEEFKNEMLLIAKL 561
+ F++ LG+G FG V + +L + VAVK L + +EEF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 562 QHRNLVRILGCCIEQGEKI------LILEYMPNKSLDVFLFD---PTKKRLLGWQARIGI 612
H ++ +++G + K +IL +M + L FL L Q +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 613 IEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ IA G+ YL S IHRDL A N +L DM ++DFGL+R
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE----VAVKRL-SSQSGQGLEEFKNEMLLIAKLQ 562
+E +G G G V GRL + VA+K L + + + +F +E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
H N++R+ G +++ EYM N SLD FL + +G++ G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRY 166
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
L S +HRDL A NVL+D ++ K+SDFGL+R+ D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-33
Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGE-EVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
+ +M+ KLG G +G VY+G VAVK L + + +EEF E ++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 278
Query: 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
V++LG C + +I E+M +L +L + ++ + + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ IHR+L A N L+ + K++DFGL+R+ GD
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 42/175 (24%), Positives = 75/175 (42%), Gaps = 25/175 (14%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGE--------EVAVKRLSSQSGQGLEEFKNEMLLIA 559
E+ LG+G F ++KG EV +K L E F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 560 KLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG 619
KL H++LV G C+ E IL+ E++ SLD +L K + ++ + + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAA 125
Query: 620 LLYL--HHYSRFRIIHRDLKASNVLLDRDMNP--------KISDFGLARMFGGDE 664
+ +L + IH ++ A N+LL R+ + K+SD G++ +
Sbjct: 126 MHFLEENTL-----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 51/154 (33%), Positives = 76/154 (49%), Gaps = 19/154 (12%)
Query: 515 KLGEGGFGPVYKGRLLNGEE----VAVKRL-SSQSGQGLEEFKNEMLLIAKLQHRNLVRI 569
+G G FG VY G LL+ + AVK L + +F E +++ H N++ +
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 570 LGCCIEQGEKIL-ILEYMPNKSLDVFL----FDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
LG C+ L +L YM + L F+ +PT K L IG +A+G+ YL
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL------IGFGLQVAKGMKYL- 144
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ + +HRDL A N +LD K++DFGLAR
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE------VAVKRL-SSQSGQGLEEFKNEMLLIAK 560
E +M +LG+G FG VY+G + VA+K + + S + EF NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-------FDPTKKRLLGWQARIGII 613
++VR+LG + ++I+E M L +L + I +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 614 EGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
IA G+ YL + + +HRDL A N ++ D KI DFG+ R
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 63/245 (25%), Positives = 99/245 (40%), Gaps = 29/245 (11%)
Query: 424 GNKKLLWIIVIVVPPMVLLPSVYIFCRQRRKCKEKENMETSQDLLAFDITTRPNEFSEAN 483
G ++ I+VP P + C S++L T + S N
Sbjct: 15 GRRRASVAAGILVPRGS--PGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72
Query: 484 GDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEE----VAVKR 539
+ + + SL +G G FG VY G LL+ + AVK
Sbjct: 73 PELVQAVQHVVIGPSSL--------IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 124
Query: 540 L-SSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL-ILEYMPNKSLDVFL-- 595
L + +F E +++ H N++ +LG C+ L +L YM + L F+
Sbjct: 125 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 184
Query: 596 --FDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISD 653
+PT K L IG +A+G+ +L + + +HRDL A N +LD K++D
Sbjct: 185 ETHNPTVKDL------IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 235
Query: 654 FGLAR 658
FGLAR
Sbjct: 236 FGLAR 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 19/184 (10%)
Query: 481 EANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEE----VA 536
+ + + KD +P + + +G+G FG VY G ++ + A
Sbjct: 2 DLDSALLAEVKDVLIPHERV--------VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCA 53
Query: 537 VKRL-SSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI-LEYMPNKSLDVF 594
+K L Q +E F E LL+ L H N++ ++G + + L YM + L F
Sbjct: 54 IKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQF 113
Query: 595 LFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDF 654
+ P +R + I +A+G+ YL + + +HRDL A N +LD K++DF
Sbjct: 114 IRSP--QRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADF 168
Query: 655 GLAR 658
GLAR
Sbjct: 169 GLAR 172
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 11/163 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE-----VAVKRL-SSQSGQGLEEFKNEMLLIAKL 561
+ + +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
H N++R+ G + ++I EYM N +LD FL K +G++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
YL + +HRDL A N+L++ ++ K+SDFGL+R+ D
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 53/165 (32%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGE------EVAVKRL-SSQSGQGLEEFKNEMLLIAK 560
+N ++ LG G FG VY+G++ +VAVK L S Q +F E L+I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARIGIIEGI 616
H+N+VR +G ++ + +++E M L FL P++ L + + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 617 AQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDFGLAR 658
A G YL IHRD+ A N LL KI DFG+AR
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 52/162 (32%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE----VAVKRL-SSQSGQGLEEFKNEMLLIAKLQ 562
N S++ +G G FG V GRL + VA+K L + + +F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
H N++R+ G + +++ EYM N SLD FL +G++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
L S +HRDL A N+L++ ++ K+SDFGL R+ D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 54/165 (32%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGE------EVAVKRL-SSQSGQGLEEFKNEMLLIAK 560
+N ++ LG G FG VY+G++ +VAVK L S Q +F E L+I+K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARIGIIEGI 616
H+N+VR +G ++ + ++LE M L FL P++ L + + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 617 AQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDFGLAR 658
A G YL IHRD+ A N LL KI DFG+AR
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 11/162 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE----VAVKRL-SSQSGQGLEEFKNEMLLIAKLQ 562
E + +GEG FG V++G ++ E VA+K + S E+F E L + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
H ++V+++G E I I+E L FL +K L + I ++ L Y
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
L R +HRD+ A NVL+ + K+ DFGL+R
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 11/162 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE----VAVKRL-SSQSGQGLEEFKNEMLLIAKLQ 562
E+ + LGEG FG VY+G N + VAVK + E+F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
H ++V+++G E+ I I+E P L +L K L + I + + Y
Sbjct: 72 HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
L +HRD+ N+L+ K+ DFGL+R ++
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-31
Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 6/157 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E+ +E KLG+G FG V+ G VA+K L + E F E ++ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 242
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
++ E+ I + EYM SL FL + L + + IA G+ Y+
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
R +HRDL+A+N+L+ ++ K++DFGLAR+ +E
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 51/179 (28%), Positives = 74/179 (41%), Gaps = 31/179 (17%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE------VAVKRL-SSQSGQGLEEFKNEMLLIAK 560
N +GEG FG V++ R VAVK L S +F+ E L+A+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL---------------------FDPT 599
+ N+V++LG C L+ EYM L+ FL
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 600 KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
L ++ I +A G+ YL S + +HRDL N L+ +M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE------VAVKRL-SSQSGQGLEEFKNEMLLIAK 560
+ + LG G FG V + ++ VAVK L + +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 561 L-QHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFL-------------FDPTKKRLLG 605
+ H N+V +LG C + G + +I+E+ +L +L + K L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 606 WQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ I +A+G+ +L + + IHRDL A N+LL KI DFGLAR
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 10/157 (6%)
Query: 512 MECKLGEGGFGPVYKGRLLNGEE---VAVKRL-SSQSGQGLEEFKNEMLLIAKLQHRNLV 567
+ +LG G FG V +G ++ VA+K L EE E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
R++G C + + ++E L FL K+ + ++ ++ G+ YL
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+HR+L A NVLL KISDFGL++ G D+
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 31/179 (17%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE------VAVKRL-SSQSGQGLEEFKNEMLLIAK 560
+N + LGEG FG V K + + VAVK L + S L + +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARIGIIEG 615
+ H +++++ G C + G +LI+EY SL FL P G + +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 616 ----------------IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
I+QG+ YL + +++HRDL A N+L+ KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 6/157 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E+ +E KLG+G FG V+ G VA+K L + E F E ++ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 325
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
++ E+ I + EYM SL FL + L + + IA G+ Y+
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
R +HRDL+A+N+L+ ++ K++DFGLAR+ +E
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 26/174 (14%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE--------VAVKRL-SSQSGQGLEEFKNEMLLI 558
+ ++ LGEG FG V + ++ VAVK L + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 559 AKL-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 604
+ +H+N++ +LG C + G +I+EY +L +L + + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 605 GWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
++ + +A+G+ YL + + IHRDL A NVL+ + KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 26/174 (14%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE--------VAVKRL-SSQSGQGLEEFKNEMLLI 558
+ ++ LGEG FG V + ++ VAVK L + + L + +EM ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 559 AKL-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 604
+ +H+N++ +LG C + G +I+EY +L +L + + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 605 GWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
++ + +A+G+ YL + + IHRDL A NVL+ + KI+DFGLAR
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 17/161 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
+++ KLGEGGF V L +G A+KR+ Q EE + E + H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 567 VRILGCCIEQGEK----ILILEYMPNKSLDVFLFDPTKKRLLGWQ----ARI-GIIEGIA 617
+R++ C+ + L+L + +L ++ ++ +I ++ GI
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTL----WNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+GL +H HRDLK +N+LL + P + D G
Sbjct: 145 RGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 50/174 (28%), Positives = 71/174 (40%), Gaps = 26/174 (14%)
Query: 508 ENFSMECKLGEGGFGPVYKGRL--LNGEE----VAVKRL-SSQSGQGLEEFKNEMLLIAK 560
S LG G FG V + L + VAVK L S E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 561 L-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEG---- 615
L H N+V +LG C G ++I EY L FL + + + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 616 -----------IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+A+G+ +L + IHRDL A N+LL KI DFGLAR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 11/162 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE----VAVKRL-SSQSGQGLEEFKNEMLLIAKLQ 562
E + +GEG FG V++G ++ E VA+K + S E+F E L + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
H ++V+++G E I I+E L FL +K L + I ++ L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
L R +HRD+ A NVL+ + K+ DFGL+R
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 53/170 (31%), Positives = 72/170 (42%), Gaps = 22/170 (12%)
Query: 508 ENFSMECKLGEGGFGPVYKGRL--LNGEE----VAVKRL-SSQSGQGLEEFKNEMLLIAK 560
N LG G FG V + L E+ VAVK L S+ E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 561 L-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-----------FDPTKKRLLGWQA 608
L QH N+V +LG C G ++I EY L FL +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 609 RIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ +AQG+ +L + IHRD+ A NVLL KI DFGLAR
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 50/185 (27%), Positives = 83/185 (44%), Gaps = 28/185 (15%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
+F +G GGFG V+K + ++G+ +KR+ + E+ + E+ +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 567 VRILGCCIEQGEKI----------------LILEYMPNKSLDVFLFDPTKKRLLGWQARI 610
V GC + +E+ +L+ ++ ++L A
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 611 GIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTK 670
+ E I +G+ Y+H S+ ++I+RDLK SN+ L KI DFGL D G
Sbjct: 127 -LFEQITKGVDYIH--SK-KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 671 RIVGT 675
R GT
Sbjct: 180 RSKGT 184
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-30
Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 26/174 (14%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGE--------EVAVKRL-SSQSGQGLEEFKNEMLLI 558
+ + LGEG FG V + + +VAVK L S + + L + +EM ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 559 AKL-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 604
+ +H+N++ +LG C + G +I+EY +L +L + L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 605 GWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ + +A+G+ YL + + IHRDL A NVL+ D KI+DFGLAR
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 43/171 (25%), Positives = 79/171 (46%), Gaps = 9/171 (5%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHR 564
E + K+GEG FG + +G + +K +S S + EE + E+ ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
N+V+ E G ++++Y L + + K L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
R +I+HRD+K+ N+ L +D ++ DFG+AR+ +GT
Sbjct: 143 --DR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 12/172 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKR--LSSQSGQGLEEFKNEMLLIAKLQHRN 565
+S+ ++G GG V++ + A+K L Q L+ ++NE+ + KLQ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 566 L--VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
+R+ I +++E N L+ +L KK + W+ + + + + + +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK--KKSIDPWERKS-YWKNMLEAVHTI 143
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
H + I+H DLK +N L+ D K+ DFG+A D VGT
Sbjct: 144 H---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 54/163 (33%), Positives = 82/163 (50%), Gaps = 9/163 (5%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCI 574
LG+G +G VY GR L N +A+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 575 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGII-EGIAQGLLYLHHYSRFRIIH 633
E G + +E +P SL L L + IG + I +GL YLH +I+H
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 634 RDLKASNVLLD-RDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
RD+K NVL++ KISDFG ++ G + T+ GT
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGT 186
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 47/163 (28%), Positives = 71/163 (43%), Gaps = 16/163 (9%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK---RLSSQSGQGLEEFKNEMLLIAKLQH 563
+ LG+GGF ++ E A K + E+ E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 564 RNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGL 620
+++V G E + + ++LE +SL + +K L +AR + I G
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGC 128
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663
YLH R R+IHRDLK N+ L+ D+ KI DFGLA D
Sbjct: 129 QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 47/156 (30%), Positives = 70/156 (44%), Gaps = 16/156 (10%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVK---RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
LG+GGF ++ E A K + E+ E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 572 CCIEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLLYLHHYSR 628
E + + ++LE +SL + +K L +AR + I G YLH R
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLH---R 159
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
R+IHRDLK N+ L+ D+ KI DFGLA D
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 12/172 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKR--LSSQSGQGLEEFKNEMLLIAKLQHRN 565
+S+ ++G GG V++ + A+K L Q L+ ++NE+ + KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 566 L--VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
+R+ I +++E N L+ +L KK + W+ + + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKS-YWKNMLEAVHTI 124
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
H + I+H DLK +N L+ D K+ DFG+A D VGT
Sbjct: 125 H---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 17/176 (9%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRN 565
+F LG GGFG V++ + ++ A+KR+ E+ E+ +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 566 LVRILGCCIEQGEKI------------LILEYMPNKSLDVFLFDPTKKRLLGWQARIGII 613
+VR +E+ + ++ ++L ++ + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 614 EGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT 669
IA+ + +LH S+ ++HRDLK SN+ D K+ DFGL DE +
Sbjct: 125 LQIAEAVEFLH--SK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 16/169 (9%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
++G G F VYKG EVA + + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 572 CCIEQGEK----ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
+ +L+ E M + +L +L + +++ + I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 628 RFRIIHRDLKASNVLLD-RDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
IIHRDLK N+ + + KI D GLA + K ++GT
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 193
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 52/187 (27%), Positives = 69/187 (36%), Gaps = 47/187 (25%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE------VAVKRL-SSQSGQGLEEFKNEMLLIAK 560
EN LG G FG V + VAVK L E +E+ ++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 561 L-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL------------------------ 595
L H N+V +LG C G LI EY L +L
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 596 --FDPTKKRLL--GWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI 651
T + LL +Q +A+G+ +L +HRDL A NVL+ KI
Sbjct: 165 DLNVLTFEDLLCFAYQ--------VAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKI 213
Query: 652 SDFGLAR 658
DFGLAR
Sbjct: 214 CDFGLAR 220
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 12/165 (7%)
Query: 515 KLGEGGFGPVYKGRLLNGEEVAVKR--LSSQSGQGLEEFKNEMLLIAKLQHRNL--VRIL 570
++G GG V++ + A+K L Q L+ ++NE+ + KLQ + +R+
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
I +++E N L+ +L KK + W+ + + + + + +H +
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKS-YWKNMLEAVHTIH---QHG 175
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
I+H DLK +N L+ D K+ DFG+A D VG
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 10/173 (5%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL---SSQSGQGLEEFKNEMLLIAKLQH 563
NF +E K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARI-GIIEGIAQGLLY 622
N+++ IE E ++LE L + K++ L + + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+H R++HRD+K +NV + K+ D GL R F ++ +VGT
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 10/176 (5%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHR 564
E++ + +G G +G K R +G+ + K S + + +E+ L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 565 NLVRILGCCIEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARI-GIIEGIAQGLL 621
N+VR I++ L ++EY L + TK+R + + ++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 622 YLH--HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
H ++HRDLK +NV LD N K+ DFGLAR+ D T VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 24/170 (14%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565
+F LG+G FG V K R L+ A+K++ + L +E++L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 566 LVRILGCCIEQGEKI-------------LILEYMPNKSLDVFLFD--PTKKRLLGWQARI 610
+VR +E+ + + +EY N +L +D ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 611 GIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
+ I + L Y+H S+ IIHRDLK N+ +D N KI DFGLA+
Sbjct: 120 RLFRQILEALSYIH--SQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 47/170 (27%), Positives = 91/170 (53%), Gaps = 8/170 (4%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565
E + + +LG+G FG VYK + G A K + ++S + LE++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+V++LG G+ +++E+ P ++D + + L Q ++ + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLH- 134
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
RIIHRDLKA NVL+ + + +++DFG++ + ++ +GT
Sbjct: 135 --SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT 180
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 46/171 (26%), Positives = 89/171 (52%), Gaps = 12/171 (7%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565
+ ++ K+G+G G VY + G+EVA+++++ Q E NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGII-EGIAQGLLYLH 624
+V L + E +++EY+ SL D + + + +I + Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD-EGQIAAVCRECLQALEFLH 133
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 33/181 (18%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN--------EMLLI 558
ENF K+GEG +G VYK R L GE VA+K++ L+ E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 559 AKLQHRNLVRILGCCIEQGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARIGI 612
+L H N+V++L + + L+ E++ + + + +Q
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----- 111
Query: 613 IEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRI 672
+ QGL + H + R++HRDLK N+L++ + K++DFGLAR F G ++ T +
Sbjct: 112 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 164
Query: 673 V 673
V
Sbjct: 165 V 165
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 52/158 (32%), Positives = 81/158 (51%), Gaps = 17/158 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL--SSQSGQGLEE-FKNEMLLIAKLQH 563
E+F + LG+G F VY+ + G EVA+K + + G+ + +NE+ + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 564 RNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTK---KRLLGWQARIGIIEGIAQG 619
+++ + E + L+LE N + K K +AR + I G
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARH-FMHQIITG 124
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
+LYLH I+HRDL SN+LL R+MN KI+DFGLA
Sbjct: 125 MLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 12/171 (7%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565
K+GEG G V R +G +VAVK + + Q E NE++++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGII-EGIAQGLLYLH 624
+V + + E +++E++ +L D + L + +I + E + Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLN-EEQIATVCEAVLQALAYLH 158
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+IHRD+K+ ++LL D K+SDFG D + + +VGT
Sbjct: 159 ---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGT 204
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 31/179 (17%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKN--------EMLLIA 559
E + K+GEG +G VYK + G VA+KR+ L+ E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 560 KLQHRNLVRILGCCIEQGEKILILEYMPN---KSLDVF--LFDPTKKRLLGWQARIGIIE 614
+L H N+V ++ + L+ E+M K LD ++ ++ +Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ------- 127
Query: 615 GIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIV 673
+ +G+ + H + RI+HRDLK N+L++ D K++DFGLAR F G ++ T +V
Sbjct: 128 -LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 6e-27
Identities = 41/167 (24%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRN 565
+ + LG+G V++GR G+ A+K + + ++ E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 566 LVRILGCCIEQGEK---ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
+V++ E+ +LI+E+ P SL L +P+ L + ++ + G+ +
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 623 LHHYSRFRIIHRDLKASNVLL----DRDMNPKISDFGLARMFGGDEL 665
L I+HR++K N++ D K++DFG AR DE
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 47/180 (26%), Positives = 85/180 (47%), Gaps = 32/180 (17%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN--------EMLLI 558
+ + K+GEG +G V+K + E VA+KR+ L++ E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 559 AKLQHRNLVRILGCCIEQGEKILILEYMPN---KSLDV--FLFDPTKKRLLGWQARIGII 613
+L+H+N+VR+ + L+ E+ K D DP + +Q
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109
Query: 614 EGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIV 673
+ +GL + H ++HRDLK N+L++R+ K+++FGLAR F G ++ + +V
Sbjct: 110 --LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 42/162 (25%), Positives = 66/162 (40%), Gaps = 12/162 (7%)
Query: 509 NFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNL 566
+ L EGGF VY+ + + +G E A+KRL S + E+ + KL H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 567 VRILGCCIEQGEK-------ILILEYMPNKSL-DVFLFDPTKKRLLGWQARIGIIEGIAQ 618
V+ E+ L+L + L + ++ L I +
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTCR 147
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
+ ++H + IIHRDLK N+LL K+ DFG A
Sbjct: 148 AVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 47/182 (25%), Positives = 89/182 (48%), Gaps = 21/182 (11%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRN 565
+++ ++ +G G V E+VA+KR++ + ++E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIE--GIA------ 617
+V + + E L+++ + S+ D K + + + G+++ IA
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 618 -QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL-ARMFGGDELQGNTKR--IV 673
+GL YLH + IHRD+KA N+LL D + +I+DFG+ A + G ++ N R V
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 674 GT 675
GT
Sbjct: 188 GT 189
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 41/167 (24%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRN 565
+ + LG+G V++GR G+ A+K + + ++ E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 566 LVRILGCCIEQGEK---ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
+V++ E+ +LI+E+ P SL L +P+ L + ++ + G+ +
Sbjct: 69 IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 623 LHHYSRFRIIHRDLKASNVLL----DRDMNPKISDFGLARMFGGDEL 665
L I+HR++K N++ D K++DFG AR DE
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (271), Expect = 3e-26
Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 31/179 (17%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKN--------EMLLIA 559
E + K+GEG +G VYK + GE A+K++ LE+ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 560 KLQHRNLVRILGCCIEQGEKILILEYMPN---KSLDV--FLFDPTKKRLLGWQARIGIIE 614
+L+H N+V++ + +L+ E++ K LDV + + Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ------- 108
Query: 615 GIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIV 673
+ G+ Y H R++HRDLK N+L++R+ KI+DFGLAR F G ++ T IV
Sbjct: 109 -LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 46/207 (22%), Positives = 76/207 (36%), Gaps = 17/207 (8%)
Query: 474 TRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGR-LLNG 532
+ D L + + ++G G FG V++ + G
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVD-YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTG 83
Query: 533 EEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLD 592
+ AVK++ + + E++ A L +V + G E + +E + SL
Sbjct: 84 FQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 593 VFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP-KI 651
+ + L + + +GL YLH RI+H D+KA NVLL D + +
Sbjct: 139 QLI---KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAAL 192
Query: 652 SDFGLARMFGGDELQGNTKR---IVGT 675
DFG A D L + I GT
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 13/172 (7%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQG-LEEFKNEMLLIAKLQHR 564
E F+ K+G+G FG V+KG + VA+K + + + +E+ + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGII-EGIAQGLLYL 623
+ + G ++ + +I+EY+ S D + L + +I I I +GL YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLD-ETQIATILREILKGLDYL 135
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
H + IHRD+KA+NVLL K++DFG+A +++ NT VGT
Sbjct: 136 H---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 49/185 (26%), Positives = 80/185 (43%), Gaps = 32/185 (17%)
Query: 505 AATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQG-----LEEFKNEMLLI 558
+++ F KLG G + VYKG G VA+K + S +G + E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 559 AKLQHRNLVRILGCCIEQGEKILILEYM----------PNKSLDVFLFDPTKKRLLGWQA 608
+L+H N+VR+ + + L+ E+M + + WQ
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116
Query: 609 RIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGN 668
+ QGL + H +I+HRDLK N+L+++ K+ DFGLAR F G +
Sbjct: 117 -------LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTF 165
Query: 669 TKRIV 673
+ +V
Sbjct: 166 SSEVV 170
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 58/180 (32%), Positives = 86/180 (47%), Gaps = 12/180 (6%)
Query: 482 ANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL 540
G R KD + L + FS ++G G FG VY R + N E VA+K++
Sbjct: 30 PAGGRAGSLKDP--DVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM 87
Query: 541 S---SQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD 597
S QS + ++ E+ + KL+H N ++ GC + + L++EY + D L +
Sbjct: 88 SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLE 145
Query: 598 PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
KK L + + G QGL YLH +IHRD+KA N+LL K+ DFG A
Sbjct: 146 VHKKPLQEVEIAA-VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 480 SEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK 538
S R+ + L + E F + KLGEG +G VYK G+ VA+K
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 539 RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSL-DVFLFD 597
++ + L+E E+ ++ + ++V+ G + + +++EY S+ D +
Sbjct: 61 QVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD--IIR 116
Query: 598 PTKKRLLGWQARIGII-EGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656
K L + I I + +GL YLH R IHRD+KA N+LL+ + + K++DFG+
Sbjct: 117 LRNKTLTEDE--IATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGV 171
Query: 657 ARMFGGDELQGNTKRIVGT 675
A + NT ++GT
Sbjct: 172 AGQLTDTMAKRNT--VIGT 188
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 50/171 (29%), Positives = 77/171 (45%), Gaps = 34/171 (19%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKN--------EML 556
+ + LGEG F VYK R + VA+K +L + E K+ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR-----SEAKDGINRTALREIK 64
Query: 557 LIAKLQHRNLVRILGCCIEQGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARI 610
L+ +L H N++ +L + L+ ++M K + L K +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM-LM--- 120
Query: 611 GIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
QGL YLH + I+HRDLK +N+LLD + K++DFGLA+ FG
Sbjct: 121 -----TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 56/216 (25%), Positives = 86/216 (39%), Gaps = 38/216 (17%)
Query: 477 NEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGR-LLNGEEV 535
+ G +++ S A A + + + KLGEG +G VYK + E V
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62
Query: 536 AVKRLSSQSGQGLEEFKN--------EMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587
A+KR+ LE + E+ L+ +LQHRN++ + LI EY
Sbjct: 63 AIKRIR------LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA- 115
Query: 588 NKSLDVFL-----FDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVL 642
L ++ + +Q + G+ + H R +HRDLK N+L
Sbjct: 116 ENDLKKYMDKNPDVSMRVIKSFLYQ--------LINGVNFCHSR---RCLHRDLKPQNLL 164
Query: 643 LDRDMNP-----KISDFGLARMFGGDELQGNTKRIV 673
L KI DFGLAR F G ++ T I+
Sbjct: 165 LSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII 199
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 31/168 (18%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN--------EMLLI 558
E + K+GEG +G V+K R G+ VA+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 559 AKLQHRNLVRILGCCIEQGEKILILEYMPN---KSLDVF--LFDPTKKRLLGWQARIGII 613
+L+H NLV +L + L+ EY + LD + + + WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ------ 110
Query: 614 EGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
Q + + H + IHRD+K N+L+ + K+ DFG AR+
Sbjct: 111 --TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 27/166 (16%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKN----EMLLIAK 560
E + +GEG +G V K R G VA+K S + K E+ L+ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPN---KSLDVF--LFDPTKKRLLGWQARIGIIEG 615
L+H NLV +L C ++ L+ E++ + L++F D + +Q
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ-------- 132
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
I G+ + H + IIHRD+K N+L+ + K+ DFG AR
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 26/165 (15%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQG-----LEEFKNEMLLIAKL 561
E + KLGEG + VYKG+ L VA+K + + +G + E L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPN---KSLDV--FLFDPTKKRLLGWQARIGIIEGI 616
+H N+V + + L+ EY+ + LD + + +L +Q +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------L 109
Query: 617 AQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
+GL Y H +++HRDLK N+L++ K++DFGLAR
Sbjct: 110 LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHR 564
F + +G G +G VYKGR + G+ A+K + +G EE K E+ ++ K HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 565 NLVRILGCCIEQGEKI------LILEYMPNKSL-DVFLFDPTKKRLLGWQARIGII-EGI 616
N+ G I++ L++E+ S+ D L TK L + I I I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLK-EEWIAYICREI 138
Query: 617 AQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+GL +LH + ++IHRD+K NVLL + K+ DFG++ + NT +GT
Sbjct: 139 LRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGT 192
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 20/156 (12%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLS----SQSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
LGEG +G V + AVK L + G K E+ L+ +L+H+N+++++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 571 G-CCIEQGEKI-LILEYMPNKSLDVFLFD-PTKKRLLGWQAR---IGIIEGIAQGLLYLH 624
E+ +K+ +++EY + + D +KR QA +I+G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
I+H+D+K N+LL KIS G+A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-25
Identities = 50/170 (29%), Positives = 75/170 (44%), Gaps = 18/170 (10%)
Query: 509 NFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEE-FKNEMLLIAKLQHRNL 566
+ M+ +LG GGFG V + GE+VA+K+ + E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 567 VRILGCCIEQGEKI-------LILEYMPNKSLDVFLFDPTKKRLLG-WQARIGIIEGIAQ 618
V + +K+ L +EY L +L L R ++ I+
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT-LLSDISS 132
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDFGLARMFGGDEL 665
L YLH RIIHRDLK N++L + KI D G A+ EL
Sbjct: 133 ALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 37/183 (20%), Positives = 75/183 (40%), Gaps = 29/183 (15%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLS-----------------SQSGQGLEE 550
++ + L +G F + + + A+K+ ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 551 FKNEMLLIAKLQHRNLVRILGCCIEQGEKI-LILEYMPNKSL------DVFLFDPTKKRL 603
FKNE+ +I +++ + G I +++ +I EYM N S+ L +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 604 LGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663
+ II+ + Y+H + I HRD+K SN+L+D++ K+SDFG +
Sbjct: 149 PIQVIKC-IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 664 ELQ 666
+++
Sbjct: 206 KIK 208
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS----SQSGQGLEEFKNEMLLIAKLQ 562
E+F + LG+G FG VY R + +A+K L ++G + + E+ + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67
Query: 563 HRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
H N++R+ G ++ LILEY P ++ + + + I +A L
Sbjct: 68 HPNILRLYGY-FHDATRVYLILEYAPLGTV--YRELQKLSKFDEQRTAT-YITELANALS 123
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
Y H R+IHRD+K N+LL KI+DFG +
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 25/224 (11%), Positives = 49/224 (21%), Gaps = 39/224 (17%)
Query: 474 TRPNEFSEANGDRRDKSKDSW---LPLFSLASVAAATENFSMECKLGEGGFGPVYKGR-L 529
R E + W + ++ + L G V+ R +
Sbjct: 25 CREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDV 84
Query: 530 LNGEEVAVKRL---SSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC------------- 573
E+ A+K + S LE A+L +
Sbjct: 85 ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144
Query: 574 -------------IEQGEKILILEYMP---NKSLDVFLFDPTKKRLLGWQARIGIIEGIA 617
+L++ F + G A + +
Sbjct: 145 QPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLI 204
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
+ L ++H N+ + D + D G
Sbjct: 205 RLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 45/180 (25%), Positives = 81/180 (45%), Gaps = 26/180 (14%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEML-----LIAKL 561
++ +LG G +G V K R + +G+ +AVKR+ + + + +L + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTV 63
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIG------IIEG 615
V G +G+ + +E M + SLD F K+++ I I
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVS 117
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
I + L +LH S+ +IHRD+K SNVL++ K+ DFG++ D++ + G
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGC 172
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 38/189 (20%), Positives = 68/189 (35%), Gaps = 18/189 (9%)
Query: 499 SLASVAAATENFSMECKLGEG--GFGPVYKGR-LLNGEEVAVKR--LSSQSGQGLEEFKN 553
++S + + +G+G V R GE V V+R L + S + + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 554 EMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARIGI 612
E+ + H N+V I E ++ +M S D L + + I
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMN-ELAIAY 132
Query: 613 I-EGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT-- 669
I +G+ + L Y+H +HR +KAS++L+ D +S +
Sbjct: 133 ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 670 ---KRIVGT 675
K V
Sbjct: 190 DFPKYSVKV 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 47/177 (26%), Positives = 82/177 (46%), Gaps = 41/177 (23%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN--------EMLLI 558
+ K+G+G FG V+K R G++VA+K++ +E K E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 559 AKLQHRNLVRILGCCIEQGEKI--------LILEYMPN------KSLDVFLFDPTKKRLL 604
L+H N+V ++ C + L+ ++ + ++ V KR++
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 605 GWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
+ GL Y+H +I+HRD+KA+NVL+ RD K++DFGLAR F
Sbjct: 131 -QM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 175
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 41/172 (23%), Positives = 62/172 (36%), Gaps = 13/172 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKL-QH 563
++F +LG G +G V+K R +G AVK + + E+ K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
VR+ E G L E SL L Q + + L +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA-WGASLPEAQVWGYLRD-TLLALAHL 173
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
H ++H D+K +N+ L K+ DFGL G + G
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGD 219
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQG---LEEFKNEMLLIAKLQHRNLVRIL 570
KLG GG VY + +VA+K + + L+ F+ E+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
E L++EY+ +L ++ L I I G+ + H R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
I+HRD+K N+L+D + KI DFG+A+ L T ++GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGT 175
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 43/193 (22%), Positives = 69/193 (35%), Gaps = 33/193 (17%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKR--LSSQSGQGLEEFKNEMLLIAKL-Q 562
T F K+G G FG V+K L+G A+KR + E+ A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEG-IAQGLL 621
H ++VR E ++ EY SL + + + +A + + + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNP-------------------KISDFGLARMFGG 662
Y+H ++H D+K SN+ + R P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 663 DELQGNTKRIVGT 675
+ + G
Sbjct: 185 ----SSPQVEEGD 193
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 45/175 (25%)
Query: 514 CKLGEGGFGPVYKGR---LLNGEEVAVKRLS----SQSGQGLEEFKNEMLLIAKLQHRNL 566
CK+G G +G VYK + + ++ A+K++ S S E+ L+ +L+H N+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNV 80
Query: 567 VRILGCCIEQGEKI--LILEYM--------------PNKSLDVFLFDPTKKRLLGWQARI 610
+ + + ++ L+ +Y V L K LL +Q
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-YQ--- 136
Query: 611 GIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP----KISDFGLARMFG 661
I G+ YLH ++HRDLK +N+L+ + KI+D G AR+F
Sbjct: 137 -----ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 22/160 (13%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEML-----LIAKL 561
E+ ++G G +G V K +G+ +AVKR+ S E+ + ++L ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSS 78
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIG------IIEG 615
+V+ G +G+ + +E M + S D F K I I
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLA 133
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655
+ L +L +IIHRD+K SN+LLDR N K+ DFG
Sbjct: 134 TVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 29/194 (14%), Positives = 58/194 (29%), Gaps = 38/194 (19%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQH-------- 563
LG+ + GE V +++ K E+L + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 564 --------RNLVRILGCC-----IEQGEKILILEY---MPNKSLDVFLF------DPTKK 601
+LV+ + +L P ++ F +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 602 RLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
+ L AR+ + + + L LHHY ++H L+ +++LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 662 GDELQGNTKRIVGT 675
G R
Sbjct: 262 GASAVSPIGRGFAP 275
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 45/183 (24%), Positives = 81/183 (44%), Gaps = 34/183 (18%)
Query: 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKN-EMLLIAKLQHRN 565
++ +G G FG V++ +L+ +EVA+K++ + FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 566 LVRILGCCIEQGEKI------LILEYMP---NKSLDVFL-----FDPTKKRLLGWQARIG 611
+V + G+K L+LEY+P ++ + +L +Q
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ---- 149
Query: 612 IIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP-KISDFGLARMFGGDELQGNTK 670
+ + L Y+H I HRD+K N+LLD K+ DFG A++ + N
Sbjct: 150 ----LLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200
Query: 671 RIV 673
I
Sbjct: 201 YIC 203
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 33/177 (18%)
Query: 506 ATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKN----EMLLI 558
AT + ++G G +G VYK R +G VA+K R+ + G G E+ L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALL 65
Query: 559 AKLQ---HRNLVRILGCCIEQGEKI-----LILEYMPN------KSLDVFLFDPTKKRLL 604
+L+ H N+VR++ C L+ E++ + L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 605 GWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
Q +GL +LH I+HRDLK N+L+ K++DFGLAR++
Sbjct: 126 MRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 18/175 (10%)
Query: 509 NFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEM-LLIAKLQHRNLV 567
+F + LG G G + + + +VAVKR+ + E+ LL +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 568 RILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
R C + + + +E +L ++ LG + +++ GL +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIELCA-ATLQEYVEQK-DFAHLGLEPIT-LLQQTTSGLAHLHSL 137
Query: 627 SRFRIIHRDLKASNVLL-----DRDMNPKISDFGLARMFGGDEL-QGNTKRIVGT 675
I+HRDLK N+L+ + ISDFGL + + GT
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS----SQSGQGLEEFKNEMLLIAKLQ 562
++F + LG+G FG VY R N +A+K L + G + + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72
Query: 563 HRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKK--RLLGWQARIGIIEGIAQG 619
H N++R+ ++I L+LE+ P L + +K R ++ +E +A
Sbjct: 73 HPNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSAT-FMEELADA 126
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQ 666
L Y H ++IHRD+K N+L+ KI+DFG + +
Sbjct: 127 LHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 7e-23
Identities = 53/168 (31%), Positives = 75/168 (44%), Gaps = 20/168 (11%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC 573
LGEG +G V + E VAVK + ++ E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 574 IEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARIG---IIEGIAQGLLYLHHYS 627
+G L LEY L FD + A+ ++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
I HRD+K N+LLD N KISDFGLA +F + + ++ GT
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-23
Identities = 36/173 (20%), Positives = 61/173 (35%), Gaps = 31/173 (17%)
Query: 515 KLGEGGFGPVYKGR--LLNGEEVAVKRLSSQSGQGLEE-FKNEMLLIAKLQHRNLVRILG 571
+ GG G +Y +NG V +K L + E +A++ H ++V+I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI-- 144
Query: 572 CCIEQGEKI---------LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
E +++EY+ +SL L I + I L Y
Sbjct: 145 --FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSY 197
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
LH +++ DLK N++L + K+ D G + GT
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGT 240
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 43/179 (24%), Positives = 84/179 (46%), Gaps = 43/179 (24%)
Query: 508 ENFSMECKLGEGGFGPVYKGR--LLNGEEVAVKRLSSQSGQGLEEFKN--------EMLL 557
+ + ++GEG +G V+K R G VA+KR+ ++ + E+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 558 IAKLQ---HRNLVRIL----GCCIEQGEKI-LILEYMPN--KSL-----DVFLFDPTKKR 602
+ L+ H N+VR+ ++ K+ L+ E++ + + + T K
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 603 LLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
++ +Q + +GL +LH + R++HRDLK N+L+ K++DFGLAR++
Sbjct: 125 MM-FQ--------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 7e-23
Identities = 41/186 (22%), Positives = 77/186 (41%), Gaps = 15/186 (8%)
Query: 478 EFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLL-NGEEVA 536
+ E D + + + ++F +LG G G V+K +G +A
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 537 VKRLSSQSGQGLEEFK---NEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDV 593
K + + E+ ++ + +V G GE + +E+M SLD
Sbjct: 63 RKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 594 FL--FDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI 651
L +++LG + + +GL YL + +I+HRD+K SN+L++ K+
Sbjct: 121 VLKKAGRIPEQILG-----KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKL 173
Query: 652 SDFGLA 657
DFG++
Sbjct: 174 CDFGVS 179
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKN-EMLLIAKLQHR 564
+++ +G G FG VY+ +L +GE VA+K++ + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 565 NLVRILGCCIEQGEKI------LILEYMP---NKSLDVFL-----FDPTKKRLLGWQARI 610
N+VR+ GEK L+L+Y+P + + +L +Q
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--- 164
Query: 611 GIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP-KISDFGLARMFGGDE 664
+ + L Y+H F I HRD+K N+LLD D K+ DFG A+ E
Sbjct: 165 -----LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 2e-22
Identities = 48/188 (25%), Positives = 70/188 (37%), Gaps = 31/188 (16%)
Query: 510 FSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEM-LLIAKLQHRNLVR 568
E LG G G V G VAVKR+ + E+ LL H N++R
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 569 ILGCCIEQGEKI-LILEYMPNKSLDVFL-----FDPTKKRLLGWQARIGIIEGIAQGLLY 622
C + + LE N +L + D K + ++ IA G+ +
Sbjct: 74 YY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPIS-LLRQIASGVAH 130
Query: 623 LHHYSRFRIIHRDLKASNVLLD-------------RDMNPKISDFGLARMFGGDE--LQG 667
LH +IIHRDLK N+L+ ++ ISDFGL + + +
Sbjct: 131 LHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 668 NTKRIVGT 675
N GT
Sbjct: 188 NLNNPSGT 195
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 53/168 (31%), Positives = 75/168 (44%), Gaps = 20/168 (11%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC 573
LGEG +G V + E VAVK + ++ E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 574 IEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARIG---IIEGIAQGLLYLHHYS 627
+G L LEY L FD + A+ ++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
I HRD+K N+LLD N KISDFGLA +F + + ++ GT
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 16/167 (9%)
Query: 509 NFSMECKLGEGGFGPVYKGR-LLNGEEVAVK-----RLSSQS---GQGLEEFKNEMLLIA 559
+S LG G FG V+ +EV VK ++ L + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 560 KLQHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQ 618
+++H N++++L E L++E + LD+F F RL A I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLAS-YIFRQLVS 141
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665
+ YL IIHRD+K N+++ D K+ DFG A +L
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 15/156 (9%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRL--SSQSGQGLEEFKNEMLLIAKLQHRNLVRILGC 572
+G+G F V R +L G EVA+K + + + L++ E+ ++ L H N+V++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 573 CIEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
IE + + LI+EY + FD R+ +AR I + Y H +
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEAR-SKFRQIVSAVQYCH---QK 133
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665
RI+HRDLKA N+LLD DMN KI+DFG + F
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 15/170 (8%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQG---LEEFKNEMLLIAKLQHRNLVRIL 570
LG GG V+ R L + +VAVK L + + F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 571 --GCCIEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
G + +++EY+ +L + + + + I +I Q L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQG-NTKRIVGT 675
+ IIHRD+K +N+++ K+ DFG+AR T ++GT
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 28/180 (15%), Positives = 56/180 (31%), Gaps = 37/180 (20%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSS---QSGQGLEEFKNEMLLIAKLQ--------- 562
LG+ + GE V +++ K E+L + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 563 ----------------HRNLVRILGCC-IEQGEKILILEYMPNKSLDVF---LFD-PTKK 601
+ ++R+ L +L F L +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 602 RLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
+ L AR+ + + + L LHHY ++H L+ +++LD+ ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 45/183 (24%), Positives = 78/183 (42%), Gaps = 28/183 (15%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHR 564
+ F + KLG G FG V+ +G E +K ++ +S +E+ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIG---------IIEG 615
N+++I + +++E L + R++ QAR +++
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LE----RIVSAQARGKALSEGYVAELMKQ 132
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRI 672
+ L Y H ++H+DLK N+L KI DFGLA +F DE
Sbjct: 133 MMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNA 186
Query: 673 VGT 675
GT
Sbjct: 187 AGT 189
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 39/166 (23%), Positives = 63/166 (37%), Gaps = 13/166 (7%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQG---LEEFKNEMLLIAKLQHRNLVRIL 570
+G GG G VY+ + VA+K +S + E +LQ ++V I
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
G+ + + + L L ++ L + I+ I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL-QGNTKRIVGT 675
HRD+K N+L+ D + DFG+A ++L Q VGT
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGT 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 51/160 (31%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVK---RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
LG G FG V G L G +VAVK R +S + + K E+ + +H +++++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 572 CCIEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARIG---IIEGIAQGLLYLHH 625
I +++EY+ L FD R+ +AR I+ + Y H
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCH- 128
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665
R ++HRDLK NVLLD MN KI+DFGL+ M E
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 32/211 (15%), Positives = 62/211 (29%), Gaps = 33/211 (15%)
Query: 468 LAFDITTRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKG 527
L+ +++ PN F K K ++ + LGEG F VY+
Sbjct: 34 LSKPVSSYPNTFEWQCKLPAIKPK---------TEFQLGSKLVYVHHLLGEGAFAQVYEA 84
Query: 528 R------LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581
N ++ +K + M + ++ + Q +L
Sbjct: 85 TQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144
Query: 582 ILEYMPNKSLD---VFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKA 638
+ E +L + +K + + + + +H IIH D+K
Sbjct: 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR-MLYMIEQVH---DCEIIHGDIKP 200
Query: 639 SNVLL-----------DRDMNPKISDFGLAR 658
N +L D + D G +
Sbjct: 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 42/229 (18%), Positives = 82/229 (35%), Gaps = 15/229 (6%)
Query: 452 RRKCKEKENMETSQDLLAFDITTRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATENFS 511
E++ I S + + P +++
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYD 160
Query: 512 MECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRIL 570
+ +LG G FG V++ G A K + + E + E+ ++ L+H LV +
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLLYLHHYSR 628
+ E ++I E+M LF+ + + + + + +GL ++H +
Sbjct: 221 DAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 275
Query: 629 FRIIHRDLKASNVLL-DRDMNP-KISDFGLARMFGGDELQGNTKRIVGT 675
+H DLK N++ + N K+ DFGL + + K GT
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGT 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 42/179 (23%), Positives = 74/179 (41%), Gaps = 35/179 (19%)
Query: 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKN----EMLLIAKL 561
+ F +E G+G FG V G+ G VA+K++ F+N M +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVL 76
Query: 562 QHRNLVRILGCCIEQGEK-------ILILEYMP---NKSLDVFLFDPTK-----KRLLGW 606
H N+V++ GE+ +++EY+P ++ + ++ +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 607 QARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP-KISDFGLARMFGGDE 664
Q + + + LH S + HRD+K NVL++ K+ DFG A+ E
Sbjct: 137 Q--------LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 50/185 (27%), Positives = 78/185 (42%), Gaps = 47/185 (25%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLS------------------SQSGQGLEEFKNEML 556
+G+G +G V + A+K LS ++ G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 557 L-----IA---KLQHRNLVRILGCCIEQGEK---ILILEYMPNKSLDVFLFD-PTKKRLL 604
IA KL H N+V+ L ++ + ++ E + + + PT K L
Sbjct: 81 EQVYQEIAILKKLDHPNVVK-LVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 605 GWQARI---GIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF- 660
QAR +I+GI YLH +IIHRD+K SN+L+ D + KI+DFG++ F
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 661 GGDEL 665
G D L
Sbjct: 189 GSDAL 193
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 41/175 (23%), Positives = 73/175 (41%), Gaps = 17/175 (9%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565
+ +++E +G G +G V A K++ + ++ FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLLYL 623
++R+ + + L++E LF+ K+ A I++ + + Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122
Query: 624 HHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
H + HRDLK N L D K+ DFGLA F ++ + VGT
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGT 171
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL--SSQSGQGLEEFKNEMLLIAKLQH 563
E +++ C LG+G FG V K + + +E AVK + +S + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLL 621
N++++ + ++ E L FD +KR A II+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 622 YLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
Y+H + I+HRDLK N+LL ++D + KI DFGL+ F + K +GT
Sbjct: 136 YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 6e-21
Identities = 53/160 (33%), Positives = 79/160 (49%), Gaps = 22/160 (13%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILG 571
LG G FG V G+ L G +VAVK L+ Q S + + + E+ + +H +++++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 572 CCIEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARIG---IIEGIAQGLLYLHH 625
I I +++EY+ L FD RL ++R I+ G+ Y H
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCH- 133
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665
R ++HRDLK NVLLD MN KI+DFGL+ M E
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 43/184 (23%), Positives = 69/184 (37%), Gaps = 25/184 (13%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK-----RLSSQSGQGLEEFKNEMLLIAK 560
+ + + +G+G F V + G++ AVK + +S G E+ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGW----QARIGIIE 614
L+H ++V +L G ++ E+M L + A +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVAS-HYMR 137
Query: 615 GIAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKR 671
I + L Y H IIHRD+K VLL + K+ FG+A G
Sbjct: 138 QILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGG 192
Query: 672 IVGT 675
VGT
Sbjct: 193 RVGT 196
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 15/174 (8%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565
+ + + +LG G FG V++ G K +++ KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLLYL 623
L+ + ++ E +LILE++ LFD + + I + +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNP--KISDFGLARMFGGDELQGNTKRIVGT 675
H + I+H D+K N++ + KI DFGLA DE K T
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTAT 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 15/172 (8%)
Query: 509 NFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
S LG G FG V+K G ++A K + ++ + EE KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLLYLHH 625
++ + + +L++EY+ LFD + L I ++ I +G+ ++H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 626 YSRFRIIHRDLKASNVLL-DRDMNP-KISDFGLARMFGGDELQGNTKRIVGT 675
I+H DLK N+L +RD KI DFGLAR + E K GT
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGT 251
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 23/160 (14%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVK---RLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILG 571
LGEG FG V ++VA+K R + + E+ + L+H +++++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 572 CCIEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARIG---IIEGIAQGLLYLHH 625
I I +++EY + LFD KKR+ + R II I Y H
Sbjct: 77 V-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH- 125
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665
R +I+HRDLK N+LLD ++N KI+DFGL+ +
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL--SSQSGQGLEEFKNEMLLIAKLQH 563
E +++ C LG+G FG V K + + +E AVK + +S + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLL 621
N++++ + ++ E LFD +KR A II+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 622 YLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
Y+H + I+HRDLK N+LL ++D + KI DFGL+ F + K +GT
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGT 186
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 36/157 (22%), Positives = 66/157 (42%), Gaps = 16/157 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEML-----LIAKL 561
+ ++G G G V+K R G +AVK++ +E +L ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSH 81
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGII-EGIAQGL 620
+V+ G I + + +E M + + + + +G + I + L
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRMQGPIP-ERILGKMTVAIVKAL 137
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657
YL + +IHRD+K SN+LLD K+ DFG++
Sbjct: 138 YYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL--SSQSGQGLEEFKNEMLLIAKLQH 563
+E + KLG G +G V R + E A+K + +S S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLL 621
N++++ ++ L++E LFD + + A II+ + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAA-VIIKQVLSGVT 150
Query: 622 YLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
YLH ++ I+HRDLK N+LL ++D KI DFGL+ +F + K +GT
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGT 201
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 48/183 (26%), Positives = 77/183 (42%), Gaps = 26/183 (14%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS--------SQSGQGLEEFKNEMLL 557
+ + M LG G G V ++VA+K +S ++ + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 558 IAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEG 615
+ KL H +++I + + ++LE M L FD KRL +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRI 672
+ + YLH IIHRDLK NVLL + D KI+DFG +++ G L + +
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 176
Query: 673 VGT 675
GT
Sbjct: 177 CGT 179
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 26/183 (14%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS--------SQSGQGLEEFKNEMLL 557
+ + M LG G G V ++VA++ +S ++ + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 558 IAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEG 615
+ KL H +++I + + ++LE M L FD KRL ++
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKL-YFYQ 247
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRI 672
+ + YLH IIHRDLK NVLL + D KI+DFG +++ G L + +
Sbjct: 248 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301
Query: 673 VGT 675
GT
Sbjct: 302 CGT 304
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 17/169 (10%)
Query: 509 NFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL------SSQSGQGLEEFKNEMLLIAKL 561
+ + LG GGFG VY G + + VA+K + E++L+ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 562 QHR--NLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQ 618
++R+L E+ + LILE P D+F F + L AR + +
Sbjct: 104 SSGFSGVIRLLDW-FERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLE 160
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRD-MNPKISDFGLARMFGGDELQ 666
+ + H ++HRD+K N+L+D + K+ DFG +
Sbjct: 161 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 26/199 (13%)
Query: 490 SKDSWLPLFSLASVAAATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK--------RL 540
++D+ LP S EN+ + LG G V + +E AVK
Sbjct: 1 TRDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58
Query: 541 SSQSGQGLEE-FKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD- 597
S++ Q L E E+ ++ K+ H N++++ L+ + M L FD
Sbjct: 59 SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDY 114
Query: 598 -PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656
K L + R I+ + + + LH + I+HRDLK N+LLD DMN K++DFG
Sbjct: 115 LTEKVTLSEKETR-KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 657 ARMFGGDELQGNTKRIVGT 675
+ E + + GT
Sbjct: 171 SCQLDPGEK---LREVCGT 186
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 40/170 (23%), Positives = 68/170 (40%), Gaps = 19/170 (11%)
Query: 509 NFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL------SSQSGQGLEEFKNE----MLL 557
+ + LG+GGFG V+ G L + +VA+K + E +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 558 IAKLQHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGI 616
A H ++R+L E E L+LE P + D+F + K L +R +
Sbjct: 92 GAGGGHPGVIRLLDW-FETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSR-CFFGQV 148
Query: 617 AQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP-KISDFGLARMFGGDEL 665
+ + H ++HRD+K N+L+D K+ DFG + +
Sbjct: 149 VAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY 195
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 9e-20
Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 20/178 (11%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS---SQSGQGLEEFKNEMLLIAKLQ 562
++ + + LG+G FG V + + G+E AVK +S + E E+ L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGL 620
H N++++ ++G L+ E L FD ++KR A II + G+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGI 139
Query: 621 LYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
Y+H I+HRDLK N+LL +D N +I DFGL+ F + K +GT
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGT 191
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 33/174 (18%), Positives = 70/174 (40%), Gaps = 16/174 (9%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565
E + + LG G FG V++ + + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLLYL 623
++ + E ++I E++ +F+ T L + + + + + L +L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNP--KISDFGLARMFGGDELQGNTKRIVGT 675
H ++ I H D++ N++ + KI +FG AR + + +
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTA 166
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 45/177 (25%), Positives = 77/177 (43%), Gaps = 19/177 (10%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL--SSQSGQGLEEFKNEMLLIAKLQH 563
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLL 621
N+VR+ E+ L+ + + LF+ ++ A I+ I + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 622 YLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
Y H I+HR+LK N+LL + K++DFGLA E GT
Sbjct: 120 YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 51/181 (28%), Positives = 78/181 (43%), Gaps = 22/181 (12%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK------RLSSQSGQGLEEFKNEMLLIA 559
+ + + +LG G F V K R G E A K +S+ G EE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 560 KLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQ 618
++ H N++ + + + +LILE + LFD +K L + I+ I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNP----KISDFGLARMFGGDELQGNTKRIVG 674
G+ YLH +I H DLK N++L P K+ DFGLA K I G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 675 T 675
T
Sbjct: 181 T 181
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 22/181 (12%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK------RLSSQSGQGLEEFKNEMLLIA 559
+++ M +LG G F V K R G+E A K SS+ G EE + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 560 KLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQ 618
+++H N++ + + + +LILE + LFD +K L ++ I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQILD 119
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNP----KISDFGLARMFGGDELQGNTKRIVG 674
G+ YLH RI H DLK N++L P K+ DFG+A K I G
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFG 173
Query: 675 T 675
T
Sbjct: 174 T 174
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 21/149 (14%), Positives = 48/149 (32%), Gaps = 14/149 (9%)
Query: 515 KLGEGGFGPVYKGR--LLNGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRI 569
G ++ L +VA+ + Q L+E + L ++++ + R+
Sbjct: 38 FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
L + +++ E++ SL A I ++ +A H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA-IRAMQSLAAAADAAH---RA 148
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+ S V + D + ++
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 42/221 (19%), Positives = 71/221 (32%), Gaps = 60/221 (27%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK-----RLSSQSGQGLEEFKNEMLLIAK 560
+ + ++ +G+G +G V A+K ++ + + +E K E+ L+ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 561 LQHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIG-------- 611
L H N+ R+ E + I L++E L D + +
Sbjct: 85 LHHPNIARLYEV-YEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQI 139
Query: 612 ---------------------------------IIEGIAQGLLYLHHYSRFRIIHRDLKA 638
I+ I L YLH I HRD+K
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKP 196
Query: 639 SNVLL--DRDMNPKISDFGLARMFGGDELQGNT--KRIVGT 675
N L ++ K+ DFGL++ F GT
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 51/181 (28%), Positives = 78/181 (43%), Gaps = 22/181 (12%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK------RLSSQSGQGLEEFKNEMLLIA 559
+ + + +LG G F V K R G E A K +S+ G EE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 560 KLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQ 618
++ H N++ + + + +LILE + LFD +K L + I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNP----KISDFGLARMFGGDELQGNTKRIVG 674
G+ YLH +I H DLK N++L P K+ DFGLA K I G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 675 T 675
T
Sbjct: 181 T 181
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 49/238 (20%), Positives = 92/238 (38%), Gaps = 25/238 (10%)
Query: 450 RQRRKCKEKENMETSQDLLAFDITTRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATEN 509
R + + +++ L N + + LP ++ A +
Sbjct: 38 RAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK--EFYQK 95
Query: 510 FSMECKLGEGGFGPVYKGR-LLNGEEVAVK-------RLSSQSGQGLEE-FKNEMLLIAK 560
+ + +G G V + G E AVK RLS + + + E + E ++ +
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 561 L-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIA 617
+ H +++ ++ L+ + M L FD K L + R I+ +
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMRSLL 210
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ + +LH I+HRDLK N+LLD +M ++SDFG + E + + GT
Sbjct: 211 EAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGT 262
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 42/185 (22%), Positives = 72/185 (38%), Gaps = 38/185 (20%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565
+ F LG G F V+ + L G+ A+K + +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARI------------GII 613
+V + L+++ + LFD RI +I
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGE----LFD-----------RILERGVYTEKDASLVI 112
Query: 614 EGIAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTK 670
+ + + YLH I+HRDLK N+L + + I+DFGL++M +
Sbjct: 113 QQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----S 165
Query: 671 RIVGT 675
GT
Sbjct: 166 TACGT 170
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 51/181 (28%), Positives = 78/181 (43%), Gaps = 22/181 (12%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL------SSQSGQGLEEFKNEMLLIA 559
+ + +LG G F V K R G + A K + SS+ G E+ + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 560 KLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQ 618
++QH N++ + + + ILILE + LFD +K L + ++ I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILN 125
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLL----DRDMNPKISDFGLARMFGGDELQGNTKRIVG 674
G+ YLH +I H DLK N++L KI DFGLA K I G
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179
Query: 675 T 675
T
Sbjct: 180 T 180
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 45/177 (25%), Positives = 77/177 (43%), Gaps = 19/177 (10%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL--SSQSGQGLEEFKNEMLLIAKLQH 563
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLL 621
N+VR+ E+ L+ + + LF+ ++ A I+ I + +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-HCIQQILESIA 142
Query: 622 YLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
Y H I+HR+LK N+LL + K++DFGLA E GT
Sbjct: 143 YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 193
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 48/188 (25%), Positives = 81/188 (43%), Gaps = 30/188 (15%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS-------------SQSGQGLEEFK 552
E++ KLG G +G V + E A+K + + EE
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 553 NEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARI 610
NE+ L+ L H N++++ ++ L+ E+ L F+ + + A
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149
Query: 611 GIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQG 667
I++ I G+ YLH ++ I+HRD+K N+LL + +N KI DFGL+ F D
Sbjct: 150 NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 668 NTKRIVGT 675
+ +GT
Sbjct: 206 --RDRLGT 211
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHR-NLVRIL 570
+LG G F V + G+E A K + + E +E+ ++ + ++ +
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW---QARIGIIEGIAQGLLYLHHYS 627
E ILILEY + F L I +I+ I +G+ YLH
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLH--- 148
Query: 628 RFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ I+H DLK N+LL + KI DFG++R G + I+GT
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGT 196
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-18
Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 38/187 (20%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL--SSQSGQGLEEFKNEMLLIAKLQH 563
TE + + +LG+G F V + +L G+E A + S + ++ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARI------------G 611
N+VR+ E+G LI + + LF+ I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGE----LFE-----------DIVAREYYSEADASH 114
Query: 612 IIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGN 668
I+ I + +L+ H ++HR+LK N+LL + K++DFGLA G+ Q
Sbjct: 115 CIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQA 169
Query: 669 TKRIVGT 675
GT
Sbjct: 170 WFGFAGT 176
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 44/179 (24%), Positives = 85/179 (47%), Gaps = 41/179 (22%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---------EML 556
+ + + +G G +G V + L VA+K++ F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 557 LIAKLQHRNLVRILGCCI----EQGEKI-LILEYMPN------KSLDVFLFDPTKKRLLG 605
++ +L H ++V++L I E+ +++ ++LE + ++ V+L + K LL
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLL- 162
Query: 606 WQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ + G+ Y+H S I+HRDLK +N L+++D + K+ DFGLAR E
Sbjct: 163 YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 24/160 (15%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEE-FKNEMLLIAKLQHRNLVRILGCC 573
+G G FG R L E VAVK + G ++E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVR-FKEV 84
Query: 574 IEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARIG---IIEGIAQGLLYLHHYS 627
I + +I+EY L ++ R +AR ++ G++ Y H
Sbjct: 85 ILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH--- 133
Query: 628 RFRIIHRDLKASNVLLDRD--MNPKISDFGLARMFGGDEL 665
+I HRDLK N LLD KI DFG ++
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 52/174 (29%), Positives = 73/174 (41%), Gaps = 14/174 (8%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQH 563
E+F LGEG F V R L E A+K L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 564 RNLVRILGCCIEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
V++ Q ++ L L Y N L + R E I L
Sbjct: 90 PFFVKLYFTF--QDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTAE-IVSALE 144
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
YLH IIHRDLK N+LL+ DM+ +I+DFG A++ + Q VGT
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 41/182 (22%), Positives = 65/182 (35%), Gaps = 40/182 (21%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCC 573
LGEG V L+ +E AVK + Q G E+ ++ + Q HRN++ ++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 574 IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARI------------GIIEGIAQGLL 621
E+ L+ E M S+ I +++ +A L
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LS-----------HIHKRRHFNELEASVVVQDVASALD 125
Query: 622 YLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMF-----GGDELQGNTKRIV 673
+LH+ I HRDLK N+L ++ KI DF L
Sbjct: 126 FLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 674 GT 675
G+
Sbjct: 183 GS 184
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 41/176 (23%), Positives = 69/176 (39%), Gaps = 20/176 (11%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565
T+ + ++ +G G + + E AVK + EE +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARIGIIEGIAQGLLYL 623
++ + + ++ E M L D +K +A ++ I + + YL
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEYL 132
Query: 624 HHYSRFRIIHRDLKASNVLL-DRDMNP---KISDFGLARMFGGDELQGNTKRIVGT 675
H ++HRDLK SN+L D NP +I DFG A+ + G T
Sbjct: 133 H---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYT 183
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 39/185 (21%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565
++ F +E +LG G VY+ + + A+K L + + + E+ ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARI------------GII 613
++++ E L+LE + L FD RI +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FD-----------RIVEKGYYSERDAADAV 154
Query: 614 EGIAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTK 670
+ I + + YLH I+HRDLK N+L D KI+DFGL+++ L K
Sbjct: 155 KQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MK 208
Query: 671 RIVGT 675
+ GT
Sbjct: 209 TVCGT 213
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 40/207 (19%), Positives = 80/207 (38%), Gaps = 65/207 (31%)
Query: 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKN-EMLLIAKLQHR 564
++ +S+ LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60
Query: 565 NLVRILGCCIEQGEKI--------------------------------------LILEYM 586
N+++++ G++ +I+EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 587 P---NKSLDVFLFDPTK-----KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKA 638
P +K L F+ + +Q + + + ++H I HRD+K
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQ--------LFRAVGFIHS---LGICHRDIKP 169
Query: 639 SNVLLDRDMNP-KISDFGLARMFGGDE 664
N+L++ N K+ DFG A+ E
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSE 196
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 40/174 (22%), Positives = 66/174 (37%), Gaps = 30/174 (17%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNE-MLLIAKLQHRNLVRILGC 572
LG G G V + G++ A+K L + + E ++V IL
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 573 CIEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGW----QARIGIIEGIAQGLLYLH 624
+I+E M L F ++R +A I+ I + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLH 145
Query: 625 HYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
++ I HRD+K N+L ++D K++DFG A+ + LQ T
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYT 192
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 40/178 (22%), Positives = 68/178 (38%), Gaps = 40/178 (22%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGC 572
LGEG F K + + AVK +S + + E+ + + H N+V++
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 573 CIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARI------------GIIEGIAQGL 620
+Q L++E + L F+ RI I+ + +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FE-----------RIKKKKHFSETEASYIMRKLVSAV 119
Query: 621 LYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
++H ++HRDLK N+L + ++ KI DFG AR+ D K T
Sbjct: 120 SHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFT 172
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 7e-15
Identities = 51/173 (29%), Positives = 76/173 (43%), Gaps = 13/173 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQ---SGQGLEEFKNEMLLIAKLQH 563
F LG+GGFG V ++ ++ A K+L + +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 564 RNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
R +V L E + + L+L M L ++ + +A E I GL
Sbjct: 244 RFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLED 301
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
LH R RI++RDLK N+LLD + +ISD GLA + K VGT
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.3 bits (184), Expect = 9e-15
Identities = 36/203 (17%), Positives = 61/203 (30%), Gaps = 46/203 (22%)
Query: 502 SVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRL--------SSQSGQGLEEFKN 553
S TE K+GEG FG V++ + VA+K + + + EE
Sbjct: 14 SHCLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 554 EMLLIAKLQ---------HRNLVRILGCCIEQGE--KILILEYM--------PNKSLDVF 594
E+++ +L + + QG +L+ + N D F
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 595 ----------------LFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKA 638
+ + +L I+ + L R HRDL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 639 SNVLLDRDMNPKISDFGLARMFG 661
NVLL + K+ +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSST 213
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-15
Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 14/175 (8%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQ---SGQGLEEFKNEMLLIAKLQH 563
+ F LG GGFG V+ ++ ++ A K+L+ + +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 564 RNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKK--RLLGWQARIGIIEGIAQGL 620
R +V L E + L++ M + +++ + +A + I GL
Sbjct: 245 RFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGL 302
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+LH + II+RDLK NVLLD D N +ISD GLA + TK GT
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGT 352
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 21/159 (13%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HR 564
+++ + KLG G + V++ + N E+V VK L + + K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 565 NLVRILGCCIEQGEK--ILILEYMPNKSLDVFL--FDPTKKRLLGWQARIGIIEGIAQGL 620
N++ + + + L+ E++ N R ++ I + L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKAL 143
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRD-MNPKISDFGLAR 658
Y H S I+HRD+K NV++D + ++ D+GLA
Sbjct: 144 DYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 37/180 (20%), Positives = 64/180 (35%), Gaps = 34/180 (18%)
Query: 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEE--FKN---------EM 555
++++ + G +G V G G VA+KR+ + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 556 LLIAKLQHRNLVRILGCCIEQGEKI-----LILEYMPN------KSLDVFLFDPTKKRLL 604
L+ H N++ + + E L+ E M + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 605 GWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ I GL LH ++HRDL N+LL + + I DF LAR D
Sbjct: 141 -YH--------ILLGLHVLH--EA-GVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 45/234 (19%), Positives = 68/234 (29%), Gaps = 66/234 (28%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRN 565
+F +G GGFG V++ + ++ A+KR+ E+ E+ +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGI------------- 612
+VR +E + E D P + I
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 613 --IEGIAQGLLY----------LHHYSRFRI-----------------------IH---- 633
+ LY L + R +H
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 634 --RDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTK----------RIVGT 675
RDLK SN+ D K+ DFGL DE + VGT
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 9e-14
Identities = 52/176 (29%), Positives = 75/176 (42%), Gaps = 19/176 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNE--ML-LIAK 560
+FS+ +G GGFG VY R G+ A+K L + QG NE ML L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 561 LQHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG 619
+V + +K+ IL+ M L L R E I G
Sbjct: 249 GDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAE-IILG 304
Query: 620 LLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
L ++H +++RDLK +N+LLD + +ISD GLA F + VGT
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 38/176 (21%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---------EML 556
+ + +G G +G V +GE+VA+K+LS F++ E+L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 557 LIAKLQHRNLVRIL-----GCCIEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQ 607
L+ +QH N++ +L + L++ +M K + + + + L+ +Q
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-YQ 134
Query: 608 ARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663
+ +GL Y+H S ++HRDLK N+ ++ D KI DFGLAR +
Sbjct: 135 --------MLKGLKYIH--SA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 41/179 (22%), Positives = 80/179 (44%), Gaps = 41/179 (22%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---------EML 556
+N+ ++ +G G +G VY + VA+K+++ F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77
Query: 557 LIAKLQHRNLVRILGCCIEQGEKI-----LILEYMPN------KSLDVFLFDPTKKRLLG 605
++ +L+ ++R+ I ++LE + K+ +FL + K +L
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTIL- 135
Query: 606 WQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ + G ++H IIHRDLK +N LL++D + K+ DFGLAR ++
Sbjct: 136 YN--------LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 38/174 (21%), Positives = 64/174 (36%), Gaps = 29/174 (16%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNE-MLLIAKLQHRNLVRILGC 572
LG G G V + E+ A+K L + + E L Q ++VRI+
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123
Query: 573 CIEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGW----QARIGIIEGIAQGLLYLH 624
+++E + L F + R +A I++ I + + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 178
Query: 625 HYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ I HRD+K N+L + K++DFG A+ + T
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYT 226
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 37/176 (21%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---------EML 556
++ +GEG +G V LN VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 557 LIAKLQHRNLVRILGC----CIEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQA 608
++ + +H N++ I IEQ + + ++ + M K L +Q
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136
Query: 609 RIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
I +GL Y+H S ++HRDLK SN+LL+ + KI DFGLAR+ D
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 6e-13
Identities = 21/126 (16%), Positives = 46/126 (36%), Gaps = 19/126 (15%)
Query: 27 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISD 86
+ +T + G+ L + L ++ T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCN-----LVLYDH---STSVWASNTGIL-GK 50
Query: 87 HNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYL 146
+ ++G V+ + ++W++++ N V L++DGN+VI + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------I 102
Query: 147 WQSFDY 152
W + Y
Sbjct: 103 WSTGTY 108
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 39/165 (23%), Positives = 64/165 (38%), Gaps = 27/165 (16%)
Query: 509 NFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
NF + K+G G FG + G+ L E VA+K +S + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARIGIIEGIAQGL 620
++ ++LE + SL+ LFD + + Q I +E
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSLKTVLMIAIQL-ISRME------ 119
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPK-----ISDFGLARMF 660
Y+H + +I+RD+K N L+ R N I DF LA+ +
Sbjct: 120 -YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 40/186 (21%), Positives = 70/186 (37%), Gaps = 48/186 (25%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---------EML 556
+ LG GG G V+ + VA+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 557 LIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-----------------FDPT 599
+I +L H N+V++ G ++ + V++
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 600 KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD-RDMNPKISDFGLAR 658
RL +Q + +GL Y+H S ++HRDLK +N+ ++ D+ KI DFGLAR
Sbjct: 121 HARLFMYQ--------LLRGLKYIH--SA-NVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 659 MFGGDE 664
+
Sbjct: 170 IMDPHY 175
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 41/173 (23%), Positives = 76/173 (43%), Gaps = 12/173 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEE---FKNEMLLIAKLQH 563
E+F + +G G FG V +L N ++V A+K L+ E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 564 RNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
+ + L + + L+++Y L + L + RL AR + E + +
Sbjct: 134 KWITT-LHYAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+H + +HRD+K N+L+D + + +++DFG D + VGT
Sbjct: 191 VH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGT 239
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 26/156 (16%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNE-MLLIAKLQHRNLVRILGC 572
LG G G V + E+ A+K L + + E L Q ++VRI+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 573 CIEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGW----QARIGIIEGIAQGLLYLH 624
+++E + L F + R +A I++ I + + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 134
Query: 625 HYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLA 657
+ I HRD+K N+L + K++DFG A
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 31/160 (19%), Positives = 55/160 (34%), Gaps = 19/160 (11%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLSSQSGQG-LEEFKNEMLLIAK 560
+ + LG G FG V + VAVK L + +E+ ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 561 L-QHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQ 618
+ H N+V +LG C + G + +I+E+ +L +L R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
G + I DLK + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+A+G+ +L + + IHRDL A N+LL KI DFGLAR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 38/177 (21%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---------EML 556
+ + +G G G V + VA+K+LS F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 557 LIAKLQHRNLVRIL-----GCCIEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQ 607
L+ + H+N++ +L +E+ + + L++E M + + + L LL +Q
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL-YQ 172
Query: 608 ARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ G+ +LH S IIHRDLK SN+++ D KI DFGLAR G
Sbjct: 173 --------MLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 35/168 (20%), Positives = 74/168 (44%), Gaps = 31/168 (18%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHR 564
++ + ++GEG FG +++G LLN ++VA+K S + Q +E++ LL
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARIGIIEGIA 617
+ + E +L+++ + SL+ L D ++ Q + ++
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLDLCGRKFSVKTVAMAAKQM-LARVQ--- 120
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPK-----ISDFGLARMF 660
+H S +++RD+K N L+ R + + DFG+ + +
Sbjct: 121 ----SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 43/165 (26%), Positives = 69/165 (41%), Gaps = 27/165 (16%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQH-RN 565
+ + K+G G FG +Y G + GEEVA+K ++ E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARIGIIEGIAQ 618
+ I C E ++++E + SL+ LF+ ++ L Q I IE
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRKFSLKTVLLLADQM-ISRIE---- 119
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPK---ISDFGLARMF 660
Y+H + IHRD+K N L+ I DFGLA+ +
Sbjct: 120 ---YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 38/178 (21%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---------EML 556
+ + +G G G V + VA+K+LS F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 557 LIAKLQHRNLVRIL-----GCCIEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQ 607
L+ + H+N++ +L +E+ + + +++E M + + + L LL +Q
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-YQ 135
Query: 608 ARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665
+ G+ +LH S IIHRDLK SN+++ D KI DFGLAR G +
Sbjct: 136 --------MLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 50/237 (21%), Positives = 92/237 (38%), Gaps = 20/237 (8%)
Query: 449 CRQRRKCKEKENMETSQDLLAFDITTRPNEFSEANGDRRDKSKDSWLPLFS-----LASV 503
+ E + D L + + R++K+ D++L + + +
Sbjct: 6 FEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPA-LRKNKNIDNFLSRYKDTINKIRDL 64
Query: 504 AAATENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEE---FKNEMLLIA 559
E++ + +G G FG V R + +V A+K LS + F E ++A
Sbjct: 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 560 KLQHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQ 618
+V+ L + + +++EYMP L + + + AR E +
Sbjct: 125 FANSPWVVQ-LFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAE-VVL 179
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
L +H IHRD+K N+LLD+ + K++DFG + + VGT
Sbjct: 180 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGT 232
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 40/173 (23%), Positives = 74/173 (42%), Gaps = 12/173 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQ---SGQGLEEFKNEMLLIAKLQH 563
++F + +G G F V ++ +V A+K ++ + F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 564 RNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
R + + L + + L++EY L + L +R+ AR + E I +
Sbjct: 121 RWITQ-LHFAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDS 177
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+H R +HRD+K N+LLDR + +++DFG D + VGT
Sbjct: 178 VH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGT 226
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 39/172 (22%), Positives = 71/172 (41%), Gaps = 37/172 (21%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---------EML 556
+ +F ++ LGEG +G V GE VA+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 557 LIAKLQHRNLVRILGCCIEQGEKI-----LILEYMP---NKSLDVFLFDPTKKRLLGWQA 608
++ +H N++ I + +I E M ++ + + + +Q
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ- 120
Query: 609 RIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660
+ + LH +IHRDLK SN+L++ + + K+ DFGLAR+
Sbjct: 121 -------TLRAVKVLH--GS-NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 41/176 (23%), Positives = 73/176 (41%), Gaps = 37/176 (21%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---------EML 556
+ +G G +G V G +VA+K+L F++ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 557 LIAKLQHRNLVRIL-----GCCIEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQ 607
L+ ++H N++ +L ++ L++ +M K + + + L +Q
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 608 ARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663
+ +GL Y+H + IIHRDLK N+ ++ D KI DFGLAR +
Sbjct: 137 --------MLKGLRYIH--AA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-11
Identities = 25/123 (20%), Positives = 45/123 (36%), Gaps = 19/123 (15%)
Query: 27 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISD 86
++++ + + G L + L ++ VW +N S
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCN-----FVLYDS---GKPVWASNTGGLGSG 52
Query: 87 HNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYL 146
L NNG LV+ +Q+N IW T + + + V L+ D N+VI +
Sbjct: 53 CRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 147 WQS 149
W +
Sbjct: 103 WAT 105
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 34/181 (18%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNE----------M 555
+ + KLG+G +G V+K GE VAVK++ + F+N M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 556 LLIAKLQHRNLVRILGCCI-EQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQARI 610
+L H N+V +L + + L+ +YM + + + +P K+ + +Q
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ--- 117
Query: 611 GIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTK 670
+ + + YLH S ++HRD+K SN+LL+ + + K++DFGL+R F N
Sbjct: 118 -----LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 671 R 671
Sbjct: 170 P 170
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 36/182 (19%), Positives = 67/182 (36%), Gaps = 43/182 (23%)
Query: 509 NFSMECKLGEGGFGPVYKGRLLNGE------EVAVKRLSSQSGQGLEEFKNEMLLIAKLQ 562
+ + +G+GGFG +Y + + E VK S +G E K Q
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 563 HRNLV-----------RILGCCIEQGEK----ILILEYMPNKSLDVFLFDPTKKRL---- 603
+ + + G + +I++ L +++ KR
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ-KIYEANAKRFSRKT 153
Query: 604 ---LGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI--SDFGLAR 658
L + + I+E Y+H + +H D+KASN+LL+ ++ D+GLA
Sbjct: 154 VLQLSLRI-LDILE-------YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
Query: 659 MF 660
+
Sbjct: 203 RY 204
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 48/171 (28%), Positives = 73/171 (42%), Gaps = 37/171 (21%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKN---------EML 556
E + +G G +G V G VAVK+LS F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 557 LIAKLQHRNLVRIL-----GCCIEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQ 607
L+ ++H N++ +L +E+ + L+ M N + + L +Q
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 608 ARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
I +GL Y+H S IIHRDLK SN+ ++ D KI DFGLAR
Sbjct: 141 --------ILRGLKYIH--SA-DIIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-11
Identities = 26/124 (20%), Positives = 50/124 (40%), Gaps = 18/124 (14%)
Query: 26 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPIS 85
+D + + G L + + L ++ + VW + +
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN---NRAVWASGTNGK-- 48
Query: 86 DHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENY 145
VL + N+G LV+ + + IW++N + + N L+ D N+VI DNS+ N
Sbjct: 49 ASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 146 LWQS 149
+W +
Sbjct: 103 IWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-05
Identities = 19/65 (29%), Positives = 33/65 (50%), Gaps = 1/65 (1%)
Query: 88 NAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLW 147
+ I N+ LVL + N +W++ + +A V ++++DGNLVI S N
Sbjct: 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWASNTNR 78
Query: 148 QSFDY 152
Q+ +Y
Sbjct: 79 QNGNY 83
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 25/183 (13%), Positives = 63/183 (34%), Gaps = 43/183 (23%)
Query: 508 ENFSMECKLGEGGFGPVYKGR---------LLNGEEVAVKRLSSQSGQGLEEFK------ 552
+ ++ G +Y+ ++ ++K L ++ G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 553 --NEMLLIAKLQHRNLV---RILGCCIEQGE-KILILEYMPNKSL-DVFLFDPTKK---- 601
++ KL L+ +G + Q + + L+L + +SL P
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER 159
Query: 602 --RLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI--SDFGLA 657
+ + + +E +LH +H ++ A N+ +D + ++ + +G A
Sbjct: 160 SVLQVACRL-LDALE-------FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
Query: 658 RMF 660
+
Sbjct: 209 FRY 211
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 17/173 (9%)
Query: 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLS----SQSGQGLEEFKNEMLLIAKLQ 562
+ F LG G FG V + +G A+K L + Q +E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
LV++ + +++EY+ + F R AR + I Y
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQ-IVLTFEY 156
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
LH +I+RDLK N+L+D+ +++DFG A+ ++G T + GT
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 6e-11
Identities = 21/123 (17%), Positives = 39/123 (31%), Gaps = 20/123 (16%)
Query: 27 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISD 86
+ + + L + + L + L + +W +N DR
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCN-----LVKYQN---GRQIWASNTDR--RG 50
Query: 87 HNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYL 146
LT+ ++G LV+ + N +W + + L+ DG VI L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 147 WQS 149
W
Sbjct: 103 WSL 105
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 27/165 (16%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
F + K+G G FG +Y G + EEVA+K + ++ E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64
Query: 567 V-RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARIGIIEGIAQ 618
+ + +E +L+++ + SL+ LF+ ++L L Q I +E
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQM-INRVE---- 117
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPK---ISDFGLARMF 660
++H S +HRD+K N L+ I DFGLA+ +
Sbjct: 118 ---FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-10
Identities = 26/123 (21%), Positives = 47/123 (38%), Gaps = 20/123 (16%)
Query: 27 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISD 86
+ + + GE L ++ R+ L ++ D +W N D
Sbjct: 2 NILYSGETLSPGEFL--NNGRYVFIMQEDCN-----LVLYDV---DKPIWATNTGGL--D 49
Query: 87 HNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYL 146
L++ ++G LV+ + N IW++N E N V L+ D N+VI +
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA--------R 101
Query: 147 WQS 149
W +
Sbjct: 102 WAT 104
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 36/179 (20%), Positives = 67/179 (37%), Gaps = 40/179 (22%)
Query: 509 NFSMECKLGEGGFGPVYKG-RLLNGEEVA---VKRLSSQSGQGLEEFKNEMLL-----IA 559
+ + K+G GGFG +Y E+ A VK ++G E K + I
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 560 KLQHRNLVRILG----------CCIEQGEKILILEYMPNKSLDVFLFDPTKK------RL 603
K R + LG + + +++E + L +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKKSTVLQ 155
Query: 604 LGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI--SDFGLARMF 660
LG + + ++E Y+H +H D+KA+N+LL ++ +D+GL+ +
Sbjct: 156 LGIRM-LDVLE-------YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 4e-10
Identities = 17/78 (21%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 72 DTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNL 131
+ +W N + + +G LV++ N T+W + + +A + V L+ D N+
Sbjct: 48 NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNV 105
Query: 132 VIRDNSSVNTTENYLWQS 149
VI ++ LW +
Sbjct: 106 VIYGDA--------LWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 5e-08
Identities = 20/88 (22%), Positives = 32/88 (36%), Gaps = 6/88 (6%)
Query: 62 YLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNP 121
+ P + + + H + + LVL + N IW+TN
Sbjct: 5 FSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGC 63
Query: 122 VAQLRDDGNLVIRDNSSVNTTENYLWQS 149
A L+ DG LV+ N + +WQS
Sbjct: 64 RAVLQPDGVLVVITNEN-----VTVWQS 86
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 11/167 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEEF---KNEMLLIAKLQH 563
F LG+G FG V + A+K L + +E E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 564 RNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
L L + +++ ++EY ++F ++ +AR E I L Y
Sbjct: 208 PFLTA-LKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFYGAE-IVSALDY 263
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT 669
LH S +++RDLK N++LD+D + KI+DFGL + D T
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 40/163 (24%), Positives = 72/163 (44%), Gaps = 12/163 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKN---EMLLIAKLQH 563
++F + +G+G FG V + + A+K ++ Q E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 564 RNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
LV L + E + ++++ + D+ ++ I E + L Y
Sbjct: 75 PFLVN-LWYSFQDEEDMFMVVDLLLGG--DLRYHLQQNVHFKEETVKLFICE-LVMALDY 130
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665
L RIIHRD+K N+LLD + I+DF +A M +
Sbjct: 131 LQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 15/172 (8%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEF---KNEMLLIAKLQH 563
++F + LG G FG V+ R NG A+K L + L++ +E L+++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
++R+ G + + +I++Y+ L F +R A+ E + L YL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE-VCLALEYL 122
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
H II+RDLK N+LLD++ + KI+DFG A+ + T + GT
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 166
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 62/395 (15%), Positives = 116/395 (29%), Gaps = 32/395 (8%)
Query: 287 DYCGKYGYCGAN-----TICGPDQKPMCQCLEGFRLKSQFNQTGPIKCERSHSSECIKGD 341
D+CG Y + C + C + S + R + I +
Sbjct: 117 DHCGSLLYGLIHQGMKCDTCMMNVHKRCVMN----VPSLCGTDHTERRGRIYIQAHIDRE 172
Query: 342 QFIKLDNIKAPDFIEVSLNQSMNLQQCAAECLKNCTCKAYANSNVTEGSGCLMWFGELLD 401
I + S + K + + +
Sbjct: 173 VLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQL 232
Query: 402 ASRPIRNFTGQSVYLRQPASGPGNKKLLWIIVIVVPPMVLLPSVYIFCRQRRKCKEKENM 461
++ S + + + + F ++ E N+
Sbjct: 233 KESDKDRRLSVEIWDWDLTS---RNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNV 289
Query: 462 ETSQDLLAFDITTRPNEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSMEC-----KL 516
+ + R G ++ S + + L
Sbjct: 290 PVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVL 349
Query: 517 GEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEEFKNEM----LLIAKLQHRNLVRILG 571
G+G FG V +E+ AVK L ++ + M +L + L + L
Sbjct: 350 GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ-LH 408
Query: 572 CCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFR 630
C + +++ ++EY+ D+ R A E IA GL +L
Sbjct: 409 SCFQTMDRLYFVMEYVNGG--DLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQ---SKG 462
Query: 631 IIHRDLKASNVLLDRDMNPKISDFGLAR--MFGGD 663
II+RDLK NV+LD + + KI+DFG+ + ++ G
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 3e-09
Identities = 24/126 (19%), Positives = 44/126 (34%), Gaps = 23/126 (18%)
Query: 24 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRP 83
L + + + L + F+L Y G W +
Sbjct: 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCNL-VLYNGNWQSNTAN----------- 46
Query: 84 ISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTE 143
+ + LT+++ G+LV+ N T+W + A S N A + DG LV+ S
Sbjct: 47 -NGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPS------ 99
Query: 144 NYLWQS 149
+++
Sbjct: 100 --VFKI 103
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 6e-09
Identities = 21/112 (18%), Positives = 45/112 (40%), Gaps = 13/112 (11%)
Query: 22 VSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRD 81
+ + + + +L + + +L L ++ W +N
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVLY----GGKYGWQSNTH 50
Query: 82 RPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVI 133
+ + L +++ G+L++ + TIWS+ +SS+ V L+DDG VI
Sbjct: 51 G--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-06
Identities = 15/71 (21%), Positives = 27/71 (38%), Gaps = 7/71 (9%)
Query: 79 NRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSS 138
D ++ N L + + LVL W +N ++ +L G L+I+D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGGK--YGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73
Query: 139 VNTTENYLWQS 149
+W S
Sbjct: 74 -----KTIWSS 79
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 7e-09
Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 15/164 (9%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEEFKNEM----LLIAKLQ 562
E+F + LG+G FG V+ + A+K L ++ + M +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 563 HRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
H L + C + E + ++EY+ D+ + + +A E I GL
Sbjct: 77 HPFLTH-MFCTFQTKENLFFVMEYLNGG--DLMYHIQSCHKFDLSRATFYAAE-IILGLQ 132
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR--MFGGD 663
+LH I++RDLK N+LLD+D + KI+DFG+ + M G
Sbjct: 133 FLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 15/164 (9%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEEFKNEM----LLIAKLQ 562
++F + +G G + V RL + + A+K + + E+ +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 563 HRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
H LV L C + ++ ++EY+ D+ +++L AR E I+ L
Sbjct: 69 HPFLVG-LHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALN 124
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR--MFGGD 663
YLH II+RDLK NVLLD + + K++D+G+ + + GD
Sbjct: 125 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEEFKNEM----LLIAKLQ 562
+F +G+G FG V R E AVK L ++ +E K+ M +L+ ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 563 HRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
H LV L + +K+ +L+Y+ ++F ++ L +AR E IA L
Sbjct: 98 HPFLVG-LHFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAE-IASALG 153
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR--MFGGD 663
YLH I++RDLK N+LLD + ++DFGL + +
Sbjct: 154 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 14/163 (8%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEEF---KNEMLLIAKLQH 563
+F LG+G FG V R A+K L + +E E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 564 RNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
L L + +++ ++EY ++F ++ +AR E I L Y
Sbjct: 65 PFLTA-LKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE-IVSALEY 120
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR--MFGGD 663
LH +++RD+K N++LD+D + KI+DFGL + + G
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLN----GEEVAVKRLS----SQSGQGLEEFKNEMLLIA 559
E F + LG+GG+G V++ R + G+ A+K L ++ + K E ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 560 KLQHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQ 618
+++H +V L + G K+ LILEY+ L F+ + + A + E I+
Sbjct: 77 EVKHPFIVD-LIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISM 132
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR--MFGGD 663
L +LH + II+RDLK N++L+ + K++DFGL + + G
Sbjct: 133 ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 42/165 (25%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV----AVKRLSSQS--GQGLEEFKNEMLLIAKL 561
F + LG+G FG V+ + ++G + A+K L + + K E ++ ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 562 QHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGL 620
H +V+ L + K+ LIL+++ L F + + + E +A L
Sbjct: 84 NHPFIVK-LHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAE-LALAL 139
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR--MFGGD 663
+LH II+RDLK N+LLD + + K++DFGL++ +
Sbjct: 140 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 42/201 (20%), Positives = 80/201 (39%), Gaps = 20/201 (9%)
Query: 476 PNEFSEANGDRRDKSKDSWLPLFSLASVAAATENFSME----CK-LGEGGFGPVYKGRLL 530
P + + + A+ + ++ + +G G + V RL
Sbjct: 15 PTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLK 74
Query: 531 NGEEV-AVKRLSSQSGQGLEEFKNEM----LLIAKLQHRNLVRILGCCIEQGEKI-LILE 584
+ + A++ + + E+ + H LV L C + ++ ++E
Sbjct: 75 KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG-LHSCFQTESRLFFVIE 133
Query: 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD 644
Y+ D+ +++L AR E I+ L YLH II+RDLK NVLLD
Sbjct: 134 YVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH---ERGIIYRDLKLDNVLLD 187
Query: 645 RDMNPKISDFGLAR--MFGGD 663
+ + K++D+G+ + + GD
Sbjct: 188 SEGHIKLTDYGMCKEGLRPGD 208
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-08
Identities = 15/125 (12%), Positives = 47/125 (37%), Gaps = 18/125 (14%)
Query: 25 AADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPI 84
+ + + + D +L +++ + L L + + +VW +
Sbjct: 5 VRNVLFSSQVMYDNAQL--ATRDYSLVMRDDCN-----LVLTKGSKTN-IVWESGTSG-- 54
Query: 85 SDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTEN 144
+ + + ++G+L + + T++ +N + + V L+ +G V+ +
Sbjct: 55 RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGPA------- 107
Query: 145 YLWQS 149
+W +
Sbjct: 108 -VWST 111
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 44/171 (25%), Positives = 72/171 (42%), Gaps = 29/171 (16%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEEFKNEM----LLIAKLQ 562
+F+ LG+G FG V +E+ AVK L ++ + M +L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 563 HRNLVRILGCCIEQGEKI-LILEYMPNKSL-------DVFLFDPTKKRLLGWQARIGIIE 614
L + L C + +++ ++EY+ L F A E
Sbjct: 80 PPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---------HAVFYAAE 129
Query: 615 GIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR--MFGGD 663
IA GL +L II+RDLK NV+LD + + KI+DFG+ + ++ G
Sbjct: 130 -IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 15/156 (9%)
Query: 516 LGEGGFGPVYKGRLLNGEEV-AVKRLSSQSGQGLEEFKNEM----LLIAKLQHRNLVRIL 570
LG+G FG V R+ ++ AVK L ++ + M +L H L + L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ-L 89
Query: 571 GCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
CC + +++ ++E++ D+ +R +AR E I L++LH
Sbjct: 90 FCCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAE-IISALMFLH---DK 143
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLA--RMFGGD 663
II+RDLK NVLLD + + K++DFG+ + G
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 51.1 bits (121), Expect = 3e-07
Identities = 19/79 (24%), Positives = 29/79 (36%), Gaps = 10/79 (12%)
Query: 71 PDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGN 130
D VW N + NG++ +L N +W++ S A V L+ D N
Sbjct: 167 RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 224
Query: 131 LVIRDNSSVNTTENYLWQS 149
L I + LW +
Sbjct: 225 LAIYGGA--------LWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 6e-05
Identities = 15/90 (16%), Positives = 36/90 (40%), Gaps = 6/90 (6%)
Query: 66 WFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQL 125
+ + D + + + L++ + LVL + + +WSTN + + A L
Sbjct: 129 YSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD-RDDRVWSTNTAGKGTGCRAVL 187
Query: 126 RDDGNLVIRDNSSVNTTENYLWQSFDYPTD 155
+ +G + + N + +W S + +
Sbjct: 188 QPNGRMDVLTNQN-----IAVWTSGNSRSA 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 18/178 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEV----AVKRLS----SQSGQGLEEFKNE-MLLI 558
ENF + LG G +G V+ R ++G + A+K L Q + E + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 559 AKLQHRNLVRILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIA 617
Q LV L + K+ LIL+Y+ L F ++R + +I + E I
Sbjct: 114 HIRQSPFLVT-LHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGE-IV 169
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
L +LH + II+RD+K N+LLD + + ++DFGL++ F DE + GT
Sbjct: 170 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 44/184 (23%), Positives = 68/184 (36%), Gaps = 50/184 (27%)
Query: 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRIL 570
KLG G F V+ + ++N VA+K + +E I LQ N
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE-------IKLLQRVNDADNT 78
Query: 571 GCCIEQGEKILILEYMPNKSLDVF------------LFDPTKKRLLGWQAR-------IG 611
IL L LD F +F+ + LL + +
Sbjct: 79 KEDSMGANHILKL-------LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 131
Query: 612 IIEGIAQ----GLLYLHHYSRFRIIHRDLKASNVLLDRDMNP------KISDFGLARMFG 661
++ I++ GL Y+H R IIH D+K NVL++ +P KI+D G A +
Sbjct: 132 YVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWY 188
Query: 662 GDEL 665
+
Sbjct: 189 DEHY 192
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.4 bits (111), Expect = 6e-06
Identities = 14/66 (21%), Positives = 26/66 (39%), Gaps = 8/66 (12%)
Query: 88 NAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLW 147
+G LV+ N +W ++ A + V +L+ +G++ I D V W
Sbjct: 196 AVRAVFQGDGNLVVYGAGNAVLWHSHTGGHA-SAVLRLQANGSIAILDEKPV-------W 247
Query: 148 QSFDYP 153
F +
Sbjct: 248 ARFGFQ 253
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.2 bits (108), Expect = 1e-05
Identities = 31/165 (18%), Positives = 57/165 (34%), Gaps = 22/165 (13%)
Query: 23 SLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDR 82
+ + + G+ L+S +QRF+L G L I VWVAN +
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQD---NGATVWVANEQQ 62
Query: 83 PIS------DHNAVLTISNNGKLVLLNQTNGTIW-----STNASSEAKNPVAQLRDDGNL 131
P S + A L L + + +W + ++ + L+DDGN+
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122
Query: 132 VIRDNSSVNTTENYLWQSFDYPTDTLL---QDMKMGWDLKNRRER 173
V+ D+ ++ + LL ++ G +
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASK 167
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 7e-06
Identities = 11/51 (21%), Positives = 20/51 (39%), Gaps = 2/51 (3%)
Query: 88 NAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSS 138
+A + + LVL N + +N + +L + G L I +S
Sbjct: 21 SAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANS 69
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 7e-05
Identities = 12/81 (14%), Positives = 32/81 (39%), Gaps = 13/81 (16%)
Query: 72 DTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGT---IWSTNASSEAKNPVAQLRDD 128
+ + +N + L ++N G+L + + + T ++ + ++ N A L D
Sbjct: 37 EAGGFQSNTHG--RGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPD 94
Query: 129 GNLVIRDNSSVNTTENYLWQS 149
++ I + +W +
Sbjct: 95 QHVTIYGPA--------IWST 107
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 38/171 (22%), Positives = 62/171 (36%), Gaps = 41/171 (23%)
Query: 510 FSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHR- 564
+ ++ +G+G FG V K + E VA+K + ++ Q E + L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHD 111
Query: 565 -----NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKK-----------RLLGWQA 608
+V + + + L+ E L L+D + R Q
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQ- 165
Query: 609 RIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP--KISDFGLA 657
+ LL+L IIH DLK N+LL KI DFG +
Sbjct: 166 -------MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 25/156 (16%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHR------N 565
+G+G FG V K + VA+K + ++ Q EE + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKK-RLLGWQARIGIIEGIAQGLLY-L 623
++ +L + + E L + L++ KK + G+ + ++ A +L L
Sbjct: 161 VIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFS--LPLVRKFAHSILQCL 213
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNP--KISDFGLA 657
+ RIIH DLK N+LL + K+ DFG +
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 9e-06
Identities = 88/561 (15%), Positives = 152/561 (27%), Gaps = 173/561 (30%)
Query: 157 LLQDMKMGWDLKNRRE---RYLSSWRSDD---DPSPGKFTNRLDIHVLPKMCTFNGSVKY 210
+D K+ ++ LS D T RL +L K
Sbjct: 25 FEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSK---------- 74
Query: 211 TCTGEWTGDGFVSALSNTN--FLYKQFLVENQDE--ISYWYEPYNRPSIMTLKLSPSGFV 266
E FV + N FL E + ++ Y ++ V
Sbjct: 75 ---QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV 131
Query: 267 TR-QLWNEDSNEWDELFSIPDDYCGKYGYCGANTICGPDQKPMCQCLEGFRLKSQFNQTG 325
+R Q + + EL P G G G K +
Sbjct: 132 SRLQPYLKLRQALLEL--RPAKNVLIDGVLG----SG---K---TWVALDVC-------- 171
Query: 326 PIKCERSHSSECIKGDQ-F-IKLDNIKAPDFIEVSLNQSMNLQQCAAECLKNCTCKAYAN 383
S+ +C + F + L N +P+ + L LQ+ + N T ++ +
Sbjct: 172 -----LSYKVQCKMDFKIFWLNLKNCNSPETV---LEM---LQKLLYQIDPNWTSRSDHS 220
Query: 384 SNVTEGSGCLMWFGELLDASRPIRNFTGQSVYLRQPASGPGNKKLLWIIVIVVPPMVLLP 443
SN+ + +R Y LL VL
Sbjct: 221 SNIKL---------RIHSIQAELRRLLKSKPY---------ENCLL----------VL-- 250
Query: 444 SVYIFCRQRRKCKEKENMETSQDLLAFD------ITTRPNEFSEANGDRRDKSKDSWLPL 497
N++ ++ AF+ +TT R K +L
Sbjct: 251 ---------------LNVQNAKAWNAFNLSCKILLTT------------RFKQVTDFL-- 281
Query: 498 FSLASVAAATENFSMECKLGEGGFGPVY-KGRLLNGEEVAVKRLSSQSGQGL-------- 548
AA T + S++ P K LL + + L +
Sbjct: 282 -----SAATTTHISLD--HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA 334
Query: 549 EEFKNEMLLIAKLQHRN---LVRILGCCIEQGEKILILEYMPNKSLDVFLFD---PTKKR 602
E ++ + +H N L I+ + E + L VF PT
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF--DRLSVFPPSAHIPTI-- 390
Query: 603 LLG--WQARIGI-IEGIAQGL--------------LYLHHYSRFRIIHRDLKASNVLLDR 645
LL W I + + L + + I+ +LK + +
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS------IYLELKV-KLENEY 443
Query: 646 DMNPKISD-FGLARMFGGDEL 665
++ I D + + + F D+L
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDL 464
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 675 | |||
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.98 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.98 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.98 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.98 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.96 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.96 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.94 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.94 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.94 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.94 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.94 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.94 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.94 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.94 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.94 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.94 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.94 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.94 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.94 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.94 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.93 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.93 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.93 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.93 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.93 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.93 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.93 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.93 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.93 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.93 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.93 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.93 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.93 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.93 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.93 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.93 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.93 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.93 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.93 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.93 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.93 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.93 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.93 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.93 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.93 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.93 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.93 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.93 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.93 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.93 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.93 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.93 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.92 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.92 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.92 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.92 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.92 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.92 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.92 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.92 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.92 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.92 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.92 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.92 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.92 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.92 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.92 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.92 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.92 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.92 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.92 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.92 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.92 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.92 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.92 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.92 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.92 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.92 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.92 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.92 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.92 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.92 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.92 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.92 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.92 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.92 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.92 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.92 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.92 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.92 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.92 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.92 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.92 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.92 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.92 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.92 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.92 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.92 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.92 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.92 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.92 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.92 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.92 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.92 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.91 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.91 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.91 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.91 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.91 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.91 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.91 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.91 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.91 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.91 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.91 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.91 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.91 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.91 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.91 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.91 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.91 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.91 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.91 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.91 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.91 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.91 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.91 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.91 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.91 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.91 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.91 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.91 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.91 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.91 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.91 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.91 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.91 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.91 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.91 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.91 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.91 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.91 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.91 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.91 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.91 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.91 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.91 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.91 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.91 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.91 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.91 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.91 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.91 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.91 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.91 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.91 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.91 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.9 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.9 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.9 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.9 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.9 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.9 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.9 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.9 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.9 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.9 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.9 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.9 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.9 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.9 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.9 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.9 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.9 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.9 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.9 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.9 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.9 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.9 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.9 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.9 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.9 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.9 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.9 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.9 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.9 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.9 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.9 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.9 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.9 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.9 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.9 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.9 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.9 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.9 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.89 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.89 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.89 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.89 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.89 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.89 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.89 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.89 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.89 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.89 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.89 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.89 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.89 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.89 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.89 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.89 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.89 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.88 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.88 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.88 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.88 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.88 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.88 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.88 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.88 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.88 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.88 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.87 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.87 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.87 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.87 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.87 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.87 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.86 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.85 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.85 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.83 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.82 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.77 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.71 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.69 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.69 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.64 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.62 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.61 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.5 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.38 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.32 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.21 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.18 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.95 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.55 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.53 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.49 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.35 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.3 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.06 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.0 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.83 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.67 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.33 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.25 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.23 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.2 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.15 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.14 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.08 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.85 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.4 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.09 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.03 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.51 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 88.03 | |
| 1b9w_A | 95 | Protein (merozoite surface protein 1); MSP-1, cand | 82.42 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 81.54 |
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=368.88 Aligned_cols=232 Identities=19% Similarity=0.214 Sum_probs=181.9
Q ss_pred ccccccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCC-CcEEEEecCCCCCCCC----cceEEEeeCC
Q 005825 23 SLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVP-DTVVWVANRDRPISDH----NAVLTISNNG 97 (675)
Q Consensus 23 ~~~~~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~-~tvVW~Anr~~pv~~~----~~~l~l~~~G 97 (675)
+++.|+|++|++|++|++|+|++|.|+||||+++ ++|| |+ + + |||+|||++|+.++ +++|+|+.||
T Consensus 11 ~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred cccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 4567999999999999999999999999999543 5677 77 6 7 99999999999875 7899999999
Q ss_pred eEEE--EeCCCCeEEEeccCCC-----CCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhccccccccccCC
Q 005825 98 KLVL--LNQTNGTIWSTNASSE-----AKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKNR 170 (675)
Q Consensus 98 ~Lvl--~~~~g~~vWss~~~~~-----~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~~tg 170 (675)
+||| .|++|++||+++++.. ..+.+|+|+|+|||||+| +.+|||| ||||||||||++|.++.+|
T Consensus 82 ~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~-------~~~lWqS--~ptdtlLpg~~~~~~l~~g 152 (276)
T 3m7h_A 82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD-------SLALWNG--TPAIPLVPGAIDSLLLAPG 152 (276)
T ss_dssp SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE-------EEEEEES--CTTSCCCCSCTTCEEECSS
T ss_pred cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC-------CceeeCc--ccccccccccccccccccC
Confidence 9999 7888999999998642 235789999999999997 3589999 9999999999999999888
Q ss_pred CceeEEEecCCCCCCCceeeeeecCCCCceEEEEc-CCeeeeeeCccCCCceeeeeecCceeeEEEEeeecCeeEEEEee
Q 005825 171 RERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFN-GSVKYTCTGEWTGDGFVSALSNTNFLYKQFLVENQDEISYWYEP 249 (675)
Q Consensus 171 ~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~-~~~~y~~~g~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (675)
.. | ++.+||++|.|+++||++|. +++++ +...||++|+|++.. ....+.....+ .+.++.+ ..+.++.
T Consensus 153 ~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~-~~l~l~~dGnL--vl~d~~~-~~vWsS~ 221 (276)
T 3m7h_A 153 SE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGA-VRAVFQGDGNL--VVYGAGN-AVLWHSH 221 (276)
T ss_dssp EE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTC-CEEEECTTSCE--EEECTTS-CEEEECS
T ss_pred cc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCcc-EEEEEcCCCeE--EEEeCCC-cEEEEec
Confidence 44 6 67899999999999999996 44455 458999999998654 22233322211 1223322 2233333
Q ss_pred cCCCceEEEEECcCccEEEEEecCCCCceEEeeeccC
Q 005825 250 YNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPD 286 (675)
Q Consensus 250 ~~~~~~~r~~l~~~G~l~~~~~~~~~~~W~~~~~~p~ 286 (675)
......+|++|+.||++++|.| ...|..++.+|.
T Consensus 222 t~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 222 TGGHASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp CTTCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred CCCCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 3333458999999999999998 345666666554
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=309.94 Aligned_cols=216 Identities=15% Similarity=0.171 Sum_probs=164.4
Q ss_pred cccccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEe
Q 005825 24 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLN 103 (675)
Q Consensus 24 ~~~~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~ 103 (675)
++.|+|++|++|.+|++| ++|.|+|||+.+++ +. +|.. +|+||+|||+.| .+++|+|+.||+|||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~-ly~~--~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LV-LFDS--DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EE-EEES--SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EE-EEEC--CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 567999999999999999 59999999997765 23 3433 799999999988 46899999999999999
Q ss_pred CCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhh-hccccccccc-cCCC-----ceeEE
Q 005825 104 QTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTL-LQDMKMGWDL-KNRR-----ERYLS 176 (675)
Q Consensus 104 ~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTl-Lpg~~l~~~~-~tg~-----~~~l~ 176 (675)
++|.+||+|++.......+|+|+|+|||||++ . ++||||||||||+ ||+| +.+. .+|. ++.|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~------~--~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG------P--GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC------S--EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEec------C--CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 99999999998654445689999999999985 2 7999999999777 5554 4443 4443 46776
Q ss_pred EecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCccCCCceeee-eecCceeeEEEEeeecCeeEEEEeecCCCce
Q 005825 177 SWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGEWTGDGFVSA-LSNTNFLYKQFLVENQDEISYWYEPYNRPSI 255 (675)
Q Consensus 177 S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~w~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (675)
+.+||++|.|+|+++++| +++++++..+||++++|++. +... .+.....+ ..+..++.+++.++...+ ...
T Consensus 143 ---s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl-~ly~~~~~~vw~s~~~~~-~~~ 214 (236)
T 1dlp_A 143 ---ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM-DVLTNQNIAVWTSGNSRS-AGR 214 (236)
T ss_dssp ---SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE-EEEETTTEEEEECCCCCS-SSC
T ss_pred ---cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE-EEEeCCCcEEEEeCCCCC-CCC
Confidence 578999999999999999 57778888899999999654 4333 44333211 112223334444443333 346
Q ss_pred EEEEECcCccEEEEE
Q 005825 256 MTLKLSPSGFVTRQL 270 (675)
Q Consensus 256 ~r~~l~~~G~l~~~~ 270 (675)
+|++||+||++++|.
T Consensus 215 ~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 215 YVFVLQPDRNLAIYG 229 (236)
T ss_dssp CEEEECSSSCEEEEC
T ss_pred EEEEEcCCCcEEEeC
Confidence 899999999999994
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.78 Aligned_cols=166 Identities=30% Similarity=0.494 Sum_probs=142.1
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357889999999999999999864 47789999998766666788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC----------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeE
Q 005825 581 LILEYMPNKSLDVFLFDP----------TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPK 650 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 650 (675)
||||||++|+|.++|+.. .....++|.+++.|+.|||+||+|||+++ ||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 999999999999999642 22356999999999999999999999987 99999999999999999999
Q ss_pred EeeeccceecCCCcccCCCCceecC
Q 005825 651 ISDFGLARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 651 l~DFGla~~~~~~~~~~~~~~~~GT 675 (675)
|+|||+|+.+...+....+...+||
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt 193 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLP 193 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEEC
T ss_pred ECCcccceecCCCCceeecCceecC
Confidence 9999999987655433333344554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=306.54 Aligned_cols=166 Identities=30% Similarity=0.504 Sum_probs=134.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 357888899999999999999864 47889999998766666788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC
Q 005825 581 LILEYMPNKSLDVFLFDPT------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN 648 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 648 (675)
||||||++|+|.++++... ....++|.+++.|+.|||+||+|||+++ ||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 9999999999999996532 2346899999999999999999999987 999999999999999999
Q ss_pred eEEeeeccceecCCCcccCCCCceecC
Q 005825 649 PKISDFGLARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 649 ~kl~DFGla~~~~~~~~~~~~~~~~GT 675 (675)
+||+|||+|+.+...+....+.+.+||
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt 223 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLP 223 (329)
T ss_dssp EEECCCC----------------CCCC
T ss_pred EEEcccccceeccCCCcceecCccccc
Confidence 999999999988655443334445565
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.45 Aligned_cols=165 Identities=33% Similarity=0.474 Sum_probs=140.9
Q ss_pred CCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
.++++.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677899999999999999863 46789999997543 345678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC
Q 005825 581 LILEYMPNKSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM 647 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 647 (675)
||||||++|+|.++|.... ....++|.+++.|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996432 1346899999999999999999999987 99999999999999999
Q ss_pred CeEEeeeccceecCCCcccCCCCceecC
Q 005825 648 NPKISDFGLARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 648 ~~kl~DFGla~~~~~~~~~~~~~~~~GT 675 (675)
++||+|||+|+.+...+....+...+||
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred CEEECCcccceeccCCCceeEecccccC
Confidence 9999999999988655444444455665
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=297.73 Aligned_cols=162 Identities=30% Similarity=0.407 Sum_probs=145.9
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||+||+|+. .+++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999986 46899999999753 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++|+|.+++. +.+.+++.+...++.||+.||+|||+++ |+||||||+||||++++++||+|||+|+.+..+
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999994 3457899999999999999999999998 999999999999999999999999999998766
Q ss_pred cccCCCCceecC
Q 005825 664 ELQGNTKRIVGT 675 (675)
Q Consensus 664 ~~~~~~~~~~GT 675 (675)
.....+.+++||
T Consensus 186 ~~~~~~~~~~GT 197 (311)
T 4aw0_A 186 SKQARANSFVGT 197 (311)
T ss_dssp TTCCCBCCCCSC
T ss_pred CCcccccCcccC
Confidence 555556667887
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.09 Aligned_cols=159 Identities=27% Similarity=0.411 Sum_probs=143.1
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
..|++.++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999875 69999999998666666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCccc
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQ 666 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (675)
++|+|.+++.. ..+++.+...|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+.+..+...
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999842 35899999999999999999999998 999999999999999999999999999988654432
Q ss_pred CCCCceecC
Q 005825 667 GNTKRIVGT 675 (675)
Q Consensus 667 ~~~~~~~GT 675 (675)
+++++||
T Consensus 227 --~~~~~GT 233 (346)
T 4fih_A 227 --RKSLVGT 233 (346)
T ss_dssp --BCCCCSC
T ss_pred --ccccccC
Confidence 3446787
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=294.85 Aligned_cols=161 Identities=29% Similarity=0.482 Sum_probs=132.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.+++++.++||+|+||+||+|++.+ .||||+++.. ..+..++|.+|+.++++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4678889999999999999998743 5999999753 33456789999999999999999999998864 56899999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
||++|+|.++|+.. ...++|.+++.|+.|||+||+|||+++ ||||||||+||||++++++||+|||+|+.+....
T Consensus 112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999999643 346999999999999999999999987 9999999999999999999999999999886544
Q ss_pred ccCCCCceecC
Q 005825 665 LQGNTKRIVGT 675 (675)
Q Consensus 665 ~~~~~~~~~GT 675 (675)
....+.+.+||
T Consensus 187 ~~~~~~~~~GT 197 (307)
T 3omv_A 187 GSQQVEQPTGS 197 (307)
T ss_dssp -------CCCC
T ss_pred cceeecccccC
Confidence 33344556776
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=299.97 Aligned_cols=160 Identities=27% Similarity=0.408 Sum_probs=143.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.+.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 367999999999999999999874 5999999999876666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCcc
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (675)
|++|+|.+++.. ..+++.+...|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+..+..
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999842 35899999999999999999999998 99999999999999999999999999998865543
Q ss_pred cCCCCceecC
Q 005825 666 QGNTKRIVGT 675 (675)
Q Consensus 666 ~~~~~~~~GT 675 (675)
. ...++||
T Consensus 303 ~--~~~~~GT 310 (423)
T 4fie_A 303 R--RKSLVGT 310 (423)
T ss_dssp C--BCCCEEC
T ss_pred c--ccccccC
Confidence 2 3446887
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.27 Aligned_cols=162 Identities=25% Similarity=0.412 Sum_probs=135.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++|++.++||+|+||+||+|+.. +|+.||||+++.. .....+.|.+|+.+|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999864 5999999999754 23345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|++||+|.+++... +...+++.+...|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999542 3345788999999999999999999998 9999999999999999999999999999875432
Q ss_pred ccCCCCceecC
Q 005825 665 LQGNTKRIVGT 675 (675)
Q Consensus 665 ~~~~~~~~~GT 675 (675)
. .++..+||
T Consensus 180 ~--~~~~~~GT 188 (350)
T 4b9d_A 180 E--LARACIGT 188 (350)
T ss_dssp H--HHHHHHSC
T ss_pred c--cccccCCC
Confidence 2 12335665
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=284.19 Aligned_cols=154 Identities=27% Similarity=0.412 Sum_probs=127.9
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC--------
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG-------- 577 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~-------- 577 (675)
++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999864 68999999997543 234567999999999999999999999997654
Q ss_pred ----eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEee
Q 005825 578 ----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISD 653 (675)
Q Consensus 578 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 653 (675)
..++||||+++|+|.+++.........++...+.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976544445677778899999999999999998 99999999999999999999999
Q ss_pred eccceecCCCc
Q 005825 654 FGLARMFGGDE 664 (675)
Q Consensus 654 FGla~~~~~~~ 664 (675)
||+|+.+..++
T Consensus 162 FGla~~~~~~~ 172 (299)
T 4g31_A 162 FGLVTAMDQDE 172 (299)
T ss_dssp CCCC-------
T ss_pred CccceecCCCc
Confidence 99999886543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=282.44 Aligned_cols=157 Identities=30% Similarity=0.451 Sum_probs=133.0
Q ss_pred ceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeEEEEE
Q 005825 511 SMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE----QGEKILIL 583 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~----~~~~~lV~ 583 (675)
++.++||+|+||+||+|+.. +++.||||++... .....+.|.+|+.++++++|||||++++++.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 66788999999999999875 5889999999753 23345679999999999999999999999875 34579999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc-CCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD-RDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~ 662 (675)
|||++|+|.+++. +...+++..+..|+.||+.||+|||+++ ++||||||||+||||+ +++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999994 3457899999999999999999999874 3599999999999998 479999999999987543
Q ss_pred CcccCCCCceecC
Q 005825 663 DELQGNTKRIVGT 675 (675)
Q Consensus 663 ~~~~~~~~~~~GT 675 (675)
.. +++++||
T Consensus 185 ~~----~~~~~GT 193 (290)
T 3fpq_A 185 SF----AKAVIGT 193 (290)
T ss_dssp TS----BEESCSS
T ss_pred Cc----cCCcccC
Confidence 32 3346776
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=278.64 Aligned_cols=158 Identities=27% Similarity=0.486 Sum_probs=126.0
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.+.||+|+||+||+|+. .+++.||||++++. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999986 46999999999753 2334567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+ +|+|.+++. +...+++.+...++.||+.||+|||+++ |+||||||+||||++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 689999884 3456899999999999999999999998 999999999999999999999999999987544
Q ss_pred cccCCCCceecC
Q 005825 664 ELQGNTKRIVGT 675 (675)
Q Consensus 664 ~~~~~~~~~~GT 675 (675)
.. ..+.+||
T Consensus 166 ~~---~~~~~GT 174 (275)
T 3hyh_A 166 NF---LKTSCGS 174 (275)
T ss_dssp ------------
T ss_pred Cc---cCCeeEC
Confidence 32 2335666
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=287.73 Aligned_cols=158 Identities=27% Similarity=0.337 Sum_probs=133.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.+.|++.++||+|+||+||+|+.. +|+.||||+++.... +.+|+.++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999999999999874 589999999975322 24699999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC-CeEEeeeccceecCCCc
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-NPKISDFGLARMFGGDE 664 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 664 (675)
++||+|.+++. +.+.+++.+...|+.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+..+.
T Consensus 132 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999994 3456999999999999999999999987 99999999999999987 69999999999986554
Q ss_pred ccC---CCCceecC
Q 005825 665 LQG---NTKRIVGT 675 (675)
Q Consensus 665 ~~~---~~~~~~GT 675 (675)
... ....++||
T Consensus 206 ~~~~~~~~~~~~GT 219 (336)
T 4g3f_A 206 LGKSLLTGDYIPGT 219 (336)
T ss_dssp --------CCCCCC
T ss_pred cccceecCCccccC
Confidence 221 22346777
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=285.10 Aligned_cols=162 Identities=28% Similarity=0.373 Sum_probs=130.5
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC----eEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG----EKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~----~~~lV~ 583 (675)
++|.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4678889999999999999998 689999999975321 1223345666667899999999999998764 579999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc-----CCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY-----SRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
|||++|+|.++++. ..++|..++.|+.|+++||+|||++ +.++||||||||+||||++++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 3589999999999999999999986 23469999999999999999999999999999
Q ss_pred ecCCCcc--cCCCCceecC
Q 005825 659 MFGGDEL--QGNTKRIVGT 675 (675)
Q Consensus 659 ~~~~~~~--~~~~~~~~GT 675 (675)
....... ...+.+.+||
T Consensus 157 ~~~~~~~~~~~~~~~~~GT 175 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EEETTTTEESCC-----CC
T ss_pred cccCCCCceeeeccccccc
Confidence 8855432 2223345676
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-33 Score=287.99 Aligned_cols=160 Identities=27% Similarity=0.347 Sum_probs=131.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc----CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
++|++.++||+|+||+||+|+.. .++.||||++++.. .....++.+|+.+|++++|||||++++++.+.+..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999762 47899999997542 2334578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||++||+|.+++. +...+++.+...++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.+.
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999994 3457899999999999999999999998 9999999999999999999999999999775
Q ss_pred CCcccCCCCceecC
Q 005825 662 GDELQGNTKRIVGT 675 (675)
Q Consensus 662 ~~~~~~~~~~~~GT 675 (675)
..+.. ..+.+||
T Consensus 178 ~~~~~--~~~~~GT 189 (304)
T 3ubd_A 178 DHEKK--AYSFCGT 189 (304)
T ss_dssp ---CC--CCSCCCC
T ss_pred CCCcc--ccccccC
Confidence 44332 3346776
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=287.81 Aligned_cols=169 Identities=28% Similarity=0.391 Sum_probs=141.9
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEEcC------CcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCC-CceeeEEEEEEe
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQH-RNLVRILGCCIE 575 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H-~nIv~l~g~~~~ 575 (675)
+...++|++.++||+|+||+||+|++.. ++.||||+++.... ...++|.+|+.+|.++.| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 3456889999999999999999998643 36899999986433 345679999999999965 999999999977
Q ss_pred C-CeEEEEEEecCCCCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCE
Q 005825 576 Q-GEKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNV 641 (675)
Q Consensus 576 ~-~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NI 641 (675)
. +..+||||||++|+|.++|+... ....++|.+++.|+.|||+||+|||+++ ||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccce
Confidence 5 56899999999999999996422 1345899999999999999999999987 99999999999
Q ss_pred EEcCCCCeEEeeeccceecCCCcccCCCCceecC
Q 005825 642 LLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 642 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 675 (675)
||++++.+||+|||+|+.+..+.....+...+||
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt 250 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence 9999999999999999988665544344455665
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-30 Score=275.09 Aligned_cols=162 Identities=25% Similarity=0.410 Sum_probs=135.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEe------CC
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIE------QG 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~------~~ 577 (675)
.++|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999987 469999999997542 2335678899999999999999999999864 35
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
..|||||||+ |+|.+++. ....+++.+...|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 67999984 3457999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCc--ccCCCCceecC
Q 005825 658 RMFGGDE--LQGNTKRIVGT 675 (675)
Q Consensus 658 ~~~~~~~--~~~~~~~~~GT 675 (675)
+.+.... ........+||
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT 225 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVAT 225 (398)
T ss_dssp BCC-------CCCCCSSCCC
T ss_pred eecccCccccccccccceeC
Confidence 9875432 22234456776
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=283.94 Aligned_cols=159 Identities=29% Similarity=0.352 Sum_probs=136.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHH---HHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKN---EMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~---E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
.++|++.++||+|+||+||+|+.. +|+.||||++++. .......+.+ ++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999875 5999999999753 1223333444 46677778999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
||||||++||+|..+|. +...+++.....++.||+.||+|||+++ ||||||||+||||+++|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999994 3456899999999999999999999988 99999999999999999999999999998
Q ss_pred cCCCcccCCCCceecC
Q 005825 660 FGGDELQGNTKRIVGT 675 (675)
Q Consensus 660 ~~~~~~~~~~~~~~GT 675 (675)
+.... +.+.+||
T Consensus 342 ~~~~~----~~t~~GT 353 (689)
T 3v5w_A 342 FSKKK----PHASVGT 353 (689)
T ss_dssp CSSCC----CCSCCSC
T ss_pred cCCCC----CCCccCC
Confidence 86543 2345777
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=266.65 Aligned_cols=149 Identities=26% Similarity=0.398 Sum_probs=132.7
Q ss_pred HHHhcCCcceeeeeCCcCceeEEEEEEc----CCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005825 503 VAAATENFSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQG 577 (675)
Q Consensus 503 ~~~~~~~f~~~~~IG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~ 577 (675)
+....+.|++.++||+|+||+||+|+.. .++.||||++.+. ....++.+|+++|.++ +|||||++++++.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3445688999999999999999999753 4678999998753 3456788999999998 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC-CCeEEeeecc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD-MNPKISDFGL 656 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGl 656 (675)
+.+|||||+++|+|.+++. .+++.+...++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 94 ~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 9999999999999999982 3788999999999999999999998 9999999999999876 7999999999
Q ss_pred ceecCC
Q 005825 657 ARMFGG 662 (675)
Q Consensus 657 a~~~~~ 662 (675)
|+.+..
T Consensus 165 a~~~~~ 170 (361)
T 4f9c_A 165 AQGTHD 170 (361)
T ss_dssp CEECTT
T ss_pred CcccCC
Confidence 997754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=278.83 Aligned_cols=161 Identities=23% Similarity=0.388 Sum_probs=141.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.++|++.+.||+|+||+||+|+.. +|+.||||.+........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999874 5999999999865555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC--CCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD--MNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~ 663 (675)
|++|+|.+++.. +...+++.+...++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999853 2346889999999999999999999998 9999999999999854 89999999999998655
Q ss_pred cccCCCCceecC
Q 005825 664 ELQGNTKRIVGT 675 (675)
Q Consensus 664 ~~~~~~~~~~GT 675 (675)
+. ....+||
T Consensus 311 ~~---~~~~~GT 319 (573)
T 3uto_A 311 QS---VKVTTGT 319 (573)
T ss_dssp SE---EEEECSS
T ss_pred Cc---eeeeEEC
Confidence 42 2334665
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=249.44 Aligned_cols=158 Identities=42% Similarity=0.720 Sum_probs=143.2
Q ss_pred HHHHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 502 SVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 502 ~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
++...+++|++.+.||+|+||.||+|+..+++.||||++........+++.+|+.++++++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34457789999999999999999999988899999999987666667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 582 ILEYMPNKSLDVFLFDPTK-KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999864322 335899999999999999999999987 999999999999999999999999999976
Q ss_pred CC
Q 005825 661 GG 662 (675)
Q Consensus 661 ~~ 662 (675)
..
T Consensus 190 ~~ 191 (321)
T 2qkw_B 190 TE 191 (321)
T ss_dssp SS
T ss_pred cc
Confidence 54
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-27 Score=256.91 Aligned_cols=160 Identities=19% Similarity=0.269 Sum_probs=140.5
Q ss_pred HHHHHHhcCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEe
Q 005825 500 LASVAAATENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE 575 (675)
Q Consensus 500 ~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~ 575 (675)
+.++....++|++.++||+|+||+||+|+... ++.||||++++. .....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34445567899999999999999999999764 789999999752 22334458999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
.+..+|||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999542 346899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCc
Q 005825 656 LARMFGGDE 664 (675)
Q Consensus 656 la~~~~~~~ 664 (675)
+|+.+..+.
T Consensus 221 la~~~~~~~ 229 (437)
T 4aw2_A 221 SCLKLMEDG 229 (437)
T ss_dssp TCEECCTTS
T ss_pred hhhhcccCC
Confidence 998876544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=239.54 Aligned_cols=152 Identities=26% Similarity=0.434 Sum_probs=138.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
..++|++.++||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999986 5689999999986666667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|+++++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999843 35889999999999999999999997 9999999999999999999999999999876544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=241.33 Aligned_cols=152 Identities=28% Similarity=0.482 Sum_probs=138.1
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.++|++.++||+|+||+||+++.. +++.||+|++........+.|.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 468899999999999999999875 5899999999776666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++++|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999542 346899999999999999999999998 999999999999999999999999999987544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=241.17 Aligned_cols=160 Identities=29% Similarity=0.408 Sum_probs=142.8
Q ss_pred cccHHHHHHhcCC----------cceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCc
Q 005825 497 LFSLASVAAATEN----------FSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565 (675)
Q Consensus 497 ~~~~~~~~~~~~~----------f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~n 565 (675)
.+++.++..+++. |...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3566666655543 777889999999999999876 69999999998766667788999999999999999
Q ss_pred eeeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC
Q 005825 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR 645 (675)
Q Consensus 566 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 645 (675)
|+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999999842 35899999999999999999999987 999999999999999
Q ss_pred CCCeEEeeeccceecCCC
Q 005825 646 DMNPKISDFGLARMFGGD 663 (675)
Q Consensus 646 ~~~~kl~DFGla~~~~~~ 663 (675)
++.+||+|||+++.+..+
T Consensus 177 ~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp TCCEEECCCTTCEECCSS
T ss_pred CCcEEEeeeeeeeecccC
Confidence 999999999999987654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-26 Score=241.94 Aligned_cols=154 Identities=25% Similarity=0.387 Sum_probs=135.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-------
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG------- 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~------- 577 (675)
.++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999885 68999999997533 334578999999999999999999999987654
Q ss_pred --------------------------------------------------eEEEEEEecCCCCHHHHhcCCCCcccCCHH
Q 005825 578 --------------------------------------------------EKILILEYMPNKSLDVFLFDPTKKRLLGWQ 607 (675)
Q Consensus 578 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 607 (675)
..++||||+++++|.+++..........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999776555667788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 608 ARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 608 ~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
.++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 88999999999999999987 999999999999999999999999999988654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=245.07 Aligned_cols=150 Identities=25% Similarity=0.315 Sum_probs=135.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.+.||+|+||+||+++.. +++.||||++++. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999875 5899999999753 234567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+....
T Consensus 84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999984 3456889999999999999999999987 99999999999999999999999999987543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=244.99 Aligned_cols=152 Identities=30% Similarity=0.471 Sum_probs=136.8
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
..++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 347899999999999999999987 57999999999753 233456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 93 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999999843 356889999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
.
T Consensus 167 ~ 167 (328)
T 3fe3_A 167 G 167 (328)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-27 Score=245.46 Aligned_cols=169 Identities=43% Similarity=0.708 Sum_probs=148.6
Q ss_pred CCcccHHHHHHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEE
Q 005825 495 LPLFSLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCC 573 (675)
Q Consensus 495 ~~~~~~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~ 573 (675)
...+++.++....++|++.++||+|+||.||+|+..+++.||||+++.... .....+.+|+.++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456788899999999999999999999999999988899999999986432 2344799999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 005825 574 IEQGEKILILEYMPNKSLDVFLFDPT-KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKIS 652 (675)
Q Consensus 574 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 652 (675)
.+.+..++||||+++++|.+++.... ....+++..+..|+.|++.||+|||+++..+|+||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997543 34468999999999999999999999833349999999999999999999999
Q ss_pred eeccceecCCC
Q 005825 653 DFGLARMFGGD 663 (675)
Q Consensus 653 DFGla~~~~~~ 663 (675)
|||+|+.+...
T Consensus 177 Dfg~~~~~~~~ 187 (326)
T 3uim_A 177 DFGLAKLMDYK 187 (326)
T ss_dssp CCSSCEECCSS
T ss_pred cCccccccCcc
Confidence 99999987544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=243.06 Aligned_cols=151 Identities=32% Similarity=0.420 Sum_probs=133.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 68999999987532 2334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|+++++|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999984 3446899999999999999999999987 999999999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8e-27 Score=253.51 Aligned_cols=156 Identities=22% Similarity=0.272 Sum_probs=138.1
Q ss_pred HHHHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 005825 502 SVAAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG 577 (675)
Q Consensus 502 ~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~ 577 (675)
.+....++|++.++||+|+||+||+++.. +++.||||++++. .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34456689999999999999999999875 4889999999752 2234456889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999843 35888999999999999999999987 999999999999999999999999999
Q ss_pred eecCCCc
Q 005825 658 RMFGGDE 664 (675)
Q Consensus 658 ~~~~~~~ 664 (675)
+.+....
T Consensus 216 ~~~~~~~ 222 (410)
T 3v8s_A 216 MKMNKEG 222 (410)
T ss_dssp EECCTTS
T ss_pred EeeccCC
Confidence 9886543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-26 Score=238.13 Aligned_cols=165 Identities=41% Similarity=0.616 Sum_probs=147.5
Q ss_pred CCcccHHHHHHhcCCccee------eeeCCcCceeEEEEEEcCCcEEEEEEecCcC----ccCHHHHHHHHHHHHhcCCC
Q 005825 495 LPLFSLASVAAATENFSME------CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQS----GQGLEEFKNEMLLIAKLQHR 564 (675)
Q Consensus 495 ~~~~~~~~~~~~~~~f~~~------~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~----~~~~~~f~~E~~il~~l~H~ 564 (675)
.+.+++.++..++++|... ++||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568889999999999877 8999999999999987 67899999987532 23356799999999999999
Q ss_pred ceeeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc
Q 005825 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD 644 (675)
Q Consensus 565 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 644 (675)
||+++++++.+.+..++||||+++++|.+++........+++..+..++.||+.||+|||+++ |+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999965444567899999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccceecCCC
Q 005825 645 RDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 645 ~~~~~kl~DFGla~~~~~~ 663 (675)
+++.+||+|||+++.....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKF 186 (307)
T ss_dssp TTCCEEECCCTTCEECCSC
T ss_pred CCCcEEEeecccccccccc
Confidence 9999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=247.05 Aligned_cols=155 Identities=30% Similarity=0.530 Sum_probs=135.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc--------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL--------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQ 576 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~ 576 (675)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ....+++.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999863 35579999998643 23456899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE
Q 005825 577 GEKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL 643 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 643 (675)
+..++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999996432 1235789999999999999999999987 9999999999999
Q ss_pred cCCCCeEEeeeccceecCCCc
Q 005825 644 DRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 644 ~~~~~~kl~DFGla~~~~~~~ 664 (675)
++++.+||+|||+|+.+....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~ 257 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNID 257 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCC
T ss_pred CCCCCEEEccccCCcccCccc
Confidence 999999999999999875543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=246.04 Aligned_cols=151 Identities=28% Similarity=0.398 Sum_probs=134.4
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~ 580 (675)
..++|++.++||+|+||+||+++.. +++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999875 5899999999753 234566788999999988 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999984 3456899999999999999999999997 999999999999999999999999999865
Q ss_pred CC
Q 005825 661 GG 662 (675)
Q Consensus 661 ~~ 662 (675)
..
T Consensus 175 ~~ 176 (353)
T 3txo_A 175 IC 176 (353)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=252.41 Aligned_cols=160 Identities=21% Similarity=0.285 Sum_probs=140.2
Q ss_pred HHHHHHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEe
Q 005825 500 LASVAAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE 575 (675)
Q Consensus 500 ~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~ 575 (675)
+.+.....++|++.++||+|+||+||+++.. +++.||||++++. .....+.+.+|..++.+++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3344456789999999999999999999875 6899999999752 12334568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999999532 236889999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCc
Q 005825 656 LARMFGGDE 664 (675)
Q Consensus 656 la~~~~~~~ 664 (675)
+|+.+..+.
T Consensus 208 la~~~~~~~ 216 (412)
T 2vd5_A 208 SCLKLRADG 216 (412)
T ss_dssp TCEECCTTS
T ss_pred hheeccCCC
Confidence 999886543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=248.01 Aligned_cols=148 Identities=24% Similarity=0.371 Sum_probs=131.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|++.++||+|+||+||+++.. +++.||||++++.. ....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999875 48899999997542 23445688999999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+..
T Consensus 131 V~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999984 3456899999999999999999999998 999999999999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-26 Score=245.83 Aligned_cols=151 Identities=23% Similarity=0.354 Sum_probs=136.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.+.||+|+||.||+++.. +++.||||.+.+. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 368999999999999999999875 4889999998753 234567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999953 456899999999999999999999998 99999999999999999999999999998754
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
.
T Consensus 168 ~ 168 (384)
T 4fr4_A 168 E 168 (384)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=241.50 Aligned_cols=164 Identities=32% Similarity=0.478 Sum_probs=136.2
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC----eEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG----EKIL 581 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~----~~~l 581 (675)
..++|++.++||+|+||.||+|+.. ++.||||+++.. ......+..|+.++++++||||+++++++.+.. ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3478999999999999999999875 789999999753 233445667999999999999999999998754 4799
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc-------CCCceEecCCCCCCEEEcCCCCeEEeee
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY-------SRFRIIHRDLKASNVLLDRDMNPKISDF 654 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~~~iiHrDlkp~NILl~~~~~~kl~DF 654 (675)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +..+|+||||||+|||+++++.+||+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999999943 3489999999999999999999987 1113999999999999999999999999
Q ss_pred ccceecCCCcccCCCCceecC
Q 005825 655 GLARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 655 Gla~~~~~~~~~~~~~~~~GT 675 (675)
|+|+.+............+||
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCC
T ss_pred CcccccccccCccccccCccC
Confidence 999988655443333334444
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=240.54 Aligned_cols=152 Identities=29% Similarity=0.404 Sum_probs=136.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc------cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG------QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE 578 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~ 578 (675)
..+.|++.+.||+|+||.||+++.. +++.||||.++.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3468999999999999999999875 589999999975432 135789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC----CeEEeee
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM----NPKISDF 654 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DF 654 (675)
.++||||+++|+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999994 3456899999999999999999999987 99999999999998877 7999999
Q ss_pred ccceecCCC
Q 005825 655 GLARMFGGD 663 (675)
Q Consensus 655 Gla~~~~~~ 663 (675)
|+|+.+...
T Consensus 164 G~a~~~~~~ 172 (361)
T 2yab_A 164 GLAHEIEDG 172 (361)
T ss_dssp SSCEECCTT
T ss_pred CCceEcCCC
Confidence 999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=242.28 Aligned_cols=151 Identities=25% Similarity=0.368 Sum_probs=134.5
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeE
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~ 579 (675)
...++|.+.+.||+|+||.||+|+.. +++.||||++++.. ....+.+..|..++.++ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 35689999999999999999999875 58999999997532 34567788999999887 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999843 346899999999999999999999997 99999999999999999999999999987
Q ss_pred cC
Q 005825 660 FG 661 (675)
Q Consensus 660 ~~ 661 (675)
..
T Consensus 168 ~~ 169 (345)
T 1xjd_A 168 NM 169 (345)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-26 Score=238.66 Aligned_cols=150 Identities=29% Similarity=0.422 Sum_probs=135.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.+.||+|+||.||+++.. +++.||+|++++. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999875 6899999999753 234567788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999943 346889999999999999999999987 99999999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-26 Score=236.08 Aligned_cols=151 Identities=28% Similarity=0.460 Sum_probs=134.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.++||+|+||.||+++.. +++.||+|.+.... ....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 478999999999999999999864 58999999986432 23356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999984 3456899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
.
T Consensus 164 ~ 164 (294)
T 4eqm_A 164 T 164 (294)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-26 Score=241.31 Aligned_cols=148 Identities=25% Similarity=0.365 Sum_probs=132.9
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV 582 (675)
++|++.+.||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999875 58899999997542 23345688999999988 899999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+...
T Consensus 89 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999984 3346899999999999999999999997 9999999999999999999999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=243.87 Aligned_cols=151 Identities=19% Similarity=0.233 Sum_probs=133.0
Q ss_pred HhcCCcceeeeeCCcCceeEEEEE------EcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC---CCceeeEEEEEEe
Q 005825 505 AATENFSMECKLGEGGFGPVYKGR------LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ---HRNLVRILGCCIE 575 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~------~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~---H~nIv~l~g~~~~ 575 (675)
...++|.+.++||+|+||.||+|+ ..+++.||||+++.. ...++..|+.++.+++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 456889999999753 4567888999888887 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCC--CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC--------
Q 005825 576 QGEKILILEYMPNKSLDVFLFDP--TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-------- 645 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------- 645 (675)
.+..++||||+++|+|.+++... .....+++..++.|+.||+.||+|||+++ |+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999532 13456999999999999999999999987 999999999999998
Q ss_pred ---CCCeEEeeeccceecC
Q 005825 646 ---DMNPKISDFGLARMFG 661 (675)
Q Consensus 646 ---~~~~kl~DFGla~~~~ 661 (675)
++.+||+|||+|+.+.
T Consensus 216 ~~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp ---CTTEEECCCTTCEEGG
T ss_pred ccccCCEEEeeCchhhhhh
Confidence 8999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=238.11 Aligned_cols=156 Identities=30% Similarity=0.548 Sum_probs=132.2
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
..++|++.++||+|+||.||+|+. +++.||||++.... ....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 457899999999999999999987 68899999997543 233567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++++|.+++........+++..++.++.||+.||+|||+++ .+|+||||||+|||+++++.+||+|||+|+.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999965443445899999999999999999999874 34999999999999999999999999999876443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.4e-26 Score=239.33 Aligned_cols=150 Identities=28% Similarity=0.387 Sum_probs=125.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEE----cCCcEEEEEEecCcC----ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL----LNGEEVAVKRLSSQS----GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~ 578 (675)
.++|++.++||+|+||.||+++. .+++.||||++++.. ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999987 468999999997642 2345668899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.++||||+++++|.+++. ....+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999984 3446888999999999999999999997 9999999999999999999999999998
Q ss_pred ecCC
Q 005825 659 MFGG 662 (675)
Q Consensus 659 ~~~~ 662 (675)
....
T Consensus 170 ~~~~ 173 (327)
T 3a62_A 170 ESIH 173 (327)
T ss_dssp ----
T ss_pred cccc
Confidence 7543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-26 Score=241.03 Aligned_cols=150 Identities=27% Similarity=0.330 Sum_probs=134.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCc---CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~ 580 (675)
..++|++.+.||+|+||+||+++... ++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35789999999999999999998764 789999999753 234567788999999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999843 346899999999999999999999997 999999999999999999999999999875
Q ss_pred C
Q 005825 661 G 661 (675)
Q Consensus 661 ~ 661 (675)
.
T Consensus 172 ~ 172 (353)
T 2i0e_A 172 I 172 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=240.06 Aligned_cols=150 Identities=25% Similarity=0.330 Sum_probs=135.9
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999875 5899999999753 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999943 346889999999999999999999988 999999999999999999999999999987543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=238.30 Aligned_cols=152 Identities=32% Similarity=0.562 Sum_probs=134.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc----CCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|++.++||+|+||.||+|+.. .+..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 468999999999999999999874 3456999999864 33345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++++|.+++... ...+++.++..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999999542 346899999999999999999999997 9999999999999999999999999999885
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 203 ~~ 204 (325)
T 3kul_A 203 DD 204 (325)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=234.66 Aligned_cols=155 Identities=28% Similarity=0.438 Sum_probs=137.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC--eEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG--EKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~--~~~lV 582 (675)
.++|++.++||+|+||.||+|+... ++.||||+++... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3679999999999999999998754 8999999997543 345678899999999999999999999998765 78999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE----cCCCCeEEeeeccce
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL----DRDMNPKISDFGLAR 658 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~ 658 (675)
|||+++++|.+++........+++.++..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976544445899999999999999999999997 9999999999999 788889999999999
Q ss_pred ecCCCc
Q 005825 659 MFGGDE 664 (675)
Q Consensus 659 ~~~~~~ 664 (675)
.+....
T Consensus 165 ~~~~~~ 170 (319)
T 4euu_A 165 ELEDDE 170 (319)
T ss_dssp ECCTTC
T ss_pred ecCCCC
Confidence 886543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-25 Score=234.05 Aligned_cols=151 Identities=21% Similarity=0.313 Sum_probs=135.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.++|++.+.||+|+||.||+++.. +++.||+|.++.. ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999875 5889999999753 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC--CCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR--DMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 663 (675)
+++++|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999943 2346899999999999999999999997 999999999999987 789999999999988544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=230.11 Aligned_cols=151 Identities=32% Similarity=0.567 Sum_probs=137.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.++|++.+.||+|+||.||+|+..+++.||||++... ....+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 3689999999999999999999988999999999863 344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999999542 346899999999999999999999998 999999999999999999999999999877543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=233.11 Aligned_cols=150 Identities=25% Similarity=0.410 Sum_probs=128.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--------------------------cCHHHHHHHHHHHH
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--------------------------QGLEEFKNEMLLIA 559 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--------------------------~~~~~f~~E~~il~ 559 (675)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999874 588999999875321 12357899999999
Q ss_pred hcCCCceeeEEEEEEe--CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCC
Q 005825 560 KLQHRNLVRILGCCIE--QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLK 637 (675)
Q Consensus 560 ~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 637 (675)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.||+.||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56899999999999998765 2346899999999999999999999997 9999999
Q ss_pred CCCEEEcCCCCeEEeeeccceecCCC
Q 005825 638 ASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 638 p~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|+|||++.++.+||+|||+|+.+...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHHEEECCCCCEEEecCCCccccccc
Confidence 99999999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=245.30 Aligned_cols=153 Identities=29% Similarity=0.472 Sum_probs=136.2
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
..++|.+.++||+|+||.||+|+.. +++.||||.++... ....++|.+|+.++++++||||+++++++.+.+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3468899999999999999999986 68999999997542 233457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999953 2345889999999999999999999998 999999999999999999999999999976543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-25 Score=233.01 Aligned_cols=151 Identities=29% Similarity=0.401 Sum_probs=135.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc------cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG------QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
.+.|.+.+.||+|+||.||+++.. +++.||||.++.... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 357999999999999999999875 589999999875322 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC----CeEEeeec
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM----NPKISDFG 655 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFG 655 (675)
++||||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999994 3456899999999999999999999987 99999999999999887 89999999
Q ss_pred cceecCCC
Q 005825 656 LARMFGGD 663 (675)
Q Consensus 656 la~~~~~~ 663 (675)
+|+.+...
T Consensus 164 ~a~~~~~~ 171 (326)
T 2y0a_A 164 LAHKIDFG 171 (326)
T ss_dssp TCEECCTT
T ss_pred CCeECCCC
Confidence 99988543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=243.43 Aligned_cols=162 Identities=29% Similarity=0.443 Sum_probs=137.9
Q ss_pred cHHHHHHhcCCcceeeeeCCcCceeEEEEEE------cCCcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEE
Q 005825 499 SLASVAAATENFSMECKLGEGGFGPVYKGRL------LNGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRIL 570 (675)
Q Consensus 499 ~~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~ 570 (675)
.........++|++.++||+|+||.||+|++ .+++.||||+++... ....+.+.+|+.++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3444455678999999999999999999974 246789999998643 23456799999999999 799999999
Q ss_pred EEEEeCCe-EEEEEEecCCCCHHHHhcCCCC-------------------------------------------------
Q 005825 571 GCCIEQGE-KILILEYMPNKSLDVFLFDPTK------------------------------------------------- 600 (675)
Q Consensus 571 g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------- 600 (675)
+++.+.+. .++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987654 8999999999999999965322
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 601 --------------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 601 --------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122889999999999999999999997 999999999999999999999999999977443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=228.02 Aligned_cols=152 Identities=32% Similarity=0.489 Sum_probs=137.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.++|++.+.||+|+||.||+|+..++..||||+++.. ....+++.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 4689999999999999999999988889999999753 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
++++|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999998532 345899999999999999999999987 9999999999999999999999999999875543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-25 Score=229.89 Aligned_cols=150 Identities=28% Similarity=0.451 Sum_probs=131.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++|++.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 58999999997543 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|++++ +.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 82 ~~~~~-l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQD-LKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEE-HHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCCC-HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 99864 4444422 2356899999999999999999999997 999999999999999999999999999987543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=244.38 Aligned_cols=152 Identities=34% Similarity=0.593 Sum_probs=128.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc----CCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 368899999999999999999864 4678999999754 23345689999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++++|.+++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999642 346899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 199 ~~ 200 (373)
T 2qol_A 199 DD 200 (373)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-25 Score=233.07 Aligned_cols=151 Identities=31% Similarity=0.434 Sum_probs=132.8
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
..++|++.++||+|+||+||+|+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 347899999999999999999999889999999997542 223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+++ +|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.++.
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99985 77777753 2345889999999999999999999987 99999999999999999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=9.5e-26 Score=239.00 Aligned_cols=158 Identities=31% Similarity=0.503 Sum_probs=138.2
Q ss_pred HHHhcCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEe
Q 005825 503 VAAATENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIE 575 (675)
Q Consensus 503 ~~~~~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~ 575 (675)
+....++|++.+.||+|+||.||+|+.. +++.||||.++... ....+.|.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445689999999999999999999874 34789999998643 2345679999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCC---------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEec
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPTK---------------------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHR 634 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHr 634 (675)
.+..++||||+++++|.+++..... ...+++.+++.|+.||++||+|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999864211 256899999999999999999999997 9999
Q ss_pred CCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 635 DLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 635 Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||||+|||+++++.+||+|||+++.+...
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 227 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSA 227 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccC
Confidence 99999999999999999999999876443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=241.13 Aligned_cols=155 Identities=32% Similarity=0.514 Sum_probs=136.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc--------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL--------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIE 575 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~ 575 (675)
..++|.+.++||+|+||.||+|+.. .+..||||+++... ....+++.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3478999999999999999999852 23579999997643 33457799999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEE
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPTK-------------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVL 642 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 642 (675)
.+..++||||+++|+|.+++..... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999964321 245899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeeeccceecCCC
Q 005825 643 LDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 643 l~~~~~~kl~DFGla~~~~~~ 663 (675)
+++++.+||+|||+|+.+...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~ 244 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHI 244 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCC
T ss_pred EcCCCcEEEcccCcccccccc
Confidence 999999999999999987554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-25 Score=228.89 Aligned_cols=152 Identities=30% Similarity=0.484 Sum_probs=135.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
..++|++.++||+|+||.||+++..++..||||+++.. ....+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 35789999999999999999999988889999999863 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999999542 345899999999999999999999987 999999999999999999999999999877543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-25 Score=249.36 Aligned_cols=155 Identities=27% Similarity=0.346 Sum_probs=138.1
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
..++|++.+.||+|+||.||+++.. +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3568999999999999999999875 6899999999753 23456778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++|+|..++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.+.
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999986532 334899999999999999999999997 9999999999999999999999999999886
Q ss_pred CCc
Q 005825 662 GDE 664 (675)
Q Consensus 662 ~~~ 664 (675)
..+
T Consensus 338 ~~~ 340 (576)
T 2acx_A 338 EGQ 340 (576)
T ss_dssp TTC
T ss_pred cCc
Confidence 543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-25 Score=226.84 Aligned_cols=153 Identities=24% Similarity=0.407 Sum_probs=138.4
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
..++|++.++||+|+||.||+|+... +..||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34679999999999999999998754 77999999987666677899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE---cCCCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 661 (675)
|+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999998843 456899999999999999999999998 9999999999999 888999999999999875
Q ss_pred CCc
Q 005825 662 GDE 664 (675)
Q Consensus 662 ~~~ 664 (675)
...
T Consensus 161 ~~~ 163 (277)
T 3f3z_A 161 PGK 163 (277)
T ss_dssp TTS
T ss_pred Ccc
Confidence 443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-26 Score=235.11 Aligned_cols=152 Identities=34% Similarity=0.563 Sum_probs=132.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-----cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-----LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~ 579 (675)
.++|++.++||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999984 35889999999876666667899999999999999999999998654 458
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999542 335899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
+...
T Consensus 164 ~~~~ 167 (295)
T 3ugc_A 164 LPQD 167 (295)
T ss_dssp ----
T ss_pred ccCC
Confidence 7543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=233.53 Aligned_cols=156 Identities=33% Similarity=0.533 Sum_probs=136.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE------cCCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL------LNGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE 578 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~ 578 (675)
..++|.+.+.||+|+||.||+|+. .+++.||||.++... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 357899999999999999999976 235789999997543 3445789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCC---------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCC
Q 005825 579 KILILEYMPNKSLDVFLFDPTK---------------------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLK 637 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 637 (675)
.++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999964321 234889999999999999999999987 9999999
Q ss_pred CCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 638 ASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 638 p~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|+|||+++++.+||+|||+++.+....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~ 204 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEED 204 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTS
T ss_pred hheEEEcCCCCEEEccccccccccccc
Confidence 999999999999999999999875543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-25 Score=245.03 Aligned_cols=152 Identities=30% Similarity=0.497 Sum_probs=137.1
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|.+.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999875 6999999999753 223456899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999994 3456899999999999999999999987 99999999999999999999999999998765
Q ss_pred Cc
Q 005825 663 DE 664 (675)
Q Consensus 663 ~~ 664 (675)
.+
T Consensus 169 ~~ 170 (476)
T 2y94_A 169 GE 170 (476)
T ss_dssp TC
T ss_pred cc
Confidence 43
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-25 Score=237.96 Aligned_cols=153 Identities=25% Similarity=0.372 Sum_probs=136.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.+.|++.++||+|+||.||+|+.. +++.||+|.+..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999875 5889999999865555566899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC--CCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR--DMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 663 (675)
+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+|+.+..+
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999853 2345899999999999999999999987 999999999999974 578999999999988654
Q ss_pred c
Q 005825 664 E 664 (675)
Q Consensus 664 ~ 664 (675)
.
T Consensus 205 ~ 205 (387)
T 1kob_A 205 E 205 (387)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-25 Score=237.16 Aligned_cols=152 Identities=26% Similarity=0.411 Sum_probs=134.6
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3468999999999999999999874 58999999997542 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC---CCeEEeeecccee
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD---MNPKISDFGLARM 659 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~ 659 (675)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999999843 456899999999999999999999997 9999999999999865 4599999999998
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
+...
T Consensus 181 ~~~~ 184 (362)
T 2bdw_A 181 VNDS 184 (362)
T ss_dssp CTTC
T ss_pred ecCC
Confidence 7644
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=240.90 Aligned_cols=149 Identities=26% Similarity=0.315 Sum_probs=124.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHH-HHhcCCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLL-IAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~i-l~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|++.+.||+|+||+||+++.. +++.||||++++.. ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999875 48899999997643 2234556777776 577899999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++|+|..++. +...+++.....++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+...
T Consensus 117 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999984 3446888899999999999999999988 9999999999999999999999999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=249.20 Aligned_cols=154 Identities=31% Similarity=0.526 Sum_probs=138.3
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
...+|++.++||+|+||.||+|++.. +..||||.++.. ....++|.+|+.++++++||||++++++|.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34678999999999999999999865 889999999864 3457889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|+++|+|.+++... ....+++..++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..+.
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999642 2345889999999999999999999987 9999999999999999999999999999875543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=236.10 Aligned_cols=151 Identities=26% Similarity=0.448 Sum_probs=134.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999987 56899999998743 223456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+ +|+|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 7888888843 356899999999999999999999998 99999999999999999999999999998754
Q ss_pred Cc
Q 005825 663 DE 664 (675)
Q Consensus 663 ~~ 664 (675)
..
T Consensus 161 ~~ 162 (336)
T 3h4j_B 161 GN 162 (336)
T ss_dssp SB
T ss_pred Cc
Confidence 43
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.5e-26 Score=249.26 Aligned_cols=150 Identities=25% Similarity=0.301 Sum_probs=125.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.++||+|+||.||+++.. +++.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999864 5899999999753 334456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH-YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|||+++++|..++. ....+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999984 34568999999999999999999998 66 9999999999999999999999999998754
Q ss_pred C
Q 005825 662 G 662 (675)
Q Consensus 662 ~ 662 (675)
.
T Consensus 301 ~ 301 (446)
T 4ejn_A 301 K 301 (446)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-25 Score=234.24 Aligned_cols=155 Identities=25% Similarity=0.373 Sum_probs=134.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc-----CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ-----SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
.+.|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999874 5899999998632 1234678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC---eEEeeecc
Q 005825 581 LILEYMPNKSLDVFLFDPT-KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN---PKISDFGL 656 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGl 656 (675)
+||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988774321 2335889999999999999999999987 999999999999987654 99999999
Q ss_pred ceecCCCc
Q 005825 657 ARMFGGDE 664 (675)
Q Consensus 657 a~~~~~~~ 664 (675)
|+.+....
T Consensus 180 a~~~~~~~ 187 (351)
T 3c0i_A 180 AIQLGESG 187 (351)
T ss_dssp CEECCTTS
T ss_pred eeEecCCC
Confidence 99886543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=235.75 Aligned_cols=155 Identities=33% Similarity=0.493 Sum_probs=133.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCc-CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQG 577 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~ 577 (675)
..++|.+.+.||+|+||.||+|+.. +++.||||.++.. .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999862 3568999999754 234557899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCCC--------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCC
Q 005825 578 EKILILEYMPNKSLDVFLFDPTK--------------------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLK 637 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 637 (675)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 99999999999999999965322 134789999999999999999999987 9999999
Q ss_pred CCCEEEcCCCCeEEeeeccceecCCC
Q 005825 638 ASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 638 p~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|+|||++.++.+||+|||+++.+...
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~ 225 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSD 225 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccC
Confidence 99999999999999999999877544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=236.96 Aligned_cols=147 Identities=27% Similarity=0.350 Sum_probs=130.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.++|++.++||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 478999999999999999999875 6899999999753 33446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC--eEEeeeccceec
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN--PKISDFGLARMF 660 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFGla~~~ 660 (675)
+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+|+..
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 999999999843 346899999999999999999999988 999999999999987765 999999999854
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=230.21 Aligned_cols=149 Identities=30% Similarity=0.458 Sum_probs=133.4
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.++||+|+||.||+|+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998789999999997532 23357789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 986 898888532 345889999999999999999999987 99999999999999999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=246.37 Aligned_cols=152 Identities=32% Similarity=0.486 Sum_probs=136.2
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
..++|++.++||+|+||.||+|+..++..||||+++.. ....++|.+|+.++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 45789999999999999999999988899999999864 346788999999999999999999999986 5678999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 264 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999542 2235788999999999999999999987 999999999999999999999999999987543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.9e-26 Score=242.18 Aligned_cols=152 Identities=35% Similarity=0.523 Sum_probs=132.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
.++|++.++||+|+||.||+|+.. +++.||||+++.. ......++.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367899999999999999999853 4678999999754 334456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC---CeEEe
Q 005825 580 ILILEYMPNKSLDVFLFDPT----KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM---NPKIS 652 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~ 652 (675)
++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996421 2245899999999999999999999998 99999999999999554 59999
Q ss_pred eeccceecC
Q 005825 653 DFGLARMFG 661 (675)
Q Consensus 653 DFGla~~~~ 661 (675)
|||+|+.+.
T Consensus 227 DFG~a~~~~ 235 (367)
T 3l9p_A 227 DFGMARDIY 235 (367)
T ss_dssp CCHHHHHHH
T ss_pred CCccccccc
Confidence 999998663
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-25 Score=246.14 Aligned_cols=155 Identities=29% Similarity=0.387 Sum_probs=138.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|.+.+.||+|+||+||+++.. +++.||||++.+. .....+.+..|+.++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999875 5899999999753 234567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 583 LEYMPNKSLDVFLFDPT-KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|||+++|+|..++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999986532 2446899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCc
Q 005825 662 GDE 664 (675)
Q Consensus 662 ~~~ 664 (675)
...
T Consensus 341 ~~~ 343 (543)
T 3c4z_A 341 AGQ 343 (543)
T ss_dssp TTC
T ss_pred CCC
Confidence 544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9e-26 Score=236.29 Aligned_cols=151 Identities=25% Similarity=0.381 Sum_probs=129.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC----e
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG----E 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~----~ 578 (675)
.++|++.++||+|+||.||+++. .+++.||||+++.... ...+.+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999986 5689999999976432 23457899999999999999999999987654 3
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.++||||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 4999999999999999943 346899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCC
Q 005825 659 MFGGD 663 (675)
Q Consensus 659 ~~~~~ 663 (675)
.+...
T Consensus 165 ~~~~~ 169 (311)
T 3ork_A 165 AIADS 169 (311)
T ss_dssp -----
T ss_pred ccccc
Confidence 87543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-25 Score=232.27 Aligned_cols=155 Identities=30% Similarity=0.530 Sum_probs=135.1
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc--------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL--------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIE 575 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~ 575 (675)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478999999999999999999863 46789999998543 23456799999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEE
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPTK-------------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVL 642 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 642 (675)
.+..++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999965321 234889999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeeeccceecCCC
Q 005825 643 LDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 643 l~~~~~~kl~DFGla~~~~~~ 663 (675)
++.++.+||+|||+++.+...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~ 210 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNI 210 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTT
T ss_pred EcCCCCEEEcccccccccccc
Confidence 999999999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-25 Score=242.65 Aligned_cols=153 Identities=26% Similarity=0.420 Sum_probs=133.8
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
..++|++.++||+|+||.||++.. .+++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 457899999999999999999976 468999999987543 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc---CCCCeEEeeecccee
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD---RDMNPKISDFGLARM 659 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~ 659 (675)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+|+.
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999998843 356899999999999999999999998 99999999999998 568899999999988
Q ss_pred cCCCc
Q 005825 660 FGGDE 664 (675)
Q Consensus 660 ~~~~~ 664 (675)
+....
T Consensus 163 ~~~~~ 167 (444)
T 3soa_A 163 VEGEQ 167 (444)
T ss_dssp CCTTC
T ss_pred ecCCC
Confidence 76543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=236.91 Aligned_cols=148 Identities=30% Similarity=0.433 Sum_probs=127.2
Q ss_pred eeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCCCC
Q 005825 512 MECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKS 590 (675)
Q Consensus 512 ~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (675)
..+.||+|+||.||+|+.. +++.||||+++.......+++.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3578999999999999874 589999999987555566789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE--cCCCCeEEeeeccceecCCCc
Q 005825 591 LDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL--DRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 591 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl--~~~~~~kl~DFGla~~~~~~~ 664 (675)
|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+.+...+
T Consensus 173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9988853 2345889999999999999999999988 9999999999999 567899999999999886543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-25 Score=231.60 Aligned_cols=150 Identities=25% Similarity=0.308 Sum_probs=133.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.++||+|+||.||+|+. .+++.||||.+.... ..+.+..|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999986 568999999987532 335688999999999 99999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC-----eEEeeecccee
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN-----PKISDFGLARM 659 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~DFGla~~ 659 (675)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++. +||+|||+|+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998542 346899999999999999999999997 999999999999998887 99999999998
Q ss_pred cCCCc
Q 005825 660 FGGDE 664 (675)
Q Consensus 660 ~~~~~ 664 (675)
+....
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 75543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-25 Score=241.68 Aligned_cols=150 Identities=31% Similarity=0.515 Sum_probs=133.3
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-eEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG-EKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~-~~~lV~E 584 (675)
..++|++.++||+|+||.||+|+.. ++.||||.++... ..+.|.+|+.++++++||||+++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4578999999999999999999884 7899999998643 5578999999999999999999999988766 7999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 99999999999642 2234789999999999999999999997 99999999999999999999999999997643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=233.11 Aligned_cols=152 Identities=33% Similarity=0.524 Sum_probs=131.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcE----EEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEE----VAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~----vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
.++|++.++||+|+||.||+|+.. +++. ||+|.+.... ....+++.+|+.++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 368999999999999999999864 3443 8888876432 344567889999999999999999999986 56789
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999999643 346888999999999999999999997 999999999999999999999999999988
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
....
T Consensus 166 ~~~~ 169 (325)
T 3kex_A 166 PPDD 169 (325)
T ss_dssp CCCT
T ss_pred Cccc
Confidence 6554
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-25 Score=237.85 Aligned_cols=155 Identities=28% Similarity=0.438 Sum_probs=136.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC--eEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG--EKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~--~~~lV 582 (675)
.++|++.++||+|+||.||+|+... ++.||||+++... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3679999999999999999998754 8999999997543 345678889999999999999999999998765 78999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE----cCCCCeEEeeeccce
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL----DRDMNPKISDFGLAR 658 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~ 658 (675)
|||+++++|.+++........+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999965444445899999999999999999999997 9999999999999 778889999999999
Q ss_pred ecCCCc
Q 005825 659 MFGGDE 664 (675)
Q Consensus 659 ~~~~~~ 664 (675)
.+....
T Consensus 165 ~~~~~~ 170 (396)
T 4eut_A 165 ELEDDE 170 (396)
T ss_dssp ECCCGG
T ss_pred EccCCC
Confidence 886544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-25 Score=234.03 Aligned_cols=150 Identities=26% Similarity=0.408 Sum_probs=122.4
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
..+.|++.++||+|+||.||+|+.. +++.||||+++... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999886 47899999997532 34678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---CCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~~ 661 (675)
|+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999843 456899999999999999999999987 999999999999975 8899999999999875
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 203 ~~ 204 (349)
T 2w4o_A 203 HQ 204 (349)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=233.63 Aligned_cols=156 Identities=31% Similarity=0.526 Sum_probs=122.5
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEcC-C---cEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLLN-G---EEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE 578 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~~-g---~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~ 578 (675)
...++|++.+.||+|+||.||+|+... + ..||||.++.. .....+++.+|+.++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345789999999999999999998654 2 27999999754 33456789999999999999999999999987765
Q ss_pred E------EEEEEecCCCCHHHHhcCCC---CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCe
Q 005825 579 K------ILILEYMPNKSLDVFLFDPT---KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP 649 (675)
Q Consensus 579 ~------~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 649 (675)
. ++||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 99999999999999985321 1225899999999999999999999997 9999999999999999999
Q ss_pred EEeeeccceecCCC
Q 005825 650 KISDFGLARMFGGD 663 (675)
Q Consensus 650 kl~DFGla~~~~~~ 663 (675)
||+|||+|+.+...
T Consensus 177 kl~Dfg~a~~~~~~ 190 (323)
T 3qup_A 177 CVADFGLSRKIYSG 190 (323)
T ss_dssp EECCCCC-------
T ss_pred EEeecccccccccc
Confidence 99999999877543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-25 Score=230.71 Aligned_cols=156 Identities=32% Similarity=0.462 Sum_probs=136.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE------cCCcEEEEEEecCcCc-cCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL------LNGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQG 577 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~ 577 (675)
..++|++.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346899999999999999999985 2467899999985432 3457899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCCC---------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEE
Q 005825 578 EKILILEYMPNKSLDVFLFDPTK---------------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVL 642 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 642 (675)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999864321 225899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeeeccceecCCCc
Q 005825 643 LDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 643 l~~~~~~kl~DFGla~~~~~~~ 664 (675)
+++++.+||+|||+++.+....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~ 199 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDS 199 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCT
T ss_pred EcCCCCEEEccccccccccccc
Confidence 9999999999999999886543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=8.3e-25 Score=224.24 Aligned_cols=150 Identities=33% Similarity=0.418 Sum_probs=135.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 468999999999999999999875 68999999987533 3345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|+++++|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 999999999884 3346889999999999999999999987 99999999999999999999999999987643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=237.43 Aligned_cols=150 Identities=29% Similarity=0.376 Sum_probs=134.3
Q ss_pred CCcceeeeeCCcCceeEEEEEE----cCCcEEEEEEecCcC----ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL----LNGEEVAVKRLSSQS----GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGE 578 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~ 578 (675)
++|++.++||+|+||.||+++. .+++.||||+++... ....+.+..|+.++.++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6899999999999999999987 368999999997532 23456788899999999 69999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999943 346889999999999999999999987 9999999999999999999999999999
Q ss_pred ecCCC
Q 005825 659 MFGGD 663 (675)
Q Consensus 659 ~~~~~ 663 (675)
.+...
T Consensus 208 ~~~~~ 212 (355)
T 1vzo_A 208 EFVAD 212 (355)
T ss_dssp ECCGG
T ss_pred ecccC
Confidence 87543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-25 Score=230.50 Aligned_cols=150 Identities=28% Similarity=0.286 Sum_probs=128.2
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--cCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||+||+|+.. +++.||||++..... ....++..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999886 689999999875322 2334555666666555 8999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+ +++|.+++... ...+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 77898888532 346899999999999999999999987 999999999999999999999999999887544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-25 Score=240.74 Aligned_cols=151 Identities=26% Similarity=0.439 Sum_probs=132.1
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----C
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ-----G 577 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~-----~ 577 (675)
..++|++.++||+|+||.||+|+.. +++.||||+++.. .....+++.+|+.++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999874 5889999999753 223456899999999999999999999999776 5
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
..++||||++ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 7899999987 599999843 456899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCC
Q 005825 658 RMFGGD 663 (675)
Q Consensus 658 ~~~~~~ 663 (675)
+.+...
T Consensus 177 ~~~~~~ 182 (432)
T 3n9x_A 177 RTINSE 182 (432)
T ss_dssp EEC---
T ss_pred cccccc
Confidence 987544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-25 Score=234.40 Aligned_cols=151 Identities=25% Similarity=0.373 Sum_probs=131.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCC--CceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQH--RNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H--~nIv~l~g~~~~~~~~~lV 582 (675)
.+.|++.++||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999888999999998753 23345789999999999976 9999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|| +.+++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+|+.+..
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 568899999953 456889999999999999999999997 99999999999997 57899999999998865
Q ss_pred Ccc
Q 005825 663 DEL 665 (675)
Q Consensus 663 ~~~ 665 (675)
+..
T Consensus 160 ~~~ 162 (343)
T 3dbq_A 160 DTT 162 (343)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=233.58 Aligned_cols=152 Identities=36% Similarity=0.580 Sum_probs=128.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCc----EEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGE----EVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
.++|++.++||+|+||.||+|+.. +++ +||+|.++.. .....++|.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 367999999999999999999864 344 4688888643 3456678999999999999999999999998754 78
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999999642 345899999999999999999999987 999999999999999999999999999988
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
....
T Consensus 168 ~~~~ 171 (327)
T 3poz_A 168 GAEE 171 (327)
T ss_dssp TTTC
T ss_pred cCCc
Confidence 6544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=225.71 Aligned_cols=146 Identities=32% Similarity=0.452 Sum_probs=127.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHh--cCCCceeeEEEEEEeC----CeEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAK--LQHRNLVRILGCCIEQ----GEKI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~--l~H~nIv~l~g~~~~~----~~~~ 580 (675)
.++|++.++||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999988 6899999999643 34566677777766 7999999999997653 4589
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHH--------hcCCCceEecCCCCCCEEEcCCCCeEEe
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH--------HYSRFRIIHRDLKASNVLLDRDMNPKIS 652 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~kl~ 652 (675)
+||||+++|+|.+++. ...+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999993 245899999999999999999999 655 9999999999999999999999
Q ss_pred eeccceecCCC
Q 005825 653 DFGLARMFGGD 663 (675)
Q Consensus 653 DFGla~~~~~~ 663 (675)
|||+|+.....
T Consensus 156 Dfg~a~~~~~~ 166 (301)
T 3q4u_A 156 DLGLAVMHSQS 166 (301)
T ss_dssp CCTTCEEEETT
T ss_pred eCCCeeecccc
Confidence 99999887544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=226.95 Aligned_cols=150 Identities=28% Similarity=0.398 Sum_probs=133.8
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999875 489999999865432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|+++++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998843 345889999999999999999999997 999999999999999999999999999987543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=227.58 Aligned_cols=152 Identities=32% Similarity=0.467 Sum_probs=120.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468899999999999999999864 58999999997543 3345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC---CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDP---TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|++ ++|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5998888532 12245889999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 005825 662 G 662 (675)
Q Consensus 662 ~ 662 (675)
.
T Consensus 160 ~ 160 (317)
T 2pmi_A 160 I 160 (317)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.6e-25 Score=232.95 Aligned_cols=153 Identities=25% Similarity=0.378 Sum_probs=135.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCc--------cCHHHHHHHHHHHHhcCCCceeeEEEEEEeC
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSG--------QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ 576 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~--------~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~ 576 (675)
..++|++.++||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999986 4689999999975421 1345688899999999999999999999999
Q ss_pred CeEEEEEEecCCC-CHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 577 GEKILILEYMPNK-SLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 577 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
+..++||||+.+| +|.+++.. ...+++..+..|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99999843 346899999999999999999999997 9999999999999999999999999
Q ss_pred cceecCCCc
Q 005825 656 LARMFGGDE 664 (675)
Q Consensus 656 la~~~~~~~ 664 (675)
+++.+....
T Consensus 176 ~a~~~~~~~ 184 (335)
T 3dls_A 176 SAAYLERGK 184 (335)
T ss_dssp TCEECCTTC
T ss_pred cceECCCCC
Confidence 999876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=244.23 Aligned_cols=149 Identities=24% Similarity=0.419 Sum_probs=122.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----Ce
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ-----GE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~-----~~ 578 (675)
.++|++.++||+|+||.||+|+.. +++.||||++... .....+++.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999864 6899999999753 223456799999999999999999999999543 56
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.++||||+ +++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 5789988843 456899999999999999999999997 9999999999999999999999999999
Q ss_pred ecCC
Q 005825 659 MFGG 662 (675)
Q Consensus 659 ~~~~ 662 (675)
.+..
T Consensus 205 ~~~~ 208 (458)
T 3rp9_A 205 TVDY 208 (458)
T ss_dssp CTTS
T ss_pred hccC
Confidence 8754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=234.51 Aligned_cols=148 Identities=22% Similarity=0.317 Sum_probs=126.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcC--------ccCHHHHHHHHHHHHhcC---------CCceeeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQS--------GQGLEEFKNEMLLIAKLQ---------HRNLVRI 569 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--------~~~~~~f~~E~~il~~l~---------H~nIv~l 569 (675)
.++|++.++||+|+||+||+|+. +++.||||+++... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999988 78999999997542 233478999999999886 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHH
Q 005825 570 LGCCI------------------------------EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQG 619 (675)
Q Consensus 570 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 619 (675)
.+.+. +.+..++||||+++|++.+.+.. ..+++..+..|+.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 88754 26789999999999976666522 457899999999999999
Q ss_pred HHHHH-hcCCCceEecCCCCCCEEEcCCC--------------------CeEEeeeccceecCC
Q 005825 620 LLYLH-HYSRFRIIHRDLKASNVLLDRDM--------------------NPKISDFGLARMFGG 662 (675)
Q Consensus 620 L~yLH-~~~~~~iiHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~ 662 (675)
|+||| +++ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 99999 887 99999999999999887 899999999998754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.5e-25 Score=252.34 Aligned_cols=162 Identities=28% Similarity=0.342 Sum_probs=139.2
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~ 580 (675)
..++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999875 5889999999753 234567788999999987 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|||||+++|+|..++.. ...+++..+..|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999943 346899999999999999999999997 999999999999999999999999999975
Q ss_pred CCCcccCCCCceecC
Q 005825 661 GGDELQGNTKRIVGT 675 (675)
Q Consensus 661 ~~~~~~~~~~~~~GT 675 (675)
..+.. .+...+||
T Consensus 493 ~~~~~--~~~~~~GT 505 (674)
T 3pfq_A 493 IWDGV--TTKTFCGT 505 (674)
T ss_dssp CCTTC--CBCCCCSC
T ss_pred ccCCc--ccccccCC
Confidence 43332 23335555
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=227.89 Aligned_cols=151 Identities=29% Similarity=0.411 Sum_probs=135.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc------cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG------QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
.+.|++.+.||+|+||.||+++.. +++.||||.++.... ...+++.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999875 589999999875422 1367899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC----CeEEeeec
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM----NPKISDFG 655 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFG 655 (675)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999953 346889999999999999999999987 99999999999999888 79999999
Q ss_pred cceecCCC
Q 005825 656 LARMFGGD 663 (675)
Q Consensus 656 la~~~~~~ 663 (675)
+++.+...
T Consensus 165 ~~~~~~~~ 172 (321)
T 2a2a_A 165 LAHEIEDG 172 (321)
T ss_dssp TCEECCTT
T ss_pred cceecCcc
Confidence 99987554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=226.78 Aligned_cols=151 Identities=34% Similarity=0.565 Sum_probs=132.0
Q ss_pred CCcceeeeeCCcCceeEEEEEE-----cCCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-----LNGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEK 579 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~ 579 (675)
+.|++.++||+|+||.||+|++ .+++.||||+++.. .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5689999999999999999984 35889999999854 334567899999999999999999999999876 568
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999998432 345899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
+...
T Consensus 176 ~~~~ 179 (302)
T 4e5w_A 176 IETD 179 (302)
T ss_dssp CCTT
T ss_pred ccCC
Confidence 7554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=234.93 Aligned_cols=151 Identities=21% Similarity=0.302 Sum_probs=135.3
Q ss_pred hcCCcceeeeeCCc--CceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 506 ATENFSMECKLGEG--GFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 506 ~~~~f~~~~~IG~G--~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
..++|++.++||+| +||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34789999999999 99999999875 68999999997542 334567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||+++++|.+++... ....+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999998543 2245899999999999999999999998 999999999999999999999999998765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=244.05 Aligned_cols=152 Identities=32% Similarity=0.549 Sum_probs=132.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
..++|++.++||+|+||.||+|+..++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 446789999999999999999999888889999998643 456789999999999999999999999876 678999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++|+|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999999431 2245889999999999999999999987 999999999999999999999999999987543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-25 Score=233.06 Aligned_cols=157 Identities=24% Similarity=0.327 Sum_probs=133.7
Q ss_pred HHHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc-----CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC
Q 005825 503 VAAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ-----SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ 576 (675)
Q Consensus 503 ~~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~ 576 (675)
+....++|++.++||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4556689999999999999999999874 5889999998643 234567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCC-------------------------------------CcccCCHHHHHHHHHHHHHH
Q 005825 577 GEKILILEYMPNKSLDVFLFDPT-------------------------------------KKRLLGWQARIGIIEGIAQG 619 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~ 619 (675)
+..++||||+++|+|.+++.... ....+++.....|+.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999984110 01223567788899999999
Q ss_pred HHHHHhcCCCceEecCCCCCCEEEcCCC--CeEEeeeccceecCC
Q 005825 620 LLYLHHYSRFRIIHRDLKASNVLLDRDM--NPKISDFGLARMFGG 662 (675)
Q Consensus 620 L~yLH~~~~~~iiHrDlkp~NILl~~~~--~~kl~DFGla~~~~~ 662 (675)
|+|||+++ |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 99999997 99999999999998776 899999999997643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=229.69 Aligned_cols=152 Identities=30% Similarity=0.473 Sum_probs=135.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-----cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEE--eCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-----LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCI--EQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~--~~~~~ 579 (675)
.++|++.++||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36899999999999999999984 358899999998766666678999999999999999999999987 44568
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999998532 345899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
+...
T Consensus 177 ~~~~ 180 (327)
T 3lxl_A 177 LPLD 180 (327)
T ss_dssp CCTT
T ss_pred cccC
Confidence 7544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.7e-25 Score=226.65 Aligned_cols=151 Identities=28% Similarity=0.450 Sum_probs=135.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC-C-------cEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN-G-------EEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~-g-------~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~ 578 (675)
.++|++.+.||+|+||.||+|+... + ..||+|.+........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4689999999999999999997643 3 4799999987666677889999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC--------eE
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN--------PK 650 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~k 650 (675)
.++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999542 334889999999999999999999998 999999999999998887 99
Q ss_pred EeeeccceecCC
Q 005825 651 ISDFGLARMFGG 662 (675)
Q Consensus 651 l~DFGla~~~~~ 662 (675)
|+|||+++....
T Consensus 162 l~Dfg~~~~~~~ 173 (289)
T 4fvq_A 162 LSDPGISITVLP 173 (289)
T ss_dssp ECCCCSCTTTSC
T ss_pred eccCcccccccC
Confidence 999999976643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=221.83 Aligned_cols=152 Identities=36% Similarity=0.547 Sum_probs=134.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.++|++.+.||+|+||.||+|+..+++.||||.++.. ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 4689999999999999999999888889999999753 345678999999999999999999999986 45689999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
++++|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 999999998431 1236899999999999999999999987 9999999999999999999999999999875543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=222.36 Aligned_cols=151 Identities=31% Similarity=0.507 Sum_probs=135.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.+.||+|+||.||+|+. .+++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999987 46899999999643 223457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++... ...+++..+..++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++.+..
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999999542 346899999999999999999999987 99999999999999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-24 Score=223.83 Aligned_cols=150 Identities=27% Similarity=0.351 Sum_probs=134.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|.+.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 468999999999999999999875 47899999987532 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++. ....+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999884 3346899999999999999999999997 99999999999999999999999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.92 E-value=9.2e-25 Score=238.53 Aligned_cols=152 Identities=26% Similarity=0.354 Sum_probs=128.8
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--------ccCHHHHHHHHHHHHhcCCCceeeEEEEEEe
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--------GQGLEEFKNEMLLIAKLQHRNLVRILGCCIE 575 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--------~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~ 575 (675)
...++|.+.++||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34689999999999999999999874 58999999987531 122345889999999999999999999975
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC---CCeEEe
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD---MNPKIS 652 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~ 652 (675)
.+..++||||+++++|.+++. ....+++.++..++.|++.||+|||+++ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 566899999999999999884 3456899999999999999999999987 9999999999999654 459999
Q ss_pred eeccceecCCC
Q 005825 653 DFGLARMFGGD 663 (675)
Q Consensus 653 DFGla~~~~~~ 663 (675)
|||+|+.+...
T Consensus 285 DFG~a~~~~~~ 295 (419)
T 3i6u_A 285 DFGHSKILGET 295 (419)
T ss_dssp CSSTTTSCC--
T ss_pred ecccceecCCC
Confidence 99999987543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-24 Score=226.34 Aligned_cols=149 Identities=26% Similarity=0.363 Sum_probs=131.3
Q ss_pred cCCccee-eeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEE
Q 005825 507 TENFSME-CKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 507 ~~~f~~~-~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.+.|++. +.||+|+||.||+|+. .+++.||||+++.......+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3577774 6899999999999986 46899999999876666678899999999985 7999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC---eEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN---PKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla~~~ 660 (675)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.+
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999943 346889999999999999999999997 999999999999998776 999999999876
Q ss_pred C
Q 005825 661 G 661 (675)
Q Consensus 661 ~ 661 (675)
.
T Consensus 165 ~ 165 (316)
T 2ac3_A 165 K 165 (316)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=222.37 Aligned_cols=150 Identities=31% Similarity=0.554 Sum_probs=136.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.++|++.+.||+|+||.||+++..+++.||+|+++.. ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-TBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEcccc-CCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 4688999999999999999999988899999999864 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999532 345889999999999999999999998 99999999999999999999999999987644
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=222.71 Aligned_cols=156 Identities=26% Similarity=0.355 Sum_probs=135.3
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~l 581 (675)
..++|++.++||+|+||.||+|+.. +++.||||+++... .....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3468999999999999999999875 68999999997532 33456788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---------------
Q 005825 582 ILEYMPNKSLDVFLFDPTK-KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR--------------- 645 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--------------- 645 (675)
||||+++++|.+++..... ...+++..+..|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999954211 256899999999999999999999997 999999999999984
Q ss_pred ----CCCeEEeeeccceecCCCc
Q 005825 646 ----DMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 646 ----~~~~kl~DFGla~~~~~~~ 664 (675)
...+||+|||+++......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~ 188 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ 188 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC
T ss_pred ccCCceEEEEcccccccccCCcc
Confidence 4479999999999886544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=224.79 Aligned_cols=154 Identities=25% Similarity=0.418 Sum_probs=133.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|.+.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367999999999999999999874 58899999987643 3456889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE---cCCCCeEEeeeccceec
Q 005825 585 YMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMF 660 (675)
Q Consensus 585 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~ 660 (675)
|+++++|.+++... .....+++..+..|+.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988532 12356899999999999999999999987 9999999999999 45688999999999887
Q ss_pred CCC
Q 005825 661 GGD 663 (675)
Q Consensus 661 ~~~ 663 (675)
...
T Consensus 178 ~~~ 180 (285)
T 3is5_A 178 KSD 180 (285)
T ss_dssp ---
T ss_pred CCc
Confidence 544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=232.39 Aligned_cols=156 Identities=29% Similarity=0.464 Sum_probs=135.6
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG 577 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~ 577 (675)
...++|++.+.||+|+||.||+|+.. .++.||||.+.... .....++.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999754 36789999997543 234457899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCC-------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeE
Q 005825 578 EKILILEYMPNKSLDVFLFDPT-------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPK 650 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 650 (675)
..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 9999999999999999985321 1245688999999999999999999997 99999999999999999999
Q ss_pred EeeeccceecCCC
Q 005825 651 ISDFGLARMFGGD 663 (675)
Q Consensus 651 l~DFGla~~~~~~ 663 (675)
|+|||+++.+...
T Consensus 179 l~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 179 IGDFGMTRDIYET 191 (322)
T ss_dssp ECCTTCCCGGGGG
T ss_pred ECcCccccccccc
Confidence 9999999876443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=228.86 Aligned_cols=151 Identities=26% Similarity=0.351 Sum_probs=135.3
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
..++|.+.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3468999999999999999999875 47899999987532 2345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++++|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 119 v~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999884 2356899999999999999999999997 9999999999999999999999999999875
Q ss_pred C
Q 005825 662 G 662 (675)
Q Consensus 662 ~ 662 (675)
.
T Consensus 193 ~ 193 (335)
T 2owb_A 193 Y 193 (335)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=221.29 Aligned_cols=152 Identities=34% Similarity=0.556 Sum_probs=125.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcC----ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQS----GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~----~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.++||+|+||.||+|+.. ++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999974 8899999987532 23457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC--------CCCeEEeee
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR--------DMNPKISDF 654 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--------~~~~kl~DF 654 (675)
|||+++++|.+++. ...+++..+..++.|++.||+|||+++..+|+||||||+|||+++ ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999983 346889999999999999999999987666999999999999986 778999999
Q ss_pred ccceecCCC
Q 005825 655 GLARMFGGD 663 (675)
Q Consensus 655 Gla~~~~~~ 663 (675)
|+++.+...
T Consensus 161 g~~~~~~~~ 169 (271)
T 3dtc_A 161 GLAREWHRT 169 (271)
T ss_dssp CC-------
T ss_pred Ccccccccc
Confidence 999877543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=235.73 Aligned_cols=160 Identities=24% Similarity=0.360 Sum_probs=132.2
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcC--CCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQ--HRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~--H~nIv~l~g~~~~~~~~~lV~ 583 (675)
..|++.++||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 569999999999999999999888999999998753 2334578999999999996 599999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
| +.+++|.+++.. ...+++.++..|+.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+|+.+..+
T Consensus 136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 578999999853 346788899999999999999999987 99999999999995 579999999999988654
Q ss_pred cccCCCCceecC
Q 005825 664 ELQGNTKRIVGT 675 (675)
Q Consensus 664 ~~~~~~~~~~GT 675 (675)
.........+||
T Consensus 208 ~~~~~~~~~~gt 219 (390)
T 2zmd_A 208 TTSVVKDSQVGA 219 (390)
T ss_dssp ------CCSCCC
T ss_pred CccccCCCCCcC
Confidence 433222334454
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=220.86 Aligned_cols=150 Identities=29% Similarity=0.422 Sum_probs=133.6
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc------cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG------QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
++|++.+.||+|+||.||+++.. +++.||||.++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57899999999999999999876 589999999875321 24678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC----CeEEeeecc
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM----NPKISDFGL 656 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGl 656 (675)
+||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||++++++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999843 446899999999999999999999987 99999999999998877 899999999
Q ss_pred ceecCCC
Q 005825 657 ARMFGGD 663 (675)
Q Consensus 657 a~~~~~~ 663 (675)
++.+...
T Consensus 159 ~~~~~~~ 165 (283)
T 3bhy_A 159 AHKIEAG 165 (283)
T ss_dssp CEECC--
T ss_pred ceeccCC
Confidence 9987543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=221.65 Aligned_cols=151 Identities=32% Similarity=0.450 Sum_probs=132.3
Q ss_pred CcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 509 NFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
.|.....||+|+||.||+|+. .+++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 444556899999999999986 4588999999987666667889999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-CCCeEEeeeccceecCC
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-DMNPKISDFGLARMFGG 662 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~ 662 (675)
+++|.+++........+++..+..++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||+++.+..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999965433445678889999999999999999987 999999999999987 89999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-24 Score=220.80 Aligned_cols=152 Identities=26% Similarity=0.426 Sum_probs=134.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999875 58999999987532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC---eEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN---PKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla~~~ 660 (675)
||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++. +||+|||+++..
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888843 356899999999999999999999997 999999999999986655 999999999887
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
....
T Consensus 159 ~~~~ 162 (284)
T 3kk8_A 159 NDSE 162 (284)
T ss_dssp CSSC
T ss_pred ccCc
Confidence 5443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-25 Score=228.97 Aligned_cols=161 Identities=29% Similarity=0.446 Sum_probs=136.9
Q ss_pred HHHHHHhcCCcceeeeeCCcCceeEEEEEE------cCCcEEEEEEecCcCc-cCHHHHHHHHHHHHhc-CCCceeeEEE
Q 005825 500 LASVAAATENFSMECKLGEGGFGPVYKGRL------LNGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKL-QHRNLVRILG 571 (675)
Q Consensus 500 ~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l-~H~nIv~l~g 571 (675)
........++|++.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 334445568999999999999999999974 3468999999986432 3456799999999999 7999999999
Q ss_pred EEEeCC-eEEEEEEecCCCCHHHHhcCCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCC
Q 005825 572 CCIEQG-EKILILEYMPNKSLDVFLFDPTK-------------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLK 637 (675)
Q Consensus 572 ~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 637 (675)
++.+.+ ..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+++ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 998765 48999999999999999965322 123789999999999999999999987 9999999
Q ss_pred CCCEEEcCCCCeEEeeeccceecCCC
Q 005825 638 ASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 638 p~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|+|||++.++.+||+|||+++.+...
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 201 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKD 201 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTC
T ss_pred cceEEECCCCCEEECCCccccccccC
Confidence 99999999999999999999987544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.4e-24 Score=220.59 Aligned_cols=151 Identities=29% Similarity=0.439 Sum_probs=136.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.+.|++.++||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467999999999999999999864 58999999997543 3456889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999842 45899999999999999999999997 9999999999999999999999999998876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=224.27 Aligned_cols=154 Identities=32% Similarity=0.531 Sum_probs=138.1
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
..++|++.++||+|+||.||+|+... ++.||||.++. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45789999999999999999998764 88999999975 34456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|+++++|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+|+.+..+.
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999542 2345899999999999999999999998 9999999999999999999999999999876443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=232.99 Aligned_cols=150 Identities=28% Similarity=0.503 Sum_probs=124.0
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCC--e
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQG--E 578 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~--~ 578 (675)
...++|++.++||+|+||.||+|+. .+++.||||++... .....+++.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457999999999999999999986 46899999999653 2334567889999999997 999999999998654 6
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 589888843 46889999999999999999999998 9999999999999999999999999999
Q ss_pred ecCC
Q 005825 659 MFGG 662 (675)
Q Consensus 659 ~~~~ 662 (675)
.+..
T Consensus 158 ~~~~ 161 (388)
T 3oz6_A 158 SFVN 161 (388)
T ss_dssp ESSS
T ss_pred cccc
Confidence 8743
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=6.7e-25 Score=247.03 Aligned_cols=152 Identities=32% Similarity=0.549 Sum_probs=135.3
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
..++|++.++||+|+||.||+|++.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..+|||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 346789999999999999999999888889999998643 456789999999999999999999999876 678999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++|+|.+++... ....+++.+++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+...
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999431 2245889999999999999999999987 999999999999999999999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=228.55 Aligned_cols=141 Identities=26% Similarity=0.337 Sum_probs=125.3
Q ss_pred eeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEEEecCCCCH
Q 005825 514 CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILILEYMPNKSL 591 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (675)
++||+|+||.||+++.. +++.||||++... ....+.+|+.++.++. ||||+++++++.+....++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 68999999999999875 5899999999642 4467889999999997 99999999999999999999999999999
Q ss_pred HHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC---CeEEeeeccceecCCC
Q 005825 592 DVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM---NPKISDFGLARMFGGD 663 (675)
Q Consensus 592 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~ 663 (675)
.+++.. ...+++.++..|+.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999953 456899999999999999999999987 99999999999998765 8999999999977544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-24 Score=228.63 Aligned_cols=158 Identities=23% Similarity=0.370 Sum_probs=138.5
Q ss_pred HHHHHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--------cCHHHHHHHHHHHHhc-CCCceeeEE
Q 005825 501 ASVAAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--------QGLEEFKNEMLLIAKL-QHRNLVRIL 570 (675)
Q Consensus 501 ~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~f~~E~~il~~l-~H~nIv~l~ 570 (675)
.......++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999985 699999999875431 1145688999999999 799999999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeE
Q 005825 571 GCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPK 650 (675)
Q Consensus 571 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 650 (675)
+++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999843 346899999999999999999999987 99999999999999999999
Q ss_pred EeeeccceecCCCc
Q 005825 651 ISDFGLARMFGGDE 664 (675)
Q Consensus 651 l~DFGla~~~~~~~ 664 (675)
|+|||+++.+....
T Consensus 241 l~DfG~~~~~~~~~ 254 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE 254 (365)
T ss_dssp ECCCTTCEECCTTC
T ss_pred EEecCcccccCCCc
Confidence 99999999886543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=238.43 Aligned_cols=152 Identities=29% Similarity=0.445 Sum_probs=132.8
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc-------------cCHHHHHHHHHHHHhcCCCceeeEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG-------------QGLEEFKNEMLLIAKLQHRNLVRILG 571 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-------------~~~~~f~~E~~il~~l~H~nIv~l~g 571 (675)
..++|++.++||+|+||+||+|+.. +++.||||+++.... ...+++.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999875 588999999875321 34578999999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC---C
Q 005825 572 CCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM---N 648 (675)
Q Consensus 572 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~ 648 (675)
++.+....++||||+++|+|.+++.. ...+++..+..|+.||+.||+|||+++ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999998843 356899999999999999999999997 99999999999998776 6
Q ss_pred eEEeeeccceecCCC
Q 005825 649 PKISDFGLARMFGGD 663 (675)
Q Consensus 649 ~kl~DFGla~~~~~~ 663 (675)
+||+|||+|+.+...
T Consensus 188 ~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD 202 (504)
T ss_dssp EEECCCTTCEECCTT
T ss_pred EEEEECCCCEEcCCC
Confidence 999999999988654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=222.38 Aligned_cols=150 Identities=30% Similarity=0.402 Sum_probs=132.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999875 4779999998643 223456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999843 345889999999999999999999987 99999999999999999999999999976543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-24 Score=223.23 Aligned_cols=147 Identities=37% Similarity=0.549 Sum_probs=130.8
Q ss_pred cceeeeeCCcCceeEEEEEEc-----CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeEEE
Q 005825 510 FSMECKLGEGGFGPVYKGRLL-----NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEKIL 581 (675)
Q Consensus 510 f~~~~~IG~G~fG~Vy~~~~~-----~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~~l 581 (675)
|++.++||+|+||.||++.+. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 489999999999999988642 58899999998643 23456799999999999999999999999884 57899
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999943 24889999999999999999999998 9999999999999999999999999999885
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 186 ~~ 187 (318)
T 3lxp_A 186 EG 187 (318)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=224.08 Aligned_cols=149 Identities=34% Similarity=0.530 Sum_probs=123.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
..++|++.++||+|+||.||+|+.. ..||||+++... ....+.|.+|+.++++++||||+++++++ ..+..++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3478999999999999999999864 359999997543 33457799999999999999999999965 556789999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+++++|.+++.. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999953 3456899999999999999999999987 99999999999999999999999999987654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.3e-24 Score=220.33 Aligned_cols=152 Identities=27% Similarity=0.342 Sum_probs=135.3
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---------ccCHHHHHHHHHHHHhcC-CCceeeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---------GQGLEEFKNEMLLIAKLQ-HRNLVRILGCCI 574 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---------~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~ 574 (675)
..++|++.+.||+|+||.||+|+.. +++.||||.++... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999875 58999999997532 122456889999999996 999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeee
Q 005825 575 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDF 654 (675)
Q Consensus 575 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 654 (675)
+.+..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999943 346899999999999999999999987 999999999999999999999999
Q ss_pred ccceecCCC
Q 005825 655 GLARMFGGD 663 (675)
Q Consensus 655 Gla~~~~~~ 663 (675)
|+++.+...
T Consensus 169 g~~~~~~~~ 177 (298)
T 1phk_A 169 GFSCQLDPG 177 (298)
T ss_dssp TTCEECCTT
T ss_pred cchhhcCCC
Confidence 999987544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.4e-25 Score=230.91 Aligned_cols=155 Identities=34% Similarity=0.490 Sum_probs=134.7
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC------CcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQG 577 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~ 577 (675)
..++|++.+.||+|+||.||+|+... .+.||+|.++... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45789999999999999999998643 2479999997643 23456799999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCC-----------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC
Q 005825 578 EKILILEYMPNKSLDVFLFDPT-----------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD 646 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~ 646 (675)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++++
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 9999999999999999985321 1235789999999999999999999987 9999999999999999
Q ss_pred CCeEEeeeccceecCCC
Q 005825 647 MNPKISDFGLARMFGGD 663 (675)
Q Consensus 647 ~~~kl~DFGla~~~~~~ 663 (675)
+.+||+|||+|+.+...
T Consensus 201 ~~~kl~Dfg~~~~~~~~ 217 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMND 217 (333)
T ss_dssp GEEEBCCCGGGCCGGGC
T ss_pred CeEEECccccccccccc
Confidence 99999999999977443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=238.50 Aligned_cols=148 Identities=28% Similarity=0.387 Sum_probs=124.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC------C
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ------G 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~------~ 577 (675)
.++|++.++||+|+||.||+|+.. +++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999864 5899999999753 233456788999999999999999999999654 4
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
+.++||||++++ |.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 679999999865 555552 23888999999999999999999997 999999999999999999999999999
Q ss_pred eecCCC
Q 005825 658 RMFGGD 663 (675)
Q Consensus 658 ~~~~~~ 663 (675)
+.....
T Consensus 212 ~~~~~~ 217 (464)
T 3ttj_A 212 RTAGTS 217 (464)
T ss_dssp -----C
T ss_pred eecCCC
Confidence 987543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=228.73 Aligned_cols=150 Identities=33% Similarity=0.497 Sum_probs=131.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.+.|+..+.||+|+||.||+|+. .+++.||||++..... ...+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35689999999999999999986 5689999999975322 2346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||++ |+|.+++.. ....+++..+..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 677777742 2346899999999999999999999997 99999999999999999999999999988754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=223.35 Aligned_cols=151 Identities=28% Similarity=0.421 Sum_probs=124.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC----CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|++.+.||+|+||.||+|+... +..||+|.++... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4689999999999999999998643 4579999987532 334567999999999999999999999984 567899
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999532 335889999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 168 ~~ 169 (281)
T 1mp8_A 168 DS 169 (281)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=219.38 Aligned_cols=151 Identities=28% Similarity=0.453 Sum_probs=135.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.+.||+|+||.||+|+.. +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 478999999999999999999875 6899999998653 234567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999843 345889999999999999999999998 99999999999999999999999999988754
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
.
T Consensus 164 ~ 164 (276)
T 2h6d_A 164 G 164 (276)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=227.59 Aligned_cols=157 Identities=32% Similarity=0.539 Sum_probs=126.8
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEEc----CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG 577 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~ 577 (675)
....++|.+.+.||+|+||.||+|+.. .++.||||.++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 345678999999999999999999764 34589999987542 334567999999999999999999999998765
Q ss_pred e-----EEEEEEecCCCCHHHHhcCC---CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCe
Q 005825 578 E-----KILILEYMPNKSLDVFLFDP---TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP 649 (675)
Q Consensus 578 ~-----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 649 (675)
. .++||||+++++|.+++... .....+++..++.++.||++||.|||+++ |+||||||+|||+++++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 3 49999999999999998432 23456899999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceecCCC
Q 005825 650 KISDFGLARMFGGD 663 (675)
Q Consensus 650 kl~DFGla~~~~~~ 663 (675)
||+|||+++.+...
T Consensus 187 kl~Dfg~~~~~~~~ 200 (313)
T 3brb_A 187 CVADFGLSKKIYSG 200 (313)
T ss_dssp EECSCSCC------
T ss_pred EEeecCcceecccc
Confidence 99999999877543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-24 Score=228.54 Aligned_cols=159 Identities=27% Similarity=0.281 Sum_probs=137.2
Q ss_pred ccHHHHHHhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-----CCceeeEEE
Q 005825 498 FSLASVAAATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-----HRNLVRILG 571 (675)
Q Consensus 498 ~~~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-----H~nIv~l~g 571 (675)
+++.......++|++.++||+|+||.||+|+. .+++.||||+++. .....+.+..|+.++++++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 34444445678999999999999999999987 4688999999974 2344567888999999997 999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC------
Q 005825 572 CCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR------ 645 (675)
Q Consensus 572 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~------ 645 (675)
++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 999999986432 235889999999999999999999987 999999999999975
Q ss_pred -------------------CCCeEEeeeccceecCC
Q 005825 646 -------------------DMNPKISDFGLARMFGG 662 (675)
Q Consensus 646 -------------------~~~~kl~DFGla~~~~~ 662 (675)
++.+||+|||+|+....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 78999999999997644
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=225.50 Aligned_cols=151 Identities=29% Similarity=0.442 Sum_probs=127.1
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.++|++.+.||+|+||.||+++.. ++.||||++.. ....+.|.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 367899999999999999999874 78899999974 334578999999999999999999999886 3478999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC-eEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN-PKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-~kl~DFGla~~~~~ 662 (675)
++++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.+..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999976544456788999999999999999999943345999999999999998887 79999999987643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.4e-24 Score=237.50 Aligned_cols=152 Identities=28% Similarity=0.408 Sum_probs=130.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.+.|++.++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 357999999999999999999875 58899999997542 344678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---CCCeEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~ 660 (675)
||+++|+|.+++. ....+++..+..|+.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.+
T Consensus 116 e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999998884 3356889999999999999999999987 999999999999976 455999999999988
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
....
T Consensus 190 ~~~~ 193 (494)
T 3lij_A 190 ENQK 193 (494)
T ss_dssp BTTB
T ss_pred CCCc
Confidence 6543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=226.53 Aligned_cols=152 Identities=34% Similarity=0.580 Sum_probs=134.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-----cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC--eE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-----LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG--EK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~--~~ 579 (675)
.++|++.++||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46789999999999999999984 358899999998766666778999999999999999999999987654 67
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999542 245889999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
+...
T Consensus 195 ~~~~ 198 (326)
T 2w1i_A 195 LPQD 198 (326)
T ss_dssp CCSS
T ss_pred cccc
Confidence 8544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.9e-24 Score=220.59 Aligned_cols=153 Identities=30% Similarity=0.496 Sum_probs=128.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC-----ccCHHHHHHHHHHHHhcC---CCceeeEEEEEEeC
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS-----GQGLEEFKNEMLLIAKLQ---HRNLVRILGCCIEQ 576 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~f~~E~~il~~l~---H~nIv~l~g~~~~~ 576 (675)
..++|++.++||+|+||+||+|+. .+++.||||+++... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999986 468999999987422 122356778888777764 99999999999876
Q ss_pred C-----eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEE
Q 005825 577 G-----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKI 651 (675)
Q Consensus 577 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 651 (675)
. ..++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999997 59999986432 234899999999999999999999998 999999999999999999999
Q ss_pred eeeccceecCCC
Q 005825 652 SDFGLARMFGGD 663 (675)
Q Consensus 652 ~DFGla~~~~~~ 663 (675)
+|||+|+.+...
T Consensus 162 ~Dfg~a~~~~~~ 173 (308)
T 3g33_A 162 ADFGLARIYSYQ 173 (308)
T ss_dssp CSCSCTTTSTTC
T ss_pred eeCccccccCCC
Confidence 999999877543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-24 Score=223.21 Aligned_cols=152 Identities=22% Similarity=0.281 Sum_probs=130.9
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
..++|++.+.||+|+||.||+++.. +++.||||.+..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4578999999999999999999875 688999999975432 234679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999943 346899999999999999999999997 9999999999999999999999999998775
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 186 ~~ 187 (309)
T 2h34_A 186 DE 187 (309)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-24 Score=219.35 Aligned_cols=150 Identities=29% Similarity=0.486 Sum_probs=132.3
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEe---------
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE--------- 575 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~--------- 575 (675)
..++|++.+.||+|+||.||+|+.. +++.||||+++... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467999999999999999999885 68999999997532 467789999999999999999999864
Q ss_pred -------CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC
Q 005825 576 -------QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN 648 (675)
Q Consensus 576 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 648 (675)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34579999999999999999542 2346899999999999999999999987 999999999999999999
Q ss_pred eEEeeeccceecCCC
Q 005825 649 PKISDFGLARMFGGD 663 (675)
Q Consensus 649 ~kl~DFGla~~~~~~ 663 (675)
+||+|||+++.+...
T Consensus 161 ~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 161 VKIGDFGLVTSLKND 175 (284)
T ss_dssp EEECCCTTCEESSCC
T ss_pred EEECcchhheecccc
Confidence 999999999988654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=7.2e-24 Score=218.97 Aligned_cols=151 Identities=31% Similarity=0.533 Sum_probs=132.4
Q ss_pred cCCcceee-eeCCcCceeEEEEEEc---CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMEC-KLGEGGFGPVYKGRLL---NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~-~IG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|.+.+ .||+|+||.||+|+.. +++.||||+++... ....+++.+|+.++++++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35666666 9999999999999753 57889999998643 34567899999999999999999999999 5667999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+||++++++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999953 3446899999999999999999999997 9999999999999999999999999999885
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 162 ~~ 163 (287)
T 1u59_A 162 AD 163 (287)
T ss_dssp TC
T ss_pred cC
Confidence 44
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.3e-24 Score=225.51 Aligned_cols=148 Identities=21% Similarity=0.356 Sum_probs=128.9
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
..++|++.+.||+|+||.||+++.. +++.||||++++... .+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3568999999999999999999875 589999999976432 245688888887 7999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC----CCeEEeeecccee
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD----MNPKISDFGLARM 659 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~ 659 (675)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+|+.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999853 356899999999999999999999997 9999999999998543 3599999999998
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
+...
T Consensus 170 ~~~~ 173 (342)
T 2qr7_A 170 LRAE 173 (342)
T ss_dssp CBCT
T ss_pred CcCC
Confidence 7544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=244.74 Aligned_cols=150 Identities=31% Similarity=0.524 Sum_probs=130.6
Q ss_pred CCcceee-eeCCcCceeEEEEEEc---CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 508 ENFSMEC-KLGEGGFGPVYKGRLL---NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 508 ~~f~~~~-~IG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
+++.+.+ +||+|+||.||+|.+. ++..||||+++... ....++|.+|+.+|++++|||||++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4555555 8999999999999764 46689999998643 3457889999999999999999999999976 569999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++|+|.+++.. ....+++..+..|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999954 2456899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
+
T Consensus 489 ~ 489 (613)
T 2ozo_A 489 D 489 (613)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=225.57 Aligned_cols=150 Identities=29% Similarity=0.445 Sum_probs=130.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 368999999999999999999875 489999999865332 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999988743 345899999999999999999999997 99999999999999999999999999987754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=229.77 Aligned_cols=152 Identities=22% Similarity=0.345 Sum_probs=126.8
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC------CcEEEEEEecCcCccC-----------HHHHHHHHHHHHhcCCCceee
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLSSQSGQG-----------LEEFKNEMLLIAKLQHRNLVR 568 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~~-----------~~~f~~E~~il~~l~H~nIv~ 568 (675)
..++|++.++||+|+||.||+|++.. ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 4789999987543211 122445666777888999999
Q ss_pred EEEEEEeC----CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc
Q 005825 569 ILGCCIEQ----GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD 644 (675)
Q Consensus 569 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 644 (675)
+++++.+. ...+|||||+ +++|.+++.. ....+++..++.|+.||+.||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999775 4589999999 9999999954 2356899999999999999999999997 99999999999999
Q ss_pred --CCCCeEEeeeccceecCCC
Q 005825 645 --RDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 645 --~~~~~kl~DFGla~~~~~~ 663 (675)
.++.+||+|||+|+.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGG
T ss_pred cCCCCeEEEEECCcceecccC
Confidence 8899999999999987544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.9e-24 Score=224.55 Aligned_cols=149 Identities=30% Similarity=0.529 Sum_probs=129.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEe--------
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIE-------- 575 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~-------- 575 (675)
.++|++.++||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999987 468999999986542 2335678899999999999999999999987
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
.+..++||||+++ +|...+... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999985 666666432 345899999999999999999999997 9999999999999999999999999
Q ss_pred cceecC
Q 005825 656 LARMFG 661 (675)
Q Consensus 656 la~~~~ 661 (675)
+|+.+.
T Consensus 170 ~a~~~~ 175 (351)
T 3mi9_A 170 LARAFS 175 (351)
T ss_dssp TCEECC
T ss_pred hccccc
Confidence 999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=222.53 Aligned_cols=150 Identities=29% Similarity=0.521 Sum_probs=132.8
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
..+.|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4478999999999999999999885 489999999987666777899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 9999999998853 2345889999999999999999999987 999999999999999999999999998643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=228.04 Aligned_cols=153 Identities=31% Similarity=0.456 Sum_probs=127.1
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc-----cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG-----QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE 578 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-----~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~ 578 (675)
...++|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999875 589999999975321 123578899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.++||||+++ +|..++.. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 88888853 2345788889999999999999999998 9999999999999999999999999999
Q ss_pred ecCCC
Q 005825 659 MFGGD 663 (675)
Q Consensus 659 ~~~~~ 663 (675)
.+...
T Consensus 161 ~~~~~ 165 (346)
T 1ua2_A 161 SFGSP 165 (346)
T ss_dssp TTTSC
T ss_pred eccCC
Confidence 87543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-24 Score=224.53 Aligned_cols=153 Identities=27% Similarity=0.379 Sum_probs=133.2
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE----QGEKI 580 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~----~~~~~ 580 (675)
..++|++.++||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 357899999999999999999987 5689999999876555667789999999999999999999999973 34789
Q ss_pred EEEEecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 581 LILEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
+||||+++++|.+++... .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999998532 12456899999999999999999999997 99999999999999999999999999876
Q ss_pred cC
Q 005825 660 FG 661 (675)
Q Consensus 660 ~~ 661 (675)
..
T Consensus 184 ~~ 185 (317)
T 2buj_A 184 AC 185 (317)
T ss_dssp SC
T ss_pred cc
Confidence 53
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-23 Score=218.60 Aligned_cols=150 Identities=20% Similarity=0.334 Sum_probs=132.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46899999999999999999986 56899999998643 2345688999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC-----eEEeeecccee
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN-----PKISDFGLARM 659 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~DFGla~~ 659 (675)
|+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+|+.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999532 335899999999999999999999987 999999999999987776 99999999998
Q ss_pred cCCCc
Q 005825 660 FGGDE 664 (675)
Q Consensus 660 ~~~~~ 664 (675)
+....
T Consensus 161 ~~~~~ 165 (298)
T 1csn_A 161 YRDPV 165 (298)
T ss_dssp SBCTT
T ss_pred ccccc
Confidence 86543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-24 Score=224.29 Aligned_cols=153 Identities=28% Similarity=0.408 Sum_probs=128.2
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhc--CCCceeeEEEEEEeC----C
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL--QHRNLVRILGCCIEQ----G 577 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l--~H~nIv~l~g~~~~~----~ 577 (675)
....++|++.++||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344578999999999999999999875 899999998642 234455566666554 899999999999887 7
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcC-----CCceEecCCCCCCEEEcCCCCeEEe
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS-----RFRIIHRDLKASNVLLDRDMNPKIS 652 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~kl~ 652 (675)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+++ ..+|+||||||+|||++.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 89999999999999999943 35899999999999999999999871 1239999999999999999999999
Q ss_pred eeccceecCCCc
Q 005825 653 DFGLARMFGGDE 664 (675)
Q Consensus 653 DFGla~~~~~~~ 664 (675)
|||+|+.+....
T Consensus 185 Dfg~a~~~~~~~ 196 (337)
T 3mdy_A 185 DLGLAVKFISDT 196 (337)
T ss_dssp CCTTCEECC---
T ss_pred eCCCceeecccc
Confidence 999998875443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=227.85 Aligned_cols=152 Identities=32% Similarity=0.461 Sum_probs=127.4
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc--cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG--QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
....++|++.++||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345578999999999999999999864 689999999975432 23456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE-----cCCCCeEEeeec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL-----DRDMNPKISDFG 655 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl-----~~~~~~kl~DFG 655 (675)
+||||+++ +|.+++.. ...+++..+..|+.||+.||+|||+++ |+||||||+|||+ ++.+.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999985 99999843 345889999999999999999999997 9999999999999 455569999999
Q ss_pred cceecCC
Q 005825 656 LARMFGG 662 (675)
Q Consensus 656 la~~~~~ 662 (675)
+|+.+..
T Consensus 183 ~a~~~~~ 189 (329)
T 3gbz_A 183 LARAFGI 189 (329)
T ss_dssp HHHHHC-
T ss_pred CccccCC
Confidence 9987753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=228.60 Aligned_cols=159 Identities=25% Similarity=0.364 Sum_probs=132.8
Q ss_pred cHHHHHHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCcc-----------CHHHHHHHHHHHHhcCCCcee
Q 005825 499 SLASVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQ-----------GLEEFKNEMLLIAKLQHRNLV 567 (675)
Q Consensus 499 ~~~~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~-----------~~~~f~~E~~il~~l~H~nIv 567 (675)
...++....++|++.++||+|+||.||+|+..+++.||||++...... ..+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 355677888999999999999999999999888999999998643221 136799999999999999999
Q ss_pred eEEEEEEeC-----CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEE
Q 005825 568 RILGCCIEQ-----GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVL 642 (675)
Q Consensus 568 ~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 642 (675)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999999643 36899999998 678777753 3346899999999999999999999997 999999999999
Q ss_pred EcCCCCeEEeeeccceecCCC
Q 005825 643 LDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 643 l~~~~~~kl~DFGla~~~~~~ 663 (675)
++.++.+||+|||+|+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~ 187 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD 187 (362)
T ss_dssp ECTTCCEEECCTTC-------
T ss_pred EcCCCCEEEEecCcccccccc
Confidence 999999999999999865433
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=238.47 Aligned_cols=152 Identities=28% Similarity=0.485 Sum_probs=134.9
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
..++|++.++||+|+||+||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3468999999999999999999875 6899999998643 234567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc---CCCCeEEeeecccee
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD---RDMNPKISDFGLARM 659 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~ 659 (675)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999988843 356899999999999999999999998 99999999999995 566899999999987
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
+...
T Consensus 174 ~~~~ 177 (486)
T 3mwu_A 174 FQQN 177 (486)
T ss_dssp BCCC
T ss_pred CCCC
Confidence 7544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=7.4e-24 Score=218.43 Aligned_cols=150 Identities=28% Similarity=0.409 Sum_probs=134.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.+.||+|+||.||+|+.. +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 368999999999999999999875 5789999998643 233457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999843 345889999999999999999999987 99999999999999999999999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.91 E-value=7.5e-24 Score=229.82 Aligned_cols=147 Identities=24% Similarity=0.314 Sum_probs=125.0
Q ss_pred cCCccee-eeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHH-hcCCCceeeEEEEEEe----CCeE
Q 005825 507 TENFSME-CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIA-KLQHRNLVRILGCCIE----QGEK 579 (675)
Q Consensus 507 ~~~f~~~-~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~-~l~H~nIv~l~g~~~~----~~~~ 579 (675)
.++|.+. ++||+|+||+||+++.. +++.||||+++. ...+.+|+.++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567766 68999999999999875 588999999963 246778888874 4589999999999875 5578
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---CCCeEEeeecc
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDFGL 656 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGl 656 (675)
+|||||+++|+|.+++... ....+++..+..|+.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999999642 2345899999999999999999999987 999999999999998 78999999999
Q ss_pred ceecCC
Q 005825 657 ARMFGG 662 (675)
Q Consensus 657 a~~~~~ 662 (675)
|+....
T Consensus 211 a~~~~~ 216 (400)
T 1nxk_A 211 AKETTS 216 (400)
T ss_dssp CEECC-
T ss_pred ccccCC
Confidence 997754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=227.83 Aligned_cols=152 Identities=26% Similarity=0.406 Sum_probs=135.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccC-----------------HHHHHHHHHHHHhcCCCceeeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQG-----------------LEEFKNEMLLIAKLQHRNLVRI 569 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~-----------------~~~f~~E~~il~~l~H~nIv~l 569 (675)
.++|++.+.||+|+||.||+|+. +++.||||.+....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999998 89999999987432111 1789999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHH------hcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCEE
Q 005825 570 LGCCIEQGEKILILEYMPNKSLDVF------LFDPTKKRLLGWQARIGIIEGIAQGLLYLHH-YSRFRIIHRDLKASNVL 642 (675)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NIL 642 (675)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.|++.||+|||+ ++ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 432 224678999999999999999999998 76 999999999999
Q ss_pred EcCCCCeEEeeeccceecCCC
Q 005825 643 LDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 643 l~~~~~~kl~DFGla~~~~~~ 663 (675)
++.++.+||+|||+++.+...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~ 205 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK 205 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT
T ss_pred EcCCCcEEEeccccccccccc
Confidence 999999999999999987543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=225.94 Aligned_cols=152 Identities=34% Similarity=0.571 Sum_probs=129.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC-----CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN-----GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
.++|.+.+.||+|+||.||+|+... +..||||.++... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678889999999999999998643 2469999997543 234567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||+++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999953 2346899999999999999999999997 999999999999999999999999999987
Q ss_pred CCC
Q 005825 661 GGD 663 (675)
Q Consensus 661 ~~~ 663 (675)
...
T Consensus 198 ~~~ 200 (333)
T 1mqb_A 198 EDD 200 (333)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=226.84 Aligned_cols=149 Identities=30% Similarity=0.441 Sum_probs=128.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.++||+|+||.||+|+.. +++.||||+++.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999875 689999999975432 2223456799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 98 5888888532 346889999999999999999999997 99999999999999999999999999987643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-23 Score=220.26 Aligned_cols=146 Identities=24% Similarity=0.399 Sum_probs=130.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEe--CCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIE--QGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~--~~~~~lV 582 (675)
.++|++.++||+|+||.||+|+. .+++.||||+++. ...+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 47899999999999999999986 5689999999974 34578999999999997 9999999999988 5678999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC-CeEEeeeccceecC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-NPKISDFGLARMFG 661 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~ 661 (675)
|||+++++|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999882 3788999999999999999999998 99999999999999776 89999999999875
Q ss_pred CCc
Q 005825 662 GDE 664 (675)
Q Consensus 662 ~~~ 664 (675)
...
T Consensus 183 ~~~ 185 (330)
T 3nsz_A 183 PGQ 185 (330)
T ss_dssp TTC
T ss_pred CCC
Confidence 443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=238.43 Aligned_cols=151 Identities=29% Similarity=0.466 Sum_probs=135.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999875 68999999986532 34567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE---cCCCCeEEeeecccee
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARM 659 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~ 659 (675)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999998853 346889999999999999999999997 9999999999999 5678999999999988
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
+...
T Consensus 179 ~~~~ 182 (484)
T 3nyv_A 179 FEAS 182 (484)
T ss_dssp BCCC
T ss_pred cccc
Confidence 7544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.5e-24 Score=221.42 Aligned_cols=149 Identities=30% Similarity=0.490 Sum_probs=132.1
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEe----------
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE---------- 575 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~---------- 575 (675)
.++|++.+.||+|+||.||+|+.. +++.||||+++. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999874 689999999964 33445789999999999999999999999865
Q ss_pred ---CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 005825 576 ---QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKIS 652 (675)
Q Consensus 576 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 652 (675)
.+..++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 34679999999999999999542 345778899999999999999999997 9999999999999999999999
Q ss_pred eeccceecC
Q 005825 653 DFGLARMFG 661 (675)
Q Consensus 653 DFGla~~~~ 661 (675)
|||+++.+.
T Consensus 159 dfg~~~~~~ 167 (303)
T 1zy4_A 159 DFGLAKNVH 167 (303)
T ss_dssp CCCCCSCTT
T ss_pred eCcchhhcc
Confidence 999998774
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=219.50 Aligned_cols=152 Identities=29% Similarity=0.497 Sum_probs=130.7
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
...+.|++.+.||+|+||.||+|+.. +++.||||.+... ...+++.+|+.++.+++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999875 4899999999753 34578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++++|.+++.. ....+++..+..++.+|+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999842 2346899999999999999999999987 999999999999999999999999999887544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.8e-24 Score=222.85 Aligned_cols=161 Identities=26% Similarity=0.377 Sum_probs=137.6
Q ss_pred cHHHHHHhcCCccee-eeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcC-CCceeeEEEEE
Q 005825 499 SLASVAAATENFSME-CKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQ-HRNLVRILGCC 573 (675)
Q Consensus 499 ~~~~~~~~~~~f~~~-~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~-H~nIv~l~g~~ 573 (675)
.+.......+.|.+. ++||+|+||.||+|+.. +++.||||+++... .....++.+|+.++.++. ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344455666788887 88999999999999875 58999999997542 344678999999999995 69999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---CCCeE
Q 005825 574 IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPK 650 (675)
Q Consensus 574 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~k 650 (675)
.+.+..++||||+++++|.+++... ....+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999998542 2356899999999999999999999997 999999999999988 78999
Q ss_pred EeeeccceecCCC
Q 005825 651 ISDFGLARMFGGD 663 (675)
Q Consensus 651 l~DFGla~~~~~~ 663 (675)
|+|||+|+.+...
T Consensus 175 L~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 175 IVDFGMSRKIGHA 187 (327)
T ss_dssp ECCGGGCEEC---
T ss_pred EeeCccccccCCc
Confidence 9999999987544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.1e-24 Score=222.03 Aligned_cols=150 Identities=23% Similarity=0.388 Sum_probs=131.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.++|.+.+.||+|+||.||+++.. +++.||||.++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 468999999999999999999875 6899999999865444556799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE---cCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.+++.. ...+++.....++.|++.||+|||+++ |+||||||+||++ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999998843 346889999999999999999999987 9999999999999 7889999999999987643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.6e-24 Score=220.47 Aligned_cols=151 Identities=26% Similarity=0.387 Sum_probs=129.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC----ccCHHHHHHHHHHHHhcCCCceeeEEEEEE--eCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS----GQGLEEFKNEMLLIAKLQHRNLVRILGCCI--EQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~----~~~~~~f~~E~~il~~l~H~nIv~l~g~~~--~~~~~ 579 (675)
.++|++.+.||+|+||.||+++.. +++.||||.++... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999874 58899999997532 344678999999999999999999999984 44578
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||++++ |.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 66666432 2446899999999999999999999997 99999999999999999999999999998
Q ss_pred cCC
Q 005825 660 FGG 662 (675)
Q Consensus 660 ~~~ 662 (675)
+..
T Consensus 159 ~~~ 161 (305)
T 2wtk_C 159 LHP 161 (305)
T ss_dssp CCT
T ss_pred cCc
Confidence 754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-24 Score=225.74 Aligned_cols=152 Identities=36% Similarity=0.580 Sum_probs=126.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCc----EEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGE----EVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
.++|++.++||+|+||.||+|+.. +++ +||+|.+... .....+++.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999864 344 3578877643 3456788999999999999999999999998754 78
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998542 345889999999999999999999997 999999999999999999999999999987
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
....
T Consensus 168 ~~~~ 171 (327)
T 3lzb_A 168 GAEE 171 (327)
T ss_dssp ----
T ss_pred cCcc
Confidence 5443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-24 Score=228.97 Aligned_cols=148 Identities=26% Similarity=0.343 Sum_probs=133.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.++||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999875 58999999997642 3345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc-CCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY-SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
|+++++|.+++.. ...+++..+..++.+++.||+|||+. + |+||||||+|||++.++.+||+|||+|+.+
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999943 34688999999999999999999986 6 999999999999999999999999999765
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.1e-24 Score=221.05 Aligned_cols=148 Identities=28% Similarity=0.429 Sum_probs=125.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEE-----------
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCI----------- 574 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~----------- 574 (675)
.++|++.++||+|+||.||+|+... ++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4789999999999999999998764 8999999998666666788999999999999999999999873
Q ss_pred ---eCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc-CCCCeE
Q 005825 575 ---EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD-RDMNPK 650 (675)
Q Consensus 575 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~k 650 (675)
+....++||||++ |+|.+++. ...+++..+..++.|++.||+|||+++ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 69999983 245889999999999999999999987 99999999999997 567999
Q ss_pred EeeeccceecCC
Q 005825 651 ISDFGLARMFGG 662 (675)
Q Consensus 651 l~DFGla~~~~~ 662 (675)
|+|||+++.+..
T Consensus 162 l~Dfg~~~~~~~ 173 (320)
T 2i6l_A 162 IGDFGLARIMDP 173 (320)
T ss_dssp ECCCTTCBCC--
T ss_pred EccCccccccCC
Confidence 999999998753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-24 Score=231.20 Aligned_cols=151 Identities=30% Similarity=0.525 Sum_probs=123.4
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC----CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEe-CCeEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIE-QGEKIL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~-~~~~~l 581 (675)
..|.+.++||+|+||.||+|+..+ +..||||.++... ....++|.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 357788999999999999998642 2468999987532 3456789999999999999999999999765 457899
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++|+|.+++... ...+++.+++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 169 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999999542 345788999999999999999999997 9999999999999999999999999998774
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 244 ~~ 245 (373)
T 3c1x_A 244 DK 245 (373)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-24 Score=225.60 Aligned_cols=153 Identities=34% Similarity=0.520 Sum_probs=130.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEE------cCCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL------LNGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~------~~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
.++|++.+.||+|+||.||+|+. .+++.||||.+... ......++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999984 34778999999753 334456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---CCCeEEe
Q 005825 580 ILILEYMPNKSLDVFLFDPT----KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKIS 652 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~ 652 (675)
++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999996432 1245889999999999999999999987 999999999999984 4569999
Q ss_pred eeccceecCC
Q 005825 653 DFGLARMFGG 662 (675)
Q Consensus 653 DFGla~~~~~ 662 (675)
|||+++.+..
T Consensus 186 Dfg~~~~~~~ 195 (327)
T 2yfx_A 186 DFGMARDIYR 195 (327)
T ss_dssp CCHHHHHHHC
T ss_pred cccccccccc
Confidence 9999986643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.3e-24 Score=223.95 Aligned_cols=155 Identities=30% Similarity=0.481 Sum_probs=134.2
Q ss_pred HHHhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEe-----
Q 005825 503 VAAATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIE----- 575 (675)
Q Consensus 503 ~~~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~----- 575 (675)
+....++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 344678999999999999999999987 46899999998753 34457899999999999 79999999999987
Q ss_pred -CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeee
Q 005825 576 -QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDF 654 (675)
Q Consensus 576 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 654 (675)
.+..++||||+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeC
Confidence 46789999999999999998543 2356889999999999999999999997 999999999999999999999999
Q ss_pred ccceecCC
Q 005825 655 GLARMFGG 662 (675)
Q Consensus 655 Gla~~~~~ 662 (675)
|+++.+..
T Consensus 174 g~~~~~~~ 181 (326)
T 2x7f_A 174 GVSAQLDR 181 (326)
T ss_dssp TTTC----
T ss_pred cCceecCc
Confidence 99987753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.1e-24 Score=218.67 Aligned_cols=150 Identities=32% Similarity=0.503 Sum_probs=130.8
Q ss_pred cCCcceee-eeCCcCceeEEEEEEc---CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 507 TENFSMEC-KLGEGGFGPVYKGRLL---NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 507 ~~~f~~~~-~IG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
.++|.+.+ .||+|+||.||+|.+. .++.||||+++... ....+++.+|+.++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788888 9999999999999652 36889999997543 22357899999999999999999999999 667889
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999953 345889999999999999999999997 999999999999999999999999999987
Q ss_pred CCC
Q 005825 661 GGD 663 (675)
Q Consensus 661 ~~~ 663 (675)
...
T Consensus 168 ~~~ 170 (291)
T 1xbb_A 168 RAD 170 (291)
T ss_dssp CTT
T ss_pred ccC
Confidence 544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-24 Score=221.04 Aligned_cols=151 Identities=31% Similarity=0.457 Sum_probs=130.5
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC----CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE-EE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK-IL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~-~l 581 (675)
-.|...++||+|+||.||+|+..+ +..||+|.++... ....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 356667999999999999998643 2379999997543 23457899999999999999999999999877665 99
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+.+++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999964 2346789999999999999999999997 9999999999999999999999999998764
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 176 ~~ 177 (298)
T 3pls_A 176 DR 177 (298)
T ss_dssp TG
T ss_pred CC
Confidence 43
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=4.8e-24 Score=228.70 Aligned_cols=148 Identities=28% Similarity=0.422 Sum_probs=124.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG------ 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~------ 577 (675)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .....+++.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 47899999999999999999987 46899999999653 2233567889999999999999999999997653
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8899999843 35889999999999999999999998 999999999999999999999999999
Q ss_pred eecCC
Q 005825 658 RMFGG 662 (675)
Q Consensus 658 ~~~~~ 662 (675)
+....
T Consensus 176 ~~~~~ 180 (367)
T 1cm8_A 176 RQADS 180 (367)
T ss_dssp EECCS
T ss_pred ccccc
Confidence 98754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=5.7e-24 Score=220.81 Aligned_cols=153 Identities=31% Similarity=0.533 Sum_probs=131.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC----CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEe-CCeE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIE-QGEK 579 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~-~~~~ 579 (675)
....|++.++||+|+||.||+|+..+ ...+|+|.++... ....+.+.+|+.++++++||||+++++++.+ .+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34578899999999999999998643 2368999987533 3345789999999999999999999999754 4578
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++++|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999954 2345789999999999999999999997 99999999999999999999999999997
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
+...
T Consensus 178 ~~~~ 181 (298)
T 3f66_A 178 MYDK 181 (298)
T ss_dssp CSCG
T ss_pred cccc
Confidence 7543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.6e-24 Score=220.84 Aligned_cols=154 Identities=27% Similarity=0.452 Sum_probs=127.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999986 468999999997532 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 583 LEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
|||+++++|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998532 12346889999999999999999999987 9999999999999999999999999998775
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 188 ~~ 189 (310)
T 2wqm_A 188 SK 189 (310)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=221.19 Aligned_cols=151 Identities=26% Similarity=0.358 Sum_probs=128.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--------ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--------GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ 576 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--------~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~ 576 (675)
..++|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3468999999999999999999875 58899999987532 12234688999999999999999999998765
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC---eEEee
Q 005825 577 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN---PKISD 653 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~D 653 (675)
+ .++||||+++++|.+++. ....+++.....++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999984 3456899999999999999999999987 999999999999987654 99999
Q ss_pred eccceecCCC
Q 005825 654 FGLARMFGGD 663 (675)
Q Consensus 654 FGla~~~~~~ 663 (675)
||+++.+...
T Consensus 161 fg~~~~~~~~ 170 (322)
T 2ycf_A 161 FGHSKILGET 170 (322)
T ss_dssp CTTCEECCCC
T ss_pred Cccceecccc
Confidence 9999987543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-24 Score=234.43 Aligned_cols=152 Identities=16% Similarity=0.233 Sum_probs=125.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHH---HHHHhcCCCceeeEE-------EE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEM---LLIAKLQHRNLVRIL-------GC 572 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~---~il~~l~H~nIv~l~-------g~ 572 (675)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+ .++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999986 56899999999743 334457899999 555666899999998 66
Q ss_pred EEeCCe-----------------EEEEEEecCCCCHHHHhcCCC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 005825 573 CIEQGE-----------------KILILEYMPNKSLDVFLFDPT----KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRI 631 (675)
Q Consensus 573 ~~~~~~-----------------~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 631 (675)
+...+. .++||||+ +|+|.+++.... ....+++..++.|+.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 689999985321 1223446888899999999999999997 9
Q ss_pred EecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 632 IHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 632 iHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+||||||+|||++.++.+||+|||+|+..+.
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 258 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC
Confidence 9999999999999999999999999997543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.8e-24 Score=222.90 Aligned_cols=149 Identities=34% Similarity=0.544 Sum_probs=123.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHH--HHhcCCCceeeEEEEEEe-----CCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLL--IAKLQHRNLVRILGCCIE-----QGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~i--l~~l~H~nIv~l~g~~~~-----~~~~ 579 (675)
.++|++.++||+|+||.||+|+. +++.||||+++.. ....+..|..+ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 47899999999999999999977 6899999999743 23445555555 445899999999986643 2257
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcC------CCceEecCCCCCCEEEcCCCCeEEee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS------RFRIIHRDLKASNVLLDRDMNPKISD 653 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiHrDlkp~NILl~~~~~~kl~D 653 (675)
++||||+++|+|.+++.. ...++..+..|+.||++||+|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 899999999999999943 23588999999999999999999881 11399999999999999999999999
Q ss_pred eccceecCCC
Q 005825 654 FGLARMFGGD 663 (675)
Q Consensus 654 FGla~~~~~~ 663 (675)
||+|+.+...
T Consensus 164 FG~a~~~~~~ 173 (336)
T 3g2f_A 164 FGLSMRLTGN 173 (336)
T ss_dssp CTTCEECSSS
T ss_pred ccceeecccc
Confidence 9999987543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=216.23 Aligned_cols=144 Identities=13% Similarity=0.076 Sum_probs=127.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.++||+|+||.||+|+... ++.||||.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3689999999999999999998754 89999999986432 2347899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
|||+++++|.+++.. . ....+...|+.||+.||+|||+++ |+||||||+|||+++++.+||+++|...
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence 999999999999932 1 245567889999999999999998 9999999999999999999999877543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=222.04 Aligned_cols=150 Identities=34% Similarity=0.586 Sum_probs=130.5
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcE--EEEEEecCc-CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEE--VAVKRLSSQ-SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~--vAvK~l~~~-~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV 582 (675)
++|++.+.||+|+||.||+|+.. ++.. +|||.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999864 4654 499998753 334556799999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCe
Q 005825 583 LEYMPNKSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP 649 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 649 (675)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 2346899999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceec
Q 005825 650 KISDFGLARMF 660 (675)
Q Consensus 650 kl~DFGla~~~ 660 (675)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999854
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=220.73 Aligned_cols=150 Identities=29% Similarity=0.424 Sum_probs=132.7
Q ss_pred HHHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHh--cCCCceeeEEEEEEeCC---
Q 005825 503 VAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAK--LQHRNLVRILGCCIEQG--- 577 (675)
Q Consensus 503 ~~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~--l~H~nIv~l~g~~~~~~--- 577 (675)
.....++|.+.+.||+|+||.||+|+. +++.||||++... ..+.+..|++++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344567999999999999999999988 5899999999642 34678889998887 78999999999998876
Q ss_pred -eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHH--------hcCCCceEecCCCCCCEEEcCCCC
Q 005825 578 -EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH--------HYSRFRIIHRDLKASNVLLDRDMN 648 (675)
Q Consensus 578 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiHrDlkp~NILl~~~~~ 648 (675)
..++||||+++|+|.+++.. ..+++.+++.++.|++.||+||| +.+ |+||||||+|||+++++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCC
Confidence 78999999999999999943 35889999999999999999999 555 999999999999999999
Q ss_pred eEEeeeccceecCCC
Q 005825 649 PKISDFGLARMFGGD 663 (675)
Q Consensus 649 ~kl~DFGla~~~~~~ 663 (675)
+||+|||+|+.+...
T Consensus 186 ~kL~Dfg~~~~~~~~ 200 (342)
T 1b6c_B 186 CCIADLGLAVRHDSA 200 (342)
T ss_dssp EEECCCTTCEEEETT
T ss_pred EEEEECCCceecccc
Confidence 999999999887554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-24 Score=222.60 Aligned_cols=155 Identities=25% Similarity=0.415 Sum_probs=121.1
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
...++|++.+.||+|+||.||+|+. .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 4468999999999999999999986 468899999987532 34457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcC-----CCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 583 LEYMPNKSLDVFLFD-----PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
|||+++++|.+++.. ......+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999853 112456899999999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 005825 658 RMFGG 662 (675)
Q Consensus 658 ~~~~~ 662 (675)
+.+..
T Consensus 169 ~~~~~ 173 (303)
T 2vwi_A 169 AFLAT 173 (303)
T ss_dssp HHCC-
T ss_pred heecc
Confidence 87643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.1e-24 Score=224.85 Aligned_cols=150 Identities=18% Similarity=0.294 Sum_probs=124.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc----CCcEEEEEEecCcCcc-----------CHHHHHHHHHHHHhcCCCceeeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLSSQSGQ-----------GLEEFKNEMLLIAKLQHRNLVRILG 571 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~~~-----------~~~~f~~E~~il~~l~H~nIv~l~g 571 (675)
.++|++.++||+|+||.||+|+.. .+..+|||++...... ..+.+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999875 5778999998754321 1234677888999999999999999
Q ss_pred EEEe----CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC
Q 005825 572 CCIE----QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM 647 (675)
Q Consensus 572 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 647 (675)
++.. ....++||||+ +++|.+++.. ...+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 9999999843 337899999999999999999999987 99999999999999887
Q ss_pred --CeEEeeeccceecCCC
Q 005825 648 --NPKISDFGLARMFGGD 663 (675)
Q Consensus 648 --~~kl~DFGla~~~~~~ 663 (675)
.+||+|||+|+.+...
T Consensus 189 ~~~~kL~Dfg~a~~~~~~ 206 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPN 206 (345)
T ss_dssp TTSEEECCCTTCEESSGG
T ss_pred CCcEEEEeCCCceecccc
Confidence 9999999999987543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-24 Score=244.27 Aligned_cols=144 Identities=33% Similarity=0.502 Sum_probs=126.3
Q ss_pred eeeCCcCceeEEEEEEc---CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLL---NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
++||+|+||.||+|.+. .++.||||+++... ....++|.+|+.++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 46789999998643 334678999999999999999999999986 4568899999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|+|.+++. ....+++..+..|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..++
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 99999994 3456899999999999999999999997 9999999999999999999999999999875543
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=216.93 Aligned_cols=150 Identities=32% Similarity=0.507 Sum_probs=130.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 68999999999999999999875 68999999987532 2345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|++ ++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~-~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 998 6999988543 2245788999999999999999999997 99999999999999999999999999987753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=225.26 Aligned_cols=153 Identities=24% Similarity=0.375 Sum_probs=125.9
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC------
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ------ 576 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~------ 576 (675)
....++|++.++||+|+||.||+|+. .+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34568999999999999999999986 5689999999875322 234699999999999999999998543
Q ss_pred --------------------------------CeEEEEEEecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHH
Q 005825 577 --------------------------------GEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYL 623 (675)
Q Consensus 577 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yL 623 (675)
...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 5777776431 2345689999999999999999999
Q ss_pred HhcCCCceEecCCCCCCEEEc-CCCCeEEeeeccceecCCCc
Q 005825 624 HHYSRFRIIHRDLKASNVLLD-RDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 624 H~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~ 664 (675)
|+++ |+||||||+|||++ +++.+||+|||+|+.+...+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 9987 99999999999998 68899999999999875443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=223.70 Aligned_cols=149 Identities=28% Similarity=0.398 Sum_probs=131.1
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----CeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ-----GEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~-----~~~ 579 (675)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999864 58899999997533 23346789999999999999999999999765 368
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||++ ++|.+++.. ..+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 589888842 35889999999999999999999998 99999999999999999999999999998
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
....
T Consensus 178 ~~~~ 181 (364)
T 3qyz_A 178 ADPD 181 (364)
T ss_dssp CCGG
T ss_pred cCCC
Confidence 7544
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=227.74 Aligned_cols=151 Identities=26% Similarity=0.411 Sum_probs=125.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe------EE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE------KI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~------~~ 580 (675)
..+|++.++||+|+||.||+|+...+..||+|++..... ...+|+.+++.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999987777799998865322 22369999999999999999999965443 78
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc-CCCCeEEeeecccee
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD-RDMNPKISDFGLARM 659 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~ 659 (675)
+||||++++.+............+++..+..++.||++||+|||+++ |+||||||+|||++ +++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988655544322223456889999999999999999999987 99999999999999 799999999999998
Q ss_pred cCCCc
Q 005825 660 FGGDE 664 (675)
Q Consensus 660 ~~~~~ 664 (675)
+...+
T Consensus 192 ~~~~~ 196 (394)
T 4e7w_A 192 LIAGE 196 (394)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 75443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.2e-23 Score=213.91 Aligned_cols=151 Identities=30% Similarity=0.576 Sum_probs=130.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCcc-------CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQ-------GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-------~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~ 578 (675)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999874 6899999998653322 1267899999999999999999999987655
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC-----eEEee
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN-----PKISD 653 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~D 653 (675)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6999999999998888543 346899999999999999999999874 34999999999999988776 99999
Q ss_pred eccceecCC
Q 005825 654 FGLARMFGG 662 (675)
Q Consensus 654 FGla~~~~~ 662 (675)
||+|+....
T Consensus 173 fg~~~~~~~ 181 (287)
T 4f0f_A 173 FGLSQQSVH 181 (287)
T ss_dssp CTTCBCCSS
T ss_pred CCccccccc
Confidence 999986543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=214.51 Aligned_cols=153 Identities=25% Similarity=0.406 Sum_probs=133.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ--GEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~--~~~~lV 582 (675)
.++|++.++||+|+||.||+|+.. ++.||||+++... ....++|.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 367899999999999999999984 8899999997542 33456799999999999999999999999887 678999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++++|.+++... ....+++..+..++.|++.||+|||+++ .+|+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999999653 2335899999999999999999999864 3599999999999999999999999998876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=215.50 Aligned_cols=152 Identities=29% Similarity=0.432 Sum_probs=130.8
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE----QGEKI 580 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~----~~~~~ 580 (675)
..|.+.++||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788899999999999999874 5889999998753 23345679999999999999999999999875 34689
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc-CCCCeEEeeecccee
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD-RDMNPKISDFGLARM 659 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~ 659 (675)
+||||+++++|.+++. ....+++..+..++.||+.||+|||+++ .+|+||||||+|||++ +++.+||+|||+++.
T Consensus 106 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999994 3356889999999999999999999874 3599999999999997 789999999999986
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
....
T Consensus 182 ~~~~ 185 (290)
T 1t4h_A 182 KRAS 185 (290)
T ss_dssp CCTT
T ss_pred cccc
Confidence 6443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.6e-24 Score=222.91 Aligned_cols=155 Identities=29% Similarity=0.385 Sum_probs=133.6
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEe--------
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIE-------- 575 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~-------- 575 (675)
...+|++.++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3468999999999999999999874 68999999997655556678999999999996 9999999999953
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
....++||||++ |+|.+++........+++.++..|+.||+.||+|||+++ .+|+||||||+|||+++++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 335799999996 789888854334456899999999999999999999874 349999999999999999999999999
Q ss_pred cceecCC
Q 005825 656 LARMFGG 662 (675)
Q Consensus 656 la~~~~~ 662 (675)
+++.+..
T Consensus 184 ~~~~~~~ 190 (337)
T 3ll6_A 184 SATTISH 190 (337)
T ss_dssp TCBCCSS
T ss_pred cceeccc
Confidence 9998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-24 Score=242.23 Aligned_cols=141 Identities=18% Similarity=0.221 Sum_probs=111.2
Q ss_pred eeCCcCceeEEEEE-EcCCcEEEEEEecCcC----------ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEE
Q 005825 515 KLGEGGFGPVYKGR-LLNGEEVAVKRLSSQS----------GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 515 ~IG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~----------~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV 582 (675)
..+.|++|.+..++ .--|+.+|||.+.+.. ....++|.+|+++|+++ +|+||+++++++.+.+..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777776653 3358889999987531 22346799999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||++|++|.++|.+ .+.++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+.+..
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999954 3455553 48899999999999998 99999999999999999999999999998865
Q ss_pred Cc
Q 005825 663 DE 664 (675)
Q Consensus 663 ~~ 664 (675)
+.
T Consensus 392 ~~ 393 (569)
T 4azs_A 392 DC 393 (569)
T ss_dssp --
T ss_pred CC
Confidence 44
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9e-24 Score=217.01 Aligned_cols=157 Identities=28% Similarity=0.447 Sum_probs=131.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIE--QGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~--~~~~~l 581 (675)
.++|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999875 68999999997532 2345679999999999999999999998864 568999
Q ss_pred EEEecCCCCHHHHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhcC--CCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 582 ILEYMPNKSLDVFLFDPT-KKRLLGWQARIGIIEGIAQGLLYLHHYS--RFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||+++++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999985421 2335899999999999999999999875 2349999999999999999999999999998
Q ss_pred ecCCC
Q 005825 659 MFGGD 663 (675)
Q Consensus 659 ~~~~~ 663 (675)
.+...
T Consensus 165 ~~~~~ 169 (279)
T 2w5a_A 165 ILNHD 169 (279)
T ss_dssp HC---
T ss_pred eeccc
Confidence 77543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=216.73 Aligned_cols=152 Identities=30% Similarity=0.458 Sum_probs=130.4
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC----CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
..++|.+.+.||+|+||.||+|+..+ +..||||.++... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34789999999999999999998643 3469999998642 3346789999999999999999999999765 4568
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999953 2345889999999999999999999987 999999999999999999999999999877
Q ss_pred CCC
Q 005825 661 GGD 663 (675)
Q Consensus 661 ~~~ 663 (675)
...
T Consensus 164 ~~~ 166 (281)
T 3cc6_A 164 EDE 166 (281)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=223.88 Aligned_cols=148 Identities=28% Similarity=0.381 Sum_probs=124.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG------ 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~------ 577 (675)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999864 5889999999753 2234567889999999999999999999997665
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
..++||||+++ +|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 6877773 24788999999999999999999997 999999999999999999999999999
Q ss_pred eecCCC
Q 005825 658 RMFGGD 663 (675)
Q Consensus 658 ~~~~~~ 663 (675)
+.....
T Consensus 175 ~~~~~~ 180 (371)
T 2xrw_A 175 RTAGTS 180 (371)
T ss_dssp ------
T ss_pred cccccc
Confidence 877543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=216.59 Aligned_cols=149 Identities=32% Similarity=0.539 Sum_probs=125.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC-CeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ-GEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~-~~~~lV~Ey 585 (675)
.++|++.+.||+|+||.||+++. .++.||||.++.. ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46899999999999999999987 4889999999753 3557899999999999999999999997655 468999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+++++|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999998532 1234788999999999999999999987 99999999999999999999999999987644
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=220.48 Aligned_cols=148 Identities=28% Similarity=0.426 Sum_probs=130.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----CeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ-----GEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~-----~~~ 579 (675)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999875 58999999997532 23456788999999999999999999998764 678
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 689988843 45889999999999999999999987 99999999999999999999999999998
Q ss_pred cCC
Q 005825 660 FGG 662 (675)
Q Consensus 660 ~~~ 662 (675)
+..
T Consensus 162 ~~~ 164 (353)
T 2b9h_A 162 IDE 164 (353)
T ss_dssp CC-
T ss_pred ccc
Confidence 754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.6e-23 Score=213.74 Aligned_cols=148 Identities=24% Similarity=0.339 Sum_probs=128.5
Q ss_pred cCCccee-eeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHH-HhcCCCceeeEEEEEEe----CCeE
Q 005825 507 TENFSME-CKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLI-AKLQHRNLVRILGCCIE----QGEK 579 (675)
Q Consensus 507 ~~~f~~~-~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il-~~l~H~nIv~l~g~~~~----~~~~ 579 (675)
.++|.+. +.||+|+||.||+++. .+++.||||+++. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3677777 7799999999999987 4689999999964 25677888887 56689999999999987 6678
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---CCCeEEeeecc
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDFGL 656 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGl 656 (675)
++||||+++++|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999642 2346899999999999999999999987 999999999999998 78999999999
Q ss_pred ceecCCC
Q 005825 657 ARMFGGD 663 (675)
Q Consensus 657 a~~~~~~ 663 (675)
|+.+.+.
T Consensus 167 a~~~~~~ 173 (299)
T 3m2w_A 167 AKETTGE 173 (299)
T ss_dssp CEECTTC
T ss_pred ccccccc
Confidence 9987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=227.87 Aligned_cols=148 Identities=29% Similarity=0.440 Sum_probs=122.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC----C--eEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ----G--EKI 580 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~----~--~~~ 580 (675)
..|++.++||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999885 58999999987532 2234699999999999999999998642 2 367
Q ss_pred EEEEecCCCCHHHHhcC-CCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC-CCeEEeeeccce
Q 005825 581 LILEYMPNKSLDVFLFD-PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD-MNPKISDFGLAR 658 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~ 658 (675)
+||||+++ +|...+.. ......+++..+..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 55555432 123456899999999999999999999987 9999999999999965 568999999999
Q ss_pred ecCCC
Q 005825 659 MFGGD 663 (675)
Q Consensus 659 ~~~~~ 663 (675)
.+...
T Consensus 206 ~~~~~ 210 (420)
T 1j1b_A 206 QLVRG 210 (420)
T ss_dssp ECCTT
T ss_pred hcccC
Confidence 87544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=242.37 Aligned_cols=148 Identities=22% Similarity=0.338 Sum_probs=128.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc--CCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-----
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL--NGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE----- 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~--~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~----- 578 (675)
.++|++.++||+|+||.||+++.. +++.||||++... .....+.+..|+.++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999875 5899999998753 23345678999999999999999999999987665
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.+|||||+++++|.+++.. .+++.+++.|+.||+.||.|||+++ |+||||||+|||++++ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999887632 5899999999999999999999998 9999999999999986 99999999999
Q ss_pred ecCCC
Q 005825 659 MFGGD 663 (675)
Q Consensus 659 ~~~~~ 663 (675)
.+...
T Consensus 230 ~~~~~ 234 (681)
T 2pzi_A 230 RINSF 234 (681)
T ss_dssp ETTCC
T ss_pred hcccC
Confidence 87543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=217.03 Aligned_cols=153 Identities=28% Similarity=0.367 Sum_probs=121.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCc-c-CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSG-Q-GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~-~-~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.++|++.++||+|+||.||+++. .+++.||||+++.... . ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 47899999999999999999987 4689999999975422 2 2234455556688889999999999999999999999
Q ss_pred EecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhc-CCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 584 EYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHY-SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||++ ++|.+++... .....+++..+..++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9998 4887776431 2345689999999999999999999997 7 9999999999999999999999999998775
Q ss_pred CC
Q 005825 662 GD 663 (675)
Q Consensus 662 ~~ 663 (675)
..
T Consensus 162 ~~ 163 (290)
T 3fme_A 162 DD 163 (290)
T ss_dssp --
T ss_pred cc
Confidence 44
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-23 Score=225.73 Aligned_cols=148 Identities=31% Similarity=0.413 Sum_probs=116.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC------C
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ------G 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~------~ 577 (675)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999986 46899999999753 223456788999999999999999999999754 5
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 7899888742 45899999999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 005825 658 RMFGG 662 (675)
Q Consensus 658 ~~~~~ 662 (675)
+....
T Consensus 180 ~~~~~ 184 (367)
T 2fst_X 180 RHTAD 184 (367)
T ss_dssp -----
T ss_pred ccccc
Confidence 87653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=216.01 Aligned_cols=151 Identities=32% Similarity=0.452 Sum_probs=124.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc--CCc--EEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL--NGE--EVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~--~g~--~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
.++|++.++||+|+||.||+|+.. +++ .||||.++.. .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 468999999999999999999853 233 6899998754 2334678999999999999999999999998754 8
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998532 345889999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
+...
T Consensus 171 ~~~~ 174 (291)
T 1u46_A 171 LPQN 174 (291)
T ss_dssp CCC-
T ss_pred cccc
Confidence 7544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-23 Score=221.25 Aligned_cols=159 Identities=25% Similarity=0.313 Sum_probs=120.6
Q ss_pred HHHHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe--
Q 005825 502 SVAAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE-- 578 (675)
Q Consensus 502 ~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~-- 578 (675)
......++|++.++||+|+||.||+|+.. +++.||||++... ......+..|+..++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34566789999999999999999999874 5899999998653 3334567788899999999999999999976443
Q ss_pred -----EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHH--hcCCCceEecCCCCCCEEEcC-CCCeE
Q 005825 579 -----KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH--HYSRFRIIHRDLKASNVLLDR-DMNPK 650 (675)
Q Consensus 579 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~iiHrDlkp~NILl~~-~~~~k 650 (675)
.++||||++++.+..+.........+++..+..++.|++.||.||| +++ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987533322211134556888999999999999999999 776 999999999999997 89999
Q ss_pred EeeeccceecCCCc
Q 005825 651 ISDFGLARMFGGDE 664 (675)
Q Consensus 651 l~DFGla~~~~~~~ 664 (675)
|+|||+|+.+....
T Consensus 173 l~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE 186 (360)
T ss_dssp ECCCTTCBCCCTTS
T ss_pred EeeCCCceecCCCC
Confidence 99999999876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-23 Score=224.70 Aligned_cols=147 Identities=16% Similarity=0.262 Sum_probs=128.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC---------CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceee---------
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN---------GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVR--------- 568 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~--------- 568 (675)
.++|++.+.||+|+||.||+|+... ++.||||.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999998753 789999998753 46889999999999999987
Q ss_pred ------EEEEEEe-CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCE
Q 005825 569 ------ILGCCIE-QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNV 641 (675)
Q Consensus 569 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NI 641 (675)
+++++.. .+..++||||+ +++|.+++... ....+++.+++.|+.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6788876 67889999999 99999999542 2356899999999999999999999997 99999999999
Q ss_pred EEcCCC--CeEEeeeccceecCCC
Q 005825 642 LLDRDM--NPKISDFGLARMFGGD 663 (675)
Q Consensus 642 Ll~~~~--~~kl~DFGla~~~~~~ 663 (675)
|++.++ .+||+|||+|+.+...
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGG
T ss_pred EEcCCCCceEEEecCcceeeccCC
Confidence 999998 9999999999887543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-23 Score=212.58 Aligned_cols=154 Identities=27% Similarity=0.466 Sum_probs=135.7
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
....++|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344578999999999999999999875 6899999998653 2345678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC---CCeEEeeeccc
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD---MNPKISDFGLA 657 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla 657 (675)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999988843 346889999999999999999999987 9999999999999764 47999999999
Q ss_pred eecCCC
Q 005825 658 RMFGGD 663 (675)
Q Consensus 658 ~~~~~~ 663 (675)
+.+...
T Consensus 172 ~~~~~~ 177 (287)
T 2wei_A 172 TCFQQN 177 (287)
T ss_dssp GTBCCC
T ss_pred eeecCC
Confidence 877543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=217.54 Aligned_cols=153 Identities=24% Similarity=0.359 Sum_probs=131.5
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcC--CCceeeEEEEEEeCCeE
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQ--HRNLVRILGCCIEQGEK 579 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~--H~nIv~l~g~~~~~~~~ 579 (675)
....++|++.+.||+|+||.||+++..+++.||||.+.... ....+.+.+|+.++.+++ ||||+++++++.+.+..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 34557899999999999999999998889999999987532 334578999999999997 59999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||| +.+++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||+++ +.+||+|||+++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccc
Confidence 99999 678999999853 346889999999999999999999987 999999999999975 8999999999998
Q ss_pred cCCCc
Q 005825 660 FGGDE 664 (675)
Q Consensus 660 ~~~~~ 664 (675)
+....
T Consensus 176 ~~~~~ 180 (313)
T 3cek_A 176 MQPDT 180 (313)
T ss_dssp -----
T ss_pred ccCcc
Confidence 75443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.89 E-value=6.7e-23 Score=212.10 Aligned_cols=151 Identities=24% Similarity=0.404 Sum_probs=126.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEE-EeCCeEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC-IEQGEKILIL 583 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~-~~~~~~~lV~ 583 (675)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ..+++..|+.++.+++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 568999999876432 234688999999999988877666655 6677889999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE---cCCCCeEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~ 660 (675)
||+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+|+.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998532 345899999999999999999999998 9999999999999 78999999999999988
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
....
T Consensus 159 ~~~~ 162 (296)
T 4hgt_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cCcc
Confidence 6543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=224.15 Aligned_cols=151 Identities=14% Similarity=0.161 Sum_probs=114.1
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc---cCHHHHHHHHHHHHhc--CCCceeeEE-------EEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKL--QHRNLVRIL-------GCC 573 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l--~H~nIv~l~-------g~~ 573 (675)
...|++.++||+|+||.||+|+.. +++.||||+++.... ...+.+++|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346899999999999999999875 689999999986432 3355678885544444 699988865 454
Q ss_pred EeC-----------------CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHH------HHHHHHHHHHHHHHHhcCCCc
Q 005825 574 IEQ-----------------GEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR------IGIIEGIAQGLLYLHHYSRFR 630 (675)
Q Consensus 574 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~ 630 (675)
... ...++||||++ ++|.+++... ...+.+..+ ..++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 33799999999 8999999542 223455556 788899999999999998
Q ss_pred eEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 631 IIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 631 iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
|+||||||+|||+++++.+||+|||+|+..+..
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~ 247 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence 999999999999999999999999999987543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.89 E-value=5.5e-23 Score=216.09 Aligned_cols=152 Identities=28% Similarity=0.479 Sum_probs=129.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE--cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhc---CCCceeeEEEEEE----
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL--LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKL---QHRNLVRILGCCI---- 574 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~--~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l---~H~nIv~l~g~~~---- 574 (675)
..++|++.+.||+|+||.||+|+. .+++.||||+++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 358899999987432 22234677788777766 8999999999997
Q ss_pred -eCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEee
Q 005825 575 -EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISD 653 (675)
Q Consensus 575 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 653 (675)
.....++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 69999985432 334889999999999999999999997 99999999999999999999999
Q ss_pred eccceecCC
Q 005825 654 FGLARMFGG 662 (675)
Q Consensus 654 FGla~~~~~ 662 (675)
||+++.+..
T Consensus 164 fg~~~~~~~ 172 (326)
T 1blx_A 164 FGLARIYSF 172 (326)
T ss_dssp CCSCCCCCG
T ss_pred CcccccccC
Confidence 999987753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=210.00 Aligned_cols=151 Identities=24% Similarity=0.405 Sum_probs=129.5
Q ss_pred hcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEE-EeCCeEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCC-IEQGEKILIL 583 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~-~~~~~~~lV~ 583 (675)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+.++++++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999986 568999999987533 335789999999999988866655555 6677889999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE---cCCCCeEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~ 660 (675)
||+ +++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+|+.+
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 9999999853 2345899999999999999999999997 9999999999999 58899999999999988
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
....
T Consensus 159 ~~~~ 162 (296)
T 3uzp_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cccc
Confidence 6543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-23 Score=217.23 Aligned_cols=155 Identities=26% Similarity=0.414 Sum_probs=125.9
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCc------cCHHHHHHHHHHHHhc----CCCceeeEEEE
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSG------QGLEEFKNEMLLIAKL----QHRNLVRILGC 572 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~f~~E~~il~~l----~H~nIv~l~g~ 572 (675)
....++|++.++||+|+||.||+|+. .+++.||||+++.... .....+..|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34567899999999999999999986 4688999999975432 1234566799999998 89999999999
Q ss_pred EEeCCeEEEEEEe-cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc-CCCCeE
Q 005825 573 CIEQGEKILILEY-MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD-RDMNPK 650 (675)
Q Consensus 573 ~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~k 650 (675)
+.+.+..++|||| +++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++ +++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 899999999943 346899999999999999999999997 99999999999999 889999
Q ss_pred EeeeccceecCCCc
Q 005825 651 ISDFGLARMFGGDE 664 (675)
Q Consensus 651 l~DFGla~~~~~~~ 664 (675)
|+|||+++.+....
T Consensus 181 l~dfg~~~~~~~~~ 194 (312)
T 2iwi_A 181 LIDFGSGALLHDEP 194 (312)
T ss_dssp ECCCSSCEECCSSC
T ss_pred EEEcchhhhcccCc
Confidence 99999999886543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-22 Score=221.36 Aligned_cols=151 Identities=23% Similarity=0.257 Sum_probs=130.3
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhc------CCCceeeEEEEEEeCCe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL------QHRNLVRILGCCIEQGE 578 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l------~H~nIv~l~g~~~~~~~ 578 (675)
...+|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+..|+.++..+ .|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3468999999999999999999875 4899999999753 33446778888888877 57799999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC--eEEeeecc
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN--PKISDFGL 656 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFGl 656 (675)
.++||||++ ++|.+++... ....+++..+..|+.||+.||+|||+++ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 6898888543 2234899999999999999999999997 999999999999999887 99999999
Q ss_pred ceecCC
Q 005825 657 ARMFGG 662 (675)
Q Consensus 657 a~~~~~ 662 (675)
|+....
T Consensus 249 a~~~~~ 254 (429)
T 3kvw_A 249 SCYEHQ 254 (429)
T ss_dssp CEETTC
T ss_pred ceecCC
Confidence 987643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=225.30 Aligned_cols=149 Identities=27% Similarity=0.454 Sum_probs=116.0
Q ss_pred CCcce-eeeeCCcCceeEEEEEEc---CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeEEE
Q 005825 508 ENFSM-ECKLGEGGFGPVYKGRLL---NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE--QGEKIL 581 (675)
Q Consensus 508 ~~f~~-~~~IG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~--~~~~~l 581 (675)
+.|.+ .++||+|+||.||+|+.. +++.||||++... ...+.+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 458999999999999865 4789999999753 234578899999999999999999999965 668999
Q ss_pred EEEecCCCCHHHHhcCC------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE----cCCCCeEE
Q 005825 582 ILEYMPNKSLDVFLFDP------TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL----DRDMNPKI 651 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl 651 (675)
||||+++ +|.+++... .....+++..+..|+.||+.||+|||+++ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 777766421 12235899999999999999999999998 9999999999999 77899999
Q ss_pred eeeccceecCC
Q 005825 652 SDFGLARMFGG 662 (675)
Q Consensus 652 ~DFGla~~~~~ 662 (675)
+|||+|+.+..
T Consensus 174 ~Dfg~a~~~~~ 184 (405)
T 3rgf_A 174 ADMGFARLFNS 184 (405)
T ss_dssp CCTTCCC----
T ss_pred EECCCceecCC
Confidence 99999998754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=7.8e-23 Score=214.92 Aligned_cols=154 Identities=23% Similarity=0.369 Sum_probs=133.9
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCcc------CHHHHHHHHHHHHhcC--CCceeeEEEEEE
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQ------GLEEFKNEMLLIAKLQ--HRNLVRILGCCI 574 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~------~~~~f~~E~~il~~l~--H~nIv~l~g~~~ 574 (675)
....++|++.+.||+|+||.||+|+. .+++.||||.++..... ..+.+..|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999986 46899999999754221 2356788999999996 599999999999
Q ss_pred eCCeEEEEEEecCC-CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc-CCCCeEEe
Q 005825 575 EQGEKILILEYMPN-KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD-RDMNPKIS 652 (675)
Q Consensus 575 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~ 652 (675)
+.+..++|||++.+ ++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 999999843 456889999999999999999999987 99999999999999 78999999
Q ss_pred eeccceecCCC
Q 005825 653 DFGLARMFGGD 663 (675)
Q Consensus 653 DFGla~~~~~~ 663 (675)
|||+++.+...
T Consensus 193 Dfg~~~~~~~~ 203 (320)
T 3a99_A 193 DFGSGALLKDT 203 (320)
T ss_dssp CCTTCEECCSS
T ss_pred eCccccccccc
Confidence 99999987644
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.1e-23 Score=220.25 Aligned_cols=135 Identities=25% Similarity=0.324 Sum_probs=113.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC--------CCceeeEEEEEE---
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ--------HRNLVRILGCCI--- 574 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~--------H~nIv~l~g~~~--- 574 (675)
.++|++.++||+|+||.||+|+. .+++.||||+++.. ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999986 45889999999753 334567889999999985 788999999997
Q ss_pred -eCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc-CCCceEecCCCCCCEEEcCCC
Q 005825 575 -EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY-SRFRIIHRDLKASNVLLDRDM 647 (675)
Q Consensus 575 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~ 647 (675)
+....++||||+ +++|.+++... ....+++..+..|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 455789999999 55555555332 234589999999999999999999998 6 99999999999999775
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=224.33 Aligned_cols=150 Identities=25% Similarity=0.397 Sum_probs=130.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCC-CceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQH-RNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.++||+|+||.||+|+. .+++.||||++.... ..+++..|++++..++| ++|..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999986 568999999887532 23468899999999986 566677777788889999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE---cCCCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL---DRDMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 661 (675)
|+ +++|.+++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||| ++++.+||+|||+|+.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998532 346899999999999999999999997 9999999999999 688999999999999886
Q ss_pred CCc
Q 005825 662 GDE 664 (675)
Q Consensus 662 ~~~ 664 (675)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.88 E-value=6.4e-23 Score=220.21 Aligned_cols=149 Identities=27% Similarity=0.436 Sum_probs=126.9
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE---
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK--- 579 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~--- 579 (675)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3578999999999999999999864 58999999997542 22356788999999999999999999999877654
Q ss_pred ---EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecc
Q 005825 580 ---ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGL 656 (675)
Q Consensus 580 ---~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 656 (675)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 68888772 23889999999999999999999997 99999999999999999999999999
Q ss_pred ceecCCC
Q 005825 657 ARMFGGD 663 (675)
Q Consensus 657 a~~~~~~ 663 (675)
|+.....
T Consensus 191 a~~~~~~ 197 (371)
T 4exu_A 191 ARHADAE 197 (371)
T ss_dssp C------
T ss_pred ccccccC
Confidence 9876543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.8e-23 Score=235.72 Aligned_cols=152 Identities=28% Similarity=0.417 Sum_probs=132.1
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEcC----CcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
..++|++.+.||+|+||.||+|+... +..||||+++... ....+.|.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 45789999999999999999998742 4679999987543 234578999999999999999999999985 46689
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999999532 335889999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 005825 661 GGD 663 (675)
Q Consensus 661 ~~~ 663 (675)
...
T Consensus 542 ~~~ 544 (656)
T 2j0j_A 542 EDS 544 (656)
T ss_dssp CC-
T ss_pred CCC
Confidence 544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-22 Score=212.16 Aligned_cols=150 Identities=23% Similarity=0.328 Sum_probs=130.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEE--cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCc------eeeEEEEEEeCCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL--LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN------LVRILGCCIEQGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~--~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~n------Iv~l~g~~~~~~~ 578 (675)
.++|++.++||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.+++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 35889999999753 334567889999999887654 9999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-------------
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR------------- 645 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~------------- 645 (675)
.++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 89999998543 2235889999999999999999999997 999999999999987
Q ss_pred ------CCCeEEeeeccceecCC
Q 005825 646 ------DMNPKISDFGLARMFGG 662 (675)
Q Consensus 646 ------~~~~kl~DFGla~~~~~ 662 (675)
++.+||+|||+|+....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS
T ss_pred ccccccCCCceEeeCcccccCcc
Confidence 67899999999997654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-23 Score=218.30 Aligned_cols=150 Identities=31% Similarity=0.528 Sum_probs=128.5
Q ss_pred HHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 504 AAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 504 ~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
....++|++.+.||+|+||.||+|+..+ .+|+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3346789999999999999999998753 5999998753 23345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+|+...
T Consensus 107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp ECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999999542 346888999999999999999999997 99999999999998 6799999999988763
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=217.00 Aligned_cols=147 Identities=27% Similarity=0.436 Sum_probs=127.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-----
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGE----- 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~----- 578 (675)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999874 58999999997532 2235678899999999999999999999987654
Q ss_pred -EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 579 -KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 579 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58877762 24889999999999999999999997 999999999999999999999999999
Q ss_pred eecCC
Q 005825 658 RMFGG 662 (675)
Q Consensus 658 ~~~~~ 662 (675)
+....
T Consensus 174 ~~~~~ 178 (353)
T 3coi_A 174 RHADA 178 (353)
T ss_dssp TC---
T ss_pred cCCCC
Confidence 87643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=213.25 Aligned_cols=153 Identities=26% Similarity=0.368 Sum_probs=126.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEML-LIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~-il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.++|++.+.||+|+||.||+|+.. +++.||||+++... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368899999999999999999874 68999999997542 233445666665 777789999999999999999999999
Q ss_pred EecCCCCHHHHhcCC--CCcccCCHHHHHHHHHHHHHHHHHHHhc-CCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 584 EYMPNKSLDVFLFDP--TKKRLLGWQARIGIIEGIAQGLLYLHHY-SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 777776421 1245688999999999999999999998 7 999999999999999999999999999877
Q ss_pred CCC
Q 005825 661 GGD 663 (675)
Q Consensus 661 ~~~ 663 (675)
...
T Consensus 177 ~~~ 179 (327)
T 3aln_A 177 VDS 179 (327)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=221.91 Aligned_cols=150 Identities=28% Similarity=0.329 Sum_probs=121.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEEec
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 455667889999999998776678999999998642 345678999999886 8999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcc----cCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCC-------------CCe
Q 005825 587 PNKSLDVFLFDPTKKR----LLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRD-------------MNP 649 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-------------~~~ 649 (675)
+ |+|.+++....... ...+..++.|+.||+.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999996432211 1123345789999999999999987 9999999999999754 489
Q ss_pred EEeeeccceecCCCc
Q 005825 650 KISDFGLARMFGGDE 664 (675)
Q Consensus 650 kl~DFGla~~~~~~~ 664 (675)
||+|||+|+.+....
T Consensus 168 kL~DFG~a~~~~~~~ 182 (434)
T 2rio_A 168 LISDFGLCKKLDSGQ 182 (434)
T ss_dssp EECCCTTCEECCC--
T ss_pred EEcccccceecCCCC
Confidence 999999999886543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.4e-22 Score=209.46 Aligned_cols=150 Identities=23% Similarity=0.284 Sum_probs=121.9
Q ss_pred hcCCcceee-eeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeE
Q 005825 506 ATENFSMEC-KLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE----QGEK 579 (675)
Q Consensus 506 ~~~~f~~~~-~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~----~~~~ 579 (675)
..++|.+.+ .||+|+||.||+|+.. +++.||||++... .....+....+..+.||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 357899855 6999999999999875 5899999999652 1222223344567799999999999976 4458
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---CCCeEEeeecc
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDFGL 656 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGl 656 (675)
++||||+++|+|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999999643 2346899999999999999999999997 999999999999976 45699999999
Q ss_pred ceecCCC
Q 005825 657 ARMFGGD 663 (675)
Q Consensus 657 a~~~~~~ 663 (675)
|+.....
T Consensus 178 ~~~~~~~ 184 (336)
T 3fhr_A 178 AKETTQN 184 (336)
T ss_dssp CEEC---
T ss_pred ceecccc
Confidence 9877543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=221.33 Aligned_cols=148 Identities=24% Similarity=0.380 Sum_probs=121.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
..+|...++||+|+||+|+.....+++.||||++.... ...+.+|+.+++++ +|||||++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 35688999999999999766656689999999997532 23467899999999 799999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-----CCCeEEeeeccceec
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-----DMNPKISDFGLARMF 660 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DFGla~~~ 660 (675)
++ |+|.+++.... ....+.....++.||+.||+|||+++ |+||||||+|||++. ...+||+|||+|+.+
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 59999986432 22344456789999999999999997 999999999999953 346889999999987
Q ss_pred CCC
Q 005825 661 GGD 663 (675)
Q Consensus 661 ~~~ 663 (675)
...
T Consensus 174 ~~~ 176 (432)
T 3p23_A 174 AVG 176 (432)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.1e-22 Score=209.45 Aligned_cols=151 Identities=23% Similarity=0.356 Sum_probs=116.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc-c-CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG-Q-GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~-~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.++|++.+.||+|+||.||+|+.. +++.||||++..... . ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999875 689999999975422 2 2234455556788889999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc-CCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY-SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+ ++.+..+... ....+++..+..++.|+++||.|||++ + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 5555555422 234688999999999999999999985 6 99999999999999999999999999987644
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
.
T Consensus 178 ~ 178 (318)
T 2dyl_A 178 D 178 (318)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.4e-23 Score=232.38 Aligned_cols=154 Identities=30% Similarity=0.394 Sum_probs=132.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEe------CCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE------QGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~------~~~ 578 (675)
.++|++.++||+|+||.||+|+. .+++.||||+++.. .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 37899999999999999999987 45899999998754 33445679999999999999999999999765 667
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCC---eEEeeec
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMN---PKISDFG 655 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFG 655 (675)
.++||||+++++|.+++........+++..+..|+.+++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976544456888999999999999999999987 999999999999997765 9999999
Q ss_pred cceecCCC
Q 005825 656 LARMFGGD 663 (675)
Q Consensus 656 la~~~~~~ 663 (675)
+|+.+...
T Consensus 170 ~a~~~~~~ 177 (676)
T 3qa8_A 170 YAKELDQG 177 (676)
T ss_dssp CCCBTTSC
T ss_pred cccccccc
Confidence 99987544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-21 Score=210.78 Aligned_cols=154 Identities=25% Similarity=0.344 Sum_probs=129.3
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CC-----ceeeEEEEEEeCCe
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HR-----NLVRILGCCIEQGE 578 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~-----nIv~l~g~~~~~~~ 578 (675)
..++|++.++||+|+||+||+|+.. +++.||||+++.. ....+++..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4579999999999999999999875 5889999999753 334567888999988885 55 49999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc--CCCCeEEeeecc
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD--RDMNPKISDFGL 656 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGl 656 (675)
.++||||++ ++|.+++.... ...+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 59999885432 24588999999999999999999952 22499999999999994 578899999999
Q ss_pred ceecCCC
Q 005825 657 ARMFGGD 663 (675)
Q Consensus 657 a~~~~~~ 663 (675)
|+.+...
T Consensus 208 a~~~~~~ 214 (382)
T 2vx3_A 208 SCQLGQR 214 (382)
T ss_dssp CEETTCC
T ss_pred ceecccc
Confidence 9987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-21 Score=207.87 Aligned_cols=150 Identities=23% Similarity=0.337 Sum_probs=127.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CC-cEEEEEEecCcCccCHHHHHHHHHHHHhcCCCc------eeeEEEEEEeCCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NG-EEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN------LVRILGCCIEQGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g-~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~n------Iv~l~g~~~~~~~ 578 (675)
.++|++.+.||+|+||.||+|+.. ++ +.||||+++.. ....+.+..|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999874 34 78999999753 344567889999999997766 9999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE---------------
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL--------------- 643 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl--------------- 643 (675)
.++||||+ +++|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 56666666432 2245899999999999999999999987 9999999999999
Q ss_pred ----cCCCCeEEeeeccceecCC
Q 005825 644 ----DRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 644 ----~~~~~~kl~DFGla~~~~~ 662 (675)
+.++.+||+|||+|+....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS
T ss_pred cccccCCCcEEEeecCccccccc
Confidence 6788999999999997644
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.86 E-value=6.9e-22 Score=211.74 Aligned_cols=150 Identities=24% Similarity=0.383 Sum_probs=128.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-----------CCceeeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-----------HRNLVRILGCCI 574 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-----------H~nIv~l~g~~~ 574 (675)
.++|++.++||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999986 46899999999752 334567889999999886 899999999998
Q ss_pred eCC----eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc-CCCceEecCCCCCCEEEc-----
Q 005825 575 EQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY-SRFRIIHRDLKASNVLLD----- 644 (675)
Q Consensus 575 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~----- 644 (675)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 999999985422 34588999999999999999999997 7 99999999999994
Q ss_pred -CCCCeEEeeeccceecCC
Q 005825 645 -RDMNPKISDFGLARMFGG 662 (675)
Q Consensus 645 -~~~~~kl~DFGla~~~~~ 662 (675)
..+.+||+|||+|+.+..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp TTEEEEEECCCTTCEETTB
T ss_pred cCcceEEEcccccccccCC
Confidence 445899999999998754
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-21 Score=202.44 Aligned_cols=144 Identities=19% Similarity=0.190 Sum_probs=115.8
Q ss_pred HHHHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCc------------------cCHHHHHHHHHHHHhcCC
Q 005825 502 SVAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSG------------------QGLEEFKNEMLLIAKLQH 563 (675)
Q Consensus 502 ~~~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~f~~E~~il~~l~H 563 (675)
.+......|++.+.||+|+||.||+|+..+++.||||.++.... .....+.+|+.++++++|
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 44555677888899999999999999987799999999964321 124568999999999995
Q ss_pred CceeeEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE
Q 005825 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL 643 (675)
Q Consensus 564 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 643 (675)
+++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+++ |+||||||+|||+
T Consensus 164 ---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 164 ---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp ---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred ---CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 444444433 45699999999999988 421 123469999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccceecCCC
Q 005825 644 DRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 644 ~~~~~~kl~DFGla~~~~~~ 663 (675)
+ ++.+||+|||+|+.....
T Consensus 227 ~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp E-TTEEEECCCTTCEETTST
T ss_pred E-CCcEEEEECCCCeECCCC
Confidence 9 999999999999987543
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.5e-21 Score=166.80 Aligned_cols=104 Identities=16% Similarity=0.398 Sum_probs=90.9
Q ss_pred ccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCCC
Q 005825 27 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTN 106 (675)
Q Consensus 27 ~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~g 106 (675)
++|.+||.|.+||+|.| |.|.|.|...++ |.++.. .++||+|||+.|..+ .+.|+|+.||+|||+|+++
T Consensus 2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~~---~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~~~ 70 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYDH---STSTWASNTEIGGKS-GCSAVLQSDGNFVVYDSSG 70 (105)
T ss_dssp CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET---TEEEEECCCCCTTCC-SCEEEECTTSCEEEECTTC
T ss_pred CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEEC---CEEEEEecCCCCCCc-cEEEEEeCCccEEEECCCc
Confidence 68999999999999998 889999988876 566543 589999999999763 5789999999999999999
Q ss_pred CeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeee
Q 005825 107 GTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQS 149 (675)
Q Consensus 107 ~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqS 149 (675)
.+||+|++.......+|+|+|+|||||++. +||||
T Consensus 71 ~~vWss~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S 105 (105)
T 4h3o_A 71 RSLWASHSTRGSGNYILILQDDGNVIIYGS--------DIWST 105 (105)
T ss_dssp CEEEECCCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred EEEEEecCCCCCCCEEEEEeCCCeEEEECC--------cEecC
Confidence 999999987655667899999999999973 59998
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.8e-22 Score=223.42 Aligned_cols=136 Identities=21% Similarity=0.273 Sum_probs=109.1
Q ss_pred eeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCcc--------CHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 512 MECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQ--------GLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 512 ~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~--------~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
..++||+|+||.||+|+. .++.+++|+....... ..+++.+|++++++++||||+++..++...++.+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999954 5788999986542211 1345899999999999999996666666778889999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||+++ .+||+|||+|+.+...
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999843 4579999999999999987 999999999999999 9999999999998664
Q ss_pred c
Q 005825 664 E 664 (675)
Q Consensus 664 ~ 664 (675)
+
T Consensus 483 ~ 483 (540)
T 3en9_A 483 E 483 (540)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=4.7e-21 Score=170.00 Aligned_cols=108 Identities=19% Similarity=0.366 Sum_probs=94.6
Q ss_pred cccccccCCCcCCCCCEEE--eCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEE
Q 005825 24 LAADTVTPASFIRDGEKLV--SSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVL 101 (675)
Q Consensus 24 ~~~~~i~~g~~l~~~~~l~--S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl 101 (675)
++.++|++|++|.+|++|+ |++|.|+|+|+++|+ + +||++ +++||+|||+.| +.++.|+|+.||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 5678999999999999999 999999999999875 2 58876 799999999877 3457899999999999
Q ss_pred EeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeee
Q 005825 102 LNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQS 149 (675)
Q Consensus 102 ~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqS 149 (675)
+|.++.++|+|++....+...++|+|+|||||++. ++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~--------~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc--------cEeCC
Confidence 99999999999987544566899999999999872 79998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.5e-21 Score=165.83 Aligned_cols=110 Identities=24% Similarity=0.433 Sum_probs=95.2
Q ss_pred cccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCC
Q 005825 26 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQT 105 (675)
Q Consensus 26 ~~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~ 105 (675)
+|+|.+|+.|.+|++|+ ++|.|+|+|+..|+ | |+|+ ..++||.||++.|. .++.|+|..||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECCC
Confidence 47899999999999999 99999999998876 2 6776 37899999998763 3578999999999999999
Q ss_pred CCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCc
Q 005825 106 NGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPT 154 (675)
Q Consensus 106 g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~Pt 154 (675)
|.++|+|++....+...++|+|+|||||++ . ++||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~------~--~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYG------P--VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEEC------S--EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEEC------C--CEecCCCcCC
Confidence 999999998764455689999999999986 2 6999999984
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.7e-20 Score=163.61 Aligned_cols=110 Identities=18% Similarity=0.360 Sum_probs=93.7
Q ss_pred cccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCC
Q 005825 26 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQT 105 (675)
Q Consensus 26 ~~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~ 105 (675)
.|+|.+||.|.+|++|+ +|.|+|+|+++|+ . ++|+ ..++||+||++.|. .++.|+|+.||+|||+|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn---l---vly~--~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN---L---VKYQ--NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC---E---EEEE--TTEEEEECSCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc---E---EEEe--CCEEEEeCCCCCCC--CceEEEECCCCcEEEECCC
Confidence 47899999999999998 8999999988775 2 2465 37899999999883 4578999999999999998
Q ss_pred CCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCch
Q 005825 106 NGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTD 155 (675)
Q Consensus 106 g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtD 155 (675)
+.++|+|++.......+|+|+|+|||||++ . ++||||.++..
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~------~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYG------P--VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEEC------S--EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEEC------C--CEEECCCCCCc
Confidence 999999998754456789999999999985 2 79999998764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.4e-20 Score=203.04 Aligned_cols=152 Identities=18% Similarity=0.252 Sum_probs=115.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcCC-Cce----------e----
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQH-RNL----------V---- 567 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~H-~nI----------v---- 567 (675)
...|...++||+|+||.||+|+. .+++.||||+++... ....+.|++|+.+++.++| +|. +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 35678889999999999999986 468999999988432 2346789999999999987 221 1
Q ss_pred -------eEEEEEEe-----CCeEEEEEEecCCCCHHHHhcC----CCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 005825 568 -------RILGCCIE-----QGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRI 631 (675)
Q Consensus 568 -------~l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 631 (675)
.+..++.. ....+++|+++ +++|.+++.. ......+++..++.|+.||++||+|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111111 12356667654 7899988831 123456788899999999999999999987 9
Q ss_pred EecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 632 IHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 632 iHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
+||||||+||||+.++.+||+|||+|+..+.
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC
Confidence 9999999999999999999999999987643
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.81 E-value=8.6e-20 Score=160.53 Aligned_cols=110 Identities=23% Similarity=0.466 Sum_probs=93.6
Q ss_pred cccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCC
Q 005825 26 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQT 105 (675)
Q Consensus 26 ~~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~ 105 (675)
+|+|.+||.|.+|++| ++|.|+|+|+++|+ | ++|+. .++||+||++.+ +.++.|.|..||||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4899999999999999 58999999999886 2 46765 689999999754 345789999999999999 8
Q ss_pred CCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCC
Q 005825 106 NGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYP 153 (675)
Q Consensus 106 g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~P 153 (675)
+.++|+|++.......+++|+++|||||++. .+.++||||++.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~-----~~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN-----SNNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECT-----TSCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECC-----CCceEEECCCcc
Confidence 8899999876544567899999999999974 457999999985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=184.79 Aligned_cols=141 Identities=16% Similarity=0.182 Sum_probs=109.2
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcE--EEEEEecCcCcc------------------------CHHHHHHHHHHHHh
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEE--VAVKRLSSQSGQ------------------------GLEEFKNEMLLIAK 560 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~--vAvK~l~~~~~~------------------------~~~~f~~E~~il~~ 560 (675)
.-|++.+.||+|+||.||+|+. .+|+. ||||+++..... ....+..|+.++.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999987 78888 999987542111 01368899999999
Q ss_pred cCCCce--eeEEEEEEeCCeEEEEEEecCC-C----CHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHH-hcCCCceE
Q 005825 561 LQHRNL--VRILGCCIEQGEKILILEYMPN-K----SLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH-HYSRFRII 632 (675)
Q Consensus 561 l~H~nI--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ii 632 (675)
++|+++ ..++.. +..+|||||+.+ | +|.++... .++.....++.|++.||.||| +.+ |+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 988754 444443 356899999942 4 67666521 123456789999999999999 777 99
Q ss_pred ecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 633 HRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 633 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||||||+|||+++ .+||+|||+|.....+
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 9999999999998 9999999999987544
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=151.85 Aligned_cols=103 Identities=24% Similarity=0.437 Sum_probs=87.3
Q ss_pred ccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCCC
Q 005825 27 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTN 106 (675)
Q Consensus 27 ~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~g 106 (675)
++|.+||.|.+|+.|+ +|.|+|.|+..|+ .+ .|.. .++||++|++.+ +.++.|.|..||+|||+|.++
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn---Lv---ly~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~~ 69 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN---LV---LYDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRN 69 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC---EE---EEET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTTS
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc---EE---EEeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCCC
Confidence 5899999999999997 7999999998875 22 2654 689999999876 345789999999999999999
Q ss_pred CeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeee
Q 005825 107 GTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQS 149 (675)
Q Consensus 107 ~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqS 149 (675)
.++|++++.+.....+|+|+|+|||||++. ++|||
T Consensus 70 ~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s 104 (109)
T 3dzw_A 70 NPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWAT 104 (109)
T ss_dssp CEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCC
T ss_pred CEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeC
Confidence 999999987544456899999999999973 69998
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.9e-17 Score=143.47 Aligned_cols=105 Identities=20% Similarity=0.354 Sum_probs=85.9
Q ss_pred cccccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEe
Q 005825 24 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLN 103 (675)
Q Consensus 24 ~~~~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~ 103 (675)
.+.|+|.+||.|.+|+.|+|. .|.|-|...|+ |.+ |.. ++||.+|++.. +.++.|.|+.||+|||+|
T Consensus 4 ~~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp CBTTEEETTCEEETTEEEECS--SCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred cccCEECCCCEecCCCEEEeC--CEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 367999999999999999984 58987766554 444 654 58999999863 345789999999999999
Q ss_pred CCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeee
Q 005825 104 QTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQS 149 (675)
Q Consensus 104 ~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqS 149 (675)
.++.++|++++.......+|+|+|+|||||++. ++|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~~--------~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP--------AIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEecC--------CEecC
Confidence 999999999986544457899999999999972 69987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.69 E-value=1.8e-16 Score=139.29 Aligned_cols=107 Identities=14% Similarity=0.293 Sum_probs=88.6
Q ss_pred ccccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeC
Q 005825 25 AADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQ 104 (675)
Q Consensus 25 ~~~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~ 104 (675)
+.++|.+||.|.+|+.|.+ |.|.|-|...|+ |.++. .-..++||.+|+..+- .++.|.|..||+|||+|.
T Consensus 5 ~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~-~~~~~~vWssnt~~~~--~~~~l~l~~dGNLVl~d~ 74 (113)
T 3mez_B 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTK-GSKTNIVWESGTSGRG--QHCFMRLGHSGELDITDD 74 (113)
T ss_dssp CSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE-TTTTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred cCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEE-CCCCEEEEECCcccCC--cCEEEEEeCCCcEEEECC
Confidence 5689999999999999975 889999987775 55543 2136899999998662 357899999999999999
Q ss_pred CCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeee
Q 005825 105 TNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQS 149 (675)
Q Consensus 105 ~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqS 149 (675)
++.++|++++.......+|+|+|+|||||++ ..||+|
T Consensus 75 ~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~--------~~~W~s 111 (113)
T 3mez_B 75 RLNTVFVSNTVGQEGDYVLILQINGQAVVYG--------PAVWST 111 (113)
T ss_dssp TSCEEEECSCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred CCCEEEECCCcCCCCCEEEEEcCCceEEEec--------CCEecC
Confidence 9999999998654445789999999999996 369997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-16 Score=140.79 Aligned_cols=97 Identities=22% Similarity=0.403 Sum_probs=79.2
Q ss_pred CCCCCCcceEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhccc
Q 005825 82 RPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDM 161 (675)
Q Consensus 82 ~pv~~~~~~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~ 161 (675)
.|+.+...+|.|+.||+|+|++. +++||++++.......+|+|+|+|||||++ + +.++||||+
T Consensus 14 ~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~-----~~~~W~S~~---------- 76 (112)
T 1xd5_A 14 GSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G-----SRAIWASNT---------- 76 (112)
T ss_dssp CEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T-----TEEEEECCC----------
T ss_pred CEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C-----CEEEEECCc----------
Confidence 34445567899999999999987 789999998754445789999999999998 3 469999994
Q ss_pred cccccccCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEc-CCeeeeeeCccCC
Q 005825 162 KMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFN-GSVKYTCTGEWTG 218 (675)
Q Consensus 162 ~l~~~~~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~-~~~~y~~~g~w~~ 218 (675)
+|++|.|++.++++|+ ++++. ...+||++++|+|
T Consensus 77 ---------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ---------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ---------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ---------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4456889999999998 45555 4679999999986
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=4.1e-16 Score=136.26 Aligned_cols=89 Identities=19% Similarity=0.340 Sum_probs=74.4
Q ss_pred CcceEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhcccccccc
Q 005825 87 HNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWD 166 (675)
Q Consensus 87 ~~~~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~ 166 (675)
...+|.|+.||+|||++ .+++||++++.......+|+|+|+|||||++. .+.+|||||
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~-----~~~~~W~S~---------------- 77 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQ-----SNRVIWQTK---------------- 77 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TCCEEEECC----------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECC-----CCcEEEecC----------------
Confidence 45789999999999999 58999999987544467899999999999985 467999999
Q ss_pred ccCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCcc
Q 005825 167 LKNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGEW 216 (675)
Q Consensus 167 ~~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~w 216 (675)
+++++|.|+++++++|+ ++++++ .||+++++
T Consensus 78 ---------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ---------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ---------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ---------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 24567899999999998 555665 79999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=4.3e-17 Score=173.01 Aligned_cols=143 Identities=13% Similarity=0.162 Sum_probs=103.0
Q ss_pred HHHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCc--------------cCHHH--------HHHHHHHHHh
Q 005825 503 VAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSG--------------QGLEE--------FKNEMLLIAK 560 (675)
Q Consensus 503 ~~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~--------------~~~~~--------f~~E~~il~~ 560 (675)
+.....-|++.++||+|+||.||+|...+|+.||||+++.... ..... ...|...|.+
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 3344445999999999999999999998999999998763210 00111 1245666666
Q ss_pred cCCCcee--eEEEEEEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCC
Q 005825 561 LQHRNLV--RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKA 638 (675)
Q Consensus 561 l~H~nIv--~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp 638 (675)
+++.++. ..+.. . ..+|||||++++.|..+... .....++.|++.+|.|||+.+ ||||||||
T Consensus 170 L~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp HHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred HHhcCCCCCeeeec--c--CceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 6544432 22222 1 23799999999988654411 123467889999999999987 99999999
Q ss_pred CCEEEcCCC----------CeEEeeeccceecC
Q 005825 639 SNVLLDRDM----------NPKISDFGLARMFG 661 (675)
Q Consensus 639 ~NILl~~~~----------~~kl~DFGla~~~~ 661 (675)
.|||+++++ .+.|+||+-+....
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999998877 38999999887654
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.64 E-value=7.6e-16 Score=134.20 Aligned_cols=102 Identities=22% Similarity=0.392 Sum_probs=84.9
Q ss_pred ccccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeC
Q 005825 25 AADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQ 104 (675)
Q Consensus 25 ~~~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~ 104 (675)
|.|+|.+||.|..|+.| .+|.|.|.|...|+ | +.|.. +|.+|+..+ +.++.|+|+.||+|||+|.
T Consensus 2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----L-vl~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d~ 66 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----L-VLYNG-----NWQSNTANN--GRDCKLTLTDYGELVIKNG 66 (109)
T ss_dssp CCSEEETTCEECTTCEE--EETTEEEEECTTSC-----E-EEETT-----TEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----E-EEEeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEeC
Confidence 57899999999999999 57999999987775 2 22432 799998765 2357899999999999999
Q ss_pred CCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeee
Q 005825 105 TNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQS 149 (675)
Q Consensus 105 ~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqS 149 (675)
++.++|++++.+.....+|+|+|+|||||++ .++|+|
T Consensus 67 ~~~~vWss~t~~~~~~~~~~L~~dGNlvly~--------~~~W~s 103 (109)
T 3r0e_A 67 DGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG--------PSVFKI 103 (109)
T ss_dssp TSCEEEECCCCCSSSCCEEEEETTTEEEEEC--------SEEEEE
T ss_pred CCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe--------cCEECC
Confidence 9999999998654445689999999999996 369997
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.62 E-value=2.1e-15 Score=133.55 Aligned_cols=87 Identities=24% Similarity=0.313 Sum_probs=72.7
Q ss_pred cceEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhccccccccc
Q 005825 88 NAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDL 167 (675)
Q Consensus 88 ~~~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~ 167 (675)
..+|.|+.||+|||++. +++||++|+........|+|+|+|||||+|. .+.+|||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~-----~~~~lW~S~----------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN-----ENVTVWQSP----------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TCCEEEECS-----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC-----CCcEEEcCC-----------------
Confidence 35799999999999987 8999999987544457899999999999985 467999999
Q ss_pred cCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCc
Q 005825 168 KNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGE 215 (675)
Q Consensus 168 ~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~ 215 (675)
++|++|.|++.++++|+ +++++ ..||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 35567899999999998 45555 38999886
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=3.1e-15 Score=131.87 Aligned_cols=91 Identities=26% Similarity=0.342 Sum_probs=75.6
Q ss_pred cceEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhccccccccc
Q 005825 88 NAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDL 167 (675)
Q Consensus 88 ~~~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~ 167 (675)
..+|.|+.||+|+|++ .+++||++++........++|+|+|||||+|. .+.++||||++|
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~-----~~~~vW~S~~~~-------------- 80 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH-----NNNDVWGSACWG-------------- 80 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT-----TCCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC-----CceEEEEcCCCC--------------
Confidence 4679999999999998 57899999987544457899999999999985 457999999982
Q ss_pred cCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCccCCC
Q 005825 168 KNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGEWTGD 219 (675)
Q Consensus 168 ~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~w~~~ 219 (675)
++|.|++.++++|+ +++++. .||++++|...
T Consensus 81 -----------------~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 81 -----------------DNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp -----------------SSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred -----------------CCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 45789999999998 555654 89999999653
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.50 E-value=8.9e-14 Score=121.47 Aligned_cols=103 Identities=17% Similarity=0.271 Sum_probs=82.4
Q ss_pred cccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCC
Q 005825 26 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQT 105 (675)
Q Consensus 26 ~~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~ 105 (675)
.++|.+||.|.+|+.| .+|.|.|-|...|+ |.+ |.. .. ||.+|+..+. ..+.|.|..||+|||+|.+
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~~--~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGRG--VDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTSC--SSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccCC--cCEEEEEcCCCcEEEEeCC
Confidence 4789999999999999 47899999987775 333 532 34 9999998762 3578999999999999998
Q ss_pred CC-eEEEeccCC--CCCCceEEEccCCCEEEEeCCCCCCCcceeeee
Q 005825 106 NG-TIWSTNASS--EAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQS 149 (675)
Q Consensus 106 g~-~vWss~~~~--~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqS 149 (675)
+. ++|++++.. .....+++|+|+|||||++ .++|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG--------PAIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC--------SEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec--------cCEEcc
Confidence 76 599999642 2345689999999999996 369987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.38 E-value=2e-12 Score=113.28 Aligned_cols=96 Identities=18% Similarity=0.276 Sum_probs=74.0
Q ss_pred CCCCCCCCcceEEEeeCCeEEEEeC-CCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhh
Q 005825 80 RDRPISDHNAVLTISNNGKLVLLNQ-TNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLL 158 (675)
Q Consensus 80 r~~pv~~~~~~l~l~~~G~Lvl~~~-~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlL 158 (675)
.+.|+.+...+|.++.||+|||++. .+.++|++++.....+..++|+|+|||||++. .+.++|||=.+
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~-----~~~~iW~S~t~------ 85 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD-----RLNTVFVSNTV------ 85 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TSCEEEECSCC------
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC-----CCCEEEECCCc------
Confidence 3556665667999999999999998 48999999987544457899999999999985 45789997211
Q ss_pred ccccccccccCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCc
Q 005825 159 QDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGE 215 (675)
Q Consensus 159 pg~~l~~~~~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~ 215 (675)
...|.|.+.++.+|+..++ + .+.|.+|+
T Consensus 86 -------------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 -------------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp -------------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -------------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0124589999999996655 4 57898774
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=3e-12 Score=129.77 Aligned_cols=146 Identities=18% Similarity=0.096 Sum_probs=116.4
Q ss_pred HhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEE
Q 005825 505 AATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 505 ~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.....|++...++.|+.+.||+.... ++.+++|+...........+..|+.+++.+. |..+.++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34467888888999999999999754 6889999987532233456889999999985 678889999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY------------------------------------- 626 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------- 626 (675)
||++|.+|.+.+.. ......++.+++++|+.||+.
T Consensus 90 e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999999876411 112346788999999999981
Q ss_pred -------------------CCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 627 -------------------SRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 627 -------------------~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
.+..++|+|++|.|||++++..+.|+||+.|..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113489999999999998876678999998864
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.32 E-value=4.5e-12 Score=110.60 Aligned_cols=95 Identities=16% Similarity=0.232 Sum_probs=71.6
Q ss_pred CCCCCCcceEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhccc
Q 005825 82 RPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDM 161 (675)
Q Consensus 82 ~pv~~~~~~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~ 161 (675)
.++.....+|.++.||+|||++.++ +|++++........++|+|+|||||++.+ ...++|||.-+
T Consensus 15 ~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~----~~~~vW~S~t~--------- 79 (111)
T 3mez_A 15 NQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSAN----SNTPVWVYPRS--------- 79 (111)
T ss_dssp CEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSS----CSSCSEEESSS---------
T ss_pred CEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCC----CCEEEEEeccc---------
Confidence 3444455789999999999999876 99999875444578999999999999852 23369998621
Q ss_pred cccccccCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCc
Q 005825 162 KMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGE 215 (675)
Q Consensus 162 ~l~~~~~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~ 215 (675)
.....|.|.+.++.+|+..++ . .++|.+++
T Consensus 80 --------------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 --------------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp --------------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred --------------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 111346899999999996665 3 67898775
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=9e-12 Score=126.76 Aligned_cols=113 Identities=18% Similarity=0.369 Sum_probs=87.5
Q ss_pred cccccccCCCc----CCCCCEEEeCCCeEEEeeeCCC--CCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCC
Q 005825 24 LAADTVTPASF----IRDGEKLVSSSQRFELGFFSPG--KSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNG 97 (675)
Q Consensus 24 ~~~~~i~~g~~----l~~~~~l~S~~g~F~lGF~~~~--~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G 97 (675)
..+||+.||+. |..|+.|.|+ ..++.|+|... ...+.+| |.+ ..+++|.+++..+- . ..|.|+.+|
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlvL---y~~-~~~~yW~Sgt~~~~--~-~~l~l~~dG 205 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLVA---YGP-NGAATWNAGTQGKG--A-VRAVFQGDG 205 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEEE---ECT-TSSEEEECCCTTTT--C-CEEEECTTS
T ss_pred ccccccccccccccccccCcccccC-CCCCCceEEEeecCCceEEE---EeC-CCeEEEECCCCCCc--c-EEEEEcCCC
Confidence 56799999999 8889998654 56777766531 1223333 322 25889999998762 2 689999999
Q ss_pred eEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccC
Q 005825 98 KLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDY 152 (675)
Q Consensus 98 ~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~ 152 (675)
+|+++|.++.++|++++.+ ....+|+|+++|||||++ . .++||||||
T Consensus 206 nLvl~d~~~~~vWsS~t~~-~~~~rl~Ld~dGnLvly~------~-~~~Wqsf~~ 252 (276)
T 3m7h_A 206 NLVVYGAGNAVLWHSHTGG-HASAVLRLQANGSIAILD------E-KPVWARFGF 252 (276)
T ss_dssp CEEEECTTSCEEEECSCTT-CTTCEEEECTTSCEEEEE------E-EEEEESSSC
T ss_pred eEEEEeCCCcEEEEecCCC-CCCEEEEEcCCccEEEEc------C-CCeEEccCc
Confidence 9999999889999999765 345789999999999997 2 579999997
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=2.2e-11 Score=122.74 Aligned_cols=139 Identities=17% Similarity=0.173 Sum_probs=104.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCc--eeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN--LVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey 585 (675)
..+.+....+.|..+.||+....+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 445553333456679999998777888999997643 3356788999999886544 56689988888889999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS-------------------------------------- 627 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------- 627 (675)
++|.+|. ... .. ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999884 211 11 1256777888888888643
Q ss_pred -----------------CCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 628 -----------------RFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 628 -----------------~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+..++|+|++|.|||++++..++|+||+.|..-
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999988777789999998754
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=5.3e-11 Score=103.54 Aligned_cols=87 Identities=23% Similarity=0.344 Sum_probs=67.1
Q ss_pred cceEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhccccccccc
Q 005825 88 NAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDL 167 (675)
Q Consensus 88 ~~~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~ 167 (675)
..+|.|+.||+|||++. +.++|++++........++|+|+|||||++. .+.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~-----~~~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP-----RNNPIWASNTGG-------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT-----TSCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC-----CCCEEEECCCCC--------------
Confidence 46899999999999987 7899999987543457899999999999985 457899974211
Q ss_pred cCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCc
Q 005825 168 KNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGE 215 (675)
Q Consensus 168 ~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~ 215 (675)
..+.|.+.++.+|+..++ +. +.|.++.
T Consensus 80 -----------------~~~~~~~~L~ddGNlvly--~~--~~W~s~t 106 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVVIY--GT--ARWATGT 106 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEEEE--ES--CCCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEEEE--CC--CEEeCCC
Confidence 124588999999996654 32 6777664
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.18 E-value=8.4e-11 Score=102.34 Aligned_cols=86 Identities=20% Similarity=0.311 Sum_probs=66.1
Q ss_pred cceEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhccccccccc
Q 005825 88 NAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDL 167 (675)
Q Consensus 88 ~~~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~ 167 (675)
..+|.++.||+|||++. .++|++++........++|+|+|||||++. .+.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~-----~~~~iW~S~t~~-------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDD-----DFKTIWSSRSSS-------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECT-----TCCEEEECCCCC--------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeC-----CCCEEEEcCCcC--------------
Confidence 46899999999999876 599999987533446899999999999985 457899983210
Q ss_pred cCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCc
Q 005825 168 KNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGE 215 (675)
Q Consensus 168 ~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~ 215 (675)
..|.|.+.++.+|+..++ + .+.|.+|+
T Consensus 84 -----------------~~~~~~~~L~~dGNlvly--~--~~~W~t~~ 110 (110)
T 3r0e_B 84 -----------------KQGEYVLILQDDGFGVIY--G--PAIFETSS 110 (110)
T ss_dssp -----------------SSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -----------------CCCCEEEEEcCCccEEEe--c--CCEecCCC
Confidence 124588999999996654 4 37888763
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.1e-10 Score=101.45 Aligned_cols=93 Identities=18% Similarity=0.342 Sum_probs=70.6
Q ss_pred CCCCCCCcceEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhcc
Q 005825 81 DRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQD 160 (675)
Q Consensus 81 ~~pv~~~~~~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg 160 (675)
+.|+.+....|.++.||+|||+++ +|++++........++|+++|||||+|. .+.++|+|-.
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~-----~~~~vWss~t--------- 76 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG-----DGSTVWKSGA--------- 76 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT-----TSCEEEECCC---------
T ss_pred CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC-----CCCEEEcCCC---------
Confidence 445554567899999999999984 7999987544457899999999999985 4578997611
Q ss_pred ccccccccCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCccC
Q 005825 161 MKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGEWT 217 (675)
Q Consensus 161 ~~l~~~~~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~w~ 217 (675)
....+.|.+.++++|+..++ + .+.|.+++|-
T Consensus 77 ----------------------~~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~~ 107 (109)
T 3r0e_A 77 ----------------------QSVKGNYAAVVHPDGRLVVF--G--PSVFKIDPWV 107 (109)
T ss_dssp ----------------------CCSSSCCEEEEETTTEEEEE--C--SEEEEECTTS
T ss_pred ----------------------cCCCcCEEEEEcCCCeEEEE--e--cCEECCCCcc
Confidence 01235688999999986655 3 5789999873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=4.6e-10 Score=119.21 Aligned_cols=143 Identities=13% Similarity=0.211 Sum_probs=107.9
Q ss_pred ceeeeeCCcCceeEEEEEEcCCcEEEEEEec--CcC-ccCHHHHHHHHHHHHhcC--CCceeeEEEEEEeC---CeEEEE
Q 005825 511 SMECKLGEGGFGPVYKGRLLNGEEVAVKRLS--SQS-GQGLEEFKNEMLLIAKLQ--HRNLVRILGCCIEQ---GEKILI 582 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~--~~~-~~~~~~f~~E~~il~~l~--H~nIv~l~g~~~~~---~~~~lV 582 (675)
...+.|+.|.++.||+.+..+ ..+++|+.. ... ......+..|+.+++.+. +..+.+++.++.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 345789999999999998754 578888775 321 123457888999999997 45688999998776 458999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS----------------------------------- 627 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------- 627 (675)
|||++|..+.+.. ...++..++..++.++++.|+.||...
T Consensus 120 me~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999998874321 123667888899999999999999731
Q ss_pred --------------------CCceEecCCCCCCEEEcCCCC--eEEeeecccee
Q 005825 628 --------------------RFRIIHRDLKASNVLLDRDMN--PKISDFGLARM 659 (675)
Q Consensus 628 --------------------~~~iiHrDlkp~NILl~~~~~--~kl~DFGla~~ 659 (675)
+..++|+|++|.|||++.++. ++|.||++|..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 356999999999999997753 69999999874
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.95 E-value=4.2e-09 Score=90.69 Aligned_cols=77 Identities=22% Similarity=0.378 Sum_probs=60.2
Q ss_pred ceEEEeeCCeEEEEeCCCCeEEEeccCCC-CCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhccccccccc
Q 005825 89 AVLTISNNGKLVLLNQTNGTIWSTNASSE-AKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDL 167 (675)
Q Consensus 89 ~~l~l~~~G~Lvl~~~~g~~vWss~~~~~-~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~ 167 (675)
-+|.++.||||||++. +.+||++|+..+ .....++|+++|||||+|. .+.++|+|-
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~-----~~~~vWss~----------------- 77 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDS-----SGRSLWASH----------------- 77 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECT-----TCCEEEECC-----------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECC-----CcEEEEEec-----------------
Confidence 4699999999999985 679999998643 3356899999999999986 567899861
Q ss_pred cCCCceeEEEecCCCCCCCceeeeeecCCCCceEE
Q 005825 168 KNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMC 202 (675)
Q Consensus 168 ~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~ 202 (675)
+....+.|.+.++++|+..++
T Consensus 78 --------------t~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 78 --------------STRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp --------------CCCCSSCEEEEECTTSCEEEE
T ss_pred --------------CCCCCCCEEEEEeCCCeEEEE
Confidence 112345688999999996654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.90 E-value=4.1e-09 Score=104.99 Aligned_cols=89 Identities=21% Similarity=0.277 Sum_probs=69.4
Q ss_pred cceEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhccccccccc
Q 005825 88 NAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDL 167 (675)
Q Consensus 88 ~~~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~ 167 (675)
.-+|.|..||+|+|++. +++||.+|+... ....++|+++|||||+|. .+.+||+|+.+.
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~-~~~~l~l~~dGnLvl~d~-----~~~~vW~s~~~~-------------- 85 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRAVLQSDGLLVILTA-----QNTIRWSSGTKG-------------- 85 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSC-SCCBCCBCSSSCBCCBCT-----TTCCSCCCCCCC--------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCC-CCeEEEEcCCCcEEEEcC-----CCcEEEeCCccc--------------
Confidence 35688888999999986 789999998754 567899999999999985 567999998651
Q ss_pred cCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCccCC
Q 005825 168 KNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGEWTG 218 (675)
Q Consensus 168 ~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~w~~ 218 (675)
..|.|.+.++.+|+..++ +. .+|.+..+..
T Consensus 86 -----------------~~~~~~~~l~d~Gnlvl~--~~--~~W~S~~~p~ 115 (236)
T 1dlp_A 86 -----------------SIGNYVLVLQPDRTVTIY--GP--GLWDSGTSNK 115 (236)
T ss_dssp -----------------CSSCCEEEECSSSCEEEE--CS--EEEECSCCCS
T ss_pred -----------------cCCcEEEEEeCCCCEEEe--cC--CEEECCCCCC
Confidence 235578889999986554 32 7898877653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.55 E-value=1.2e-07 Score=98.14 Aligned_cols=136 Identities=19% Similarity=0.193 Sum_probs=100.0
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCc--eeeEEEEEEeCC---eEEEEEEecC
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRN--LVRILGCCIEQG---EKILILEYMP 587 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~n--Iv~l~g~~~~~~---~~~lV~Ey~~ 587 (675)
+.++.|....||+.. ..+++|..... .....+..|+.+++.+. +.. +.+++......+ ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568999999999863 56888886532 34567899999998883 333 455655544333 3488999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY----------------------------------------- 626 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------------- 626 (675)
|..|..... ..++..++..++.++++.|+.||..
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 998865331 2356677778888888888888861
Q ss_pred --------------CCCceEecCCCCCCEEEcC--CCCeEEeeeccceec
Q 005825 627 --------------SRFRIIHRDLKASNVLLDR--DMNPKISDFGLARMF 660 (675)
Q Consensus 627 --------------~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~ 660 (675)
.+..++|+|++|.||++++ ...+.|+||+.+..-
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1245899999999999998 566899999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=9.1e-07 Score=91.57 Aligned_cols=137 Identities=21% Similarity=0.169 Sum_probs=95.7
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCC---ceeeEEEEEE-eCCeEEEEEEecCC
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHR---NLVRILGCCI-EQGEKILILEYMPN 588 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~---nIv~l~g~~~-~~~~~~lV~Ey~~~ 588 (675)
.+.++.|....||+. +..+++|.-. .......+..|..+|..+.+. .+.+++.++. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888888899987 5678888753 223456789999999999752 3667777774 34567899999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY------------------------------------------ 626 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------ 626 (675)
..+...... .++..++..++.++++.|+.||..
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 988763211 123444445555555555555532
Q ss_pred ---------------CCCceEecCCCCCCEEEcC---CCC-eEEeeeccceec
Q 005825 627 ---------------SRFRIIHRDLKASNVLLDR---DMN-PKISDFGLARMF 660 (675)
Q Consensus 627 ---------------~~~~iiHrDlkp~NILl~~---~~~-~kl~DFGla~~~ 660 (675)
.+..++|+|++|.|||++. ++. +.|+||+.|..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999987 455 489999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=4.1e-06 Score=84.61 Aligned_cols=143 Identities=18% Similarity=0.164 Sum_probs=100.3
Q ss_pred cCCcceeeeeCCcCce-eEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEE
Q 005825 507 TENFSMECKLGEGGFG-PVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG-~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~ 583 (675)
...|+. +.+..|..+ .||+.... ++..+.+|+-... ....+..|..+|+.+. +-.+.++++++.+.+..++||
T Consensus 24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 344543 345555544 68987754 4667889886532 3456888999998884 445778999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY------------------------------------- 626 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------- 626 (675)
|+++|.++.+..... ......++.++++.|+-||..
T Consensus 100 e~l~G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp ECCCSEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EeeCCccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 999999887654211 112234555566666666631
Q ss_pred ------------------CCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 627 ------------------SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 627 ------------------~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
.+..++|+|+.|.|||+++++.+-|+||+.|..-
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1123799999999999998877889999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.2e-06 Score=92.65 Aligned_cols=80 Identities=8% Similarity=0.023 Sum_probs=57.3
Q ss_pred eeee-CCcCceeEEEEEEc-------CCcEEEEEEecCcC---ccCHHHHHHHHHHHHhcC-C--CceeeEEEEEEeC--
Q 005825 513 ECKL-GEGGFGPVYKGRLL-------NGEEVAVKRLSSQS---GQGLEEFKNEMLLIAKLQ-H--RNLVRILGCCIEQ-- 576 (675)
Q Consensus 513 ~~~I-G~G~fG~Vy~~~~~-------~g~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~-H--~nIv~l~g~~~~~-- 576 (675)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4677 88989999998764 26678888765422 112356788998888884 2 4577888887665
Q ss_pred -CeEEEEEEecCCCCHH
Q 005825 577 -GEKILILEYMPNKSLD 592 (675)
Q Consensus 577 -~~~~lV~Ey~~~gsL~ 592 (675)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=1.8e-05 Score=84.76 Aligned_cols=75 Identities=9% Similarity=0.148 Sum_probs=51.1
Q ss_pred eeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc-------cCHHHHHHHHHHHHhcCC--C-ceeeEEEEEEeCCeEEE
Q 005825 513 ECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG-------QGLEEFKNEMLLIAKLQH--R-NLVRILGCCIEQGEKIL 581 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-------~~~~~f~~E~~il~~l~H--~-nIv~l~g~~~~~~~~~l 581 (675)
.+.||.|..+.||+++.. +++.++||....... ...+++..|.++++.+.+ + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999754 467899998653211 234567889998887742 3 34466654 3455689
Q ss_pred EEEecCCC
Q 005825 582 ILEYMPNK 589 (675)
Q Consensus 582 V~Ey~~~g 589 (675)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.00 E-value=2.3e-05 Score=81.71 Aligned_cols=141 Identities=14% Similarity=0.155 Sum_probs=81.4
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-----CCceeeEE-E--EEEeCCeEEEEEEe
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-----HRNLVRIL-G--CCIEQGEKILILEY 585 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-----H~nIv~l~-g--~~~~~~~~~lV~Ey 585 (675)
+.|+.|..+.||+....++ .+++|+.... ..++..|..++..+. .|.++... | +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 5576677899999987555 5889988752 233444555555443 24443310 0 12346678999999
Q ss_pred cCCCCHH-----H---------HhcC----CC-C------cccCCHHHHH------------------------------
Q 005825 586 MPNKSLD-----V---------FLFD----PT-K------KRLLGWQARI------------------------------ 610 (675)
Q Consensus 586 ~~~gsL~-----~---------~l~~----~~-~------~~~l~~~~~~------------------------------ 610 (675)
++|..+. . .++. .. . .....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 0 0110 00 0 0112332211
Q ss_pred -HHHHHHHHHHHHHHh----------cCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 611 -GIIEGIAQGLLYLHH----------YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 611 -~i~~~ia~~L~yLH~----------~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
.+...+..++.+|++ ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223446667763 1245699999999999998888999999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00012 Score=75.60 Aligned_cols=140 Identities=20% Similarity=0.110 Sum_probs=94.0
Q ss_pred ceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeEEEEEEecC
Q 005825 511 SMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ---HRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
...+.|+.|....+|+... ++..+++|+-... ....|..|...|+.+. ...+.+++.++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3457899999999999986 4678888886532 3567889999888884 3678899999888889999999999
Q ss_pred CCCHHH-----------HhcCCCC-c------------------ccCCHHHHH---HHHH----------------HHHH
Q 005825 588 NKSLDV-----------FLFDPTK-K------------------RLLGWQARI---GIIE----------------GIAQ 618 (675)
Q Consensus 588 ~gsL~~-----------~l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~ 618 (675)
+..+.. -|+.... . -.-+|.+.. ++.. .+..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 986521 1121110 0 012454321 1111 1111
Q ss_pred H-HHHHHh-cCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 619 G-LLYLHH-YSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 619 ~-L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
. ...|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223321 2356799999999999999887 9999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.76 E-value=8.5e-05 Score=75.76 Aligned_cols=80 Identities=18% Similarity=0.237 Sum_probs=61.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCC---CceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQH---RNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H---~nIv~l~g~~~~~~~~~lV~E 584 (675)
....-.+.+|.|..+.||+.++.+|+.+.||+-..........|..|...|+.+.. -.+.+++++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 35566688999999999999999999999998765544555678899999988842 2355666552 3478999
Q ss_pred ecCCCCH
Q 005825 585 YMPNKSL 591 (675)
Q Consensus 585 y~~~gsL 591 (675)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.0002 Score=77.23 Aligned_cols=74 Identities=14% Similarity=0.178 Sum_probs=47.0
Q ss_pred eeeeeCCcCceeEEEEEEcCCcEEEEEEecCc------C-cc--CHHHHHHHHHHHH-hcCCCceeeEEEEEEeCCeEEE
Q 005825 512 MECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ------S-GQ--GLEEFKNEMLLIA-KLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 512 ~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~------~-~~--~~~~f~~E~~il~-~l~H~nIv~l~g~~~~~~~~~l 581 (675)
..+.||.|....||+... +++.++||..... . .. ....+..|+..+. ...+..+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 347899999999999965 4678999943221 1 11 2233444443332 22335667777765 566799
Q ss_pred EEEec-CC
Q 005825 582 ILEYM-PN 588 (675)
Q Consensus 582 V~Ey~-~~ 588 (675)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00073 Score=69.77 Aligned_cols=144 Identities=17% Similarity=0.134 Sum_probs=81.9
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCc--eeeEEEE------EEeCCeEEEEEE
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN--LVRILGC------CIEQGEKILILE 584 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~n--Iv~l~g~------~~~~~~~~lV~E 584 (675)
.+.|+.|....+|+....++ .+++|..... ...+++..|+.++..+.... +.+++.. ....+..+++||
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 35677888899999987665 6788887652 12245566777776664212 2333321 123456789999
Q ss_pred ecCCCCHHH----H----------hc----CCCCc-----ccCCHHHHHH------------HHHHHHHHHHHHHhc---
Q 005825 585 YMPNKSLDV----F----------LF----DPTKK-----RLLGWQARIG------------IIEGIAQGLLYLHHY--- 626 (675)
Q Consensus 585 y~~~gsL~~----~----------l~----~~~~~-----~~l~~~~~~~------------i~~~ia~~L~yLH~~--- 626 (675)
|++|..+.. . ++ ..... ....|...+. +...+.+.++++++.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 999865421 0 11 00000 1112332111 011244556666542
Q ss_pred -CCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 627 -SRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 627 -~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
.+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234699999999999999876668999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00046 Score=74.64 Aligned_cols=73 Identities=18% Similarity=0.278 Sum_probs=50.7
Q ss_pred eeeeCCcCceeEEEEEEcC--------CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeEEEEE
Q 005825 513 ECKLGEGGFGPVYKGRLLN--------GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL-VRILGCCIEQGEKILIL 583 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nI-v~l~g~~~~~~~~~lV~ 583 (675)
.+.|+.|-...+|+....+ ++.+.+|+.... ...+.+..|..++..+...++ .++++.+.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678888889999998753 478888887431 122566689998888853333 567776542 3899
Q ss_pred EecCCCCH
Q 005825 584 EYMPNKSL 591 (675)
Q Consensus 584 Ey~~~gsL 591 (675)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0019 Score=67.12 Aligned_cols=142 Identities=15% Similarity=0.129 Sum_probs=73.5
Q ss_pred eeeCCcCcee-EEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC--CCceeeEEEEEEeCCeEEEEEEecCCCC
Q 005825 514 CKLGEGGFGP-VYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ--HRNLVRILGCCIEQGEKILILEYMPNKS 590 (675)
Q Consensus 514 ~~IG~G~fG~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (675)
+.|+.|.... +|+....+++.+++|....... +.+..|+.++..+. .-.+.+++.+..+.+ ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565554443 6676654466777776543211 33445666666663 234566777644333 78999998766
Q ss_pred HHHHhcCC---------------------CC--cccCCHHHHH--------------------HHHHHHHHHHHHHH---
Q 005825 591 LDVFLFDP---------------------TK--KRLLGWQARI--------------------GIIEGIAQGLLYLH--- 624 (675)
Q Consensus 591 L~~~l~~~---------------------~~--~~~l~~~~~~--------------------~i~~~ia~~L~yLH--- 624 (675)
+.+.+... .. ...++..... .....+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 64433110 00 0011111000 00011122233331
Q ss_pred hcCCCceEecCCCCCCEEEcCC----CCeEEeeeccceec
Q 005825 625 HYSRFRIIHRDLKASNVLLDRD----MNPKISDFGLARMF 660 (675)
Q Consensus 625 ~~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~~ 660 (675)
...+..++|+|+.+.||+++.+ ..+.|+||+.|..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1224569999999999999875 68999999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0039 Score=67.81 Aligned_cols=74 Identities=14% Similarity=0.110 Sum_probs=48.8
Q ss_pred eeeeCCcCceeEEEEEEcC-CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeEEEEEEecCCCC
Q 005825 513 ECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL-VRILGCCIEQGEKILILEYMPNKS 590 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gs 590 (675)
.+.|+.|-...+|+....+ +..+.+|+....... .-.-..|..++..+...++ .++++.+. + .+||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3678888889999998865 477888876542221 1122578888988865444 56777763 2 25999999855
Q ss_pred H
Q 005825 591 L 591 (675)
Q Consensus 591 L 591 (675)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0033 Score=64.94 Aligned_cols=142 Identities=14% Similarity=0.146 Sum_probs=83.5
Q ss_pred eeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCC--CceeeEEEE-----EEeCCeEEEEEEec
Q 005825 514 CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQH--RNLVRILGC-----CIEQGEKILILEYM 586 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H--~nIv~l~g~-----~~~~~~~~lV~Ey~ 586 (675)
..++ |....||+....+|+.+++|..... ....+.+..|..++..+.. -.+.+++.. ....+..++|||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4576 7788999988777778999998642 1234567778888777742 223444432 12345678899999
Q ss_pred CCCCHH-----HH---------hc----CC--CCcccCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 005825 587 PNKSLD-----VF---------LF----DP--TKKRLLGWQAR----IGI---------------IEGIAQGLLYLHHY- 626 (675)
Q Consensus 587 ~~gsL~-----~~---------l~----~~--~~~~~l~~~~~----~~i---------------~~~ia~~L~yLH~~- 626 (675)
+|..+. .. ++ .. ......++... ..+ ...+.+.++.+.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 985532 11 11 00 00111222110 001 11112223333321
Q ss_pred ---CCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 627 ---SRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 627 ---~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
.+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 344589999999999999 4 899999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0014 Score=69.44 Aligned_cols=141 Identities=17% Similarity=0.208 Sum_probs=83.1
Q ss_pred eeeCCcCceeEEEEEEcC--------CcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEEE
Q 005825 514 CKLGEGGFGPVYKGRLLN--------GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~E 584 (675)
+.|..|-...+|+....+ ++.+.+|+-.. .......+.+|..+++.+. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 567778788899988642 46888888533 2234566778999988874 3223567776643 28999
Q ss_pred ecCCCCHHHH-----------------hcCCC--CcccCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 005825 585 YMPNKSLDVF-----------------LFDPT--KKRLLG--WQARIGIIEGIA-------------------QGLLYLH 624 (675)
Q Consensus 585 y~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~ia-------------------~~L~yLH 624 (675)
|++|..|..- |+... -.+... |.+..++..++. +.+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665311 11110 011122 333333333321 2233333
Q ss_pred h-----cCCCceEecCCCCCCEEEcCC----CCeEEeeecccee
Q 005825 625 H-----YSRFRIIHRDLKASNVLLDRD----MNPKISDFGLARM 659 (675)
Q Consensus 625 ~-----~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~ 659 (675)
+ ..+..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 223468999999999999876 7899999998874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0017 Score=66.45 Aligned_cols=138 Identities=12% Similarity=0.101 Sum_probs=75.9
Q ss_pred eeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeEEEEEEec-CCCC
Q 005825 513 ECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL-VRILGCCIEQGEKILILEYM-PNKS 590 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~-~~gs 590 (675)
.+.|+.|....+|+. +.+.+|+-...... ......|+.+++.+....+ .++++. ..+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 478989999999998 56888877643221 1223567777777642222 456654 344457899999 6654
Q ss_pred HHHH------------------hcCCCC--cccCCHHHH-HHHHH--------------HHHHHHHHH----Hh-cCCCc
Q 005825 591 LDVF------------------LFDPTK--KRLLGWQAR-IGIIE--------------GIAQGLLYL----HH-YSRFR 630 (675)
Q Consensus 591 L~~~------------------l~~~~~--~~~l~~~~~-~~i~~--------------~ia~~L~yL----H~-~~~~~ 630 (675)
+... +|.... ........+ ..+.. .+.+.+..| .. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4210 111100 000111111 01100 011111111 11 22345
Q ss_pred eEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 631 IIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 631 iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++|+|+.|.||+ .+++.+.|+||..|..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667889999998874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0019 Score=68.20 Aligned_cols=74 Identities=12% Similarity=0.092 Sum_probs=44.7
Q ss_pred eeeeCCcCceeEEEEEEcC---------CcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCc-eeeEEEEEEeCCeEEEE
Q 005825 513 ECKLGEGGFGPVYKGRLLN---------GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN-LVRILGCCIEQGEKILI 582 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~n-Iv~l~g~~~~~~~~~lV 582 (675)
.+.|+.|-...+|+....+ ++.+.+|+...... .......|..++..+...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3568888888999998754 26788887654222 1223467888888775333 44676554 2 2689
Q ss_pred EEecCCCCH
Q 005825 583 LEYMPNKSL 591 (675)
Q Consensus 583 ~Ey~~~gsL 591 (675)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.013 Score=60.90 Aligned_cols=33 Identities=24% Similarity=0.419 Sum_probs=28.9
Q ss_pred CCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 628 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+..++|+|+.+.||++++++.+.|+||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 456999999999999998889999999887753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.03 E-value=0.11 Score=55.63 Aligned_cols=74 Identities=12% Similarity=0.088 Sum_probs=48.7
Q ss_pred eeeeCCcCceeEEEEEEcC--------CcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEEEE
Q 005825 513 ECKLGEGGFGPVYKGRLLN--------GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~lV~ 583 (675)
.+.|..|--..+|+....+ ++.+.+|+-.... ...-...+|..+++.+. +.-..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 4678778888999998753 5788888864432 22223457888887774 33345666543 2 27899
Q ss_pred EecCCCCH
Q 005825 584 EYMPNKSL 591 (675)
Q Consensus 584 Ey~~~gsL 591 (675)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.51 E-value=0.46 Score=50.38 Aligned_cols=29 Identities=24% Similarity=0.418 Sum_probs=25.2
Q ss_pred eEecCCCCCCEEE------cCCCCeEEeeecccee
Q 005825 631 IIHRDLKASNVLL------DRDMNPKISDFGLARM 659 (675)
Q Consensus 631 iiHrDlkp~NILl------~~~~~~kl~DFGla~~ 659 (675)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999999874
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=88.03 E-value=0.51 Score=37.59 Aligned_cols=34 Identities=24% Similarity=0.471 Sum_probs=28.4
Q ss_pred cCCHHHHHHHHhccCceeeeecccccCCceeEEecc
Q 005825 362 SMNLQQCAAECLKNCTCKAYANSNVTEGSGCLMWFG 397 (675)
Q Consensus 362 ~~~~~~C~~~Cl~nCsC~A~~~~~~~~~~~C~~w~~ 397 (675)
..++++|++.|+.+=.|.||.|... ...|+++.+
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~~--s~~CflKs~ 62 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNVK--SGLCYPKRG 62 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEETT--TTEEEEEES
T ss_pred CCCHHHHHHHhhccCCCCeEEeccC--CCceEcccC
Confidence 4689999999999999999999732 456999765
|
| >1b9w_A Protein (merozoite surface protein 1); MSP-1, candidate malaria vaccine, surface antigen; 1.80A {Plasmodium cynomolgi} SCOP: g.3.11.4 g.3.11.4 PDB: 2npr_A | Back alignment and structure |
|---|
Probab=82.42 E-value=0.36 Score=38.88 Aligned_cols=47 Identities=21% Similarity=0.335 Sum_probs=36.1
Q ss_pred cCCCCCCCccCCCCcccC-C-CCCCCCCccCCCccCCCCCCCCCCCCccCCCCCCCC
Q 005825 285 PDDYCGKYGYCGANTICG-P-DQKPMCQCLEGFRLKSQFNQTGPIKCERSHSSECIK 339 (675)
Q Consensus 285 p~~~C~~~~~CG~~g~C~-~-~~~~~C~C~~Gf~~~~~~~~~~~~gC~r~~~~~C~~ 339 (675)
+...| ++..|+.|+.|- + +....|.|+.||... ...|+++...+|..
T Consensus 3 ~~h~C-~~tkcp~NA~Cyr~~dg~EecRCllnykk~-------~~kCV~~~~~~C~~ 51 (95)
T 1b9w_A 3 SEHRC-IDTNVPENAACYRYLDGTEEWRCLLYFKED-------AGKCVPAPNMTCKD 51 (95)
T ss_dssp GGGSC-SSCCCCTTEEEEECTTSCEEEEECTTEEEE-------TTEEEECTTCCTTT
T ss_pred cCccc-ccCCCCCCcCeEEEcCCCEEEEEECCeEec-------CCEEEcCCCCCccc
Confidence 45668 667999999994 2 467899999999974 23588888777754
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=81.54 E-value=41 Score=32.79 Aligned_cols=73 Identities=15% Similarity=0.274 Sum_probs=45.6
Q ss_pred EEEEEecCCCcEEEEecCCCC--CC----CCcceEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeC
Q 005825 63 LGIWFRKVPDTVVWVANRDRP--IS----DHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDN 136 (675)
Q Consensus 63 lgiw~~~~~~tvVW~Anr~~p--v~----~~~~~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~ 136 (675)
+.+|= .-..+++|...+..+ +. .+.+.+-++.++.+...|.+|..+|.-..........+..+.+||+++-+.
T Consensus 17 v~~~d-~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 17 IAIIN-KDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp EEEEE-TTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred EEEEE-CCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 45552 112678899877542 11 123445556666677778889999998764222334567788899888764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 675 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-26 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-25 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 4e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-18 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-16 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 4e-15 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 0.003 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 9e-15 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 2e-14 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 4e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 7e-47
Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 6/168 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
++ ++G G FG VYKG+ V + +++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
+G + ++ ++ SL L + I I AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
IIHRDLK++N+ L D+ KI DFGLA + +++ G+
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-45
Identities = 42/172 (24%), Positives = 74/172 (43%), Gaps = 11/172 (6%)
Query: 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGL-EEFKNEMLLIAKLQH 563
++F +LG G G V+K +G +A K + + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
+V G GE + +E+M SLD L K + Q + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ +I+HRD+K SN+L++ K+ DFG++ VGT
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGT 166
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-45
Identities = 42/164 (25%), Positives = 82/164 (50%), Gaps = 6/164 (3%)
Query: 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN 565
+ + + +LG+G FG VYK + A K + ++S + LE++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+V++L + +++E+ ++D + + +R L + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH- 127
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT 669
+IIHRDLKA N+L D + K++DFG++ + ++
Sbjct: 128 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 7/168 (4%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
+ ++G G FG V+ G LN ++VA+K + + E+F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
++ G C+EQ L+ E+M + L +L ++ L + +G+ + +G + +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+IHRDL A N L+ + K+SDFG+ R D+ ++
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 54/168 (32%), Positives = 83/168 (49%), Gaps = 7/168 (4%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E + +LG G FG V+ G +VAVK L Q + F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
R+ + +I EYM N SL FL P+ +L + + IA+G+ ++ +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
IHRDL+A+N+L+ ++ KI+DFGLAR+ +E
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFP 173
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (394), Expect = 3e-43
Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 16/173 (9%)
Query: 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLS---SQSGQGLEEFKNEMLLIAKLQ 562
+ FS ++G G FG VY R + N E VA+K++S QS + ++ E+ + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
H N ++ GC + + L++EY + D+ K+ L + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
LH + +IHRD+KA N+LL K+ DFG A + VGT
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGT 174
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-42
Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 8/170 (4%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRL--SSQSGQGLEEFKNEMLLIAKLQHR 564
E++ + +G G +G K R +G+ + K L S + + +E+ L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 565 NLVRILGCCIEQGEKIL--ILEYMPNKSLDVFLFDPTKKR-LLGWQARIGIIEGIAQGLL 621
N+VR I++ L ++EY L + TK+R L + + ++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 622 YLH--HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT 669
H ++HRDLK +NV LD N K+ DFGLAR+ D
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (387), Expect = 2e-42
Identities = 53/191 (27%), Positives = 85/191 (44%), Gaps = 19/191 (9%)
Query: 498 FSLASVAAATENFSMEC---------KLGEGGFGPVYKGRLL----NGEEVAVKRL-SSQ 543
F+ A F+ E +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 544 SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRL 603
+ + +F +E ++ + H N++ + G + ++I E+M N SLD FL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 604 LGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663
+G++ GIA G+ YL +HRDL A N+L++ ++ K+SDFGL+R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 664 ELQGNTKRIVG 674
+G
Sbjct: 182 TSDPTYTSALG 192
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 5e-42
Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 7/168 (4%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
++ + +LG G FG V G+ +VA+K + S +EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
++ G C +Q +I EYM N L +L + + Q + + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES-- 118
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ +HRDL A N L++ K+SDFGL+R DE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 164
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 7e-42
Identities = 51/170 (30%), Positives = 75/170 (44%), Gaps = 8/170 (4%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLS-SQSGQGLEEFKNEMLLIAKLQHRN 565
E++ + LGEG +G V E VAVK + ++ E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+V+ G E + L LEY L + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
I HRD+K N+LLD N KISDFGLA +F + + ++ GT
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (381), Expect = 1e-41
Identities = 49/163 (30%), Positives = 84/163 (51%), Gaps = 6/163 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
+ +M+ KLG G +G VY+G VAVK L + + +EEF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
V++LG C + +I E+M +L +L + ++ + + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK 134
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT 669
IHRDL A N L+ + K++DFGL+R+ GD +
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 17/172 (9%)
Query: 515 KLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCI 574
+G+G FG V++G+ GEEVAVK SS+ + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 575 EQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH----- 625
+ L+ +Y + SL +L + + + I + A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF--GGDELQGNTKRIVGT 675
+ I HRDLK+ N+L+ ++ I+D GLA D + VGT
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-41
Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 6/162 (3%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
E+ +E KLG+G FG V+ G VA+K L + E F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 568 RILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS 627
++ + ++ EYM SL FL T K L + + IA G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132
Query: 628 RFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT 669
+HRDL+A+N+L+ ++ K++DFGLAR+ +E
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-40
Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 8/163 (4%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
+ + +G+G FG V G G +VAVK + + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 568 RILGCCIEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
++LG +E+ + ++ EYM SL +L + +LG + + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT 669
+HRDL A NVL+ D K+SDFGL + + G
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-40
Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 12/176 (6%)
Query: 506 ATENFSM-ECKLGEGGFGPVYKGRLL---NGEEVAVKRLSSQSGQG-LEEFKNEMLLIAK 560
+N + + +LG G FG V +G +VA+K L + + EE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGL 620
L + +VR++G C + +L++E L FL K+ + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKR-IVGT 675
YL +HRDL A NVLL KISDFGL++ G D+ +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 6e-40
Identities = 49/196 (25%), Positives = 79/196 (40%), Gaps = 31/196 (15%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLSSQSGQGLE-EFKNEMLLIAK 560
N +GEG FG V++ R VAVK L ++ ++ +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRL----------------- 603
+ N+V++LG C L+ EYM L+ FL + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 604 ----LGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659
L ++ I +A G+ YL + +HRDL N L+ +M KI+DFGL+R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 660 FGGDELQGNTKRIVGT 675
+
Sbjct: 190 IYSADYYKADGNDAIP 205
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 6e-39
Identities = 48/178 (26%), Positives = 87/178 (48%), Gaps = 10/178 (5%)
Query: 499 SLASVAAATENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLL 557
S+ SV + ++ K+G+G G VY + G+EVA+++++ Q E NE+L+
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 558 IAKLQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIA 617
+ + ++ N+V L + E +++EY+ S L D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126
Query: 618 QGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
Q L +LH ++IHRD+K+ N+LL D + K++DFG + Q +VGT
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 9e-39
Identities = 51/196 (26%), Positives = 73/196 (37%), Gaps = 31/196 (15%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLSSQSGQG-LEEFKNEMLLIAK 560
EN LG G FG V +VAVK L ++ E +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 561 L-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKK------------------ 601
L H N+V +LG C G LI EY L +L +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 602 --RLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659
+L ++ + +A+G+ +L +HRDL A NVL+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 660 FGGDELQGNTKRIVGT 675
D
Sbjct: 214 IMSDSNYVVRGNARLP 229
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-38
Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLS---SQSGQGLEEFKNEMLLIAKLQH 563
E+F + LG+G FG VY R + +A+K L + + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
N++R+ G + LILEY P ++ L +K Q I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
H R+IHRD+K N+LL KI+DFG + + GT
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 50/191 (26%), Positives = 69/191 (36%), Gaps = 26/191 (13%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSGQG-LEEFKNEMLLIAK 560
S LG G FG V + VAVK L + E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 561 L-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRL---------------L 604
L H N+V +LG C G ++I EY L FL + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 605 GWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ + +A+G+ +L IHRDL A N+LL KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 665 LQGNTKRIVGT 675
Sbjct: 200 NYVVKGNARLP 210
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 2e-38
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 16/171 (9%)
Query: 513 ECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRI 569
+ ++G G F VYKG EVA L + + + FK E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 570 LGCCIEQGEK----ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+ +L+ E M + +L +L + +++ + I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 626 YSRFRIIHRDLKASNVLL-DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ IIHRDLK N+ + + KI D GLA + K ++GT
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 176
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 9e-38
Identities = 45/171 (26%), Positives = 69/171 (40%), Gaps = 10/171 (5%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS---SQSGQGLEEFKNEMLLIAKLQH 563
E+F LGEG F V R L E A+K L + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
V++ + + L Y N L ++ R A+ + L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYT----AEIVSAL 121
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVG 674
+ IIHRDLK N+LL+ DM+ +I+DFG A++ + Q VG
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-37
Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 515 KLGEGGFGPVYKGRLLN---GEEVAVKRLSSQSGQG--LEEFKNEMLLIAKLQHRNLVRI 569
+LG G FG V KG + VAVK L +++ +E E ++ +L + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 570 LGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
+G C E +L++E L+ +L + R + + I ++ ++ G+ YL
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 630 RIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTK-RIVGT 675
+HRDL A NVLL KISDFGL++ DE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 8e-37
Identities = 52/175 (29%), Positives = 77/175 (44%), Gaps = 13/175 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAK 560
++ + KLG+G FG V +G VAVK L + +++F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGL 620
L HRNL+R+ G + ++ E P SL L LLG +R + +A+G+
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
YL R IHRDL A N+LL KI DFGL R ++ +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 139 bits (350), Expect = 9e-37
Identities = 35/170 (20%), Positives = 69/170 (40%), Gaps = 8/170 (4%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
+++ + +LG G FG V++ G A K + + E + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
V + + E ++I E+M L + D + + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 627 SRFRIIHRDLKASNVLLDRDMNP--KISDFGLARMFGGDELQGNTKRIVG 674
+H DLK N++ + K+ DFGL + T
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-36
Identities = 55/174 (31%), Positives = 87/174 (50%), Gaps = 12/174 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEE----VAVKRLS-SQSGQGLEEFKNEMLLIAKL 561
F LG G FG VYKG + GE+ VA+K L + S + +E +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
+ ++ R+LG C+ LI + MP L + K +G Q + IA+G+
Sbjct: 69 DNPHVCRLLGICLT-STVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
YL R++HRDL A NVL+ + KI+DFGLA++ G +E + + +
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 11/163 (6%)
Query: 515 KLGEGGFGPVYKGRLLN----GEEVAVKRLSSQSGQG-LEEFKNEMLLIAKLQHRNLVRI 569
+G G FG VY G LL+ AVK L+ + G + +F E +++ H N++ +
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 570 LGCCIE-QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSR 628
LG C+ +G +++L YM + L F+ + T + G+ + +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLAS 148
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKR 671
+ +HRDL A N +LD K++DFGLAR E +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 135 bits (341), Expect = 1e-35
Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 8/161 (4%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
+ + + +LG G FG V++ G K +++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
+ + ++ E +LILE++ L + + + I + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 627 SRFRIIHRDLKASNVLLDRDMNP--KISDFGLARMFGGDEL 665
I+H D+K N++ + KI DFGLA DE+
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 17/182 (9%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLS-SQSGQGLEEFKNEMLLIAK 560
E +M +LG+G FG VY+G VA+K ++ + S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARIGII 613
++VR+LG + ++I+E M L +L I +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 614 EGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIV 673
IA G+ YL+ + +HRDL A N ++ D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 674 GT 675
Sbjct: 197 LP 198
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 4e-35
Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 24/186 (12%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNG---EEVAVKRLS-SQSGQGLEEFKNEMLLIAKL-Q 562
+ + +GEG FG V K R+ + A+KR+ S +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLLGWQAR 609
H N++ +LG C +G L +EY P+ +L FL + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 610 IGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT 669
+ +A+G+ YL + IHRDL A N+L+ + KI+DFGL+R
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 670 KRIVGT 675
Sbjct: 184 TMGRLP 189
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 133 bits (335), Expect = 1e-34
Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 13/166 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQ- 562
+FS+ +G GGFG VY R G+ A+K L + QG NE ++++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 563 --HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGL 620
+V + + IL+ M L L + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQ 666
++H+ +++RDLK +N+LLD + +ISD GLA F +
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-34
Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 12/173 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE----VAVKRLSSQSGQGL-EEFKNEMLLIAKLQ 562
E + +GEG FG V++G ++ E VA+K + + + E+F E L + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
H ++V+++G E +I+E L FL L + I ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
L R +HRD+ A NVL+ + K+ DFGL+R +
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLP 172
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-34
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQG-LEEFKNEMLLIAKLQHR 564
++ +GEG +G V +N VA+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
N++ I + + Y+ + L+ K + L + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT 669
++HRDLK SN+LL+ + KI DFGLAR+ D
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 47/190 (24%), Positives = 70/190 (36%), Gaps = 25/190 (13%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSGQG--LEEFKNEMLLIA 559
+ + LG G FG V + VAVK L + +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 560 KLQHRNLVRILGCCIEQGEKILIL-EYMPNKSLDVFLF-------------DPTKKRLLG 605
H N+V +LG C + G ++++ E+ +L +L + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 606 WQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDEL 665
+ I +A+G+ +L + IHRDL A N+LL KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 666 QGNTKRIVGT 675
Sbjct: 190 YVRKGDARLP 199
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-34
Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 11/168 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEE-----VAVKRLSSQSGQG-LEEFKNEMLLIAKL 561
+ + +G G FG VYKG L VA+K L + + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 562 QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
H N++R+ G + ++I EYM N +LD FL + K +G++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGM- 123
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT 669
+ + +HRDL A N+L++ ++ K+SDFGL+R+ D T
Sbjct: 124 --KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (324), Expect = 1e-33
Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 10/160 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLS---SQSGQGLEEFKNEMLLIAKLQH 563
++F + LG G FG V+ R NG A+K L + +E +E L+++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
++R+ G + + +I++Y+ L L +++ A+ L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELF-SLLRKSQRFPNPVAKFY-----AAEVCLAL 117
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663
+ II+RDLK N+LLD++ + KI+DFG A+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 125 bits (316), Expect = 7e-33
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGL---------EEFKNEMLL 557
EN+ + LG G V + +E AVK + G E E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 558 IAKLQ-HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGI 616
+ K+ H N++++ L+ + M L +L T+K L + I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 617 AQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ + LH + I+HRDLK N+LLD DMN K++DFG + E + + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGT 172
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 15/169 (8%)
Query: 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLV 567
+++ +G G FG VY+ +L +GE VA+K++ E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 568 RILGCCIEQGEK------ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLL 621
R+ GEK L+L+Y+P V K+ L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 622 YLHHYSRFRIIHRDLKASNVLLDRD-MNPKISDFGLARMFGGDELQGNT 669
Y+H + I HRD+K N+LLD D K+ DFG A+ E +
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (311), Expect = 3e-32
Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 8/164 (4%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHRN 565
E + K+GEG +G VYK + GE A+K RL + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 566 LVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH 625
+V++ + +L+ E++ + + L + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 626 YSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNT 669
R++HRDLK N+L++R+ KI+DFGLAR FG +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-32
Identities = 32/160 (20%), Positives = 66/160 (41%), Gaps = 9/160 (5%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
E + + LG G FG V++ + + K + + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
+ + E ++I E++ + + T L + + + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLH-- 119
Query: 627 SRFRIIHRDLKASNVLLDRDMNP--KISDFGLARMFGGDE 664
I H D++ N++ + KI +FG AR +
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 5e-32
Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 26/191 (13%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL--------NGEEVAVKRLSSQ-SGQGLEEFKNEMLLI 558
+ + LGEG FG V + +VAVK L S + + L + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 559 AKL-QHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLL 604
+ +H+N++ +LG C + G +I+EY +L +L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 605 GWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
+ + +A+G+ YL + IHRDL A NVL+ D KI+DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 665 LQGNTKRIVGT 675
T
Sbjct: 190 YYKKTTNGRLP 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (308), Expect = 2e-31
Identities = 37/171 (21%), Positives = 67/171 (39%), Gaps = 8/171 (4%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEE-FKNEMLLIAKLQHR 564
+ + LG G F V + VA+K ++ ++ +G E +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
N+V + G LI++ + L + +K + +I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ LD D ISDFGL++M + GT
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 8/160 (5%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHR 564
ENF K+GEG +G VYK R L GE VA+K RL +++ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
N+V++L + + L+ E++ L + Q L L
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGLA 116
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
R++HRDLK N+L++ + K++DFGLAR FG
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 9e-31
Identities = 43/173 (24%), Positives = 69/173 (39%), Gaps = 13/173 (7%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLS---SQSGQGLEEFKNE-MLLIAKLQ 562
E+F + LG+G FG V+ + A+K L +E E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 563 HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLY 622
H L + + ++EY+ L + I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 623 LHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
LH I++RDLK N+LLD+D + KI+DFG+ + + + NT GT
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 118 bits (296), Expect = 3e-30
Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 15/178 (8%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS---SQSGQGLEEFKNEMLLIAKLQ 562
++ + + LG GG V+ R L +VAVK L ++ F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 563 HRNLVRILGCCIEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQ 618
H +V + + +++EY+ +L + + + I +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG-GDELQGNTKRIVGT 675
L + H + IIHRD+K +N+++ K+ DFG+AR T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 8e-30
Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 19/181 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRL--SSQSGQGLEEFKNEMLLIAKLQHR 564
+ K+G+G FG V+K R G++VA+K++ ++ E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 565 NLVRILGCCIEQGEKI--------LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGI 616
N+V ++ C + L+ ++ + + + K L R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRV-----M 123
Query: 617 AQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKR--IVG 674
L L++ R +I+HRD+KA+NVL+ RD K++DFGLAR F + + V
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 675 T 675
T
Sbjct: 184 T 184
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 3e-29
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 12/155 (7%)
Query: 515 KLGEGGFGPVYKGRLLN-GEEVAVKRLSSQSGQGLEE-----FKNEMLLIAKLQHRNLVR 568
LGEG F VYK R N + VA+K++ ++ E+ L+ +L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSR 628
+L + L+ ++M +L + QGL YLH +
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 629 FRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663
I+HRDLK +N+LLD + K++DFGLA+ FG
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-29
Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 9/160 (5%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVK--RLSSQSGQGLEEFKNEMLLIAKLQHR 564
+ + K+GEG +G V+K + E VA+K RL E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 565 NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLH 624
N+VR+ + L+ E+ F G + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 625 HYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664
++HRDLK N+L++R+ K+++FGLAR FG
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (282), Expect = 3e-28
Identities = 33/179 (18%), Positives = 75/179 (41%), Gaps = 18/179 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL 566
++ + ++GEG FG +++G LLN ++VA+K +S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 567 VRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY 626
+ + ++G +++ + SL+ L R + + + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 627 SRFRIIHRDLKASNVLLDRDMNP-----KISDFGLARMFGGDELQGN-----TKRIVGT 675
+++RD+K N L+ R + + DFG+ + + + + K + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 7e-28
Identities = 39/172 (22%), Positives = 67/172 (38%), Gaps = 12/172 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQH 563
+F LG+G FG V R G A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
L + ++EY L L + + + R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFY--GAEIVSAL 118
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ +++RD+K N++LD+D + KI+DFGL + D K GT
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 168
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 1e-27
Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 16/180 (8%)
Query: 506 ATENFSMECKLGEGGFGPVYKGRLL--NGEEVAVKRLSSQSGQGLEEFK-----NEMLLI 558
A + + ++GEG +G V+K R L G VA+KR+ Q+G+ + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 559 AKLQHRNLVRILGCCIEQGEKILILEYMPNKSLD---VFLFDPTKKRLLGWQARIGIIEG 615
+H N+VR+ C + + +D D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ +GL +LH R++HRDLK N+L+ K++DFGLAR++ Q +V T
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 3e-27
Identities = 38/176 (21%), Positives = 68/176 (38%), Gaps = 19/176 (10%)
Query: 510 FSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEE------FKNEMLLIAKLQ 562
+ + LG GGFG VY G + + VA+K + E E++L+ K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 563 --HRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGL 620
++R+L +LILE T++ L + + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRD-MNPKISDFGLARMFGGDELQGNTKRIVGT 675
+ H+ ++HRD+K N+L+D + K+ DFG + GT
Sbjct: 124 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGT 172
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 4e-27
Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 15/168 (8%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLS----SQSGQGLEEFKNEMLLIA 559
ENF + LG G +G V+ R + G+ A+K L Q + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 560 KLQHR-NLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQ 618
++ LV + + + LIL+Y+ L L + Q + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQ 666
+L L H + II+RD+K N+LLD + + ++DFGL++ F DE +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-27
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRL------SSQSGQGLEEFKNEMLLIAK 560
+ + +LG G F V K R G + A K + SS+ G E+ + E+ ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 561 LQHRNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGL 620
+QH N++ + + + ILILE + L +K L + ++ I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNG- 125
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNP----KISDFGLARMFGGDELQGNTKRIVGT 675
+++ +I H DLK N++L P KI DFGLA K I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 179
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 7e-26
Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 17/165 (10%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRL--SSQSGQGLEEFKNEMLLIAKLQHR 564
+ +G G +G V G +VA+K+L QS + E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 565 NLVRILGCCIEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQ 618
N++ +L + L++ +M + K LG ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663
GL Y+H IIHRDLK N+ ++ D KI DFGLAR +
Sbjct: 133 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 107 bits (267), Expect = 9e-26
Identities = 37/160 (23%), Positives = 64/160 (40%), Gaps = 10/160 (6%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQH 563
+ F LG G FG V + +G A+K L Q + +E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLVRILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
LV++ + +++EY+ + L + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 624 HHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663
H +I+RDLK N+L+D+ +++DFG A+ G
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 2e-25
Identities = 36/158 (22%), Positives = 64/158 (40%), Gaps = 18/158 (11%)
Query: 516 LGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCC 573
LG G G V + E+ A+K L + + E+ L + Q ++VRI+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 574 ----IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRF 629
+ ++++E + L + D + +A I++ I + + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE-IMKSIGEAIQYLH---SI 130
Query: 630 RIIHRDLKASNVLLDRDMNP---KISDFGLARMFGGDE 664
I HRD+K N+L K++DFG A+
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (261), Expect = 2e-25
Identities = 38/175 (21%), Positives = 71/175 (40%), Gaps = 16/175 (9%)
Query: 510 FSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVR 568
+ + K+G G FG +Y G + GEEVA+K ++ + E + +Q +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66
Query: 569 ILGCCIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSR 628
+ C +G+ +++ + SL+ R + + + + + + Y+H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 121
Query: 629 FRIIHRDLKASNVL---LDRDMNPKISDFGLARMFGGDELQGN-----TKRIVGT 675
IHRD+K N L + I DFGLA+ + + K + GT
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (261), Expect = 3e-25
Identities = 37/173 (21%), Positives = 75/173 (43%), Gaps = 20/173 (11%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRN 565
+++ + KLG G + V++ + N E+V VK L ++ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 566 LVRILGCCIEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYL 623
++ + + + L+ E++ N + L + R + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKALDYC 145
Query: 624 HHYSRFRIIHRDLKASNVLLDRD-MNPKISDFGLARMFGGDELQGNTKRIVGT 675
H I+HRD+K NV++D + ++ D+GLA + + V +
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVAS 192
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 99.9 bits (248), Expect = 8e-25
Identities = 28/158 (17%), Positives = 56/158 (35%), Gaps = 28/158 (17%)
Query: 515 KLGEGGFGPVYKGRLLNGEEVAVK--RLSSQSGQ--------GLEEFKNEMLLIAKLQHR 564
+GEG V+ E VK ++ S + G F + A+ + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 565 NLVRILGCCI----EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGL 620
L ++ G + +++E + K + + + +++ I + +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEEV 116
Query: 621 LYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658
+H I+H DL NVL+ + I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 92.3 bits (229), Expect = 4e-23
Identities = 22/118 (18%), Positives = 49/118 (41%), Gaps = 13/118 (11%)
Query: 35 IRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTIS 94
+ +GE L + Q ++ + + L ++ T VW +N +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYDH---STSVWASNTGILG-KKGCKAVLQ 58
Query: 95 NNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDY 152
++G V+ + ++W++++ N V L++DGN+VI + +W + Y
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------IWSTGTY 108
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 8e-23
Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 507 TENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS--SQSGQGLEEFKNEMLLIAKLQH 563
E + +G G +G V G VAVK+LS QS + E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 564 RNLVRILGCC-----IEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQ 618
N++ +L +E+ + ++ ++ L+ + K + L +I I +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILR 132
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661
GL Y+H IIHRDLK SN+ ++ D KI DFGLAR
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.1 bits (243), Expect = 8e-23
Identities = 44/177 (24%), Positives = 74/177 (41%), Gaps = 21/177 (11%)
Query: 508 ENFSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLS--SQSGQGLEEFKNEMLLIAKLQHR 564
+ + +G G G V + VA+K+LS Q+ + E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 565 NLVRILGCCIEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQ 618
N++ +L Q + L++E M V + + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130
Query: 619 GLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675
G+ +LH IIHRDLK SN+++ D KI DFGLAR G + V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVT 181
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.5 bits (205), Expect = 8e-18
Identities = 33/180 (18%), Positives = 67/180 (37%), Gaps = 18/180 (10%)
Query: 510 FSMECKLGEGGFGPVYKGR-LLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVR 568
+ + KLG G F V+ + ++N VA+K + E ++E+ L+ ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73
Query: 569 ILGCCIEQGEKIL-------------ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEG 615
K+L ++ + + L + R + I +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 616 IAQGLLYLHHYSRFRIIHRDLKASNVLLDR-DMNPKISDFGLARMFGGDELQGNTKRIVG 674
+ GL Y+H R IIH D+K NVL++ D + +A + + +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 73.4 bits (180), Expect = 2e-16
Identities = 16/97 (16%), Positives = 37/97 (38%), Gaps = 9/97 (9%)
Query: 65 IWFRKVP-DTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVA 123
I + D + + + L++ + LVL ++ + +WSTN + + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70
Query: 124 QLRDDGNLVIRDNSSVNTTENYLWQSFD--YPTDTLL 158
L+ +G + + N + +W S + +
Sbjct: 71 VLQPNGRMDVLTNQN-----IAVWTSGNSRSAGRYVF 102
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 69.3 bits (169), Expect = 4e-15
Identities = 25/126 (19%), Positives = 45/126 (35%), Gaps = 20/126 (15%)
Query: 27 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISD 86
+ + + GE L + F L ++ D +W N
Sbjct: 2 NILYSGETLSTGEFL--NYGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGLSR- 50
Query: 87 HNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYL 146
+ L++ +G LV+ N +N IW++N + N V L+ D N+VI
Sbjct: 51 -SCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101
Query: 147 WQSFDY 152
W + +
Sbjct: 102 WATGTH 107
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 35.8 bits (82), Expect = 0.003
Identities = 16/77 (20%), Positives = 34/77 (44%), Gaps = 1/77 (1%)
Query: 84 ISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTE 143
++ + V + + LVL + + IW+TN +++ ++ DGNLV+ + S+
Sbjct: 16 LNYGSFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWA 74
Query: 144 NYLWQSFDYPTDTLLQD 160
+ L +D
Sbjct: 75 SNTGGQNGNYVCILQKD 91
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 68.7 bits (167), Expect = 9e-15
Identities = 26/130 (20%), Positives = 49/130 (37%), Gaps = 18/130 (13%)
Query: 26 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPIS 85
+D + + G L + + + VW + + S
Sbjct: 1 SDRLNSGHQLDTGGSLAEG--GYLFIIQNDCNLVLYD--------NNRAVWASGTNGKAS 50
Query: 86 DHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENY 145
VL + N+G LV+ + + IW++N + + N L+ D N+VI DNS+ N
Sbjct: 51 --GCVLKMQNDGNLVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 146 LWQSFDYPTD 155
+W + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 68.1 bits (166), Expect = 2e-14
Identities = 18/112 (16%), Positives = 42/112 (37%), Gaps = 18/112 (16%)
Query: 41 LVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLV 100
++ + + + L ++ + +W N + + +G LV
Sbjct: 25 ILFGTHVYRFIMQTDCN-----LVLY---DNNNPIWATNTGGL--GNGCRAVLQPDGVLV 74
Query: 101 LLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDY 152
++ N T+W + + +A + V L+ D N+VI ++ LW +
Sbjct: 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA--------LWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 55.3 bits (133), Expect = 4e-10
Identities = 17/116 (14%), Positives = 29/116 (25%), Gaps = 39/116 (33%)
Query: 65 IWF-RKVPDTVVWVANRDRPISDHNAVLTISNNGKLV----------------------- 100
I F + + + + + T+ ++ LV
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 101 -------LLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQS 149
+L N WS+ N V L+ D + I LW S
Sbjct: 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPG--------LWDS 110
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 675 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.97 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.96 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.96 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.96 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.95 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.95 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.95 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.95 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.95 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.95 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.95 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.94 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.94 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.94 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.94 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.94 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.94 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.93 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.93 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.93 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.93 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.92 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.85 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.83 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.83 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.83 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.72 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.62 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.6 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.4 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.15 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.12 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.06 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.98 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.79 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.98 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.96 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.6 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.24 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 92.81 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 86.24 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 85.18 | |
| d1dx5i2 | 35 | Thrombomodulin, different EGF-like domains {Human | 82.18 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 81.29 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-33 Score=284.26 Aligned_cols=163 Identities=31% Similarity=0.410 Sum_probs=140.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.++||+|+||+||+|+.. +++.||||++.... ....+++.+|+.++++++|||||++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 367999999999999999999874 68999999997543 3345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|+++|+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..+.
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999984 3456899999999999999999999988 9999999999999999999999999999886554
Q ss_pred ccCCCCceecC
Q 005825 665 LQGNTKRIVGT 675 (675)
Q Consensus 665 ~~~~~~~~~GT 675 (675)
........+||
T Consensus 158 ~~~~~~~~~GT 168 (271)
T d1nvra_ 158 RERLLNKMCGT 168 (271)
T ss_dssp EECCBCCCCSC
T ss_pred ccccccceeeC
Confidence 44444456776
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.7e-32 Score=277.98 Aligned_cols=159 Identities=27% Similarity=0.443 Sum_probs=141.2
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
++|++.++||+|+||+||+|+. .+|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999986 469999999998665566788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCccc
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDELQ 666 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (675)
++|+|.+++.. ..+++.+...++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+..+...
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999998742 35899999999999999999999998 999999999999999999999999999988654432
Q ss_pred CCCCceecC
Q 005825 667 GNTKRIVGT 675 (675)
Q Consensus 667 ~~~~~~~GT 675 (675)
....+||
T Consensus 173 --~~~~~gt 179 (293)
T d1yhwa1 173 --RSTMVGT 179 (293)
T ss_dssp --BCCCCSC
T ss_pred --ccccccC
Confidence 2234565
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-32 Score=277.33 Aligned_cols=152 Identities=32% Similarity=0.574 Sum_probs=132.4
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.++|++.++||+|+||+||+|++.+++.||||+++. .....++|.+|+.++++++|||||+++|+|.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 368999999999999999999998889999999986 3455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
++|+|.+++.. ....+++..++.|+.|||+||+|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 99999999854 3456889999999999999999999987 9999999999999999999999999999885543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=1e-32 Score=283.24 Aligned_cols=154 Identities=32% Similarity=0.527 Sum_probs=139.0
Q ss_pred hcCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 506 ATENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 506 ~~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
..++|++.++||+|+||+||+|++. +++.||||+++.. ....++|++|+.+|++++|||||+++++|.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3468999999999999999999875 4889999999753 4456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|+++|+|.+++... ....+++..++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+.
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999998643 3456899999999999999999999987 9999999999999999999999999999886554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5e-32 Score=275.98 Aligned_cols=152 Identities=35% Similarity=0.545 Sum_probs=135.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.++|++.++||+|+||+||+|++.+++.||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 4688999999999999999999988899999999753 4456789999999999999999999998754 5679999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
++|+|.+++... ....+++..++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+...+
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999987542 2335899999999999999999999987 9999999999999999999999999999986554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.9e-32 Score=278.78 Aligned_cols=150 Identities=28% Similarity=0.460 Sum_probs=137.6
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
+.|++.++||+|+||+||+|+.. +++.||||+++.......+.|.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 57899999999999999999874 58999999998766677789999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
++|+|.+++.+ ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999998743 2346899999999999999999999998 99999999999999999999999999987643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7e-32 Score=276.76 Aligned_cols=162 Identities=30% Similarity=0.418 Sum_probs=138.4
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999874 6899999999743 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++|+|.+++. ..+.+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999884 3456899999999999999999999998 999999999999999999999999999998655
Q ss_pred cccCCCCceecC
Q 005825 664 ELQGNTKRIVGT 675 (675)
Q Consensus 664 ~~~~~~~~~~GT 675 (675)
.........+||
T Consensus 162 ~~~~~~~~~~GT 173 (288)
T d1uu3a_ 162 SKQARANSFVGT 173 (288)
T ss_dssp --------CCCC
T ss_pred CcccccccccCC
Confidence 444444455676
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.1e-32 Score=277.02 Aligned_cols=161 Identities=33% Similarity=0.492 Sum_probs=131.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.++||+|+||+||+|+.. ..||||+++.. .....++|++|+.++++++|||||++++++.+ ++.++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467889999999999999999864 36999999753 34456789999999999999999999998754 56899999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|+++|+|.+++... ...+++..++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999999643 345899999999999999999999987 9999999999999999999999999999886544
Q ss_pred ccCCCCceecC
Q 005825 665 LQGNTKRIVGT 675 (675)
Q Consensus 665 ~~~~~~~~~GT 675 (675)
......++.||
T Consensus 159 ~~~~~~~~~gt 169 (276)
T d1uwha_ 159 GSHQFEQLSGS 169 (276)
T ss_dssp -------CCCC
T ss_pred CcccccccccC
Confidence 33334445565
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-31 Score=271.17 Aligned_cols=150 Identities=31% Similarity=0.412 Sum_probs=136.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 5899999998642 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++|+|.+++. ....+++..+..|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999984 3456899999999999999999999987 999999999999999999999999999877544
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.8e-32 Score=283.00 Aligned_cols=150 Identities=26% Similarity=0.335 Sum_probs=135.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.++++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999874 68999999997643 3345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc-CCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY-SRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|+++|+|.+++. +...+++..+..++.|++.||.|||++ + |+||||||+||||++++++||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999994 345689999999999999999999975 6 99999999999999999999999999997743
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.4e-31 Score=267.43 Aligned_cols=152 Identities=30% Similarity=0.494 Sum_probs=138.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
.++|++.++||+|+||+||+|+.+++++||||+++.. ....++|++|+.++++++||||++++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 3688999999999999999999988899999999863 445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
++|+|..++.. ....+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...+
T Consensus 82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 99999999754 3456889999999999999999999987 9999999999999999999999999999876544
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=1.3e-31 Score=276.58 Aligned_cols=152 Identities=33% Similarity=0.560 Sum_probs=126.8
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC-C---cEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN-G---EEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~-g---~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
++|++.++||+|+||+||+|+... + ..||||++... .....++|.+|+.+|++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 568888999999999999998743 3 36899998754 334457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++|+|.+++... ...++|.+++.|+.|||+||+|||+++ |+||||||+||||++++++||+|||+|+.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 9999999999988542 346899999999999999999999987 99999999999999999999999999998865
Q ss_pred Cc
Q 005825 663 DE 664 (675)
Q Consensus 663 ~~ 664 (675)
..
T Consensus 181 ~~ 182 (299)
T d1jpaa_ 181 DT 182 (299)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-31 Score=270.78 Aligned_cols=157 Identities=27% Similarity=0.441 Sum_probs=126.7
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIE--QGEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~--~~~~~lV 582 (675)
++|++.+.||+|+||+||+|+.. +|+.||||.++... ....+.+.+|+.++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999874 68999999997542 2345679999999999999999999999975 3468999
Q ss_pred EEecCCCCHHHHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhcC--CCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 583 LEYMPNKSLDVFLFDP-TKKRLLGWQARIGIIEGIAQGLLYLHHYS--RFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
|||+++|+|.+++... .....+++..++.++.||+.||+|||+++ ..+||||||||+||||++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998532 22456899999999999999999999865 23599999999999999999999999999998
Q ss_pred cCCCc
Q 005825 660 FGGDE 664 (675)
Q Consensus 660 ~~~~~ 664 (675)
+..+.
T Consensus 164 ~~~~~ 168 (269)
T d2java1 164 LNHDT 168 (269)
T ss_dssp C----
T ss_pred cccCC
Confidence 86543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=1.5e-30 Score=274.06 Aligned_cols=153 Identities=23% Similarity=0.402 Sum_probs=137.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.++|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999874 6899999999876555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc--CCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD--RDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~ 663 (675)
+++|+|.+++.. ....+++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999853 2346899999999999999999999998 99999999999995 4678999999999988654
Q ss_pred c
Q 005825 664 E 664 (675)
Q Consensus 664 ~ 664 (675)
.
T Consensus 180 ~ 180 (350)
T d1koaa2 180 Q 180 (350)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-30 Score=266.74 Aligned_cols=152 Identities=31% Similarity=0.528 Sum_probs=132.0
Q ss_pred cCCcceee-eeCCcCceeEEEEEEc---CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMEC-KLGEGGFGPVYKGRLL---NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~-~IG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|.+.+ +||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|++.. +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 35677777 4999999999999764 35589999997643 3346789999999999999999999999864 56899
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++|+|.+++.. ....+++..+..|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999999843 2346899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCc
Q 005825 662 GDE 664 (675)
Q Consensus 662 ~~~ 664 (675)
..+
T Consensus 161 ~~~ 163 (285)
T d1u59a_ 161 ADD 163 (285)
T ss_dssp TCS
T ss_pred ccc
Confidence 543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.6e-31 Score=270.22 Aligned_cols=151 Identities=33% Similarity=0.558 Sum_probs=132.1
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMP 587 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 587 (675)
++|++.+.||+|+||+||+|++.+++.||||+++. .....++|.+|+.++++++|||||+++|+|.+ ++.++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECc-ccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 67999999999999999999998888999999975 34556789999999999999999999999854 56889999999
Q ss_pred CCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 588 NKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 588 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
+|+|..++... ....++|.+++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999988542 2346899999999999999999999987 9999999999999999999999999999875444
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.6e-31 Score=273.80 Aligned_cols=166 Identities=31% Similarity=0.429 Sum_probs=136.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC------CcEEEEEEecCc-CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN------GEEVAVKRLSSQ-SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~------g~~vAvK~l~~~-~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~ 578 (675)
.++|++.++||+|+||+||+|+... ...||||.+... .......|.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4689999999999999999998643 236999998754 334557899999999998 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCC--------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCC
Q 005825 579 KILILEYMPNKSLDVFLFDPTK--------------------KRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKA 638 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp 638 (675)
.++||||+++|+|.+++..... ...+++..++.|+.||++||+|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999964321 235899999999999999999999987 99999999
Q ss_pred CCEEEcCCCCeEEeeeccceecCCCcccCCCCceecC
Q 005825 639 SNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 639 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 675 (675)
+|||++.++.+||+|||+|+............+..||
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 229 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence 9999999999999999999987655433323334444
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-30 Score=273.60 Aligned_cols=161 Identities=26% Similarity=0.328 Sum_probs=141.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
.++|++.+.||+|+||+||+|+. .+++.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999987 46999999999753 234567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++|+|.+++. +...+++.....++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.+..
T Consensus 84 ~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999984 3456888999999999999999999998 99999999999999999999999999998754
Q ss_pred CcccCCCCceecC
Q 005825 663 DELQGNTKRIVGT 675 (675)
Q Consensus 663 ~~~~~~~~~~~GT 675 (675)
... .....+||
T Consensus 158 ~~~--~~~~~~GT 168 (337)
T d1o6la_ 158 DGA--TMKTFCGT 168 (337)
T ss_dssp TTC--CBCCCEEC
T ss_pred CCc--ccccceeC
Confidence 432 23346776
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=2e-30 Score=273.38 Aligned_cols=152 Identities=26% Similarity=0.387 Sum_probs=137.1
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEec
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYM 586 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 586 (675)
++|++.++||+|+||+||+|+. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999987 469999999998655555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc--CCCCeEEeeeccceecCCCc
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD--RDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~ 664 (675)
++|+|.+++.. ....+++.+...|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+..++
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999888743 3346899999999999999999999988 99999999999998 67899999999999986654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-30 Score=266.00 Aligned_cols=144 Identities=33% Similarity=0.502 Sum_probs=125.4
Q ss_pred eeeCCcCceeEEEEEEcC---CcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 005825 514 CKLGEGGFGPVYKGRLLN---GEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEYMPN 588 (675)
Q Consensus 514 ~~IG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 588 (675)
++||+|+||+||+|.+.+ ++.||||+++... ....++|.+|+.++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998643 4689999997532 3345689999999999999999999999864 567899999999
Q ss_pred CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 589 KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 589 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|+|.+++. ....+++..++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 99999984 3456899999999999999999999987 9999999999999999999999999999886543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-30 Score=263.88 Aligned_cols=149 Identities=30% Similarity=0.442 Sum_probs=128.5
Q ss_pred ceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeEEEEE
Q 005825 511 SMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE----QGEKILIL 583 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~----~~~~~lV~ 583 (675)
++.++||+|+||+||+|+.. +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 66778999999999999875 5889999998753 23345679999999999999999999999875 34579999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc-CCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD-RDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~ 662 (675)
||+++|+|.+++. +...+++.++..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999994 3456899999999999999999999874 4599999999999996 578999999999987644
Q ss_pred C
Q 005825 663 D 663 (675)
Q Consensus 663 ~ 663 (675)
.
T Consensus 168 ~ 168 (270)
T d1t4ha_ 168 S 168 (270)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.1e-30 Score=270.50 Aligned_cols=149 Identities=33% Similarity=0.520 Sum_probs=133.4
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
..|+..++||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3589999999999999999986 4688999999975432 23457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
||+++|+|+.++. ....+++.++..|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987763 3456899999999999999999999998 99999999999999999999999999997654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=3.4e-30 Score=262.66 Aligned_cols=152 Identities=28% Similarity=0.362 Sum_probs=136.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCcc---------CHHHHHHHHHHHHhcC-CCceeeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQ---------GLEEFKNEMLLIAKLQ-HRNLVRILGCCIE 575 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~---------~~~~f~~E~~il~~l~-H~nIv~l~g~~~~ 575 (675)
.++|++.++||+|+||+||+|+. .+++.||||++++.... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999987 46899999999754221 1246889999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
++..+|||||+++|+|.+++. ....+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999994 3456899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCc
Q 005825 656 LARMFGGDE 664 (675)
Q Consensus 656 la~~~~~~~ 664 (675)
+|+.+....
T Consensus 156 ~a~~~~~~~ 164 (277)
T d1phka_ 156 FSCQLDPGE 164 (277)
T ss_dssp TCEECCTTC
T ss_pred heeEccCCC
Confidence 999886543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=1.6e-30 Score=269.14 Aligned_cols=160 Identities=26% Similarity=0.369 Sum_probs=123.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
.+.|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999875 58999999997543 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc---CCCCeEEeeeccceecC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD---RDMNPKISDFGLARMFG 661 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~~~ 661 (675)
|+++|+|.+++.. ...+++.+...++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999953 456899999999999999999999998 99999999999994 57899999999999875
Q ss_pred CCcccCCCCceecC
Q 005825 662 GDELQGNTKRIVGT 675 (675)
Q Consensus 662 ~~~~~~~~~~~~GT 675 (675)
..+. ....+||
T Consensus 162 ~~~~---~~~~~GT 172 (307)
T d1a06a_ 162 PGSV---LSTACGT 172 (307)
T ss_dssp --------------
T ss_pred CCCe---eeeeeeC
Confidence 5432 2234565
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2e-30 Score=265.69 Aligned_cols=153 Identities=33% Similarity=0.569 Sum_probs=129.1
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCC-----cEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNG-----EEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g-----~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
.+.|+..++||+|+||+||+|++.+. ..||||+++... .....+|.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35788899999999999999987542 479999997543 334567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||++++++.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+
T Consensus 86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999988753 2356899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
....
T Consensus 161 ~~~~ 164 (283)
T d1mqba_ 161 EDDP 164 (283)
T ss_dssp ----
T ss_pred cCCC
Confidence 5543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=3.2e-30 Score=268.00 Aligned_cols=150 Identities=29% Similarity=0.425 Sum_probs=135.5
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999987 45899999999753 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+++|+|..++. ....+++.....++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999884 3456788888899999999999999987 999999999999999999999999999987543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=9e-31 Score=270.74 Aligned_cols=169 Identities=29% Similarity=0.450 Sum_probs=140.5
Q ss_pred HHHhcCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEe
Q 005825 503 VAAATENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIE 575 (675)
Q Consensus 503 ~~~~~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~ 575 (675)
++...++|++.++||+|+||+||+|+.. +++.||||+++.... ...++|.+|+.++++++||||++++++|.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3345678999999999999999999864 357899999976433 345679999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCC---------------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEec
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPT---------------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHR 634 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHr 634 (675)
.+..++||||+++|+|.+++.... ....+++..++.|+.|++.||+|||+++ ||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence 999999999999999999985321 1234889999999999999999999987 9999
Q ss_pred CCCCCCEEEcCCCCeEEeeeccceecCCCcccCCCCceec
Q 005825 635 DLKASNVLLDRDMNPKISDFGLARMFGGDELQGNTKRIVG 674 (675)
Q Consensus 635 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G 674 (675)
||||+||||+.++.+||+|||+|+.+...+....+....|
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~ 204 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI 204 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCB
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCc
Confidence 9999999999999999999999998755543333333344
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.8e-30 Score=261.86 Aligned_cols=152 Identities=30% Similarity=0.418 Sum_probs=135.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC------ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS------GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~------~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
.+.|++.+.||+|+||+||+|+. .+|+.||||++++.. ....+.|.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999987 468999999986432 22467899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC----CeEEeeec
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM----NPKISDFG 655 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFG 655 (675)
+|||||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999984 3456899999999999999999999998 99999999999998876 49999999
Q ss_pred cceecCCCc
Q 005825 656 LARMFGGDE 664 (675)
Q Consensus 656 la~~~~~~~ 664 (675)
+|+.+....
T Consensus 163 ~a~~~~~~~ 171 (293)
T d1jksa_ 163 LAHKIDFGN 171 (293)
T ss_dssp TCEECTTSC
T ss_pred hhhhcCCCc
Confidence 999885443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.6e-29 Score=260.63 Aligned_cols=152 Identities=20% Similarity=0.303 Sum_probs=134.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.++|++.+.||+|+||+||+|+.. +++.||||.++... .....+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 368999999999999999999874 68899999997642 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC--CCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR--DMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 663 (675)
+++|+|.+++.. ....+++.+...|+.||+.||+|||+++ |+||||||+|||++. ...+||+|||+|+.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999943 2336899999999999999999999988 999999999999985 458999999999987554
Q ss_pred c
Q 005825 664 E 664 (675)
Q Consensus 664 ~ 664 (675)
.
T Consensus 158 ~ 158 (321)
T d1tkia_ 158 D 158 (321)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=1.9e-29 Score=265.76 Aligned_cols=150 Identities=25% Similarity=0.337 Sum_probs=136.2
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~ 583 (675)
++|++.++||+|+||.||+|+.. +|+.||||++++. .....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999874 6999999998643 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
||+.+|+|..++. +...+++.....++.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999984 3456899999999999999999999998 999999999999999999999999999988543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-29 Score=263.55 Aligned_cols=162 Identities=33% Similarity=0.526 Sum_probs=132.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCc----EEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGE----EVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.+|++.++||+|+||+||+|+.. +|+ +||||+++.. .....++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 343 6899998753 445678899999999999999999999999864 5678
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
++||+.+++|.+++.. ....+++..++.|+.|||.||+|||+++ |+||||||+||||+.++++||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999988754 3456899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCcccCCCCceecC
Q 005825 662 GDELQGNTKRIVGT 675 (675)
Q Consensus 662 ~~~~~~~~~~~~GT 675 (675)
..+....+...+||
T Consensus 163 ~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 163 AEEKEYHAEGGKVP 176 (317)
T ss_dssp TTCC--------CC
T ss_pred cccccccccccccC
Confidence 65544444444554
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=1.9e-29 Score=267.10 Aligned_cols=152 Identities=29% Similarity=0.357 Sum_probs=131.8
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHH---HHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNE---MLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E---~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
.++|++.++||+|+||.||+|+.. +|+.||||++.+. .......+.+| +.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999875 5899999998642 12233344444 6677778899999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
++||||+++|+|.+++. ....+++..+..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999994 3456888999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCc
Q 005825 660 FGGDE 664 (675)
Q Consensus 660 ~~~~~ 664 (675)
+....
T Consensus 157 ~~~~~ 161 (364)
T d1omwa3 157 FSKKK 161 (364)
T ss_dssp CSSSC
T ss_pred cCCCc
Confidence 86543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-29 Score=262.30 Aligned_cols=166 Identities=27% Similarity=0.420 Sum_probs=139.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEK 579 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~ 579 (675)
.++|++.++||+|+||+||+|++. +++.||||+++... ......|.+|+.++++++|||||+++++|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 368899999999999999999763 35789999997543 23445799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCC-------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 005825 580 ILILEYMPNKSLDVFLFDP-------TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKIS 652 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 652 (675)
++||||+++|+|.+++... .....+++..+..|+.|+|+||.|||+++ |+||||||+||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999998532 12235789999999999999999999987 9999999999999999999999
Q ss_pred eeccceecCCCcccCCCCceecC
Q 005825 653 DFGLARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 653 DFGla~~~~~~~~~~~~~~~~GT 675 (675)
|||+|+.+........+.+..||
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t 198 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLP 198 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEEC
T ss_pred ecccceeccCCcceeeccceecc
Confidence 99999988655443333333443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.8e-29 Score=259.46 Aligned_cols=160 Identities=26% Similarity=0.380 Sum_probs=137.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCc---CccCHHHHHHHHHHHH-hcCCCceeeEEEEEEeCCeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQ---SGQGLEEFKNEMLLIA-KLQHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~il~-~l~H~nIv~l~g~~~~~~~~~lV 582 (675)
++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999874 5899999999753 2345567777877765 68999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 005825 583 LEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGG 662 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (675)
|||+++|+|.+++. ....+++.+...++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.+..
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999994 3456888999999999999999999998 99999999999999999999999999997754
Q ss_pred CcccCCCCceecC
Q 005825 663 DELQGNTKRIVGT 675 (675)
Q Consensus 663 ~~~~~~~~~~~GT 675 (675)
.... ....+||
T Consensus 156 ~~~~--~~~~~gt 166 (320)
T d1xjda_ 156 GDAK--TNTFCGT 166 (320)
T ss_dssp TTCC--BCCCCSC
T ss_pred cccc--ccccCCC
Confidence 4332 2234565
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.8e-29 Score=258.05 Aligned_cols=152 Identities=31% Similarity=0.473 Sum_probs=131.2
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++|++.++||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.++++++|||||++++++.++++.++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999987 568999999997532 2346789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
|+.++.+..... .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....+.
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 998665544432 23446899999999999999999999998 9999999999999999999999999999875443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.4e-29 Score=259.69 Aligned_cols=166 Identities=28% Similarity=0.406 Sum_probs=129.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcC-ccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC-
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQG- 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~- 577 (675)
.++|++.++||+|+||+||+|+.. +++.||||+++... ....+++..|+.++.++ +|+||+++++++.+.+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 468999999999999999999863 24689999997543 33456788888888877 6899999999987654
Q ss_pred eEEEEEEecCCCCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc
Q 005825 578 EKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD 644 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 644 (675)
..++||||+++|+|.+++.... ....+++.+++.++.||++||+|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 6899999999999999986422 1345889999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccceecCCCcccCCCCceecC
Q 005825 645 RDMNPKISDFGLARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 645 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 675 (675)
+++++||+|||+|+..........+...+||
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 199 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLP 199 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred CCCcEEEccCcchhhccccccccccCceeeC
Confidence 9999999999999988655544444455665
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.4e-29 Score=257.35 Aligned_cols=148 Identities=29% Similarity=0.425 Sum_probs=125.8
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHH--HHHHHHHhcCCCceeeEEEEEEeCC----eEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFK--NEMLLIAKLQHRNLVRILGCCIEQG----EKIL 581 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~--~E~~il~~l~H~nIv~l~g~~~~~~----~~~l 581 (675)
+.|.+.++||+|+||.||+|++ +|+.||||+++.. ..+++. .|+..+.+++|||||+++++|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 5678889999999999999997 6889999999743 223333 4555556789999999999998754 5799
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhc-----CCCceEecCCCCCCEEEcCCCCeEEeeecc
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHY-----SRFRIIHRDLKASNVLLDRDMNPKISDFGL 656 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 656 (675)
||||+++|+|.+++.+ ..++|..++.++.++|.||+|||+. +..+|+||||||+||||++++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999953 3589999999999999999999974 234699999999999999999999999999
Q ss_pred ceecCCC
Q 005825 657 ARMFGGD 663 (675)
Q Consensus 657 a~~~~~~ 663 (675)
++.+...
T Consensus 155 ~~~~~~~ 161 (303)
T d1vjya_ 155 AVRHDSA 161 (303)
T ss_dssp CEEEETT
T ss_pred cccccCC
Confidence 9988554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-29 Score=255.70 Aligned_cols=151 Identities=32% Similarity=0.452 Sum_probs=124.5
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC--C--cEEEEEEecCc---CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN--G--EEVAVKRLSSQ---SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKI 580 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~--g--~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 580 (675)
++|++.+.||+|+||+||+|++.. + .+||||++++. .....++|.+|+.++++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 679999999999999999998632 2 37899998753 23345789999999999999999999999965 4678
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+||||+++|++.+++.. ....+++..++.++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999988753 3456899999999999999999999987 999999999999999999999999999988
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
....
T Consensus 162 ~~~~ 165 (273)
T d1u46a_ 162 PQND 165 (273)
T ss_dssp CC-C
T ss_pred ccCC
Confidence 5544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.96 E-value=4.9e-29 Score=255.72 Aligned_cols=150 Identities=28% Similarity=0.443 Sum_probs=135.6
Q ss_pred CCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.++||+|+||+||+|+..+++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999899999999997542 33467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+.++.+..+. .....+++..+..|+.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9988887776 33466999999999999999999999987 999999999999999999999999999887543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.3e-29 Score=255.26 Aligned_cols=152 Identities=28% Similarity=0.427 Sum_probs=124.1
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC----CcEEEEEEecCcCc-cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN----GEEVAVKRLSSQSG-QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~l 581 (675)
.++|++.+.||+|+||+||+|+... +..||||.++.... ...+.|.+|+.++++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3689999999999999999998643 35799999875433 34567999999999999999999999985 467899
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecC
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFG 661 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 661 (675)
||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||++++++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998743 3446899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCc
Q 005825 662 GDE 664 (675)
Q Consensus 662 ~~~ 664 (675)
...
T Consensus 160 ~~~ 162 (273)
T d1mp8a_ 160 DST 162 (273)
T ss_dssp ---
T ss_pred CCc
Confidence 443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.2e-29 Score=257.25 Aligned_cols=152 Identities=34% Similarity=0.575 Sum_probs=132.0
Q ss_pred CCcceeeeeCCcCceeEEEEEEcC-Cc--EEEEEEecCc-CccCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLLN-GE--EVAVKRLSSQ-SGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGEKILI 582 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~~-g~--~vAvK~l~~~-~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~~~lV 582 (675)
++|++.++||+|+||+||+|++.+ +. .||||+++.. .....++|.+|+++|.++ +|||||+++++|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 688999999999999999998754 44 5788888643 344567899999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-------------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCe
Q 005825 583 LEYMPNKSLDVFLFDP-------------TKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNP 649 (675)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 649 (675)
|||+++|+|.++++.. .....+++..++.++.|||+||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 23457899999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceecCC
Q 005825 650 KISDFGLARMFGG 662 (675)
Q Consensus 650 kl~DFGla~~~~~ 662 (675)
||+|||+|+....
T Consensus 167 kl~DfG~a~~~~~ 179 (309)
T d1fvra_ 167 KIADFGLSRGQEV 179 (309)
T ss_dssp EECCTTCEESSCE
T ss_pred EEccccccccccc
Confidence 9999999987643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.95 E-value=8.3e-29 Score=252.78 Aligned_cols=163 Identities=25% Similarity=0.367 Sum_probs=132.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCc---cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC----e
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSG---QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG----E 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~----~ 578 (675)
.++|++.+.||+|+||+||+|+. .+++.||||+++.... ...+.|.+|+.++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999986 4699999999976432 33457999999999999999999999998654 3
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.+|||||+++++|.+++. ....+++.+...|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999884 3456899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCc-ccCCCCceecC
Q 005825 659 MFGGDE-LQGNTKRIVGT 675 (675)
Q Consensus 659 ~~~~~~-~~~~~~~~~GT 675 (675)
.+.... ........+||
T Consensus 160 ~~~~~~~~~~~~~~~~Gt 177 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGT 177 (277)
T ss_dssp ECC---------------
T ss_pred hhccccccccccccccCc
Confidence 774332 22223334554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5e-29 Score=258.73 Aligned_cols=166 Identities=30% Similarity=0.406 Sum_probs=140.3
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc------CCcEEEEEEecCcCc-cCHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL------NGEEVAVKRLSSQSG-QGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQGE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~~~ 578 (675)
.++|++.++||+|+||.||+|++. +++.||||+++.... ....+|.+|+.+++++ +|||||+++++|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 468999999999999999999752 367899999986433 3456799999999999 69999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCC---------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE
Q 005825 579 KILILEYMPNKSLDVFLFDPT---------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL 643 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 643 (675)
.++||||+++|+|.++++... ....+++..+..++.||++||+|||+++ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986421 2336889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccceecCCCcccCCCCceecC
Q 005825 644 DRDMNPKISDFGLARMFGGDELQGNTKRIVGT 675 (675)
Q Consensus 644 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 675 (675)
+.++.+||+|||+|+.+.............||
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred cccCcccccccchheeccCCCcceEeeecccC
Confidence 99999999999999988655433333334444
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.6e-29 Score=256.94 Aligned_cols=147 Identities=31% Similarity=0.411 Sum_probs=126.3
Q ss_pred eeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCc-----cCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEEe
Q 005825 512 MECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSG-----QGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILEY 585 (675)
Q Consensus 512 ~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-----~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 585 (675)
.+++||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.++++++|||||++++++.++++.++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3579999999999999874 589999999975322 1235689999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
++++++..+. .....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..+.
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9998877665 33456888889999999999999999998 9999999999999999999999999999876543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.9e-28 Score=254.03 Aligned_cols=147 Identities=32% Similarity=0.558 Sum_probs=128.3
Q ss_pred eeeeCCcCceeEEEEEEcCC----cEEEEEEecCc-CccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC-CeEEEEEEec
Q 005825 513 ECKLGEGGFGPVYKGRLLNG----EEVAVKRLSSQ-SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ-GEKILILEYM 586 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~g----~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~ 586 (675)
.++||+|+||+||+|++.+. ..||||+++.. .....++|.+|++++++++|||||+++|++.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987542 36899999753 344567899999999999999999999998764 5899999999
Q ss_pred CCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCCc
Q 005825 587 PNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGDE 664 (675)
Q Consensus 587 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (675)
++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.+...+
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999864 3445778899999999999999999987 9999999999999999999999999999886543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.3e-29 Score=252.37 Aligned_cols=150 Identities=31% Similarity=0.535 Sum_probs=126.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC-CeEEEEEEe
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ-GEKILILEY 585 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~-~~~~lV~Ey 585 (675)
.++|++.++||+|+||.||+|++ .|++||||+++.. ...++|.+|++++++++||||++++|+|.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35788999999999999999998 5788999999753 3457899999999999999999999999654 568999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
+++|+|.+++... ....++|..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999999999542 2335899999999999999999999987 999999999999999999999999999977543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.5e-28 Score=253.73 Aligned_cols=165 Identities=31% Similarity=0.467 Sum_probs=134.9
Q ss_pred cCCcceeeeeCCcCceeEEEEEEcC--------CcEEEEEEecCcCc-cCHHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLLN--------GEEVAVKRLSSQSG-QGLEEFKNEMLLIAKL-QHRNLVRILGCCIEQ 576 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~-~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~~ 576 (675)
.++|++.++||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4689999999999999999997532 34799999976533 3457899999999888 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEE
Q 005825 577 GEKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLL 643 (675)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 643 (675)
+..++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999996432 1246899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccceecCCCcccCCCCceec
Q 005825 644 DRDMNPKISDFGLARMFGGDELQGNTKRIVG 674 (675)
Q Consensus 644 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G 674 (675)
+.++.+||+|||+++..........+...+|
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 199 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred cCCCCeEeccchhhccccccccccccccCCC
Confidence 9999999999999998865544333333444
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.3e-28 Score=253.18 Aligned_cols=149 Identities=23% Similarity=0.327 Sum_probs=127.7
Q ss_pred cCCcceee-eeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhc-CCCceeeEEEEEEe----CCeE
Q 005825 507 TENFSMEC-KLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKL-QHRNLVRILGCCIE----QGEK 579 (675)
Q Consensus 507 ~~~f~~~~-~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~H~nIv~l~g~~~~----~~~~ 579 (675)
.++|.+.+ .||+|+||+||+|+. .+++.||||+++. ...+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36898875 599999999999986 5689999999964 25678899987655 89999999999875 3568
Q ss_pred EEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC---CCCeEEeeecc
Q 005825 580 ILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR---DMNPKISDFGL 656 (675)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGl 656 (675)
++||||++||+|.+++... ....+++.+...|+.||+.||+|||+++ |+||||||+|||+++ .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999642 2346899999999999999999999998 999999999999985 56799999999
Q ss_pred ceecCCCc
Q 005825 657 ARMFGGDE 664 (675)
Q Consensus 657 a~~~~~~~ 664 (675)
|+.+...+
T Consensus 161 a~~~~~~~ 168 (335)
T d2ozaa1 161 AKETTSHN 168 (335)
T ss_dssp CEECCCCC
T ss_pred eeeccCCC
Confidence 99886544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.3e-28 Score=246.84 Aligned_cols=151 Identities=24% Similarity=0.368 Sum_probs=130.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCc------cCHHHHHHHHHHHHhcC--CCceeeEEEEEEeCC
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSG------QGLEEFKNEMLLIAKLQ--HRNLVRILGCCIEQG 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~f~~E~~il~~l~--H~nIv~l~g~~~~~~ 577 (675)
.++|++.++||+|+||+||+|+. .+++.||||++++... ....++.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36899999999999999999986 4689999999875321 12345778999999996 899999999999999
Q ss_pred eEEEEEEecCC-CCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-CCCeEEeeec
Q 005825 578 EKILILEYMPN-KSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-DMNPKISDFG 655 (675)
Q Consensus 578 ~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFG 655 (675)
..++||||+.+ +++.+++. ....+++.++..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999986 67777773 3456899999999999999999999988 999999999999985 4799999999
Q ss_pred cceecCCC
Q 005825 656 LARMFGGD 663 (675)
Q Consensus 656 la~~~~~~ 663 (675)
+|+.....
T Consensus 157 ~a~~~~~~ 164 (273)
T d1xwsa_ 157 SGALLKDT 164 (273)
T ss_dssp TCEECCSS
T ss_pred cceecccc
Confidence 99987543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.4e-27 Score=242.38 Aligned_cols=150 Identities=28% Similarity=0.427 Sum_probs=135.2
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeEEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~~~~lV~E 584 (675)
++|++.++||+|+||+||+|+. .+++.||||+++... ....+++++|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999987 468999999997542 2346789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMFGGD 663 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (675)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988874 3456788999999999999999999987 999999999999999999999999999987544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.1e-27 Score=250.51 Aligned_cols=149 Identities=31% Similarity=0.461 Sum_probs=124.6
Q ss_pred CcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------eEEE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG------EKIL 581 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~------~~~l 581 (675)
.|+..++||+|+||+||+|+.. +++.||||+++.... .+.+|+.+|++++||||+++++++.... +.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888899999999999999875 589999999976432 2346999999999999999999996432 4789
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC-CeEEeeeccceec
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-NPKISDFGLARMF 660 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~ 660 (675)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755544432234456899999999999999999999987 99999999999999775 8999999999988
Q ss_pred CCCc
Q 005825 661 GGDE 664 (675)
Q Consensus 661 ~~~~ 664 (675)
...+
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 6544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.9e-27 Score=250.33 Aligned_cols=150 Identities=27% Similarity=0.398 Sum_probs=127.2
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC-ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC----eEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS-GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG----EKI 580 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~----~~~ 580 (675)
+.+|++.++||+|+||+||+|+. .+|+.||||++++.. ....+.+++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999986 579999999997543 334567899999999999999999999997643 335
Q ss_pred EEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccceec
Q 005825 581 LILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLARMF 660 (675)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 660 (675)
+++||+.+|+|.+++.. ..+++..+..++.||++||+|||+++ ||||||||+||||++++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55677789999999842 35899999999999999999999998 999999999999999999999999999987
Q ss_pred CCC
Q 005825 661 GGD 663 (675)
Q Consensus 661 ~~~ 663 (675)
...
T Consensus 160 ~~~ 162 (345)
T d1pmea_ 160 DPD 162 (345)
T ss_dssp CGG
T ss_pred cCC
Confidence 544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.94 E-value=4.8e-27 Score=245.62 Aligned_cols=145 Identities=24% Similarity=0.410 Sum_probs=127.9
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeC--CeEEEEE
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQ--GEKILIL 583 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~--~~~~lV~ 583 (675)
++|++.++||+|+||+||+|+. .+++.||||+++. ...+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6899999999999999999987 4689999999974 33577899999999995 99999999999754 4689999
Q ss_pred EecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCC-CeEEeeeccceecCC
Q 005825 584 EYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDM-NPKISDFGLARMFGG 662 (675)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 662 (675)
||+++++|..+. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987654 34889999999999999999999998 99999999999998655 699999999998865
Q ss_pred Cc
Q 005825 663 DE 664 (675)
Q Consensus 663 ~~ 664 (675)
.+
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.6e-26 Score=240.47 Aligned_cols=151 Identities=28% Similarity=0.495 Sum_probs=128.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCc--CccCHHHHHHHHHHHHhcCCCceeeEEEEEEe--------
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQ--SGQGLEEFKNEMLLIAKLQHRNLVRILGCCIE-------- 575 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~-------- 575 (675)
.++|++.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999987 46999999998643 33455778999999999999999999999865
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 005825 576 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFG 655 (675)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 655 (675)
....++||||++++.+..+. .....++......|+.||+.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34579999999988877655 33446788889999999999999999987 9999999999999999999999999
Q ss_pred cceecCCC
Q 005825 656 LARMFGGD 663 (675)
Q Consensus 656 la~~~~~~ 663 (675)
+|+.+...
T Consensus 163 ~~~~~~~~ 170 (318)
T d3blha1 163 LARAFSLA 170 (318)
T ss_dssp TCEECCC-
T ss_pred eeeecccc
Confidence 99887644
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.9e-27 Score=244.51 Aligned_cols=151 Identities=28% Similarity=0.395 Sum_probs=133.3
Q ss_pred CCcceeeeeCCcCceeEEEEEEc----CCcEEEEEEecCc----CccCHHHHHHHHHHHHhcCC-CceeeEEEEEEeCCe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRLL----NGEEVAVKRLSSQ----SGQGLEEFKNEMLLIAKLQH-RNLVRILGCCIEQGE 578 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~~----~g~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~H-~nIv~l~g~~~~~~~ 578 (675)
++|++.++||+|+||+||+|+.. +|+.||||.+++. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 57999999999999999999752 4789999998753 22345678899999999966 899999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.++||||+.+|+|.+++. ....+.......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999984 3445678888899999999999999987 9999999999999999999999999999
Q ss_pred ecCCCc
Q 005825 659 MFGGDE 664 (675)
Q Consensus 659 ~~~~~~ 664 (675)
.+....
T Consensus 178 ~~~~~~ 183 (322)
T d1vzoa_ 178 EFVADE 183 (322)
T ss_dssp ECCGGG
T ss_pred hhcccc
Confidence 875544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.1e-26 Score=244.68 Aligned_cols=149 Identities=27% Similarity=0.410 Sum_probs=124.6
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQG------ 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~~------ 577 (675)
.++|++.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 478999999999999999999874 59999999997532 233567899999999999999999999997654
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
+.++||||+ +.+|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 579999999 667777763 346899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCC
Q 005825 658 RMFGGD 663 (675)
Q Consensus 658 ~~~~~~ 663 (675)
+.....
T Consensus 169 ~~~~~~ 174 (346)
T d1cm8a_ 169 RQADSE 174 (346)
T ss_dssp EECCSS
T ss_pred eccCCc
Confidence 987543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.93 E-value=4.8e-26 Score=233.98 Aligned_cols=149 Identities=21% Similarity=0.341 Sum_probs=129.7
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcCccCHHHHHHHHHHHHhcCC-CceeeEEEEEEeCCeEEEEEE
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQH-RNLVRILGCCIEQGEKILILE 584 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-~nIv~l~g~~~~~~~~~lV~E 584 (675)
.++|++.++||+|+||+||+|+.. +++.||||.+.... ....+++|+++++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999864 58999999986532 33567889999999975 899999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcC-----CCCeEEeeecccee
Q 005825 585 YMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDR-----DMNPKISDFGLARM 659 (675)
Q Consensus 585 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DFGla~~ 659 (675)
|+ +++|.+++.. ....+++.+...++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 7899988853 2346899999999999999999999988 999999999999975 57899999999998
Q ss_pred cCCC
Q 005825 660 FGGD 663 (675)
Q Consensus 660 ~~~~ 663 (675)
+...
T Consensus 156 ~~~~ 159 (293)
T d1csna_ 156 YRDP 159 (293)
T ss_dssp SBCT
T ss_pred cccC
Confidence 8543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2e-26 Score=238.28 Aligned_cols=152 Identities=28% Similarity=0.452 Sum_probs=126.0
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-C-CcEEEEEEecCcC--ccCHHHHHHHHHHHHhc---CCCceeeEEEEEEe----
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-N-GEEVAVKRLSSQS--GQGLEEFKNEMLLIAKL---QHRNLVRILGCCIE---- 575 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~-g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l---~H~nIv~l~g~~~~---- 575 (675)
.++|++.++||+|+||+||+|+.. + ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999873 4 6779999986532 22334566777777665 79999999999863
Q ss_pred -CCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeee
Q 005825 576 -QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDF 654 (675)
Q Consensus 576 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 654 (675)
....+++|||++++.+..... .....+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 236799999999988765543 23456889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCC
Q 005825 655 GLARMFGGD 663 (675)
Q Consensus 655 Gla~~~~~~ 663 (675)
|+++.....
T Consensus 161 g~~~~~~~~ 169 (305)
T d1blxa_ 161 GLARIYSFQ 169 (305)
T ss_dssp CSCCCCCGG
T ss_pred hhhhhhccc
Confidence 999876443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.93 E-value=1.8e-25 Score=230.35 Aligned_cols=149 Identities=25% Similarity=0.388 Sum_probs=122.9
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL-VRILGCCIEQGEKILILEY 585 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nI-v~l~g~~~~~~~~~lV~Ey 585 (675)
++|++.++||+|+||+||+|+. .+++.||||.+.... ..+++..|++++++++|+|+ +.+.++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999987 458999999987532 23568899999999987765 4555666778889999999
Q ss_pred cCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEc---CCCCeEEeeeccceecCC
Q 005825 586 MPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLD---RDMNPKISDFGLARMFGG 662 (675)
Q Consensus 586 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~~~~ 662 (675)
+. ++|...+.. ....+++..+..++.|++.||+|||+++ ||||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 555555532 2446899999999999999999999998 99999999999985 456799999999998865
Q ss_pred Cc
Q 005825 663 DE 664 (675)
Q Consensus 663 ~~ 664 (675)
..
T Consensus 159 ~~ 160 (299)
T d1ckia_ 159 AR 160 (299)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=6.3e-26 Score=239.00 Aligned_cols=149 Identities=29% Similarity=0.377 Sum_probs=126.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----Ce
Q 005825 507 TENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIEQ-----GE 578 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~~-----~~ 578 (675)
.++|++.++||+|+||+||+|+. .+|+.||||++++.. ....+++.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999986 469999999997542 23446788999999999999999999998643 34
Q ss_pred EEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 579 KILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.+++|||+.+|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5777888899999999842 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCC
Q 005825 659 MFGG 662 (675)
Q Consensus 659 ~~~~ 662 (675)
....
T Consensus 170 ~~~~ 173 (348)
T d2gfsa1 170 HTDD 173 (348)
T ss_dssp CCTG
T ss_pred ccCc
Confidence 7643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.8e-25 Score=234.54 Aligned_cols=148 Identities=28% Similarity=0.368 Sum_probs=121.5
Q ss_pred cCCcceeeeeCCcCceeEEEEEEc-CCcEEEEEEecCcC--ccCHHHHHHHHHHHHhcCCCceeeEEEEEEe------CC
Q 005825 507 TENFSMECKLGEGGFGPVYKGRLL-NGEEVAVKRLSSQS--GQGLEEFKNEMLLIAKLQHRNLVRILGCCIE------QG 577 (675)
Q Consensus 507 ~~~f~~~~~IG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~H~nIv~l~g~~~~------~~ 577 (675)
.++|++.++||+|+||+||+|+.. +|+.||||+++... ....+++.+|+.++++++|||||++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999875 59999999997542 2344578999999999999999999999964 36
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEeeeccc
Q 005825 578 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKISDFGLA 657 (675)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 657 (675)
+.++||||+.++.+..+. ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 889999999776555432 34788999999999999999999998 999999999999999999999999999
Q ss_pred eecCCC
Q 005825 658 RMFGGD 663 (675)
Q Consensus 658 ~~~~~~ 663 (675)
+.....
T Consensus 167 ~~~~~~ 172 (355)
T d2b1pa1 167 RTAGTS 172 (355)
T ss_dssp ------
T ss_pred hccccc
Confidence 877543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=7.3e-22 Score=189.26 Aligned_cols=135 Identities=21% Similarity=0.239 Sum_probs=107.0
Q ss_pred ceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCc------------------cCHHHHHHHHHHHHhcCCCceeeEEEE
Q 005825 511 SMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSG------------------QGLEEFKNEMLLIAKLQHRNLVRILGC 572 (675)
Q Consensus 511 ~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~f~~E~~il~~l~H~nIv~l~g~ 572 (675)
.+.++||+|+||+||+|+..+|++||||.++.... .....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 56789999999999999998999999998753210 001234568889999999999998866
Q ss_pred EEeCCeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 005825 573 CIEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYSRFRIIHRDLKASNVLLDRDMNPKIS 652 (675)
Q Consensus 573 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 652 (675)
. ..+++|||+++..+.. +.......++.|++++|+|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 2379999999876533 222334578999999999999988 9999999999999975 48999
Q ss_pred eeccceecCCC
Q 005825 653 DFGLARMFGGD 663 (675)
Q Consensus 653 DFGla~~~~~~ 663 (675)
|||+|+....+
T Consensus 145 DFG~a~~~~~~ 155 (191)
T d1zara2 145 DFPQSVEVGEE 155 (191)
T ss_dssp CCTTCEETTST
T ss_pred ECCCcccCCCC
Confidence 99999887544
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.85 E-value=1.8e-21 Score=169.02 Aligned_cols=112 Identities=23% Similarity=0.435 Sum_probs=95.8
Q ss_pred cccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCC
Q 005825 26 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQT 105 (675)
Q Consensus 26 ~~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~ 105 (675)
+|+|.|||.|.+|+.|+| |.|+|.|...|+ |.++. +.++||.||++.|.. ++.|.|+.||+|+|+|.
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccCCC--CcEEEEeccccEEEEec-
Confidence 589999999999999985 999999998886 55654 368999999998854 47899999999999996
Q ss_pred CCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCch
Q 005825 106 NGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTD 155 (675)
Q Consensus 106 g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtD 155 (675)
+.++|++++.......+|+|+|+|||||++. .+.++|||+.+|++
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~-----~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN-----SNNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECT-----TSCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECC-----CCcEEecCCCccCC
Confidence 5678888877655677899999999999985 56789999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.83 E-value=5.5e-21 Score=201.74 Aligned_cols=151 Identities=23% Similarity=0.308 Sum_probs=120.1
Q ss_pred CCcceeeeeCCcCceeEEEEEE-cCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-----------CCceeeEEEEEEe
Q 005825 508 ENFSMECKLGEGGFGPVYKGRL-LNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-----------HRNLVRILGCCIE 575 (675)
Q Consensus 508 ~~f~~~~~IG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-----------H~nIv~l~g~~~~ 575 (675)
++|++.++||+|+||+||+|+. .+|+.||||++++. ....+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999987 46999999999853 233467888999988875 4789999988864
Q ss_pred C--CeEEEEEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCEEEcCCCC----
Q 005825 576 Q--GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHH-YSRFRIIHRDLKASNVLLDRDMN---- 648 (675)
Q Consensus 576 ~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~---- 648 (675)
. ...+++|+++..+..............+.+.....++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4667777777655443333222345567888999999999999999998 54 999999999999987654
Q ss_pred --eEEeeeccceecCC
Q 005825 649 --PKISDFGLARMFGG 662 (675)
Q Consensus 649 --~kl~DFGla~~~~~ 662 (675)
+||+|||.|+....
T Consensus 169 ~~~kl~dfg~s~~~~~ 184 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE 184 (362)
T ss_dssp EEEEECCCTTCEETTB
T ss_pred ceeeEeeccccccccc
Confidence 99999999987643
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.83 E-value=1.9e-20 Score=161.09 Aligned_cols=107 Identities=20% Similarity=0.374 Sum_probs=91.6
Q ss_pred ccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCCC
Q 005825 27 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTN 106 (675)
Q Consensus 27 ~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~g 106 (675)
|+|.+||.|.+|+.|.+ |.|.|+|...|+ |.++. ..++||+||++.|... .+.|.|+.||+|||+|++|
T Consensus 2 ~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~g 70 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAEG 70 (109)
T ss_dssp CEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSSS
T ss_pred CCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeCCC
Confidence 68999999999999974 889999988776 45543 2688999999999863 5789999999999999999
Q ss_pred CeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccC
Q 005825 107 GTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDY 152 (675)
Q Consensus 107 ~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~ 152 (675)
.+||+|+++......+|+|+|+|||||+++ .+|||+-|
T Consensus 71 ~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~ 108 (109)
T d1kj1a_ 71 RSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108 (109)
T ss_dssp CEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred cEEEEEeeECCCCCEEEEEeCCCcEEEECC--------CEecCCCc
Confidence 999999987655667899999999999963 49999864
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.83 E-value=1.1e-20 Score=162.50 Aligned_cols=106 Identities=24% Similarity=0.380 Sum_probs=91.9
Q ss_pred ccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCCC
Q 005825 27 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTN 106 (675)
Q Consensus 27 ~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~g 106 (675)
|+|.+||.|.+|+.|. +|.|+|.|+..|+ |.|+.. .++||.||++.|- ..+.|.|+.||+|+|.+++|
T Consensus 2 ~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~---~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~~g 69 (108)
T d1jpca_ 2 NILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV---DKPIWATNTGGLS--RSCFLSMQTDGNLVVYNPSN 69 (108)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET---TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTC
T ss_pred CCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEeC---CceeeEeCCCCCC--CccEEEEeccceEEEECCCc
Confidence 6899999999999995 6999999999986 667653 5889999999884 35689999999999999999
Q ss_pred CeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccC
Q 005825 107 GTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDY 152 (675)
Q Consensus 107 ~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~ 152 (675)
.+||++++.......+|+|+|+|||||++. .+||||+|
T Consensus 70 ~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 70 KPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred cceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 999999987655566799999999999973 48999988
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.72 E-value=3.4e-18 Score=149.17 Aligned_cols=102 Identities=19% Similarity=0.303 Sum_probs=86.2
Q ss_pred EEEEecCC-CcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCC
Q 005825 64 GIWFRKVP-DTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTT 142 (675)
Q Consensus 64 giw~~~~~-~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~ 142 (675)
-|||..++ ++.+|++|++.|+.....+|.++.||+|||.+. +.++|++++.+......|+|+|+|||||++. .
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~-----~ 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN-----Q 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET-----T
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcC-----C
Confidence 58999888 899999999999987777999999999999986 6789999987655667899999999999996 5
Q ss_pred cceeeeeccCCchhhhccccccccccCCCceeEEEecCCCCCCCceeeeeecCCCCceEE
Q 005825 143 ENYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMC 202 (675)
Q Consensus 143 ~~~lWqSFd~PtDTlLpg~~l~~~~~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~ 202 (675)
+.+|||||. +..+|.|.|.||+||+..++
T Consensus 85 ~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 85 NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 689999973 33567899999999996654
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.62 E-value=1.3e-16 Score=137.66 Aligned_cols=109 Identities=20% Similarity=0.253 Sum_probs=89.2
Q ss_pred EEEecCC-CcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCc
Q 005825 65 IWFRKVP-DTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTE 143 (675)
Q Consensus 65 iw~~~~~-~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~ 143 (675)
|||.-.+ .+..|+.+++.++.....+|.|+.||||||++. +.++|++++.+ ..+..|.|+|+|||||++. .+
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~-----~~ 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAG-ATGCRAVLQSDGLLVILTA-----QN 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCS-CSCCBCCBCSSSCBCCBCT-----TT
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCC-CCceEEEEeccCCEEEEcc-----CC
Confidence 6665333 677799999999987778999999999999984 78999999875 5578899999999999986 56
Q ss_pred ceeeeeccCCchhhhccccccccccCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCc
Q 005825 144 NYLWQSFDYPTDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGE 215 (675)
Q Consensus 144 ~~lWqSFd~PtDTlLpg~~l~~~~~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~ 215 (675)
.+||||+- +.++|.|.|.|++||+..++ +.++|.+|.
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT 112 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred CEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCC
Confidence 79999852 34678999999999996544 347898875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.60 E-value=1.7e-15 Score=131.50 Aligned_cols=103 Identities=17% Similarity=0.365 Sum_probs=82.8
Q ss_pred ccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCCC
Q 005825 27 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTN 106 (675)
Q Consensus 27 ~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~g 106 (675)
++|.++|+| ...+..|.|.|.|...|+ |.+ |. +.++||.||+..|.. .+.|.|+.||+|+|.|.+|
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~--~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~g 80 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YD--NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNEN 80 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EE--TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTTC
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEE-EE--CCeEEEEecCCCCCc--ceEEEEEeCCCEEEECCCC
Confidence 456666655 346789999999999987 444 33 268899999987743 4789999999999999999
Q ss_pred CeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeecc
Q 005825 107 GTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFD 151 (675)
Q Consensus 107 ~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd 151 (675)
.+||++++.+.....+|+|+|+|||||++. ++|||-.
T Consensus 81 ~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg~--------~~W~S~T 117 (119)
T d1b2pa_ 81 VTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWATQT 117 (119)
T ss_dssp CEEEECSCCCCSSCEEEEECTTSCEEEEES--------EEEECCC
T ss_pred cEEEECCCcCCCCceEEEEcCCCCEEEECC--------CEeccCC
Confidence 999999987655566799999999999863 6999853
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.40 E-value=6.9e-14 Score=120.26 Aligned_cols=97 Identities=24% Similarity=0.365 Sum_probs=76.9
Q ss_pred CcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCCCCeEEEe
Q 005825 33 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTNGTIWST 112 (675)
Q Consensus 33 ~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~g~~vWss 112 (675)
|.|.++|.| .+|.|.|.|...|+ |.++. +.++||.+|...+ ..+.+.|..||+|||.|.++.+||++
T Consensus 15 ~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 15 QTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp SCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred ceecCCCcE--EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEEc
Confidence 445555555 46779999998887 56654 3578999997542 35789999999999999999999999
Q ss_pred ccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeec
Q 005825 113 NASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSF 150 (675)
Q Consensus 113 ~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSF 150 (675)
++.......+++|+++|||||++. ++|+|-
T Consensus 82 ~t~~~~g~y~l~Lq~DGNlvlY~~--------~~Wssg 111 (115)
T d1dlpa1 82 GTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSG 111 (115)
T ss_dssp CCCCCSSCCEEEECSSSCEEEECS--------EEEECS
T ss_pred CCCCCCCCEEEEECCCCcEEEeCC--------CeecCC
Confidence 987656666899999999999862 699984
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.15 E-value=6.2e-11 Score=102.50 Aligned_cols=97 Identities=23% Similarity=0.370 Sum_probs=71.5
Q ss_pred ccccCCCcCCCCCEEEeCCCeEEEeeeCCCCCCCeEEEEEEecCCCcEEEEecCCCCCCCCcceEEEeeCCeEEEEeCCC
Q 005825 27 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIWFRKVPDTVVWVANRDRPISDHNAVLTISNNGKLVLLNQTN 106 (675)
Q Consensus 27 ~~i~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~tvVW~Anr~~pv~~~~~~l~l~~~G~Lvl~~~~g 106 (675)
+++.++|+|.. |.|.|.|-..|+ |.++. +..+||.++-. ..+..+.+.|..+|+|||+|.++
T Consensus 24 ~~l~~~q~l~~--------g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d~~~ 85 (120)
T d1dlpa2 24 QTLHATQSLQL--------SPYRLSMETDCN-----LVLFD---RDDRVWSTNTA--GKGTGCRAVLQPNGRMDVLTNQN 85 (120)
T ss_dssp CEECSSCCCBC--------SSCEEEEETTTE-----EEEEB---TTBCCSCCCCC--SSCSSCEEEEETTTEEEEEETTT
T ss_pred cEEcCCCeeEc--------CCEEEEEcCCCc-----EEEec---CCcEEEEEccc--cCCCcEEEEEeCCeeEEEEcCCC
Confidence 45555555554 557777766654 44442 24678988743 33445789999999999999999
Q ss_pred CeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeee
Q 005825 107 GTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQS 149 (675)
Q Consensus 107 ~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqS 149 (675)
.++|++++.......+++|+++|||||++. .+|.|
T Consensus 86 ~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~~--------~~W~t 120 (120)
T d1dlpa2 86 IAVWTSGNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT 120 (120)
T ss_dssp EEEEECCCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred CEEEEeCCCCCCCcEEEEECCCCcEEEeCC--------CcccC
Confidence 999999987655666899999999999962 48875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.12 E-value=1.5e-10 Score=99.70 Aligned_cols=85 Identities=25% Similarity=0.308 Sum_probs=67.5
Q ss_pred eEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhccccccccccC
Q 005825 90 VLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLKN 169 (675)
Q Consensus 90 ~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~~t 169 (675)
.|.+..||||||.++ +.++|++++.+...+..+.|.++|||||++. .+.+||+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~-----~g~~vWsS~------------------- 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN-----ENVTVWQSP------------------- 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TCCEEEECS-------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECC-----CCcEEEECC-------------------
Confidence 688999999999876 5689999987655578899999999999986 567899751
Q ss_pred CCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCc
Q 005825 170 RRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGE 215 (675)
Q Consensus 170 g~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~ 215 (675)
+.-+.|.|.+.||+||+..++ . .+.|.++.
T Consensus 88 ------------t~~~~~~~~l~Lq~DGNlvlY--g--~~~W~S~T 117 (119)
T d1b2pa_ 88 ------------VAGKAGHYVLVLQPDRNVVIY--G--DALWATQT 117 (119)
T ss_dssp ------------CCCCSSCEEEEECTTSCEEEE--E--SEEEECCC
T ss_pred ------------CcCCCCceEEEEcCCCCEEEE--C--CCEeccCC
Confidence 112456789999999997664 2 46888765
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.06 E-value=2.6e-10 Score=96.77 Aligned_cols=85 Identities=22% Similarity=0.409 Sum_probs=66.4
Q ss_pred ceEEEeeCCeEEEEeCCCCeEEEeccCCCCCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhcccccccccc
Q 005825 89 AVLTISNNGKLVLLNQTNGTIWSTNASSEAKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDLK 168 (675)
Q Consensus 89 ~~l~l~~~G~Lvl~~~~g~~vWss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~~ 168 (675)
-+|.++.||||||++. +.+||++++.+......+.|+++|||||++. .+.+||+|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~-----~g~~vWsS------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNP-----SNKPIWAS------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TCCEEEEC-------------------
T ss_pred EEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECC-----CccceEEc-------------------
Confidence 4789999999999874 6799999987655567899999999999986 56889986
Q ss_pred CCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeC
Q 005825 169 NRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTG 214 (675)
Q Consensus 169 tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g 214 (675)
.+....+.|.+.|+++|+..++ . .+.|.++
T Consensus 76 ------------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~ 105 (108)
T d1jpca_ 76 ------------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATG 105 (108)
T ss_dssp ------------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCC
T ss_pred ------------cccCCCCcEEEEEcCCCCEEEe--C--CCcccCC
Confidence 1122456788999999996655 3 2466655
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.98 E-value=1.6e-09 Score=91.90 Aligned_cols=87 Identities=23% Similarity=0.360 Sum_probs=66.6
Q ss_pred ceEEEeeCCeEEEEeCCCCeEEEeccCCC-CCCceEEEccCCCEEEEeCCCCCCCcceeeeeccCCchhhhccccccccc
Q 005825 89 AVLTISNNGKLVLLNQTNGTIWSTNASSE-AKNPVAQLRDDGNLVIRDNSSVNTTENYLWQSFDYPTDTLLQDMKMGWDL 167 (675)
Q Consensus 89 ~~l~l~~~G~Lvl~~~~g~~vWss~~~~~-~~~~~a~L~d~GNlVl~~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~ 167 (675)
-.|.+..||+|||.+ .+.+||++++... .....+.|.++|||||++. .+.++|+|
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~-----~g~~vW~s------------------ 76 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA-----EGRSLWAS------------------ 76 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECS-----SSCEEEEC------------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeC-----CCcEEEEE------------------
Confidence 568899999999987 5689999998643 3356799999999999986 56889986
Q ss_pred cCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCcc
Q 005825 168 KNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGEW 216 (675)
Q Consensus 168 ~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~w 216 (675)
.+....|.|.+.|+++|+..++ + .+.|.++.+
T Consensus 77 -------------~t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t~ 108 (109)
T d1kj1a_ 77 -------------HSVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGTY 108 (109)
T ss_dssp -------------CCCCCSSCCEEEECTTSCEEEE--C--CEEEECCCC
T ss_pred -------------eeECCCCCEEEEEeCCCcEEEE--C--CCEecCCCc
Confidence 1112356789999999996654 3 368887653
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.79 E-value=2.5e-08 Score=84.93 Aligned_cols=112 Identities=8% Similarity=-0.026 Sum_probs=72.6
Q ss_pred chhhhccccccccccCCCceeEEEecCCCCCCCceeeeeecCCCCceEEEEcCCeeeeeeCccCCCceeeeeecCceeeE
Q 005825 154 TDTLLQDMKMGWDLKNRRERYLSSWRSDDDPSPGKFTNRLDIHVLPKMCTFNGSVKYTCTGEWTGDGFVSALSNTNFLYK 233 (675)
Q Consensus 154 tDTlLpg~~l~~~~~tg~~~~l~S~~s~~dps~G~y~l~~~~~~~~~~~~~~~~~~y~~~g~w~~~~~~~~~~~~~~~~~ 233 (675)
||||+|||.|..+ ..|+ .|.|.|.|+.||++. ++.....+|.++......-..+.+.....+.
T Consensus 1 tDtL~~gq~L~~g------~~l~---------~g~~~l~~q~DGNLv--ly~~~~~vW~s~~~~~~~~~~l~l~~dGnLv 63 (112)
T d1xd5a_ 1 SDRLNSGHQLDTG------GSLA---------EGGYLFIIQNDCNLV--LYDNNRAVWASGTNGKASGCVLKMQNDGNLV 63 (112)
T ss_dssp CCEEETTEEECTT------CEEE---------ETTEEEEECTTSCEE--EEETTEEEEECCCTTSCSSEEEEECTTSCEE
T ss_pred CCEecCCCEecCC------CEEE---------ECCEEEEEcCCCCEE--EEcCCcEEEEccCccCCCCcEEEEeccccEE
Confidence 7999999999876 4464 399999999999854 4677789998876543222223333322221
Q ss_pred EEEeeecCeeEEEEeecCCCceEEEEECcCccEEEEEecCCCCceEEeeeccCCCCC
Q 005825 234 QFLVENQDEISYWYEPYNRPSIMTLKLSPSGFVTRQLWNEDSNEWDELFSIPDDYCG 290 (675)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~~~~~~~~W~~~~~~p~~~C~ 290 (675)
+.+.....+..........++++|+.||+|++|. ......|+...+.|.
T Consensus 64 ---l~~~~~~~w~s~t~~~~~~~~l~L~ddGNlvly~-----~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 64 ---IYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYD-----NSNNAIWATHTNVGN 112 (112)
T ss_dssp ---EEETTEEEEECCCCCSCCCCEEEECTTSCEEEEC-----TTSCEEEECCCCCCC
T ss_pred ---EEecCCeEEEEeeccCCCceEEEEcCCCCEEEEC-----CCCcEEecCCCccCC
Confidence 1123333333333334456799999999999993 123578988877663
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.58 E-value=2.5e-07 Score=90.80 Aligned_cols=148 Identities=17% Similarity=0.106 Sum_probs=103.7
Q ss_pred HHHhcCCcceeeeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeEEE
Q 005825 503 VAAATENFSMECKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ-HRNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 503 ~~~~~~~f~~~~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-H~nIv~l~g~~~~~~~~~l 581 (675)
+......|+..+..+-++...||+... +++.+.+|+...........+..|...+..+. +--+.+++.+..+++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 444456777666554455678998865 55667888887654445556788988887774 5557788888888899999
Q ss_pred EEEecCCCCHHHHhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 005825 582 ILEYMPNKSLDVFLFDPTKKRLLGWQARIGIIEGIAQGLLYLHHYS---------------------------------- 627 (675)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------- 627 (675)
|||+++|..+....... . ....++.++++.|+.||+..
T Consensus 88 v~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999999886554211 1 11224455555555555321
Q ss_pred ----------------------CCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 628 ----------------------RFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 628 ----------------------~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
+..++|+|+.|.|||+++++.+-|.||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999887778999998875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.98 E-value=1.5e-05 Score=77.04 Aligned_cols=143 Identities=17% Similarity=0.139 Sum_probs=88.2
Q ss_pred eeeCCcC-ceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcC--CCceeeEEEEEEeCCeEEEEEEecCCCC
Q 005825 514 CKLGEGG-FGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQ--HRNLVRILGCCIEQGEKILILEYMPNKS 590 (675)
Q Consensus 514 ~~IG~G~-fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (675)
+.+..|. -..||+....++..+.+|.-.... ...+..|...++.+. ...+.+++.+..+++..++|||+++|.+
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EEcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3455554 468999988788888889866432 235677887777664 3446778888888889999999999876
Q ss_pred HHHHh-----------------cCCC-CcccC--CHHHHHHHHH--------------------HHHHHHHHHHhc----
Q 005825 591 LDVFL-----------------FDPT-KKRLL--GWQARIGIIE--------------------GIAQGLLYLHHY---- 626 (675)
Q Consensus 591 L~~~l-----------------~~~~-~~~~l--~~~~~~~i~~--------------------~ia~~L~yLH~~---- 626 (675)
+.+.. +... ..... .+.....-.. .....+..+...
T Consensus 93 ~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (255)
T d1nd4a_ 93 LLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG 172 (255)
T ss_dssp TTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred cccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCcc
Confidence 53211 1000 00000 0000000000 011223333322
Q ss_pred CCCceEecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 627 SRFRIIHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 627 ~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
.+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 122379999999999999887788999998875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.46 E-value=0.00019 Score=74.21 Aligned_cols=76 Identities=11% Similarity=0.155 Sum_probs=50.1
Q ss_pred eeeeCCcCceeEEEEEEcC-CcEEEEEEecCc-------CccCHHHHHHHHHHHHhcC-C--CceeeEEEEEEeCCeEEE
Q 005825 513 ECKLGEGGFGPVYKGRLLN-GEEVAVKRLSSQ-------SGQGLEEFKNEMLLIAKLQ-H--RNLVRILGCCIEQGEKIL 581 (675)
Q Consensus 513 ~~~IG~G~fG~Vy~~~~~~-g~~vAvK~l~~~-------~~~~~~~f~~E~~il~~l~-H--~nIv~l~g~~~~~~~~~l 581 (675)
.+.||.|....||+....+ ++.+.||.-... -+....+...|...|+.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3579999999999998754 678999964321 1223445566887777662 3 346666655 4556689
Q ss_pred EEEecCCCC
Q 005825 582 ILEYMPNKS 590 (675)
Q Consensus 582 V~Ey~~~gs 590 (675)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.96 E-value=0.0014 Score=65.42 Aligned_cols=135 Identities=13% Similarity=0.130 Sum_probs=79.3
Q ss_pred eeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCce--eeEE-----EEEEeCCeEEEEEEecCCCCHH--
Q 005825 522 GPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL--VRIL-----GCCIEQGEKILILEYMPNKSLD-- 592 (675)
Q Consensus 522 G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nI--v~l~-----g~~~~~~~~~lV~Ey~~~gsL~-- 592 (675)
-.||+.+..+|+.+++|.-+.. ....+++..|...+..|....+ +..+ ......+..+.++++++|..++
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5799999999999999987653 2345778889888877743222 1111 1123456788999999875431
Q ss_pred ---HH-------------hcC--CCCcccCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCce
Q 005825 593 ---VF-------------LFD--PTKKRLLGWQ-------------------ARIGIIEGIAQGLLYLHH----YSRFRI 631 (675)
Q Consensus 593 ---~~-------------l~~--~~~~~~l~~~-------------------~~~~i~~~ia~~L~yLH~----~~~~~i 631 (675)
.+ ... .......++. .+..+...+.+.++.+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 000 0111111111 111122222333334332 234568
Q ss_pred EecCCCCCCEEEcCCCCeEEeeecccee
Q 005825 632 IHRDLKASNVLLDRDMNPKISDFGLARM 659 (675)
Q Consensus 632 iHrDlkp~NILl~~~~~~kl~DFGla~~ 659 (675)
||+|+.|.|||++++ ..+.||+.|..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 46899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.60 E-value=0.0022 Score=65.87 Aligned_cols=76 Identities=16% Similarity=0.252 Sum_probs=50.7
Q ss_pred CcceeeeeCCcCceeEEEEEEcCC--------cEEEEEEecCcCccCHHHHHHHHHHHHhcCCCc-eeeEEEEEEeCCeE
Q 005825 509 NFSMECKLGEGGFGPVYKGRLLNG--------EEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRN-LVRILGCCIEQGEK 579 (675)
Q Consensus 509 ~f~~~~~IG~G~fG~Vy~~~~~~g--------~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~n-Iv~l~g~~~~~~~~ 579 (675)
.+++ +.|+.|---.+|+....++ +.|.+++.. . ........+|..+++.+.-.+ ..++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 4444 6788888899999987542 345555543 2 233445668888888885334 4578887743
Q ss_pred EEEEEecCCCCH
Q 005825 580 ILILEYMPNKSL 591 (675)
Q Consensus 580 ~lV~Ey~~~gsL 591 (675)
.+||||++|..|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 688999987654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.24 E-value=0.065 Score=52.30 Aligned_cols=157 Identities=13% Similarity=0.038 Sum_probs=80.1
Q ss_pred cHHHHHHhcCCccee-----eeeCCcCceeEEEEEEcCCcEEEEEEecCcCccCHHHHHHHHHHHHhcCCCce--eeEEE
Q 005825 499 SLASVAAATENFSME-----CKLGEGGFGPVYKGRLLNGEEVAVKRLSSQSGQGLEEFKNEMLLIAKLQHRNL--VRILG 571 (675)
Q Consensus 499 ~~~~~~~~~~~f~~~-----~~IG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H~nI--v~l~g 571 (675)
+..++.....+|.+. +.|..|---+.|+.+..+| .+++|+..... ..+++..|++++..+.+.++ ...+-
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 344555666677653 3355676688899987665 48888876432 22344556666666532221 11110
Q ss_pred ------EEEeCCeEEEEEEecCCCCHHHH--------------hc----C--CC-CcccCCH-----------------H
Q 005825 572 ------CCIEQGEKILILEYMPNKSLDVF--------------LF----D--PT-KKRLLGW-----------------Q 607 (675)
Q Consensus 572 ------~~~~~~~~~lV~Ey~~~gsL~~~--------------l~----~--~~-~~~~l~~-----------------~ 607 (675)
+.........+++++.+...... ++ . .. ......+ .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 01224456677777776543110 00 0 00 0000000 0
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCEEEcCCCCeEEeeeccce
Q 005825 608 ARIGIIEGIAQGLLYLHH-YSRFRIIHRDLKASNVLLDRDMNPKISDFGLAR 658 (675)
Q Consensus 608 ~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 658 (675)
.....+..+...+.-.+. .-+.++||+|+.+.||+++.+...-|.||+.|.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011111112222222221 234459999999999999998878899999886
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.81 E-value=0.015 Score=36.00 Aligned_cols=32 Identities=31% Similarity=0.575 Sum_probs=25.7
Q ss_pred CCCCCCccCCCCcccCCC-CCCCCCccCCCccCC
Q 005825 287 DYCGKYGYCGANTICGPD-QKPMCQCLEGFRLKS 319 (675)
Q Consensus 287 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 319 (675)
|+|.+-..||. |-|+.- ..-.|.|-+||+|..
T Consensus 2 dECsignpCGn-GTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCGN-GTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSSS-SCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccCC-ceeeecccceEEeecCCcCCCc
Confidence 67999999994 889643 455799999999864
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.24 E-value=0.076 Score=34.99 Aligned_cols=31 Identities=29% Similarity=0.551 Sum_probs=24.2
Q ss_pred CCCCC-CccCCCCcccCCC-CCCCCCccCCCcc
Q 005825 287 DYCGK-YGYCGANTICGPD-QKPMCQCLEGFRL 317 (675)
Q Consensus 287 ~~C~~-~~~CG~~g~C~~~-~~~~C~C~~Gf~~ 317 (675)
|+|.. ...|..+|.|... ..-.|.|++||+-
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYTG 36 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence 66875 5789999999743 3457999999983
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.18 E-value=0.19 Score=32.35 Aligned_cols=31 Identities=35% Similarity=0.715 Sum_probs=23.5
Q ss_pred CCCCCCccCCCCcccCCC-CCCCCCccCCCccC
Q 005825 287 DYCGKYGYCGANTICGPD-QKPMCQCLEGFRLK 318 (675)
Q Consensus 287 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~~~ 318 (675)
|+|. ...|...|.|... ..-.|.|++||+-.
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGK 32 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEETT
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcC
Confidence 4576 4779999999754 45689999999843
|
| >d1dx5i2 g.3.11.1 (I:388-422) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.18 E-value=0.17 Score=30.47 Aligned_cols=19 Identities=37% Similarity=1.013 Sum_probs=14.4
Q ss_pred ccCCCCCCCCCccCCCccC
Q 005825 300 ICGPDQKPMCQCLEGFRLK 318 (675)
Q Consensus 300 ~C~~~~~~~C~C~~Gf~~~ 318 (675)
.|+.+....|+||+||...
T Consensus 11 dCdP~~p~~C~CPeGyIld 29 (35)
T d1dx5i2 11 DCDPNTQASCECPEGYILD 29 (35)
T ss_dssp EECTTSTTCEECCTTEEEE
T ss_pred ccCCCCCCcccCCCceEec
Confidence 3555666789999999864
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.29 E-value=0.53 Score=30.85 Aligned_cols=31 Identities=23% Similarity=0.384 Sum_probs=23.5
Q ss_pred CCCCCCCccCCCCcccCCC-CCCCCCccCCCcc
Q 005825 286 DDYCGKYGYCGANTICGPD-QKPMCQCLEGFRL 317 (675)
Q Consensus 286 ~~~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~~ 317 (675)
.|+|.... |+.++.|... ++-.|.|++||+.
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 47897654 5578999754 4568999999986
|